Citrus Sinensis ID: 009208
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 540 | 2.2.26 [Sep-21-2011] | |||||||
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | yes | no | 0.961 | 0.821 | 0.793 | 0.0 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.940 | 0.8 | 0.647 | 0.0 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.942 | 0.797 | 0.638 | 0.0 | |
| Q0WVM4 | 634 | Probable LRR receptor-lik | no | no | 0.944 | 0.804 | 0.611 | 1e-175 | |
| Q8VYT3 | 648 | Probable LRR receptor-lik | no | no | 0.927 | 0.773 | 0.615 | 1e-172 | |
| C0LGU5 | 614 | Probable LRR receptor-lik | no | no | 0.95 | 0.835 | 0.567 | 1e-164 | |
| Q94AG2 | 625 | Somatic embryogenesis rec | no | no | 0.974 | 0.841 | 0.551 | 1e-146 | |
| Q9XIC7 | 628 | Somatic embryogenesis rec | no | no | 0.988 | 0.850 | 0.541 | 1e-144 | |
| Q94F62 | 615 | BRASSINOSTEROID INSENSITI | no | no | 0.922 | 0.809 | 0.552 | 1e-143 | |
| Q9SKG5 | 620 | Somatic embryogenesis rec | no | no | 0.888 | 0.774 | 0.562 | 1e-142 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 798 bits (2062), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/523 (79%), Positives = 464/523 (88%), Gaps = 4/523 (0%)
Query: 1 MEMKSYKFWRVGFLVLA-LIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITS 59
ME + WR+GFLV DI ATLSP G+NYEV ALVAVKN L+DPY VLENWD+ S
Sbjct: 1 MEGVRFVVWRLGFLVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNS 60
Query: 60 VDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLG 119
VDPCSWRM++C+ DGYVS+L LPSQSLSGTLSP IGNLT LQSV+LQNNAI GPIP ++G
Sbjct: 61 VDPCSWRMVSCT-DGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIG 119
Query: 120 KLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSY 179
+LEKLQ+LDLSNN FTGEIP SLG+L NLNYLRLNNNSL G+CPESLSKIE LTLVD+SY
Sbjct: 120 RLEKLQSLDLSNNSFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISY 179
Query: 180 NNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRV 239
NNLSGSLPK+SARTFKV GN LICGPKA +NC+AV PEPL+LP +G D+S + T H V
Sbjct: 180 NNLSGSLPKVSARTFKVIGNALICGPKAVSNCSAV-PEPLTLPQDG-PDESGTRTNGHHV 237
Query: 240 AVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAA 299
A+A ASF AAFFV G+ +W RYR N+QIFFDVN+QYDPEVSLGHLKRYTFKELR+A
Sbjct: 238 ALAFAASFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSA 297
Query: 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
T++F++KNILGRGG+GIVYKG +DG LVAVKRLKD NIAGGEVQFQTEVETISLA+HRN
Sbjct: 298 TNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRN 357
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
LLRL GFCS+ ER+LVYPYMPNGSVASRL+D+I G PALDW+RRK+IA+GTARGL+YLH
Sbjct: 358 LLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLH 417
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS
Sbjct: 418 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 477
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
TGQSSEKTDVFGFGILLLELITGQ+ALDFGR+A+Q+GVMLDWV
Sbjct: 478 TGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWV 520
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 676 bits (1743), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/517 (64%), Positives = 403/517 (77%), Gaps = 9/517 (1%)
Query: 24 ATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPS 83
A L+ G+N+EVVAL+ +K++L DP+ VL NWD T+VDPCSW MITCS DG+V L PS
Sbjct: 32 AELTDKGVNFEVVALIGIKSSLTDPHGVLMNWDDTAVDPCSWNMITCS-DGFVIRLEAPS 90
Query: 84 QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
Q+LSGTLS IGNLT LQ+VLLQNN I G IP +GKL KL+TLDLS N FTG+IP +L
Sbjct: 91 QNLSGTLSSSIGNLTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLS 150
Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLIC 203
NL YLR+NNNSLTG+ P SL+ + LT +DLSYNNLSG +P+ A+TF V GN IC
Sbjct: 151 YSKNLQYLRVNNNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLAKTFNVMGNSQIC 210
Query: 204 GPKATNNCTAVFPEPLSLPPNGLKDQS-DSGTKSHRVAVALGASFGAAFFVIIVVGLLVW 262
+C P+P+S+ N +++S D GTK+ ++AV G S +II G L+W
Sbjct: 211 PTGTEKDCNGTQPKPMSITLNSSQNKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGFLLW 270
Query: 263 LRYRHNQQI-FFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGC 321
R RHN+Q+ FFD+N+Q E+ LG+L+R+ FKEL++ATSNFS+KN++G+GGFG VYKGC
Sbjct: 271 WRRRHNKQVLFFDINEQNKEEMCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGNVYKGC 330
Query: 322 FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP 381
DG+++AVKRLKD N GGEVQFQTE+E ISLAVHRNLLRL GFC+T +ERLLVYPYM
Sbjct: 331 LHDGSIIAVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLVYPYMS 390
Query: 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED 441
NGSVASRL+ +P LDW RKRIALG RGLLYLHEQCDPKIIHRDVKAANILLD+
Sbjct: 391 NGSVASRLK----AKPVLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANILLDDY 446
Query: 442 FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
FEAVVGDFGLAKLLDH +SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT
Sbjct: 447 FEAVVGDFGLAKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 506
Query: 502 GQRALDFGRAANQRGVMLDWVCSHILSNQSSLDMVLN 538
G RAL+FG+AANQRG +LDWV L + L+ +++
Sbjct: 507 GLRALEFGKAANQRGAILDWV--KKLQQEKKLEQIVD 541
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 664 bits (1713), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/518 (63%), Positives = 404/518 (77%), Gaps = 9/518 (1%)
Query: 8 FWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRM 67
F +GFL L L + LSP G+N+EV AL+ +K +LHDP+ VL+NWD +VDPCSW M
Sbjct: 16 FCFLGFLCL-LCSSVHGLLSPKGVNFEVQALMDIKASLHDPHGVLDNWDRDAVDPCSWTM 74
Query: 68 ITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTL 127
+TCS + +V LG PSQ+LSGTLSP I NLT L+ VLLQNN I G IPA +G+L +L+TL
Sbjct: 75 VTCSSENFVIGLGTPSQNLSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGRLTRLETL 134
Query: 128 DLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
DLS+N F GEIP S+G L +L YLRLNNNSL+G P SLS + L +DLSYNNLSG +P
Sbjct: 135 DLSDNFFHGEIPFSVGYLQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYNNLSGPVP 194
Query: 188 KISARTFKVTGNPLIC--GPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGA 245
+ +A+TF + GNPLIC G + N T + P ++L G+ + G+++H++A+A+G+
Sbjct: 195 RFAAKTFSIVGNPLICPTGTEPDCNGTTLIPMSMNLNQTGVPLYA-GGSRNHKMAIAVGS 253
Query: 246 SFGAAFFVIIVVGLLVWLRYRHNQQIFFDVND-QYDPEVSLGHLKRYTFKELRAATSNFS 304
S G + I VGL +W R RHNQ FFDV D + EVSLG+L+R+ F+EL+ AT+NFS
Sbjct: 254 SVGTVSLIFIAVGLFLWWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQIATNNFS 313
Query: 305 AKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
+KN+LG+GG+G VYKG D +VAVKRLKD GGE+QFQTEVE ISLAVHRNLLRL
Sbjct: 314 SKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLY 373
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
GFC T+ E+LLVYPYM NGSVASR++ +P LDW+ RKRIA+G ARGL+YLHEQCDP
Sbjct: 374 GFCITQTEKLLVYPYMSNGSVASRMK----AKPVLDWSIRKRIAIGAARGLVYLHEQCDP 429
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
KIIHRDVKAANILLD+ EAVVGDFGLAKLLDH+DSHVTTAVRGTVGHIAPEYLSTGQSS
Sbjct: 430 KIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSS 489
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
EKTDVFGFGILLLEL+TGQRA +FG+AANQ+GVMLDWV
Sbjct: 490 EKTDVFGFGILLLELVTGQRAFEFGKAANQKGVMLDWV 527
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 615 bits (1586), Expect = e-175, Method: Compositional matrix adjust.
Identities = 320/523 (61%), Positives = 383/523 (73%), Gaps = 13/523 (2%)
Query: 1 MEMKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSV 60
M++ + K + V L+L C +LS N EV AL+ +KN LHDP+ V +NWD SV
Sbjct: 4 MKLITMKIFSV-LLLLCFFVTC--SLSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSV 60
Query: 61 DPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGK 120
DPCSW MI+CS D V LG PSQSLSGTLS IGNLT L+ V LQNN I G IP +
Sbjct: 61 DPCSWTMISCSSDNLVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICS 120
Query: 121 LEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN 180
L KLQTLDLSNN+F+GEIP S+ L NL YLRLNNNSL+G P SLS+I L+ +DLSYN
Sbjct: 121 LPKLQTLDLSNNRFSGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYN 180
Query: 181 NLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVA 240
NL G +PK ARTF V GNPLIC C+ +S P + +S SG +++ +A
Sbjct: 181 NLRGPVPKFPARTFNVAGNPLICKNSLPEICSG----SISASPLSVSLRSSSGRRTNILA 236
Query: 241 VALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVND-QYDPEVSLGHLKRYTFKELRAA 299
VALG S G A VI+ +G +W R + + ++D Q + + LG+L+ +TF+EL A
Sbjct: 237 VALGVSLGFAVSVILSLGF-IWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVA 295
Query: 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
T FS+K+ILG GGFG VY+G F DG +VAVKRLKD N G QF+TE+E ISLAVHRN
Sbjct: 296 TDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRN 355
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
LLRL G+C++ +ERLLVYPYM NGSVASRL+ +PALDW RK+IA+G ARGL YLH
Sbjct: 356 LLRLIGYCASSSERLLVYPYMSNGSVASRLK----AKPALDWNTRKKIAIGAARGLFYLH 411
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
EQCDPKIIHRDVKAANILLDE FEAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLS
Sbjct: 412 EQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLS 471
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
TGQSSEKTDVFGFGILLLELITG RAL+FG++ +Q+G ML+WV
Sbjct: 472 TGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLEWV 514
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VYT3|Y4052_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g30520 OS=Arabidopsis thaliana GN=At4g30520 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 606 bits (1562), Expect = e-172, Method: Compositional matrix adjust.
Identities = 315/512 (61%), Positives = 381/512 (74%), Gaps = 11/512 (2%)
Query: 14 LVLALIDICYATL--SPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCS 71
L+ + + +C++TL S N EV AL++++NNLHDP+ L NWD SVDPCSW MITCS
Sbjct: 15 LLYSFLFLCFSTLTLSSEPRNPEVEALISIRNNLHDPHGALNNWDEFSVDPCSWAMITCS 74
Query: 72 PDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN 131
PD V LG PSQSLSG LS IGNLT L+ V LQNN I G IP LG L KLQTLDLSN
Sbjct: 75 PDNLVIGLGAPSQSLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSN 134
Query: 132 NKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA 191
N+F+G+IP S+ L +L YLRLNNNSL+G P SLS+I L+ +DLSYNNLSG +PK A
Sbjct: 135 NRFSGDIPVSIDQLSSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVPKFPA 194
Query: 192 RTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAF 251
RTF V GNPLIC C+ ++ P + S SG +S+R+A+AL S G+
Sbjct: 195 RTFNVAGNPLICRSNPPEICSG----SINASPLSVSLSSSSGRRSNRLAIALSVSLGSVV 250
Query: 252 FVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVS-LGHLKRYTFKELRAATSNFSAKNILG 310
+++ +G W R + + + ++ND+ + + LG+L+ +TF+EL T FS+KNILG
Sbjct: 251 ILVLALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILG 310
Query: 311 RGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE 370
GGFG VY+G DG +VAVKRLKD N G+ QF+ E+E ISLAVH+NLLRL G+C+T
Sbjct: 311 AGGFGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCATS 370
Query: 371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRD 430
ERLLVYPYMPNGSVAS+L+ +PALDW RKRIA+G ARGLLYLHEQCDPKIIHRD
Sbjct: 371 GERLLVYPYMPNGSVASKLKS----KPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHRD 426
Query: 431 VKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 490
VKAANILLDE FEAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF
Sbjct: 427 VKAANILLDECFEAVVGDFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 486
Query: 491 GFGILLLELITGQRALDFGRAANQRGVMLDWV 522
GFGILLLELITG RAL+FG+ +Q+G ML+WV
Sbjct: 487 GFGILLLELITGLRALEFGKTVSQKGAMLEWV 518
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGU5|Y5457_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45780 OS=Arabidopsis thaliana GN=At5g45780 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 579 bits (1493), Expect = e-164, Method: Compositional matrix adjust.
Identities = 299/527 (56%), Positives = 377/527 (71%), Gaps = 14/527 (2%)
Query: 1 MEMKSYKF-----WRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENW 55
ME+ KF W + VL + + LSP G+NYEV AL++VKN + D VL W
Sbjct: 1 MEISLMKFLFLGIWVYYYSVLDSVSAMDSLLSPKGVNYEVAALMSVKNKMKDEKEVLSGW 60
Query: 56 DITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIP 115
DI SVDPC+W M+ CS +G+V +L + S+ LSG LS IG LT L ++LLQNN + GPIP
Sbjct: 61 DINSVDPCTWNMVGCSSEGFVVSLEMASKGLSGILSTSIGELTHLHTLLLQNNQLTGPIP 120
Query: 116 ASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLV 175
+ LG+L +L+TLDLS N+F+GEIP SLG L +LNYLRL+ N L+G P ++ + L+ +
Sbjct: 121 SELGQLSELETLDLSGNRFSGEIPASLGFLTHLNYLRLSRNLLSGQVPHLVAGLSGLSFL 180
Query: 176 DLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTK 235
DLS+NNLSG P ISA+ +++ GN +CGP + C+ P GL ++ +S
Sbjct: 181 DLSFNNLSGPTPNISAKDYRIVGNAFLCGPASQELCSDATP---VRNATGLSEKDNSKHH 237
Query: 236 SHRVAVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKE 295
S ++ A G F+I ++ L W+ + ++ V Q D E +GHLKR++F+E
Sbjct: 238 SLVLSFAFGI---VVAFIISLMFLFFWVLWHRSRLSRSHV--QQDYEFEIGHLKRFSFRE 292
Query: 296 LRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
++ ATSNFS KNILG+GGFG+VYKG +G +VAVKRLKD I GEVQFQTEVE I LA
Sbjct: 293 IQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLKD-PIYTGEVQFQTEVEMIGLA 351
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
VHRNLLRL GFC T ER+LVYPYMPNGSVA RLRD+ +P+LDW RR IALG ARGL
Sbjct: 352 VHRNLLRLFGFCMTPEERMLVYPYMPNGSVADRLRDNYGEKPSLDWNRRISIALGAARGL 411
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
+YLHEQC+PKIIHRDVKAANILLDE FEA+VGDFGLAKLLD RDSHVTTAVRGT+GHIAP
Sbjct: 412 VYLHEQCNPKIIHRDVKAANILLDESFEAIVGDFGLAKLLDQRDSHVTTAVRGTIGHIAP 471
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
EYLSTGQSSEKTDVFGFG+L+LELITG + +D G ++G++L WV
Sbjct: 472 EYLSTGQSSEKTDVFGFGVLILELITGHKMIDQGNGQVRKGMILSWV 518
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 518 bits (1334), Expect = e-146, Method: Compositional matrix adjust.
Identities = 294/533 (55%), Positives = 359/533 (67%), Gaps = 7/533 (1%)
Query: 11 VGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITC 70
V F++L+LI + +L A N E AL ++ L DP NVL++WD T V+PC+W +TC
Sbjct: 6 VVFILLSLILLPNHSLWLASANLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTWFHVTC 65
Query: 71 SPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLS 130
+ + V + L + LSG L P +G L LQ + L +N I GPIP++LG L L +LDL
Sbjct: 66 NNENSVIRVDLGNAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLY 125
Query: 131 NNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
N F+G IP+SLG L L +LRLNNNSLTGS P SL+ I +L ++DLS N LSGS+P
Sbjct: 126 LNSFSGPIPESLGKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNG 185
Query: 191 ARTF----KVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGAS 246
+ + N +CGP ++ C P P S A+A G +
Sbjct: 186 SFSLFTPISFANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVSTPSGYGITGAIAGGVA 245
Query: 247 FGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAK 306
GAA W R R IFFDV + DPEV LG LKR++ +EL+ A+ FS K
Sbjct: 246 AGAALLFAAPAIAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFSNK 305
Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
NILGRGGFG VYKG +DG LVAVKRLK+ GGE+QFQTEVE IS+AVHRNLLRL GF
Sbjct: 306 NILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGF 365
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
C T ERLLVYPYM NGSVAS LR+ +P LDW RKRIALG+ARGL YLH+ CDPKI
Sbjct: 366 CMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKI 425
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
IHRDVKAANILLDE+FEAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEK
Sbjct: 426 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK 485
Query: 487 TDVFGFGILLLELITGQRALDFGRAANQRGVM-LDWVCSHILSNQSSLDMVLN 538
TDVFG+GI+LLELITGQRA D R AN VM LDWV L + L+M+++
Sbjct: 486 TDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG--LLKEKKLEMLVD 536
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XIC7|SERK2_ARATH Somatic embryogenesis receptor kinase 2 OS=Arabidopsis thaliana GN=SERK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 513 bits (1320), Expect = e-144, Method: Compositional matrix adjust.
Identities = 293/541 (54%), Positives = 361/541 (66%), Gaps = 7/541 (1%)
Query: 3 MKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDP 62
M KF GF+ L + + + +L A N E AL +++ NL DP NVL++WD T V+P
Sbjct: 1 MGRKKFEAFGFVCLISLLLLFNSLWLASSNMEGDALHSLRANLVDPNNVLQSWDPTLVNP 60
Query: 63 CSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLE 122
C+W +TC+ + V + L + LSG L P +G L LQ + L +N I GP+P+ LG L
Sbjct: 61 CTWFHVTCNNENSVIRVDLGNADLSGQLVPQLGQLKNLQYLELYSNNITGPVPSDLGNLT 120
Query: 123 KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNL 182
L +LDL N FTG IPDSLG L L +LRLNNNSLTG P SL+ I +L ++DLS N L
Sbjct: 121 NLVSLDLYLNSFTGPIPDSLGKLFKLRFLRLNNNSLTGPIPMSLTNIMTLQVLDLSNNRL 180
Query: 183 SGSLPKISARTF----KVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHR 238
SGS+P + + N +CGP + C P P G S
Sbjct: 181 SGSVPDNGSFSLFTPISFANNLDLCGPVTSRPCPGSPPFSPPPPFIPPPIVPTPGGYSAT 240
Query: 239 VAVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRA 298
A+A G + GAA W R R Q+ FFDV + DPEV LG LKR++ +EL+
Sbjct: 241 GAIAGGVAAGAALLFAAPALAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQV 300
Query: 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
AT +FS KNILGRGGFG VYKG +DG LVAVKRLK+ GGE+QFQTEVE IS+AVHR
Sbjct: 301 ATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHR 360
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
NLLRL GFC T ERLLVYPYM NGSVAS LR+ + L W+ R++IALG+ARGL YL
Sbjct: 361 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYL 420
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
H+ CDPKIIHRDVKAANILLDE+FEAVVGDFGLA+L+D++D+HVTTAVRGT+GHIAPEYL
Sbjct: 421 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYL 480
Query: 479 STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM-LDWVCSHILSNQSSLDMVL 537
STG+SSEKTDVFG+GI+LLELITGQRA D R AN VM LDWV L + L+M++
Sbjct: 481 STGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG--LLKEKKLEMLV 538
Query: 538 N 538
+
Sbjct: 539 D 539
|
Serine/threonine-kinase involved in brassinosteroid-dependent and -independent signaling pathways. Acts redundantly with SERK1 as a control point for sporophytic development controlling male gametophyte production. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 508 bits (1308), Expect = e-143, Method: Compositional matrix adjust.
Identities = 285/516 (55%), Positives = 350/516 (67%), Gaps = 18/516 (3%)
Query: 8 FWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRM 67
FW + LVL L+ L +G N E AL A+KN+L DP VL++WD T V PC+W
Sbjct: 11 FWLI--LVLDLV------LRVSG-NAEGDALSALKNSLADPNKVLQSWDATLVTPCTWFH 61
Query: 68 ITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTL 127
+TC+ D V+ + L + +LSG L +G L LQ + L +N I G IP LG L +L +L
Sbjct: 62 VTCNSDNSVTRVDLGNANLSGQLVMQLGQLPNLQYLELYSNNITGTIPEQLGNLTELVSL 121
Query: 128 DLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
DL N +G IP +LG L L +LRLNNNSL+G P SL+ + +L ++DLS N L+G +P
Sbjct: 122 DLYLNNLSGPIPSTLGRLKKLRFLRLNNNSLSGEIPRSLTAVLTLQVLDLSNNPLTGDIP 181
Query: 188 KISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASF 247
V G+ + P + N PP S +G+ A+A G +
Sbjct: 182 --------VNGSFSLFTPISFANTKLTPLPASPPPPISPTPPSPAGSNRITGAIAGGVAA 233
Query: 248 GAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKN 307
GAA + L W R + Q FFDV + DPEV LG LKR++ +EL+ A+ NFS KN
Sbjct: 234 GAALLFAVPAIALAWWRRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKN 293
Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
ILGRGGFG VYKG +DG LVAVKRLK+ GGE+QFQTEVE IS+AVHRNLLRL GFC
Sbjct: 294 ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 353
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
T ERLLVYPYM NGSVAS LR+ +P LDW +R+RIALG+ARGL YLH+ CDPKII
Sbjct: 354 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 413
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
HRDVKAANILLDE+FEAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKT
Sbjct: 414 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT 473
Query: 488 DVFGFGILLLELITGQRALDFGRAANQRGVM-LDWV 522
DVFG+G++LLELITGQRA D R AN VM LDWV
Sbjct: 474 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 509
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 505 bits (1301), Expect = e-142, Method: Compositional matrix adjust.
Identities = 279/496 (56%), Positives = 338/496 (68%), Gaps = 16/496 (3%)
Query: 32 NYEVVALVAVKNNLH--DPYN-VLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSG 88
N E AL +KN+L DP N VL++WD T V PC+W +TC+P+ V+ + L + LSG
Sbjct: 30 NAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVTCNPENKVTRVDLGNAKLSG 89
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
L P +G L LQ + L +N I G IP LG L +L +LDL N +G IP SLG LG L
Sbjct: 90 KLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDLYANSISGPIPSSLGKLGKL 149
Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKA- 207
+LRLNNNSL+G P +L+ ++ L ++D+S N LSG +P V G+ + P +
Sbjct: 150 RFLRLNNNSLSGEIPMTLTSVQ-LQVLDISNNRLSGDIP--------VNGSFSLFTPISF 200
Query: 208 TNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVWLRYRH 267
NN PEP + G + +A + A A F + + WLR R
Sbjct: 201 ANNSLTDLPEPPPTSTSPTPPPPSGGQMTAAIAGGVAAGA-ALLFAVPAIAFAWWLR-RK 258
Query: 268 NQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL 327
Q FFDV + DPEV LG LKR+T +EL AT NFS KN+LGRGGFG VYKG +DG L
Sbjct: 259 PQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNL 318
Query: 328 VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVAS 387
VAVKRLK+ GGE+QFQTEVE IS+AVHRNLLRL GFC T ERLLVYPYM NGSVAS
Sbjct: 319 VAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS 378
Query: 388 RLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG 447
LR+ G PALDW +RK IALG+ARGL YLH+ CD KIIHRDVKAANILLDE+FEAVVG
Sbjct: 379 CLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVG 438
Query: 448 DFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
DFGLAKL+++ DSHVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITGQ+A D
Sbjct: 439 DFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFD 498
Query: 508 FGRAANQRGVM-LDWV 522
R AN +M LDWV
Sbjct: 499 LARLANDDDIMLLDWV 514
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 540 | ||||||
| 297739079 | 626 | unnamed protein product [Vitis vinifera] | 0.966 | 0.833 | 0.833 | 0.0 | |
| 147833308 | 608 | hypothetical protein VITISV_035381 [Viti | 0.924 | 0.820 | 0.851 | 0.0 | |
| 225425599 | 623 | PREDICTED: protein NSP-INTERACTING KINAS | 0.961 | 0.833 | 0.831 | 0.0 | |
| 224102457 | 625 | predicted protein [Populus trichocarpa] | 0.957 | 0.827 | 0.851 | 0.0 | |
| 255568858 | 618 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.95 | 0.830 | 0.845 | 0.0 | |
| 224110926 | 605 | predicted protein [Populus trichocarpa] | 0.924 | 0.824 | 0.876 | 0.0 | |
| 449450444 | 621 | PREDICTED: protein NSP-INTERACTING KINAS | 0.942 | 0.819 | 0.815 | 0.0 | |
| 357485807 | 625 | Leucine-rich repeat receptor-like kinase | 0.931 | 0.804 | 0.825 | 0.0 | |
| 356501661 | 624 | PREDICTED: protein NSP-INTERACTING KINAS | 0.957 | 0.828 | 0.830 | 0.0 | |
| 356501663 | 515 | PREDICTED: protein NSP-INTERACTING KINAS | 0.951 | 0.998 | 0.829 | 0.0 |
| >gi|297739079|emb|CBI28568.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 898 bits (2320), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/522 (83%), Positives = 473/522 (90%)
Query: 1 MEMKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSV 60
ME + Y W VG L+L L++ ATLSP+GINYEVVAL+ +KNNL+DPYNVLENWDI SV
Sbjct: 1 MESRGYVLWGVGLLLLTLMEGSSATLSPSGINYEVVALMTIKNNLNDPYNVLENWDINSV 60
Query: 61 DPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGK 120
DPCSWRM+TCS DGYVSALGLPSQSLSGTLSPWIGNLT LQSVLLQNNAI GPIP S+GK
Sbjct: 61 DPCSWRMVTCSSDGYVSALGLPSQSLSGTLSPWIGNLTNLQSVLLQNNAISGPIPDSIGK 120
Query: 121 LEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN 180
LEKL+TLDLS+NKF G IP SLG L LNYLRLNNNSLTG CPESLS++E L+LVDLS+N
Sbjct: 121 LEKLETLDLSHNKFDGGIPSSLGGLKKLNYLRLNNNSLTGPCPESLSQVEGLSLVDLSFN 180
Query: 181 NLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVA 240
NLSGS+PKISARTFK+ GNP +CG ATNNC+A+ PEPLS PP+ L+ SDSG+KSHRVA
Sbjct: 181 NLSGSMPKISARTFKIIGNPSLCGANATNNCSAISPEPLSFPPDALRAHSDSGSKSHRVA 240
Query: 241 VALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAAT 300
+A GASFGAA +II+VGL VW RYR NQQIFFDVNDQYDPEV LGHL+RYTFKELRAAT
Sbjct: 241 IAFGASFGAALLIIIIVGLSVWWRYRRNQQIFFDVNDQYDPEVRLGHLRRYTFKELRAAT 300
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
+F+ KNILGRGGFGIVYKGC +D LVAVKRLKDYN GGE+QFQTEVE ISLAVHRNL
Sbjct: 301 DHFNPKNILGRGGFGIVYKGCLNDRTLVAVKRLKDYNAVGGEIQFQTEVEMISLAVHRNL 360
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
LRLCGFC+TE+ERLLVYPYMPNGSVASRLRD IHGRPALDW+RRKRIALGTARGLLYLHE
Sbjct: 361 LRLCGFCTTESERLLVYPYMPNGSVASRLRDQIHGRPALDWSRRKRIALGTARGLLYLHE 420
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR+SHVTTAVRGTVGHIAPEYLST
Sbjct: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRESHVTTAVRGTVGHIAPEYLST 480
Query: 481 GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
GQSSEKTDVFGFGILLLELITGQ+ALDFGRAANQ+GVMLDWV
Sbjct: 481 GQSSEKTDVFGFGILLLELITGQKALDFGRAANQKGVMLDWV 522
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147833308|emb|CAN75190.1| hypothetical protein VITISV_035381 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 895 bits (2312), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/499 (85%), Positives = 459/499 (91%)
Query: 24 ATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPS 83
ATLSP+GINYEVVAL+ +KNNL+DPYNVLENWDI SVDPCSWRM+TCS DGYVSALGLPS
Sbjct: 6 ATLSPSGINYEVVALMTIKNNLNDPYNVLENWDINSVDPCSWRMVTCSSDGYVSALGLPS 65
Query: 84 QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
QSLSGTLSPWIGNLT LQSVLLQNNAI GPIP S+GKLEKL+TLDLS+NKF G IP SLG
Sbjct: 66 QSLSGTLSPWIGNLTNLQSVLLQNNAISGPIPDSIGKLEKLETLDLSHNKFDGGIPSSLG 125
Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLIC 203
L LNYLRLNNNSLTG CPESLS++E L+LVDLS+NNLSGS+PKISARTFK+ GNP +C
Sbjct: 126 GLKKLNYLRLNNNSLTGPCPESLSQVEGLSLVDLSFNNLSGSMPKISARTFKIIGNPSLC 185
Query: 204 GPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVWL 263
G ATNNC+A+ PEPLS PP+ L+ SDSG+KSHRVA+A GASFGAA +I +VGL VW
Sbjct: 186 GANATNNCSAISPEPLSFPPDALRAHSDSGSKSHRVAIAFGASFGAALLIIXIVGLSVWW 245
Query: 264 RYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS 323
RYR NQQIFFDVNDQYDPEV LGHL+RYTFKELRAAT +F+ KNILGRGGFGIVYKGC +
Sbjct: 246 RYRRNQQIFFDVNDQYDPEVRLGHLRRYTFKELRAATDHFNPKNILGRGGFGIVYKGCLN 305
Query: 324 DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG 383
D LVAVKRLKDYN GGE+QFQTEVE ISLAVHRNLLRLCGFC+TE+ERLLVYPYMPNG
Sbjct: 306 DRTLVAVKRLKDYNAVGGEIQFQTEVEMISLAVHRNLLRLCGFCTTESERLLVYPYMPNG 365
Query: 384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443
SVASRLRD IHGRPALDW+RRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE
Sbjct: 366 SVASRLRDQIHGRPALDWSRRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 425
Query: 444 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
AVVGDFGLAKLLDHR+SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ
Sbjct: 426 AVVGDFGLAKLLDHRESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 485
Query: 504 RALDFGRAANQRGVMLDWV 522
+ALDFGRAANQ+GVMLDWV
Sbjct: 486 KALDFGRAANQKGVMLDWV 504
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225425599|ref|XP_002263138.1| PREDICTED: protein NSP-INTERACTING KINASE 3-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 892 bits (2305), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/522 (83%), Positives = 472/522 (90%), Gaps = 3/522 (0%)
Query: 1 MEMKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSV 60
ME + Y W VG L+L L++ ATLSP+GINYEVVAL+ +KNNL+DPYNVLENWDI SV
Sbjct: 1 MESRGYVLWGVGLLLLTLMEGSSATLSPSGINYEVVALMTIKNNLNDPYNVLENWDINSV 60
Query: 61 DPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGK 120
DPCSWRM+TCS DGYVSALGLPSQSLSGTLSPWIGNLT LQSVLLQNNAI GPIP S+GK
Sbjct: 61 DPCSWRMVTCSSDGYVSALGLPSQSLSGTLSPWIGNLTNLQSVLLQNNAISGPIPDSIGK 120
Query: 121 LEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN 180
LEKL+TLDLS+NKF G IP SLG L LNYLRLNNNSLTG CPESLS++E L+LVDLS+N
Sbjct: 121 LEKLETLDLSHNKFDGGIPSSLGGLKKLNYLRLNNNSLTGPCPESLSQVEGLSLVDLSFN 180
Query: 181 NLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVA 240
NLSGS+PKISARTFK+ GNP +CG ATNNC+A+ PEPLS PP+ L+D SG+KSHRVA
Sbjct: 181 NLSGSMPKISARTFKIIGNPSLCGANATNNCSAISPEPLSFPPDALRD---SGSKSHRVA 237
Query: 241 VALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAAT 300
+A GASFGAA +II+VGL VW RYR NQQIFFDVNDQYDPEV LGHL+RYTFKELRAAT
Sbjct: 238 IAFGASFGAALLIIIIVGLSVWWRYRRNQQIFFDVNDQYDPEVRLGHLRRYTFKELRAAT 297
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
+F+ KNILGRGGFGIVYKGC +D LVAVKRLKDYN GGE+QFQTEVE ISLAVHRNL
Sbjct: 298 DHFNPKNILGRGGFGIVYKGCLNDRTLVAVKRLKDYNAVGGEIQFQTEVEMISLAVHRNL 357
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
LRLCGFC+TE+ERLLVYPYMPNGSVASRLRD IHGRPALDW+RRKRIALGTARGLLYLHE
Sbjct: 358 LRLCGFCTTESERLLVYPYMPNGSVASRLRDQIHGRPALDWSRRKRIALGTARGLLYLHE 417
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR+SHVTTAVRGTVGHIAPEYLST
Sbjct: 418 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRESHVTTAVRGTVGHIAPEYLST 477
Query: 481 GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
GQSSEKTDVFGFGILLLELITGQ+ALDFGRAANQ+GVMLDWV
Sbjct: 478 GQSSEKTDVFGFGILLLELITGQKALDFGRAANQKGVMLDWV 519
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224102457|ref|XP_002312685.1| predicted protein [Populus trichocarpa] gi|222852505|gb|EEE90052.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 887 bits (2291), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/519 (85%), Positives = 478/519 (92%), Gaps = 2/519 (0%)
Query: 4 KSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPC 63
+S+ F V FLVLAL++I ATLSP GIN+E ALVA+K L DPYNVLENWDI SVDPC
Sbjct: 5 RSFGFCTVVFLVLALMEISSATLSPTGINFE--ALVAIKTALLDPYNVLENWDINSVDPC 62
Query: 64 SWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEK 123
SWRM+TCSPDGYVSALGLPSQSLSGTLSP IGNLT LQSVLLQNNAI GPIP ++GKLEK
Sbjct: 63 SWRMVTCSPDGYVSALGLPSQSLSGTLSPSIGNLTNLQSVLLQNNAISGPIPVAIGKLEK 122
Query: 124 LQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
LQTLDLSNN F+G++P SLGDL NLNYLRLNNNSLTG CPESLS ++ LTLVDLS+NNLS
Sbjct: 123 LQTLDLSNNTFSGDMPTSLGDLKNLNYLRLNNNSLTGPCPESLSNLKGLTLVDLSFNNLS 182
Query: 184 GSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVAL 243
GSLPKISARTFKVTGNPLICGPKA+N+C+AVFPEPLSLPP+GL QS SGT HRVA+A
Sbjct: 183 GSLPKISARTFKVTGNPLICGPKASNSCSAVFPEPLSLPPDGLNGQSSSGTNGHRVAIAF 242
Query: 244 GASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNF 303
GASFGAAF IIV+GLLVW RYRHNQQIFFDVN+QYDPEV LGH++RYTFKELR AT +F
Sbjct: 243 GASFGAAFSTIIVIGLLVWWRYRHNQQIFFDVNEQYDPEVCLGHVRRYTFKELRTATDHF 302
Query: 304 SAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
S+KNILG GGFGIVYKG +DG +VAVKRLKD+N+AGGE+QFQTEVETISLAVHRNLLRL
Sbjct: 303 SSKNILGTGGFGIVYKGWLNDGTVVAVKRLKDFNVAGGEIQFQTEVETISLAVHRNLLRL 362
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
GFC+TENERLLVYPYMPNGSVAS+LRDHIH RPALDWARRKRIALGTARGLLYLHEQCD
Sbjct: 363 SGFCTTENERLLVYPYMPNGSVASQLRDHIHDRPALDWARRKRIALGTARGLLYLHEQCD 422
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS 483
PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI+PEYLSTGQS
Sbjct: 423 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHISPEYLSTGQS 482
Query: 484 SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
SEKTDVFGFGILLLELITGQ+ALDFGRAANQ+GVMLDWV
Sbjct: 483 SEKTDVFGFGILLLELITGQKALDFGRAANQKGVMLDWV 521
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568858|ref|XP_002525400.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223535363|gb|EEF37038.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 879 bits (2272), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/518 (84%), Positives = 473/518 (91%), Gaps = 5/518 (0%)
Query: 5 SYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCS 64
S+ WRVG LVL L++I ATLSP VVAL +K+ LHDPYNVLE+WD SVDPCS
Sbjct: 2 SFWLWRVGLLVLTLVEISSATLSPT-----VVALANIKSALHDPYNVLESWDANSVDPCS 56
Query: 65 WRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL 124
WRM+TCSPDGYV+ALGLPSQSLSGTLS IGNLT LQSVLLQNNAI GPIP ++G+LEKL
Sbjct: 57 WRMVTCSPDGYVTALGLPSQSLSGTLSSGIGNLTNLQSVLLQNNAISGPIPFAIGRLEKL 116
Query: 125 QTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
QTLDLSNN F+G+IP SLGDL NLNYLRLNNNSLTGSCPESLS IE LTLVDLS+NNLSG
Sbjct: 117 QTLDLSNNSFSGDIPASLGDLKNLNYLRLNNNSLTGSCPESLSNIEGLTLVDLSFNNLSG 176
Query: 185 SLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALG 244
SLPKISARTFKV GNPLICGPKA NNC+AV PEPLSLPP+GLK QSDSG HR+A+A G
Sbjct: 177 SLPKISARTFKVVGNPLICGPKANNNCSAVLPEPLSLPPDGLKGQSDSGHSGHRIAIAFG 236
Query: 245 ASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFS 304
ASFGAAF VII++GLLVW RYR NQQIFFDVN+QYD +V LGHL+RYTFKELRAAT +F+
Sbjct: 237 ASFGAAFSVIIMIGLLVWWRYRRNQQIFFDVNEQYDRDVCLGHLRRYTFKELRAATDHFN 296
Query: 305 AKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
+KNILGRGGFGIVY+GC +DG +VAVKRLKDYN AGGE+QFQTEVETISLAVH+NLLRL
Sbjct: 297 SKNILGRGGFGIVYRGCLTDGTVVAVKRLKDYNAAGGEIQFQTEVETISLAVHKNLLRLS 356
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
GFC+TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK+IALGTARGLLYLHEQCDP
Sbjct: 357 GFCTTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKKIALGTARGLLYLHEQCDP 416
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS
Sbjct: 417 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 476
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
EKTDVFGFGILLLELITGQ+ALDFGRAANQ+GVMLDWV
Sbjct: 477 EKTDVFGFGILLLELITGQKALDFGRAANQKGVMLDWV 514
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224110926|ref|XP_002315684.1| predicted protein [Populus trichocarpa] gi|222864724|gb|EEF01855.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 879 bits (2271), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/500 (87%), Positives = 470/500 (94%), Gaps = 1/500 (0%)
Query: 24 ATLSPAGINYE-VVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLP 82
ATLSPAGINYE VVALVA+K L DPYNVL+NWDI SVDPCSWRM+TC+PDGYV ALGLP
Sbjct: 2 ATLSPAGINYEAVVALVAIKTALRDPYNVLDNWDINSVDPCSWRMVTCTPDGYVLALGLP 61
Query: 83 SQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSL 142
SQSLSGTLSP IGNLT LQSVLLQNNAI GPIPA++GKLEKL TLDLSNN F+GE+P SL
Sbjct: 62 SQSLSGTLSPSIGNLTNLQSVLLQNNAISGPIPAAIGKLEKLLTLDLSNNTFSGEMPTSL 121
Query: 143 GDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLI 202
G+L NLNYLRLNNNSLTG CPESLSK+ LTLVDLS+NNLSGSLPKISARTFKVTGNPLI
Sbjct: 122 GNLKNLNYLRLNNNSLTGPCPESLSKLNGLTLVDLSFNNLSGSLPKISARTFKVTGNPLI 181
Query: 203 CGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVW 262
CGPKA++NC+AVFPEPLSLPPNGL QSDS T SHRVA+A GASFGAAF +II++GLLVW
Sbjct: 182 CGPKASDNCSAVFPEPLSLPPNGLNCQSDSRTNSHRVAIAFGASFGAAFSIIIIIGLLVW 241
Query: 263 LRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF 322
R RHNQQIFFDVN+QYDPEV LGHL+RYTFKELR+AT +FS+KNILGRGGFGIVYKGC
Sbjct: 242 WRCRHNQQIFFDVNEQYDPEVCLGHLRRYTFKELRSATDHFSSKNILGRGGFGIVYKGCL 301
Query: 323 SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN 382
+DG LVAVKRLKDY+IAGGE+QFQTEVETISLA+HRNLLRL GFC+TENERLLVYPYMPN
Sbjct: 302 NDGTLVAVKRLKDYDIAGGEIQFQTEVETISLAIHRNLLRLSGFCTTENERLLVYPYMPN 361
Query: 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442
GSVAS+LRDHIHGR ALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF
Sbjct: 362 GSVASQLRDHIHGRAALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 421
Query: 443 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL+TG
Sbjct: 422 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELVTG 481
Query: 503 QRALDFGRAANQRGVMLDWV 522
Q+ALDFGRAANQ+GVMLDWV
Sbjct: 482 QKALDFGRAANQKGVMLDWV 501
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450444|ref|XP_004142972.1| PREDICTED: protein NSP-INTERACTING KINASE 3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 867 bits (2240), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/515 (81%), Positives = 463/515 (89%), Gaps = 6/515 (1%)
Query: 24 ATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPS 83
ATLSP+G+N+EVVAL+A+K +L DP+NVLENWD SVDPCSWRM+TCSPDGYVS LGLPS
Sbjct: 23 ATLSPSGVNFEVVALMAIKYDLLDPHNVLENWDSNSVDPCSWRMVTCSPDGYVSVLGLPS 82
Query: 84 QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
QSLSG LSP IGNLTKL+SVLLQNN I GPIPA++GKLE LQTLDLSNN F+G+IP SLG
Sbjct: 83 QSLSGVLSPGIGNLTKLESVLLQNNDISGPIPATIGKLENLQTLDLSNNLFSGQIPSSLG 142
Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLIC 203
DL LNYLRLNNNSLTG CPESLSK+E LTLVDLSYNNLSGSLPKISARTFK+ GNPLIC
Sbjct: 143 DLKKLNYLRLNNNSLTGPCPESLSKVEGLTLVDLSYNNLSGSLPKISARTFKIVGNPLIC 202
Query: 204 GPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVWL 263
GP NNC+A+FPEPLS P+ L++ G KSHR A+A GASF AAF V++++GLLVW
Sbjct: 203 GP---NNCSAIFPEPLSFAPDALEENLGFG-KSHRKAIAFGASFSAAFIVLVLIGLLVWW 258
Query: 264 RYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS 323
RYRHNQQIFFDVNDQYDPEV LGHL+RYTFKELRAAT +F+ KNILGRGGFGIVYKGC +
Sbjct: 259 RYRHNQQIFFDVNDQYDPEVRLGHLRRYTFKELRAATDHFNPKNILGRGGFGIVYKGCLN 318
Query: 324 DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG 383
DG+LVAVKRLKDYN AGGE+QFQTEVE ISLAVHRNLL+L GFCSTE+ERLLVYP+MPNG
Sbjct: 319 DGSLVAVKRLKDYNTAGGEIQFQTEVEMISLAVHRNLLKLFGFCSTESERLLVYPFMPNG 378
Query: 384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443
SV SRLRD IHG+PALDWA RKRIALGTARGL+YLHEQCDPKIIHRDVKAANILLDEDFE
Sbjct: 379 SVGSRLRDRIHGQPALDWAMRKRIALGTARGLVYLHEQCDPKIIHRDVKAANILLDEDFE 438
Query: 444 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ
Sbjct: 439 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 498
Query: 504 RALDFGRAANQRGVMLDWVCSHILSNQSSLDMVLN 538
+ALDFGR ANQ+GVMLDWV L + L+M+++
Sbjct: 499 KALDFGRGANQKGVMLDWVKK--LHQEGKLNMMVD 531
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357485807|ref|XP_003613191.1| Leucine-rich repeat receptor-like kinase [Medicago truncatula] gi|308154498|gb|ADO15296.1| somatic embryogenesis receptor kinase-like protein 2 [Medicago truncatula] gi|355514526|gb|AES96149.1| Leucine-rich repeat receptor-like kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 858 bits (2218), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/504 (82%), Positives = 460/504 (91%), Gaps = 1/504 (0%)
Query: 19 IDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSA 78
+ + A LSP+GINYEVVAL+A+KN+L+DP+NVLENWDI VDPCSWRMITC+PDG VSA
Sbjct: 19 MKVSSAALSPSGINYEVVALMAIKNDLNDPHNVLENWDINYVDPCSWRMITCTPDGSVSA 78
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
LG PSQ+LSGTLSP IGNLT LQSVLLQNNAI G IPA++G LEKLQTLDLSNN+F+GEI
Sbjct: 79 LGFPSQNLSGTLSPRIGNLTNLQSVLLQNNAISGHIPAAIGSLEKLQTLDLSNNEFSGEI 138
Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTG 198
P SLG L NLNYLR+NNNSLTG+CP+SLS IESLTLVDLSYNNLSGSLP+I ART K+ G
Sbjct: 139 PSSLGGLKNLNYLRINNNSLTGACPQSLSNIESLTLVDLSYNNLSGSLPRIQARTLKIVG 198
Query: 199 NPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVG 258
NPLICGPK NNC+ V PEPLS PP+ LK + DSG K H VA+A GASFGAAF V+I+VG
Sbjct: 199 NPLICGPK-ENNCSTVLPEPLSFPPDALKAKPDSGKKGHHVALAFGASFGAAFVVVIIVG 257
Query: 259 LLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVY 318
LLVW RYRHNQQIFFD+++ YDPEV LGHLKRY+FKELRAAT +F++KNILGRGGFGIVY
Sbjct: 258 LLVWWRYRHNQQIFFDISEHYDPEVRLGHLKRYSFKELRAATDHFNSKNILGRGGFGIVY 317
Query: 319 KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378
K C +DG++VAVKRLKDYN AGGE+QFQTEVETISLAVHRNLLRL GFCST+NERLLVYP
Sbjct: 318 KACLNDGSVVAVKRLKDYNAAGGEIQFQTEVETISLAVHRNLLRLRGFCSTQNERLLVYP 377
Query: 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438
YM NGSVASRL+DHIHGRPALDW RRKRIALGTARGL+YLHEQCDPKIIHRDVKAANILL
Sbjct: 378 YMSNGSVASRLKDHIHGRPALDWTRRKRIALGTARGLVYLHEQCDPKIIHRDVKAANILL 437
Query: 439 DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 498
DEDFEAVVGDFGLAKLLDHRD+HVTTAVRGT+GHIAPEYLSTGQSSEKTDVFG+GILLLE
Sbjct: 438 DEDFEAVVGDFGLAKLLDHRDTHVTTAVRGTIGHIAPEYLSTGQSSEKTDVFGYGILLLE 497
Query: 499 LITGQRALDFGRAANQRGVMLDWV 522
LITG +ALDFGRAANQ+GVMLDWV
Sbjct: 498 LITGHKALDFGRAANQKGVMLDWV 521
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501661|ref|XP_003519642.1| PREDICTED: protein NSP-INTERACTING KINASE 3-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 856 bits (2212), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/518 (83%), Positives = 470/518 (90%), Gaps = 1/518 (0%)
Query: 5 SYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCS 64
S FW +G L+L L++I A LSP+GINYEVVAL+A+KN+L DP+NVLENWDI SVDPCS
Sbjct: 6 SLVFWLLGLLLLLLMEISSAALSPSGINYEVVALMAIKNDLIDPHNVLENWDINSVDPCS 65
Query: 65 WRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL 124
WRMITCSPDG VSALGLPSQ+LSGTLSP IGNLT LQSVLLQNNAI G IPA++G LEKL
Sbjct: 66 WRMITCSPDGSVSALGLPSQNLSGTLSPGIGNLTNLQSVLLQNNAISGRIPAAIGSLEKL 125
Query: 125 QTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
QTLDLSNN F+GEIP SLG L NLNYLRLNNNSLTGSCP+SLS IE LTLVDLSYNNLSG
Sbjct: 126 QTLDLSNNTFSGEIPSSLGGLKNLNYLRLNNNSLTGSCPQSLSNIEGLTLVDLSYNNLSG 185
Query: 185 SLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALG 244
SLP+ISART K+ GN LICGPKA NNC+ + PEPLS PP+ L+ QSDSG KSH VA+A G
Sbjct: 186 SLPRISARTLKIVGNSLICGPKA-NNCSTILPEPLSFPPDALRGQSDSGKKSHHVALAFG 244
Query: 245 ASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFS 304
ASFGAAF ++I+VG LVW RYR NQQIFFDVN+ YDPEV LGHLKR++FKELRAAT +F+
Sbjct: 245 ASFGAAFVLVIIVGFLVWWRYRRNQQIFFDVNEHYDPEVRLGHLKRFSFKELRAATDHFN 304
Query: 305 AKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
+KNILGRGGFGIVYK C +DG++VAVKRLKDYN AGGE+QFQTEVETISLAVHRNLLRL
Sbjct: 305 SKNILGRGGFGIVYKACLNDGSVVAVKRLKDYNAAGGEIQFQTEVETISLAVHRNLLRLS 364
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
GFCST++ERLLVYPYM NGSVASRL+DHIHGRPALDW RRKRIALGTARGL+YLHEQCDP
Sbjct: 365 GFCSTQHERLLVYPYMSNGSVASRLKDHIHGRPALDWTRRKRIALGTARGLVYLHEQCDP 424
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS
Sbjct: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
EKTDVFGFGILLLELITG +ALDFGRAANQ+GVMLDWV
Sbjct: 485 EKTDVFGFGILLLELITGHKALDFGRAANQKGVMLDWV 522
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501663|ref|XP_003519643.1| PREDICTED: protein NSP-INTERACTING KINASE 3-like isoform 2 [Glycine max] gi|223452428|gb|ACM89541.1| leucine-rich repeat receptor-like kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 854 bits (2206), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/515 (82%), Positives = 465/515 (90%), Gaps = 1/515 (0%)
Query: 19 IDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSA 78
++I A LSP+GINYEVVAL+A+KN+L DP+NVLENWDI SVDPCSWRMITCSPDG VSA
Sbjct: 1 MEISSAALSPSGINYEVVALMAIKNDLIDPHNVLENWDINSVDPCSWRMITCSPDGSVSA 60
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
LGLPSQ+LSGTLSP IGNLT LQSVLLQNNAI G IPA++G LEKLQTLDLSNN F+GEI
Sbjct: 61 LGLPSQNLSGTLSPGIGNLTNLQSVLLQNNAISGRIPAAIGSLEKLQTLDLSNNTFSGEI 120
Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTG 198
P SLG L NLNYLRLNNNSLTGSCP+SLS IE LTLVDLSYNNLSGSLP+ISART K+ G
Sbjct: 121 PSSLGGLKNLNYLRLNNNSLTGSCPQSLSNIEGLTLVDLSYNNLSGSLPRISARTLKIVG 180
Query: 199 NPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVG 258
N LICGPKA NNC+ + PEPLS PP+ L+ QSDSG KSH VA+A GASFGAAF ++I+VG
Sbjct: 181 NSLICGPKA-NNCSTILPEPLSFPPDALRGQSDSGKKSHHVALAFGASFGAAFVLVIIVG 239
Query: 259 LLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVY 318
LVW RYR NQQIFFDVN+ YDPEV LGHLKR++FKELRAAT +F++KNILGRGGFGIVY
Sbjct: 240 FLVWWRYRRNQQIFFDVNEHYDPEVRLGHLKRFSFKELRAATDHFNSKNILGRGGFGIVY 299
Query: 319 KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378
K C +DG++VAVKRLKDYN AGGE+QFQTEVETISLAVHRNLLRL GFCST++ERLLVYP
Sbjct: 300 KACLNDGSVVAVKRLKDYNAAGGEIQFQTEVETISLAVHRNLLRLSGFCSTQHERLLVYP 359
Query: 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438
YM NGSVASRL+DHIHGRPALDW RRKRIALGTARGL+YLHEQCDPKIIHRDVKAANILL
Sbjct: 360 YMSNGSVASRLKDHIHGRPALDWTRRKRIALGTARGLVYLHEQCDPKIIHRDVKAANILL 419
Query: 439 DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 498
DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE
Sbjct: 420 DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 479
Query: 499 LITGQRALDFGRAANQRGVMLDWVCSHILSNQSSL 533
LITG +ALDFGRAANQ+GVMLDWV S N S L
Sbjct: 480 LITGHKALDFGRAANQKGVMLDWVSSPTFFNISFL 514
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 540 | ||||||
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.961 | 0.821 | 0.768 | 1.1e-215 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.953 | 0.807 | 0.613 | 9.7e-167 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.925 | 0.771 | 0.596 | 4.9e-156 | |
| TAIR|locus:2061466 | 634 | AT2G23950 [Arabidopsis thalian | 0.944 | 0.804 | 0.586 | 2e-152 | |
| TAIR|locus:2171973 | 614 | AT5G45780 [Arabidopsis thalian | 0.948 | 0.833 | 0.553 | 1.2e-147 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.970 | 0.838 | 0.540 | 1.2e-134 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.977 | 0.840 | 0.532 | 1.1e-133 | |
| TAIR|locus:2040461 | 620 | SERK4 "somatic embryogenesis r | 0.912 | 0.795 | 0.544 | 1.4e-128 | |
| TAIR|locus:2145407 | 613 | AT5G10290 [Arabidopsis thalian | 0.924 | 0.814 | 0.461 | 2.5e-113 | |
| TAIR|locus:2040471 | 601 | SERK5 "somatic embryogenesis r | 0.75 | 0.673 | 0.543 | 1.5e-106 |
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2084 (738.7 bits), Expect = 1.1e-215, P = 1.1e-215
Identities = 402/523 (76%), Positives = 451/523 (86%)
Query: 1 MEMKSYKFWRVGFLVLA-LIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITS 59
ME + WR+GFLV DI ATLSP G+NYEV ALVAVKN L+DPY VLENWD+ S
Sbjct: 1 MEGVRFVVWRLGFLVFVWFFDISSATLSPTGVNYEVTALVAVKNELNDPYKVLENWDVNS 60
Query: 60 VDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLG 119
VDPCSWRM++C+ DGYVS+L LPSQSLSGTLSP IGNLT LQSV+LQNNAI GPIP ++G
Sbjct: 61 VDPCSWRMVSCT-DGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIG 119
Query: 120 KLEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSY 179
+LEKLQ+LDLSNN FTGEIP SLG+ G+CPESLSKIE LTLVD+SY
Sbjct: 120 RLEKLQSLDLSNNSFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISY 179
Query: 180 NNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRV 239
NNLSGSLPK+SARTFKV GN LICGPKA +NC+AV PEPL+LP +G D+S + T H V
Sbjct: 180 NNLSGSLPKVSARTFKVIGNALICGPKAVSNCSAV-PEPLTLPQDG-PDESGTRTNGHHV 237
Query: 240 AVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAA 299
A+A ASF AAFFV G+ +W RYR N+QIFFDVN+QYDPEVSLGHLKRYTFKELR+A
Sbjct: 238 ALAFAASFSAAFFVFFTSGMFLWWRYRRNKQIFFDVNEQYDPEVSLGHLKRYTFKELRSA 297
Query: 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
T++F++KNILGRGG+GIVYKG +DG LVAVKRLKD NIAGGEVQFQTEVETISLA+HRN
Sbjct: 298 TNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRN 357
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
LLRL GFCS+ ER+LVYPYMPNGSVASRL+D+I G PALDW+RRK+IA+GTARGL+YLH
Sbjct: 358 LLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLH 417
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS
Sbjct: 418 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 477
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
TGQSSEKTDVFGFGILLLELITGQ+ALDFGR+A+Q+GVMLDWV
Sbjct: 478 TGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWV 520
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1622 (576.0 bits), Expect = 9.7e-167, P = 9.7e-167
Identities = 322/525 (61%), Positives = 396/525 (75%)
Query: 1 MEMKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSV 60
M +S+ F +GFL L L + LSP G+N+EV AL+ +K +LHDP+ VL+NWD +V
Sbjct: 10 MITRSF-FCFLGFLCL-LCSSVHGLLSPKGVNFEVQALMDIKASLHDPHGVLDNWDRDAV 67
Query: 61 DPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGK 120
DPCSW M+TCS + +V LG PSQ+LSGTLSP I NLT L+ VLLQNN I G IPA +G+
Sbjct: 68 DPCSWTMVTCSSENFVIGLGTPSQNLSGTLSPSITNLTNLRIVLLQNNNIKGKIPAEIGR 127
Query: 121 LEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYN 180
L +L+TLDLS+N F GEIP S+G +G P SLS + L +DLSYN
Sbjct: 128 LTRLETLDLSDNFFHGEIPFSVGYLQSLQYLRLNNNSLSGVFPLSLSNMTQLAFLDLSYN 187
Query: 181 NLSGSLPKISARTFKVTGNPLIC--GPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHR 238
NLSG +P+ +A+TF + GNPLIC G + N T + P ++L G+ + G+++H+
Sbjct: 188 NLSGPVPRFAAKTFSIVGNPLICPTGTEPDCNGTTLIPMSMNLNQTGVPLYA-GGSRNHK 246
Query: 239 VAVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVND-QYDPEVSLGHLKRYTFKELR 297
+A+A+G+S G + I VGL +W R RHNQ FFDV D + EVSLG+L+R+ F+EL+
Sbjct: 247 MAIAVGSSVGTVSLIFIAVGLFLWWRQRHNQNTFFDVKDGNHHEEVSLGNLRRFGFRELQ 306
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH 357
AT+NFS+KN+LG+GG+G VYKG D +VAVKRLKD GGE+QFQTEVE ISLAVH
Sbjct: 307 IATNNFSSKNLLGKGGYGNVYKGILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVH 366
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
RNLLRL GFC T+ E+LLVYPYM NGSVASR++ +P LDW+ RKRIA+G ARGL+Y
Sbjct: 367 RNLLRLYGFCITQTEKLLVYPYMSNGSVASRMK----AKPVLDWSIRKRIAIGAARGLVY 422
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
LHEQCDPKIIHRDVKAANILLD+ EAVVGDFGLAKLLDH+DSHVTTAVRGTVGHIAPEY
Sbjct: 423 LHEQCDPKIIHRDVKAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEY 482
Query: 478 LSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
LSTGQSSEKTDVFGFGILLLEL+TGQRA +FG+AANQ+GVMLDWV
Sbjct: 483 LSTGQSSEKTDVFGFGILLLELVTGQRAFEFGKAANQKGVMLDWV 527
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1521 (540.5 bits), Expect = 4.9e-156, P = 4.9e-156
Identities = 306/513 (59%), Positives = 372/513 (72%)
Query: 14 LVLALIDICYATL--SPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCS 71
L+ + + +C++TL S N EV AL++++NNLHDP+ L NWD SVDPCSW MITCS
Sbjct: 15 LLYSFLFLCFSTLTLSSEPRNPEVEALISIRNNLHDPHGALNNWDEFSVDPCSWAMITCS 74
Query: 72 PDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN 131
PD V LG PSQSLSG LS IGNLT L+ V LQNN I G IP LG L KLQTLDLSN
Sbjct: 75 PDNLVIGLGAPSQSLSGGLSESIGNLTNLRQVSLQNNNISGKIPPELGFLPKLQTLDLSN 134
Query: 132 NKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA 191
N+F+G+IP S+ +G P SLS+I L+ +DLSYNNLSG +PK A
Sbjct: 135 NRFSGDIPVSIDQLSSLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLSGPVPKFPA 194
Query: 192 RTFKVTGNPLICGPKATNNCT-AVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAA 250
RTF V GNPLIC C+ ++ PLS+ + S SG +S+R+A+AL S G+
Sbjct: 195 RTFNVAGNPLICRSNPPEICSGSINASPLSVSLS-----SSSGRRSNRLAIALSVSLGSV 249
Query: 251 FFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVS-LGHLKRYTFKELRAATSNFSAKNIL 309
+++ +G W R + + + ++ND+ + + LG+L+ +TF+EL T FS+KNIL
Sbjct: 250 VILVLALGSFCWYRKKQRRLLILNLNDKQEEGLQGLGNLRSFTFRELHVYTDGFSSKNIL 309
Query: 310 GRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST 369
G GGFG VY+G DG +VAVKRLKD N G+ QF+ E+E ISLAVH+NLLRL G+C+T
Sbjct: 310 GAGGFGNVYRGKLGDGTMVAVKRLKDINGTSGDSQFRMELEMISLAVHKNLLRLIGYCAT 369
Query: 370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHR 429
ERLLVYPYMPNGSVAS+L+ +PALDW RKRIA+G ARGLLYLHEQCDPKIIHR
Sbjct: 370 SGERLLVYPYMPNGSVASKLKS----KPALDWNMRKRIAIGAARGLLYLHEQCDPKIIHR 425
Query: 430 DVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 489
DVKAANILLDE FEAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV
Sbjct: 426 DVKAANILLDECFEAVVGDFGLAKLLNHADSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 485
Query: 490 FGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
FGFGILLLELITG RAL+FG+ +Q+G ML+WV
Sbjct: 486 FGFGILLLELITGLRALEFGKTVSQKGAMLEWV 518
|
|
| TAIR|locus:2061466 AT2G23950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1487 (528.5 bits), Expect = 2.0e-152, P = 2.0e-152
Identities = 307/523 (58%), Positives = 370/523 (70%)
Query: 1 MEMKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSV 60
M++ + K + V L+L C + P N EV AL+ +KN LHDP+ V +NWD SV
Sbjct: 4 MKLITMKIFSV-LLLLCFFVTCSLSSEPR--NPEVEALINIKNELHDPHGVFKNWDEFSV 60
Query: 61 DPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGK 120
DPCSW MI+CS D V LG PSQSLSGTLS IGNLT L+ V LQNN I G IP +
Sbjct: 61 DPCSWTMISCSSDNLVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICS 120
Query: 121 LEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYN 180
L KLQTLDLSNN+F+GEIP S+ +G P SLS+I L+ +DLSYN
Sbjct: 121 LPKLQTLDLSNNRFSGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYN 180
Query: 181 NLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVA 240
NL G +PK ARTF V GNPLIC C+ +S P + +S SG +++ +A
Sbjct: 181 NLRGPVPKFPARTFNVAGNPLICKNSLPEICSG----SISASPLSVSLRSSSGRRTNILA 236
Query: 241 VALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVND-QYDPEVSLGHLKRYTFKELRAA 299
VALG S G A VI+ +G +W R + + ++D Q + + LG+L+ +TF+EL A
Sbjct: 237 VALGVSLGFAVSVILSLGF-IWYRKKQRRLTMLRISDKQEEGLLGLGNLRSFTFRELHVA 295
Query: 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
T FS+K+ILG GGFG VY+G F DG +VAVKRLKD N G QF+TE+E ISLAVHRN
Sbjct: 296 TDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMISLAVHRN 355
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
LLRL G+C++ +ERLLVYPYM NGSVASRL+ +PALDW RK+IA+G ARGL YLH
Sbjct: 356 LLRLIGYCASSSERLLVYPYMSNGSVASRLK----AKPALDWNTRKKIAIGAARGLFYLH 411
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
EQCDPKIIHRDVKAANILLDE FEAVVGDFGLAKLL+H DSHVTTAVRGTVGHIAPEYLS
Sbjct: 412 EQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGHIAPEYLS 471
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
TGQSSEKTDVFGFGILLLELITG RAL+FG++ +Q+G ML+WV
Sbjct: 472 TGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGAMLEWV 514
|
|
| TAIR|locus:2171973 AT5G45780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1442 (512.7 bits), Expect = 1.2e-147, P = 1.2e-147
Identities = 292/528 (55%), Positives = 371/528 (70%)
Query: 1 MEMKSYKF-----WRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENW 55
ME+ KF W + VL + + LSP G+NYEV AL++VKN + D VL W
Sbjct: 1 MEISLMKFLFLGIWVYYYSVLDSVSAMDSLLSPKGVNYEVAALMSVKNKMKDEKEVLSGW 60
Query: 56 DITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIP 115
DI SVDPC+W M+ CS +G+V +L + S+ LSG LS IG LT L ++LLQNN + GPIP
Sbjct: 61 DINSVDPCTWNMVGCSSEGFVVSLEMASKGLSGILSTSIGELTHLHTLLLQNNQLTGPIP 120
Query: 116 ASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLV 175
+ LG+L +L+TLDLS N+F+GEIP SLG +G P ++ + L+ +
Sbjct: 121 SELGQLSELETLDLSGNRFSGEIPASLGFLTHLNYLRLSRNLLSGQVPHLVAGLSGLSFL 180
Query: 176 DLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTK 235
DLS+NNLSG P ISA+ +++ GN +CGP + C+ P + GL ++ +S K
Sbjct: 181 DLSFNNLSGPTPNISAKDYRIVGNAFLCGPASQELCSDATPVRNA---TGLSEKDNS--K 235
Query: 236 SHRVAVALGASFGAAF-FVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFK 294
H ++ L +FG F+I ++ L W+ + H ++ + Q D E +GHLKR++F+
Sbjct: 236 HH--SLVLSFAFGIVVAFIISLMFLFFWVLW-HRSRLSRS-HVQQDYEFEIGHLKRFSFR 291
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
E++ ATSNFS KNILG+GGFG+VYKG +G +VAVKRLKD I GEVQFQTEVE I L
Sbjct: 292 EIQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLKD-PIYTGEVQFQTEVEMIGL 350
Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
AVHRNLLRL GFC T ER+LVYPYMPNGSVA RLRD+ +P+LDW RR IALG ARG
Sbjct: 351 AVHRNLLRLFGFCMTPEERMLVYPYMPNGSVADRLRDNYGEKPSLDWNRRISIALGAARG 410
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
L+YLHEQC+PKIIHRDVKAANILLDE FEA+VGDFGLAKLLD RDSHVTTAVRGT+GHIA
Sbjct: 411 LVYLHEQCNPKIIHRDVKAANILLDESFEAIVGDFGLAKLLDQRDSHVTTAVRGTIGHIA 470
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
PEYLSTGQSSEKTDVFGFG+L+LELITG + +D G ++G++L WV
Sbjct: 471 PEYLSTGQSSEKTDVFGFGVLILELITGHKMIDQGNGQVRKGMILSWV 518
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1319 (469.4 bits), Expect = 1.2e-134, P = 1.2e-134
Identities = 289/535 (54%), Positives = 355/535 (66%)
Query: 11 VGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITC 70
V F++L+LI + +L A N E AL ++ L DP NVL++WD T V+PC+W +TC
Sbjct: 6 VVFILLSLILLPNHSLWLASANLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTWFHVTC 65
Query: 71 SPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLS 130
+ + V + L + LSG L P +G L LQ + L +N I GPIP++LG L L +LDL
Sbjct: 66 NNENSVIRVDLGNAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLY 125
Query: 131 NNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYNNLSGSLP--- 187
N F+G IP+SLG TGS P SL+ I +L ++DLS N LSGS+P
Sbjct: 126 LNSFSGPIPESLGKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNG 185
Query: 188 KISART-FKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRV--AVALG 244
S T N +CGP ++ C P P S PP ++ S + + A+A G
Sbjct: 186 SFSLFTPISFANNLDLCGPVTSHPCPGS-P-PFSPPPPFIQPPPVSTPSGYGITGAIAGG 243
Query: 245 ASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFS 304
+ GAA W R R IFFDV + DPEV LG LKR++ +EL+ A+ FS
Sbjct: 244 VAAGAALLFAAPAIAFAWWRRRKPLDIFFDVPAEEDPEVHLGQLKRFSLRELQVASDGFS 303
Query: 305 AKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
KNILGRGGFG VYKG +DG LVAVKRLK+ GGE+QFQTEVE IS+AVHRNLLRL
Sbjct: 304 NKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLR 363
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
GFC T ERLLVYPYM NGSVAS LR+ +P LDW RKRIALG+ARGL YLH+ CDP
Sbjct: 364 GFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDP 423
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
KIIHRDVKAANILLDE+FEAVVGDFGLAKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SS
Sbjct: 424 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 483
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVML-DWVCSHILSNQSSLDMVLN 538
EKTDVFG+GI+LLELITGQRA D R AN VML DWV L + L+M+++
Sbjct: 484 EKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG--LLKEKKLEMLVD 536
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1310 (466.2 bits), Expect = 1.1e-133, P = 1.1e-133
Identities = 287/539 (53%), Positives = 353/539 (65%)
Query: 7 KFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWR 66
KF GF+ L + + + +L A N E AL +++ NL DP NVL++WD T V+PC+W
Sbjct: 5 KFEAFGFVCLISLLLLFNSLWLASSNMEGDALHSLRANLVDPNNVLQSWDPTLVNPCTWF 64
Query: 67 MITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQT 126
+TC+ + V + L + LSG L P +G L LQ + L +N I GP+P+ LG L L +
Sbjct: 65 HVTCNNENSVIRVDLGNADLSGQLVPQLGQLKNLQYLELYSNNITGPVPSDLGNLTNLVS 124
Query: 127 LDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYNNLSGSL 186
LDL N FTG IPDSLG TG P SL+ I +L ++DLS N LSGS+
Sbjct: 125 LDLYLNSFTGPIPDSLGKLFKLRFLRLNNNSLTGPIPMSLTNIMTLQVLDLSNNRLSGSV 184
Query: 187 P---KISART-FKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQ--SDSGTKSHRVA 240
P S T N +CGP + C P P S PP + G S A
Sbjct: 185 PDNGSFSLFTPISFANNLDLCGPVTSRPCPGS-P-PFSPPPPFIPPPIVPTPGGYSATGA 242
Query: 241 VALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAAT 300
+A G + GAA W R R Q+ FFDV + DPEV LG LKR++ +EL+ AT
Sbjct: 243 IAGGVAAGAALLFAAPALAFAWWRRRKPQEFFFDVPAEEDPEVHLGQLKRFSLRELQVAT 302
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
+FS KNILGRGGFG VYKG +DG LVAVKRLK+ GGE+QFQTEVE IS+AVHRNL
Sbjct: 303 DSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNL 362
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
LRL GFC T ERLLVYPYM NGSVAS LR+ + L W+ R++IALG+ARGL YLH+
Sbjct: 363 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLAWSIRQQIALGSARGLSYLHD 422
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
CDPKIIHRDVKAANILLDE+FEAVVGDFGLA+L+D++D+HVTTAVRGT+GHIAPEYLST
Sbjct: 423 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLARLMDYKDTHVTTAVRGTIGHIAPEYLST 482
Query: 481 GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML-DWVCSHILSNQSSLDMVLN 538
G+SSEKTDVFG+GI+LLELITGQRA D R AN VML DWV L + L+M+++
Sbjct: 483 GKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKG--LLKEKKLEMLVD 539
|
|
| TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1262 (449.3 bits), Expect = 1.4e-128, P = 1.4e-128
Identities = 282/518 (54%), Positives = 340/518 (65%)
Query: 13 FLVLALIDICYATLSPAGINYEVVALVAVKNNLH--DPYN-VLENWDITSVDPCSWRMIT 69
FL L L+ TL AG N E AL +KN+L DP N VL++WD T V PC+W +T
Sbjct: 14 FLYLLLL--FNFTLRVAG-NAEGDALTQLKNSLSSGDPANNVLQSWDATLVTPCTWFHVT 70
Query: 70 CSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL 129
C+P+ V+ + L + LSG L P +G L LQ + L +N I G IP LG L +L +LDL
Sbjct: 71 CNPENKVTRVDLGNAKLSGKLVPELGQLLNLQYLELYSNNITGEIPEELGDLVELVSLDL 130
Query: 130 SNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
N +G IP SLG +G P +L+ ++ L ++D+S N LSG +P
Sbjct: 131 YANSISGPIPSSLGKLGKLRFLRLNNNSLSGEIPMTLTSVQ-LQVLDISNNRLSGDIP-- 187
Query: 190 SARTFKVTGNPLICGPKA-TNNCTAVFPEPLSLPPNGLKDQSD--SGTKSHRVAVALGAS 246
V G+ + P + NN PEP PP SG + A+A G +
Sbjct: 188 ------VNGSFSLFTPISFANNSLTDLPEP---PPTSTSPTPPPPSGGQM-TAAIAGGVA 237
Query: 247 FGAAF-FVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSA 305
GAA F + + WLR R Q FFDV + DPEV LG LKR+T +EL AT NFS
Sbjct: 238 AGAALLFAVPAIAFAWWLR-RKPQDHFFDVPAEEDPEVHLGQLKRFTLRELLVATDNFSN 296
Query: 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
KN+LGRGGFG VYKG +DG LVAVKRLK+ GGE+QFQTEVE IS+AVHRNLLRL G
Sbjct: 297 KNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGELQFQTEVEMISMAVHRNLLRLRG 356
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
FC T ERLLVYPYM NGSVAS LR+ G PALDW +RK IALG+ARGL YLH+ CD K
Sbjct: 357 FCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRKHIALGSARGLAYLHDHCDQK 416
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE 485
IIHRDVKAANILLDE+FEAVVGDFGLAKL+++ DSHVTTAVRGT+GHIAPEYLSTG+SSE
Sbjct: 417 IIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTAVRGTIGHIAPEYLSTGKSSE 476
Query: 486 KTDVFGFGILLLELITGQRALDFGRAANQRGVML-DWV 522
KTDVFG+G++LLELITGQ+A D R AN +ML DWV
Sbjct: 477 KTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWV 514
|
|
| TAIR|locus:2145407 AT5G10290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1118 (398.6 bits), Expect = 2.5e-113, P = 2.5e-113
Identities = 243/526 (46%), Positives = 330/526 (62%)
Query: 1 MEMKSYKFWRVGFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSV 60
M M S + + F +L +C + +SP + + AL A++ +L N L +W+ V
Sbjct: 1 MRMFSLQKMAMAFTLLFFACLC-SFVSP---DAQGDALFALRISLRALPNQLSDWNQNQV 56
Query: 61 DPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGK 120
+PC+W + C +V++L L + SGTLS +G L L+++ L+ N I G IP G
Sbjct: 57 NPCTWSQVICDDKNFVTSLTLSDMNFSGTLSSRVGILENLKTLTLKGNGITGEIPEDFGN 116
Query: 121 LEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIESLTLVDLSYN 180
L L +LDL +N+ TG IP ++G+ G+ PESL+ + +L + L N
Sbjct: 117 LTSLTSLDLEDNQLTGRIPSTIGNLKKLQFLTLSRNKLNGTIPESLTGLPNLLNLLLDSN 176
Query: 181 NLSGSLPK--ISARTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHR 238
+LSG +P+ + T N L CG + + C + ++ +G D S T
Sbjct: 177 SLSGQIPQSLFEIPKYNFTSNNLNCGGRQPHPCVS------AVAHSG--DSSKPKT---- 224
Query: 239 VAVALGASFGAAFFVIIVVGLLVWL--RYRHN---QQIFFDVNDQYDPEVSLGHLKRYTF 293
+ G G +++ G+L++L + RH + +F DV + D ++ G LKR+ +
Sbjct: 225 -GIIAGVVAGVT---VVLFGILLFLFCKDRHKGYRRDVFVDVAGEVDRRIAFGQLKRFAW 280
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS 353
+EL+ AT NFS KN+LG+GGFG VYKG D VAVKRL D+ GG+ FQ EVE IS
Sbjct: 281 RELQLATDNFSEKNVLGQGGFGKVYKGVLPDNTKVAVKRLTDFESPGGDAAFQREVEMIS 340
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
+AVHRNLLRL GFC+T+ ERLLVYP+M N S+A RLR+ G P LDW RKRIALG AR
Sbjct: 341 VAVHRNLLRLIGFCTTQTERLLVYPFMQNLSLAHRLREIKAGDPVLDWETRKRIALGAAR 400
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
G YLHE C+PKIIHRDVKAAN+LLDEDFEAVVGDFGLAKL+D R ++VTT VRGT+GHI
Sbjct: 401 GFEYLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHI 460
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML 519
APEYLSTG+SSE+TDVFG+GI+LLEL+TGQRA+DF R + V+L
Sbjct: 461 APEYLSTGKSSERTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLL 506
|
|
| TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1054 (376.1 bits), Expect = 1.5e-106, P = 1.5e-106
Identities = 227/418 (54%), Positives = 277/418 (66%)
Query: 112 GPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDXXXXXXXXXXXXXXTGSCPESLSKIES 171
G + L +L LQ L+L NN TGEIP+ LGD +G P SL K+
Sbjct: 84 GELVPQLAQLPNLQYLELFNNNITGEIPEELGDLMELVSLDLFANNISGPIPSSLGKLGK 143
Query: 172 LTLVDLSYNNLSGSLPK-ISARTFKVT--GNPLICGPKATNNCTAVFPEPLSLPPNGLKD 228
L + L N+LSG +P+ ++A V N + G N + F +S N L+
Sbjct: 144 LRFLRLYNNSLSGEIPRSLTALPLDVLDISNNRLSGDIPVNGSFSQFTS-MSFANNKLRP 202
Query: 229 QSDSGTKSHR---VAVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSL 285
+ S + S A+ +G + GAA ++ L WLR R Q F DV + DPEV L
Sbjct: 203 RPASPSPSPSGTSAAIVVGVAAGAA----LLFALAWWLR-RKLQGHFLDVPAEEDPEVYL 257
Query: 286 GHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQF 345
G KR++ +EL AT FS +N+LG+G FGI+YKG +D LVAVKRL + GGE+QF
Sbjct: 258 GQFKRFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNEERTKGGELQF 317
Query: 346 QTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
QTEVE IS+AVHRNLLRL GFC T ERLLVYPYM NGSVAS LR+ G PALDW +RK
Sbjct: 318 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKRK 377
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
IALG+ARGL YLH+ CD KIIH DVKAANILLDE+FEAVVGDFGLAKL+++ DSHVTTA
Sbjct: 378 HIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTTA 437
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML-DWV 522
VRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITGQ+A D R AN +ML DWV
Sbjct: 438 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWV 495
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q93ZS4 | NIK3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7934 | 0.9611 | 0.8212 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 540 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-45 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-24 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-24 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-19 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-14 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-13 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 6e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| COG5238 | 388 | COG5238, RNA1, Ran GTPase-activating protein (RanG | 2e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-04 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 4e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.001 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.001 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.001 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.001 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.003 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 3e-46
Identities = 71/194 (36%), Positives = 98/194 (50%), Gaps = 10/194 (5%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
LG GGFG VY G VA+K +K + + + E+E + H N+++L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
EN LV Y GS+ L+++ L RI L GL YLH II
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSN---GII 114
Query: 428 HRDVKAANILLDED-FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-SE 485
HRD+K NILLD D + + DFGL+KLL S + T + GT ++APE L SE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSE 173
Query: 486 KTDVFGFGILLLEL 499
K+D++ G++L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 3e-45
Identities = 68/201 (33%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 306 KNILGRGGFGIVYKGCFSD-----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
LG G FG VYKG VAVK LK+ +F E + H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
++L G C+ E +V YM G + S LR + RP L + AL ARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLES 120
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
+ IHRD+ A N L+ E+ + DFGL++ L D + + + +APE L
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 481 GQSSEKTDVFGFGILLLELIT 501
G+ + K+DV+ FG+LL E+ T
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 7e-45
Identities = 126/435 (28%), Positives = 212/435 (48%), Gaps = 41/435 (9%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L L SG + +G+L++L + L N + G IP L +KL +LDLS+N+ +G+I
Sbjct: 480 LDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQI 539
Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTF 194
P S ++ L+ L L+ N L+G P++L +ESL V++S+N+L GSLP A
Sbjct: 540 PASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINAS 599
Query: 195 KVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVI 254
V GN +CG T+ LPP K + + + LG AF V+
Sbjct: 600 AVAGNIDLCGGDTTS----------GLPP--CKRVRKTPSWWFYITCTLG-----AFLVL 642
Query: 255 IVVGL-LVWLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGG 313
+V V++R R+N ++ N+ E+ K + S+ +N++ RG
Sbjct: 643 ALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGK 702
Query: 314 FGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE 372
G YKG +G VK + D N +E+ + H N+++L G C +E
Sbjct: 703 KGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEKG 757
Query: 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVK 432
L++ Y+ +++ LR+ L W RR++IA+G A+ L +LH +C P ++ ++
Sbjct: 758 AYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS 810
Query: 433 AANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 492
I++D E + L LL ++ ++APE T +EK+D++GF
Sbjct: 811 PEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKSDIYGF 864
Query: 493 GILLLELITGQRALD 507
G++L+EL+TG+ D
Sbjct: 865 GLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 4e-44
Identities = 66/199 (33%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 308 ILGRGGFGIVYKGCFSDG-----ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG VYKG VAVK LK+ +F E + H N+++
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
L G C+ E ++V YMP G + LR + L + AL ARG+ YL +
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRK--NRPKELSLSDLLSFALQIARGMEYLESK- 122
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
IHRD+ A N L+ E+ + DFGL++ L D + + + +APE L G+
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 483 SSEKTDVFGFGILLLELIT 501
+ K+DV+ FG+LL E+ T
Sbjct: 181 FTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 6e-44
Identities = 67/202 (33%), Positives = 95/202 (47%), Gaps = 10/202 (4%)
Query: 303 FSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
+ LG G FG VY G LVA+K +K I + E++ + H N++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
RL E++ LV Y G L D + R L + L YLH +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGD----LFDLLKKRGRLSEDEARFYLRQILSALEYLHSK 116
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
I+HRD+K NILLDED + DFGLA+ LD +TT V GT ++APE L
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLDP-GEKLTTFV-GTPEYMAPEVLLGK 171
Query: 482 QSSEKTDVFGFGILLLELITGQ 503
+ D++ G++L EL+TG+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 3e-43
Identities = 67/207 (32%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 307 NILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG VYKG VAVK LK+ F E + H N++R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDH-----IHGRPALDWARRKRIALGTARGLLY 417
L G C+ E LV YM G + LR + L A+ A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI---A 474
L + K +HRD+ A N L+ ED + DFGL++ + D + G I A
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK--TGGKLPIRWMA 175
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELIT 501
PE L G + K+DV+ FG+LL E+ T
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 6e-43
Identities = 76/199 (38%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 308 ILGRGGFGIVYKGCF-SDGALVAVKRL-KDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
LG G FG VYK G +VAVK L K + + + E+ + H N++RL
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
++ LV Y G L D++ L K+IAL RGL YLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGD----LFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ-SS 484
IIHRD+K NILLDE+ + DFGLAK L S +TT V GT ++APE L G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 485 EKTDVFGFGILLLELITGQ 503
K DV+ G++L EL+TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 149 bits (380), Expect = 1e-41
Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 309 LGRGGFGIVYKG-----CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
LG G FG VYKG VAVK LK+ +F E + H N++RL
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
G C+ +V YMP G + LR H L ++AL A+G+ YL +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTVGHIAPEYL 478
+HRD+ A N L+ E+ + DFGL++ + D + ++ APE L
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM----APESL 176
Query: 479 STGQSSEKTDVFGFGILLLELITG 502
G+ + K+DV+ FG+LL E+ T
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 1e-32
Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 307 NILGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAGGEV-QFQTEVETISLAVHRNLLRL 363
+LGRG FG VY G L+AVK ++ + E+ + E+ +S H N++R
Sbjct: 6 ELLGRGSFGSVYLA-LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 364 CGFCSTE--NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
G E N + Y+ GS L + L ++ GL YLH
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGS----LSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL-DHRDSHVTTAVRGTVGHIAPEYLST 480
I+HRD+K ANIL+D D + DFG AK L D T +VRGT +APE +
Sbjct: 121 ---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 481 GQSSEKTDVFGFGILLLELITGQR 504
+ D++ G ++E+ TG+
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 76/225 (33%), Positives = 105/225 (46%), Gaps = 21/225 (9%)
Query: 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
+G+G FG V G + G VAVK LKD + F E ++ H NL++L G
Sbjct: 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDD--STAAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
N +V YM GS+ LR GR + A++ AL G+ YL E+
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---N 122
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-RGTVGHIAPEYLSTGQSS 484
+HRD+ A N+L+ ED A V DFGLAK ++ + V APE L + S
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALREKKFS 177
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVCSHILSN 529
K+DV+ FGILL E+ + FGR R + L V H+
Sbjct: 178 TKSDVWSFGILLWEIYS------FGRVPYPR-IPLKDVVPHVEKG 215
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 10/204 (4%)
Query: 302 NFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
N+ +++GRG FG+VYKG G VA+K++ I ++ E++ + H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
+++ G T + ++ Y NGS+ ++ P A L +GL YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVL---QGLAYLH 116
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
EQ +IHRD+KAANIL +D + DFG+A L+ S +V GT +APE +
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIE 172
Query: 480 TGQSSEKTDVFGFGILLLELITGQ 503
+S +D++ G ++EL+TG
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 12/197 (6%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
+G+GGFG VYK G VA+K +K + + E++ + H N+++ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIK-LESKEKKEKIINEIQILKKCKHPNIVKYYG-S 65
Query: 368 STENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
+ + L +V + GS+ L+ A + +GL YLH I
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY---VCKELLKGLEYLHSN---GI 119
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
IHRD+KAANILL D E + DFGL+ L + T GT +APE ++ K
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYDYK 177
Query: 487 TDVFGFGILLLELITGQ 503
D++ GI +EL G+
Sbjct: 178 ADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 73/204 (35%), Positives = 107/204 (52%), Gaps = 8/204 (3%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
F+ + LG G FG V++G + + VA+K LK ++ + FQ EV+ + H++L
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHL 64
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
+ L CS ++ M GS+ + LR G+ L A +A A G+ YL E
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQ-VLPVASLIDMACQVAEGMAYLEE 122
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
Q IHRD+ A NIL+ ED V DFGLA+L+ D ++++ + APE S
Sbjct: 123 Q---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAPEAASH 178
Query: 481 GQSSEKTDVFGFGILLLELIT-GQ 503
G S K+DV+ FGILL E+ T GQ
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQ 202
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 307 NILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQ---FQTEVETISLAVHR 358
LG G FG V + + G VAVK L N +G E F+ E+E + H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL---NHSGEEQHRSDFEREIEILRTLDHE 66
Query: 359 NLLRLCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
N+++ G C R L+ Y+P+GS+ L+ H R ++ R + +G+
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMD 123
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIA 474
YL Q + IHRD+ A NIL++ + + DFGLAK+L + G + A
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELIT 501
PE L T + S +DV+ FG+ L EL T
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 75/215 (34%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRL-KDYNIAGGEV-QFQTEVETI-SLAVHR 358
++ LG G FG VY D LVA+K L K EV +F E++ + SL
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
N+++L F E LV Y+ GS+ L+ P L + I L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGP-LSESEALFILAQILSALEYL 117
Query: 419 HEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAKLLDHRDSHV-----TTAVRGTVGH 472
H + IIHRD+K NILLD D + DFGLAKLL S + GT G+
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 473 IAPEYL---STGQSSEKTDVFGFGILLLELITGQR 504
+APE L S +S +D++ GI L EL+TG
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
S+ +LG+G G+VYK G + A+K++ Q E++T+
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 360 LLRLCG-FCSTENERL-LVYPYMPNGSVASRLRDHIH-GRPALDWARRKRIALGTARGLL 416
+++ G F + +V YM GS+A L+ P L IA +GL
Sbjct: 61 VVKCYGAFYK--EGEISIVLEYMDGGSLADLLKKVGKIPEPVL-----AYIARQILKGLD 113
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
YLH IIHRD+K +N+L++ E + DFG++K+L++ T V GTV +++PE
Sbjct: 114 YLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE 170
Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQ 503
+ S D++ G+ LLE G+
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 25/228 (10%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLAVHRN 359
+ +G+G FG VY SDG L +K + N++ E + EV+ + H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 360 LLRLCGFCSTENERLL-VYPYMPNGSVASRLRDHIH-GRP-----ALDWARRKRIALGTA 412
+++ E +L V Y G ++ +++ G+P LDW + + L
Sbjct: 61 IIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA-- 115
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
L YLH + KI+HRD+K NI L + +GDFG++K+L T V GT +
Sbjct: 116 --LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYY 169
Query: 473 IAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVML 519
++PE L + + K+D++ G +L EL T + + N + L
Sbjct: 170 LSPE-LCQNKPYNYKSDIWSLGCVLYELCTLKHPFE---GENLLELAL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-24
Identities = 76/245 (31%), Positives = 100/245 (40%), Gaps = 54/245 (22%)
Query: 34 EVVALVAVKNNLHDPYNVLENWDITSVDPCS-----WRMITCSPDG-----YVSALGLPS 83
EV AL +K++L P W+ DPC W C D ++ LGL +
Sbjct: 373 EVSALQTLKSSLGLPLRF--GWN---GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDN 427
Query: 84 QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
Q L G + I L LQS+ L N+I G IP SLG + L+ LDLS N F G IP+SLG
Sbjct: 428 QGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG 487
Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLIC 203
L +L L LN NSL+G P +L G A F T N +C
Sbjct: 488 QLTSLRILNLNGNSLSGRVPAAL-----------------GGRLLHRAS-FNFTDNAGLC 529
Query: 204 GPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVWL 263
G C G K + +A G S F+ +V+ + W
Sbjct: 530 GIPGLRACGPHLS---------------VGAK---IGIAFGVSVA---FLFLVICAMCWW 568
Query: 264 RYRHN 268
+ R N
Sbjct: 569 KRRQN 573
|
Length = 623 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ G ++ VAVK LK ++ F E + + H L++L CS
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA--FLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 369 TENERLLVYPYMPNGSVASRLRD----HIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
E +V YM GS+ L+ + +D +A A G+ YL +
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD------MAAQIAEGMAYLESR--- 122
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
IHRD+ A NIL+ E+ + DFGLA+L++ + + + APE + G+ +
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFT 182
Query: 485 EKTDVFGFGILLLELIT 501
K+DV+ FGILL E++T
Sbjct: 183 IKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 69/203 (33%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 307 NILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++G+G FG VY G D AVK L QF E + H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 363 LCGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
L G C +E L+V PYM +G + + +R H D L A+G+ YL +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG---FGLQVAKGMEYLASK 117
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL---DHRDSHVTTAVRGTVGHIAPEYL 478
K +HRD+ A N +LDE F V DFGLA+ + ++ H T + V +A E L
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
T + + K+DV+ FG+LL EL+T
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 308 ILGRGGFGIVYKGCF---SDGAL--VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
+LG G FG VYKG + + VA+K L++ + E ++ H +++R
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTARGLLYLH 419
L G C + + L+ MP G + +R+H I + L+W + A+G+ YL
Sbjct: 74 LLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYL 478
E+ +++HRD+ A N+L+ + DFGLAKLLD + + + +A E +
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 479 STGQSSEKTDVFGFGILLLELIT-GQR 504
+ K+DV+ +G+ + EL+T G +
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 307 NILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++G G FG V +G VA+K LK + + F TE + H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
L G + +++ YM NGS+ LR++ + + G A G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTVGHIAPEY 477
+HRD+ A NIL++ + V DFGL++ L+ ++ TT +R T APE
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEA 179
Query: 478 LSTGQSSEKTDVFGFGILLLELIT-GQR 504
++ + + +DV+ FGI++ E+++ G+R
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 59/155 (38%), Positives = 90/155 (58%), Gaps = 4/155 (2%)
Query: 34 EVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPW 93
E+ L++ K++++DP L NW+ +S D C W+ ITC+ V ++ L +++SG +S
Sbjct: 30 ELELLLSFKSSINDPLKYLSNWN-SSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSA 88
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKL-EKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152
I L +Q++ L NN + GPIP + L+ L+LSNN FTG IP G + NL L
Sbjct: 89 IFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146
Query: 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
L+NN L+G P + SL ++DL N L G +P
Sbjct: 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181
|
Length = 968 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 69/201 (34%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 309 LGRGGFGIVYKGCF--SDGALVAVKRL-KDYNIAGGEV-QFQTEVETISLAVHRNLLRL- 363
LG+G FG V G L A+K L K I EV TE +S H +++L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 364 CGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
F E+L LV Y P G L H+ R + A L YLH
Sbjct: 60 YAF--QTEEKLYLVLEYAPGGE----LFSHLSKEGRFSEERARFYAAEIVLALEYLHSL- 112
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
II+RD+K NILLD D + DFGLAK L S T GT ++APE L
Sbjct: 113 --GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKG 169
Query: 483 SSEKTDVFGFGILLLELITGQ 503
+ D + G+LL E++TG+
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 7e-23
Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
+G+G FG VYKG VAVK + + +F E E + H N+++L G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
+ +V +P GS+ + LR + L + +++L A G+ YL + IH
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT----VGHIAPEYLSTGQSS 484
RD+ A N L+ E+ + DFG+++ + + T G + APE L+ G+ +
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173
Query: 485 EKTDVFGFGILLLELITG 502
++DV+ +GILL E +
Sbjct: 174 SESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 8e-23
Identities = 67/205 (32%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 307 NILGRGGFGIVYKG-CFSDGALVAVKR--LKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
++G G +VY C + VA+KR L+ + E++ EV+ +S H N+++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELR--KEVQAMSQCNHPNVVKY 64
Query: 364 CGFCS-TENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
+ S + L LV PY+ GS+ ++ + R LD A + +GL YLH
Sbjct: 65 --YTSFVVGDELWLVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGL-AKLLDHRD--SHVTTAVRGTVGHIAPEYL 478
IHRD+KA NILL ED + DFG+ A L D D V GT +APE +
Sbjct: 122 ---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 479 STGQS-SEKTDVFGFGILLLELITG 502
K D++ FGI +EL TG
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 309 LGRGGFGIVYKGC---FSDGAL---VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG+VY+G G VA+K + + ++F E + +++R
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR------DHIHGRPALDWARRKRIALGTARGLL 416
L G ST L+V M G + S LR ++ G + ++A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAP 475
YL + K +HRD+ A N ++ ED +GDFG+ + + D + V +AP
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 476 EYLSTGQSSEKTDVFGFGILLLELIT 501
E L G + K+DV+ FG++L E+ T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 3e-22
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 8/202 (3%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
++ + K+ LG G +G VY+G + VAVK LK+ + E F E + H N
Sbjct: 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPN 63
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
L++L G C+ E ++ +M G++ LR+ R ++ +A + + YL
Sbjct: 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE 121
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
++ IHRD+ A N L+ E+ V DFGL++L+ + + APE L+
Sbjct: 122 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 178
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
+ S K+DV+ FG+LL E+ T
Sbjct: 179 YNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 36/221 (16%)
Query: 306 KNILGRGGFGIVYKG-CFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
K LG G FG V+ G C+ D LVAVK LK+ F+ E E ++ H N
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA--LDWARRK----------RI 407
+++ G C+ + ++V+ YM +G + LR HG A L +I
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRS--HGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
A+ A G++YL Q +HRD+ N L+ D +GDFG++ RD + T R
Sbjct: 128 AVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMS-----RDVYTTDYYR 179
Query: 468 GTVGH-------IAPEYLSTGQSSEKTDVFGFGILLLELIT 501
GH + PE + + + ++DV+ FG++L E+ T
Sbjct: 180 -VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 20/210 (9%)
Query: 308 ILGRGGFGIVYKGCFSD-GALVAVKRLK-DYNIAGGEVQFQ--------TEVETISLAVH 357
++G+G +G VY G ++AVK+++ IAG Q +E+ET+ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
N+++ GF +TE + Y+P GS+ S LR + L + GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFFTEQVLEGLAY 123
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPE 476
LH + I+HRD+KA N+L+D D + DFG++K D D+ +++G+V +APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 477 YLSTGQS--SEKTDVFGFGILLLELITGQR 504
+ + S K D++ G ++LE+ G+R
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 9e-22
Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V++G +++ VAVK LK + + F E + + H L++L C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD--FLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
E +V M GS+ L+ GR AL + +A A G+ YL Q IH
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQ-GGAGR-ALKLPQLIDMAAQVASGMAYLEAQ---NYIH 126
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
RD+ A N+L+ E+ V DFGLA+++ + + APE + S K+D
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 489 VFGFGILLLELITGQRALDFGR 510
V+ FGILL E++T +GR
Sbjct: 187 VWSFGILLTEIVT------YGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 309 LGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
LG+G FG V + + G +VAVK+L+ ++ A F+ E+E + H N+++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-HSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 364 CGFCSTENER--LLVYPYMPNGSVASRLRDH-IHGRPALDWARRKRIALGTARGLLYLHE 420
G C + R LV Y+P GS LRD+ R LD + A +G+ YL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGS----LRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYL 478
+ + +HRD+ NIL++ + +GDFGL K+L D V + APE L
Sbjct: 127 K---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
+ + S +DV+ FG++L EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 2e-21
Identities = 66/199 (33%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 309 LGRGGFGIVYKGCFSDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
LG G FG+V +G +S VAVK LK ++ F E + H NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
G T ++V P GS+ RLR + A+ A G+ YL +
Sbjct: 63 GVVLTH-PLMMVTELAPLGSLLDRLRKD--ALGHFLISTLCDYAVQIANGMRYLESK--- 116
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV--GHIAPEYLSTGQ 482
+ IHRD+ A NILL D + +GDFGL + L + H V APE L T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 483 SSEKTDVFGFGILLLELIT 501
S +DV+ FG+ L E+ T
Sbjct: 177 FSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 4e-21
Identities = 69/204 (33%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
I+G G FG V +G ++ G VAVK +K A F E ++ H+NL+RL G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
N +V M G++ + LR GR + + + +L A G+ YL + K++
Sbjct: 69 -LHNGLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLV 122
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
HRD+ A NIL+ ED A V DFGLA++ S + V APE L + S K+
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKS 178
Query: 488 DVFGFGILLLELITGQRALDFGRA 511
DV+ +G+LL E+ + +GRA
Sbjct: 179 DVWSYGVLLWEVFS------YGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 4e-21
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 307 NILGRGGFGIVYKGCFSDGALVAVKR--LKDYNIAGGEVQF---QTEVETISLAVHRNLL 361
+LG+G +G VY G + G L+AVK+ L N+ E ++ Q EV+ + H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
+ G C +N + ++P GS++S L P + + + L G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFCKYTKQIL---DGVAYLHNN 121
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT-----TAVRGTVGHIAPE 476
C ++HRD+K N++L + + DFG A+ L H T ++ GT +APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQ 503
++ K+D++ G + E+ TG+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 309 LGRGGFGIVYKGCF--SDGAL--VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
LG G FG V KG + G VAVK LK +IA G+ +F E ++ H ++RL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
G C E +LV P G L ++ R + + K +A A G+ YL +
Sbjct: 63 GVCKGE-PLMLVMELAPLGP----LLKYLKKRREIPVSDLKELAHQVAMGMAYLESK--- 114
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH--VTTAVRGTVGHIAPEYLSTGQ 482
+HRD+ A N+LL +A + DFG+++ L + TTA R + APE ++ G+
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 483 SSEKTDVFGFGILLLELIT-GQR 504
S K+DV+ +G+ L E + G +
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 66/226 (29%), Positives = 106/226 (46%), Gaps = 23/226 (10%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEV--ETISLAV--H 357
+F N +G+G FG+V+K V +K +++ + + E E LA
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYA--MKQIDLSKMNRREREEAIDEARVLAKLDS 58
Query: 358 RNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALD---WARRKRIALGTAR 413
++R + +L +V Y NG + L+ GRP + W R +
Sbjct: 59 SYIIRYYE-SFLDKGKLNIVMEYAENGDLHKLLKMQ-RGRPLPEDQVW----RFFIQILL 112
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
GL +LH + KI+HRD+K+ N+ LD +GD G+AKLL + T V GT ++
Sbjct: 113 GLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYL 168
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML 519
+PE +EK+DV+ G++L E TG+ D A NQ ++L
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALIL 211
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 13/211 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
S+ + + ++G G FG V++G VA+K LK F +E +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
H N++RL G + +++ YM NG++ LRDH + R G A G+
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMK 121
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIA 474
YL D +HRD+ A NIL++ + E V DFGL+++L D ++ T+ + + A
Sbjct: 122 YL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
PE ++ + + +DV+ FGI++ E+++ G+R
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG+V+ G + VA+K +++ ++ E F E + + H NL++L G C+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
+ +V YM NG + + LR+ G+ +W + + YL IH
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRER-KGKLGTEWLLD--MCSDVCEAMEYLESNG---FIH 123
Query: 429 RDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHVTTAVRGT---VGHIAPEYLSTGQSS 484
RD+ A N L+ ED V DFGLA+ +LD D + T+ +GT V PE + S
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLD--DQY--TSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 485 EKTDVFGFGILLLELITGQRALDFGRAAN 513
K+DV+ FG+L+ E+ + + + + R +N
Sbjct: 180 SKSDVWSFGVLMWEVFSEGK-MPYERFSN 207
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 9/194 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
LG G FG V+ G +++ VAVK LK ++ VQ F E + H L+RL
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
+ E ++ YM GS+ L+ G+ L + + A G+ Y+ + I
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NYI 125
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
HRD++AAN+L+ E + DFGLA++++ + + + APE ++ G + K+
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 488 DVFGFGILLLELIT 501
DV+ FGILL E++T
Sbjct: 186 DVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 61/201 (30%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
LG+GGFG V C + G + A K+L K GE E + + R ++ L
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRKRIALGTARGLLYLHEQC 422
T+++ LV M G L+ HI G P AR A GL +LH++
Sbjct: 60 YAFETKDDLCLVMTLMNGGD----LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR- 114
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
+I++RD+K N+LLD+ + D GLA ++ + GT G++APE L
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEV 170
Query: 483 SSEKTDVFGFGILLLELITGQ 503
D F G L E+I G+
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 68/202 (33%), Positives = 96/202 (47%), Gaps = 17/202 (8%)
Query: 309 LGRGGFGIVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
LG G FG V C+ G +VAVK LK ++ E+ + H N+++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 364 CGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
G CS + + L+ Y+P GS LRD++ + L+ A+ A G+ YLH Q
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGS----LRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEYLS 479
IHRD+ A N+LLD D +GDFGLAK + H V V A E L
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
+ S +DV+ FG+ L EL+T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 5e-20
Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 6/191 (3%)
Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
+LG+G FG V+KG D VAVK K+ +++F +E + H N+++L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
+ +V +P G S LR + L + + AL A G+ YL + I
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCI 115
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
HRD+ A N L+ E+ + DFG+++ D + + + APE L+ G+ S ++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 488 DVFGFGILLLE 498
DV+ +GILL E
Sbjct: 176 DVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 8e-20
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 33/210 (15%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVKR--LKDYNIAGGEV--QFQTEVETISLAVHRNLLRL 363
LG G FG VY+G D G AVK L D G E Q + E+ +S H N+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 364 CGFCSTENERLLVY-PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR---GLLYLH 419
G E + L ++ +P GS+A L+ + I L T + GL YLH
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKY-------GSFPEPVIRLYTRQILLGLEYLH 119
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT-----AVRGTVGHIA 474
++ +HRD+K ANIL+D + + DFG+AK V + +G+ +A
Sbjct: 120 DR---NTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGSPYWMA 169
Query: 475 PEYL-STGQSSEKTDVFGFGILLLELITGQ 503
PE + G D++ G +LE+ TG+
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 8e-20
Identities = 54/193 (27%), Positives = 93/193 (48%), Gaps = 8/193 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
+G G FG+V+ G + + VA+K +++ A E F E + + H L++L G C+
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREG--AMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
+ LV+ +M +G ++ LR R + L G+ YL +IH
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
RD+ A N L+ E+ V DFG+ + + +T + V +PE S + S K+D
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 489 VFGFGILLLELIT 501
V+ FG+L+ E+ +
Sbjct: 184 VWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 9e-20
Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 308 ILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNL 360
LG G FG V K ++ + VAVK LKD +E+E + + H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDH---------IHGRPALDWARRKRI---A 408
+ L G C+ E +V Y +G++ LR RP + +K + A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVR 467
ARG+ +L + K IHRD+ A N+L+ ED + DFGLA+ + H D + TT R
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
V +APE L + ++DV+ FG+LL E+ T
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-19
Identities = 54/141 (38%), Positives = 77/141 (54%), Gaps = 5/141 (3%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L L +L+G + +GNL LQ + L N + GPIP S+ L+KL +LDLS+N +GEI
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300
Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTG 198
P+ + L NL L L +N+ TG P +L+ + L ++ L N SG +PK +
Sbjct: 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH----- 355
Query: 199 NPLICGPKATNNCTAVFPEPL 219
N L +TNN T PE L
Sbjct: 356 NNLTVLDLSTNNLTGEIPEGL 376
|
Length = 968 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 308 ILGRGGFGIVYKGCFS--DGAL--VAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLR 362
ILG G FG V +G S DG+ VAVK +K E++ F +E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 363 LCGFCSTENER------LLVYPYMPNGSVASRL-RDHIHGRPA-LDWARRKRIALGTARG 414
L G C + +++ P+M +G + S L + G P L + + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT-AVRGTVGHI 473
+ YL + IHRD+ A N +L ED V DFGL+K + D + + V I
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELIT-GQ 503
A E L+ + K+DV+ FG+ + E+ T GQ
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 60/205 (29%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 303 FSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
F LG G +G VYK G +VA+K + + + E+ + ++
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIV 61
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
+ G + +V Y GSV+ ++ I + L I T +GL YLH
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKT-LTEEEIAAILYQTLKGLEYLHSN 118
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV-G---HIAPEY 477
K IHRD+KA NILL+E+ +A + DFG++ L T A R TV G +APE
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNTVIGTPFWMAPEV 170
Query: 478 LSTGQSSEKTDVFGFGILLLELITG 502
+ + K D++ GI +E+ G
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 63/217 (29%), Positives = 91/217 (41%), Gaps = 42/217 (19%)
Query: 303 FSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
F+ +G+G FG VYK +VA+K + ++ E E+E I + L
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI---DLEEAE----DEIEDIQQEI--QFL 53
Query: 362 RLC---------GFCSTENERL-LVYPYMPNGSVASRLR------DHIHGRPALDWARRK 405
C G + +L ++ Y GS L+ +I
Sbjct: 54 SQCRSPYITKYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYI-----------A 101
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
I GL YLHE+ IHRD+KAANILL E+ + + DFG++ L S T
Sbjct: 102 FILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF 158
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
V GT +APE + EK D++ GI +EL G
Sbjct: 159 V-GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-19
Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ G ++ VA+K LK +++ F E + H L+RL
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVV- 70
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI--ALGTARGLLYLHEQCDPKI 426
T+ ++ YM NGS L D + + K I A A G+ ++ +
Sbjct: 71 TQEPIYIITEYMENGS----LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NY 123
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
IHRD++AANIL+ E + DFGLA+L++ + + + APE ++ G + K
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 487 TDVFGFGILLLELITGQR 504
+DV+ FGILL E++T R
Sbjct: 184 SDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 70/209 (33%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
+G+G FG V G + G VAVK +K+ A F E ++ H NL++L G
Sbjct: 13 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 368 STENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
E L +V YM GS+ LR GR L + +L + YL
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
+HRD+ A N+L+ ED A V DFGL K V+ T APE L + S K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 179
Query: 487 TDVFGFGILLLELITGQRALDFGRAANQR 515
+DV+ FGILL E+ + FGR R
Sbjct: 180 SDVWSFGILLWEIYS------FGRVPYPR 202
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 5e-19
Identities = 67/218 (30%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 307 NILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGE-VQFQTEVETISLAVHRNLLRLC 364
+G+G FG V K SDG ++ K + N+ E Q +EV + H N++R
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 365 G-FCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALD----WARRKRIALGTARGLLYL 418
N+ L +V Y G +A ++ R ++ W RI L
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLLALYEC 121
Query: 419 H--EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
H ++HRD+K ANI LD + +GDFGLAK+L H S T V GT +++PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPE 180
Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ 514
L+ EK+D++ G L+ EL F A NQ
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALS--PPF-TARNQ 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 36/229 (15%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRL-KDYNIAGGEVQF-QTEVETIS-LA 355
+F I+G G F V A+K L K I +V++ + E E ++ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVL-AKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN 59
Query: 356 VHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
H +++L + + ++E L V Y PNG L +I +LD + A
Sbjct: 60 GHPGIIKL--YYTFQDEENLYFVLEYAPNGE----LLQYIRKYGSLDEKCTRFYAAEILL 113
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR------ 467
L YLH + IIHRD+K NILLD+D + DFG AK+LD S +
Sbjct: 114 ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 468 -------------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
GT +++PE L+ + + +D++ G ++ +++TG+
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 307 NILGRGGFGIVYKGC-FSDGALVAVK--RLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
N +G G FG VY G L+AVK R++D + + + E++ + L H NL++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIK-EIADEMKVLELLKHPNLVKY 64
Query: 364 CGFCSTENERLLVYPYMP---NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
G E R VY +M G++ L HGR LD + L GL YLH
Sbjct: 65 YG---VEVHREKVYIFMEYCSGGTLEELLE---HGR-ILDEHVIRVYTLQLLEGLAYLHS 117
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG---HIAPEY 477
I+HRD+K ANI LD + +GDFG A L + + + V+ G ++APE
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 478 LSTGQSSEK---TDVFGFGILLLELITGQR 504
++ G+ D++ G ++LE+ TG+R
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 6e-19
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 307 NILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLC 364
+G G +G VYK G LVA+K+++ N G + E++ + H N++RL
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 365 GFCSTENER---LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
T + +V+ YM + + L D + ++ K GL YLH
Sbjct: 65 EIV-TSKGKGSIYMVFEYMDHD--LTGLLDSPEVK--FTESQIKCYMKQLLEGLQYLHSN 119
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL--S 479
I+HRD+K +NIL++ D + DFGLA+ R+S T T+ + PE L +
Sbjct: 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA 176
Query: 480 TGQSSEKTDVFGFGILLLELITG 502
T + + D++ G +L EL G
Sbjct: 177 T-RYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 7e-19
Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 12/195 (6%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG+V G + VA+K +K+ +++ E +F E + + H L++L G C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
+ +V YM NG + + LR+H ++ + G+ YL + + IH
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKR---FQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 429 RDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHVTT-AVRGTVGHIAPEYLSTGQSSEK 486
RD+ A N L+D+ V DFGL++ +LD D + ++ + V PE L + S K
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 487 TDVFGFGILLLELIT 501
+DV+ FG+L+ E+ +
Sbjct: 182 SDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 35/221 (15%)
Query: 306 KNILGRGGFGIVYKG-CFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
K LG G FG V+ C++ D LVAVK LKD +A + FQ E E ++ H +
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-DFQREAELLTNLQHEH 68
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDH-------IHGRP-----ALDWARRKRI 407
+++ G C + ++V+ YM +G + LR H + G+P L ++ I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
A A G++YL Q +HRD+ N L+ + +GDFG++ RD + T R
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS-----RDVYSTDYYR 180
Query: 468 GTVGH-------IAPEYLSTGQSSEKTDVFGFGILLLELIT 501
GH + PE + + + ++DV+ FG++L E+ T
Sbjct: 181 -VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 60/207 (28%), Positives = 88/207 (42%), Gaps = 14/207 (6%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALV-AVKRL-KDYNIAGGEVQ-FQTEVETISLAVHR 358
+F ++G+G FG V D + A+K + K + G V+ E + H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 359 NLLRLC-GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
L+ L F EN LV + G LR H+ + + K L Y
Sbjct: 61 FLVNLWYSFQDEEN-MYLVVDLLLGGD----LRYHLSQKVKFSEEQVKFWICEIVLALEY 115
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
LH + IIHRD+K NILLDE + DF +A + +TT+ GT G++APE
Sbjct: 116 LHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPGYMAPEV 170
Query: 478 LSTGQSSEKTDVFGFGILLLELITGQR 504
L S D + G+ E + G+R
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 65/196 (33%), Positives = 97/196 (49%), Gaps = 8/196 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ G ++ VAVK LK ++ F E + + H L++L S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
E +V YM GS+ L+D GR AL +A A G+ Y+ IH
Sbjct: 72 -EEPIYIVTEYMSKGSLLDFLKDG-EGR-ALKLPNLVDMAAQVAAGMAYIERM---NYIH 125
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
RD+++ANIL+ + + DFGLA+L++ + + + APE G+ + K+D
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 489 VFGFGILLLELITGQR 504
V+ FGILL EL+T R
Sbjct: 186 VWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 23/218 (10%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEVQFQTEVETI-SLAV 356
++ ++++G G FG V K L A+KR+K+Y F E+E + L
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH--IHGRPALDWARRKRIALGT--- 411
H N++ L G C L Y P+G++ LR + PA A L +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 412 -------ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-T 463
ARG+ YL ++ + IHRD+ A NIL+ E++ A + DFGL++ ++ +V
Sbjct: 127 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 180
Query: 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
T R V +A E L+ + +DV+ +G+LL E+++
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS--DGALVAVKRL---KDYNIAGGEV-QFQTEVETISLA 355
N+ +LG+G FG VY C+ G +AVK++ D EV + E++ +
Sbjct: 3 NWRRGKLLGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 356 VHRNLLRLCGFCSTENERLLVY-PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
H +++ G C ++E L ++ YMP GSV +D + AL ++ G
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSV----KDQLKAYGALTETVTRKYTRQILEG 116
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT--TAVRGTVGH 472
+ YLH I+HRD+K ANIL D +GDFG +K L S T +V GT
Sbjct: 117 VEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELIT 501
++PE +S K DV+ G ++E++T
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-18
Identities = 43/119 (36%), Positives = 68/119 (57%), Gaps = 3/119 (2%)
Query: 72 PDGYVS---ALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLD 128
P G + L L + LSG + IG+ + L+ + L N ++G IP SL L L+ L
Sbjct: 135 PRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLT 194
Query: 129 LSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
L++N+ G+IP LG + +L ++ L N+L+G P + + SL +DL YNNL+G +P
Sbjct: 195 LASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-18
Identities = 48/110 (43%), Positives = 61/110 (55%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L L S + +G + + +L +LQ + L +N G IP +LGK L LDLS N TGEI
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372
Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
P+ L GNL L L +NSL G P+SL SL V L N+ SG LP
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
|
Length = 968 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 70/214 (32%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 307 NILGRGGFGIVYKGCFSD-------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
N LG G FG VY+G +D VAVK L+ + +F E +S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRD---HIHGRPALDWARRKRIALGTARGLL 416
+++L G C + ++ M G + S LRD G P L I L A+G +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 417 YLHEQCDPKIIHRDVKAANILLDE---DFEAVV--GDFGLAKLLDHRDSHVTTAVRG--- 468
YL IHRD+ A N L+ E D + VV GDFGLA+ + D + G
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEGL 174
Query: 469 -TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
V +APE L G+ + ++DV+ FG+L+ E++T
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 7e-18
Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 29/213 (13%)
Query: 308 ILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQ-----------FQTEVETISLA 355
++G G FG VY G S G L+AVK+++ + E+ +
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVE---LPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 356 VHRNLLRLCGFCSTENERLLVY-PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
H N+++ G S + + L ++ Y+P GSVA+ L ++ A + + +G
Sbjct: 64 QHENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKG 118
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT-----AVRGT 469
L YLH + IIHRD+K ANIL+D + DFG++K L+ T +++G+
Sbjct: 119 LNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
V +APE + + K D++ G L++E++TG
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 21/204 (10%)
Query: 308 ILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV----HR 358
+LG G FG V+KG + S VA+K ++D + G FQ E+ LA+ H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQ-EITDHMLAMGSLDHA 69
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
++RL G C + +L V P GS+ +R H R +LD R + A+G+ YL
Sbjct: 70 YIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYL 125
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEY 477
E ++HR++ A NILL D + DFG+A LL D + + + + +A E
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 478 LSTGQSSEKTDVFGFGILLLELIT 501
+ G+ + ++DV+ +G+ + E+++
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 64/198 (32%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPA--LDWARRKRIALGTARGLLYLHEQCDPKI 426
E +V YM GS L D + G L + +A A G+ Y+
Sbjct: 72 -EEPIYIVTEYMSKGS----LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 123
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
+HRD++AANIL+ E+ V DFGLA+L++ + + + APE G+ + K
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 487 TDVFGFGILLLELITGQR 504
+DV+ FGILL EL T R
Sbjct: 184 SDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 46/114 (40%), Positives = 64/114 (56%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L L S L G + +G + L+ + L N + G IP +G L L LDL N TG I
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISAR 192
P SLG+L NL YL L N L+G P S+ ++ L +DLS N+LSG +P++ +
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
|
Length = 968 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 71/248 (28%), Positives = 121/248 (48%), Gaps = 20/248 (8%)
Query: 302 NFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHR 358
+ ++GRG FGIV+ C +D LV +K++ + E Q E + + L H
Sbjct: 1 KYEKIRVVGRGAFGIVHL-CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
N++ + ++V Y P G++A ++ LD I + LL L
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR--CNSLLD---EDTILHFFVQILLAL 114
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
H I+HRD+K NILLD+ V +GDFG++K+L + T V GT +I+PE
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPEL 172
Query: 478 LSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVCSHI--LSNQSSLD- 534
++K+D++ G +L EL + +RA + AAN ++L + +S++ S D
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAFE---AANLPALVLKIMSGTFAPISDRYSPDL 229
Query: 535 --MVLNLL 540
++L++L
Sbjct: 230 RQLILSML 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 5e-17
Identities = 66/237 (27%), Positives = 107/237 (45%), Gaps = 42/237 (17%)
Query: 287 HLKRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFS-----DGALVAVKRLKDYNIAG 340
H+KR+ N K LG G FG V+ C++ D LVAVK LKD +
Sbjct: 1 HIKRH----------NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DN 49
Query: 341 GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH-------I 393
F E E ++ H ++++ G C + ++V+ YM +G + LR H
Sbjct: 50 ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMA 109
Query: 394 HGRPALDWARRK--RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451
G + + + IA A G++YL Q +HRD+ N L+ E+ +GDFG+
Sbjct: 110 EGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGM 166
Query: 452 AKLLDHRDSHVTTAVRGTVGH-------IAPEYLSTGQSSEKTDVFGFGILLLELIT 501
+ RD + T R GH + PE + + + ++DV+ G++L E+ T
Sbjct: 167 S-----RDVYSTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 9e-17
Identities = 42/110 (38%), Positives = 64/110 (58%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L L L G + + NLT L+ + L +N ++G IP LG+++ L+ + L N +GEI
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
P +G L +LN+L L N+LTG P SL +++L + L N LSG +P
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278
|
Length = 968 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 70/206 (33%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 308 ILGRGGFGIV----YKGCFSDGALVAVKRLK-DYNIAGGEVQ-FQTE---VETISLAVHR 358
+LGRG FG V YK G L A+K LK IA EV+ E ET + H
Sbjct: 6 VLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
L+ L TE+ V Y G L HIH R A GL YL
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGD----LMMHIH-TDVFSEPRAVFYAACVVLGLQYL 117
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL-LDHRDSHVTTAVRGTVGHIAPEY 477
HE KI++RD+K N+LLD + + DFGL K + D T+ GT +APE
Sbjct: 118 HEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEV 172
Query: 478 LSTGQSSEKTDVFGFGILLLELITGQ 503
L+ + D +G G+L+ E++ G+
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 66/210 (31%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 307 NILGRGGFGIVYKGCFS--DGAL----VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
LG G FG VY+G + DG VAVK L + E F E +S H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR------IALGTARG 414
+RL G R ++ M G + S LR RP + A A+G
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLR---ENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 415 LLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHRDSHVTTAVRGT-- 469
YL E IHRD+ A N LL A + DFG+A+ + +R S+ R
Sbjct: 129 CKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI-YRASYYRKGGRAMLP 184
Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLEL 499
+ + PE G + KTDV+ FG+LL E+
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 19/203 (9%)
Query: 308 ILGRGGFGIVYKGCF-SDGALV----AVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
+LG G FG VYKG + +G V A+K L + V+F E ++ H +L+R
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTARGLLYLH 419
L G C + +L V MP+G + + +H I + L+W + A+G++YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWC------VQIAKGMMYLE 126
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT-AVRGTVGHIAPEYL 478
E+ +++HRD+ A N+L+ + DFGLA+LL+ + + + +A E +
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
+ + ++DV+ +G+ + EL+T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 17/206 (8%)
Query: 309 LGRGGFGIVYKGCFSDG---ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
+G G FG V G G A V VK L+ ++ F EV+ H N+L+ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 366 FCSTENERLLVYPYMPNGSVASRLR-DHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
C LLV + P G + + LR + +R+A A GLL+LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG--HIAPEYLSTGQ 482
IH D+ N L D +GD+GLA L + + + T V +APE +
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 483 S-------SEKTDVFGFGILLLELIT 501
++K++++ G+ + EL T
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G FG+VY+G D VAVK + + ++F E + +++R
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLR------DHIHGRPALDWARRKRIALGTARGLL 416
L G S L+V M +G + S LR ++ GRP ++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TV 470
YL+ + K +HRD+ A N ++ DF +GDFG+ RD + T R V
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMT-----RDIYETDYYRKGGKGLLPV 185
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
+APE L G + +D++ FG++L E+ +
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEV---QFQTEVETISLAVHRNLLRLC 364
LG G G+V K G ++AVK ++ + E Q E++ + ++
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIR---LEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
G + + YM GS+ L++ P +IA+ +GL YLHE+
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERIL---GKIAVAVLKGLTYLHEKH-- 120
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
KIIHRDVK +NIL++ + + DFG++ L +S T V GT ++APE + S
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV-GTSSYMAPERIQGNDYS 177
Query: 485 EKTDVFGFGILLLELITGQ 503
K+D++ G+ L+EL TG+
Sbjct: 178 VKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 40/220 (18%)
Query: 309 LGRGGFGIVYKG-CF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG V+ C D LVAVK LK+ + FQ E E +++ H++++R
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVR 71
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG------------ 410
G C+ L+V+ YM +G + LR HG A A + +A G
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRS--HGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 411 -TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
A G++YL +HRD+ N L+ + +GDFG++ RD + T R
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMS-----RDIYSTDYYR-- 179
Query: 470 VGH--------IAPEYLSTGQSSEKTDVFGFGILLLELIT 501
VG + PE + + + ++D++ FG++L E+ T
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 22/211 (10%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRL------KDYNIAGGEVQFQTEVETI 352
+ +G G G VYK G VA+K++ K+ I E+ +
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII--------NEILIM 69
Query: 353 SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
H N++ +E +V YM GS+ + + ++ + +
Sbjct: 70 KDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVL 126
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
+GL YLH Q +IHRD+K+ NILL +D + DFG A L S + V GT
Sbjct: 127 QGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYW 182
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
+APE + K D++ GI+ +E+ G+
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 14/195 (7%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
+GRG FG V+ G +D VAVK ++ + +F E + H N++RL G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
+ + +V + G + LR P L ++ A G+ YL + I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT----VGHIAPEYLSTGQS 483
HRD+ A N L+ E + DFG+++ + V + G V APE L+ G+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 484 SEKTDVFGFGILLLE 498
S ++DV+ FGILL E
Sbjct: 174 SSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG+G FG V+ G ++ VA+K LK + F E + + H L+ L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM--PEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 369 TENERLLVYPYMPNGSVASRLRD----HIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
E +V +M GS+ L++ ++ +D A + A G+ Y+
Sbjct: 72 -EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQ------IADGMAYIERM--- 121
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
IHRD++AANIL+ ++ + DFGLA+L++ + + + APE G+ +
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 485 EKTDVFGFGILLLELITGQR 504
K+DV+ FGILL EL+T R
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 307 NILGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLLR 362
+++G G FG V K L A+KR+K+Y F E+E + L H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRD-----------HIHGRPALDWARRK-RIALG 410
L G C L Y P+G++ LR + + +++ A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGT 469
ARG+ YL ++ + IHRD+ A NIL+ E++ A + DFGL++ ++ +V T R
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
V +A E L+ + +DV+ +G+LL E+++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 63/207 (30%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLK-----DYNIAGGEVQFQTEVETISLAVHRNLLR 362
+G G +G VYK + G LVA+K +K D+ I Q E+ + H N++
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI------IQQEISMLKECRHPNIVA 64
Query: 363 LCGFCSTENERLLVYPYMPNGSVA---SRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
G ++ +V Y GS+ R + L A R L +GL YLH
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPL---SELQIAYVCRETL---KGLAYLH 118
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL- 478
E IHRD+K ANILL ED + + DFG++ L + + + GT +APE
Sbjct: 119 ET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAA 174
Query: 479 --STGQSSEKTDVFGFGILLLELITGQ 503
G K D++ GI +EL Q
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 31/227 (13%)
Query: 296 LRAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETI-S 353
L T F ++G G +G VYK G LVA+K + I E + + E +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD--IIEDEEEEIKEEYNILRK 58
Query: 354 LAVHRNLLRLCGF------CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR- 406
+ H N+ G +++ LV GSV + L + + +R +
Sbjct: 59 YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV-TDLVKGLRKKG-----KRLKE 112
Query: 407 -----IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
I T RGL YLHE K+IHRD+K NILL ++ E + DFG++ LD
Sbjct: 113 EWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169
Query: 462 VTTAVRGTVGHIAPEYLSTGQSSEKT-----DVFGFGILLLELITGQ 503
T + GT +APE ++ + + + DV+ GI +EL G+
Sbjct: 170 RNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 66/198 (33%), Positives = 90/198 (45%), Gaps = 20/198 (10%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQ---TEVETISLAVHRNLLRLC 364
+G G FG VY +VA+K++ Y+ ++Q EV + H N +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
G E+ LV Y GS AS + + +H +P L I G +GL YLH
Sbjct: 82 GCYLREHTAWLVMEYCL-GS-ASDILE-VHKKP-LQEVEIAAICHGALQGLAYLHSHE-- 135
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY---LSTG 481
IHRD+KA NILL E + DFG A L+ +S V GT +APE + G
Sbjct: 136 -RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEG 189
Query: 482 QSSEKTDVFGFGILLLEL 499
Q K DV+ GI +EL
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 30/227 (13%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGA------LVAVKRLKDYNIAGGEVQFQTEVETISLA 355
N LG G FG V K VAVK LK+ + +E +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR------------DHIHGRPALDWAR 403
H ++++L G CS + LL+ Y GS+ S LR D LD
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 404 RKRIALG--------TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455
+ + +G +RG+ YL E K++HRD+ A N+L+ E + + DFGL++ +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 456 DHRDSHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
DS+V + R V +A E L + ++DV+ FG+LL E++T
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 8/196 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG V+ ++ VAVK +K +++ F E + H L++L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE--AFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
E ++ +M GS+ L+ + L + + A G+ ++ ++ IH
Sbjct: 72 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 125
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
RD++AANIL+ + DFGLA++++ + + + APE ++ G + K+D
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 489 VFGFGILLLELITGQR 504
V+ FGILL+E++T R
Sbjct: 186 VWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 62/224 (27%), Positives = 109/224 (48%), Gaps = 31/224 (13%)
Query: 288 LKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF-SDGA----LVAVKRLKDYNIAGGE 342
LK FK+++ +LG G FG VYKG + +G VA+K L++
Sbjct: 4 LKETEFKKIK----------VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 53
Query: 343 VQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPAL 399
+ E ++ + ++ RL G C T +L + MP G + +R+H I + L
Sbjct: 54 KEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLL 112
Query: 400 DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DH 457
+W + A+G+ YL E+ +++HRD+ A N+L+ + DFGLAKLL D
Sbjct: 113 NWC------VQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
Query: 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
++ H + + +A E + + ++DV+ +G+ + EL+T
Sbjct: 164 KEYHAEGG-KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 306 KNILGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLL 361
++++G G FG V + L A+K LK++ F E+E + L H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRD-----------HIHGRPALDWARRK-RIAL 409
L G C + Y P G++ LR HG + +++ + A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRG 468
A G+ YL E+ + IHRD+ A N+L+ E+ + + DFGL++ + +V T R
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRL 180
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
V +A E L+ + K+DV+ FG+LL E+++
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 28/209 (13%)
Query: 308 ILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCG 365
+LG+G +GIVY S +A+K + + + VQ E+ S HRN+++ G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR----IALGTAR---GLLYL 418
S + +P GS+++ LR W K I T + GL YL
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRS--------KWGPLKDNEQTIIFYTKQILEGLKYL 124
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVV--GDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
H+ +I+HRD+K N+L++ + VV DFG +K L + T GT+ ++APE
Sbjct: 125 HDN---QIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPE 179
Query: 477 YLSTGQS--SEKTDVFGFGILLLELITGQ 503
+ G D++ G ++E+ TG+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-15
Identities = 46/111 (41%), Positives = 63/111 (56%)
Query: 78 ALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGE 137
+L L SLSG + + L L+ + L +N G IP +L L +LQ L L +NKF+GE
Sbjct: 288 SLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGE 347
Query: 138 IPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
IP +LG NL L L+ N+LTG PE L +L + L N+L G +PK
Sbjct: 348 IPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK 398
|
Length = 968 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 308 ILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQ--FQTEVETISLAV---HRNLL 361
LG G F Y+ G L+AVK++ E + + + I L H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
R+ G ++ L +M GSV+ L + A A RGL YLHE
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN 122
Query: 422 CDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTA------VRGTVGHIA 474
+IIHRDVK AN+L+D + + + DFG A L + T A + GT+ +A
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL---AAKGTGAGEFQGQLLGTIAFMA 176
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQ 503
PE L Q DV+ G +++E+ T +
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 62/199 (31%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 308 ILGRGGFG-IVYKGCFSDGALVAVKRLK-DYNIAGGEVQ-FQTEVETISLAVHRNLLRLC 364
+LG+G FG ++ G L AVK LK D + +V+ TE +SLA + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
C +RL NG L HI D AR + A L++LH++
Sbjct: 62 YCCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSALMFLHDK--- 115
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
II+RD+K N+LLD + + DFG+ K + T+ GT +IAPE L
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 485 EKTDVFGFGILLLELITGQ 503
D + G+LL E++ G
Sbjct: 175 PSVDWWAMGVLLYEMLCGH 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 30/214 (14%)
Query: 309 LGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG VYKG VA+K LK+ + +F+ E E +S H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRL------------RDHIHGRPALDWARRKRIALG 410
L G C+ E +++ Y+ +G + L + +LD + IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-----SHVTTA 465
A G+ YL +HRD+ A N L+ E + DFGL++ + D S
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 499
VR + PE + G+ + ++D++ FG++L E+
Sbjct: 190 VR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 4e-15
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 308 ILGRGGFG--IVYKGCFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLAVHRNLLRLC 364
+LG+G FG +Y+ D +LV K + ++ E + E+ +SL H N++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL--GTARGLLYLHEQC 422
+N L+ Y G++ D I + + + + Y+H+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLY----DKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA- 120
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
I+HRD+K NI L + +GDFG++K+L S T V GT +++PE +
Sbjct: 121 --GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVK 177
Query: 483 SSEKTDVFGFGILLLELITGQRALDFGRAANQ 514
+ K+D++ G +L EL+T +R D A N
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFD---ATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 303 FSAKNILGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHR 358
F +LG+GGFG V C + G + A KRL+ I GE E + + +
Sbjct: 2 FRQYRVLGKGGFGEVC-ACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLL 416
++ L T++ LV M G L+ HI+ G P + R A GL
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGD----LKFHIYNMGNPGFEEERALFYAAEILCGLE 116
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
LH + ++RD+K NILLD+ + D GLA + +S GTVG++APE
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPE 171
Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQ 503
L+ + + D +G G L+ E+I GQ
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 15/225 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
SN LGRG FG V+ LV VK L+ + +F+ E++
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGS-----VASRLRDHIHGRPALDWARRKRIAL 409
H+N++RL G C ++ Y G A++ +D P L ++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
A G+ +L + +HRD+ A N L+ E V L+K + + + +
Sbjct: 125 QIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ 514
+ +APE + S K+DV+ FG+L+ E+ T Q L F +++
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFYGLSDE 225
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 68/204 (33%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 308 ILGRGGFGIV----YKGCFSDGALVAVKRL-KDYNIAGGEVQF-QTEVETISLA-VHRNL 360
+LG+G FG V KG L AVK L KD + +V+ TE ++LA H L
Sbjct: 2 VLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 361 LRL-CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
+L F T++ V Y+ G L HI D R + A GL +LH
Sbjct: 59 TQLHSCF-QTKDRLFFVMEYVNGGD----LMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
E+ II+RD+K N+LLD + + DFG+ K T+ GT +IAPE LS
Sbjct: 114 ER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEILS 169
Query: 480 TGQSSEKTDVFGFGILLLELITGQ 503
D + G+LL E++ GQ
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 58/192 (30%), Positives = 92/192 (47%), Gaps = 25/192 (13%)
Query: 328 VAVKRLKDYNIAGGEVQFQTEVETISL-AVHRNLLRLCGFCSTENERLLVYPYMPNGSVA 386
VAVK LK +E+E + + H+N++ L G C+ + ++ Y G+
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN-- 110
Query: 387 SRLRDHIHGR--PALDWARRK--------------RIALGTARGLLYLHEQCDPKIIHRD 430
LR+++ R P +++ A ARG+ YL + K IHRD
Sbjct: 111 --LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRD 165
Query: 431 VKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDV 489
+ A N+L+ ED + DFGLA+ + H D + TT R V +APE L + ++DV
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 225
Query: 490 FGFGILLLELIT 501
+ FG+LL E+ T
Sbjct: 226 WSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
LG G FG VYK + L A ++ + E++ F E++ +S H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
EN+ ++ + G++ S + + G L + + + L +LH K+I
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERG---LTEPQIRYVCRQMLEALNFLHSH---KVI 125
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE-- 485
HRD+KA NILL D + + DFG++ T + GT +APE ++ +
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNP 184
Query: 486 ---KTDVFGFGILLLEL 499
K D++ GI L+EL
Sbjct: 185 YDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 24/205 (11%)
Query: 308 ILGRGGFGIVYKG-CFSDGALVAVKRLK----DYNIAG--GEVQFQTEVETISLAVHRNL 360
++GRG +G VY+G G +VA+K + D +++ EV ++ + + N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQ---LRQSQPPNI 64
Query: 361 LRLCGFCSTENERL-LVYPYMPNGSVASRLR-DHIHGRPALDWARRKRIALGTARGLLYL 418
+ G + RL ++ Y GSV + ++ I + R +AL Y+
Sbjct: 65 TKYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALK------YI 117
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
H+ +IHRD+KAANIL+ + DFG+A LL+ S +T V GT +APE +
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVI 173
Query: 479 STGQSSE-KTDVFGFGILLLELITG 502
+ G+ + K D++ GI + E+ TG
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 309 LGRGGFGIVYKGCFSDGAL-------VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
LG+G FG+VY+G + G + VA+K + + ++F E + +++
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRD---HIHGRPALDWARRKRI---ALGTARGL 415
RL G S L++ M G + S LR + P K++ A A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------T 469
YL+ K +HRD+ A N ++ EDF +GDFG+ RD + T R
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT-----RDIYETDYYRKGGKGLLP 184
Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
V ++PE L G + +DV+ FG++L E+ T
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
LG G FG V K + VAVK LKD +E+E + + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWARRK------------ 405
++ L G C+ + ++ Y G+ LR+++ R P +D++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGN----LREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 406 --RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
A ARG+ YL Q K IHRD+ A N+L+ ED + DFGLA+ + + D +
Sbjct: 136 LVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
TT R V +APE L + ++DV+ FG+LL E+ T
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 12/199 (6%)
Query: 309 LGRGGFGIVYK-GCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGF 366
+G G GIV+K G VA+K++ + GG Q E++ + H +++L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 367 CSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
LV YMP ++ LRD L A+ K +G+ Y+H
Sbjct: 68 -FPHGSGFVLVMEYMP-SDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHAN---G 119
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-S 484
I+HRD+K AN+L+ D + DFGLA+L + + + T + APE L +
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 485 EKTDVFGFGILLLELITGQ 503
D++ G + EL+ G
Sbjct: 180 PGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 309 LGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG V + C D G VAVK LK + + E+E + H N+++
Sbjct: 12 LGEGHFGKV-ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRL---RDHIHGRPALDWARRKRIALGTARGLLY 417
G C+ + L+ ++P+GS+ L ++ I+ + L +A + +G+ Y
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQ------ICKGMDY 124
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA--VRGTVGHIAP 475
L + + +HRD+ A N+L++ + + +GDFGL K ++ + T + V AP
Sbjct: 125 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181
Query: 476 EYLSTGQSSEKTDVFGFGILLLELIT 501
E L + +DV+ FG+ L EL+T
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 66/219 (30%), Positives = 98/219 (44%), Gaps = 33/219 (15%)
Query: 309 LGRGGFGIVYK----GCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
LG G FG V + G VAVK LKD +E+E + L H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR--PALDWA--------------R 403
++ L G C+ E ++ Y G+ LR+ + R P D+
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGN----LREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 404 RKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-V 462
A ARG+ YL + + IHRD+ A N+L+ ED + DFGLA+ + D +
Sbjct: 136 LVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
T+ R V +APE L + ++DV+ FGIL+ E+ T
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 15/211 (7%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
+ + ILG G FG + +GC VA+ L+ F E T+
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD 64
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
H N++RL G + N ++V YM NG++ S LR H G+ L + + G A G+
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH-EGQ--LVAGQLMGMLPGLASGMK 121
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG--TVGHIA 474
YL E +H+ + A +L++ D + F +L + + + T + G V A
Sbjct: 122 YLSEM---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAA 176
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
PE + S +DV+ FGI++ E+++ G+R
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 309 LGRGGFGIVYKG-----CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
LG FG +YKG LVA+K LKD N +FQ E ++ H N++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 364 CGFCSTENERLLVYPYM-------------PNGSVASRLRDHIHGRPALDWARRKRIALG 410
G + E +++ Y+ P+ V + + +LD IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGT 469
A G+ YL +H+D+ A NIL+ E + D GL++ + D + V
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
+ + PE + G+ S +D++ FG++L E+ +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 55/202 (27%), Positives = 87/202 (43%), Gaps = 18/202 (8%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQT---EVETISLAVHRNLLRLC 364
+G G +G+V K G +VA+K+ K+ E +T EV+ + H N++ L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKE--SEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA-LDWARRKRIALGTARGLLYLHEQCD 423
+ LV+ Y+ L + + P L + + + Y H
Sbjct: 67 EAFRRKGRLYLVFEYVER-----TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH-- 119
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR-DSHVTTAVRGTVGHIAPEYL-STG 481
IIHRD+K NIL+ E + DFG A+ L R S +T V T + APE L
Sbjct: 120 -NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDT 177
Query: 482 QSSEKTDVFGFGILLLELITGQ 503
+ DV+ G ++ EL+ G+
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 303 FSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHR 358
F +LG+GGFG V C G + A K+L+ I GE E + + R
Sbjct: 2 FRHYRVLGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLL 416
++ L T++ LV M G L+ HI+ G P D R A GL
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGD----LKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
LH + +I++RD+K NILLD+ + D GLA ++ + GTVG++APE
Sbjct: 117 DLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPE 171
Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQ 503
+ + + D +G G L+ E+I G+
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
S + ++G G FG V G VA+K LK F +E +
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
H N++ L G + ++V YM NGS+ + LR H + R G A G+
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMK 120
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIA 474
YL D +HRD+ A NIL++ + V DFGL+++L D ++ T + + A
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 177
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
PE ++ + + +DV+ +GI++ E+++ G+R
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGER 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 38/223 (17%)
Query: 309 LGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
+G+G FG V++ + +VAVK LK+ A + FQ E ++ H N+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 363 LCGFCSTENERLLVYPYMPNG------------------SVASRLRDHIHGRPALDWARR 404
L G C+ L++ YM G S R L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
IA A G+ YL E+ K +HRD+ N L+ E+ + DFGL+ R+ +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS-----RNIYSAD 184
Query: 465 AVRGT------VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
+ + + + PE + + + ++DV+ +G++L E+ +
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 17/215 (7%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA---VH 357
NF LG G + VYKG + G +VA LK+ ++ E T + ISL H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVA---LKEIHLDAEEGTPSTAIREISLMKELKH 57
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIALGTARGLL 416
N++RL TEN+ +LV+ YM + D HG ALD K +G+
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDKD--LKKYMD-THGVRGALDPNTVKSFTYQLLKGIA 114
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
+ HE +++HRD+K N+L+++ E + DFGLA+ + + V T+ + AP+
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPD 170
Query: 477 YLSTGQS-SEKTDVFGFGILLLELITGQRALDFGR 510
L ++ S D++ G ++ E+ITG R L G
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGT 204
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLK---DYNIAGGEVQ-FQTEVETISL 354
+N+ +LG+G FG VY C+ G +AVK+++ + EV + E++ +
Sbjct: 2 TNWRLGKLLGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN 60
Query: 355 AVHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
+H +++ G ER L +MP GS+ +D + AL ++
Sbjct: 61 LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSI----KDQLKSYGALTENVTRKYTRQIL 116
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT--TAVRGTV 470
G+ YLH I+HRD+K ANIL D +GDFG +K L T +V GT
Sbjct: 117 EGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTP 173
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
++PE +S K D++ G ++E++T
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 31/218 (14%)
Query: 309 LGRGGFGIVY--------KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRN 359
LG G FG V K + VAVK LKD +E+E + + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-----ALDWARRKRIALG---- 410
++ L G C+ + ++ Y G++ LR RP + D AR +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRAR---RPPGMEYSYDIARVPDEQMTFKDL 139
Query: 411 ------TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VT 463
ARG+ YL Q K IHRD+ A N+L+ E+ + DFGLA+ +++ D + T
Sbjct: 140 VSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
T R V +APE L + ++DV+ FG+L+ E+ T
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 35/219 (15%)
Query: 302 NFSAKNILGRGGFGIVYKGCF-----SDGAL-VAVKRLKDYNIAGGEVQFQTEVETIS-L 354
N S LG G FG V + SD + VAVK LK + +E++ +S L
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95
Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
H N++ L G C+ L++ Y G + L++ RRKR + T
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCCYGDL-------------LNFLRRKRESFLTLED 142
Query: 415 LLYLHEQ--------CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV 466
LL Q IHRD+ A N+LL + DFGLA+ + + ++V V
Sbjct: 143 LLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---V 199
Query: 467 RGT----VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
+G V +APE + + ++DV+ +GILL E+ +
Sbjct: 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 8/203 (3%)
Query: 302 NFSAKNILGRGGFGIVYK-GCFSDGALVAVKRLKDYNIAGGEVQFQ-TEVETISLAVHRN 359
+F LG+G +G VYK SD A+K + +++ E + E+ ++ H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
++ N+ +V Y P G ++ + R + RI + RGL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
EQ KI+HRD+K+ANILL + +GD G++K+L + GT ++APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPEVWK 174
Query: 480 TGQSSEKTDVFGFGILLLELITG 502
S K+D++ G LL E+ T
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATF 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 12/203 (5%)
Query: 303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLL 361
F+ +G+G FG VYKG + V ++ D A E++ Q E+ +S +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA-LDWARRKRIALGTARGLLYLHE 420
R G + ++ Y+ GS L+ P L+ I +GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLK------PGPLEETYIATILREILKGLDYLHS 119
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
+ + IHRD+KAAN+LL E + + DFG+A L T V GT +APE +
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 175
Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
K D++ GI +EL G+
Sbjct: 176 SAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 309 LGRGGFGIVYKGCFS--DGAL-VAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLC 364
LG G FG V +G + D L VAVK +K E++ F +E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 365 GFC--STENER----LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT--ARGLL 416
G C + E+E +++ P+M +G + S L G + + T A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-RGTVGHIAP 475
YL + IHRD+ A N +L+E+ V DFGL+K + + D + + + V IA
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 476 EYLSTGQSSEKTDVFGFGILLLELIT-GQ 503
E L+ + K+DV+ FG+ + E+ T GQ
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQ 212
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 65/208 (31%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 303 FSAKNILGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHR 358
F +LG+GGFG V C + G + A K+L+ I GE E + + R
Sbjct: 2 FRQYRVLGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLL 416
++ L T++ LV M G L+ HI+ G + R A GL
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGD----LKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR-GTVGHIAP 475
LH++ +I++RD+K NILLD+ + D GLA H T R GTVG++AP
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAP 170
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQ 503
E + + + D + G LL E+I GQ
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLL 361
F+ +G+G FG V+KG + V ++ D A E++ Q E+ +S +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
+ G + + ++ Y+ GS D + P LD + I +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGP-LDETQIATILREILKGLDYLHSE 120
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT-TAVRGTVGHIAPEYLST 480
K IHRD+KAAN+LL E E + DFG+A L D+ + GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
K D++ GI +EL G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-14
Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 308 ILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
++G G FG V +G VA+K LK F +E + H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
G + +++ +M NG++ S LR + + R G A G+ YL E
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEM-- 125
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGT--VGHIAPEYLS 479
+HRD+ A NIL++ + V DFGL++ L D D T+++ G + APE ++
Sbjct: 126 -NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 480 TGQSSEKTDVFGFGILLLELIT-GQR 504
+ + +DV+ +GI++ E+++ G+R
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (177), Expect = 8e-14
Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 303 FSAKNILGRGGFGIVYKG-CFSDGALVAVKRLK-DYNIAGGEVQFQT--EVETISLAVHR 358
+ LG G +G+VYK G +VA+K+++ D G + E+ + H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG--IPSTALREISLLKELKHP 58
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIALGTARGLLY 417
N+++L TE + LV+ Y L+ ++ RP L K I RGL Y
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYC-----DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-----RGTVGH 472
H +I+HRD+K NIL++ D + DFGLA+ T V R
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR----- 165
Query: 473 IAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
APE L S S+ D++ G + E+ITG+
Sbjct: 166 -APEILLGSKHYSTA-VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 22/201 (10%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
LG G FG VYK + GAL A K ++ + E + E+E ++ H +++L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYMVEIEILATCNHPYIVKLLGAF 78
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
+ + ++ + P G+V + + + G L + + I L YLH KII
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHSM---KII 132
Query: 428 HRDVKAANILLDEDFEAVVGDFGLA----KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS 483
HRD+KA N+LL D + + DFG++ K L RDS + GT +APE +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETM 187
Query: 484 SE-----KTDVFGFGILLLEL 499
+ K D++ GI L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 308 ILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
+LG G FG VYKG + DG VA+K L++ + E ++ + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTARGLLYLH 419
L G C T +L V MP G + +R++ I + L+W + A+G+ YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWC------VQIAKGMSYLE 126
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPEY 477
E +++HRD+ A N+L+ + DFGLA+LL D + H + + +A E
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG-KVPIKWMALES 182
Query: 478 LSTGQSSEKTDVFGFGILLLELIT 501
+ + + ++DV+ +G+ + EL+T
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 66/204 (32%), Positives = 91/204 (44%), Gaps = 20/204 (9%)
Query: 308 ILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQ-FQTEVETISLAVHRNLLR-- 362
+LG+G FG V+ A+K LK D + +V+ E +SLA L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
C F + EN V Y+ G L HI D R A GL +LH +
Sbjct: 62 YCTFQTKEN-LFFVMEYLNGGD----LMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK- 115
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAK---LLDHRDSHVTTAVRGTVGHIAPEYLS 479
I++RD+K NILLD D + DFG+ K L D + T GT +IAPE L
Sbjct: 116 --GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK----TCTFCGTPDYIAPEILL 169
Query: 480 TGQSSEKTDVFGFGILLLELITGQ 503
+ + D + FG+LL E++ GQ
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 32/215 (14%)
Query: 309 LGRGGFGIVYKGCFSDGA--LVAVKRLKDYNIAGGEVQFQ---------TEVETISLAV- 356
LG G FG VYK + L+A+K + +N A G+ + + +EV I +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHI------HGRPALD--WARRKRIA 408
H N++R EN+RL + + G+ L +H R + W ++
Sbjct: 68 HPNIVRYYK-TFLENDRLYIVMDLIEGA---PLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG 468
L L YLH++ +I+HRD+ NI+L ED + + DFGLAK +S +T+ V G
Sbjct: 124 LA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV-G 175
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
T+ + PE + EK DV+ FG +L ++ T Q
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLK---DYNIAGGEVQ-FQTEVETISLA 355
N+ +LGRG FG VY C+ G +AVK++ D EV + E++ +
Sbjct: 3 NWRLGKLLGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 356 VHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
H +++ G E+ L YMP GS+ +D + AL +R +
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI----KDQLKAYGALTENVTRRYTRQILQ 117
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD--HRDSHVTTAVRGTVG 471
G+ YLH I+HRD+K ANIL D +GDFG +K + +V GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
++PE +S K DV+ ++E++T
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 68/203 (33%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 308 ILGRGGFGIVYKGCFSD-GALVAVKRLK-DYNIAGGEVQFQTEVETISLAV---HRNLLR 362
+LG+G FG V A+K LK D + +V+ T VE LA+ H L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVE-CTMVERRVLALAWEHPFLTH 60
Query: 363 LCGFCS--TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
L FC+ T+ V Y+ G L HI D AR + A GL +LH+
Sbjct: 61 L--FCTFQTKEHLFFVMEYLNGGD----LMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
+ II+RD+K N+LLD+D + DFG+ K + + +T GT +IAPE L
Sbjct: 115 K---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKG 170
Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
+ +E D + FG+LL E++ GQ
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 20/200 (10%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG VYK + ++A ++ D + E++ ++ H N+++L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
EN ++ + G+V + + + L + + + T L YLHE KIIH
Sbjct: 73 YENNLWILIEFCAGGAVDAVM---LELERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 429 RDVKAANILLDEDFEAVVGDFGLA----KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
RD+KA NIL D + + DFG++ + + RDS + GT +APE + S
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSK 181
Query: 485 E-----KTDVFGFGILLLEL 499
+ K DV+ GI L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 20/199 (10%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368
LG G FG+V+ G + VA+K + + A E F E + + H L++L G C+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEG--AMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR----GLLYLHEQCDP 424
+ +V +M NG + + LR G+ K + L + G+ YL
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQR-QGK------LSKDMLLSMCQDVCEGMEYLERN--- 119
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHVTTA-VRGTVGHIAPEYLSTGQ 482
IHRD+ A N L+ V DFG+ + +LD D + +++ + V PE + +
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD--DEYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 483 SSEKTDVFGFGILLLELIT 501
S K+DV+ FG+L+ E+ T
Sbjct: 178 YSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 44/112 (39%), Positives = 56/112 (50%), Gaps = 9/112 (8%)
Query: 413 RGLL----YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTTAVR 467
R LL YLH + IIHRDVK NI LDE AV+GDFG A KL H D+
Sbjct: 192 RRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML 519
GT+ +PE L+ KTD++ G++L E+ L FG+ L
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL-FGKQVKSSSSQL 299
|
Length = 392 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 39/214 (18%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVH-RNLLRL--- 363
+GRG FG V K G ++AVKR++ + + +++ + + +++
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 364 ------CGFC------STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
C C S + VY + S + + I G+ IA+ T
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVY-----EVLKSVIPEEILGK----------IAVAT 116
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
+ L YL E + KIIHRDVK +NILLD + + DFG++ L DS T G
Sbjct: 117 VKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRP 172
Query: 472 HIAPEYLSTGQSSE---KTDVFGFGILLLELITG 502
++APE + ++DV+ GI L E+ TG
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 10/202 (4%)
Query: 303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLL 361
F+ +G+G FG V+KG + V ++ D A E++ Q E+ +S +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
+ G + ++ Y+ GS LR D + + +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
K IHRD+KAAN+LL E + + DFG+A L T V GT +APE +
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176
Query: 482 QSSEKTDVFGFGILLLELITGQ 503
K D++ GI +EL G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLK---DYNIAGGEVQ-FQTEVETISLA 355
N+ +LG+G FG VY C+ G +A K+++ + EV + E++ +
Sbjct: 3 NWRRGKLLGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 356 VHRNLLRLCGFCSTENERLLV--YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
H +++ G E+ L YMP GSV +D + AL + ++
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSV----KDQLKAYGALTESVTRKYTRQILE 117
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT--TAVRGTVG 471
G+ YLH I+HRD+K ANIL D +GDFG +K L T +V GT
Sbjct: 118 GMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174
Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
++PE +S K DV+ G ++E++T
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 66/212 (31%), Positives = 99/212 (46%), Gaps = 33/212 (15%)
Query: 309 LGRGGFGIVY---KGCFSDGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLRL 363
+ +G +G V+ K S G + A+K +K ++ Q TE + +S A +++L
Sbjct: 1 ISKGAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 364 CGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARR--KRIALGTARGLLYLH 419
+ S + ++ LV Y+P G +AS L G D AR I L L YLH
Sbjct: 59 --YYSFQGKKNLYLVMEYLPGGDLASLL--ENVGSLDEDVARIYIAEIVLA----LEYLH 110
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL--------LDHRDSHVTTAVRGTVG 471
IIHRD+K NIL+D + + DFGL+K+ L+ + V GT
Sbjct: 111 SN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPD 166
Query: 472 HIAPEYLSTGQSSEKT-DVFGFGILLLELITG 502
+IAPE + GQ KT D + G +L E + G
Sbjct: 167 YIAPEVI-LGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 67/205 (32%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQ---TEVETISLAVHRNLLRLC 364
+G G FG VY S +VAVK++ Y+ ++Q EV+ + H N +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMS-YSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
G E+ LV Y GS + L +H +P L I G +GL YLH
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLE--VHKKP-LQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY---LSTG 481
+IHRD+KA NILL E + + DFG A +S V GT +APE + G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 482 QSSEKTDVFGFGILLLELITGQRAL 506
Q K DV+ GI +EL + L
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 303 FSAKNILGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHR 358
F +LG+GGFG V C + G + A K+L+ I GE E + R
Sbjct: 2 FRHYRVLGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLL 416
++ L T++ LV M G L+ HI+ G P D R A GL
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGD----LKFHIYNMGNPGFDEQRAIFYAAELCCGLE 116
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
L + +I++RD+K NILLD+ + D GLA + + GTVG++APE
Sbjct: 117 DLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIP--EGETVRGRVGTVGYMAPE 171
Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQ 503
++ + + D +G G L+ E+I GQ
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 306 KNILGRGGFGIVYKGC-FSDGALVAVKRLK-DYNIAGGEVQFQ--TEVETISLAVHRNLL 361
+ ILG G G VYK ++AVK + D + E+Q Q +E+E + ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV---ELQKQIMSELEILYKCDSPYII 62
Query: 362 RLCGFCSTENERLLVYPYMPNGS--VASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
G EN + +M GS V ++ +H+ GR IA+ +GL YL
Sbjct: 63 GFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGR----------IAVAVVKGLTYLW 112
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
KI+HRDVK +N+L++ + + DFG++ L +S T V GT ++APE +S
Sbjct: 113 SL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYV-GTNAYMAPERIS 166
Query: 480 TGQSSEKTDVFGFGILLLELITGQ 503
Q +DV+ GI +EL G+
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 64/198 (32%), Positives = 91/198 (45%), Gaps = 20/198 (10%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQ---TEVETISLAVHRNLLRLC 364
+G G FG VY + +VA+K++ Y+ ++Q EV + H N ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
G E+ LV Y GS + L +H +P L + G +GL YLH
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDLLE--VHKKP-LQEVEIAAVTHGALQGLAYLHSH--- 134
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY---LSTG 481
+IHRDVKA NILL E +GDFG A ++ + V GT +APE + G
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEG 189
Query: 482 QSSEKTDVFGFGILLLEL 499
Q K DV+ GI +EL
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 309 LGRGGFGIVYKGCFS--DGALVAVKRLK-------DYNIAGGEVQFQTEVETISLAVHRN 359
+G G +G+VYK G +VA+K++K A E++ E+ H N
Sbjct: 7 IGEGTYGVVYK-ARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN------HPN 59
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
+++L + + LV+ +M + + ++D G L + K +GL + H
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRG---LPESLIKSYLYQLLQGLAFCH 115
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
I+HRD+K N+L++ + + DFGLA+ T V T + APE L
Sbjct: 116 SH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLL 171
Query: 480 T-GQSSEKTDVFGFGILLLELITGQ 503
S D++ G + EL++ +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 9e-13
Identities = 63/201 (31%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 308 ILGRGGFGIVYKGCFS-DGALVAVKRLK-DYNIAGGEVQ-FQTEVETISLAVHRNLLR-- 362
+LG+G FG V G AVK LK D + +V+ E ++LA L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
C F T+ V ++ G L HI + D R A GL +LH +
Sbjct: 62 YCTF-QTKEHLFFVMEFLNGGD----LMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK- 115
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
II+RD+K N++LD D + DFG+ K D+ +T GT +IAPE L +
Sbjct: 116 --GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLK 172
Query: 483 SSEKTDVFGFGILLLELITGQ 503
+ D + FG+LL E++ GQ
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 25/215 (11%)
Query: 302 NFSAKNILGRGGFGIVY----KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVE-TISLAV 356
NF +LG G +G V+ G G L A+K LK I VQ E T +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI----VQKAKTAEHTRTERQ 56
Query: 357 HRNLLRLCGFC-------STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
+R C F T+ + L+ Y+ G L H++ R + +
Sbjct: 57 VLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGG----ELFTHLYQREHFTESEVRVYIA 112
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
L +LH+ II+RD+K NILLD + V+ DFGL+K + + GT
Sbjct: 113 EIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGT 169
Query: 470 VGHIAPEYLSTGQS--SEKTDVFGFGILLLELITG 502
+ ++APE + G + D + G+L EL+TG
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 42/119 (35%), Positives = 60/119 (50%), Gaps = 2/119 (1%)
Query: 70 CSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL 129
CS G + L L S SL G + +G L+ V LQ+N+ G +P+ KL + LD+
Sbjct: 377 CS-SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDI 435
Query: 130 SNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
SNN G I D+ +L L L N G P+S + L +DLS N SG++P+
Sbjct: 436 SNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS-FGSKRLENLDLSRNQFSGAVPR 493
|
Length = 968 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 63/225 (28%), Positives = 104/225 (46%), Gaps = 23/225 (10%)
Query: 296 LRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETIS 353
LR F ++G G +G VYKG G L A+K + ++ G E + + E+ +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLK 57
Query: 354 -LAVHRNLLRLCGFCSTEN------ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
+ HRN+ G +N + LV + GSV +++ +W
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AY 115
Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV 466
I RGL +LH+ K+IHRD+K N+LL E+ E + DFG++ LD T +
Sbjct: 116 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 172
Query: 467 RGTVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELITGQRAL 506
GT +APE ++ ++ + K+D++ GI +E+ G L
Sbjct: 173 -GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 66/201 (32%), Positives = 90/201 (44%), Gaps = 19/201 (9%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VH-RNLLRLC 364
LG+GGFG V C + G L A K+L + + VE LA VH R ++ L
Sbjct: 1 LGKGGFGEVS-ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHG----RPALDWARRKRIALGTARGLLYLHE 420
T+ + LV M G LR HI+ P R GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGD----LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTTAVRGTVGHIAPEYLS 479
+ +II+RD+K N+LLD D + D GLA +L D + T GT G +APE L
Sbjct: 116 R---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQ 170
Query: 480 TGQSSEKTDVFGFGILLLELI 500
+ D F G+ L E+I
Sbjct: 171 GEEYDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 309 LGRGGFGIVYKGC--FSDGALVAVKRL----KDYNIAGGEVQFQTEVETISLAVHRNLLR 362
+G G +G+V+K C G +VA+K+ D I ++ + E+ + H NL+
Sbjct: 9 IGEGSYGVVFK-CRNRETGQIVAIKKFVESEDDPVIK--KIALR-EIRMLKQLKHPNLVN 64
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
L + + LV+ Y + +V + L + G + K+I T + + + H+
Sbjct: 65 LIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCHKH- 119
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL-STG 481
IHRDVK NIL+ + + + DFG A++L T V T + APE L
Sbjct: 120 --NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDT 176
Query: 482 QSSEKTDVFGFGILLLELITGQ 503
Q DV+ G + EL+TGQ
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 51/163 (31%), Positives = 73/163 (44%), Gaps = 27/163 (16%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRL-----KDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG VYK G +VA+K++ KD G + E++ + H N++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKD----GFPITALREIKILKKLKHPNVVP 71
Query: 363 LCGFC-----STENERLLVY---PYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTAR 413
L ++ +R VY PYM L + L ++ K L
Sbjct: 72 LIDMAVERPDKSKRKRGSVYMVTPYM-----DHDLSGLLENPSVKLTESQIKCYMLQLLE 126
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456
G+ YLHE I+HRD+KAANIL+D + DFGLA+ D
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYD 166
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 20/219 (9%)
Query: 307 NILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
N +G G G VYK G L A+K + + Q E+E + H N+++
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL-DWARRKRIALGTARGLLYLHEQCDP 424
E ++ +M GS+ HI L D AR+ G+ YLH +
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGT---HIADEQFLADVARQ------ILSGIAYLHRR--- 187
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
I+HRD+K +N+L++ + DFG++++L ++V GT+ +++PE ++T +
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNH 246
Query: 485 EK-----TDVFGFGILLLELITGQRALDFGRAANQRGVM 518
D++ G+ +LE G+ GR + +M
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM 285
|
Length = 353 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 20/203 (9%)
Query: 309 LGRGGFGIVYKGCF----SDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+GGFG V C + G + A K+L K GE E E + ++
Sbjct: 1 LGKGGFGEV---CAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLLYLHE 420
L ++ LV M G L+ HI+ G L+ R + G+L+LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGD----LKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
I++RD+K N+LLD+ + D GLA ++ +D T GT G++APE L
Sbjct: 114 M---DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKE 168
Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
S D F G + E++ G+
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 68/226 (30%), Positives = 97/226 (42%), Gaps = 21/226 (9%)
Query: 306 KNILGRGGFGIV-YKGCFSDGALVAVKRL-------KDYNIAGGEVQFQTEVETIS-LAV 356
+LG G G V SDG AVK + D N A EV + S +
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 357 HRNLLRLCGFCSTEN--ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA-LGTAR 413
H + + E +L+ + + + A LR I R + R+ A L +
Sbjct: 97 HEDFAK-----KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGH 472
LL +H +IHRD+K+ANILL + +GDFG +K+ S V GT +
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM 518
+APE S+K D+F G+LL EL+T +R D N VM
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD---GENMEEVM 254
|
Length = 496 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 309 LGRGGFGIVYKGCF---SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
LG G FG V KG + VA+K LK+ N + E E + + ++R+ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 366 FCSTENERLLVYPYMPNGSVASRL---RDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
C E +LV G + L +D I ++ + + G+ YL +
Sbjct: 63 VCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQ------VSMGMKYLEGK- 114
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT--TAVRGTVGHIAPEYLST 480
+HRD+ A N+LL A + DFGL+K L DS+ +A + + APE ++
Sbjct: 115 --NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 481 GQSSEKTDVFGFGILLLELIT-GQR 504
+ S ++DV+ +GI + E + GQ+
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 43/223 (19%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAV-H 357
+ F N +G G +GIVY+ + G +VA+K+++ N G + E+ T+ L + H
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREI-TLLLNLRH 65
Query: 358 RNLLRL---------------CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWA 402
N++ L +C + LL MP +
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT---------------PFSES 108
Query: 403 RRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462
+ K + L RGL YLHE IIHRD+K +N+LL + + DFGLA+ +
Sbjct: 109 QVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165
Query: 463 TTAVRGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
T V T+ + APE L T + D++ G +L EL+ +
Sbjct: 166 TPKVV-TLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 38/229 (16%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDG------------------ALVAVKRLKDYNIAGGEV 343
NF K LG G FG V+ C +DG LVAVK L+
Sbjct: 8 NFVEK--LGEGQFGEVHL-CEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 344 QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHI-------HGR 396
F EV+ +S N+ RL G C+ + ++ YM NG + L+ H+
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 397 PALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456
+L ++ +A A G+ YL +HRD+ N L+ +++ + DFG+++ L
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 457 HRDSHVTTAVRG-TVGHI---APEYLSTGQSSEKTDVFGFGILLLELIT 501
D + V+G I A E + G+ + K+DV+ FG+ L E++T
Sbjct: 182 SSDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 66/207 (31%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 303 FSAKNILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQ---TEVETISLA 355
F+ +G G FG VY F+ +VA+K++ Y+ ++Q EV+ +
Sbjct: 27 FTDLREIGHGSFGAVY---FARDVRTNEVVAIKKMS-YSGKQSNEKWQDIIKEVKFLQRI 82
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
H N + G E+ LV Y GS + L +H +P L I G +GL
Sbjct: 83 KHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE--VHKKP-LQEVEIAAITHGALQGL 138
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
YLH +IHRD+KA NILL E + + DFG A + +S V GT +AP
Sbjct: 139 AYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAP 190
Query: 476 EY---LSTGQSSEKTDVFGFGILLLEL 499
E + GQ K DV+ GI +EL
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 4e-12
Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 50/226 (22%)
Query: 303 FSAKNILGRGGFGIVYKGCFSD---GALVAVKRLKDYNIAGGEVQFQT---------EVE 350
+ +G G +G+V D G VA+K++ + F E++
Sbjct: 2 YELLKPIGSGAYGVVCSA--VDKRTGRKVAIKKISNV--------FDDLIDAKRILREIK 51
Query: 351 TISLAVHRNLLRLCGF-----CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
+ H N++ L N+ +V M + L I L +
Sbjct: 52 LLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-----TDLHKVIKSPQPLTDDHIQ 106
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH---- 461
RGL YLH +IHRD+K +NIL++ + + + DFGLA+ +D +
Sbjct: 107 YFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 462 ----VTTAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITG 502
VT R APE LS+ + ++ D++ G + EL+T
Sbjct: 164 TEYVVTRWYR------APELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 24/219 (10%)
Query: 303 FSAKNILGRGGFGIVYKGCF--SDGAL--VAVKRLKDYNIAGGEV-QFQTEVETISLAVH 357
F+ +LG+G FG V + DG+ VAVK LK + ++ +F E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 358 RNLLRLCGFC--STENERL----LVYPYMPNGSV-----ASRLRDHIHGRPALDWARRKR 406
N+++L G S RL ++ P+M +G + SR+ + P R
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR--- 117
Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT-TA 465
+ A G+ YL + IHRD+ A N +L+E+ V DFGL+K + D + A
Sbjct: 118 FMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQ 503
+ V +A E L+ + +DV+ FG+ + E++T GQ
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 5e-12
Identities = 64/213 (30%), Positives = 92/213 (43%), Gaps = 30/213 (14%)
Query: 301 SNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRLKDYNIA--GGEVQFQTEVETISL 354
+F LG G FG V +KG G A+K L I E +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR--RKRIALGTA 412
H L+ L G ++ LV Y+P G + S LR GR AR ++ L
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLA-- 113
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
L YLH I++RD+K N+LLD D + DFG AK + R T + GT +
Sbjct: 114 --LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEY 164
Query: 473 IAPEYLST---GQSSEKTDVFGFGILLLELITG 502
+APE + + G++ D + GIL+ E++ G
Sbjct: 165 LAPEIILSKGYGKAV---DWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 5e-12
Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQ--TEVETISLAV 356
NF + +G+G F +VYK C DG +VA+K+++ + + + + E++ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRKRIALGTARG 414
H N+++ NE +V G + SR+ H R + K +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYF-VQLCSA 118
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG--- 471
L ++H + +I+HRD+K AN+ + +GD GL + S TTA VG
Sbjct: 119 LEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPY 171
Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLEL 499
+++PE + + K+D++ G LL E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 8/95 (8%)
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA-KLLDHRDSHVTT 464
+IA +GL YLH + KIIHRD+K +NILL + + DFG++ +L++ T
Sbjct: 109 KIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT- 164
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 499
GT ++APE + S +DV+ G+ LLE+
Sbjct: 165 ---GTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 47/209 (22%), Positives = 97/209 (46%), Gaps = 13/209 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQ--TEVETISLAVH 357
+NF + +GRG F VY+ C DG VA+K+++ +++ + + E++ + H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
N+++ +NE +V G ++ ++ + + + + L +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG---HIA 474
+H + +++HRD+K AN+ + +GD GL + + TTA VG +++
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK----TTAAHSLVGTPYYMS 174
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQ 503
PE + + K+D++ G LL E+ Q
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 34/101 (33%), Positives = 58/101 (57%), Gaps = 8/101 (7%)
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
+IA+ + L YLH + +IHRDVK +N+L++ + + + DFG++ L DS T
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTI 162
Query: 466 VRGTVGHIAPEYLSTGQSSE----KTDVFGFGILLLELITG 502
G ++APE ++ + + K+DV+ GI ++EL TG
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 33/88 (37%), Positives = 50/88 (56%), Gaps = 5/88 (5%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
GL YLH Q +IIHRDVK NI +++ + +GD G A+ + + A GTV
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA--GTVET 222
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELI 500
APE L+ + + K D++ GI+L E++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 308 ILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQ-FQTEVETISLAV-HRNL 360
+LG+G FG V KG +D + A+K L KD + +V TE ++LA H L
Sbjct: 2 VLGKGSFGKVMLAELKG--TD-EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL 58
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
L T++ V Y+ G L I D R + A L++LH
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGD----LMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
+I+RD+K NILLD + + DFG+ K + TT GT +IAPE L
Sbjct: 115 H---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQE 170
Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
+ D + G+L+ E++ GQ
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 47/158 (29%), Positives = 69/158 (43%), Gaps = 28/158 (17%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGG----------EVQFQTEVETISLAVH 357
LG G + +VYK G +VA+K++K E++ E++ H
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK------H 61
Query: 358 RNLLRLCG-FCSTENERLLVYPYMPNGSVASRLRDHIHGR-PALDWARRKRIALGTARGL 415
N++ L F N L V+ +M + L I + L A K L T RGL
Sbjct: 62 PNIIGLLDVFGHKSNINL-VFEFME-----TDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453
YLH I+HRD+K N+L+ D + DFGLA+
Sbjct: 116 EYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 42/130 (32%), Positives = 70/130 (53%), Gaps = 21/130 (16%)
Query: 379 YMPNGSV------ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVK 432
+M GS+ A R+ ++I G+ I++ RGL YL E+ KI+HRDVK
Sbjct: 80 HMDGGSLDQVLKKAGRIPENILGK----------ISIAVLRGLTYLREK--HKIMHRDVK 127
Query: 433 AANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 492
+NIL++ E + DFG++ L DS + V GT +++PE L + ++D++
Sbjct: 128 PSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYTVQSDIWSL 184
Query: 493 GILLLELITG 502
G+ L+E+ G
Sbjct: 185 GLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 63/208 (30%), Positives = 92/208 (44%), Gaps = 27/208 (12%)
Query: 308 ILGRGGFGIVYKGC--FSDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
I+GRGGFG VY GC G + A+K L K + GE E +SL +
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD---- 55
Query: 364 CGF--C-----STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
C F C T ++ + M G + L H A + A GL
Sbjct: 56 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEAEMRFYAAEIILGLE 111
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
++H + +++RD+K ANILLDE + D GLA + H + GT G++APE
Sbjct: 112 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 165
Query: 477 YLSTGQSSEKT-DVFGFGILLLELITGQ 503
L G + + + D F G +L +L+ G
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 37/118 (31%), Positives = 62/118 (52%), Gaps = 6/118 (5%)
Query: 76 VSALGLPSQSLSGTLSPWI---GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNN 132
++ L L + +L+G + + GNL KL +L +N++ G IP SLG L+ + L +N
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKL---ILFSNSLEGEIPKSLGACRSLRRVRLQDN 414
Query: 133 KFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
F+GE+P L + +L ++NN+L G + SL ++ L+ N G LP
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF 472
|
Length = 968 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 51/199 (25%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 306 KNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
+G G FG VY+G + ++ VAVK K+ +F E + H +++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
+L G TEN +V P G + S L+ + + +LD A + + L YL +
Sbjct: 71 KLIGVI-TENPVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK 126
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
+ +HRD+ A N+L+ +GDFGL++ L+ + + + + +APE ++
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 482 QSSEKTDVFGFGILLLELI 500
+ + +DV+ FG+ + E++
Sbjct: 184 RFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 309 LGRGGFGIVYKGCFSDG---ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
+G G FG V G + G A V VK L+ +++F E + H NLL+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 366 FCSTENERLLVYPYMPNGSVASRLRD-HIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
C+ LLV + P G + LR D +R+A A GLL+LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG--HIAPEYLSTGQ 482
IH D+ N LL D +GD+GL+ +++ + T + V IAPE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSH-NKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 483 S-------SEKTDVFGFGILLLEL 499
+++++V+ G+ + EL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 56/198 (28%), Positives = 84/198 (42%), Gaps = 14/198 (7%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCG 365
LG GGFG V S A+K +K +I G + +E E + H +++L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 366 FCSTENERLLVYPYMPNGSVAS-RLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
+ + ++++ Y YM L + R D + YLH +
Sbjct: 59 YRTFKDKK---YIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNR--- 112
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
II+RD+K N+LLD + + DFG AK L T GT ++APE +
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEIILNKGYD 170
Query: 485 EKTDVFGFGILLLELITG 502
D + GILL EL+TG
Sbjct: 171 FSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 308 ILGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL-- 363
I+GRGGFG VY GC G + A+K L I + ET++L R +L L
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIK------MKQGETLALN-ERIMLSLVS 52
Query: 364 ---CGFC-------STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
C F T ++ + M G + L H + A
Sbjct: 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH----GVFSEKEMRFYATEIIL 108
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
GL ++H + +++RD+K ANILLDE + D GLA + H + GT G++
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 474 APEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
APE L G + + + D F G +L +L+ G
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 21/220 (9%)
Query: 296 LRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS- 353
LR F ++G G +G VYKG G L A+K + E + + E+ +
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDEEEEIKLEINMLKK 68
Query: 354 LAVHRNLLRLCGF------CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
+ HRN+ G +++ LV + GSV +++ DW I
Sbjct: 69 YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYI 126
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
RGL +LH K+IHRD+K N+LL E+ E + DFG++ LD T +
Sbjct: 127 CREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI- 182
Query: 468 GTVGHIAPEYLSTGQSSEKT-----DVFGFGILLLELITG 502
GT +APE ++ ++ + T D++ GI +E+ G
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 306 KNILGRGGFGIVYKGCFSDG----------------ALVAVKRLKDYNIAGGEVQFQTEV 349
K LG G FG V+ C ++G LVAVK L+ F E+
Sbjct: 10 KEKLGEGQFGEVHL-CEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD--------HIHGRPALDW 401
+ +S + N++RL G C +++ ++ YM NG + L H + P++
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
A +A+ A G+ YL +HRD+ N L+ + + DFG+++ L D +
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 462 VTTAVRG----TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
++G + +A E + G+ + +DV+ FG+ L E+ T
Sbjct: 186 ---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 21/209 (10%)
Query: 302 NFSAKNILGRGGFGIVY--KGCFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLAVHR 358
+ +G G FG +Y K SD +K + + E + + EV ++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHG-----RPALDWARRKRIALGTAR 413
N++ +V Y G + R+ G L W +I+LG
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ-RGVLFSEDQILSWF--VQISLG--- 113
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
L ++H D KI+HRD+K+ NI L ++ A +GDFG+A+ L+ T V GT +
Sbjct: 114 -LKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYY 168
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELIT 501
++PE + KTD++ G +L EL T
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 16/212 (7%)
Query: 302 NFSAKNILGRGGFG-IVYKGCFSDGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
+F+ +LG+G FG ++ L A+K LK D I +V+ T VE LA+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVEC-TMVEKRVLALQDK 59
Query: 360 ---LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
L +L T + V Y+ G L HI + A + GL
Sbjct: 60 PPFLTQLHSCFQTVDRLYFVMEYVNGGD----LMYHIQQVGKFKEPQAVFYAAEISVGLF 115
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR-GTVGHIAP 475
+LH + II+RD+K N++LD + + DFG+ K +H VTT GT +IAP
Sbjct: 116 FLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAP 170
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
E ++ + D + +G+LL E++ GQ D
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 308 ILGRGGFGIVY---KGCFSD-GALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLR 362
+LG+G FG V+ K D G L A+K LK + V+ + E + ++ H +++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
L TE + L+ ++ G + +RL + K A L +LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL- 117
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAK-LLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
II+RD+K NILLDE+ + DFGL+K +DH + GTV ++APE ++
Sbjct: 118 --GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRR 173
Query: 482 QSSEKTDVFGFGILLLELITG 502
++ D + FG+L+ E++TG
Sbjct: 174 GHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 8/102 (7%)
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
++ + + L YL E+ +IHRDVK +NILLD + DFG++ L DS T
Sbjct: 118 KMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTR 173
Query: 466 VRGTVGHIAPEYLSTGQSSEK----TDVFGFGILLLELITGQ 503
G ++APE + + K DV+ GI L+EL TGQ
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 16/218 (7%)
Query: 300 TSNFSAKNILGRGGFGIVYK-GCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
T + +G+G +G VYK DG+L AVK L + E++ + + SL H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQ-SLPNHP 79
Query: 359 NLLRLCGFCSTENERL-----LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
N+++ G ++ + LV GSV ++ + LD A I G
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
GL +LH +IIHRDVK NILL + + DFG++ L T+V GT +
Sbjct: 140 GLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWM 195
Query: 474 APEYLSTGQSSE-----KTDVFGFGILLLELITGQRAL 506
APE ++ Q + + DV+ GI +EL G L
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 303 FSAKNILGRGGFGIVYKGCFSDGAL-----VAVKRLKDYNIAGGEVQ---FQTEVETISL 354
+ ++L G FG ++ G D V VK +KD+ E+Q E +
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYG 64
Query: 355 AVHRNLLRLCGFCSTENERLLV-YPYMPNGSVASRLRDHIHGRPALDWARRKR----IAL 409
H+N+L + C + E V YPYM G++ L+ G A + +A+
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRG 468
A G+ YLH++ +IH+D+ A N ++DE+ + + D L++ L D H +
Sbjct: 125 QIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
V +A E L + S +DV+ FG+LL EL+T
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 22/213 (10%)
Query: 302 NFSAKNILGRGGFGIVY----KGCFSDGALVAVKRLKDYNIAGGE-VQFQTEVETISLAV 356
NF +LG G +G V+ G L A+K L+ + T E L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 357 HRN---LLRLCGFCSTENERLLVYPYMPNGSVASRL--RDHIHGRPALDWARRKRIALG- 410
R L+ L TE + L+ Y+ G + + L RD+ R G
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEV-------RFYSGE 113
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
L +LH+ I++RD+K NILLD + V+ DFGL+K + T + GT+
Sbjct: 114 IILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170
Query: 471 GHIAPEYL-STGQSSEKTDVFGFGILLLELITG 502
++APE + G + D + GIL+ EL+TG
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 307 NILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGG-------EVQFQTEVETISLAVHR 358
+G G +G VYK + G VA+K+++ G E+ ++E+ H
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE---HP 61
Query: 359 NLLRL---CGFCSTENERL--LVYPYMPNGSVASRLRDHI--HGRPALDWARRKRIALGT 411
N++RL C T+ E LV+ + V L ++ +P L K +
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
RG+ +LH I+HRD+K NIL+ D + + DFGLA++ + +T+ V T+
Sbjct: 117 LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYS-FEMALTSVVV-TLW 171
Query: 472 HIAPEYLSTGQSSEKT--DVFGFGILLLEL 499
+ APE L QSS T D++ G + EL
Sbjct: 172 YRAPEVLL--QSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 35/103 (33%), Positives = 60/103 (58%), Gaps = 5/103 (4%)
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
+IA+ GL YL+ +I+HRD+K +NIL++ + + DFG++ L +S T
Sbjct: 107 KIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL--INSIADTF 162
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508
V GT +++PE + G+ + K+DV+ GI ++EL G+ F
Sbjct: 163 V-GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 43/138 (31%), Positives = 73/138 (52%), Gaps = 17/138 (12%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL-----DHRDSHVTTAVR 467
RGL Y+H +IHRD+K +N+L++ED E +GDFG+A+ L +H+ +T V
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK-YFMTEYV- 172
Query: 468 GTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA-ANQRGVMLDWV--- 522
T + APE LS + + D++ G + E++ G+R L G+ +Q ++L +
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQLKLILSVLGSP 231
Query: 523 CSHILSNQSSLDMVLNLL 540
+L N+ D V +
Sbjct: 232 SEEVL-NRIGSDRVRKYI 248
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 309 LGRGGFGIVYKGCFS---DGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
LG G FG V KG + VAVK LK D N + + E + + ++R+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
G C E+ +LV G + L+ + H + + + G+ YL E
Sbjct: 63 GICEAES-WMLVMELAELGPLNKFLQKNKH----VTEKNITELVHQVSMGMKYLEET--- 114
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIAPEYLSTGQ 482
+HRD+ A N+LL A + DFGL+K L +++ G V APE ++ +
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 483 SSEKTDVFGFGILLLELIT-GQR 504
S K+DV+ FG+L+ E + GQ+
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 301 SNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA 355
S+F LG G FG V +KG G A+K LK I +VQ + ++I +
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILME 74
Query: 356 VHRNLL--RLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
+ + +C F + R+ + ++ G + + LR GR D A+ L A
Sbjct: 75 LSHPFIVNMMCSF--QDENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLA 130
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
YLH D II+RD+K N+LLD V DFG AK + R T + GT +
Sbjct: 131 --FEYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEY 181
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITG 502
+APE + + + D + G+LL E I G
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLK-------DYNIAGGEVQFQTEVETISLAVHRNL 360
LG G FG VY G LVA+K++K + + EV+ L H N+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEEC-MNLREVKS-----LRKLNEHPNI 60
Query: 361 LRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
++L EN+ L V+ YM G++ ++D G+P + + I +GL ++H
Sbjct: 61 VKLKEVFR-ENDELYFVFEYM-EGNLYQLMKDR-KGKP-FSESVIRSIIYQILQGLAHIH 116
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL- 478
+ HRD+K N+L+ + DFGLA+ + R + T V T + APE L
Sbjct: 117 KH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STRWYRAPEILL 171
Query: 479 -STGQSSEKTDVFGFGILLLELITGQ 503
ST SS D++ G ++ EL T +
Sbjct: 172 RSTSYSS-PVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 302 NFSAKNILGRGGFGIVY----KGCFSDGALVAVKRLK-DYNIAGGEVQ-FQTEVETISLA 355
+F+ +LG+G FG V KG +D L A+K LK D I +V+ E ++L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKG--TD-ELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
L C +RL V Y+ G L HI A A G
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGD----LMYHIQQVGKFKEPHAVFYAAEIAIG 113
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR-GTVGHI 473
L +LH + II+RD+K N++LD + + DFG+ K ++ TT GT +I
Sbjct: 114 LFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYI 168
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
APE ++ + D + FG+LL E++ GQ D
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFC 367
LG G G+V K L+ ++L I Q E++ + ++ G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 368 STENERLLVYPYMPNGSV------ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
++ E + +M GS+ A R+ + I G+ +++ RGL YL E+
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK----------VSIAVLRGLAYLREK 122
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
+I+HRDVK +NIL++ E + DFG++ L DS + V GT +++PE L
Sbjct: 123 --HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGT 177
Query: 482 QSSEKTDVFGFGILLLELITGQ 503
S ++D++ G+ L+EL G+
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFSDGAL----VAVKRL-KDYNIAGGEVQFQTEVETISL 354
T+ + +G G FG+V C + L VA+K++ K ++ + E++ +
Sbjct: 9 TNRYVDLQPVGMGAFGLV---CSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKH 65
Query: 355 AVHRNLLRLCG-FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
H N++ L F S + V + G+ RL + RP L+ + R
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELL--GTDLHRL---LTSRP-LEKQFIQYFLYQILR 119
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
GL Y+H ++HRD+K +NIL++E+ + + DFGLA++ D + T T +
Sbjct: 120 GLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYR 172
Query: 474 APEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
APE + T Q + D++ G + E++ G+
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 327 LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVA 386
LVAVK L+ F EV+ +S N++RL G C E+ ++ YM NG +
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 387 SRLRDHI---------------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDV 431
L H H PA+ ++ +AL A G+ YL +HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDL 164
Query: 432 KAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG----TVGHIAPEYLSTGQSSEKT 487
N L+ E+ + DFG+++ L D + ++G + +A E + G+ + +
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTAS 221
Query: 488 DVFGFGILLLELITGQRALDFGRAANQR 515
DV+ FG+ L E++ + +G +++
Sbjct: 222 DVWAFGVTLWEILMLCKEQPYGELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 18/213 (8%)
Query: 302 NFSAKNILGRGGFGIVY----KGCFSDGALVAVKRLK-DYNIAGGEVQ-FQTEVETISLA 355
+F+ +LG+G FG V KG L A+K LK D I +V+ E ++L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGT---DELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57
Query: 356 VHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
L C +RL V Y+ G L I A A G
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGD----LMYQIQQVGRFKEPHAVFYAAEIAIG 113
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
L +LH + II+RD+K N++LD + + DFG+ K + D T GT +IA
Sbjct: 114 LFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTFCGTPDYIA 169
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
PE ++ + D + FG+LL E++ GQ +
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 55/194 (28%), Positives = 83/194 (42%), Gaps = 19/194 (9%)
Query: 325 GALVAVKRLKDYNIAGGE--VQFQTEVETISLAVHRNLLRLCGFCSTENERLL-VYPYMP 381
G VA+K L+ +F+ E + H N++ L L V+ Y+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL--- 438
++ L AL R+ L L H Q I+HRD+K NI++
Sbjct: 63 GRTLREVLA----ADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQT 115
Query: 439 DEDFEAVVGDFGLAKLL-DHRDSHVTTAVR-----GTVGHIAPEYLSTGQSSEKTDVFGF 492
A V DFG+ LL RD+ V T R GT + APE L + +D++ +
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 493 GILLLELITGQRAL 506
G++ LE +TGQR +
Sbjct: 176 GLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 32/233 (13%)
Query: 288 LKRY-----TFKELRAATSNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRLKDYNI 338
L RY ++L+ ++ ++GRG FG V +K S + A+K L + +
Sbjct: 25 LNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEM 81
Query: 339 A--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIH 394
F E + ++ A +++L FC+ ++++ L V YMP G + + + ++
Sbjct: 82 IKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNY-- 137
Query: 395 GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454
P WA+ TA +L L +IHRDVK N+LLD+ + DFG
Sbjct: 138 DVPE-KWAK-----FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191
Query: 455 LDHRDS-HVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITG 502
+D TAV GT +I+PE L + G + D + G+ L E++ G
Sbjct: 192 MDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 50/199 (25%), Positives = 90/199 (45%), Gaps = 19/199 (9%)
Query: 312 GGFGIVYKG-CFSDGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNLLRL----CG 365
G +G+VY+ G +VA+K+LK + G + E+ + H N++ + G
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHI-HGRPALDWARRKRIALGTARGLLYLHEQCDP 424
S ++ +V Y+ + L+ + + + K + L G+ +LH+
Sbjct: 76 --SNLDKIYMVMEYVEH-----DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN--- 125
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YLSTGQS 483
I+HRD+K +N+LL+ + DFGLA+ T V T+ + APE L +
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLGAKEY 184
Query: 484 SEKTDVFGFGILLLELITG 502
S D++ G + EL+T
Sbjct: 185 STAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 309 LGRGGFGIVYKG--CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
LG G + VYKG +D LVA+K ++ + G EV + H N++ L
Sbjct: 14 LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 367 CSTENERLLVYPYMPNGSVASRLRD-----HIHGRPALDWARRKRIALGTARGLLYLHEQ 421
TE LV+ Y+ + + L D ++H K RGL Y H +
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNV--------KLFLFQLLRGLNYCHRR 123
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YLST 480
K++HRD+K N+L++E E + DFGLA+ + V T+ + P+ L +
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGS 179
Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
S + D++G G + E+ TG+
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 67/236 (28%), Positives = 102/236 (43%), Gaps = 38/236 (16%)
Query: 288 LKRY-----TFKELRAATSNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRL-KDYN 337
L RY +LR +F ++GRG FG V +K S + A+K L K
Sbjct: 25 LSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEM 81
Query: 338 IAGGEVQFQTEVETISLAVHRN---LLRLCGFCSTENERLL--VYPYMPNGSVASRLRDH 392
I + F E I H N +++L + ++++ L V YMP G + + + ++
Sbjct: 82 IKRSDSAFFWEERDI--MAHANSEWIVQLH--YAFQDDKYLYMVMEYMPGGDLVNLMSNY 137
Query: 393 IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452
WAR TA +L L IHRDVK N+LLD+ + DFG
Sbjct: 138 ---DIPEKWAR-----FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189
Query: 453 KLLDHRDS--HVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITG 502
+D + TAV GT +I+PE L + G + D + G+ L E++ G
Sbjct: 190 MKMD-ANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 17/211 (8%)
Query: 302 NFSAKNILGRGGFGIVY---KGCFSD-GALVAVKRLKDYNIA-GGEVQFQTEVETISLAV 356
NF +LG G +G V+ K D G L A+K LK I + T E L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 357 HRN---LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
R L+ L T+ + L+ Y+ G L H+ R + + + + +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGG----ELFTHLSQRERF---KEQEVQIYSGE 113
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
+L L II+RD+K NILLD + V+ DFGL+K + + GT+ ++
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 474 APEYLSTGQS--SEKTDVFGFGILLLELITG 502
AP+ + G + D + G+L+ EL+TG
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 33/100 (33%), Positives = 56/100 (56%), Gaps = 4/100 (4%)
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
L ++H D KI+HRD+K+ NI L +D +GDFG+A++L+ T + GT ++
Sbjct: 113 ALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYL 168
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAAN 513
+PE + K+D++ G +L E+ T + A + G N
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 63/238 (26%), Positives = 96/238 (40%), Gaps = 46/238 (19%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRL-KDYNIAGGEVQ-FQTEVETISLAV 356
+F ++GRG FG V+ G + A+K L K I ++ + E + ++ A
Sbjct: 1 DDFEVIKVIGRGAFGEVWL-VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD 59
Query: 357 HRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
+++L + S ++E L V YMP G + + L + AR A
Sbjct: 60 SPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETAR-----FYIAEL 110
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK--------------------- 453
+L L IHRD+K NIL+D D + DFGL K
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 454 --LLDHRDSHVTTAVR-----GTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
+L R H VR GT +IAPE L G + D + G++L E++ G
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL-RGTPYGLECDWWSLGVILYEMLYGF 227
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNL 360
+F + LG G G+V+K L+ ++L I Q E++ + +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 361 LRLCGFCSTENERLLVYPYMPNGSV------ASRLRDHIHGRPALDWARRKRIALGTARG 414
+ G ++ E + +M GS+ A R+ + I G+ +++ +G
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK----------VSIAVIKG 115
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
L YL E+ KI+HRDVK +NIL++ E + DFG++ L DS + V GT +++
Sbjct: 116 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMS 170
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQ 503
PE L S ++D++ G+ L+E+ G+
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 31/167 (18%)
Query: 346 QTEVETISLAVHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWAR 403
E + H ++RL F + ++R L + Y+P G + S LR+
Sbjct: 49 HNEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRN------------ 94
Query: 404 RKRIALGTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455
R + T L YLH + +I++RD+K NILLD++ + DFG AK L
Sbjct: 95 SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL 151
Query: 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
R T + GT ++APE + + ++ D + GIL+ E++ G
Sbjct: 152 RDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 301 SNFSAKNILGRGGFGIVYKGC----FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
S +G G GIV C S G VAVK++ E+ F EV +
Sbjct: 19 SYLDNFVKIGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQ 74
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHI-HGRPALDWARRKRIALGTARGL 415
H N++ + +E +V ++ G+ L D + H R ++ + + L + L
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGA----LTDIVTHTR--MNEEQIATVCLAVLKAL 128
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG----LAKLLDHRDSHVTTAVRGTVG 471
+LH Q +IHRD+K+ +ILL D + DFG ++K + R S V GT
Sbjct: 129 SFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPY 180
Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
+APE +S + D++ GI+++E++ G+
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
R + YLHE +IIHRD+KA NI ++ + +GDFG A +++ GT+
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRAL 506
APE L+ D++ GI+L E+ T +L
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 38/221 (17%)
Query: 303 FSAKNILGRGGFGIVYKGCFSD-GALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNL 360
F +G G +G VYK D G LVA+K+++ D G + E++ + HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 361 LRLCGFCSTENERL----------LVYPYMPN---GSVASRL----RDHIHG--RPALDW 401
+ L + + + L LV+ YM + G + S L DHI + L+
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE- 127
Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
GL Y H++ +HRD+K +NILL+ + + DFGLA+L + +S
Sbjct: 128 ------------GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 462 VTTAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELIT 501
T T+ + PE L + DV+ G +L EL T
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
RGL Y+H IIHRD+K +NI ++ED E + DFGLA+ H D +T V T +
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 181
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
APE L+ ++ D++ G ++ EL+TG+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
LG G + V+KG LVA+K ++ + G EV + H N++ L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL-GTARGLLYLHEQCDPKI 426
TE LV+ Y+ S L+ ++ L +I + RGL Y H++ KI
Sbjct: 73 HTERCLTLVFEYLD-----SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG----TVGHIAPE-YLSTG 481
+HRD+K N+L++E E + DFGLA R V T T+ + P+ L +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLA-----RAKSVPTKTYSNEVVTLWYRPPDVLLGST 179
Query: 482 QSSEKTDVFGFGILLLELITGQ 503
+ S D++G G +L E+ TG+
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 308 ILGRGGFGIVYKGCFSD-GALVAVKRLKDY-------NIAGGEVQFQTEVETISLAVHRN 359
++G G +G+V K + G +VA+K+ + IA E++ ++ H N
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR------HEN 61
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
L+ L + LV+ ++ + +V L + +G LD +R ++ RG+ + H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCH 117
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
IIHRD+K NIL+ + + DFG A+ L T V T + APE L
Sbjct: 118 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLV 173
Query: 480 TGQSSEK-TDVFGFGILLLELITGQ 503
+ D++ G L+ E++TG+
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 12/201 (5%)
Query: 309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
LG G + VYKG +G LVA+K ++ G E + H N++ L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPA-LDWARRKRIALGTARGLLYLHEQCDPKI 426
T+ LV+ Y V + L ++ P L K RGL Y+H++ I
Sbjct: 73 HTKETLTLVFEY-----VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YI 124
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YLSTGQSSE 485
+HRD+K N+L+ + E + DFGLA+ SH + T+ + P+ L + + S
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 486 KTDVFGFGILLLELITGQRAL 506
D++G G + +E+I G A
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 44/215 (20%)
Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQT---------EVETISLA 355
+G G +G V C + GA VA+K+L FQ+ E+ +
Sbjct: 23 VGSGAYGTV---CSALDRRTGAKVAIKKLYR--------PFQSELFAKRAYRELRLLKHM 71
Query: 356 VHRNLLRLCGFCSTE------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
H N++ L + + ++ LV P+M G+ +L H L R + +
Sbjct: 72 KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKH----EKLSEDRIQFLVY 125
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
+GL Y+H IIHRD+K N+ ++ED E + DFGLA+ DS +T V T
Sbjct: 126 QMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-T 178
Query: 470 VGHIAPEY-LSTGQSSEKTDVFGFGILLLELITGQ 503
+ APE L+ ++ D++ G ++ E++TG+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 45/205 (21%), Positives = 94/205 (45%), Gaps = 13/205 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQ--TEVETISLAVH 357
+NF + +GRG F VY+ C D VA+K+++ + + + + E++ + H
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
N+++ +NE +V G ++ ++ + + + + + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG---HIA 474
+H + +++HRD+K AN+ + +GD GL + S TTA VG +++
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMS 174
Query: 475 PEYLSTGQSSEKTDVFGFGILLLEL 499
PE + + K+D++ G LL E+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 36/130 (27%), Positives = 60/130 (46%), Gaps = 12/130 (9%)
Query: 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAA 434
LV Y+ G AS ++ G DWA++ G+ LH++ IIHRD+K
Sbjct: 74 LVMEYLNGGDCASLIK--TLGGLPEDWAKQ--YIAEVVLGVEDLHQR---GIIHRDIKPE 126
Query: 435 NILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGI 494
N+L+D+ + DFGL+ R+ GT ++APE + + +D + G
Sbjct: 127 NLLIDQTGHLKLTDFGLS-----RNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGC 181
Query: 495 LLLELITGQR 504
++ E + G
Sbjct: 182 VIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
+G G GIV S G LVAVK++ E+ F EV + H N++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
+E +V ++ G++ + H R ++ + + L + L LH Q +I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIV---THTR--MNEEQIAAVCLAVLKALSVLHAQ---GVI 138
Query: 428 HRDVKAANILLDEDFEAVVGDFG----LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS 483
HRD+K+ +ILL D + DFG ++K + R S V GT +APE +S
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPELISRLPY 193
Query: 484 SEKTDVFGFGILLLELITGQ 503
+ D++ GI+++E++ G+
Sbjct: 194 GPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 30/88 (34%), Positives = 53/88 (60%), Gaps = 4/88 (4%)
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
G+ ++HE+ +++HRD+K+ NI L ++ + +GDFG A+LL ++ T V GT ++
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELIT 501
PE + K+D++ G +L EL T
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 331 KRLKDYNIAGGEVQFQTEVETISLAV--HRNLLRLCGFCSTENERLLVYP---YMPNGSV 385
+ + AG Q E E ++L H N+L++ E +L YM
Sbjct: 194 RLIAKRVKAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKY 245
Query: 386 ASRLRDHIHGRPALDWARR------KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD 439
L ++ A DW R + I + Y+H D K+IHRD+K NI L+
Sbjct: 246 DFDLYSFMYDE-AFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN 301
Query: 440 EDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 499
D + V+GDFG A + GTV +PE L+ E TD++ G++LL++
Sbjct: 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
Query: 500 IT 501
++
Sbjct: 362 LS 363
|
Length = 501 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 11/196 (5%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
+G+G G VY + G VA+K++ E+ E+ + H N++
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKHPNIVNYLDSY 85
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
+E +V Y+ GS+ + + +D + + + L +LH ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
HRD+K+ NILL D + DFG + S +T V GT +APE ++ K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 488 DVFGFGILLLELITGQ 503
D++ GI+ +E++ G+
Sbjct: 197 DIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
A L YLHE+ I+HRD+K N+ L VGD G+A++L+++ +T + GT
Sbjct: 112 AMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPY 167
Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
+++PE S + K+DV+ G + E+ T + A +
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 21/213 (9%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLK-DYNIAGGEVQFQTEVETISLA---V 356
NF +G G +G+VYK G +VA+K+++ D G T + ISL
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELN 57
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA--LDWARRKRIALGTARG 414
H N+++L TEN+ LV+ ++ L+ + P + K +G
Sbjct: 58 HPNIVKLLDVIHTENKLYLVFEFL-----HQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
L + H +++HRD+K N+L++ + + DFGLA+ T V T+ + A
Sbjct: 113 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 168
Query: 475 PE-YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
PE L S D++ G + E++T +RAL
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 6e-09
Identities = 16/42 (38%), Positives = 27/42 (64%), Gaps = 1/42 (2%)
Query: 31 INYEVVALVAVKNNLHDPYN-VLENWDITSVDPCSWRMITCS 71
+N + AL+A K++L+ + L +W+ +S DPCSW +TC
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 21/204 (10%)
Query: 308 ILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQFQ-TEVETISLAVHRNLL 361
+LG+G FG V K + G A+K L K+ IA EV TE + H L
Sbjct: 2 LLGKGTFGKVILVREK---ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 362 RLCGFCSTENERL-LVYPYMPNGSVASRL-RDHIHGRPALDWARRKRIALGTARGLLYLH 419
L + ++RL V Y G + L R+ + R + L YLH
Sbjct: 59 AL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGAEIVSALGYLH 112
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
+++RD+K N++LD+D + DFGL K D GT ++APE L
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLE 168
Query: 480 TGQSSEKTDVFGFGILLLELITGQ 503
D +G G+++ E++ G+
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 31/204 (15%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLK-----DYNIAGGEVQFQTEVETISLAVHRNLLR 362
+G G +G VYK G L AVK +K D+++ Q E+ + H N++
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL------IQQEIFMVKECKHCNIVA 70
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
G + + + Y GS L+D H L + + T +GL YLH +
Sbjct: 71 YFGSYLSREKLWICMEYCGGGS----LQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR----GTVGHIAPEYL 478
+HRD+K ANILL ++ + + DFG+A + T A R GT +APE
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVAAKIT-----ATIAKRKSFIGTPYWMAPEVA 178
Query: 479 S---TGQSSEKTDVFGFGILLLEL 499
+ G ++ D++ GI +EL
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 51/206 (24%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQT---EVETISLAVHRNLLRLCG 365
LG+G +G VYK + +K+ + E +F E++ + AV ++ G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMA--MKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
E + YM GS+ +L + +RI +GL +L E+ +
Sbjct: 67 AFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN-- 123
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG---HIAPEYLSTGQ 482
IIHRDVK N+L++ + + + DFG++ L V + + +G ++APE + +G
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTNIGCQSYMAPERIKSGG 177
Query: 483 SSE------KTDVFGFGILLLELITG 502
++ ++DV+ G+ +LE+ G
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 1e-08
Identities = 27/60 (45%), Positives = 36/60 (60%)
Query: 123 KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNL 182
L++LDLSNN+ T + L NL L L+ N+LT PE+ S + SL +DLS NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 64/235 (27%), Positives = 108/235 (45%), Gaps = 36/235 (15%)
Query: 288 LKRYT-----FKELRAATSNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRLKDYNI 338
L RY ++LR ++ ++GRG FG V +K S + A+K L + +
Sbjct: 25 LNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSKFEM 81
Query: 339 A--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDH-I 393
F E + ++ A +++L F + +++R L V YMP G + + + ++ +
Sbjct: 82 IKRSDSAFFWEERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV 139
Query: 394 HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453
+ WAR TA +L L IHRDVK N+LLD+ + DFG
Sbjct: 140 PEK----WAR-----FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190
Query: 454 LLDHRDSHV--TTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITG 502
++ ++ V TAV GT +I+PE L + G + D + G+ L E++ G
Sbjct: 191 KMN-KEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 25/203 (12%)
Query: 309 LGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
+G G GIV C + G VAVK++ E+ F EV + H N++ +
Sbjct: 30 IGEGSTGIV---CIATEKHTGKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMY 85
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
+E +V ++ G++ + H R ++ + + L R L YLH Q
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIV---THTR--MNEEQIATVCLSVLRALSYLHNQ--- 137
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFG----LAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
+IHRD+K+ +ILL D + DFG ++K + R S V GT +APE +S
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-----GTPYWMAPEVISR 192
Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
+ D++ GI+++E+I G+
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 11/199 (5%)
Query: 308 ILGRGGFG-IVYKGCFSDGALVAVKRLK-DYNIAGGEVQFQ-TEVETISLAVHRNLLRLC 364
+LG+G FG ++ + G A+K LK + IA EV TE + H L L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
T++ V Y+ G L H+ R + L YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGG----ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG--- 114
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
KI++RD+K N++LD+D + DFGL K D+ GT ++APE L
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 485 EKTDVFGFGILLLELITGQ 503
D +G G+++ E++ G+
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRL-KDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
+G+G FG VY+ D + A+K L K +A EV I + R LL F
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNI---LVRTLLDESPF 57
Query: 367 C-------STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
T+++ LV YM G + L+ GR + D A+ L A L +LH
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLA--LEHLH 113
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
+ I++RD+K NILLD + DFGL+K + D+ T GT ++APE L
Sbjct: 114 KY---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLL 169
Query: 480 TGQSSEK-TDVFGFGILLLELITG 502
+ K D + G+L+ E+ G
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 28/227 (12%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGG-------EVQFQTEVETISLAVHRNL 360
+G G +G VYK G VA+K ++ G EV +E H N+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD---HPNI 64
Query: 361 LRLCGFCST-----ENERLLVYPYMPNGSVASRLRDHIHGRPA--LDWARRKRIALGTAR 413
+RL C+T E + LV+ + V LR ++ P L K + R
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEH-----VDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
GL +LH C I+HRD+K NIL+ + + DFGLA++ + T V T+ +
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYR 174
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD 520
APE L + D++ G + E+ + A+Q G + D
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 48/180 (26%), Positives = 91/180 (50%), Gaps = 19/180 (10%)
Query: 346 QTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG----SVASRLRDHIHGRPALDW 401
++E+ ++ H +++ ++++ LL+ Y G + RL++H+ P ++
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHL---PFQEY 169
Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS- 460
+ L + +L L E K++HRD+K+ANI L +GDFG +K + DS
Sbjct: 170 ----EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK--QYSDSV 223
Query: 461 --HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM 518
V ++ GT ++APE + S+K D++ G++L EL+T R + +QR +M
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIM 280
|
Length = 478 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 44/162 (27%), Positives = 71/162 (43%), Gaps = 27/162 (16%)
Query: 307 NILGRGGFGIVYKG-CFSDGALVAVKR-LKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
+G+G FG V+K +VA+K+ L + G + E++ + L H N++ L
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 365 GFCSTENERLLVYPYMPNGSVAS-------------RLRDHIHGRPALDWARRKRIALGT 411
C T+ N S L + + + L + K++
Sbjct: 78 EICRTK-------ATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL--SEIKKVMKML 128
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453
GL Y+H KI+HRD+KAANIL+ +D + DFGLA+
Sbjct: 129 LNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 43/237 (18%)
Query: 309 LGRGGFGIVYKG--CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV---------- 356
+G G +G V+K + G VA+KR V+ QT E + L+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKR----------VRVQTGEEGMPLSTIREVAVLRHL 58
Query: 357 ----HRNLLRLCGFCST-----ENERLLVYPYMPNGSVASRLRDHIHG--RPALDWARRK 405
H N++RL C+ E + LV+ + V L ++ P + K
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETIK 113
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
+ RGL +LH +++HRD+K NIL+ + + DFGLA++ + T+
Sbjct: 114 DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTS 168
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522
V T+ + APE L + D++ G + E+ + +Q G +LD +
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 56/196 (28%), Positives = 87/196 (44%), Gaps = 9/196 (4%)
Query: 309 LGRGGFGIVYKGCFSDGALV-AVKRL-KDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
+G+G FG V + D + A+K + K + ++ EV T+ V+ + F
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
E+L + NG L H+ D +R + TA L L +
Sbjct: 61 SFQSPEKLYLVLAFINGG---ELFHHLQREGRFDLSRAR---FYTAELLCALENLHKFNV 114
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
I+RD+K NILLD + DFGL K L+ +D T GT ++APE L ++
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 487 TDVFGFGILLLELITG 502
D + G+LL E++TG
Sbjct: 174 VDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLK-----DYNIAGGEVQFQTEVE 350
R +F +G G +G VYK + G L A+K +K D+ + Q E+
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVV------QQEII 58
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
+ H N++ G ++ + + GS L+D H L ++ ++
Sbjct: 59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGS----LQDIYHVTGPLSESQIAYVSRE 114
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG----LAKLLDHRDSHVTTAV 466
T +GL YLH + +HRD+K ANILL ++ + DFG + + R S +
Sbjct: 115 TLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI---- 167
Query: 467 RGTVGHIAPEYLST---GQSSEKTDVFGFGILLLEL 499
GT +APE + G ++ D++ GI +EL
Sbjct: 168 -GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 53/187 (28%), Positives = 80/187 (42%), Gaps = 10/187 (5%)
Query: 346 QTEVETISLAV-HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR 404
QTE A H L+ L TE+ V Y+ G L H+ + L
Sbjct: 43 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD----LMFHMQRQRKLPEEHA 98
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
+ + + L YLHE+ II+RD+K N+LLD + + D+G+ K R T+
Sbjct: 99 RFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTS 154
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF-GRAANQRGVMLDWVC 523
GT +IAPE L D + G+L+ E++ G+ D G + N D++
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 214
Query: 524 SHILSNQ 530
IL Q
Sbjct: 215 QVILEKQ 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 58/240 (24%), Positives = 100/240 (41%), Gaps = 44/240 (18%)
Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDG------------------ALVAV 330
KR TFKE LG G FG V+ C ++G LVAV
Sbjct: 5 KRLTFKEK------------LGEGQFGEVHL-CEAEGMEKFMDKDFSLDVSGNQPVLVAV 51
Query: 331 KRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
K L++ F E++ +S N++RL C T + ++ YM NG + L
Sbjct: 52 KMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLS 111
Query: 391 DH-------IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443
H + ++ +A A G+ YL +HRD+ N L+ +++
Sbjct: 112 RHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYT 168
Query: 444 AVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
+ DFG+++ L + + R + ++ E + G+ + +DV+ FG+ L E++T
Sbjct: 169 IKIADFGMSRNL-YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 17/199 (8%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLLRLCG- 365
+G G F V K G A+K +K + + +V E++ + L+ H N+LRL
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 366 -FCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIALGTARGLLYLHEQCD 423
F LV+ M L + I GR L R K + L ++H
Sbjct: 67 LFDRKTGRLALVFELMD-----MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN-- 119
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE-YLSTGQ 482
I HRD+K NIL+ +D + DFG + + + + T T + APE L+ G
Sbjct: 120 -GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGY 175
Query: 483 SSEKTDVFGFGILLLELIT 501
K D++ G + E+++
Sbjct: 176 YGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 25/203 (12%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETI--SLAVHR-----NL 360
+G+G G VY + G VA+K++ +Q Q + E I + V R N+
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMN--------LQQQPKKELIINEILVMRENKNPNI 78
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
+ +E +V Y+ GS+ + + +D + + + L +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHS 133
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
++IHRD+K+ NILL D + DFG + S +T V GT +APE ++
Sbjct: 134 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 189
Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
K D++ GI+ +E++ G+
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 309 LGRGGFGIVYKG--CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
LG G + V+KG ++ LVA+K ++ + G EV + H N++ L
Sbjct: 14 LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL-GTARGLLYLHEQCDPK 425
T+ LV+ Y+ L+ ++ + +I L RGL Y H + K
Sbjct: 73 VHTDKSLTLVFEYLDKD-----LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG----TVGHIAPE-YLST 480
++HRD+K N+L++E E + DFGLA R V T T+ + P+ L +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLA-----RAKSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
+ S + D++G G + E+ +G+
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
RGL Y+H IIHRD+K +N+ ++ED E + DFGLA+ H D +T V T +
Sbjct: 131 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYV-ATRWY 183
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
APE L+ ++ D++ G ++ EL+TG+
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 59/200 (29%), Positives = 84/200 (42%), Gaps = 14/200 (7%)
Query: 308 ILGRGGFG-IVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL---AVHRNLLRL 363
++G+G FG ++ SDG+ AVK L+ I + Q E L H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 364 CGFCSTENERLLVYPYMPNGSVASRL-RDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
T + V Y+ G + L R+ P R + A A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVASAIGYLHSL- 115
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
II+RD+K NILLD V+ DFGL K T+ GT ++APE L
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 483 SSEKTDVFGFGILLLELITG 502
D + G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 61/245 (24%), Positives = 105/245 (42%), Gaps = 31/245 (12%)
Query: 302 NFSAKNILGRGGFG----IVYKGCFSDGALVAVKRLKDYNIAGGE--VQFQTEVETISLA 355
+F K+++GRG FG + K + G + A+K +K + E F+ E + +S++
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREK---ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
+ +L ++ LV Y P G + S L + + D A+ A +
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQ-----FYLAELV 112
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIA 474
L +H +HRD+K N+L+D + DFG A L + V + GT +IA
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT-ANKMVNSKLPVGTPDYIA 171
Query: 475 PEYLSTGQSSEKT------DVFGFGILLLELITGQRALDFGRAANQRGVMLDWVCSHILS 528
PE L+T K D + G++ E+I G+ G +A ++I++
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--------TYNNIMN 223
Query: 529 NQSSL 533
Q L
Sbjct: 224 FQRFL 228
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 14/198 (7%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYN-IAGGE------VQFQTEVETISLAVHRNLL 361
LG+G FG VY D VA +RLK I GE VQ E + +S H ++
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
+ + ++ Y + +L + H L + + G+ Y+H++
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
+I+HRD+KA NI L + +GDFG+++LL + T GT +++PE L
Sbjct: 126 ---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPEALKHQ 180
Query: 482 QSSEKTDVFGFGILLLEL 499
K+D++ G +L E+
Sbjct: 181 GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 40/139 (28%), Positives = 62/139 (44%), Gaps = 8/139 (5%)
Query: 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428
T + LV Y+ G L H+ + L + A L +LHE+ II+
Sbjct: 67 TTSRLFLVIEYVNGGD----LMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIY 119
Query: 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTD 488
RD+K N+LLD D + D+G+ K T+ GT +IAPE L + D
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVD 178
Query: 489 VFGFGILLLELITGQRALD 507
+ G+L+ E++ G+ D
Sbjct: 179 WWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 50/154 (32%), Positives = 76/154 (49%), Gaps = 14/154 (9%)
Query: 311 RGGFGIVY---KGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
RG FG VY K + L AVK +K ++ + Q + E +LA+ ++ + +
Sbjct: 14 RGAFGKVYLGRKKN--NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 368 S--TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
S + N LV Y+ G V S L HI+G + A K I+ A L YLH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLL--HIYGYFDEEMAV-KYIS-EVALALDYLHRH---G 124
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
IIHRD+K N+L+ + + DFGL+K+ +R+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 3/94 (3%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
+L + NL L+++ L N + +P L L L LDLS NK + ++P + L L
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL 211
Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNL 182
L L+NNS+ SLS +++L+ ++LS N L
Sbjct: 212 EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL 244
|
Length = 394 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 13/209 (6%)
Query: 298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
AATS + + LG G + VYKG +G LVA+K + G E +
Sbjct: 3 AATSYLNLEK-LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK 61
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
H N++ L T+ V+ YM + +A + H G L + RGL
Sbjct: 62 HANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGG---LHPYNVRLFMFQLLRGLA 117
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
Y+H Q I+HRD+K N+L+ E + DFGLA+ S ++ T+ + P+
Sbjct: 118 YIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPD 173
Query: 477 YL--STGQSSEKTDVFGFGILLLELITGQ 503
L +T SS D++G G + +E++ GQ
Sbjct: 174 VLLGATDYSSA-LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 51/209 (24%), Positives = 79/209 (37%), Gaps = 23/209 (11%)
Query: 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLAVHRNLLRLCGF 366
+ K LVAVK++ + + +++ Q E+ T H N+L
Sbjct: 9 CFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-T 66
Query: 367 CSTENERL-LVYPYMPNGSVASRLRDHI-HGRPALDWARRKRIALGTARGLLYLHEQCDP 424
+ L +V P M GS L+ H G P L A I L Y+H +
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF---ILKDVLNALDYIHSK--- 120
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI------APEYL 478
IHR VKA++ILL D + V+ + + + +PE L
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 479 STGQS----SEKTDVFGFGILLLELITGQ 503
Q+ +EK+D++ GI EL G
Sbjct: 181 Q--QNLQGYNEKSDIYSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 31/213 (14%)
Query: 306 KNILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
+LG+GG+G V++ GA + A+K LK I + + +T RN+L
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV------RNQKDTAHTKAERNIL 54
Query: 362 R---------LCGFCSTENERLLVYPYMPNGSVASRL-RDHIHGR-PALDWARRKRIALG 410
L T + L+ Y+ G + L R+ I A + +AL
Sbjct: 55 EAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE 114
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
+LH+Q II+RD+K NILLD + DFGL K H + VT GT+
Sbjct: 115 ------HLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTI 164
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
++APE L + D + G L+ +++TG
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 36/101 (35%), Positives = 50/101 (49%), Gaps = 6/101 (5%)
Query: 403 RRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL-LDHRDSH 461
R + A A L YLH II+RD+K NILLD V+ DFGL K ++H +
Sbjct: 97 RARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT- 152
Query: 462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
T+ GT ++APE L D + G +L E++ G
Sbjct: 153 -TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 25/218 (11%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGAL--VAVKRLKDYNIAGGEV--QFQTEV 349
++ + +F+ LG G FG V + + VA+KR + I + +E
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI-- 407
+ ++ H + L G E+ LV ++ G + LR R KR
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR------------RNKRFPN 130
Query: 408 ---ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
A+ +L I++RD+K N+LLD+D + DFG AK++D R T
Sbjct: 131 DVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TY 186
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
+ GT +IAPE L + D + GI + E++ G
Sbjct: 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 9e-08
Identities = 36/133 (27%), Positives = 65/133 (48%), Gaps = 9/133 (6%)
Query: 371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRD 430
+E +V Y+ GS+ + + +D A+ + + L +LH ++IHRD
Sbjct: 89 DELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRD 140
Query: 431 VKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVF 490
+K+ N+LL D + DFG + S +T V GT +APE ++ K D++
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 491 GFGILLLELITGQ 503
GI+ +E++ G+
Sbjct: 200 SLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
RGL Y+H ++HRD+K AN+ ++ ED +GDFGLA+++D SH G V
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 472 --HIAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
+ +P LS ++ D++ G + E++TG+
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 38/215 (17%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETI-SLAV----------H 357
+G G +G+VYK A R+ + IA +++ + E E + S A+ H
Sbjct: 10 IGEGTYGVVYK---------ARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA----LGTAR 413
N++RL +E LV+ Y+ L+ H+ P D+A+ R+ R
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLD-----LDLKKHMDSSP--DFAKNPRLIKTYLYQILR 113
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGH 472
G+ Y H +++HRD+K N+L+D A+ + DFGLA+ T V T+ +
Sbjct: 114 GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWY 169
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQRAL 506
APE L + S D++ G + E++ Q+ L
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 35/218 (16%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQT--EVETISLAVH 357
+ F ++G G +G+V K + +VA+K+ KD EV+ T E++ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE-ENEEVKETTLRELKMLRTLKQ 59
Query: 358 RNLLRLCGFCSTENERLLVYPY-----------MPNGSVASRLRDHIHGR-PALDWARRK 405
N++ L + LV+ Y MPNG ++R +I+ A+ W +
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
I+HRD+K N+L+ + + DFG A+ L + T
Sbjct: 120 -------------------DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
T + +PE L + D++ G +L EL GQ
Sbjct: 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 25/203 (12%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETI--SLAVHR-----NL 360
+G+G G VY + G VA++++ +Q Q + E I + V R N+
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN--------LQQQPKKELIINEILVMRENKNPNI 79
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
+ +E +V Y+ GS+ + + +D + + + L +LH
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS 134
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
++IHRD+K+ NILL D + DFG + S +T V GT +APE ++
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
K D++ GI+ +E+I G+
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 55/233 (23%), Positives = 102/233 (43%), Gaps = 54/233 (23%)
Query: 308 ILGRGGFGIVY----KGCFSDGALVAVKRLKDYNIAGGEV---QFQTEVETISLAVHRNL 360
++G+GG G VY C VA+K++++ +++ + +F E + + +H +
Sbjct: 9 LIGKGGMGEVYLAYDPVC---SRRVALKKIRE-DLSENPLLKKRFLREAKIAADLIHPGI 64
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR---RKRIALGTARGLL- 416
+ + CS + PY+ ++ S L+ W + K +A T+ G
Sbjct: 65 VPVYSICSDGDPVYYTMPYIEGYTLKSLLKS--------VWQKESLSKELAEKTSVGAFL 116
Query: 417 -----------YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK--------LLD- 456
Y+H + ++HRD+K NILL E V+ D+G A LLD
Sbjct: 117 SIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173
Query: 457 --------HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
+ + + GT ++APE L +SE TD++ G++L +++T
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
L +LHE+ II+RD+K N+LLD + + D+G+ K R T+ GT +IA
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIA 164
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
PE L D + G+L+ E++ G+ D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 308 ILGRGGFG-IVYKGCFSDGALVAVKRLK-DYNIAGGEVQFQ-TEVETISLAVHRNLLRLC 364
+LG+G FG ++ + G A+K LK + +A EV TE + + H L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 365 GFCSTENERLLVYPYMPNGSVASRL-RDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
T + V Y G + L R+ + D AR + +A L YLH +
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSE---DRARFYGAEIVSA--LDYLHSE-- 114
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS 483
+++RD+K N++LD+D + DFGL K +D GT ++APE L
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDY 173
Query: 484 SEKTDVFGFGILLLELITGQ 503
D +G G+++ E++ G+
Sbjct: 174 GRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 4/92 (4%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
RGL YLH I+HRD+K N+L++ + + DFGLA++ + +S T T +
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 473 IAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
APE L + + D++ G + EL+ +
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 8/94 (8%)
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
GL Y+H IIHRD+K N+ ++ED E + DFGLA+ H D+ +T V T
Sbjct: 126 MLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TR 178
Query: 471 GHIAPEY-LSTGQSSEKTDVFGFGILLLELITGQ 503
+ APE L+ ++ D++ G ++ E++TG+
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 59/249 (23%), Positives = 94/249 (37%), Gaps = 59/249 (23%)
Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG------ 341
+RY K LG G +G V K + G +VA+K++K I+
Sbjct: 8 ERYIQKG-----------AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQ 56
Query: 342 -------------EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASR 388
E++ E++ H N++ L + LV M AS
Sbjct: 57 LVGMCGIHFTTLRELKIMNEIK------HENIMGLVDVYVEGDFINLVMDIM-----ASD 105
Query: 389 LRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD 448
L+ + + L ++ K I L GL LH+ +HRD+ ANI ++ + D
Sbjct: 106 LKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIAD 162
Query: 449 FGLAK------LLDHRDSHVTTAVRG-------TVGHIAPEYL-STGQSSEKTDVFGFGI 494
FGLA+ D T R T+ + APE L + D++ G
Sbjct: 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGC 222
Query: 495 LLLELITGQ 503
+ EL+TG+
Sbjct: 223 IFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
+ L YLH Q +IHRD+K+ +ILL D + DFG + +D ++ GT
Sbjct: 128 QALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYW 183
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
+APE +S + D++ GI+++E++ G+
Sbjct: 184 MAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 38/148 (25%), Positives = 66/148 (44%), Gaps = 13/148 (8%)
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
+ N ++L +T +L+ Y+ +G L D + L A K+I L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGD----LFDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
LH+ IIH D+K N+L D + + + D+GL K++ + GT+ + +P
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSP 175
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQ 503
E + D + G+L EL+TG+
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 4e-07
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 45/218 (20%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGG----------EVQFQTEVETISLAVH 357
LG+G +GIV+K +VA+K++ D A E+ F E L H
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFD---AFRNATDAQRTFREIMFLQE-----LGDH 66
Query: 358 RNLLRLCGFCSTENER--LLVYPYMPNG--SV--ASRLRDHIHGRPALDWARRKRIALGT 411
N+++L EN++ LV+ YM +V A+ L D +H ++ I
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED-VH---------KRYIMYQL 116
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR---- 467
+ L Y+H +IHRD+K +NILL+ D + DFGLA+ L + + V
Sbjct: 117 LKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV 173
Query: 468 GTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
T + APE L ST + ++ D++ G +L E++ G+
Sbjct: 174 ATRWYRAPEILLGST-RYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV---HRNLLRLC 364
+G G +G+VYKG G +VA+K+++ + G T + ISL H N++ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPS--TAIREISLLKELQHPNIVCLQ 65
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA---LDWARRKRIALGTARGLLYLHEQ 421
E+ L++ ++ + L+ ++ P +D K +G+L+ H +
Sbjct: 66 DVLMQESRLYLIFEFL-----SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
+++HRD+K N+L+D + DFGLA+ V T T+ + APE L
Sbjct: 121 ---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFG-IPVRVYTHEVVTLWYRAPEVLLGS 176
Query: 482 QS-SEKTDVFGFGILLLELIT 501
S D++ G + E+ T
Sbjct: 177 PRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 5e-07
Identities = 20/60 (33%), Positives = 30/60 (50%)
Query: 99 KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSL 158
L+S+ L NN + + L L+ LDLS N T P++ L +L L L+ N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 42/216 (19%)
Query: 309 LGRGGFGIV-----YKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
+G G FG V Y + A V VK LK + + +F + + + H N+L+
Sbjct: 3 IGNGWFGKVLLSEIYTD--TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR-------KRIALGTARGLL 416
G C LLV+ Y G + S L W RR +R+A A G+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQE-------QWHRRNSQLLLLQRMACEIAAGVT 113
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT------AVRGTV 470
++H+ +H D+ N L D VGD+G+ +++ ++ T +R
Sbjct: 114 HMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWL- 168
Query: 471 GHIAPEYLSTGQ----SSEKT---DVFGFGILLLEL 499
APE + ++E+T +V+ G+ L EL
Sbjct: 169 ---APELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 309 LGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
LG G + VYKG S G LVA+K ++ + G E + H N++ L
Sbjct: 13 LGEGSYATVYKG-RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
T+ LV+ Y+ + + + D G L + RGL Y H++ ++
Sbjct: 72 IHTKKTLTLVFEYL-DTDLKQYMDDCGGG---LSMHNVRLFLFQLLRGLAYCHQR---RV 124
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAK---LLDHRDSH--VTTAVRGTVGHIAPEYL--S 479
+HRD+K N+L+ E E + DFGLA+ + S+ VT R P+ L S
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR------PPDVLLGS 178
Query: 480 TGQSSEKTDVFGFGILLLELITGQ 503
T S+ D++G G + E+ TG+
Sbjct: 179 TEYSTS-LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 20/153 (13%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVK--RLKDYNIAGGEVQFQTEVETISL---AVHRNLLR 362
+G G +G+VYK G +VA+K RL+ + E T + ISL H N++R
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETED----EGVPSTAIREISLLKELNHPNIVR 62
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP--ALDWARRKRIALGTARGLLYLHE 420
L +EN+ LV+ + + L+ ++ P LD K +G+ Y H
Sbjct: 63 LLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453
+++HRD+K N+L+D + + DFGLA+
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 64/258 (24%), Positives = 102/258 (39%), Gaps = 64/258 (24%)
Query: 308 ILGRGGFG-IVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVET-ISLAVHRNL 360
+LG G FG +V F S VAVK LK+ A +E++ I + H N+
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 361 LRLCGFCSTENERLLV-YPYMPNGSVASRLR---------------DHIHGRPALDWAR- 403
+ L G C+ N L+V + G++++ LR R ++ +R
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133
Query: 404 RKRIALGTARGLLYLH-----EQCDP---------------------------------- 424
+RI G A L +P
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT-AVRGTVGHIAPEYLSTGQS 483
K IHRD+ A NILL E+ + DFGLA+ + +V + R + +APE +
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY 253
Query: 484 SEKTDVFGFGILLLELIT 501
+ ++DV+ FG+LL E+ +
Sbjct: 254 TTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 29/157 (18%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETI-SLAV---------- 356
+G G +G V+K + +VA+KR V+ + E + S A+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKR----------VRLDDDDEGVPSSALREICLLKELK 57
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
H+N++RL ++ + LV+ Y + D +G D K +GL
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYCDQD--LKKYFDSCNGDI--DPEIVKSFMFQLLKGLA 113
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453
+ H ++HRD+K N+L++++ E + DFGLA+
Sbjct: 114 FCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 54/199 (27%), Positives = 83/199 (41%), Gaps = 11/199 (5%)
Query: 308 ILGRGGFG-IVYKGCFSDGALVAVKRL-KDYNIAGGEVQFQ-TEVETISLAVHRNLLRLC 364
+LG+G FG ++ + G A+K L K+ IA EV TE + H L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
T + V Y G L H+ R + L YLH +
Sbjct: 62 YAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--- 114
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSS 484
+++RD+K N++LD+D + DFGL K D GT ++APE L
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 485 EKTDVFGFGILLLELITGQ 503
D +G G+++ E++ G+
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 38/225 (16%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R+ ++ NI+G G FG+VY+ C VA+K+ L+D E+ +
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLN---- 117
Query: 355 AVHRNLLRLCGFCSTE----NERLL----VYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
H N++ L + TE NE+ + V ++P +V ++ + AL K
Sbjct: 118 --HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKL 174
Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTA 465
+ R L Y+H + I HRD+K N+L+D + + + DFG AK L A
Sbjct: 175 YSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL--------LA 223
Query: 466 VRGTVGHI------APEYLSTGQSSEKT--DVFGFGILLLELITG 502
+ +V +I APE L G ++ T D++ G ++ E+I G
Sbjct: 224 GQRSVSYICSRFYRAPE-LMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 39/140 (27%), Positives = 64/140 (45%), Gaps = 19/140 (13%)
Query: 90 LSPWIGNLT-KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
+ P IG L L+ + L +N I +P+ L L L+ LDLS N + ++P L +L NL
Sbjct: 131 IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL 188
Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICG 204
N L L+ N ++ P + + +L +DLS N++ L +S +++ N L
Sbjct: 189 NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED- 246
Query: 205 PKATNNCTAVFPEPLSLPPN 224
PE + N
Sbjct: 247 ----------LPESIGNLSN 256
|
Length = 394 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VRGTV 470
ARG+ +L + K IHRD+ A NILL E+ + DFGLA+ + +V R +
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
+APE + + ++DV+ FG+LL E+ +
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
RGL Y+H IIHRD+K +N+ ++ED E + DFGLA+ D T T +
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWY 181
Query: 473 IAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
APE L+ ++ D++ G ++ EL+ G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 16/209 (7%)
Query: 309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF- 366
+G+G +G V+K +G+ AVK L + E++ + + +L+ H N+++ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILK-ALSDHPNVVKFYGMY 84
Query: 367 ----CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
++ LV GSV ++ + ++ I GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
K IHRDVK NILL + + DFG++ L T+V GT +APE ++ Q
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQ 200
Query: 483 S-----SEKTDVFGFGILLLELITGQRAL 506
+ DV+ GI +EL G L
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 57/199 (28%), Positives = 81/199 (40%), Gaps = 12/199 (6%)
Query: 308 ILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISL---AVHRNLLRL 363
++G+G FG V DG AVK L+ + + Q E L H L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
T + V ++ G L H+ + R + A A L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGG----ELFFHLQRERSFPEPRARFYAAEIASALGYLHSI-- 115
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS 483
I++RD+K NILLD V+ DFGL K S TT GT ++APE +
Sbjct: 116 -NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 484 SEKTDVFGFGILLLELITG 502
D + G +L E++ G
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 45/172 (26%), Positives = 69/172 (40%), Gaps = 42/172 (24%)
Query: 310 GRGGFGIVYKG---CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA---VHRNLLRL 363
GRG +G VYK DG A+K+ K + Q+ I+L H N++ L
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS-QSACREIALLRELKHENVVSL 67
Query: 364 CGFCSTENERL--LVYPYMPNGSVASR-----LRDHIHGRPALDWARRKRIALGTAR--- 413
++ L++ Y A ++ H A+R I +
Sbjct: 68 VEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQ-------AKRVSIPPSMVKSLL 114
Query: 414 -----GLLYLHEQCDPKIIHRDVKAANILL--DEDFEAVV--GDFGLAKLLD 456
G+ YLH ++HRD+K ANIL+ + VV GD GLA+L +
Sbjct: 115 WQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
RGL Y+H ++HRD+K +N+LL+ + + + DFGLA+ + +T V T +
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 473 IAPEYLSTGQSSEKT---DVFGFGILLLELITGQ 503
APE L SE T DV+ G + EL+ +
Sbjct: 175 RAPELLLN--CSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 45/219 (20%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEV-----------------ET 351
LG+G F ++KG + + DY GE+ +TEV E
Sbjct: 3 LGQGTFTKIFKGIRRE--------VGDY----GELH-KTEVLLKVLDKSHRNYSESFFEA 49
Query: 352 ISLAV---HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
S+ H++L+ G C +E ++V Y+ GS+ + L+ + + W
Sbjct: 50 ASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS-W------K 102
Query: 409 LGTARGLLY-LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
L A+ L + LH D + H +V A N+LL + + G+ KL D S
Sbjct: 103 LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE 162
Query: 468 GTVGHI---APEYLSTGQS-SEKTDVFGFGILLLELITG 502
+ I PE + Q+ S D + FG L E+ +G
Sbjct: 163 ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
R + A+G+ +L + IHRDV A N+LL + A + DFGLA+ + + ++V
Sbjct: 216 RFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272
Query: 466 -VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
R V +APE + + ++DV+ +GILL E+ +
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 52/229 (22%), Positives = 95/229 (41%), Gaps = 30/229 (13%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGA------LVAVKRLKDYNIAGGEVQFQTE 348
E+ +T F + LG FG VYKG A VA+K LKD +F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 349 VETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL------------RDHIHGR 396
S H N++ L G + E +++ Y + + L D +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 397 PALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456
L+ A I A G+ +L ++H+D+ N+L+ + + D GL + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 457 HRDSHVTTAVRGT----VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
D + + G + ++PE + G+ S +D++ +G++L E+ +
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 5e-06
Identities = 29/93 (31%), Positives = 53/93 (56%), Gaps = 6/93 (6%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD--HRDSHVTTAVRGTV 470
RGL Y+H ++HRD+K +N+LL+ + + + DFGLA++ D H + T T
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 471 GHIAPE-YLSTGQSSEKTDVFGFGILLLELITG 502
+ APE L++ ++ D++ G +L E+++
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 57/201 (28%), Positives = 85/201 (42%), Gaps = 16/201 (7%)
Query: 308 ILGRGGFGIVYKGCF-SDGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLC 364
++G+G FG V ++ AVK L+ I E +E + V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 365 GFCSTENERL-LVYPYMPNGSVASRL-RDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
F ++L V Y+ G + L R+ P R + A A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGYLHSL- 115
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKL-LDHRDSHVTTAVRGTVGHIAPEYLSTG 481
I++RD+K NILLD V+ DFGL K ++H + T+ GT ++APE L
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQ 171
Query: 482 QSSEKTDVFGFGILLLELITG 502
D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VRGTV 470
A+G+ +L + K IHRD+ A NILL E+ + DFGLA+ + +V R +
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
+APE + + ++DV+ FG+LL E+ +
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 27/211 (12%)
Query: 309 LGRGGFGIVYKGCF---SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV----HRNLL 361
LG+G +GIV S+ VA+K++ N+ ++ + + + L H+N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKIT--NVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 362 RLCG----FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
L F NE +Y Y + + L I L A + GL Y
Sbjct: 66 CLYDMDIVFPGNFNE---LYLYEE--LMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKY 120
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD----HRDSHVTTAVRGTVGHI 473
+H ++HRD+K N+L++ D E + DFGLA+ +T V T +
Sbjct: 121 IHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATRWYR 176
Query: 474 APEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
APE + + QS K DV+ G +L EL+ +
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 55/197 (27%), Positives = 82/197 (41%), Gaps = 32/197 (16%)
Query: 325 GALVAVKRLKDYNIAGGE--VQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN 382
G LV V R+ D E Q EV H N++ +T + ++ P+M
Sbjct: 25 GTLVTV-RITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83
Query: 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442
GS S L+ + + A I G RGL YLH+ IHR++KA++IL+ D
Sbjct: 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGD- 137
Query: 443 EAVVGDFGLAKL--LDHRDSHVTTAVRGTVGHIAPEYLSTGQ---SSE-----------K 486
GL L L H S V + V + P++ ++ S E K
Sbjct: 138 -------GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVK 190
Query: 487 TDVFGFGILLLELITGQ 503
+D++ GI EL TG+
Sbjct: 191 SDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 10/94 (10%)
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT-- 469
ARG+ +L + +HRD+ A N+LL + + DFGLA+ + H ++V+ +G+
Sbjct: 247 ARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300
Query: 470 --VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
V +APE + + +DV+ +GILL E+ +
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-VRGTV 470
A+G+ +L + IHRD+ A NILL + DFGLA+ + + ++V R V
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
+APE + + ++DV+ +GILL E+ +
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 8/92 (8%)
Query: 412 ARGLL----YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD-HRDSHVTTAV 466
AR LL Y+H + IIHRD+K N+L++ + +GDFG A + +
Sbjct: 266 ARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322
Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 498
GTV APE L+ + D++ G+++ E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 68/238 (28%), Positives = 95/238 (39%), Gaps = 62/238 (26%)
Query: 309 LGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEV-QFQTEVETISLAVHRNLLR 362
LG+G G V+ KG G L A+K L K I +V + TE E ++ H L
Sbjct: 9 LGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPT 65
Query: 363 LCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR------- 413
L + S + E LV Y P G + L+ +P K ++ AR
Sbjct: 66 L--YASFQTETYLCLVMDYCPGGELFRLLQR----QP------GKCLSEEVARFYAAEVL 113
Query: 414 -GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR----- 467
L YLH I++RD+K NILL E ++ DF L+K D V+ A+R
Sbjct: 114 LALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 468 -----------------------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
GT +IAPE +S D + GILL E++ G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 42/228 (18%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALV---------AVKRLKDYN-IAGGEVQFQTEVE 350
+F ++ G +G VY LV A+K++ N I ++Q Q VE
Sbjct: 1 EDFETIKLISNGAYGAVY--------LVRHKETRQRFAMKKINKQNLILRNQIQ-QVFVE 51
Query: 351 TISLAVHRNLLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
L N + FCS E +R L V Y+ G A+ L+ +I P D AR
Sbjct: 52 RDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK-NIGALPV-DMARMYFAE 109
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL------------LD 456
T L YLH I+HRD+K N+L+ + DFGL+K+
Sbjct: 110 --TVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164
Query: 457 HRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
+D+ + V GT +IAPE + + D + GI+L E + G
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 35/127 (27%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438
Y+P+ +R I+ PAL + + A G+ +L + +HRD+ A N+L+
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI 272
Query: 439 DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT----VGHIAPEYLSTGQSSEKTDVFGFGI 494
E + DFGLA+ + ++++ +G+ + +APE + + +DV+ FGI
Sbjct: 273 CEGKLVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGI 329
Query: 495 LLLELIT 501
LL E+ T
Sbjct: 330 LLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 56/238 (23%), Positives = 92/238 (38%), Gaps = 48/238 (20%)
Query: 309 LGRGGFGIVYKGCF---SDGAL--------VAVKRLK-DYNIAGGEVQFQTEVETISLAV 356
LG+G F +YKG SD + V +K L D+ + + F +S
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDS---LAFFETASLMSQLS 59
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL-GTARGL 415
H++L++L G C +E ++V Y+ G L +H K A L
Sbjct: 60 HKHLVKLYGVC-VRDENIMVEEYVKFGP----LDVFLHREKNNVSLHWKLDVAKQLASAL 114
Query: 416 LYLHEQCDPKIIHRDVKAANILL--DEDFE-----AVVGDFGLAKLLDHRDSHVTTAVRG 468
YL ++ K++H +V NIL+ E + D G+ + R+ V
Sbjct: 115 HYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI--- 168
Query: 469 TVGHIAPEYLSTGQSS--EKTDVFGFGILLLEL----------ITGQRALDFGRAANQ 514
IAPE + GQ+S D + FG LLE+ ++ F + ++
Sbjct: 169 --PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR 224
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 40/223 (17%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYN-IAGGEVQFQTEV----ETISLAV 356
+F ++GRG FG VAV ++K I ++ + E+ ET
Sbjct: 2 DFEIIKVIGRGAFG-----------EVAVVKMKHTERIYAMKILNKWEMLKRAETACFRE 50
Query: 357 HRNLLRLCGFCS----------TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
RN+L + G C EN LV Y G + + L R D AR
Sbjct: 51 ERNVL-VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLL-SKFEDRLPEDMAR--- 105
Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV 466
A +L +H +HRD+K N+LLD + + DFG + L ++D V ++V
Sbjct: 106 --FYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSV 162
Query: 467 R-GTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQ 503
GT +I+PE L G+ + D + G+ + E++ G+
Sbjct: 163 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALV-AVKRLKDYNI--AGGEVQFQTEVETISLAVHR 358
+F ++GRG FG V + V A+K L + + F+ E + + ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 359 NLLRLCGFCSTENERLLVYPYMPNG---SVASRLRDHIHGRPALDWARRKRIALGTARGL 415
+ L EN LV Y G ++ S+ D + A + IA+ + L
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG-LAKLLDHRDSHVTTAVRGTVGHIA 474
Y +HRD+K NIL+D + + DFG KL++ + AV GT +I+
Sbjct: 122 HY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYIS 171
Query: 475 PEYLST-----GQSSEKTDVFGFGILLLELITGQ 503
PE L G+ + D + G+ + E++ G+
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|227563 COG5238, RNA1, Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 33/93 (35%), Positives = 44/93 (47%), Gaps = 10/93 (10%)
Query: 118 LGKLEKLQTLDLSNNKFTGEIPDSLGDL----GNLNYLRLNNNSLTGSCPESLSKIESLT 173
L K +LQ +DLS+N F E P+ LGDL +L +L+LNNN L + K
Sbjct: 88 LLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGK----A 143
Query: 174 LVDLSYNNLSGSLPKISARTFKVTGNPLICGPK 206
L L+YN + PK+ N L G K
Sbjct: 144 LFHLAYNKKAADKPKL--EVVICGRNRLENGSK 174
|
Length = 388 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 49/214 (22%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 308 ILGRGGFGIVYKGC-FSDGALVAVKR----LKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
+G G +G VYK + G LVA+K+ + + I ++ + ++ +S +++ ++R
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY--IVR 65
Query: 363 LCGFCSTENER-----LLVYPYMPNGSVASRLRDHI------HGRPALDWARRKRIALGT 411
L E + LV+ Y+ S L+ + GRP L K
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYL-----DSDLKKFMDSNGRGPGRP-LPAKTIKSFMYQL 119
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTV 470
+G+ + H+ ++HRD+K N+L+D+ + + D GL + T + T+
Sbjct: 120 LKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TL 175
Query: 471 GHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
+ APE L + S D++ G + E+ Q
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 34/111 (30%), Positives = 52/111 (46%), Gaps = 18/111 (16%)
Query: 124 LQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESL-SKIESLTLVDLSYNNL 182
LQ+LDL +NK + +P++L + L YL + +NS+ + P L S I L + S L
Sbjct: 264 LQSLDLFHNKISC-LPENLPE--ELRYLSVYDNSIR-TLPAHLPSGITHLNVQSNSLTAL 319
Query: 183 SGSLPKISARTFKVTGNPLICGPKA----------TNNCTAVFPEPLSLPP 223
+LP +T + N L P + + N V PE +LPP
Sbjct: 320 PETLP-PGLKTLEAGENALTSLPASLPPELQVLDVSKNQITVLPE--TLPP 367
|
Length = 754 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 22/201 (10%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNI-AGGEV-QFQTEVETISLAVHRNLLRLC- 364
+G+GG+G V+ D G +VA+KR+K + EV TE + ++ L++L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
F E L Y+P G + L + G + D AR + A + LHE
Sbjct: 69 AFQDDEY-LYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEA--VDALHEL--- 120
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG---HIAPEYLSTG 481
IHRD+K N L+D + DFGL+K + T VG ++APE L
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSK-------GIVTYANSVVGSPDYMAPEVLRGK 173
Query: 482 QSSEKTDVFGFGILLLELITG 502
D + G +L E + G
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 5e-04
Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 7/95 (7%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK--LLDHRDSHVTTAVRGTV 470
R L Y+H + HRD+K NIL + D + + DFGLA+ D + T T
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 471 GHIAPEYLST--GQSSEKTDVFGFGILLLELITGQ 503
+ APE + + + D++ G + E++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 22/218 (10%)
Query: 288 LKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRL-KDYNIAGGEVQF 345
LKRY ++L+ +G G GIV + G VAVK+L + + +
Sbjct: 20 LKRY--QQLKP----------IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRA 67
Query: 346 QTEVETISLAVHRNLLRLCG-FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR 404
E+ + H+N++ L F ++ Y+ + + L IH LD R
Sbjct: 68 YRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME--LDHERM 125
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
+ G+ +LH IIHRD+K +NI++ D + DFGLA+ + + T
Sbjct: 126 SYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC--TNFMMT 180
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
T + APE + E D++ G ++ EL+ G
Sbjct: 181 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 39/199 (19%), Positives = 83/199 (41%), Gaps = 27/199 (13%)
Query: 316 IVYKGCFSDGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLRLCGFCSTENER 373
+YKG F + V ++ K ++ + + E++ + N+L++ GF +
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 374 LLVYPYMPNGSV------ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
L P S+ LR+ + L + + +A+ +GL L++
Sbjct: 94 L------PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKP 145
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS-HVTTAV---RGTVGHIAPEYLSTGQS 483
++++ + + L+ E+++ + GL K+L +V V + I EY
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYT----- 200
Query: 484 SEKTDVFGFGILLLELITG 502
K D++ G++L E+ TG
Sbjct: 201 -IKDDIYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 29/90 (32%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
G+ +LH IIHRD+K +NI++ D + DFGLA+ S + T T +
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYR 184
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
APE + E D++ G ++ E+I G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 51/195 (26%), Positives = 75/195 (38%), Gaps = 28/195 (14%)
Query: 325 GALVAVKRLKDYNIAGGEVQF-QTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG 383
G V V+R+ V F Q E+ L H N++ +NE +V +M G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 384 SVASRLRDH-IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442
S + H + G L A I G + L Y+H +HR VKA++IL+ D
Sbjct: 85 SAKDLICTHFMDGMSELAIA---YILQGVLKALDYIHHM---GYVHRSVKASHILISVDG 138
Query: 443 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGH------------IAPEYLSTGQS--SEKTD 488
+ + GL L S + R V H ++PE L K+D
Sbjct: 139 KVYLS--GLRSNL----SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 192
Query: 489 VFGFGILLLELITGQ 503
++ GI EL G
Sbjct: 193 IYSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 36.3 bits (85), Expect = 0.001
Identities = 18/37 (48%), Positives = 25/37 (67%), Gaps = 2/37 (5%)
Query: 123 KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT 159
L+TLDLSNN+ T ++P L +L NL L L+ N +T
Sbjct: 2 NLETLDLSNNQIT-DLP-PLSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 5/105 (4%)
Query: 399 LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458
LD R + G+ +LH IIHRD+K +NI++ D + DFGLA+
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 177
Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
S + T T + APE + E D++ G ++ E+I G
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 9/84 (10%)
Query: 427 IHRDVKAANILLDEDFEAVVGDFG-LAKLLDHRDSHVTTAVR-GTVGHIAPEYL-----S 479
+HRD+K N+LLD++ + DFG +LL D V + V GT +I+PE L
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLA--DGTVQSNVAVGTPDYISPEILQAMEDG 181
Query: 480 TGQSSEKTDVFGFGILLLELITGQ 503
G+ + D + G+ + E++ G+
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 40/176 (22%), Positives = 61/176 (34%), Gaps = 55/176 (31%)
Query: 302 NFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
+F LG G FG+VYK +G V +K+ +Y G V+
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKATEY----GAVEIWM-------- 179
Query: 356 VHRNLLRLCG-----FCST---------ENERLLVYPYMPNGSVASRLRDH--------- 392
+ + R C F E+E LV+ Y ++A ++
Sbjct: 180 -NERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPY 238
Query: 393 ----IHGRPALDWARRKRIALGTARGLLY----LHEQCDPKIIHRDVKAANILLDE 440
+ P R +I R +L+ LH I+HRDVK NI+ E
Sbjct: 239 LLGKVQDLPK-GLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNIIFSE 290
|
Length = 566 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 30/102 (29%), Positives = 48/102 (47%), Gaps = 5/102 (4%)
Query: 399 LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458
LD R + G+ +LH IIHRD+K +NI++ D + DFGLA+
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-- 170
Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 500
S + T T + APE + E D++ G ++ E++
Sbjct: 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 32/216 (14%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDY---NIAGGEVQFQT--EVETISLAVHRNLLRL 363
+GRG +G VYK DG K +DY I G + E+ + H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDG-----KDDRDYALKQIEGTGISMSACREIALLRELKHPNVISL 63
Query: 364 CG-FCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL--GTARGLLY-- 417
F S + ++ L++ Y A HI A +K + L G + LLY
Sbjct: 64 QKVFLSHADRKVWLLFDY------AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117
Query: 418 ---LHEQCDPKIIHRDVKAANILL----DEDFEAVVGDFGLAKLLDHRDSHVT--TAVRG 468
+H ++HRD+K ANIL+ E + D G A+L + + V
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 469 TVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
T + APE L + K D++ G + EL+T +
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 35.6 bits (83), Expect = 0.004
Identities = 18/49 (36%), Positives = 25/49 (51%), Gaps = 4/49 (8%)
Query: 147 NLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
NL L L+NN LT + + +L ++DLS NNL+ IS F
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS----ISPEAFS 45
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 540 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.98 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.98 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.87 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.59 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.39 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.32 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.3 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.24 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.23 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.22 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.18 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.17 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.13 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.13 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.13 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.12 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.98 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.97 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.97 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.95 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.94 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.93 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.93 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.82 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.79 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.78 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.77 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.74 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.73 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.71 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.7 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.66 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.61 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.59 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.58 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.58 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.58 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.57 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.56 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.54 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.53 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.53 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.45 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.39 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.29 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.28 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.28 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.25 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.22 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.22 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.21 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.19 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-55 Score=503.31 Aligned_cols=413 Identities=31% Similarity=0.523 Sum_probs=303.2
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|++++.+|..+.++++|+.|+|++|++++.+|..+.++++|++|+|++|+++|.+|..+..+++|+.|+|
T Consensus 475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 554 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL 554 (968)
T ss_pred ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEEC
Confidence 36888899999998888888888999999999999999889988999999999999999999889999999999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCCcCCCCCCCCccCCCCCCCCCCCCCcCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGPKATNNCTAVFPEPLSLPPNGLKDQ 229 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~~~~~~c~~~~p~~~~~p~~~~~~~ 229 (540)
++|++++.+|..+..+++|+.|++++|+++|.+|.... ....+.||+..|+..... ..+++..
T Consensus 555 s~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~----------~~~~c~~--- 621 (968)
T PLN00113 555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTS----------GLPPCKR--- 621 (968)
T ss_pred CCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCcccc----------CCCCCcc---
Confidence 99999988998888899999999999999998887533 233567888888643211 1111110
Q ss_pred CCCCCCcccchhhhhhhhhhHHHHHHHHHhhhhheecccccccccCCCCCCCcccc---CcccccCHHHHHHHhcCCCcC
Q 009208 230 SDSGTKSHRVAVALGASFGAAFFVIIVVGLLVWLRYRHNQQIFFDVNDQYDPEVSL---GHLKRYTFKELRAATSNFSAK 306 (540)
Q Consensus 230 ~~~~~~~~~~~iii~~~~g~~~~~ii~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~~~~~~~~ 306 (540)
..+.....+++++++++++++++++.+++++|+|++.+...........+... .....+.++++ ...|...
T Consensus 622 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 695 (968)
T PLN00113 622 ---VRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEE 695 (968)
T ss_pred ---ccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcc
Confidence 00111122233333333333333333333333332221110000000011100 11122334443 3457788
Q ss_pred CeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCCh
Q 009208 307 NILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 385 (540)
+.||+|+||.||+|.. .++..||||+++.... ...+|++.+++++||||++++|+|..++..++||||+++|+|
T Consensus 696 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L 770 (968)
T PLN00113 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL 770 (968)
T ss_pred cEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcH
Confidence 8999999999999997 4789999999865331 123568889999999999999999999999999999999999
Q ss_pred hhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCceeec
Q 009208 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465 (540)
Q Consensus 386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 465 (540)
.++++. ++|..+.+++.|+++||+|||..+.++|+||||||+||+++.++.+++. ||........ ..
T Consensus 771 ~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~ 837 (968)
T PLN00113 771 SEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TK 837 (968)
T ss_pred HHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CC
Confidence 999853 7899999999999999999997777799999999999999999888875 6655432211 12
Q ss_pred cccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcccccccCCcHHHHHHHH
Q 009208 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVCSH 525 (540)
Q Consensus 466 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~w~~~~ 525 (540)
..+|+.|+|||++.+..++.|+|||||||++|||+||+.||+.... ......+|++..
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~ 895 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG--VHGSIVEWARYC 895 (968)
T ss_pred ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC--CCCcHHHHHHHh
Confidence 2578999999999999999999999999999999999999964322 234566777643
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-51 Score=411.80 Aligned_cols=247 Identities=51% Similarity=0.851 Sum_probs=214.3
Q ss_pred cccccCHHHHHHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEE
Q 009208 287 HLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366 (540)
Q Consensus 287 ~~~~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 366 (540)
....|++++++.+|++|...+.||+|+||.||+|.+.+|..||||++....... ..+|.+|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 567799999999999999999999999999999999999999999887655433 5679999999999999999999999
Q ss_pred EecCC-eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeE
Q 009208 367 CSTEN-ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV 445 (540)
Q Consensus 367 ~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 445 (540)
|.+.+ +.+||||||++|+|.++|+..... +++|.+|.+||.++|+||+|||+.+.++||||||||+|||+|+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99998 599999999999999999874322 899999999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcccccccCCcHHHHHHHH
Q 009208 446 VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVCSH 525 (540)
Q Consensus 446 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~w~~~~ 525 (540)
|+|||+|+..............||.+|+|||++..+..++|+|||||||+++|++||++|.+..++. ....+++|++..
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~-~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR-GELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc-ccccHHHHHHHH
Confidence 9999999754431111111117999999999999999999999999999999999999999976533 334488999888
Q ss_pred hhcCCcchhhhhc
Q 009208 526 ILSNQSSLDMVLN 538 (540)
Q Consensus 526 ~~~~~~~~~~l~~ 538 (540)
+... ...+++++
T Consensus 297 ~~~~-~~~eiiD~ 308 (361)
T KOG1187|consen 297 LEEG-KLREIVDP 308 (361)
T ss_pred HHCc-chhheeCC
Confidence 8776 55665553
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=355.87 Aligned_cols=200 Identities=28% Similarity=0.442 Sum_probs=180.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC-ccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN-IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
..+|...+.||+|+||+||+|+++ ++..||||.+.... .....+....|+++|+.++|||||++++++..++..++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 456778888999999999999985 58999999998765 3344556789999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC------CCeEEccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED------FEAVVGDFGL 451 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~------~~~kl~Dfgl 451 (540)
|||.||+|.+|++.+ +.+++.+.+.++.|+|.||++||++ +||||||||.|||++.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999864 4799999999999999999999999 99999999999999864 3589999999
Q ss_pred ccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|+.+.+. ......+|++.|||||+++.++|+.|+|+||+|+|+|||++|+.||+.
T Consensus 162 AR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 162 ARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 9988743 344567899999999999999999999999999999999999999994
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=336.49 Aligned_cols=214 Identities=27% Similarity=0.379 Sum_probs=185.0
Q ss_pred cCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCC-eeEEEEecCCC
Q 009208 305 AKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN-ERLLVYPYMPN 382 (540)
Q Consensus 305 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lV~e~~~~ 382 (540)
..+.||+|..|+|||+.++ +++.+|+|++.....+..++++.+|++++.+.+||+||.++|.|..++ +..|+||||++
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 4578999999999999986 588999999976655666788999999999999999999999999988 59999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|||++.+... +.+++....+|+.++++||.|||+.+ +||||||||+|||++..|++||||||.+..+... .
T Consensus 163 GSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~ 233 (364)
T KOG0581|consen 163 GSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I 233 (364)
T ss_pred CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence 9999998753 56999999999999999999999632 9999999999999999999999999999977654 4
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcccccccCCcHHHHHHHHhhcC
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVCSHILSN 529 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~w~~~~~~~~ 529 (540)
.....||..|||||.+++..|+.++||||||+.++|+.+|+.||.... .........+...+.++
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~--~~~~~~~~Ll~~Iv~~p 298 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN--PPYLDIFELLCAIVDEP 298 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC--CCCCCHHHHHHHHhcCC
Confidence 456779999999999999999999999999999999999999998541 11223444444444433
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=353.42 Aligned_cols=199 Identities=37% Similarity=0.590 Sum_probs=174.4
Q ss_pred CcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCcccc-HHHHHHHHHHHhcccCCCccceeEEEecCC-eeEEEEecCC
Q 009208 304 SAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCSTEN-ERLLVYPYMP 381 (540)
Q Consensus 304 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lV~e~~~ 381 (540)
...+.+|+|+||+||+|.++....||||++........ ..+|.+|+.++.+++|||||+++|+|.++. ..++|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 34466999999999999996555599999986542222 568999999999999999999999999887 7999999999
Q ss_pred CCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCceeeCCCC-CeEEcccccccccCCCC
Q 009208 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK-IIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~~ 459 (540)
+|+|.++++.. ....+++..+..++.|||+||.|||++ + ||||||||+|||++.++ .+||+|||+++......
T Consensus 124 ~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 124 GGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 99999999864 456899999999999999999999999 6 99999999999999997 99999999998765432
Q ss_pred Cceeeccccccccccccccc--cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLS--TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~--~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||..
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~ 248 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFED 248 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCC
Confidence 2233367999999999999 56899999999999999999999999974
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=333.24 Aligned_cols=201 Identities=30% Similarity=0.391 Sum_probs=181.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcccc--HHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG--EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.++|++.++||+|+||+||.++-+ .++.+|+|++++...... .....+|..++.+++||.||++.-.+++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 567899999999999999999865 589999999987665443 44678999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
+||+.||.|..+|.+ ++.+++..+..++..|+.||.|||+. +||||||||+|||+|++|.++|+|||+++.--
T Consensus 104 ld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999998875 46799999999999999999999999 99999999999999999999999999998533
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ....+...+||+.|||||++....|+..+|.||+|+++|||++|.+||..
T Consensus 177 ~-~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~ 227 (357)
T KOG0598|consen 177 K-DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA 227 (357)
T ss_pred c-CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC
Confidence 2 33445667899999999999999999999999999999999999999984
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=343.84 Aligned_cols=200 Identities=28% Similarity=0.462 Sum_probs=182.3
Q ss_pred cCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
..|...+.||+|||+.+|+++. ..|+.||+|++.+.... ..+....+|+++.++++|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688889999999999999998 78999999999764332 33456899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
|+|++|+|..++++ +++++++.++.+..||+.||.|||+. +|+|||||..|+++++++++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999998874 56899999999999999999999999 999999999999999999999999999998875
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
+. +...+.+|||.|+|||++.....+..+||||+|||+|-|+.|++||+.
T Consensus 171 ~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet 220 (592)
T KOG0575|consen 171 DG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET 220 (592)
T ss_pred cc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc
Confidence 43 334567899999999999999999999999999999999999999984
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=321.19 Aligned_cols=206 Identities=24% Similarity=0.386 Sum_probs=181.2
Q ss_pred cCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccc-cHHHHHHHHHHHhcccCCCccceeEE-EecCCe-eEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGF-CSTENE-RLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~-~~~~~~-~~lV 376 (540)
.+|++.++||+|.||+|||+.. .+|..||.|.++-..... .+.....|+.+|++++|||||+.++. +..+.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4567778999999999999985 589999999998554333 34468999999999999999999994 444555 8899
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK--IIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
|||+..|+|...++.....+..+++..+++++.|+++||.++|.+. ++ |+||||||.||+++.+|.+|++|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999988788889999999999999999999999942 24 89999999999999999999999999998
Q ss_pred cCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
+.... ......+|||.||+||.+....|+.||||||+||++|||+.-+.||..
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g 230 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG 230 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc
Confidence 87544 334567799999999999999999999999999999999999999984
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=328.27 Aligned_cols=200 Identities=28% Similarity=0.433 Sum_probs=174.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccc------cHHHHHHHHHHHhcccCCCccceeEEEecCCe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAG------GEVQFQTEVETISLAVHRNLLRLCGFCSTENE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 372 (540)
.+.|.+.+.+|+|+||.|-+|.- ++|+.||||++++..... ......+|+++|.++.|||||++.+++..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 45677889999999999999986 479999999998755433 22345799999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC---CCeEEccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED---FEAVVGDF 449 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Df 449 (540)
.||||||++||+|.+++-. .+.+.+..-+.++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999998865 35677788899999999999999999 99999999999999865 78999999
Q ss_pred ccccccCCCCCceeeccccccccccccccccCC--C-CccCCeehhhHHHHHHHhCCCCCCc
Q 009208 450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ--S-SEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~-~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|+|+... ......+.+|||.|.|||++.+.. + ..++|+||+||++|-+++|.+||..
T Consensus 324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~ 383 (475)
T KOG0615|consen 324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE 383 (475)
T ss_pred chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence 9999765 344567789999999999997653 3 4488999999999999999999973
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=337.22 Aligned_cols=198 Identities=34% Similarity=0.543 Sum_probs=177.5
Q ss_pred CCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCC
Q 009208 303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+...+.||+|.||+||.|.++....||+|.++... .....|.+|+++|.+++|+|||+++|+|..++..+||||||+.
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 33457899999999999999888899999998753 3345799999999999999999999999999999999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|.+||+. .+...+...+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+|||+|+...++....
T Consensus 286 GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 286 GSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred CcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 999999986 3456789999999999999999999999 99999999999999999999999999999665544444
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCC
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALD 507 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~ 507 (540)
.....-...|.|||.+..+.++.|||||||||+||||+| |+.||.
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~ 406 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP 406 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC
Confidence 444456779999999999999999999999999999999 888886
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=317.89 Aligned_cols=197 Identities=35% Similarity=0.542 Sum_probs=168.0
Q ss_pred CCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhc--ccCCCccceeEEEecCC----eeEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL--AVHRNLLRLCGFCSTEN----ERLL 375 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~----~~~l 375 (540)
..+..+.+|+|.||.||||.+ +++.||||++.. ..+..|++|-++++. ++|+||++++++-.... +++|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred chhhHHHhhcCccceeehhhc-cCceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 344557899999999999999 569999999975 345679999999875 58999999999987655 8999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEecCCCCCceeeCCCCCeEEccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ------CDPKIIHRDVKAANILLDEDFEAVVGDF 449 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------~~~~ivH~Dlk~~NILl~~~~~~kl~Df 449 (540)
|++|.++|+|.+||..+ .++|....+++..+++||+|||+. ++|+|+|||||++|||+.+|+++.|+||
T Consensus 286 Vt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 99999999999999864 699999999999999999999974 5789999999999999999999999999
Q ss_pred ccccccCCCCCce-eeccccccccccccccccCCC------CccCCeehhhHHHHHHHhCCCCCCc
Q 009208 450 GLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQS------SEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 450 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~------~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|+|.++....... ....+||.+|||||++.+... -.+.||||+|.|+|||+++-..++.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~ 426 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP 426 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC
Confidence 9999887543222 234679999999999876432 2468999999999999998876654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=302.34 Aligned_cols=199 Identities=27% Similarity=0.391 Sum_probs=179.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccH--HHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGE--VQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|+..+.||.|+||+|..++.+ +|..+|+|++.+....+-+ ....+|..++..+.||+++++.+.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45777899999999999999975 5889999999875533222 24678999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||.+||.|.++|++ .+.++++.++.++.+|+.|++|||+. .|++||+||+|||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999986 35799999999999999999999999 999999999999999999999999999997654
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
. +.+.+|||.|+|||++....+...+|.|||||++|||+.|..||...+
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 2 567889999999999999999999999999999999999999998543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=321.63 Aligned_cols=206 Identities=26% Similarity=0.375 Sum_probs=177.1
Q ss_pred cCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccH-HHHHHHHHHHhcccCCCccceeEEEecC--CeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGE-VQFQTEVETISLAVHRNLLRLCGFCSTE--NERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV 376 (540)
+.|+..+.||+|.||.||||+. .+|+.||+|+++......+. .-..+||.+|++++||||+++.+..... ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 3455567899999999999985 57999999999877644443 3457999999999999999999998765 789999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
+|||+. +|.-.+.. ..-.+++.++..+++|++.||+|+|.+ +|+|||||.+|||||++|.+||+|||+|+++.
T Consensus 197 FeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999976 66665543 234699999999999999999999999 99999999999999999999999999999888
Q ss_pred CCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcccccc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAAN 513 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~ 513 (540)
.......+..+-|..|.|||++.+. .|+..+|+||.|||+.||++|++.|....+.+
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve 327 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE 327 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH
Confidence 7766556666789999999998875 69999999999999999999999998544333
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=327.82 Aligned_cols=213 Identities=26% Similarity=0.390 Sum_probs=186.5
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+....+ +-+.+.+|+++++.++||||+.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778889999999999999976 57899999987655333 33458999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+.| +|..+|.+ .+.+++..+..++.+++.||.|||+. +|.|||+||.|||++..+.+|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9987 99998875 46799999999999999999999999 9999999999999999999999999999987753
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcccccccCCcHHHHHHHHhhcC
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVCSHILSN 529 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~w~~~~~~~~ 529 (540)
......+.|||-|||||+..++.|+..+|+||+|||+||+++|++||... .+...++....++
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------si~~Lv~~I~~d~ 216 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------SITQLVKSILKDP 216 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------HHHHHHHHHhcCC
Confidence 44566778999999999999999999999999999999999999999732 2445555554444
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=337.50 Aligned_cols=207 Identities=29% Similarity=0.468 Sum_probs=181.8
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCe
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE 372 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 372 (540)
...+....+.||+|+||+||+|... +...||||.+++....+.+.+|++|+++++.++|||||+++|+|..++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3455667789999999999999853 3567999999998877778899999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhccccCC------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 009208 373 RLLVYPYMPNGSVASRLRDHIH------G----RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~ 442 (540)
.++|+|||..|+|.+||+.+.. + .++++..+.+.||.|||.||+||-++ .+|||||..+|+|+.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence 9999999999999999975211 1 23489999999999999999999999 999999999999999999
Q ss_pred CeEEcccccccccCCCCCceee-ccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 443 EAVVGDFGLAKLLDHRDSHVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 443 ~~kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.+||+|||+++..-..+.+... ...-..+|||||.|..+++|++||||||||+|||++| |+-||..
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g 708 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG 708 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc
Confidence 9999999999976555544332 3445789999999999999999999999999999998 9999973
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=335.13 Aligned_cols=213 Identities=27% Similarity=0.463 Sum_probs=185.0
Q ss_pred cccCHHHHHHHhcCC---------CcCCeeeeccCccEEEEEeC----CCcEEEEEEeccCCccccHHHHHHHHHHHhcc
Q 009208 289 KRYTFKELRAATSNF---------SAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLA 355 (540)
Q Consensus 289 ~~~~~~~l~~~~~~~---------~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 355 (540)
..++|++.-++...| .+.++||.|.||+||+|.++ ....||||.+|....+..+.+|+.|..+|.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 445666554444443 46789999999999999985 24679999999887777788999999999999
Q ss_pred cCCCccceeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 009208 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAAN 435 (540)
Q Consensus 356 ~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~N 435 (540)
.||||+++.|+.......+||+|||++|+|++||+++ .+.+.+.+...+..+||.||+||-+. ++|||||..+|
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARN 761 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARN 761 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhh
Confidence 9999999999999999999999999999999999975 45699999999999999999999999 99999999999
Q ss_pred eeeCCCCCeEEcccccccccCCCCCceeec--cccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCC
Q 009208 436 ILLDEDFEAVVGDFGLAKLLDHRDSHVTTA--VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALD 507 (540)
Q Consensus 436 ILl~~~~~~kl~Dfgla~~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~ 507 (540)
||++.+..+|++|||+++.+.++....... ..-..+|.|||.|..+++|..||||||||+|||.++ |++||=
T Consensus 762 ILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW 836 (996)
T KOG0196|consen 762 ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 836 (996)
T ss_pred eeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence 999999999999999999886544222222 223579999999999999999999999999999887 999984
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=316.23 Aligned_cols=225 Identities=21% Similarity=0.328 Sum_probs=192.2
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc--cHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
...++|++...||+|+||+||.++-+ .|+.+|+|++++...-. .......|..+|....+|.||+++..|++.+..|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35688999999999999999999865 69999999998765322 2235789999999999999999999999999999
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
|||||++||++.+.|.. ...+++..+..++.+++-|+..+|+. |||||||||+|+|||..|.+||+|||++.-
T Consensus 218 LiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999875 46799999999999999999999999 999999999999999999999999999853
Q ss_pred cCC---------------C-------C-C-----c------------------eeeccccccccccccccccCCCCccCC
Q 009208 455 LDH---------------R-------D-S-----H------------------VTTAVRGTVGHIAPEYLSTGQSSEKTD 488 (540)
Q Consensus 455 ~~~---------------~-------~-~-----~------------------~~~~~~gt~~y~aPE~~~~~~~~~k~D 488 (540)
+.. . . . . .....+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 211 0 0 0 0 001245999999999999999999999
Q ss_pred eehhhHHHHHHHhCCCCCCcccccccCCcHHHHHHHHhhcC
Q 009208 489 VFGFGILLLELITGQRALDFGRAANQRGVMLDWVCSHILSN 529 (540)
Q Consensus 489 v~S~Gvil~elltg~~p~~~~~~~~~~~~~~~w~~~~~~~~ 529 (540)
.||+|||+|||+.|.+||....+.+.-..++.|.......+
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~ 411 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE 411 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC
Confidence 99999999999999999998777776677778886554433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=317.69 Aligned_cols=204 Identities=27% Similarity=0.411 Sum_probs=179.2
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcccc--HHHHHHHHHHHhcc-cCCCccceeEEEecCCeeE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG--EVQFQTEVETISLA-VHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 374 (540)
...+|...+.||+|+|++|++|+.. .++.+|||++.+.-.-.. .+-...|-++|.++ .||.|++++-.|+++...|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 4567888899999999999999965 689999999865433222 22467888999999 8999999999999999999
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+|+||.++|+|.++|++. +.+++...+.++.+|+.|++|||+. |||||||||+|||+|+||.++|+|||.|+.
T Consensus 151 FvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999874 6799999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCc---------e---eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 455 LDHRDSH---------V---TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 455 ~~~~~~~---------~---~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+.+.... . ...++||..|.+||++.....++.+|+|+||||+|+|+.|++||...
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~ 290 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA 290 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence 7643211 1 13477999999999999999999999999999999999999999743
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=320.70 Aligned_cols=195 Identities=30% Similarity=0.520 Sum_probs=174.4
Q ss_pred ccccCHHHHHHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEE
Q 009208 288 LKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367 (540)
Q Consensus 288 ~~~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 367 (540)
...++|+++.. .+.||.|+.|.||.|++ .++.||||+++..+ ..+|+-|++++||||+.+.|+|
T Consensus 118 ~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 118 LWEIPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hccCCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeee
Confidence 34566766543 47899999999999999 67899999987532 5689999999999999999999
Q ss_pred ecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEc
Q 009208 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG 447 (540)
Q Consensus 368 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 447 (540)
.....++||||||+.|-|++.|+. ..+++......+.++||.||.|||.. .|||||||+-||||..+..+||+
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIs 254 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKIS 254 (904)
T ss_pred cCCceeEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEec
Confidence 999999999999999999999975 45788888999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 448 DFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 448 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
|||.++..... .....++||..|||||+|.+...++|+||||||||||||+||..||.
T Consensus 255 DFGTS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYk 312 (904)
T KOG4721|consen 255 DFGTSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYK 312 (904)
T ss_pred cccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcc
Confidence 99999876543 33456789999999999999999999999999999999999999996
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=324.32 Aligned_cols=233 Identities=26% Similarity=0.377 Sum_probs=192.0
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcc-cCCCccceeEEEecCCee
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLA-VHRNLLRLCGFCSTENER 373 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 373 (540)
...++|...++||+|.||+|+.+..+ +++.+|||.+++...- +.....+.|.+++... +||.+++++..++++++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578899999999999999999986 5789999999987643 3334577888888776 599999999999999999
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++||||..||++..+.+ ...+++..+..++..++.||.|||++ +|||||||.+|||+|.+|.+||+|||+++
T Consensus 445 ~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999444333 35799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcccccccCCcHH-HHHHHHhhcCCcc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML-DWVCSHILSNQSS 532 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~-~w~~~~~~~~~~~ 532 (540)
.-- .....+.+++|||.|||||++.+..|+..+|.|||||+||||+.|+.||..+++++.-..++ +-+..-+.....+
T Consensus 517 e~m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea 595 (694)
T KOG0694|consen 517 EGM-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEA 595 (694)
T ss_pred ccC-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHH
Confidence 533 22345778899999999999999999999999999999999999999999776665444333 3333333333444
Q ss_pred hhhhhcc
Q 009208 533 LDMVLNL 539 (540)
Q Consensus 533 ~~~l~~~ 539 (540)
..++..|
T Consensus 596 ~~il~~l 602 (694)
T KOG0694|consen 596 IAIMRRL 602 (694)
T ss_pred HHHHHHH
Confidence 4444433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=295.37 Aligned_cols=199 Identities=24% Similarity=0.331 Sum_probs=170.8
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.|+....+|+|+||.|||++.+ .|+.||||++....... -++-.++|++++++++|+|+|.++.+|......++|+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4666778999999999999986 59999999998654322 233468999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
++. ++.+-|..+ ...++.....+++.|+++|+.|+|++ ++|||||||+|||++.++.+|+||||+|+.+...
T Consensus 83 ~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 83 CDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred cch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 976 343445443 33578899999999999999999999 9999999999999999999999999999988742
Q ss_pred Cceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
+...+..+.|..|.|||.+.+ ..|+..+||||+||++.||++|.+.|..
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG 204 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG 204 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC
Confidence 333455678999999999987 6899999999999999999999988864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=285.12 Aligned_cols=199 Identities=28% Similarity=0.409 Sum_probs=174.7
Q ss_pred cCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCcccc-HHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
++|...+.+|+|.||.||+|+. +.|+.||||+++.....++ .....+|++.++.++|+||+.+++++...+..-+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3566778999999999999996 4799999999987655444 3467899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
||+. +|...+++. ...++...+..++.++.+|++|+|.+ .|+||||||.|+|++++|.+||+|||+++.+...
T Consensus 82 fm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9975 888888753 56789999999999999999999999 9999999999999999999999999999988765
Q ss_pred CCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
....+.. +-|..|.|||.+.+. .|+..+||||.|||+.||+-|.+-|.
T Consensus 155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp 203 (318)
T KOG0659|consen 155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP 203 (318)
T ss_pred Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC
Confidence 5443333 579999999998775 58999999999999999999986665
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=318.85 Aligned_cols=206 Identities=30% Similarity=0.481 Sum_probs=175.5
Q ss_pred HHHHHHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCcccc-HHHHHHHHHHHhcccCCCccceeEEEecCC
Q 009208 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCSTEN 371 (540)
Q Consensus 293 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 371 (540)
.+++....+++.+.+.||+|.||+||+|.|. -.||||+++....... -+.|++|+..+++-+|.||+-+.|||..++
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3455555666778899999999999999994 3699999987654333 457999999999999999999999999887
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
. .||+.+|+|-+|+.+||.. +..++..+...|++||++||.|||.+ +|||||||+.||++.+++.|||+|||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred e-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence 7 9999999999999999864 36799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCC-CCceeeccccccccccccccccC---CCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 452 AKLLDHR-DSHVTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 452 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
+.....- ........-|..-|||||+++.+ .|++.+||||||+++|||+||..||.
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 8743211 11112223378899999999654 58999999999999999999999997
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=314.26 Aligned_cols=202 Identities=24% Similarity=0.389 Sum_probs=177.6
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc----ccHHHHHHHHHHHhccc-CCCccceeEEEecCCe
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA----GGEVQFQTEVETISLAV-HRNLLRLCGFCSTENE 372 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 372 (540)
....|.+.+.||+|+||+|+.|... +++.||+|.+...... .....+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4567889999999999999999764 6899999977654221 23445678999999999 9999999999999999
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGL 451 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgl 451 (540)
.++||||+.+|+|.+++.+ .+++.+..+..++.|++.|++|+|+. +|+||||||+|||++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999975 45788899999999999999999999 99999999999999999 9999999999
Q ss_pred ccccCCCCCceeeccccccccccccccccCC-C-CccCCeehhhHHHHHHHhCCCCCCc
Q 009208 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ-S-SEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
+.... .........+||+.|+|||++.+.. | +.++||||+||++|.|++|+.||+.
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d 225 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD 225 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 99774 2233455677999999999999876 7 4889999999999999999999984
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=299.06 Aligned_cols=202 Identities=30% Similarity=0.443 Sum_probs=168.9
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhc--ccCCCccceeEEEe
Q 009208 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL--AVHRNLLRLCGFCS 368 (540)
Q Consensus 291 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~ 368 (540)
.++--.+....+..+.+.||+|.||+||+|.| .|+.||||++.. .++..+.+|.++++. ++|+||+.+++.-.
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 34444455667788899999999999999999 689999999975 346679999999975 59999999998865
Q ss_pred cCC----eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEecCCCCCceeeC
Q 009208 369 TEN----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-----QCDPKIIHRDVKAANILLD 439 (540)
Q Consensus 369 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-----~~~~~ivH~Dlk~~NILl~ 439 (540)
.++ +.+||++|.+.|||++||.+ .+++....++++..+|.||+|||. +.+|.|.|||||+.|||+.
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK 350 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 350 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence 433 57899999999999999975 479999999999999999999995 4689999999999999999
Q ss_pred CCCCeEEcccccccccCCCCCce---eeccccccccccccccccCC------CCccCCeehhhHHHHHHHhC
Q 009208 440 EDFEAVVGDFGLAKLLDHRDSHV---TTAVRGTVGHIAPEYLSTGQ------SSEKTDVFGFGILLLELITG 502 (540)
Q Consensus 440 ~~~~~kl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~~~k~Dv~S~Gvil~elltg 502 (540)
+++.+.|+|+|+|.......... ....+||.+|||||++...- ....+||||||.|+||+.-+
T Consensus 351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 99999999999998765543222 23456999999999986542 24578999999999998654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=311.43 Aligned_cols=198 Identities=26% Similarity=0.379 Sum_probs=177.4
Q ss_pred cCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
..|.....||+|+.|.||.|.- ..++.||||++.....+ .+.-..+|+.+|+..+|+|||+++..+...++.++||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 4566678899999999999985 46899999999876533 344578999999999999999999999888999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
|++|+|.+.+.. ..+++.++..|+..+++||+|||.+ +|+|||||++|||++.+|.+||+|||++..+....
T Consensus 352 m~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999988865 3589999999999999999999999 99999999999999999999999999998876554
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ......|||.|||||++....|++|+||||||++++||+.|++||-.
T Consensus 424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 4 34456799999999999999999999999999999999999999974
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=302.82 Aligned_cols=201 Identities=32% Similarity=0.530 Sum_probs=171.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCC--eeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN--ERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lV~ 377 (540)
.++...+.||+|+||+||++...+ |+..|||.+....... ...+.+|+++|.+++|||||+.+|...... .+++.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 446667899999999999999864 8999999987653222 446899999999999999999999855544 688999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-CCCeEEcccccccccC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDFGLAKLLD 456 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~~~ 456 (540)
||+++|+|.+++.+. +. .+++..+..+..||++||+|||++ +||||||||+|||++. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~--g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRY--GG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHc--CC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 999999999999864 12 699999999999999999999999 9999999999999999 7999999999998776
Q ss_pred C--CCCceeeccccccccccccccccCC-CCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 H--RDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ..........||+.|||||++..+. ...++||||+||++.||+||+.||..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 3 2223344577999999999998643 34599999999999999999999973
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=316.76 Aligned_cols=202 Identities=22% Similarity=0.328 Sum_probs=174.5
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|+..+.||+|+||+||++... +++.||+|+++.... ......+.+|++++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999875 589999999975332 122346788999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.+ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999875 34689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC----------------------------------ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCC
Q 009208 458 RDS----------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503 (540)
Q Consensus 458 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~ 503 (540)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012346999999999999999999999999999999999999
Q ss_pred CCCCcc
Q 009208 504 RALDFG 509 (540)
Q Consensus 504 ~p~~~~ 509 (540)
.||...
T Consensus 234 ~Pf~~~ 239 (363)
T cd05628 234 PPFCSE 239 (363)
T ss_pred CCCCCC
Confidence 999743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.67 Aligned_cols=202 Identities=20% Similarity=0.298 Sum_probs=172.5
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|.+.+.||+|+||.||++... +++.||+|++..... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999864 689999999865321 222346889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999864 24688999999999999999999999 999999999999999999999999999863321
Q ss_pred CCCc----------------------------------------------eeeccccccccccccccccCCCCccCCeeh
Q 009208 458 RDSH----------------------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 491 (540)
Q Consensus 458 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S 491 (540)
.... ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 001245999999999999889999999999
Q ss_pred hhHHHHHHHhCCCCCCcc
Q 009208 492 FGILLLELITGQRALDFG 509 (540)
Q Consensus 492 ~Gvil~elltg~~p~~~~ 509 (540)
|||++|||++|+.||...
T Consensus 234 lGvil~elltG~~Pf~~~ 251 (377)
T cd05629 234 LGAIMFECLIGWPPFCSE 251 (377)
T ss_pred cchhhhhhhcCCCCCCCC
Confidence 999999999999999743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=290.88 Aligned_cols=205 Identities=25% Similarity=0.334 Sum_probs=175.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcccc-HHHHHHHHHHHhcccCCCccceeEEEe--cCCeeEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCS--TENERLL 375 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~l 375 (540)
.++|+..+.|++|.||.||+|+.+ +++.||+|+++-.....+ .....+|+.++.+++|||||.+-.+.. +-+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 355777899999999999999975 689999999986553332 235789999999999999999998875 4567999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||++. +|.+.+... ..++.......+..|+++|++|||.. .|+|||||++|+|+++.|.+||+|||+|+.+
T Consensus 155 VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999976 788887753 35799999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCccccc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAA 512 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~ 512 (540)
.... ...+..+-|..|.|||++.+. .|++.+||||+|||+.||+++++.|....+.
T Consensus 228 gsp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~ 284 (419)
T KOG0663|consen 228 GSPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI 284 (419)
T ss_pred cCCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH
Confidence 7653 334556689999999998876 5899999999999999999999999854433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=296.72 Aligned_cols=203 Identities=28% Similarity=0.401 Sum_probs=180.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.+.|.+.++||.|..++||+|... .++.||||++.-+.....-..+.+|+..+..++||||++.+..|..+.+.|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 467888899999999999999864 6799999999877666666789999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
||.+||+.+.++..... .+++..+..|.+++++||.|||.+ |.||||||+.|||++.+|.+||+|||.+..+...
T Consensus 105 fMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999876543 389999999999999999999999 9999999999999999999999999988766544
Q ss_pred CCcee---ecccccccccccccccc--CCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 459 DSHVT---TAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 459 ~~~~~---~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
..... ....||+.|||||+++. ..|+.|+||||||+...||.+|..||.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~ 233 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS 233 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc
Confidence 32221 34579999999999654 358999999999999999999999997
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=317.40 Aligned_cols=202 Identities=25% Similarity=0.344 Sum_probs=172.7
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.|...+.||+|+||.||+|... +++.||+|+++..... .....+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999874 5789999999754322 223468899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 99999999998652 4588999999999999999999999 9999999999999999999999999997543110
Q ss_pred CC----------------------------------------------ceeeccccccccccccccccCCCCccCCeehh
Q 009208 459 DS----------------------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 492 (540)
Q Consensus 459 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~ 492 (540)
.. .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123469999999999998889999999999
Q ss_pred hHHHHHHHhCCCCCCccc
Q 009208 493 GILLLELITGQRALDFGR 510 (540)
Q Consensus 493 Gvil~elltg~~p~~~~~ 510 (540)
||++|||+||+.||....
T Consensus 235 G~il~elltG~~Pf~~~~ 252 (381)
T cd05626 235 GVILFEMLVGQPPFLAPT 252 (381)
T ss_pred hhHHHHHHhCCCCCcCCC
Confidence 999999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=316.38 Aligned_cols=203 Identities=23% Similarity=0.361 Sum_probs=174.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|++.+.||+|+||.||+|... +|+.||||+++.... ......+.+|++++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999975 589999999975422 122345788999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999865 34689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCc-------------------------------------eeeccccccccccccccccCCCCccCCeehhhHHHHHHH
Q 009208 458 RDSH-------------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 500 (540)
Q Consensus 458 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ell 500 (540)
.... ......||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011235899999999999989999999999999999999
Q ss_pred hCCCCCCccc
Q 009208 501 TGQRALDFGR 510 (540)
Q Consensus 501 tg~~p~~~~~ 510 (540)
+|+.||....
T Consensus 234 ~G~~Pf~~~~ 243 (364)
T cd05599 234 VGYPPFCSDN 243 (364)
T ss_pred cCCCCCCCCC
Confidence 9999997543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=310.09 Aligned_cols=198 Identities=25% Similarity=0.342 Sum_probs=175.1
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
+|.+.+.||+|+||.||+|... +++.||+|+++..... .....+.+|++++..++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 6888899999999999999986 5899999999754321 234468899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 82 YVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999864 34688999999999999999999999 999999999999999999999999999975543
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence 2234468999999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=300.38 Aligned_cols=201 Identities=29% Similarity=0.425 Sum_probs=174.2
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.|...+.||+|+||.||+|... +|+.||+|.+...... .....+.+|++++.+++|+||+++.+++...+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3667789999999999999874 6899999998754322 233467899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999998887642 234689999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 2 223346899999999999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=309.49 Aligned_cols=207 Identities=28% Similarity=0.408 Sum_probs=172.5
Q ss_pred HhcCCCcCCeeeeccCccEEEEEe------CCCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCC
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTEN 371 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 371 (540)
..++|.+.+.||+|+||.||+|.. .+++.||||+++..........+.+|++++..+ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 456788899999999999999974 235789999997654344455789999999999 8999999999987644
Q ss_pred -eeEEEEecCCCCChhhhccccCC--------------------------------------------------------
Q 009208 372 -ERLLVYPYMPNGSVASRLRDHIH-------------------------------------------------------- 394 (540)
Q Consensus 372 -~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 394 (540)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999864211
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc-eeeccccccc
Q 009208 395 --GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVG 471 (540)
Q Consensus 395 --~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~ 471 (540)
...++++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++........ ......+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 023588899999999999999999999 9999999999999999999999999999865432221 1223346788
Q ss_pred cccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 472 HIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 472 y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~ 279 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 279 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCC
Confidence 999999998899999999999999999997 9999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=294.29 Aligned_cols=198 Identities=28% Similarity=0.409 Sum_probs=168.3
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCe-----eEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE-----RLL 375 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----~~l 375 (540)
.|...+++|+|+||.||+|... +++.||||+...+.. .--+|+++|+.+.|||||++.-++....+ ..+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 4556789999999999999975 479999999876542 12468999999999999999998864322 348
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEcccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAKL 454 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla~~ 454 (540)
|||||+. +|.++++.....+..++...++-+..|+.+||.|||+. +|+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999976 89999987666677888888999999999999999998 99999999999999955 8999999999998
Q ss_pred cCCCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
+..+... .....|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s 230 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS 230 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC
Confidence 8765443 445589999999999875 68999999999999999999999997543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=305.60 Aligned_cols=204 Identities=25% Similarity=0.347 Sum_probs=177.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEecCC-eeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTEN-ERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~-~~~lV 376 (540)
.++|...+.||.|.||.||+|+-. .|+.||||+++..-..-.+.--.+|++.|++++ ||||+++.+++.+.+ ..++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 356778899999999999999964 689999999986543333334579999999998 999999999998887 99999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
||||+ .+|++.++++ +..+++..++.|+.||.+||+|+|.+ |+.|||+||+|||+.....+||+|||+|+...
T Consensus 89 fE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 99995 5899999864 67899999999999999999999999 99999999999999988899999999999877
Q ss_pred CCCCceeeccccccccccccccc-cCCCCccCCeehhhHHHHHHHhCCCCCCccccc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELITGQRALDFGRAA 512 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~ 512 (540)
.... .+..+.|..|.|||++. .+.|+.+.||||+|||++|+.+-++.|.+..+.
T Consensus 162 SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~ 216 (538)
T KOG0661|consen 162 SKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI 216 (538)
T ss_pred cCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH
Confidence 5443 45667899999999875 467899999999999999999999999755443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=305.88 Aligned_cols=198 Identities=25% Similarity=0.330 Sum_probs=174.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|++.+.||+|+||.||+|... +|+.||+|++..... ......+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999975 689999999865322 123346889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999865 34688999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 154 RT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred Cc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 21 2345899999999999888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=278.43 Aligned_cols=201 Identities=29% Similarity=0.433 Sum_probs=179.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.++|++.+.||+|.||.||.|+.+ ++..||+|++.+.... .-+.++.+|+++-+.++||||+++++++.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 467889999999999999999975 5789999998765432 2345789999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
+||..+|++...|.+. ....+++.....++.|+|.|+.|+|.. +++||||||+|+|++.++..|++|||=+..-.
T Consensus 101 lEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999842 245688899999999999999999999 99999999999999999999999999886433
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.......+||..|.+||...+..++..+|+|++|++.||++.|.+||..
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes 224 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES 224 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh
Confidence 2334567799999999999999999999999999999999999999984
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.60 Aligned_cols=203 Identities=23% Similarity=0.350 Sum_probs=174.9
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
...++|.+.+.||+|+||.||++... +++.||+|.+..... ......+.+|+.+++.++||||+++++++..++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34577999999999999999999976 578999999864321 222345789999999999999999999999999999
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999988642 478889999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeccccccccccccccccC----CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.............||+.|+|||++... .++.++||||+||++|||++|+.||..
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 654332223355699999999998654 378899999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=330.93 Aligned_cols=206 Identities=33% Similarity=0.514 Sum_probs=178.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC--Cc----EEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD--GA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~--g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 373 (540)
.++.+..+.||+|+||.||+|.+.+ |. .||||.+++....+...+|.+|..+|+.++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4556677899999999999999753 33 49999999877777778999999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhccccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIH---GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 450 (540)
+|++|||++|+|.+||++... ....++..+.+.++.|||+|+.||+++ ++|||||..+|+|+++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999987421 134688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceee-ccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 451 LAKLLDHRDSHVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 451 la~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+|+.+.....+... ...-...|||||.+..+.+|.|+|||||||++||++| |..||..
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~ 907 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS 907 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC
Confidence 99954433333322 2234579999999999999999999999999999999 8888863
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=296.94 Aligned_cols=199 Identities=23% Similarity=0.432 Sum_probs=180.8
Q ss_pred cCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccH--HHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGE--VQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
.+|++.+.||+|.||.|-+|+. ..|+.||||.+++....+.. ..+.+|+++|..++||||++++.+|.+.+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4566778899999999999986 57999999999988765543 36889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||..+|.|++|+.+ .+.+++....+++.||+.|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+..
T Consensus 133 EYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999986 46799999999999999999999999 999999999999999999999999999987764
Q ss_pred CCCceeeccccccccccccccccCCC-CccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ....+++|++-|.+||++.+..| ++.+|-||+||++|-|+.|.-|||.
T Consensus 206 ~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 206 K--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred c--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 3 33466789999999999999887 6899999999999999999999994
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=308.74 Aligned_cols=223 Identities=25% Similarity=0.354 Sum_probs=189.6
Q ss_pred CCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCC-c-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 303 FSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYN-I-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
|...+.||+|+-|.|-.|+. ..|+.+|||++.+.. . ......+.+|+-+|+.+.|||+++++++++++.++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 55678999999999999986 479999999997652 1 22234688999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++|.|.+++.. ++++.+..+.+++.||+.|+.|+|.. +|+|||+||+|+|+|.++++||+|||+|..-..
T Consensus 94 v~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-- 164 (786)
T KOG0588|consen 94 VPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP-- 164 (786)
T ss_pred cCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence 999999999975 46899999999999999999999999 999999999999999999999999999986443
Q ss_pred CceeeccccccccccccccccCCC-CccCCeehhhHHHHHHHhCCCCCCcccccccCCcHHHHHHHHhhcCCcchhhhh
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVCSHILSNQSSLDMVL 537 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~l~ 537 (540)
.....+.+|+|.|.|||++++..| +.++||||.|||+|.|+||+.|||. .+-+..+++--++...+.........
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV~~G~f~MPs~Is~eaQ 240 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKVQRGVFEMPSNISSEAQ 240 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHHHcCcccCCCcCCHHHH
Confidence 334456689999999999999887 6899999999999999999999993 23344455666666666655443333
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.81 Aligned_cols=198 Identities=27% Similarity=0.340 Sum_probs=173.9
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC--CcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD--GALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
.++|.+.+.||+|+||.||+|..++ +..||+|++..... ......+.+|++++..++||||+++++++...+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568889999999999999998643 36899999865321 2233468899999999999999999999999999999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999875 34688999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 230 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence 432 2234699999999999988899999999999999999999999974
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.57 Aligned_cols=202 Identities=25% Similarity=0.322 Sum_probs=172.1
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.|...+.||+|+||.||+|... +++.||+|++..... ......+.+|++++++++|+||+++++.+...+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5778899999999999999874 588999999875322 2223468899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.+++.+. ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999988652 4588899999999999999999999 9999999999999999999999999997532100
Q ss_pred C----------------------------------------------CceeeccccccccccccccccCCCCccCCeehh
Q 009208 459 D----------------------------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGF 492 (540)
Q Consensus 459 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~ 492 (540)
. ........||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000122458999999999999899999999999
Q ss_pred hHHHHHHHhCCCCCCccc
Q 009208 493 GILLLELITGQRALDFGR 510 (540)
Q Consensus 493 Gvil~elltg~~p~~~~~ 510 (540)
||++|||++|+.||...+
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (382)
T cd05625 235 GVILYEMLVGQPPFLAQT 252 (382)
T ss_pred hHHHHHHHhCCCCCCCCC
Confidence 999999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=304.40 Aligned_cols=197 Identities=27% Similarity=0.359 Sum_probs=174.4
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|.+.+.||+|+||.||+|... +++.||+|.++.... ......+.+|++++.+++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999985 589999999875432 122346889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.+ ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999998875 34688899999999999999999999 999999999999999999999999999986643
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 217 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence 22 234689999999999998899999999999999999999999964
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=310.44 Aligned_cols=203 Identities=25% Similarity=0.357 Sum_probs=177.3
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|.+.+.||+|+||.||+|... +|+.||+|+++.... ......+.+|++++..++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999975 689999999975432 123456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999998753 5689999999999999999999998 999999999999999999999999999986554
Q ss_pred CC----------------------------CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RD----------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11223345899999999999999999999999999999999999999754
Q ss_pred c
Q 009208 510 R 510 (540)
Q Consensus 510 ~ 510 (540)
.
T Consensus 234 ~ 234 (350)
T cd05573 234 T 234 (350)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.75 Aligned_cols=202 Identities=24% Similarity=0.323 Sum_probs=172.7
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
+|.+.+.||+|+||.||+|... +++.||+|.+..... ......+.+|++++.+++|+||+++++.+..++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999875 589999999865321 1223468899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.+++.+ ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999865 34588899999999999999999999 9999999999999999999999999997532100
Q ss_pred C------------------------------------------CceeeccccccccccccccccCCCCccCCeehhhHHH
Q 009208 459 D------------------------------------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 496 (540)
Q Consensus 459 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil 496 (540)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001134699999999999999999999999999999
Q ss_pred HHHHhCCCCCCccc
Q 009208 497 LELITGQRALDFGR 510 (540)
Q Consensus 497 ~elltg~~p~~~~~ 510 (540)
|||++|+.||....
T Consensus 235 yell~G~~Pf~~~~ 248 (376)
T cd05598 235 YEMLVGQPPFLADT 248 (376)
T ss_pred eehhhCCCCCCCCC
Confidence 99999999998544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=311.09 Aligned_cols=206 Identities=31% Similarity=0.441 Sum_probs=175.0
Q ss_pred HHHHhcCCCcCCeeeeccCccEEEEEeCC--C--cE-EEEEEeccC--CccccHHHHHHHHHHHhcccCCCccceeEEEe
Q 009208 296 LRAATSNFSAKNILGRGGFGIVYKGCFSD--G--AL-VAVKRLKDY--NIAGGEVQFQTEVETISLAVHRNLLRLCGFCS 368 (540)
Q Consensus 296 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--g--~~-vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 368 (540)
++...++....+.||+|+||.||+|.++. + .. ||||..+.. .......+|.+|.++|++++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34445566667899999999999999753 2 23 899998852 33445668999999999999999999999999
Q ss_pred cCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcc
Q 009208 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD 448 (540)
Q Consensus 369 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 448 (540)
.+...++|||+|+||+|.+||++. ...++..++..++.+.|.||+|||++ +++||||..+|+|++.++.+||+|
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCc
Confidence 999999999999999999999864 23699999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceee-ccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCcc
Q 009208 449 FGLAKLLDHRDSHVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFG 509 (540)
Q Consensus 449 fgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~~ 509 (540)
||+++.-.. ..... ...-...|+|||.+....+++++|||||||++||+++ |..||...
T Consensus 306 FGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~ 366 (474)
T KOG0194|consen 306 FGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM 366 (474)
T ss_pred cccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC
Confidence 999874331 11111 1125689999999999999999999999999999999 89999743
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=307.48 Aligned_cols=208 Identities=22% Similarity=0.350 Sum_probs=177.6
Q ss_pred HHHHHHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEec
Q 009208 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCST 369 (540)
Q Consensus 293 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 369 (540)
+.++....++|.+.+.||+|+||.||++..+ +++.||+|.+..... ......+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3445556689999999999999999999976 578999999864321 1223457889999999999999999999999
Q ss_pred CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccc
Q 009208 370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF 449 (540)
Q Consensus 370 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 449 (540)
.+..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999998864 2478888999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeccccccccccccccccC----CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|++..+............||+.|+|||++... .++.++|||||||++|||++|+.||..
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 99987654332233445699999999998654 378999999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=301.57 Aligned_cols=194 Identities=26% Similarity=0.318 Sum_probs=169.0
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG 383 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 383 (540)
+.||+|+||.||++... +|+.||+|+++.... ......+.+|++++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999874 689999999875432 222346788999999999999999999999999999999999999
Q ss_pred ChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCcee
Q 009208 384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463 (540)
Q Consensus 384 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 463 (540)
+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 99988864 34689999999999999999999999 99999999999999999999999999987533221 222
Q ss_pred eccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 464 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 197 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence 345699999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=301.16 Aligned_cols=195 Identities=25% Similarity=0.326 Sum_probs=168.6
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG 383 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 383 (540)
+.||+|+||.||++... +|+.||+|.++.... ......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999874 689999999875432 222346788999999999999999999999999999999999999
Q ss_pred ChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCcee
Q 009208 384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463 (540)
Q Consensus 384 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 463 (540)
+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 99888864 34689999999999999999999999 99999999999999999999999999987532221 122
Q ss_pred eccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 464 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 3356899999999999889999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=302.07 Aligned_cols=202 Identities=22% Similarity=0.329 Sum_probs=174.0
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|.+.+.||+|+||.||++... +++.||+|.+..... ......+.+|..++..++|+||+++++++...+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999975 578999999865321 122345788999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999752 24688999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCceeecccccccccccccccc-----CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 33323334569999999999865 4678899999999999999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.84 Aligned_cols=203 Identities=22% Similarity=0.339 Sum_probs=174.5
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|+..+.||+|+||.||++... +++.||+|+++.... ......+.+|++++..++|+||+++++.+...+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999875 589999999875321 222346788999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.+ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999865 34689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCC----------------------------------ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCC
Q 009208 458 RDS----------------------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503 (540)
Q Consensus 458 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~ 503 (540)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0012346999999999999999999999999999999999999
Q ss_pred CCCCccc
Q 009208 504 RALDFGR 510 (540)
Q Consensus 504 ~p~~~~~ 510 (540)
.||....
T Consensus 234 ~Pf~~~~ 240 (360)
T cd05627 234 PPFCSET 240 (360)
T ss_pred CCCCCCC
Confidence 9997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=299.35 Aligned_cols=192 Identities=26% Similarity=0.325 Sum_probs=167.8
Q ss_pred eeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCCh
Q 009208 309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385 (540)
Q Consensus 309 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 385 (540)
||+|+||.||+|... +++.||+|.++.... ......+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999975 578999999875321 22334678999999999999999999999999999999999999999
Q ss_pred hhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCceeec
Q 009208 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465 (540)
Q Consensus 386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 465 (540)
.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 998864 34689999999999999999999999 99999999999999999999999999997543222 22334
Q ss_pred cccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 466 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 5699999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=301.67 Aligned_cols=200 Identities=28% Similarity=0.379 Sum_probs=171.5
Q ss_pred CCCcCCeeeeccCccEEEEEe----CCCcEEEEEEeccCCc---cccHHHHHHHHHHHhccc-CCCccceeEEEecCCee
Q 009208 302 NFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNI---AGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENER 373 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 373 (540)
+|.+.+.||+|+||.||++.. .+++.||+|+++.... ......+.+|++++..++ |+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 3578999999875322 122345788999999994 89999999999999999
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++||||+++|+|.+++.+ ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999998864 34688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..............||+.|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 6544333333445699999999998765 478899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=306.75 Aligned_cols=202 Identities=23% Similarity=0.341 Sum_probs=173.3
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
..++|++.+.||+|+||.||++... +++.||+|.++.... ......+.+|+++++.++||||+++++++...+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3567889999999999999999875 588999999865321 1223457889999999999999999999999999999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999998864 2477888899999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCceeeccccccccccccccccC----CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTG----QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
............||+.|+|||++... .++.++|||||||++|||++|+.||..
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 249 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC
Confidence 54332223345699999999998653 478999999999999999999999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=300.05 Aligned_cols=202 Identities=23% Similarity=0.341 Sum_probs=173.4
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|.+.+.||+|+||.||++... +++.||+|.++.... ......+.+|+.++..++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999975 589999999874221 222345889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.+. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999998652 34588999999999999999999999 999999999999999999999999999876554
Q ss_pred CCCceeecccccccccccccccc-----CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 33322333458999999999863 4578899999999999999999999974
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.82 Aligned_cols=194 Identities=27% Similarity=0.334 Sum_probs=169.0
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG 383 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 383 (540)
+.||+|+||.||++... +|+.||+|+++.... ......+.+|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 689999999975432 223346889999999999999999999999999999999999999
Q ss_pred ChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCcee
Q 009208 384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463 (540)
Q Consensus 384 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 463 (540)
+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 99888864 34689999999999999999999999 99999999999999999999999999987533221 122
Q ss_pred eccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 464 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~ 197 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence 345699999999999988999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=285.39 Aligned_cols=205 Identities=25% Similarity=0.339 Sum_probs=172.8
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCC-ccceeEEEecCC------
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRN-LLRLCGFCSTEN------ 371 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~------ 371 (540)
..|...++||+|.||+||+|..+ +|+.||+|+++-.... .....-.+|+.++..++|+| |+++.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34555677999999999999965 6899999999865432 22334689999999999999 999999998776
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
..++|+||++ -+|..++.........++...++.++.|+++|++|||++ +|+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 7889999995 489999887543224567788999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
|+....+... ....++|..|.|||++.+. .|+...||||+|||+.||++++..|....
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s 225 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS 225 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence 9976644332 3445689999999999887 68999999999999999999999887543
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=297.24 Aligned_cols=194 Identities=25% Similarity=0.358 Sum_probs=168.0
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||++... +++.||+|+++..... .....+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999875 5889999999764322 2234578899999888 699999999999999999999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 999888764 34689999999999999999999999 9999999999999999999999999998743221 122
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 3345699999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=302.85 Aligned_cols=203 Identities=25% Similarity=0.347 Sum_probs=176.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|.+.+.||+|+||.||++... +|+.||+|+++.... ......+.+|+.++..++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999875 689999999976432 223446889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.+. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++..+..
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999753 34689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccccccccccccccc------cCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLS------TGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 4333334456899999999986 456789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=296.34 Aligned_cols=205 Identities=28% Similarity=0.434 Sum_probs=172.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeCC-----------------CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccce
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSD-----------------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 363 (540)
.+|.+.+.||+|+||.||++.+.+ +..||+|.++.........+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 567888999999999999997532 347999998865444455679999999999999999999
Q ss_pred eEEEecCCeeEEEEecCCCCChhhhccccC---------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 009208 364 CGFCSTENERLLVYPYMPNGSVASRLRDHI---------------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIH 428 (540)
Q Consensus 364 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH 428 (540)
++++...+..++||||+++|+|.+++.... .....++|..+..++.|++.||.|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999886421 1123578899999999999999999999 9999
Q ss_pred cCCCCCceeeCCCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh--CCCC
Q 009208 429 RDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT--GQRA 505 (540)
Q Consensus 429 ~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt--g~~p 505 (540)
|||||+|||+++++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865433221 1223345789999999988889999999999999999997 4566
Q ss_pred CCc
Q 009208 506 LDF 508 (540)
Q Consensus 506 ~~~ 508 (540)
|..
T Consensus 242 ~~~ 244 (304)
T cd05096 242 YGE 244 (304)
T ss_pred CCc
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.62 Aligned_cols=202 Identities=22% Similarity=0.328 Sum_probs=172.8
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|.+.+.||+|+||.||++..+ .++.+|+|.+.+... ......+.+|+.++..++|+||+++++++...+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888899999999999999976 478899999864221 122335888999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++++. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999752 34688999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeccccccccccccccc-----cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 3333333456999999999986 34578999999999999999999999974
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=293.46 Aligned_cols=196 Identities=29% Similarity=0.393 Sum_probs=170.3
Q ss_pred eeeccCccEEEEEeC-CCcEEEEEEeccCCccc--cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCCh
Q 009208 309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385 (540)
Q Consensus 309 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 385 (540)
||+|+||+||++... +++.||+|.+....... ....+..|++++..++|+||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 68999999987543222 224678899999999999999999999999999999999999999
Q ss_pred hhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCceeec
Q 009208 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465 (540)
Q Consensus 386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 465 (540)
.+++.........+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++..+..... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988865444456799999999999999999999999 999999999999999999999999999986654332 2233
Q ss_pred cccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 466 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 4689999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=293.96 Aligned_cols=201 Identities=27% Similarity=0.382 Sum_probs=172.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
++|...+.||+|+||.||+|..+ +++.||+|.++..........+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888899999999999999875 68999999987654344445678999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 974 898888643 23578899999999999999999999 99999999999999999999999999997654322
Q ss_pred Cceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 460 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
. ......+++.|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1233458999999998865 56899999999999999999999999743
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=297.73 Aligned_cols=194 Identities=27% Similarity=0.378 Sum_probs=167.7
Q ss_pred CeeeeccCccEEEEEe----CCCcEEEEEEeccCCc---cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 307 NILGRGGFGIVYKGCF----SDGALVAVKRLKDYNI---AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+.||+|+||.||++.. ..++.||+|.++.... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 3578999999875432 12234578899999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++|+|.+++.. ...+.+..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999998864 34578889999999999999999999 99999999999999999999999999987533222
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 122345689999999999988899999999999999999999999974
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=289.71 Aligned_cols=203 Identities=27% Similarity=0.403 Sum_probs=173.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC----CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
..+|++.+.||+|+||.||+|.++ .+..||+|.++..........|.+|+..+.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356788899999999999999863 3678999999865444445679999999999999999999999999999999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||+++|+|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999998753 34689999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~ 211 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 3222222222335678999999999999999999999999999875 9999964
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=291.11 Aligned_cols=204 Identities=26% Similarity=0.374 Sum_probs=167.6
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-------------ccHHHHHHHHHHHhcccCCCccce
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-------------GGEVQFQTEVETISLAVHRNLLRL 363 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nIv~l 363 (540)
...++|.+.+.||+|.||.|-+|+.. +++.||+|++.+.... ...+...+|+.+|+++.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999864 6899999998653211 112368899999999999999999
Q ss_pred eEEEec--CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC
Q 009208 364 CGFCST--ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED 441 (540)
Q Consensus 364 ~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~ 441 (540)
+.+..+ .+..|||+|||..|.+... ......+++.++++++.+++.||+|||.+ +||||||||+|+|++++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 999865 4678999999999985432 22233399999999999999999999999 99999999999999999
Q ss_pred CCeEEcccccccccCCCC----CceeeccccccccccccccccCC----CCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 442 FEAVVGDFGLAKLLDHRD----SHVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 442 ~~~kl~Dfgla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|.+||+|||.+....... ........|||.|+|||...++. .+.+.||||+||.||-|+.|+.||..
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~ 321 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD 321 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence 999999999987652211 11123367999999999987732 36788999999999999999999973
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=293.85 Aligned_cols=201 Identities=27% Similarity=0.395 Sum_probs=172.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|.+.+.||+|+||.||+|... +++.||+|+++..........+.+|+++++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999976 6899999998765434444567899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|++ ++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 6788777643 34588899999999999999999999 9999999999999999999999999998754322
Q ss_pred CCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2 12233458999999998865 4578899999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=296.99 Aligned_cols=200 Identities=27% Similarity=0.361 Sum_probs=170.5
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
+|.+.+.||+|+||.||+|... +++.||+|.++.... ......+..|..++... +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999876 578999999875432 22233567788888776 5899999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999988864 24688999999999999999999999 999999999999999999999999999975432
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 204 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC
Confidence 22 1233456899999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=294.01 Aligned_cols=194 Identities=26% Similarity=0.364 Sum_probs=167.0
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||+|... +++.||+|.++..... .....+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 5789999999764322 2234577888888766 799999999999999999999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 999888764 34689999999999999999999999 99999999999999999999999999987533222 12
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 2345689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=296.91 Aligned_cols=200 Identities=25% Similarity=0.351 Sum_probs=175.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|+..+.||+|+||.||++... +|..||+|.++.........++.+|++++.+++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367888999999999999999976 5889999998764433445579999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+||++++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999865 245889999999999999999999852 6999999999999999999999999998765432
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred c---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2 2334689999999999988999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=299.31 Aligned_cols=198 Identities=30% Similarity=0.419 Sum_probs=168.1
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHH---hcccCCCccceeEEEecCCeeEEE
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETI---SLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
|.+.+.||+|+||.||+|... +++.||||+++.... ......+.+|++++ ..++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999875 589999999975421 12233566666655 567899999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++|+|..+++. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999888753 3689999999999999999999999 99999999999999999999999999987533
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 222 2233456999999999999989999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=295.47 Aligned_cols=200 Identities=28% Similarity=0.365 Sum_probs=170.5
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCC-CccceeEEEecCCeeEEEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHR-NLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lV~ 377 (540)
+|.+.+.||+|+||.||+|... +++.||+|+++.... ......+..|.+++..+.|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999875 478999999875422 22344678899999988765 5888889999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999988864 34688999999999999999999999 999999999999999999999999999874322
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. .......||+.|+|||++.+..++.++||||+||++|||+||+.||+..
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 22 1233456999999999999989999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=298.25 Aligned_cols=204 Identities=27% Similarity=0.407 Sum_probs=180.9
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
+.+...+.+.||+|-||+|..+....+..||||+++.......+.+|.+|+++|.+++||||++++|+|..++..++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 34556678999999999999999978899999999998888888899999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
||++|+|.+|+.++.. +..+-....+|+.||+.||+||.+. ++||||+.++|+|+|.++++||+|||+++-+-..
T Consensus 616 YmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999987532 2245566677999999999999999 9999999999999999999999999999966544
Q ss_pred CCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh--CCCCCC
Q 009208 459 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT--GQRALD 507 (540)
Q Consensus 459 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt--g~~p~~ 507 (540)
+.+ ......-..+|||||.+..+++|+++|||+|||.+||+++ .+.||.
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~ 742 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYS 742 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchh
Confidence 443 3445556789999999999999999999999999999755 778986
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=293.96 Aligned_cols=194 Identities=29% Similarity=0.415 Sum_probs=165.3
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhc-ccCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISL-AVHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||+|... +++.||+|.++.... ......+..|.+++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 578999999875421 2223345667777764 4899999999999999999999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999988864 24688999999999999999999999 99999999999999999999999999997543322 22
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~ 198 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC
Confidence 3345689999999999988999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=291.13 Aligned_cols=202 Identities=21% Similarity=0.299 Sum_probs=173.6
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
++|.+.+.||+|+||.||++..+ +++.||+|+++.... ......+.+|++++..++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888899999999999999986 578999999876432 2234568899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|++++.+..+... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998877654322 34688999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 322233456899999999998888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=297.02 Aligned_cols=194 Identities=26% Similarity=0.324 Sum_probs=167.7
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG 383 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 383 (540)
+.||+|+||.||++... +|+.||+|.++.... ......+.+|++++..++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 689999999975432 222346788999999999999999999999999999999999999
Q ss_pred ChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 384 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
+|..++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence 99988864 3468999999999999999999997 6 99999999999999999999999999987533222 12
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~ 198 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC
Confidence 2334699999999999988999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=294.49 Aligned_cols=195 Identities=29% Similarity=0.396 Sum_probs=167.5
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||+|... +++.||+|+++.... ......+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 478999999875432 22334577888888765 799999999999999999999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|..++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 999988864 34688999999999999999999999 99999999999999999999999999987543222 22
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 23456899999999999889999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=289.20 Aligned_cols=201 Identities=29% Similarity=0.430 Sum_probs=173.8
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
+|+..+.||+|+||.||++... +++.||+|++...... .....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4677899999999999999874 6899999998754322 223457889999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.+++... ....+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999888642 234689999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. .....|++.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 21 22345899999999999888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=297.68 Aligned_cols=194 Identities=29% Similarity=0.372 Sum_probs=164.8
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHH-HHhcccCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVE-TISLAVHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||+|... +|+.||+|++..... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 689999999875322 122234555555 45789999999999999999999999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|..++.. ...+++..+..++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 999988864 34688999999999999999999999 99999999999999999999999999987532221 22
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 198 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence 3345689999999999998999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=301.17 Aligned_cols=206 Identities=29% Similarity=0.395 Sum_probs=173.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEe------CCCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 372 (540)
.++|.+.+.||+|+||.||+|++ ..+..||||+++..........+.+|++++..+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45688889999999999999974 235689999997655444556789999999999 89999999999999999
Q ss_pred eEEEEecCCCCChhhhccccCC----------------------------------------------------------
Q 009208 373 RLLVYPYMPNGSVASRLRDHIH---------------------------------------------------------- 394 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 394 (540)
.++||||+++|+|.+++++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864210
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc
Q 009208 395 -------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461 (540)
Q Consensus 395 -------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 461 (540)
....++|..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 112578999999999999999999998 9999999999999999999999999999865433221
Q ss_pred e-eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 462 V-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 462 ~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
. .....++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~ 319 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 1 122335678999999999999999999999999999998 8899864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=303.14 Aligned_cols=198 Identities=29% Similarity=0.397 Sum_probs=175.5
Q ss_pred cCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCC------eeEEEE
Q 009208 305 AKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN------ERLLVY 377 (540)
Q Consensus 305 ~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~lV~ 377 (540)
..+.||+|+||.||+|+. ..|+.||||.++............+|++++++++|+|||+++++-.... ...+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 447899999999999995 5799999999998777777888999999999999999999999876543 678999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC--CCC--CeEEccccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD--EDF--EAVVGDFGLAK 453 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~--~~~--~~kl~Dfgla~ 453 (540)
|||.+|||...|.+ ..+...+++...+.+..+++.||.|||++ +|+||||||.||++. ++| --||+|||.|+
T Consensus 97 EyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 99999999999986 34556799999999999999999999998 999999999999985 334 46999999999
Q ss_pred ccCCCCCceeeccccccccccccccc-cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.++++. ......||..|++||+.. +..|+..+|.|||||++||++||..||.+
T Consensus 173 el~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 173 ELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 877543 556778999999999998 48899999999999999999999999975
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=292.18 Aligned_cols=199 Identities=30% Similarity=0.404 Sum_probs=178.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
..|...+.||+|.||.||||... .++.||+|++.-....+...+.++|+.++.+++++||.+.+|.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34666689999999999999974 68999999998877677777899999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
|.+|++.+.|+. ...+++....-+..++..|+.|||.+ +.+|||||+.|||+.++|.+|++|||.+-.+....
T Consensus 93 ~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999988864 33457778888999999999999999 99999999999999999999999999998776544
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
... ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+.
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s 212 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHS 212 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCc
Confidence 333 66789999999999998899999999999999999999999996
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=300.56 Aligned_cols=208 Identities=29% Similarity=0.396 Sum_probs=174.3
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecC
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE 370 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 370 (540)
...++|++.+.||+|+||.||+|... ++..||+|.++..........+.+|+++++.+ +|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34457888999999999999998742 34579999998655444455788999999999 899999999999999
Q ss_pred CeeEEEEecCCCCChhhhccccCC--------------------------------------------------------
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIH-------------------------------------------------------- 394 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 394 (540)
+..++||||+++|+|.++++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999998864210
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce-e
Q 009208 395 ----------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-T 463 (540)
Q Consensus 395 ----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~ 463 (540)
...++++..+.+++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++.+....... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 113578899999999999999999999 99999999999999999999999999998654332211 1
Q ss_pred eccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 464 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
....++..|+|||++....++.++|||||||++|||++ |+.||..
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~ 317 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 22235678999999988899999999999999999997 9999974
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=293.19 Aligned_cols=195 Identities=30% Similarity=0.420 Sum_probs=167.3
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||+|..+ +++.||+|+++.... ......+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 588999999875321 22334577888888766 699999999999999999999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 999988865 24688999999999999999999999 99999999999999999999999999987543222 22
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 33456999999999999889999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=291.49 Aligned_cols=194 Identities=26% Similarity=0.357 Sum_probs=167.6
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||++... +++.||+|+++..... .....+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 5789999999764322 2234578899998887 699999999999999999999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|..++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 999888764 24689999999999999999999999 99999999999999999999999999987532221 22
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 3345699999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=286.21 Aligned_cols=209 Identities=17% Similarity=0.295 Sum_probs=173.2
Q ss_pred cCcccccCHHHHHHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCcccc--HHHHHHHHHHHhcccCCCccc
Q 009208 285 LGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG--EVQFQTEVETISLAVHRNLLR 362 (540)
Q Consensus 285 ~~~~~~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~ 362 (540)
....+.++.+++. ......||+|++|.||+|.+ +|+.||||+++....... ...|.+|++++.+++||||++
T Consensus 9 ~~~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 82 (283)
T PHA02988 9 INDIKCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILK 82 (283)
T ss_pred cCcceecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEE
Confidence 3445555666652 22236799999999999998 789999999976542221 346789999999999999999
Q ss_pred eeEEEec----CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009208 363 LCGFCST----ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438 (540)
Q Consensus 363 l~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl 438 (540)
++|++.+ ....++||||+++|+|.+++++ ...+++.....++.+++.|+.|||+.. +++||||||+||++
T Consensus 83 ~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill 156 (283)
T PHA02988 83 IYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLV 156 (283)
T ss_pred EeeeEEecccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEE
Confidence 9999876 3467899999999999999875 346889999999999999999999732 78899999999999
Q ss_pred CCCCCeEEcccccccccCCCCCceeecccccccccccccccc--CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 439 DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 439 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
++++.+||+|||+++.+.... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~ 225 (283)
T PHA02988 157 TENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225 (283)
T ss_pred CCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC
Confidence 999999999999998654322 12347899999999976 67899999999999999999999999843
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=293.71 Aligned_cols=200 Identities=25% Similarity=0.359 Sum_probs=175.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|++.+.||+|+||.||++... ++..+|+|.++..........+.+|++++.+++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367889999999999999999986 5788999988765433445578999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.+++.. ...+++.....++.+++.||.|||+.+ +|+||||||+||++++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999865 245889999999999999999999742 6999999999999999999999999998755332
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 158 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred c---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1 2234589999999999988899999999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=296.87 Aligned_cols=195 Identities=27% Similarity=0.345 Sum_probs=165.3
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHH-HHhcccCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVE-TISLAVHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||+|... +|+.||+|++..... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 689999999865321 122335566655 46778999999999999999999999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|..++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 999888764 34689999999999999999999999 99999999999999999999999999987532221 12
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 23456999999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=296.33 Aligned_cols=195 Identities=24% Similarity=0.400 Sum_probs=165.0
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
+|+..+.||+|+||.||+|... +++.||+|++...........+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3455688999999999999875 689999999876543444567899999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++|+|.... ...+..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999976432 345677889999999999999999 999999999999999999999999999986653221
Q ss_pred ceeecccccccccccccccc-----CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 461 HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
......||..|+|||++.. ...+.++|||||||++|||++|+.||..
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 1233468999999998743 2345689999999999999999999973
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=295.03 Aligned_cols=194 Identities=29% Similarity=0.397 Sum_probs=169.2
Q ss_pred CeeeeccCccEEEEEe----CCCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCC
Q 009208 307 NILGRGGFGIVYKGCF----SDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP 381 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 381 (540)
+.||+|+||.||++.. .+|+.||+|+++..... .....+.+|++++.+++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 35899999999754322 233467889999999999999999999999999999999999
Q ss_pred CCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc
Q 009208 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461 (540)
Q Consensus 382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 461 (540)
+|+|.+++.+ ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 9999998864 34689999999999999999999999 99999999999999999999999999997654332 2
Q ss_pred eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 462 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
......||+.|+|||.+....++.++|||||||++|||++|+.||..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence 23345689999999999888899999999999999999999999974
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=290.19 Aligned_cols=195 Identities=29% Similarity=0.400 Sum_probs=166.6
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhc-ccCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISL-AVHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||+|..+ +|+.||+|.++.... ......+..|.+++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999976 588999999875421 2233456778878765 4899999999999999999999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 999988864 34688999999999999999999999 99999999999999999999999999987432222 22
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 33456899999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=290.05 Aligned_cols=194 Identities=30% Similarity=0.407 Sum_probs=166.0
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhc-ccCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISL-AVHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||+|... +++.||+|.++.... ......+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 478999999875421 2233456677888875 5899999999999999999999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|.+++.. ...+++.....++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 999998864 24688999999999999999999999 99999999999999999999999999987532222 12
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 3345689999999999988999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=291.33 Aligned_cols=195 Identities=28% Similarity=0.357 Sum_probs=164.7
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHH-HHhcccCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVE-TISLAVHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||+|... +++.||+|.+..... .....++.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 588999999875332 122334555654 57889999999999999999999999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|..++.. ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 999888764 34688889999999999999999998 99999999999999999999999999987532222 22
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 23456899999999999888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=291.67 Aligned_cols=200 Identities=26% Similarity=0.355 Sum_probs=170.1
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhccc-CCCccceeEEEecCCeeEEEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~ 377 (540)
+|+..+.||+|+||.||+|... +|+.||+|+++.... ......+..|.+++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999875 689999999875421 223345778888888776 577888999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999988864 34689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 22 1223445899999999999888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=297.10 Aligned_cols=194 Identities=24% Similarity=0.328 Sum_probs=169.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
..+|.+.+.||+|+||.||++... .++.||+|.... ..+.+|++++++++||||+++++++......++|+|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 357999999999999999999874 688999997532 346889999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
++. ++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 164 ~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 164 RYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred cCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 995 688888764 24588999999999999999999999 9999999999999999999999999999754332
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 22233345699999999999988999999999999999999999988753
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=280.55 Aligned_cols=201 Identities=26% Similarity=0.434 Sum_probs=173.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
++|++.+.||+|+||.||++.++++..+|+|.++... ....++.+|++++++++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 4577788999999999999999888899999986443 23457899999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|++|||.++.......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999988753 23589999999999999999999999 999999999999999999999999999886543322
Q ss_pred ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCcc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFG 509 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~~ 509 (540)
.......++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~ 205 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK 205 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 22222335678999999988889999999999999999999 89999743
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=285.98 Aligned_cols=200 Identities=25% Similarity=0.391 Sum_probs=166.9
Q ss_pred CCCcCCeeeeccCccEEEEEeC--CCcEEEEEEeccCCccc-cHHHHHHHHHHHhcc---cCCCccceeEEEe-----cC
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAG-GEVQFQTEVETISLA---VHRNLLRLCGFCS-----TE 370 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~nIv~l~~~~~-----~~ 370 (540)
+|.+.+.||+|+||.||+|... +++.||+|.++...... ....+.+|++++..+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6888899999999999999863 46889999987543222 234566777777655 6999999999885 24
Q ss_pred CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccc
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 450 (540)
...++||||++ ++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 56889999996 6899988653 234589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 212 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 212 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCC
Confidence 99865433 2233455899999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.12 Aligned_cols=203 Identities=21% Similarity=0.308 Sum_probs=176.0
Q ss_pred CCCcCCeeeeccCccEEEEEeC-C-CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-D-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.|.+.+.||+|+||.||+|... + ++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3788899999999999999864 3 6788888765432 22334678899999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++|+|.+++++......++++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999999876555566789999999999999999999999 99999999999999999999999999998765432
Q ss_pred C-ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 S-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. .......||++|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~ 273 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 2 123345699999999999999999999999999999999999999974
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=289.66 Aligned_cols=201 Identities=28% Similarity=0.493 Sum_probs=171.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCc----EEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
.+|+..+.||+|+||.||+|.+. +++ .||+|.++.........++.+|+.++..++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999864 333 48999987654444556799999999999999999999999764 5679
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
|+||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999998753 34588999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcee-eccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 456 DHRDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 456 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
........ ....++..|+|||++.+..++.++|||||||++|||++ |+.||+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 54332221 22234678999999999999999999999999999998 9999974
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=290.59 Aligned_cols=194 Identities=28% Similarity=0.355 Sum_probs=163.6
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHH-HHhcccCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVE-TISLAVHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||+|... +++.||+|++..... .....++..|.. ++..++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 578899999875321 122234444544 46788999999999999999999999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|.+++.. ...+.+.....++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 999998864 34577888899999999999999999 99999999999999999999999999987543222 12
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence 3345699999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=306.96 Aligned_cols=207 Identities=25% Similarity=0.323 Sum_probs=176.9
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCC-----
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN----- 371 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 371 (540)
...+|.+.+.||+|+||.||+|... +|+.||||.+..... ......+.+|+..+..++|+||+++...+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 4568999999999999999999864 689999999875433 233456889999999999999999988765332
Q ss_pred ---eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcc
Q 009208 372 ---ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD 448 (540)
Q Consensus 372 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 448 (540)
..++||||+++|+|.++++........+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 36799999999999999986555556799999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCC-CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 449 FGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 449 fgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~ 247 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99998654322 1222345699999999999999999999999999999999999999974
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=288.01 Aligned_cols=194 Identities=31% Similarity=0.414 Sum_probs=167.0
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||+|... +++.||+|.++.... ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 578999999975431 22334577888888877 699999999999999999999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|..++.+ ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence 999988864 34689999999999999999999999 99999999999999999999999999987532222 12
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~ 198 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence 2334589999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=289.53 Aligned_cols=202 Identities=28% Similarity=0.420 Sum_probs=180.5
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcccc-HHHHHHHHHHHhcccCCCccceeEEEecCCe-eEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCSTENE-RLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~lV~ 377 (540)
++|...+.+|+|+||.++....+ ++..+++|++.-...... +....+|+.++++++|||||.+.+.+..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56778899999999999988765 578999999986654333 3467899999999999999999999998888 99999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
+|++||++.+.+.+.. ..-+++..+..++.|+..|+.|||++ +|+|||||+.||+++.+..+||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999997642 46799999999999999999999998 999999999999999999999999999999886
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ......||+.||+||.+.+..|..|+||||+||++|||++-+++|..
T Consensus 159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a 208 (426)
T KOG0589|consen 159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA 208 (426)
T ss_pred chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc
Confidence 552 34556799999999999999999999999999999999999999984
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=283.72 Aligned_cols=199 Identities=32% Similarity=0.563 Sum_probs=168.7
Q ss_pred cCCeeeeccCccEEEEEeC-----CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 305 AKNILGRGGFGIVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 305 ~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
..+.||.|.||.||+|.+. .+..|+||.++.........+|.+|++.+.+++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3468999999999999986 25789999997655444567899999999999999999999999988889999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++|+|.++|+.. ....+++..+..++.|+++||.|||+. +++|+||+++||++++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999874 345789999999999999999999999 99999999999999999999999999998763222
Q ss_pred C-ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 460 S-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 460 ~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
. ...........|+|||.+....++.++||||||+++||+++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~ 208 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD 208 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2 22233447789999999999999999999999999999999 7888863
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=291.21 Aligned_cols=199 Identities=21% Similarity=0.373 Sum_probs=166.6
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecC-----CeeE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NERL 374 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~ 374 (540)
+|.+.+.||+|+||.||+|... +|+.||+|+++.... .....++.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999965 689999999874321 22344688999999999999999999988543 2479
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+||||+. ++|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 688888764 34689999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCC--ceeecccccccccccccccc--CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 455 LDHRDS--HVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 455 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
...... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 432211 11233468999999999866 5789999999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=289.00 Aligned_cols=201 Identities=25% Similarity=0.374 Sum_probs=180.5
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCccc--cHHHHHHHHHHHhccc-CCCccceeEEEecCCeeEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAG--GEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~l 375 (540)
.+.|.+.+.||+|.||.||++..+. |+.+|+|.+.+..... ....+.+|+++|+++. |||||.+.+++.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4568888999999999999999875 9999999998765433 3357899999999998 9999999999999999999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC----CCeEEccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED----FEAVVGDFGL 451 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~Dfgl 451 (540)
|||++.||.|.+.+... .+++..+..++.|++.+++|||+. +|+|||+||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999764 289999999999999999999998 99999999999999733 4799999999
Q ss_pred ccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||....
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~ 242 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET 242 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence 998776 445667789999999999999999999999999999999999999998543
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=295.37 Aligned_cols=207 Identities=26% Similarity=0.374 Sum_probs=174.4
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEecCC
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTEN 371 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 371 (540)
..++|.+.+.||+|+||.||+|+.. .+..||||+++..........+.+|++++.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3567888999999999999999853 235799999976554444567999999999996 999999999999999
Q ss_pred eeEEEEecCCCCChhhhccccCC---------------------------------------------------------
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIH--------------------------------------------------------- 394 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 394 (540)
..++||||+++|+|.+++++...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998864210
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC
Q 009208 395 -----------------------------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD 439 (540)
Q Consensus 395 -----------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~ 439 (540)
....+++..+..++.|+++||+|||+. +|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 013478889999999999999999998 999999999999999
Q ss_pred CCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 440 EDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 440 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 9999999999999865432221 1223346788999999988889999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=278.90 Aligned_cols=202 Identities=28% Similarity=0.467 Sum_probs=175.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.++|++.+.||+|+||.||+|...++..||+|.+.... .....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 45788899999999999999998888899999986533 2345789999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++|+|.++++.. ....+++..+..++.+++.|++|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999999998753 234688999999999999999999998 99999999999999999999999999998765433
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
........++..|+|||++....++.++||||||+++|||+| |+.||..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 222223346778999999988889999999999999999998 9999963
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=282.34 Aligned_cols=205 Identities=29% Similarity=0.486 Sum_probs=175.6
Q ss_pred cCCCcCCeeeeccCccEEEEEeCC------CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
.+|.+.+.||+|+||.||+|...+ +..||+|.++.....+....+.+|++++..++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778999999999999998643 47899999987654445678999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhccccC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCe
Q 009208 375 LVYPYMPNGSVASRLRDHI----------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA 444 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 444 (540)
+||||+++|+|.++++... .....+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999997531 2234588999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 445 VVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 445 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+|+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~ 227 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG 227 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999755332211 1223345788999999999999999999999999999999 9999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=311.44 Aligned_cols=205 Identities=23% Similarity=0.336 Sum_probs=174.1
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
.+|.+.+.||+|+||.||+|... .|+.||+|+++..... ....+|.+|++++++++||||+++++++...+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888999999999999999975 5899999998754322 23457999999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccc
Q 009208 378 PYMPNGSVASRLRDHIH-------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 450 (540)
||+++|+|.+++..... .....++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 123466788899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC-----------------ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 451 LAKLLDHRDS-----------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 451 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9986521110 011224589999999999999999999999999999999999999974
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=277.65 Aligned_cols=202 Identities=31% Similarity=0.434 Sum_probs=175.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.++|.+.+.||+|++|.||+|...+++.||+|.++... ....++.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 45688889999999999999998788899999987543 2355789999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++.... ...+++..+..++.+++.|+.|||+. +|+||||||+||++++++.++|+|||+++......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999987532 34689999999999999999999999 99999999999999999999999999998765332
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.........+..|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 207 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 221222223468999999998899999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=276.52 Aligned_cols=205 Identities=25% Similarity=0.386 Sum_probs=170.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEecc-CCccccHHHHHHHHHHHhcccCCCccceeEEEec-----CCe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKD-YNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST-----ENE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~ 372 (540)
...|...+.||+|+||.|.+|..+ +|+.||||++.. ......-++-.+|+++++.++|+||+.+.+++.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 445666789999999999999875 689999999872 2223344577899999999999999999998754 356
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.|+|+|+| +-+|.+.++. ++.++......+..|+++||.|+|+. +|+|||+||+|++++.+...||+|||+|
T Consensus 101 vYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 89999999 4576666653 45689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC-Cceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCccccc
Q 009208 453 KLLDHRD-SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGRAA 512 (540)
Q Consensus 453 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~ 512 (540)
+...... ....+....|..|.|||++.. ..||...||||.|||+.||++|+..|.+.+.-
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v 234 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV 234 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH
Confidence 9875431 122345668999999998754 57999999999999999999999999865433
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=282.12 Aligned_cols=207 Identities=27% Similarity=0.429 Sum_probs=173.7
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCe
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE 372 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 372 (540)
..++|+..+.||+|+||.||+|.+. .+..||+|+++.........++.+|+.++..++||||+++++++...+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4577899999999999999999753 3567999998654433445578999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhccccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEE
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHG------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVV 446 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl 446 (540)
.++||||+++|+|.+++.+.... ...+++..+..++.|+++|++|||+. +++||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653211 23468899999999999999999998 9999999999999999999999
Q ss_pred cccccccccCCCCCcee-eccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 447 GDFGLAKLLDHRDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 447 ~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+|||+++.......... ....+++.|+|||++....++.++|||||||++|||++ |+.||..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~ 224 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 224 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999875543222111 12235788999999998889999999999999999999 7888864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=281.39 Aligned_cols=205 Identities=29% Similarity=0.478 Sum_probs=174.4
Q ss_pred cCCCcCCeeeeccCccEEEEEeCC------CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
++|++.+.||+|+||.||+|.... ...||+|.++.........+|.+|++.+.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467788999999999999998643 25799999876544444567999999999999999999999999989999
Q ss_pred EEEecCCCCChhhhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 009208 375 LVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~ 442 (540)
++|||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999875321 114688999999999999999999999 999999999999999999
Q ss_pred CeEEcccccccccCCCCC-ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 443 EAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 443 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.++|+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG 229 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999976543222 12233346789999999988899999999999999999998 9999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=285.86 Aligned_cols=201 Identities=25% Similarity=0.384 Sum_probs=171.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
++|...+.||+|+||.||+|..+ +++.||+|.++..........+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999875 57889999987655444455688999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 888877643 34578999999999999999999999 99999999999999999999999999997544322
Q ss_pred Cceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 460 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
. ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2 1223457899999998865 45789999999999999999999999743
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=294.30 Aligned_cols=201 Identities=24% Similarity=0.333 Sum_probs=169.6
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCC-----eeE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN-----ERL 374 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~ 374 (540)
+|++.+.||+|+||.||++... +|+.||+|++..... .....++.+|++++..++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999964 689999999865321 223456889999999999999999999998776 789
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 577776643 35689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
.............+|+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 544333223334578999999998764 47899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=276.93 Aligned_cols=201 Identities=29% Similarity=0.479 Sum_probs=174.4
Q ss_pred cCCCcCCeeeeccCccEEEEEeCC----CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
++|.+.+.||+|+||.||+|.+.. ...||+|.++.........+|.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998742 4579999987655444556799999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++++|.+++... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++++|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999998753 23689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCC
Q 009208 457 HRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALD 507 (540)
Q Consensus 457 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~ 507 (540)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~ 210 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence 22221 2222335678999999998899999999999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=280.47 Aligned_cols=199 Identities=29% Similarity=0.418 Sum_probs=172.1
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc--cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
|+..+.||+|+||.||++... +++.||+|.+....... ....+.+|+.++.+++|+|++++.+.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566789999999999999875 68899999987543222 234577899999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999988642 234589999999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. .....|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 1 2234689999999999998999999999999999999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=276.70 Aligned_cols=193 Identities=28% Similarity=0.363 Sum_probs=169.9
Q ss_pred CCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 302 NFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
+|+..+.||+|+||.||+|.. .+++.||+|.+..........++.+|++++.+++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577789999999999999986 4689999999875543444567899999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999986542 367888999999999999999999 99999999999999999999999999997654322
Q ss_pred ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....||..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 2234689999999999988999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=275.98 Aligned_cols=199 Identities=28% Similarity=0.447 Sum_probs=171.4
Q ss_pred CCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCC
Q 009208 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP 381 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 381 (540)
+|++.+.||+|+||.||+|.++++..+|+|.+.... ....++.+|+++++.++||||+++++++...+..++|+||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 467788999999999999998878899999986533 234568899999999999999999999999999999999999
Q ss_pred CCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc
Q 009208 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461 (540)
Q Consensus 382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 461 (540)
+++|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999998753 23689999999999999999999999 9999999999999999999999999999765432222
Q ss_pred eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 462 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||+.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 204 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence 2222224567999999998899999999999999999999 8999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=278.33 Aligned_cols=193 Identities=28% Similarity=0.397 Sum_probs=166.9
Q ss_pred eeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCCh
Q 009208 309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385 (540)
Q Consensus 309 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 385 (540)
||+|+||.||++..+ +|+.||+|.+...... ..+..+..|++++.+++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999875 5899999998653322 2233466799999999999999999999999999999999999999
Q ss_pred hhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCceeec
Q 009208 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465 (540)
Q Consensus 386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 465 (540)
.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 9888642 234588999999999999999999999 99999999999999999999999999998664322 2233
Q ss_pred cccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 466 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..|+..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 4589999999999888899999999999999999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=295.11 Aligned_cols=199 Identities=31% Similarity=0.509 Sum_probs=176.5
Q ss_pred cCCeeeeccCccEEEEEeC-C----CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 305 AKNILGRGGFGIVYKGCFS-D----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 305 ~~~~lG~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
..++||+|+||+||||.|- + ..+||+|++..........++.+|+-+|.+++|||+++++|+|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 4578999999999999973 3 35799999998887888889999999999999999999999998776 7899999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
|+.|+|.+|++.+ +..+.-...+.|..|||+||.|||++ +++||||..+|||+.+-..+||.|||+++.+.+..
T Consensus 779 mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred cccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999875 45678889999999999999999999 99999999999999999999999999999887654
Q ss_pred Cce-eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCccc
Q 009208 460 SHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGR 510 (540)
Q Consensus 460 ~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~~~ 510 (540)
.+. .....-.+.|||-|.+....++.++|||||||.+||++| |..|++...
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~ 905 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP 905 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC
Confidence 333 233345678999999999999999999999999999999 999998543
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=275.59 Aligned_cols=200 Identities=28% Similarity=0.458 Sum_probs=172.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
++|.+.+.||+|+||.||+|.+.++..||+|.++... ....+|.+|+.++.+++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 3577788999999999999998777789999987543 23457899999999999999999999999888999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++|+|.+++... ...+++..+..++.|++.|++|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999998753 23689999999999999999999999 999999999999999999999999999886543322
Q ss_pred ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.......++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 204 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 22222335678999999988889999999999999999999 9999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=263.40 Aligned_cols=207 Identities=28% Similarity=0.366 Sum_probs=176.0
Q ss_pred hcCCCcCCeeeeccCccEEEEE-eCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecC-----Cee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 373 (540)
.++|.+.+.+|+|||+.||.++ ..++..+|+|++.... .++....++|++..++++|||++++++++..+ .+.
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 4678889999999999999998 4578999999998765 45566789999999999999999999987543 358
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
|++++|+..|||.+.+.....+...+++.+.+.|+.++++||++||+. .+++.||||||.|||+.+.+.+++.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999988766677899999999999999999999997 4469999999999999999999999999987
Q ss_pred ccCCCCCc--------eeeccccccccccccccc---cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 454 LLDHRDSH--------VTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 454 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
...-.... .......|..|.|||.+. +...++++|||||||++|+|+.|..||+.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 54321100 011234799999999984 44579999999999999999999999983
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=279.83 Aligned_cols=200 Identities=30% Similarity=0.419 Sum_probs=172.4
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
|...+.||+|+||+||+|... +++.||+|.+...... .....+.+|++++..++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 556688999999999999875 6889999998654322 2234578899999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999888642 234699999999999999999999998 99999999999999999999999999997654322
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
. .....|+..|+|||++.+..++.++|+||||+++|||++|+.||...
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 1 22345899999999999889999999999999999999999999743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=267.56 Aligned_cols=200 Identities=25% Similarity=0.378 Sum_probs=173.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
+++|++.++||+|.|+.||+.... .|+.+|+|.+..... ..+.+++.+|+++-+.++||||+++...+...+..++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456778889999999999998754 688889888764332 335667899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEcccccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDFGLAKL 454 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgla~~ 454 (540)
|+|+|++|..-+-.. ..+++..+..++.||+++|.|+|.+ +|||||+||+|+++-. .--+|++|||+|..
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999988766442 3577888999999999999999999 9999999999999963 33589999999998
Q ss_pred cCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
+. .........|||+|||||++....|+..+|||+-|||+|-|+.|..||..
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 77 44555667799999999999999999999999999999999999999974
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=272.56 Aligned_cols=196 Identities=31% Similarity=0.480 Sum_probs=169.7
Q ss_pred CeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCChh
Q 009208 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVA 386 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 386 (540)
++||+|+||.||+|...++..||+|.++..........+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999876544444557899999999999999999999999999999999999999999
Q ss_pred hhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCceeecc
Q 009208 387 SRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV 466 (540)
Q Consensus 387 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 466 (540)
+++... ...+++..+..++.+++.||.|+|+. +++||||||+||++++++.+|++|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 988643 34588999999999999999999998 999999999999999999999999999875443222222222
Q ss_pred ccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 467 ~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.++..|+|||++....++.++||||||+++||+++ |+.||..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~ 197 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC
Confidence 35678999999988899999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=297.19 Aligned_cols=199 Identities=25% Similarity=0.335 Sum_probs=165.0
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecC--------
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-------- 370 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-------- 370 (540)
..+|.+.+.||+|+||.||+|... .++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 457889999999999999999875 68899999885432 2345799999999999999999876432
Q ss_pred CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEccc
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDF 449 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Df 449 (540)
...++||||+++ ++.+++.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 236689999974 77777765444556799999999999999999999999 999999999999999654 7999999
Q ss_pred ccccccCCCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99986643322 2234589999999998654 6899999999999999999999999753
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=275.23 Aligned_cols=201 Identities=30% Similarity=0.465 Sum_probs=173.1
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.+|...+.||+|+||.||+|... .++.||+|.++... ....++.+|++++.+++|+||+++++++..++..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 45777899999999999999975 48899999987532 2345789999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++... ....+++..+..++.|+++||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 84 MTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 9999999998653 234689999999999999999999999 99999999999999999999999999998765432
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 222222234678999999988899999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=287.22 Aligned_cols=206 Identities=29% Similarity=0.409 Sum_probs=171.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecC-C
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE-N 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~ 371 (540)
.++|.+.+.||+|+||.||+|... .++.||+|+++..........+.+|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457888999999999999999642 25789999987654344445688899999999 799999999988654 5
Q ss_pred eeEEEEecCCCCChhhhccccCCC--------------------------------------------------------
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHG-------------------------------------------------------- 395 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 395 (540)
..++++||+++|+|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999988642110
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce-eeccccccccc
Q 009208 396 -RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHI 473 (540)
Q Consensus 396 -~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~ 473 (540)
...++|..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||+++.+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 13689999999999999999999999 99999999999999999999999999998764332221 22234677899
Q ss_pred cccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 474 APEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 474 aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=275.79 Aligned_cols=202 Identities=27% Similarity=0.410 Sum_probs=176.2
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+|...+.||+|++|.||+|..+ +++.|++|.+..... .....++.+|+++++.++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999975 689999999865332 33455789999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.++++.. ....+++..+..++.++++|+.|||+. +++||||||+||++++++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999999753 235689999999999999999999998 99999999999999999999999999998665432
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. .....|++.|+|||+..+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 204 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN 204 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 22 23345889999999999988999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=277.29 Aligned_cols=202 Identities=28% Similarity=0.469 Sum_probs=168.1
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCc----EEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
++|...+.||+|+||.||+|.+. +++ .|++|.+..........++..|+..++++.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45777899999999999999874 344 4788887543323334567888889999999999999998754 45778
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999753 34689999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCcc
Q 009208 456 DHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFG 509 (540)
Q Consensus 456 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~~ 509 (540)
...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 433221 2233446789999999988899999999999999999998 99999743
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=278.01 Aligned_cols=205 Identities=28% Similarity=0.437 Sum_probs=173.1
Q ss_pred cCCCcCCeeeeccCccEEEEEe-----CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
++|++.+.||+|+||.||+|.. ..+..||+|.++.........++.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999984 24688999999765434444578999999999999999999999999999999
Q ss_pred EEecCCCCChhhhccccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 009208 376 VYPYMPNGSVASRLRDHIH-------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~ 442 (540)
||||+++++|.+++..... ....+++.....++.|++.||+|||++ +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853211 123588999999999999999999999 999999999999999999
Q ss_pred CeEEcccccccccCCCCC-ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 443 EAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 443 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999999999986543221 11223335678999999988889999999999999999999 9999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=275.65 Aligned_cols=204 Identities=21% Similarity=0.356 Sum_probs=176.3
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|.+.+.||+|+||.||+|... +++.||||.++.... ......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888999999999999999975 689999998865332 223346899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.........+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998875444455688999999999999999999999 999999999999999999999999999886653
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~ 208 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 321 12234588899999999888899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=280.24 Aligned_cols=199 Identities=25% Similarity=0.347 Sum_probs=173.4
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
++|++.+.||+|+||.||++... ++..+|+|.++.........++.+|++++.+++||||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999875 57889999987543333345688999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.++++.. ..+++..+..++.|+++||.|||+.+ +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999998753 46889999999999999999999732 89999999999999999999999999987553321
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 2334588999999999888899999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=273.08 Aligned_cols=204 Identities=22% Similarity=0.383 Sum_probs=178.1
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|++.+.||+|+||.||+|... +|+.||+|.++.... ......+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999986 789999999874332 223457899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.........+++..+..++.++++|+.|||+. +|+||||+|+||++++++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999876544456789999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... .....+++.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 3222 2234588999999999888899999999999999999999999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=286.43 Aligned_cols=208 Identities=29% Similarity=0.450 Sum_probs=182.6
Q ss_pred HHHHHHhcCCCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCe
Q 009208 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE 372 (540)
Q Consensus 294 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 372 (540)
++++....+....+.||-|.||.||.|.|+. .-.||||.++.+.++ ..+|+.|..+|..++|||+|+++|+|..+..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe--veEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh--HHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 4555556677788999999999999999975 568999999986533 4589999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
+|||+|||.+|+|.+||++.. +..++....+.++.||+.||+||..+ ++|||||..+|+|+.++..+||+|||++
T Consensus 338 FYIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred eEEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 999999999999999999753 44577778889999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+++..+.....-...-...|.|||-+....++.|+|||+|||+|||+.| |..||..
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 9987654433333335678999999999999999999999999999998 8899974
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=299.85 Aligned_cols=234 Identities=23% Similarity=0.284 Sum_probs=186.6
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCC-cEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEE-Eec------CC
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDG-ALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGF-CST------EN 371 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~-~~~------~~ 371 (540)
.++.+.+.|.+|||+.||.|....+ ..+|+|++-... +..-....+|+++|++++ |+|||.+++. ... .-
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d-e~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND-EEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC-HHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 4566778999999999999998766 999999987653 444557899999999997 9999999993 211 23
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
+.+|.||||++|.|-+++..+.+.+ |++.++++|+.|+++|+++||.. +|+|||||||.+|||++.+++.||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 6789999999999999998766543 99999999999999999999985 78899999999999999999999999999
Q ss_pred ccccCCCC-Cc-------eeeccccccccccccccc---cCCCCccCCeehhhHHHHHHHhCCCCCCcc-----------
Q 009208 452 AKLLDHRD-SH-------VTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDFG----------- 509 (540)
Q Consensus 452 a~~~~~~~-~~-------~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvil~elltg~~p~~~~----------- 509 (540)
+...-... .. ......-|+.|+|||++. +...++|+|||+|||+||-|+....||+..
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~ 272 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYS 272 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecccc
Confidence 86432221 11 011233799999999874 556899999999999999999999999843
Q ss_pred cc--cccCCcHHHHHHHHhhcCCcchhhhhc
Q 009208 510 RA--ANQRGVMLDWVCSHILSNQSSLDMVLN 538 (540)
Q Consensus 510 ~~--~~~~~~~~~w~~~~~~~~~~~~~~l~~ 538 (540)
-+ ......+.+.++..+..+..-+.-+++
T Consensus 273 ~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Q 303 (738)
T KOG1989|consen 273 FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQ 303 (738)
T ss_pred CCCCccHHHHHHHHHHHHhccCcccCCCHHH
Confidence 11 233345557777777777666655543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=278.29 Aligned_cols=202 Identities=30% Similarity=0.436 Sum_probs=177.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.+.|..-++||+||||.||-...+ +|+.+|.|++.+.... .++.-..+|-.++.++..+.||.+--.+.+++..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356777799999999999988865 6999999988654322 3344568899999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
+..|.||+|.-+|.++ +.+.+++..+..++.+|+-||++||.. +||+||+||+|||+|++|+++|+|.|+|..+.
T Consensus 264 LtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999888764 446899999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..... ...+||.||||||++.+..|+...|.||+||++|||+.|+.||..
T Consensus 339 ~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 339 EGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred CCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 54332 233699999999999999999999999999999999999999973
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=271.37 Aligned_cols=203 Identities=28% Similarity=0.335 Sum_probs=173.6
Q ss_pred CCCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCcccc--HHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 302 NFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGG--EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.|...+.||+|.-|+||.+..++ +...|+|++.+...... ..+.+.|.+||+.+.||.+..+++.+..+...++|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 34456789999999999999864 58999999987654432 2367889999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC-
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH- 457 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~- 457 (540)
||+||+|....++ +....+++..++.++..++-||+|||.. |||+|||||+|||+.++|.+-|+||.++.....
T Consensus 158 yCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 158 YCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred cCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999988765 3456799999999999999999999999 999999999999999999999999998642210
Q ss_pred --------------------------------C-C---------------------CceeeccccccccccccccccCCC
Q 009208 458 --------------------------------R-D---------------------SHVTTAVRGTVGHIAPEYLSTGQS 483 (540)
Q Consensus 458 --------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 483 (540)
. . ...+...+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 011123459999999999999999
Q ss_pred CccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 484 SEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 484 ~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+.++|.|+|||++|||+.|+.||-..
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~ 338 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGS 338 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCC
Confidence 99999999999999999999999743
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=272.00 Aligned_cols=195 Identities=28% Similarity=0.431 Sum_probs=175.4
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCC
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP 381 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 381 (540)
|.+.+.+|+|+||.||||..+ .|+.||+|.+.. ..+-.++.+|+.++.+++.|++|+.+|.+......++|||||.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 556788999999999999875 699999999865 3455689999999999999999999999999999999999999
Q ss_pred CCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc
Q 009208 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461 (540)
Q Consensus 382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 461 (540)
.|+..+.++-+ ++++.+..+..+....++||+|||.. .-||||||..|||++-+|.+|++|||.+-.+.+...
T Consensus 112 AGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA- 184 (502)
T KOG0574|consen 112 AGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA- 184 (502)
T ss_pred CCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-
Confidence 99999998753 56899999999999999999999998 889999999999999999999999999976554322
Q ss_pred eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 462 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
....+.|||.|||||++..-.|..++||||+|+...||..|++||.
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYs 230 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYS 230 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcc
Confidence 2345679999999999999999999999999999999999999996
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=271.29 Aligned_cols=196 Identities=30% Similarity=0.448 Sum_probs=167.3
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCCh
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 385 (540)
+.||+|+||.||+|... +++.||+|.+......+....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999975 68999999987544344456799999999999999999999999999999999999999999
Q ss_pred hhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCcee-e
Q 009208 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT-T 464 (540)
Q Consensus 386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~-~ 464 (540)
.+++... ...+++..+..++.|+++||.|||+. +++||||||+||+++.++.+|++|||++........... .
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9998642 34689999999999999999999999 999999999999999999999999999876543211111 1
Q ss_pred ccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 465 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||+.
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 1123467999999998889999999999999999998 8889863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=286.99 Aligned_cols=192 Identities=26% Similarity=0.315 Sum_probs=161.1
Q ss_pred eeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcc---cCCCccceeEEEecCCeeEEEEecCCC
Q 009208 309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLA---VHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 309 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
||+|+||.||+|... +++.||+|++...... .....+..|..++... .||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999875 5899999998643221 1223455666776655 699999999999999999999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|.+++.+ ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.++|+|||+++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 999988864 34689999999999999999999999 99999999999999999999999999987543222 22
Q ss_pred eeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 463 TTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 2345699999999998754 479999999999999999999999974
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=276.57 Aligned_cols=206 Identities=28% Similarity=0.443 Sum_probs=175.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC------CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 373 (540)
.++|.+.+.||+|+||.||+|...+ +..||+|.+...........+.+|+.++..++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578888999999999999998742 3689999987554344456789999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhccccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEc
Q 009208 374 LLVYPYMPNGSVASRLRDHIH------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG 447 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 447 (540)
++||||+++|+|.+++..... ....++|..+..++.|++.|+.|||+. +++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 999999999999999875332 123578999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCC-ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 448 DFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 448 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
|||+++.+..... .......++..|+|||.+....++.++||||||+++||++| |+.||..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 224 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG 224 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc
Confidence 9999976543322 11223346789999999988889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=272.03 Aligned_cols=199 Identities=26% Similarity=0.350 Sum_probs=171.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|++.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.++.+++||||+++++++..++..++|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 35688899999999999999997 468899999987543 2233467899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++++|.++++. ...+++..+..++.|+++|+.|||+. +|+|||++|+||++++++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 87 YCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 9999999998864 34688999999999999999999998 9999999999999999999999999999866432
Q ss_pred CCceeeccccccccccccccc---cCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 459 DSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
.. ......|++.|+|||.+. ...++.++|||||||++|||++|+.||.
T Consensus 160 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 160 IA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred cc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 21 122345889999999874 3457889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=278.14 Aligned_cols=208 Identities=32% Similarity=0.455 Sum_probs=175.5
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecC
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE 370 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 370 (540)
...++|+..+.||+|+||.||++... ....+|+|.++.........++.+|++++.++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34567888899999999999999864 23679999987654444445788999999999 799999999999999
Q ss_pred CeeEEEEecCCCCChhhhccccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009208 371 NERLLVYPYMPNGSVASRLRDHI------------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl 438 (540)
+..++||||+++|+|.++++... .....+++..+..++.|++.|++|||+. +|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence 99999999999999999986421 2345689999999999999999999998 99999999999999
Q ss_pred CCCCCeEEcccccccccCCCCCce-eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 439 DEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 439 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
++++.+|++|||+++.+....... .....++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 999999999999998665432211 122235678999999988899999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=274.77 Aligned_cols=203 Identities=35% Similarity=0.496 Sum_probs=176.9
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
+..+|+..+.||+|+||.||+|...++..+|+|.++... .....++.+|+.+++.++|+||+++++++...+..++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 345688889999999999999999889999999987643 2234578999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.+++++. ....+++..+..++.++++|+.|||+. +|+||||||+||++++++.+||+|||.+......
T Consensus 83 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 83 LMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999999753 234689999999999999999999999 9999999999999999999999999999866433
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
... .....++..|+|||.+....++.++||||||+++|+|++ |+.||..
T Consensus 158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~ 207 (261)
T cd05148 158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207 (261)
T ss_pred ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Confidence 222 223346778999999988889999999999999999998 8999964
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=272.69 Aligned_cols=199 Identities=29% Similarity=0.420 Sum_probs=165.2
Q ss_pred CeeeeccCccEEEEEeCC---CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCC
Q 009208 307 NILGRGGFGIVYKGCFSD---GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG 383 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 383 (540)
+.||+|+||.||+|...+ +..+|+|.++..........+.+|+.++++++||||+++++++......++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 46799999876554444557899999999999999999999999999999999999999
Q ss_pred ChhhhccccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 384 SVASRLRDHIH-GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 384 sL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
+|.++++.... .....++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975322 233567888899999999999999999 99999999999999999999999999997543322211
Q ss_pred -eeccccccccccccccccC-------CCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 463 -TTAVRGTVGHIAPEYLSTG-------QSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 463 -~~~~~gt~~y~aPE~~~~~-------~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.....++..|+|||++... .++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 1233467889999998642 35789999999999999996 9999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=271.38 Aligned_cols=201 Identities=29% Similarity=0.412 Sum_probs=173.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc----cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG----GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
++|...+.||+|++|.||++... +++.||+|.++...... ....+.+|++++.+++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56888999999999999999864 68999999987543211 12468899999999999999999999999999999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
|+||+++++|.+++.. ...+++.....++.+++.|+.|||+. +|+||||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999998865 24588899999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCcee--eccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 456 DHRDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 456 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
........ ....++..|+|||++.+..++.++||||+|+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 43221111 234578899999999998899999999999999999999999963
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=272.21 Aligned_cols=200 Identities=31% Similarity=0.459 Sum_probs=171.5
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
.+|.+.+.||+|+||.||+|...+...||+|.++... ....+|.+|++++..++|+||+++++++. .+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 4588889999999999999998777789999987543 23457899999999999999999999874 45678999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++|+|.+++.+. ....+++..+..++.++++||+|+|+. +++||||||+||++++++.++|+|||.++.+.....
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999999753 234578999999999999999999999 999999999999999999999999999986654332
Q ss_pred ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.......++..|+|||+..+..++.++||||||+++|||+| |+.||..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~ 206 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 22223346778999999988889999999999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=278.04 Aligned_cols=207 Identities=28% Similarity=0.450 Sum_probs=173.4
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCe
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE 372 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 372 (540)
..++|++.+.||+|+||.||+|..+ .+..||+|.++.........++.+|+..++.++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678899999999999999999753 2458999998755433444578899999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhccccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEE
Q 009208 373 RLLVYPYMPNGSVASRLRDHI------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVV 446 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl 446 (540)
.++||||+++|+|.+++++.. ......++..+..++.|++.||.|||+. +|+||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997532 1234567888999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCce-eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 447 GDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 447 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+|||+++......... .....++..|+|||.+....++.++|||||||++|||++ |+.||..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~ 224 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 224 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999998654322211 112235678999999988889999999999999999999 7888863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=279.33 Aligned_cols=204 Identities=30% Similarity=0.474 Sum_probs=170.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCc--EEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGA--LVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 375 (540)
.++|++.+.||+|+||.||+|..+ ++. .+|+|.++.........++.+|++++.++ +|+||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 456888899999999999999975 343 46888876544344456789999999999 89999999999999999999
Q ss_pred EEecCCCCChhhhccccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC
Q 009208 376 VYPYMPNGSVASRLRDHI------------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 443 (540)
|+||+++|+|.+++++.. .....+++..+..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 999999999999997532 1123688999999999999999999999 9999999999999999999
Q ss_pred eEEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 444 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 444 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+||+|||++....... ......++..|+|||++....++.++|||||||++|||+| |..||..
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 226 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 226 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc
Confidence 9999999986432111 1111224678999999988889999999999999999998 9999963
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=279.73 Aligned_cols=199 Identities=23% Similarity=0.377 Sum_probs=173.5
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.+|+..+.||+|+||.||+|... +++.||+|.+...... ....+.+|++++..+.|+|++++++.+......++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 46778889999999999999864 6899999998764433 345688999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++.+ ..+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999998864 3578999999999999999999999 99999999999999999999999999987654332
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. .....+++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~ 219 (296)
T cd06654 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (296)
T ss_pred cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 21 22335889999999998888999999999999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=276.06 Aligned_cols=206 Identities=29% Similarity=0.409 Sum_probs=175.9
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC-----CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEec-CCee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD-----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST-ENER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~ 373 (540)
.++|.+.+.||+|+||.||+|...+ +..|++|+++..........+.+|+.++.+++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999999865 788999998765444445678999999999999999999998765 5678
Q ss_pred EEEEecCCCCChhhhccccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHG----RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF 449 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 449 (540)
++++||+++|+|.+++...... ...+++..+..++.+++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998754222 15689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCce-eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 450 GLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 450 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
|+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 222 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc
Confidence 9998664433221 122346778999999988889999999999999999999 9999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=271.25 Aligned_cols=201 Identities=31% Similarity=0.485 Sum_probs=172.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.++|++.+.||+|+||.||+|...++..||+|.++.... ....+.+|+.++.+++|+|++++++++. .+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 356788899999999999999988888999999876432 3457999999999999999999999875 4568899999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++++. ....+++..+..++.+++.|++|||+. +|+||||||+||++++++.++|+|||++..+....
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999998753 234589999999999999999999999 99999999999999999999999999998665432
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
........++..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 222222335678999999988889999999999999999999 8999964
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=279.64 Aligned_cols=204 Identities=29% Similarity=0.488 Sum_probs=172.4
Q ss_pred cCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
.+|.+.+.||+|+||.||+|... ++..+++|.++... ......+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 45777899999999999999742 35679999986543 233457899999999999999999999999999999
Q ss_pred EEEecCCCCChhhhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 009208 375 LVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~ 442 (540)
+||||+++++|.+++..... ....+++..+..++.|++.|++|||++ +|+||||||+||++++++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 99999999999999975321 224589999999999999999999999 999999999999999999
Q ss_pred CeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 443 EAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 443 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.++|+|||++......... ......++..|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 228 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ 228 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999765432211 1223346788999999998899999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=284.63 Aligned_cols=203 Identities=25% Similarity=0.442 Sum_probs=181.3
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCC---C--cEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCee
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSD---G--ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~---g--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 373 (540)
..+.....++||.|-||.||+|.+.+ | -.||||.-+....++..+.|.+|..+|+.++||||++++|+|.+. ..
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence 34445567899999999999999743 3 359999998877777888999999999999999999999999765 57
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
+||||.++.|.|..||... +..++..+...++.||..||.|||+. ++|||||..+|||+.....+|++|||+++
T Consensus 466 WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence 8999999999999999864 55788999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.++....+......-...|||||-+.-+++|.++|||.|||.+||+++ |..||..
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG 595 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence 998877776666666789999999999999999999999999999877 9999974
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=276.39 Aligned_cols=198 Identities=30% Similarity=0.396 Sum_probs=175.3
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
+|+..+.||.|++|.||+|... +++.||+|.+...........+.+|+++++.++|+||+++++++......++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777889999999999999975 589999999876543444557899999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++++|.+++... .+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||+++.+.....
T Consensus 82 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 82 GGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999998742 689999999999999999999998 999999999999999999999999999987654322
Q ss_pred ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
......+++.|+|||++.+..++.++||||||+++|||+||+.||+.
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~ 200 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 22334588899999999988899999999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=271.65 Aligned_cols=201 Identities=30% Similarity=0.485 Sum_probs=173.6
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.++|++.+.||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++++|+||+++++++ ..+..++|+||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 467888899999999999999998899999999875442 345789999999999999999999986 45678999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 82 MENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999998653 234689999999999999999999998 99999999999999999999999999998665332
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
........++..|+|||++....++.++||||||+++||+++ |+.||..
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 206 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 222223346678999999988889999999999999999999 9999963
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=277.70 Aligned_cols=203 Identities=28% Similarity=0.457 Sum_probs=169.5
Q ss_pred cCCCcCCeeeeccCccEEEEEeCC-C--cEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSD-G--ALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~-g--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV 376 (540)
++|++.+.||+|+||.||+|..++ + ..+++|.++..........+.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998753 3 357888887544344456789999999999 799999999999999999999
Q ss_pred EecCCCCChhhhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCe
Q 009208 377 YPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA 444 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 444 (540)
+||+++|+|.++++.... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999865321 123588999999999999999999998 99999999999999999999
Q ss_pred EEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 445 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 445 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
||+|||++........ ......+..|+|||++....++.++|||||||++|||++ |+.||..
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~ 221 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG 221 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999864321111 111123567999999988889999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=274.73 Aligned_cols=202 Identities=28% Similarity=0.479 Sum_probs=171.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCc----EEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
.++|+..+.||+|+||.||+|.+. ++. .||+|.++.........++.+|+.++..+.|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 356788899999999999999864 444 4899998765545556678999999999999999999999875 4577
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+++||+++|+|.+++++. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999998753 34689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCce-eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 455 LDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 455 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
........ .....+++.|+|||...+..++.++||||||+++|||++ |+.||+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 65332211 122235678999999988899999999999999999998 9999974
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=276.04 Aligned_cols=205 Identities=29% Similarity=0.481 Sum_probs=172.9
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 373 (540)
..+|.+.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++.+++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 356888899999999999999752 34669999987543 33345789999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhccccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCe
Q 009208 374 LLVYPYMPNGSVASRLRDHI---------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA 444 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 444 (540)
++||||+++++|.+++.... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999999987532 1123589999999999999999999998 99999999999999999999
Q ss_pred EEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 445 VVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 445 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+|+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~ 225 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999865432211 1122335778999999998889999999999999999999 9999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=275.01 Aligned_cols=206 Identities=30% Similarity=0.398 Sum_probs=172.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC------CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 373 (540)
+++|.+.+.||+|++|.||+|.+.+ +..||+|.+........+..|.+|+.+++.++|+||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678889999999999999999753 5789999887554444456799999999999999999999999998999
Q ss_pred EEEEecCCCCChhhhccccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC---CeEEc
Q 009208 374 LLVYPYMPNGSVASRLRDHIH---GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF---EAVVG 447 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~ 447 (540)
++||||+++++|.+++..... ....++|..+..++.||+.|++|||+. +++||||||+||+++.++ .+|++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999999875421 123589999999999999999999999 999999999999998654 59999
Q ss_pred ccccccccCCCCCce-eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 448 DFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 448 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~ 224 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG 224 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 999998663322111 112223568999999998999999999999999999997 9999974
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=278.52 Aligned_cols=202 Identities=27% Similarity=0.389 Sum_probs=172.3
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
++|...+.||+|+||.||+|..+ +++.||+|.++..........+.+|+.++..++||||+++++++..++..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888899999999999999875 57899999987654444455688999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
++ ++|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 5888888653 34688999999999999999999999 99999999999999999999999999997544322
Q ss_pred CceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
. ......+++.|+|||.+.+. .++.++|||||||++|||+||+.||...+
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 12233478999999987654 57889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=286.72 Aligned_cols=193 Identities=32% Similarity=0.430 Sum_probs=168.6
Q ss_pred CCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccc--cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 303 FSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
|...+.||.|+||.||-|+. .+.+.||||++....-.. ...++.+|++.+.+++|||++..-|++......++||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 34456799999999999986 468999999997654222 234789999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
|- ||-.+.+.-+ ++++.+..+..|..+.++||+|||+. +.||||||..|||+++.|.+|++|||.|....+.
T Consensus 108 Cl-GSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 108 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred Hh-ccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 95 5777777644 46789999999999999999999999 9999999999999999999999999999876653
Q ss_pred Cceeeccccccccccccccc---cCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 460 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
..++|||.|||||++. .+.|+-|+||||+|+...||...++|+-
T Consensus 180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 3467999999999974 5789999999999999999999999985
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=288.96 Aligned_cols=208 Identities=26% Similarity=0.377 Sum_probs=174.1
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEecC
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTE 370 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 370 (540)
...++|.+.+.||+|+||.||+|.+. .+..||+|+++..........+.+|++++.++. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34456778899999999999999863 346899999986543444457899999999997 99999999999999
Q ss_pred CeeEEEEecCCCCChhhhccccC---------------------------------------------------------
Q 009208 371 NERLLVYPYMPNGSVASRLRDHI--------------------------------------------------------- 393 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------------- 393 (540)
+..++|+||+++|+|.++++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999986531
Q ss_pred -------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 009208 394 -------------------------------------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANI 436 (540)
Q Consensus 394 -------------------------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NI 436 (540)
.....+++.....++.|++.||+|||+. +++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 1123478888999999999999999998 999999999999
Q ss_pred eeCCCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 437 LLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 437 Ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
|+++++.+||+|||+++.+...... ......++..|+|||.+....++.++|||||||++|||++ |+.||..
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999865332211 1123346789999999988889999999999999999998 8999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=269.71 Aligned_cols=193 Identities=28% Similarity=0.442 Sum_probs=163.5
Q ss_pred eeeccCccEEEEEeC---CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCCh
Q 009208 309 LGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385 (540)
Q Consensus 309 lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 385 (540)
||+|+||.||+|.+. .+..||+|.+..........++.+|+.++++++|+||+++++++. .+..++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999864 356799999876544444567999999999999999999999885 4578899999999999
Q ss_pred hhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCcee--
Q 009208 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT-- 463 (540)
Q Consensus 386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~-- 463 (540)
.+++... ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...........
T Consensus 82 ~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 82 NKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9998642 34689999999999999999999999 999999999999999999999999999986543322211
Q ss_pred eccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 464 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
....++..|+|||.+....++.++||||||+++||+++ |+.||..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 201 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKK 201 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCc
Confidence 11223578999999988889999999999999999996 9999973
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=272.86 Aligned_cols=199 Identities=28% Similarity=0.408 Sum_probs=175.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|+..+.||+|+||.||+|...+ ++.+++|.++.... ..++.+|++++++++|+||+++++++..+...++++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 3578888999999999999999865 78999999875432 5689999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++++|.+++... ...+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 79 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 79 YCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred cCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999998642 35689999999999999999999999 9999999999999999999999999999866543
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. ......++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 153 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~ 201 (256)
T cd06612 153 MA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201 (256)
T ss_pred cc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 21 22234478999999999888999999999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=271.81 Aligned_cols=202 Identities=28% Similarity=0.451 Sum_probs=172.4
Q ss_pred cCCCcCCeeeeccCccEEEEEeC----CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.+|.+.+.||+|+||.||+|... .+..+|+|.++..........+.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999864 23479999987644344456789999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++++|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||++..+.
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999753 24689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceee--ccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 457 HRDSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
........ ...++..|+|||++.+..++.++||||||+++||+++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence 43322221 1223568999999998889999999999999999887 9999964
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=282.60 Aligned_cols=199 Identities=25% Similarity=0.298 Sum_probs=167.8
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCC-----
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN----- 371 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 371 (540)
..++|...+.||+|+||.||++... .|+.||+|+++.... .....++.+|+.++..++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999874 589999999875422 233456889999999999999999999886443
Q ss_pred -eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccc
Q 009208 372 -ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450 (540)
Q Consensus 372 -~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 450 (540)
..++||||+++ ++.+.++. .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46899999975 56555532 478889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 99754322 1223346899999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=275.83 Aligned_cols=204 Identities=32% Similarity=0.436 Sum_probs=171.5
Q ss_pred CCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
+|++.+.||+|+||.||+|... ....+|+|.++.........++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999853 2357999988765433444578999999999999999999999999999999
Q ss_pred EEecCCCCChhhhccccC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 009208 376 VYPYMPNGSVASRLRDHI--------------------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAAN 435 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~N 435 (540)
|+||+++|+|.+++.... .....+++..+..++.|++.|+.|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999986421 1123588999999999999999999998 99999999999
Q ss_pred eeeCCCCCeEEcccccccccCCCCCce-eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 436 ILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 436 ILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
|++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999997654332211 122335678999999988889999999999999999999 9999974
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=272.53 Aligned_cols=198 Identities=27% Similarity=0.391 Sum_probs=162.4
Q ss_pred eeeeccCccEEEEEeCC---CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCC
Q 009208 308 ILGRGGFGIVYKGCFSD---GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS 384 (540)
Q Consensus 308 ~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 384 (540)
.||+|+||.||+|...+ ...+|+|.+...........+.+|++.++.++|+||+++++.+...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 457888887654434445578999999999999999999999999999999999999999
Q ss_pred hhhhccccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce-
Q 009208 385 VASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV- 462 (540)
Q Consensus 385 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~- 462 (540)
|.+++...... ....++.....++.|++.|++|||+. +|+||||||+||++++++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764321 23457888899999999999999999 99999999999999999999999999987543322111
Q ss_pred eecccccccccccccccc-------CCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 463 TTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.....+++.|+|||+... ..++.++|||||||++|||++ |+.||..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence 122345678999998743 356889999999999999999 7888864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=278.12 Aligned_cols=213 Identities=25% Similarity=0.346 Sum_probs=177.3
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEe
Q 009208 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCS 368 (540)
Q Consensus 291 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 368 (540)
+.++.+..+.++|++.+.||+|+||.||++... +++.+|+|.++... ....++.+|+.++.++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 334555667889999999999999999999875 57899999876532 2235688899999998 6999999999874
Q ss_pred -----cCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC
Q 009208 369 -----TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443 (540)
Q Consensus 369 -----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 443 (540)
..+..++||||+++++|.++++........+++..+..++.|+++|+.|||+. +++||||||+||++++++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCC
Confidence 34568999999999999998875444456789999999999999999999998 9999999999999999999
Q ss_pred eEEcccccccccCCCCCceeecccccccccccccccc-----CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 444 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 444 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
++++|||++..+..... ......|++.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999986543222 2233458999999998753 44788999999999999999999999743
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=272.79 Aligned_cols=200 Identities=27% Similarity=0.446 Sum_probs=172.4
Q ss_pred CCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCcc-----ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-----GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
+|...+.||+|+||.||+|...+++.+|+|.++..... .....+.+|++++++++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 46778999999999999999888999999998643211 1123588999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
+||+++++|.+++.+. ..+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999998653 3578999999999999999999998 99999999999999999999999999987543
Q ss_pred CCC-----CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRD-----SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ........|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 211 1112234588999999999988899999999999999999999999974
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=277.86 Aligned_cols=199 Identities=23% Similarity=0.376 Sum_probs=174.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
..+|...+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 36788889999999999999996 4789999999875442 334568899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++++|.+++.+ ..+++..+..++.+++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999998864 3578899999999999999999999 9999999999999999999999999999865443
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 169 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 169 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred ccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 222 2234588999999999988899999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=269.58 Aligned_cols=201 Identities=20% Similarity=0.319 Sum_probs=175.4
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
+|++.+.||+|+||.||++... +++.+|+|.++..........+.+|+.+++.++|+||+++.+.+..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999875 689999999875443444567889999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++|+|.+++... ....+++.....++.|++.||.|||+. +|+|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 999999988642 234578999999999999999999999 999999999999999999999999999976543222
Q ss_pred ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||+.
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 202 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC
Confidence 22334588999999999888899999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=271.13 Aligned_cols=203 Identities=31% Similarity=0.484 Sum_probs=176.2
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
..++|.+.+.||+|+||.||+|..+++..||+|.+.... ....++.+|++++++++|+||+++++++......++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 346788899999999999999998888899999987543 234679999999999999999999999998899999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++++|.+++.+. ....+++..+..++.+++.|+.|||+. +++|+||||+||++++++.++++|||.+......
T Consensus 82 ~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 82 YMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred ccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999763 234689999999999999999999999 9999999999999999999999999999866532
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.........++..|+|||.+.+..++.++||||||+++||+++ |+.||..
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 207 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 2222222235678999999998889999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=275.44 Aligned_cols=203 Identities=27% Similarity=0.372 Sum_probs=170.9
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++++|.+.+.||+|+||.||+|... +|+.||+|.++..........+.+|+++++.++|+||+++.+++...+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3577889999999999999999864 689999999876543444456789999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+. +++.+++... ...+.+..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9995 6777776532 24578888999999999999999999 999999999999999999999999999875433
Q ss_pred CCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||+..
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 156 PSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 221 12233478999999998754 5788999999999999999999999743
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=277.98 Aligned_cols=196 Identities=24% Similarity=0.328 Sum_probs=160.4
Q ss_pred CCeeeeccCccEEEEEeC---CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEec--CCeeEEEEecC
Q 009208 306 KNILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST--ENERLLVYPYM 380 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~e~~ 380 (540)
.+.||+|+||.||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 367999999999999864 46789999986532 23457899999999999999999998854 45678999998
Q ss_pred CCCChhhhccccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----CCCCCeEEccccc
Q 009208 381 PNGSVASRLRDHI-----HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL----DEDFEAVVGDFGL 451 (540)
Q Consensus 381 ~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~Dfgl 451 (540)
. ++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 6 57877765321 1123588999999999999999999999 99999999999999 4567899999999
Q ss_pred ccccCCCCCc--eeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 452 AKLLDHRDSH--VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 452 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
++........ ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 9876543211 22345689999999998764 589999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=276.43 Aligned_cols=205 Identities=30% Similarity=0.445 Sum_probs=172.9
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC--------CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecC
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS--------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE 370 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 370 (540)
.++|.+.+.||+|+||.||+|... ++..||+|.++.........++.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 466788899999999999999741 34579999987544344456789999999999 899999999999999
Q ss_pred CeeEEEEecCCCCChhhhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl 438 (540)
+..++||||+++|+|.+++.+... ....+++..+..++.|+++||.|||+. +++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 999999999999999999975321 123588999999999999999999999 99999999999999
Q ss_pred CCCCCeEEcccccccccCCCCCce-eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCC
Q 009208 439 DEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALD 507 (540)
Q Consensus 439 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~ 507 (540)
++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999998664322221 222345678999999988889999999999999999998 788886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=288.19 Aligned_cols=194 Identities=24% Similarity=0.286 Sum_probs=167.5
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
..+|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+||+++++++...+..++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 346888999999999999999986 478899996432 246789999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
++. ++|.+++... ...++|..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 241 ~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KYR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred ccC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 995 7888888642 23699999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 459 DSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 459 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
... ......||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 221 1224569999999999999999999999999999999999887654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=304.10 Aligned_cols=209 Identities=25% Similarity=0.380 Sum_probs=185.6
Q ss_pred HHHHHHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEec
Q 009208 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCST 369 (540)
Q Consensus 293 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 369 (540)
..+++...++|.+.++||+|+||.|..++.+ .++.+|.|++++...- .....|..|..+|...+.+-|+++.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4566777889999999999999999999986 5889999999874321 233468999999999999999999999999
Q ss_pred CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccc
Q 009208 370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF 449 (540)
Q Consensus 370 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 449 (540)
....|+|||||+||+|-..+.++ ..+++..++.++..|+-||.-+|+. |+|||||||+|||+|..|.+|++||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999999864 2688999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccccccccccc-----CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|.+-.++..+.-.+...+|||.|++||++.. +.|++.+|.||+||++|||+.|..||..
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 9998888665555666779999999999842 5789999999999999999999999983
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=272.01 Aligned_cols=204 Identities=22% Similarity=0.383 Sum_probs=176.4
Q ss_pred cCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|.+.+.||+|+||.||+|.. .+++.+|||.+..... .....++.+|++++..++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677889999999999999996 4789999998865332 223357889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++++|.+++.........+++..+..++.++++|+.|||+. +++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875444456789999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ......++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 322 12234588999999999888899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=274.41 Aligned_cols=206 Identities=27% Similarity=0.427 Sum_probs=174.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC-----------------CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccc
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD-----------------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 362 (540)
..+|.+.+.||+|+||.||+|...+ +..||+|.+..........++.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999988642 24689999886654455667999999999999999999
Q ss_pred eeEEEecCCeeEEEEecCCCCChhhhccccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 009208 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIH-------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAAN 435 (540)
Q Consensus 363 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~N 435 (540)
+++++...+..++|+||+++++|.+++.+... ....+++..+..++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999976431 123689999999999999999999998 99999999999
Q ss_pred eeeCCCCCeEEcccccccccCCCCC-ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh--CCCCCCc
Q 009208 436 ILLDEDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT--GQRALDF 508 (540)
Q Consensus 436 ILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt--g~~p~~~ 508 (540)
|++++++.++|+|||+++....... .......+++.|+|||++....++.++||||||+++|||++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999986543322 12233446789999999988889999999999999999998 6777763
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=277.80 Aligned_cols=202 Identities=23% Similarity=0.346 Sum_probs=176.9
Q ss_pred cCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCcccc-HHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.-|...+.||+|.|+.|-.|+. -.|+.||||++.+.....- ...+.+|++.|..++|||||+++.+...+...|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4467778999999999998874 3799999999987665433 3468899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-CCCCeEEcccccccccCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~ 457 (540)
.=++|+|++|+.++ ...+.+....+++.||+.|+.|+|+. .+|||||||+||.+- +-|-+|+.|||++..+.+
T Consensus 98 LGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999876 34588999999999999999999999 999999999999765 568899999999987765
Q ss_pred CCCceeeccccccccccccccccCCC-CccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
.. .....+|+..|-|||++.+..| .+.+||||+|||+|.|++|+.||....
T Consensus 172 G~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN 223 (864)
T KOG4717|consen 172 GK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN 223 (864)
T ss_pred cc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc
Confidence 44 3455679999999999999887 478999999999999999999998443
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=275.70 Aligned_cols=204 Identities=23% Similarity=0.350 Sum_probs=170.7
Q ss_pred CCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
+|.+.+.||+|+||.||+|... +++.||+|+++..........+.+|+.++..++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556788999999999999863 2578999999865433334568899999999999999999999999999999
Q ss_pred EEecCCCCChhhhccccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC
Q 009208 376 VYPYMPNGSVASRLRDHI------------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 443 (540)
++||+++++|.+++.... ..+..+++..+..++.|++.||+|+|+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999985311 1124588999999999999999999999 9999999999999999999
Q ss_pred eEEcccccccccCCCCC-ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 444 AVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 444 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+||+|||+++....... .......+++.|+|||.+....++.++||||||+++|||++ |..||..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 229 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999886543222 11223346789999999988889999999999999999998 8888863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=285.36 Aligned_cols=197 Identities=27% Similarity=0.358 Sum_probs=169.2
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhccc-C-----CCccceeEEEecCCeeE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-H-----RNLLRLCGFCSTENERL 374 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~l~~~~~~~~~~~ 374 (540)
+|.+.+.||+|.||.|.||... +++.||||+++... .-..+-..|+++|..++ | -|+|++++++...++.+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 7888999999999999999875 59999999998643 22345678999999887 3 37999999999999999
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC--CCCeEEcccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE--DFEAVVGDFGLA 452 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgla 452 (540)
||+|.+. -+|+++|+.+ ....++...++.++.||+.||.+||+. +|||+||||+|||+.+ ...+||+|||.|
T Consensus 265 iVfELL~-~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELLS-TNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhhh-hhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999984 5999999864 345699999999999999999999999 9999999999999974 448999999999
Q ss_pred cccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
......- ....-+..|.|||++.+..|+.+.||||||||+.||++|.+.|...+
T Consensus 339 c~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 339 CFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 8654322 14457889999999999999999999999999999999987776444
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=258.64 Aligned_cols=201 Identities=26% Similarity=0.415 Sum_probs=173.3
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc---cc----HHHHHHHHHHHhcc-cCCCccceeEEEec
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA---GG----EVQFQTEVETISLA-VHRNLLRLCGFCST 369 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~----~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 369 (540)
.-.+|...+++|+|..+.|-+...+ .|...|+|++...... .. ..+-.+|+.+++++ .||+|+++.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456778889999999999988765 5788999998643211 11 22457899999988 59999999999999
Q ss_pred CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccc
Q 009208 370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF 449 (540)
Q Consensus 370 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 449 (540)
+...++|+|.|+.|.|.+||.. ..++++....+|+.|+.+|+.|||.+ +||||||||+|||+|++.++||+||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 9999999999999999999975 35799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccccccccccc------CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|++..+.++ ......+|||+|+|||.+.- ..|+..+|+||.|||||.|+.|-+||-+
T Consensus 168 GFa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 168 GFACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred ceeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence 999977653 33566789999999999853 3578899999999999999999999963
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=287.14 Aligned_cols=196 Identities=27% Similarity=0.319 Sum_probs=169.6
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC---CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
..+|.+.+.||+|+||.||++... .+..||+|.+.... ...+|++++++++||||+++++++......++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 356889999999999999999753 35789999876432 456899999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
||++. ++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++....
T Consensus 165 ~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 165 MPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred ehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 99995 688888743 35789999999999999999999999 99999999999999999999999999997655
Q ss_pred CCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 457 HRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 457 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
..... ......||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 43221 223456999999999999889999999999999999999999999743
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=270.45 Aligned_cols=201 Identities=27% Similarity=0.469 Sum_probs=170.4
Q ss_pred CCCcCCeeeeccCccEEEEEeCC-C---cEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFSD-G---ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
.|.+.+.||+|+||.||+|.... + ..||+|.++.........+|..|+.+++.++||||+++.+++...+..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999998753 3 3699999876543444568999999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||++.....
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999998753 34689999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCcee--eccc--cccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 458 RDSHVT--TAVR--GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 458 ~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
...... .... .+..|+|||++....++.++||||||+++||+++ |+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~ 214 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCC
Confidence 222111 1111 2457999999998899999999999999999886 9999964
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=305.02 Aligned_cols=209 Identities=21% Similarity=0.332 Sum_probs=172.9
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEec--CCee
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCST--ENER 373 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 373 (540)
....+|.+.+.||+|+||.||+|... .+..||+|.+...... .....|..|+.++.+++||||+++++++.. ....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999975 5778999998754322 234578999999999999999999998854 4568
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCceeeCCC--------
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD----PKIIHRDVKAANILLDED-------- 441 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~ivH~Dlk~~NILl~~~-------- 441 (540)
++||||+++|+|.++|.........+++..++.|+.||+.||.|||+... .+||||||||+|||++.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999998654445679999999999999999999998521 259999999999999642
Q ss_pred ---------CCeEEcccccccccCCCCCceeecccccccccccccccc--CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 442 ---------FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 442 ---------~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..+||+|||++..+.... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||..
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 348999999998654322 2234468999999999854 4588999999999999999999999974
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=271.80 Aligned_cols=198 Identities=32% Similarity=0.471 Sum_probs=167.8
Q ss_pred CCcCCeeeeccCccEEEEEe-----CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecC--CeeEE
Q 009208 303 FSAKNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERLL 375 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 375 (540)
|...+.||+|+||+||++.+ .++..||+|.++..........+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999988653 357889999987654334456789999999999999999999988653 45789
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||+++|+|.+++.. ..+++..+..++.|+++|+.|||+. +|+||||||+||++++++.++|+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999864 2589999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCce--eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 456 DHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 456 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
....... .....++..|+|||.+....++.++||||||+++|||+||+.|+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 5322211 1122356679999999888899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=271.55 Aligned_cols=204 Identities=25% Similarity=0.388 Sum_probs=171.5
Q ss_pred HHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 297 RAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 297 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
+.+++++.....||+|+||.||+|... ++..||+|.+.... ......+.+|+++++.++|+||+++++++..++..++
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 345666666789999999999999865 57889999887543 2334578999999999999999999999999999999
Q ss_pred EEecCCCCChhhhccccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-CCCeEEcccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPAL--DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDFGLA 452 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla 452 (540)
|+||+++++|.+++.... ..+ ++..+..++.|+++|++|||+. +|+||||||+||+++. ++.++|+|||++
T Consensus 83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 999999999999997531 234 7888999999999999999999 9999999999999986 679999999998
Q ss_pred cccCCCCCceeeccccccccccccccccCC--CCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
........ ......|++.|+|||++.... ++.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 76543221 222335889999999986543 78999999999999999999999963
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=277.66 Aligned_cols=206 Identities=31% Similarity=0.428 Sum_probs=172.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC--------CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecC
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS--------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE 370 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 370 (540)
.++|.+.+.||+|+||.||++... ++..+|+|.++.........++.+|++++..+ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357889999999999999999752 23579999998654344455788999999999 799999999999999
Q ss_pred CeeEEEEecCCCCChhhhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl 438 (540)
+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999975321 123589999999999999999999998 99999999999999
Q ss_pred CCCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 439 DEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 439 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+.++.+||+|||.++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~ 245 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 99999999999998755432111 1112224578999999988889999999999999999998 8888863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=278.10 Aligned_cols=212 Identities=29% Similarity=0.393 Sum_probs=176.8
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEe
Q 009208 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCS 368 (540)
Q Consensus 291 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 368 (540)
+++.++..+.++|.+.+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++.++ +|||++++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 344555567889999999999999999999874 68899999986532 2234678899999988 7999999999986
Q ss_pred cC-----CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC
Q 009208 369 TE-----NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443 (540)
Q Consensus 369 ~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 443 (540)
.. +..++|+||+++|+|.++++........+++..+..++.|++.||+|||+. +++||||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 53 358999999999999998875444456789999999999999999999998 9999999999999999999
Q ss_pred eEEcccccccccCCCCCceeeccccccccccccccccC-----CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 444 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 444 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
+||+|||++......... .....|+..|+|||.+... .++.++|||||||++|||++|+.||..
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~ 235 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCC
Confidence 999999998865432211 2234588999999997543 368999999999999999999999974
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=277.06 Aligned_cols=199 Identities=22% Similarity=0.384 Sum_probs=174.4
Q ss_pred cCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.+|+..+.||.|++|.||+|.. .+++.||+|.+.... ......+.+|+++++.++|||++++++++...+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 4588889999999999999986 468999999987543 23345788999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++.+ ..+++..+..++.+++.|+.|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 98 LAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred cCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999998864 3589999999999999999999999 99999999999999999999999999987654332
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. .....++..|+|||.+....++.++|||||||++|+|++|+.||...
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~ 218 (296)
T cd06655 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (296)
T ss_pred cc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 21 22345889999999998888999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=271.44 Aligned_cols=200 Identities=27% Similarity=0.365 Sum_probs=170.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+.|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++.+..++..++||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 56888899999999999999975 48899999987543 33345788999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|..++.+. ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 91 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 91 CPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999998887542 34589999999999999999999998 99999999999999999999999999987543222
Q ss_pred Cceeeccccccccccccccc-----cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ......+++.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 165 Q-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred c-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 1 122345889999999984 34568899999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=275.41 Aligned_cols=204 Identities=28% Similarity=0.383 Sum_probs=173.6
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 372 (540)
.++|...+.||+|+||.||+|... .+..||+|.++..........+.+|+++++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 456888999999999999999742 35679999987654344455789999999999 79999999999999999
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.++||||+++|+|.++++... ...+++.++..++.+++.|++|||+. +|+|+||||+||+++.++.++++|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 999999999999999987532 23489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 453 KLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 453 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+.+...... ......++..|+|||.+....++.++|||||||++|||++ |+.||..
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 865433221 1122335778999999998899999999999999999998 9999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=269.76 Aligned_cols=202 Identities=29% Similarity=0.513 Sum_probs=171.8
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CC---cEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DG---ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
++|+..+.||+|+||.||+|... ++ ..+|+|.++.........++.+|++++.+++|+|++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46777899999999999999975 23 379999987654344456789999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++++|.+++... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999998652 34689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCceee--ccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 457 HRDSHVTT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
........ ....+..|+|||++....++.++|||||||++|||++ |+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~ 213 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence 32221111 1223457999999988889999999999999999998 9999963
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=272.62 Aligned_cols=198 Identities=29% Similarity=0.381 Sum_probs=174.4
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|++.+.||+|+||.||++... +++.||+|.++.... ......+.+|+++++++.||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999975 589999999865432 122446889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999998653 4688999999999999999999998 999999999999999999999999999986654
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
. .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 3 23345889999999998888899999999999999999999999743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=268.03 Aligned_cols=200 Identities=30% Similarity=0.453 Sum_probs=170.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
++|.+.+.||+|++|.||+|...++..+|+|.+.... .....+.+|++++++++|+|++++++++. .+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 4577888999999999999998777789999876543 23457899999999999999999998875 45688999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++|+|.++++.. ....+++..+..++.+++.||.|||+. +++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999999753 234588999999999999999999998 999999999999999999999999999986643322
Q ss_pred ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.......++..|+|||...+..++.++||||||+++|||+| |+.||..
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 206 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 22222346778999999988899999999999999999999 8999964
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=283.15 Aligned_cols=208 Identities=24% Similarity=0.392 Sum_probs=181.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcccc-HHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
...|.+...||+|.|+.|..|+.. .+..||+|.+.+...... ...+.+|+++|..++|||||+++.+...+...|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467888899999999999999864 689999999987654333 345889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||..+|.+.+|+.++ ....+..+..++.|+.+|++|+|++ .|||||||.+|||++.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999864 3345578889999999999999999 999999999999999999999999999998873
Q ss_pred CCCceeeccccccccccccccccCCC-CccCCeehhhHHHHHHHhCCCCCCcccccccCC
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRG 516 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvil~elltg~~p~~~~~~~~~~~ 516 (540)
.......+|++.|.|||+..+..| ++++|+||+||++|-|+.|..|||...-.+.+.
T Consensus 208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~ 265 (596)
T KOG0586|consen 208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP 265 (596)
T ss_pred --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc
Confidence 344566789999999999988765 789999999999999999999999654444443
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=271.60 Aligned_cols=201 Identities=29% Similarity=0.442 Sum_probs=170.4
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecC------
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE------ 370 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~------ 370 (540)
+...|+..+.||+|+||.||+|... +++.||+|.+.... ....++.+|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4567888899999999999999875 57899999986543 3345788999999988 699999999998653
Q ss_pred CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccc
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 450 (540)
...++||||+++|+|.+++... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 4578999999999999998753 234688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeccccccccccccccc-----cCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
++........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||+
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~ 217 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9986543222 223455899999999986 3357889999999999999999999996
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=272.30 Aligned_cols=200 Identities=25% Similarity=0.344 Sum_probs=174.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
++|++.+.||+|+||+||++... +|+.||+|++...........+.+|++++..++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45677789999999999999875 58899999987654444556899999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++.+ .+.+++.....++.+++.|+.|||+.+ +++||||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999988864 246899999999999999999999732 89999999999999999999999999987543221
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.....|+..|+|||++.+..++.++|||||||++||+++|+.||+..
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 22345899999999998888999999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=272.62 Aligned_cols=200 Identities=27% Similarity=0.368 Sum_probs=165.5
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-cHHHHHHHHHHHhcc---cCCCccceeEEEec-----CC
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLA---VHRNLLRLCGFCST-----EN 371 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~~ 371 (540)
+|++.+.||+|+||.||+|... +++.||+|.++...... ....+.+|++++..+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999875 68999999987543222 233456777777655 69999999998754 34
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
..++|+||++ ++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999997 4888888653 234589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
++...... ......||..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 98664322 123345899999999999889999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=268.91 Aligned_cols=198 Identities=24% Similarity=0.372 Sum_probs=161.3
Q ss_pred eeeeccCccEEEEEeCCC---cEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCC
Q 009208 308 ILGRGGFGIVYKGCFSDG---ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS 384 (540)
Q Consensus 308 ~lG~G~~g~Vy~~~~~~g---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 384 (540)
.||+|+||.||+|...++ ..+++|.++..........|.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975443 35667776654434455689999999999999999999999999999999999999999
Q ss_pred hhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC-Ccee
Q 009208 385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVT 463 (540)
Q Consensus 385 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~-~~~~ 463 (540)
|.+++++........++.....++.|+++||+|||+. +++||||||+||+++.++.++|+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999986433344577788889999999999999998 99999999999999999999999999986432211 1112
Q ss_pred ecccccccccccccccc-------CCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 464 TAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 464 ~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
....++..|+|||++.. ..++.++||||||+++|||++ |+.||+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 23457889999998743 245789999999999999997 5678863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=276.81 Aligned_cols=206 Identities=31% Similarity=0.443 Sum_probs=172.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC--------CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecC
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS--------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE 370 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 370 (540)
.++|.+.+.||+|+||.||++... ....||+|.++.........++.+|++++.++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 456788899999999999999742 24579999987654344455788999999999 699999999999998
Q ss_pred CeeEEEEecCCCCChhhhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl 438 (540)
+..++|+||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 999999999999999999975321 124589999999999999999999998 99999999999999
Q ss_pred CCCCCeEEcccccccccCCCCCce-eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 439 DEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 439 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 999999999999998654322211 112224568999999988889999999999999999999 8889863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=273.62 Aligned_cols=206 Identities=25% Similarity=0.377 Sum_probs=172.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-----------------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccc
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-----------------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 362 (540)
.++|++.+.||+|+||.||++... ++..||+|.++.........++.+|++++..++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998542 234699999876544444567999999999999999999
Q ss_pred eeEEEecCCeeEEEEecCCCCChhhhccccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 009208 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHG-------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAAN 435 (540)
Q Consensus 363 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~N 435 (540)
+++++...+..++||||+++|+|.+++...... ...+++..+..++.|++.|++|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999998763211 23478899999999999999999999 99999999999
Q ss_pred eeeCCCCCeEEcccccccccCCCCCce-eeccccccccccccccccCCCCccCCeehhhHHHHHHHh--CCCCCCc
Q 009208 436 ILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT--GQRALDF 508 (540)
Q Consensus 436 ILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt--g~~p~~~ 508 (540)
|++++++.++++|||+++.+....... .....+++.|+|||....+.++.++|||||||++|||++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999998654332211 122334678999999888889999999999999999998 6788863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=286.41 Aligned_cols=192 Identities=29% Similarity=0.450 Sum_probs=169.0
Q ss_pred eeeeccCccEEEEEeCC-CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCChh
Q 009208 308 ILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVA 386 (540)
Q Consensus 308 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 386 (540)
++|+|.||+||.|+..+ ...+|||.+.... .+..+-+..|+.+-++++|.|||+.+|.+.+.+..-|.||-.+||||.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 79999999999999754 5679999987544 222335789999999999999999999999999999999999999999
Q ss_pred hhccccCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-CCCCeEEcccccccccCCCCCcee
Q 009208 387 SRLRDHIHGRPAL--DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLDHRDSHVT 463 (540)
Q Consensus 387 ~~l~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~ 463 (540)
+.|+... +++ .+.++-.+.+||++||.|||++ .|||||||-+|||++ -.|.+||+|||.++++.. -+..+
T Consensus 661 sLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~T 733 (1226)
T KOG4279|consen 661 SLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCT 733 (1226)
T ss_pred HHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCccc
Confidence 9998643 345 7888899999999999999999 999999999999997 678999999999998763 44566
Q ss_pred eccccccccccccccccC--CCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 464 TAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 464 ~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
.++-||..|||||++..+ .|+..+|||||||.+.||.||++||.
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ 779 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFV 779 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCee
Confidence 677799999999999875 48899999999999999999999996
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=271.29 Aligned_cols=199 Identities=32% Similarity=0.489 Sum_probs=173.2
Q ss_pred CCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCccccHH-HHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 303 FSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEV-QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
|+..+.||+|+||+||++.... ++.||+|.+.......... ...+|+.++.+++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999999864 6789999998765433332 3456999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++++|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred ccccccccccc----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence 99999999973 35689999999999999999999999 999999999999999999999999999976422 22
Q ss_pred ceeeccccccccccccccc-cCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 461 HVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.......++..|+|||++. ....+.++||||+|+++|+|++|+.||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 3344556899999999998 788999999999999999999999999844
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=268.50 Aligned_cols=203 Identities=30% Similarity=0.412 Sum_probs=168.6
Q ss_pred CCcCCeeeeccCccEEEEEeCC----CcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCe-----
Q 009208 303 FSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENE----- 372 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 372 (540)
|.+.+.||+|+||.||+|.... +..||+|+++..... ....++.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4677899999999999998742 367999998754322 233578999999999999999999998866544
Q ss_pred -eEEEEecCCCCChhhhccccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccc
Q 009208 373 -RLLVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF 449 (540)
Q Consensus 373 -~~lV~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 449 (540)
.++|+||+++|+|..++..... ....+++.....++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 7899999999999999854321 234689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCce-eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 450 GLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 450 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
|+++......... .....++..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~ 218 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 9998665433221 112235678999999988889999999999999999999 8899864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=271.00 Aligned_cols=203 Identities=24% Similarity=0.359 Sum_probs=169.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHH-HhcccCCCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVET-ISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
++|++.+.||+|+||.||+|... +|+.||+|+++.........++..|+.. ++...||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999975 5899999998765444445566667665 556789999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|++ |+|.+++.........+++..+..++.|++.||+|||+++ +++||||||+||++++++.+||+|||++..+...
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6888888765444567999999999999999999999743 7999999999999999999999999999865432
Q ss_pred CCceeecccccccccccccccc----CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..
T Consensus 158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 158 VA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 21 122458889999998864 4468899999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=271.39 Aligned_cols=201 Identities=27% Similarity=0.462 Sum_probs=170.5
Q ss_pred cCCCcCCeeeeccCccEEEEEe-----CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecC--Cee
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NER 373 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 373 (540)
..|++.+.||+|+||.||++.+ .++..||+|.++..........+.+|+++++.++|||++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467789999999999999974 257889999987654444455799999999999999999999998765 568
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++||||+++++|.+++.+. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 8999999999999998643 23589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 454 LLDHRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 454 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
.+...... ......++..|+|||++.+..++.++||||||+++|||+|++.|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 76543321 1123446778999999988889999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=282.55 Aligned_cols=198 Identities=23% Similarity=0.275 Sum_probs=167.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecC------C
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE------N 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 371 (540)
.++|...+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467999999999999999999865 588999999875432 23345688999999999999999999987543 3
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
..++||||+++ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 57999999965 66666642 478899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 98654322 223345899999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=273.71 Aligned_cols=206 Identities=26% Similarity=0.408 Sum_probs=171.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC---------------CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCcccee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD---------------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 364 (540)
..+|.+.+.||+|+||.||++...+ ...||+|.++..........|.+|++++.+++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578888999999999999987532 2358999987654444455799999999999999999999
Q ss_pred EEEecCCeeEEEEecCCCCChhhhccccC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCce
Q 009208 365 GFCSTENERLLVYPYMPNGSVASRLRDHI--------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANI 436 (540)
Q Consensus 365 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NI 436 (540)
+++...+..++||||+++++|.+++.... .....+++..+..++.|++.|++|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 99999999999999999999999986421 1123478999999999999999999999 999999999999
Q ss_pred eeCCCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh--CCCCCCc
Q 009208 437 LLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT--GQRALDF 508 (540)
Q Consensus 437 Ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt--g~~p~~~ 508 (540)
++++++.+||+|||++......... ......++..|+|||++....++.++|||||||++|||++ |..||+.
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999999999999765432211 1122335678999999988889999999999999999998 5667763
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=285.62 Aligned_cols=193 Identities=30% Similarity=0.480 Sum_probs=165.7
Q ss_pred CCeeeeccCccEEEEEeC-CCcEEEEEEec---cCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCe--eEEEEec
Q 009208 306 KNILGRGGFGIVYKGCFS-DGALVAVKRLK---DYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE--RLLVYPY 379 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~---~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--~~lV~e~ 379 (540)
..+||+|+|-+||||.+. +|..||--.++ ....+....+|..|+.+|+.++||||++++.+..+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 367999999999999874 57778743333 22333444689999999999999999999999876554 7789999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-CCCCeEEcccccccccCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~~ 458 (540)
|..|+|..|.+++ +.++....+.|+.||++||.|||++ .|+|||||||-+||+++ ..|.+||+|+|+|..++..
T Consensus 125 ~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 9999999999875 4577889999999999999999996 78999999999999998 6789999999999987754
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
.. ..+.|||.|||||+.. -.|.+.+||||||+.++||+|+..||.
T Consensus 200 ~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 200 HA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred cc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 32 2367999999999976 679999999999999999999999997
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=270.15 Aligned_cols=202 Identities=28% Similarity=0.488 Sum_probs=171.8
Q ss_pred cCCCcCCeeeeccCccEEEEEeCC-Cc----EEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSD-GA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
.+|++.+.||+|+||.||+|.+++ |. .||+|..+.........++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467788999999999999998743 32 6899988765544445678999999999999999999999987 78899
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
|+||+++|+|.+++.+. ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999998753 33589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCcee-eccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCcc
Q 009208 456 DHRDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFG 509 (540)
Q Consensus 456 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~~ 509 (540)
........ ....++..|+|||.+....++.++||||||+++||+++ |+.||+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 215 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 54332221 11223568999999988889999999999999999999 99999754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=264.77 Aligned_cols=201 Identities=24% Similarity=0.358 Sum_probs=175.0
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC-ccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN-IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+|+..+.||+|+||.||.+... +++.+++|++.... ......++.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999998864 58899999986543 233455789999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++|+|.+++.+.. ...+++..+..++.|+++|+.|||+. +++||||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999987532 34689999999999999999999998 99999999999999999999999999998664433
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||+.
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence 2 22334589999999999888899999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=267.17 Aligned_cols=196 Identities=34% Similarity=0.495 Sum_probs=168.9
Q ss_pred CeeeeccCccEEEEEeCC--C--cEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFSD--G--ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|++|.||+|.+.+ + ..||+|.+..........++.+|++++.+++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998743 2 36999999876544445679999999999999999999999988 889999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc-
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH- 461 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~- 461 (540)
|+|.+++.+... ..+++.....++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.+......
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976422 4689999999999999999999999 9999999999999999999999999999876543221
Q ss_pred -eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 462 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 462 -~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
......++..|+|||++....++.++||||||+++|||++ |+.||+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 1122347789999999998899999999999999999999 9999963
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=268.95 Aligned_cols=202 Identities=25% Similarity=0.405 Sum_probs=170.4
Q ss_pred cCCCcCCeeeeccCccEEEEEeCC----CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
++|.+.+.||+|+||.||+|...+ ...||+|.............+.+|+.+++++.||||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999998743 246999988765433445579999999999999999999998875 457899
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++|+|.+++... ...+++..+..++.+++.|++|||+. +++||||||+||+++.++.++++|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999753 23589999999999999999999998 99999999999999999999999999998665
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCcc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFG 509 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~~ 509 (540)
...........++..|+|||.+....++.++||||||+++||+++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 212 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV 212 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 433222223335578999999988889999999999999999996 99999743
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=267.25 Aligned_cols=200 Identities=27% Similarity=0.394 Sum_probs=168.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc----ccHHHHHHHHHHHhcccCCCccceeEEEecC--Cee
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA----GGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NER 373 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 373 (540)
.+|.+.+.||+|+||.||+|... ++..||+|.+...... .....+.+|++++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999875 5899999988643211 1224678899999999999999999988653 457
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++||||+++++|.+++.+. ..+++.....++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 8999999999999998643 3578888999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCC--ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 454 LLDHRDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 454 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
....... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 210 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA 210 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence 6542211 11223458899999999988889999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=270.40 Aligned_cols=201 Identities=26% Similarity=0.355 Sum_probs=172.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|++.+.||+|+||.||+|... ++..||+|.++... ......|.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 456888899999999999999975 58999999987543 2334578899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++++|.+++.+. ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 83 FCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred ccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999998653 34689999999999999999999999 9999999999999999999999999998754432
Q ss_pred CCceeeccccccccccccccc-----cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. ......+++.|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~ 210 (280)
T cd06611 157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210 (280)
T ss_pred cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence 22 222345899999999975 33467899999999999999999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=282.11 Aligned_cols=199 Identities=23% Similarity=0.267 Sum_probs=168.0
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecC------
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE------ 370 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 370 (540)
..++|...+.||+|+||.||++... .++.||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 588999999875432 22345678899999999999999999988543
Q ss_pred CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccc
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 450 (540)
...++||||+++ ++.+.+.. .+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 346899999965 56666542 478899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 165 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred ccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 998654322 223446899999999999889999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=267.35 Aligned_cols=201 Identities=25% Similarity=0.448 Sum_probs=172.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.++|.+.+.||+|+||.||+|...++..+|+|.++... .....+.+|++++++++|+||+++.+++.. ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 46788899999999999999998788889999887532 234578999999999999999999999877 778999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++|+|.+++... ....+++..+..++.+++.||.|||+. +++||||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999999753 234688999999999999999999998 99999999999999999999999999997654332
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
........++..|+|||++....++.++|||||||++||++| |+.||..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 206 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence 222222335678999999988889999999999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=266.56 Aligned_cols=200 Identities=28% Similarity=0.500 Sum_probs=172.6
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
.+|+..+.||+|+||.||+|.+.++..+|+|.++... ....+|.+|++++.++.|||++++++++......++|+||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 4577789999999999999998778899999987543 23457899999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++++|.+++... ...+++..+..++.+++.|++|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999988643 34588999999999999999999999 999999999999999999999999999876543222
Q ss_pred ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.......++.+|+|||++.+..++.++||||||+++|||++ |+.||+.
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 204 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 21222335678999999988889999999999999999998 9999973
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=270.79 Aligned_cols=201 Identities=24% Similarity=0.359 Sum_probs=170.4
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+|...+.||+|++|.||+|+.. +++.||+|+++..... .....+.+|+.++.+++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777899999999999999975 6899999998754322 2235688999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
++ ++|.+++.... ....+++..+..++.|+++||.|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 68888886532 235689999999999999999999999 99999999999999999999999999997654322
Q ss_pred CceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ......+++.|+|||.+.+. .++.++||||||+++|||+||+.||..
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1 12233478999999987654 478999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=272.37 Aligned_cols=196 Identities=29% Similarity=0.413 Sum_probs=171.0
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCC
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP 381 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 381 (540)
|+..+.||+|+||.||+|... +++.||+|.++..........+.+|++++++++||||+++++++..++..++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 455678999999999999865 5789999998755434445578999999999999999999999999999999999999
Q ss_pred CCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc
Q 009208 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461 (540)
Q Consensus 382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 461 (540)
+++|.+++.. ..+++..+..++.++++|+.|||+. +++|+||+|+||++++++.++++|||++..+.....
T Consensus 86 ~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 86 GGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999988853 3588999999999999999999998 999999999999999999999999999976543221
Q ss_pred eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 462 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
......++..|+|||++.+..++.++||||||+++|||++|+.|+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCc
Confidence 1223457889999999998889999999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=292.75 Aligned_cols=200 Identities=22% Similarity=0.283 Sum_probs=163.1
Q ss_pred HHHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccC------CCccceeEEEe
Q 009208 296 LRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH------RNLLRLCGFCS 368 (540)
Q Consensus 296 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~l~~~~~ 368 (540)
+.....+|.+.+.||+|+||+||+|... .++.||||+++... ....++..|++++..++| .+++++++++.
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3345678999999999999999999875 57889999986432 222345667777766654 45888888886
Q ss_pred cC-CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeeCCCC----
Q 009208 369 TE-NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDF---- 442 (540)
Q Consensus 369 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~~~---- 442 (540)
.. +..++|||++ +++|.+++.+ ...+++..+..++.|++.||+|||+ . +||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccc
Confidence 54 5688999988 7788888864 2468999999999999999999997 5 899999999999998765
Q ss_pred ------------CeEEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 443 ------------EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 443 ------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+..
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998764322 223456999999999999999999999999999999999999999854
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=271.45 Aligned_cols=202 Identities=25% Similarity=0.380 Sum_probs=171.6
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
++|++.+.||+|+||.||++... +++.||+|.++..........+.+|++++.+++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999986 68999999987543333345789999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++.... ....+++..+..++.+++.|+.|||+.+ +|+||||||+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999887531 2346899999999999999999999632 89999999999999999999999999987653221
Q ss_pred CceeeccccccccccccccccC------CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 2233478899999998554 348899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=267.97 Aligned_cols=203 Identities=29% Similarity=0.405 Sum_probs=165.7
Q ss_pred CCcCCeeeeccCccEEEEEeCCC---cEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecC------Ce
Q 009208 303 FSAKNILGRGGFGIVYKGCFSDG---ALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE------NE 372 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~~g---~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~ 372 (540)
|.+.+.||+|+||.||+|.+.+. ..||+|.++.... ......+.+|++++..++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 34668899999999999997543 2699998875432 22345788999999999999999999987432 24
Q ss_pred eEEEEecCCCCChhhhccccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHI--HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 450 (540)
.++|+||+++|+|.+++.... .....+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874321 1234589999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCcee-eccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 451 LAKLLDHRDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 451 la~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+++.+........ ....+++.|+|||+.....++.++||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 217 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9987654322111 22235678999999999899999999999999999999 8899864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=271.69 Aligned_cols=200 Identities=26% Similarity=0.395 Sum_probs=170.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
++|+..+.||+|++|.||+|..+ +++.||+|.+...........+.+|++++++++|+||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999976 68999999987644333344578899999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++ +|.+++.+. ...+++.....++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 984 899888653 23688999999999999999999999 99999999999999999999999999987543222
Q ss_pred Cceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. .....++..|+|||++.+ ..++.++||||+|+++|||++|+.||..
T Consensus 158 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred cc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11 122346889999999865 4578999999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=268.00 Aligned_cols=197 Identities=30% Similarity=0.484 Sum_probs=164.2
Q ss_pred CeeeeccCccEEEEEeCC-Cc--EEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFSD-GA--LVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||+|..++ +. .+|+|.++..........+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999754 33 57889887544344456789999999999 799999999999999999999999999
Q ss_pred CChhhhccccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccc
Q 009208 383 GSVASRLRDHI------------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450 (540)
Q Consensus 383 gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 450 (540)
|+|.+++.+.. .....+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999987532 1123588999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
++....... .......+..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 214 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 986322111 1111224567999999988889999999999999999997 9999963
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=265.31 Aligned_cols=200 Identities=34% Similarity=0.503 Sum_probs=173.8
Q ss_pred CeeeeccCccEEEEEeCC----CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||+|.... +..||+|.++..........+.+|++.+..++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999754 8899999998765444466899999999999999999999999999999999999999
Q ss_pred CChhhhccccCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 383 GSVASRLRDHIHG-----RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 383 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
++|.+++...... ...+++..+..++.|+++|+.|||+. +++||||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999764221 36799999999999999999999998 999999999999999999999999999987654
Q ss_pred CCC-ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCcc
Q 009208 458 RDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFG 509 (540)
Q Consensus 458 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~~ 509 (540)
... .......++..|+|||.+....++.++||||+|+++|||++ |+.||+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 321 12233457889999999988889999999999999999999 69999743
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=270.02 Aligned_cols=204 Identities=28% Similarity=0.485 Sum_probs=171.6
Q ss_pred cCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
.+|...+.||+|+||.||++... ++..+|+|.++... ......+.+|++++..+.|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 46777899999999999999642 35689999877543 334557999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhccccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC
Q 009208 375 LVYPYMPNGSVASRLRDHIH-----------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 443 (540)
+|+||+++|+|.++++.... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999875321 113588999999999999999999998 9999999999999999999
Q ss_pred eEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 444 AVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 444 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+||+|||++......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999755432211 1122335788999999998899999999999999999998 9999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=265.07 Aligned_cols=193 Identities=29% Similarity=0.429 Sum_probs=163.5
Q ss_pred eeeeccCccEEEEEeC---CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCC
Q 009208 308 ILGRGGFGIVYKGCFS---DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG 383 (540)
Q Consensus 308 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 383 (540)
.||+|+||.||+|.++ ++..||+|+++.... .....++.+|+.+++.+.||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 578899999875432 223457899999999999999999999885 45678999999999
Q ss_pred ChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCcee
Q 009208 384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463 (540)
Q Consensus 384 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 463 (540)
+|.+++.. ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.+........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999864 24689999999999999999999999 999999999999999999999999999987654432211
Q ss_pred --eccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 464 --TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 464 --~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
....++..|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 201 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 12234578999999988889999999999999999998 9999974
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=245.01 Aligned_cols=227 Identities=22% Similarity=0.308 Sum_probs=184.9
Q ss_pred HHHHhcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhc-ccCCCccceeEEEecCCee
Q 009208 296 LRAATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 296 l~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~ 373 (540)
++...++......||+|++|.|-+-++ .+|...|+|+++..-..+..++...|+.+..+ ..+|.+|.++|.....+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 334445555667899999999988876 47999999999876656666778888888755 4799999999999999999
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++.||.|+ -||+.+-++.......+++...-+|+..+.+||.|||++. .++|||+||+|||++.+|++|+||||.+-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999995 5888887777777788999999999999999999999975 89999999999999999999999999998
Q ss_pred ccCCCCCceeecccccccccccccccc----CCCCccCCeehhhHHHHHHHhCCCCCCcccccccCCcHHHHHHHHhhcC
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVCSHILSN 529 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~w~~~~~~~~ 529 (540)
.+.++... +-..|...|||||.+.. ..|+.|+||||+|+.+.||.+++.||+.+..+ -+.+++++.+.
T Consensus 198 ~L~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp------F~qLkqvVeep 269 (282)
T KOG0984|consen 198 YLVDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP------FQQLKQVVEEP 269 (282)
T ss_pred eehhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH------HHHHHHHhcCC
Confidence 76543221 22348889999999853 36899999999999999999999999854322 13445555555
Q ss_pred Ccch
Q 009208 530 QSSL 533 (540)
Q Consensus 530 ~~~~ 533 (540)
.+-+
T Consensus 270 ~P~L 273 (282)
T KOG0984|consen 270 SPQL 273 (282)
T ss_pred CCCC
Confidence 5543
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=278.45 Aligned_cols=206 Identities=26% Similarity=0.376 Sum_probs=169.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEe------CCCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecC-C
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE-N 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~ 371 (540)
.++|.+.+.||+|+||.||+|.+ .+++.||||.++..........+.+|++++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45788899999999999999974 357889999997654344445788999999999 689999999988654 4
Q ss_pred eeEEEEecCCCCChhhhccccCC---------------------------------------------------------
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIH--------------------------------------------------------- 394 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 394 (540)
..++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999999864210
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc-eeeccc
Q 009208 395 ------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVR 467 (540)
Q Consensus 395 ------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~ 467 (540)
....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 012478889999999999999999999 9999999999999999999999999999765322211 112233
Q ss_pred cccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 468 gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
++..|+|||.+....++.++||||||+++|||++ |..||..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 284 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 5678999999988889999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=271.77 Aligned_cols=205 Identities=27% Similarity=0.441 Sum_probs=173.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 373 (540)
.++|...+.||+|+||.||+|... ++..||+|.++.........++.+|+.+++++.||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888899999999999999863 46789999987654444456799999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhccccC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 009208 374 LLVYPYMPNGSVASRLRDHI------------------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAAN 435 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~N 435 (540)
++|+||+++|+|.+++.... .....+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999997421 1123578999999999999999999999 99999999999
Q ss_pred eeeCCCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCC
Q 009208 436 ILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALD 507 (540)
Q Consensus 436 ILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~ 507 (540)
|++++++.++|+|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999998755432211 1122235678999999988899999999999999999998 888885
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=274.66 Aligned_cols=201 Identities=24% Similarity=0.326 Sum_probs=171.1
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|+..+.||+|+||.||++... .++.||+|.+..... ......+.+|++++..++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999975 578999999876432 222346889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++++|.+++... ..+++..+..++.+++.|++|||+. +++||||||+||++++++.++++|||+++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 999999999998652 4689999999999999999999998 999999999999999999999999999864211
Q ss_pred CC--------------CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RD--------------SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. ........++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~ 218 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 00 0011123478899999999888899999999999999999999999973
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=278.47 Aligned_cols=193 Identities=24% Similarity=0.329 Sum_probs=165.9
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
....+|.+.+.||+|+||.||+|... +++.||+|..... ....|+.++.+++|+||+++++++...+..++|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 34567999999999999999999975 4688999975432 235689999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
+||+. ++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 136 ~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 136 LPHYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 99995 6888888642 35689999999999999999999999 99999999999999999999999999997533
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCC
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRAL 506 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~ 506 (540)
... ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 221 223456899999999999999999999999999999999976555
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=268.85 Aligned_cols=198 Identities=25% Similarity=0.353 Sum_probs=170.5
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
++|.+.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++..++||||+++++++...+..++|+||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 45677788999999999999864 58899999987543 22234578899999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++.. ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 999999998864 34689999999999999999999999 99999999999999999999999999987654322
Q ss_pred Cceeeccccccccccccccc---cCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 460 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
. ......|+..|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 161 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred c-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 2 223345899999999874 4557899999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=274.86 Aligned_cols=196 Identities=24% Similarity=0.331 Sum_probs=159.9
Q ss_pred CeeeeccCccEEEEEeC---CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEec--CCeeEEEEecCC
Q 009208 307 NILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST--ENERLLVYPYMP 381 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~e~~~ 381 (540)
..||+|+||.||+|... ++..||+|.++... ....+.+|++++++++||||+++++++.. +...++|+||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 57999999999999975 35789999987543 23467899999999999999999998853 556789999986
Q ss_pred CCChhhhccccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----CCCCCeEEcccccc
Q 009208 382 NGSVASRLRDHI-----HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL----DEDFEAVVGDFGLA 452 (540)
Q Consensus 382 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~Dfgla 452 (540)
+ +|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+||++ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4 7777764321 1223588999999999999999999999 99999999999999 56679999999999
Q ss_pred cccCCCCCc--eeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 453 KLLDHRDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 453 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876543221 1233458999999999876 45799999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=277.99 Aligned_cols=197 Identities=25% Similarity=0.333 Sum_probs=167.0
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecC------
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTE------ 370 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 370 (540)
..++|...+.||+|+||.||+|... +++.||||++...... .....+.+|++++.+++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999864 6789999998753221 2234678899999999999999999887532
Q ss_pred CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccc
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 450 (540)
...+++++++ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 4568999988 7888877653 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99865432 223458999999999876 5689999999999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=265.51 Aligned_cols=204 Identities=29% Similarity=0.438 Sum_probs=177.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
++|++.+.||.|+||.||+|... ++..+|+|++...........+.+|++.++.++|+|++++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999964 67899999987654444556789999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.++++.... ...+++.....++.|++.|+.|||+. +++||||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999975322 24689999999999999999999999 99999999999999999999999999988665433
Q ss_pred Cc---eeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SH---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. ......|+..|+|||++... .++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 209 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK 209 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccc
Confidence 22 12334588999999998777 789999999999999999999999974
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=271.30 Aligned_cols=198 Identities=27% Similarity=0.378 Sum_probs=168.7
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCC
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP 381 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 381 (540)
|++.+.||+|+||.||+|... ++..+++|.+.... ......+.+|++++..++|||++++++++..++..++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 556788999999999999976 47788999886433 2334568899999999999999999999999999999999999
Q ss_pred CCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc
Q 009208 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461 (540)
Q Consensus 382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 461 (540)
+++|..++.+. ...+++..+..++.|+++||.|||+. +++||||||+||+++.++.+||+|||++....... .
T Consensus 86 ~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~ 158 (282)
T cd06643 86 GGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 158 (282)
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence 99998887642 34689999999999999999999999 99999999999999999999999999987543322 1
Q ss_pred eeeccccccccccccccc-----cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 462 VTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 462 ~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
......+++.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 210 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence 223345899999999984 34577899999999999999999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=267.68 Aligned_cols=189 Identities=25% Similarity=0.390 Sum_probs=160.7
Q ss_pred CeeeeccCccEEEEEeCCCc-----------EEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 307 NILGRGGFGIVYKGCFSDGA-----------LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
+.||+|+||.||+|...+.. .|++|.++..... ...|.+|+.+++.++||||+++++++.. +..++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 46899999999999986433 5788877654322 5678999999999999999999999988 78899
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-------CeEEcc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-------EAVVGD 448 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-------~~kl~D 448 (540)
|+||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+|++|
T Consensus 78 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 78 VEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 99999999999999753 22688999999999999999999998 999999999999999887 799999
Q ss_pred cccccccCCCCCceeeccccccccccccccccC--CCCccCCeehhhHHHHHHHh-CCCCCCcc
Q 009208 449 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELIT-GQRALDFG 509 (540)
Q Consensus 449 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvil~ellt-g~~p~~~~ 509 (540)
||++..... .....++..|+|||++... .++.++||||||+++|||++ |..||...
T Consensus 152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 999986543 1223467889999998776 78999999999999999999 57777643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=268.51 Aligned_cols=200 Identities=25% Similarity=0.334 Sum_probs=171.5
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
++|+..+.||+|++|.||+|..+ +|+.||+|++..... ....+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788899999999999999986 589999999865432 2234568899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++++|..++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999988877643 24589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~ 203 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 22 1223347889999999865 4578999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=268.57 Aligned_cols=200 Identities=31% Similarity=0.491 Sum_probs=167.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-----CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEec--CCee
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST--ENER 373 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 373 (540)
..|.+.+.||+|+||.||++..+ ++..||+|+++... ......+.+|++++.+++||||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46778899999999999999753 57899999987543 3334578999999999999999999998754 3467
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++|+||+++|+|.+++.+. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 8999999999999998643 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcee--eccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 454 LLDHRDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 454 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
.......... ....++..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 7654322211 11223456999999988889999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=274.51 Aligned_cols=194 Identities=25% Similarity=0.371 Sum_probs=168.3
Q ss_pred cCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCC
Q 009208 305 AKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG 383 (540)
Q Consensus 305 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 383 (540)
....||+|+||.||++... ++..||+|.+.... ......+.+|+..+..++|+||+++++.+...+..++||||++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 3467999999999999874 58899999986533 233456889999999999999999999999999999999999999
Q ss_pred ChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCcee
Q 009208 384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463 (540)
Q Consensus 384 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~ 463 (540)
+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++........ ..
T Consensus 105 ~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 175 (292)
T cd06658 105 ALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KR 175 (292)
T ss_pred cHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cC
Confidence 99998753 3588999999999999999999999 999999999999999999999999999875543222 12
Q ss_pred eccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 464 ~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
....|+..|+|||...+..++.++||||||+++|||++|+.||..
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 220 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 234588999999999888899999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=264.23 Aligned_cols=194 Identities=31% Similarity=0.504 Sum_probs=165.4
Q ss_pred CeeeeccCccEEEEEeCC----CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||+|.+.. +..+|+|.++.........++.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998632 26899999986654445567999999999999999999999876 4567999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|.+++... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999753 3689999999999999999999999 99999999999999999999999999998665433222
Q ss_pred ee--ccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 463 TT--AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 463 ~~--~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.. ...++..|+|||.+.+..++.++||||||+++|||++ |+.||+.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~ 201 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc
Confidence 11 1223568999999998899999999999999999998 9999974
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=276.22 Aligned_cols=205 Identities=32% Similarity=0.438 Sum_probs=171.6
Q ss_pred cCCCcCCeeeeccCccEEEEEeC--------CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCC
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS--------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTEN 371 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 371 (540)
.+|.+.+.||+|+||.||+|... .+..||+|.++.........++.+|++++.++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888899999999999999752 12469999887654344456789999999999 7999999999999999
Q ss_pred eeEEEEecCCCCChhhhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD 439 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~ 439 (540)
..++++||+++|+|.+++..... ....++|..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 99999999999999999875321 234588999999999999999999998 999999999999999
Q ss_pred CCCCeEEcccccccccCCCCCce-eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 440 EDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 440 ~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+++.+||+|||+++......... .....++..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999998654322111 122234568999999999899999999999999999998 8888863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=269.82 Aligned_cols=200 Identities=28% Similarity=0.396 Sum_probs=170.3
Q ss_pred CCCcCCeeeeccCccEEEEEe----CCCcEEEEEEeccCCc---cccHHHHHHHHHHHhcc-cCCCccceeEEEecCCee
Q 009208 302 NFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNI---AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENER 373 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 373 (540)
+|++.+.||+|+||.||++.. .+|+.||+|.++.... ......+.+|++++.++ .|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999986 3689999999875322 22235678899999999 589999999999988999
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++|+||+++++|.+++.. ...+++..+..++.|+++||.|||+. +++||||+|+||++++++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999865 24588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccccccccccccC--CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..............|+..|+|||.+... .++.++||||||+++|+|++|+.||+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 6654332223345588999999998653 467899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=266.65 Aligned_cols=199 Identities=28% Similarity=0.390 Sum_probs=175.6
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
+|+..+.||+|++|.||++..+ +++.||+|.+..........++.+|++++++++||||+++++.+..++..++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999986 589999999877654455667999999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
++++|.+++... ...+++.....++.|+++|+.|||+ . +++||||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999998753 2578899999999999999999999 7 99999999999999999999999999987654322
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 21 155889999999998889999999999999999999999999743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=263.56 Aligned_cols=197 Identities=35% Similarity=0.519 Sum_probs=172.6
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.++|++.+.||+|+||.||+|.. .|+.||+|.++.... ...++.+|+.++.+++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 35678889999999999999987 588999999976542 456799999999999999999999999989999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999987532 23689999999999999999999999 99999999999999999999999999998653221
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
. ....+..|+|||++....++.++||||||+++||+++ |+.||..
T Consensus 157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 202 (256)
T cd05039 157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 1 2235678999999988889999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=267.78 Aligned_cols=204 Identities=26% Similarity=0.401 Sum_probs=172.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
++|++.+.||+|+||.||+|..+ +.+.|++|.+..........++.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56788899999999999999864 346799998865433323457999999999999999999999999989999
Q ss_pred EEEecCCCCChhhhccccCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHG-----RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF 449 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 449 (540)
+||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999754321 12689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCC
Q 009208 450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALD 507 (540)
Q Consensus 450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~ 507 (540)
|++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~ 220 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY 220 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 9987543322222233346788999999988888999999999999999999 888885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=267.73 Aligned_cols=199 Identities=28% Similarity=0.395 Sum_probs=173.6
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
..|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+++++++.|+||+++++++...+..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34667788999999999999975 58899999987554344456789999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++|+|.+++.. ..+++.....++.+++.|++|||+. +++|+||+|+||++++++.++++|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998863 3578899999999999999999998 99999999999999999999999999997654332
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ......++..|+|||++.+...+.++|||||||++|||+||+.||..
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1 22334578899999999888899999999999999999999999963
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=263.47 Aligned_cols=195 Identities=32% Similarity=0.480 Sum_probs=167.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEe-cCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS-TENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lV~e~ 379 (540)
++|.+.+.||+|+||.||++.. .|..||+|.++... ....+.+|+.++++++|+|++++++++. ..+..++|+||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 4678889999999999999987 57889999986532 3457899999999999999999999764 55678999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++++. ....+++..+..++.+++.||+|||+. +++||||||+||++++++.+|++|||+++......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999998753 234588999999999999999999998 99999999999999999999999999987543322
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
....++..|+|||++....++.++||||||+++|||++ |+.||..
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 22335678999999988889999999999999999998 9999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=264.03 Aligned_cols=207 Identities=27% Similarity=0.390 Sum_probs=174.7
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEec--CCeeEEEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCST--ENERLLVY 377 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~ 377 (540)
+|++.+.||.|+||.||++... +++.||+|.++.... .....++.+|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777899999999999999864 678999999875433 2334568899999999999999999998754 45678999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC--DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||+++++|.+++.........+++..+..++.++++|+.|||..+ ..+++|+||+|+||++++++.+|++|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999765444567999999999999999999999221 229999999999999999999999999999876
Q ss_pred CCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
...... .....+++.|+|||.+....++.++||||||+++++|++|+.||+..
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 213 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence 543321 23345899999999999888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=264.24 Aligned_cols=199 Identities=29% Similarity=0.493 Sum_probs=171.0
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcccc--------HHHHHHHHHHHhcccCCCccceeEEEecCCee
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG--------EVQFQTEVETISLAVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 373 (540)
|.+...||+|++|.||+|... +++.||+|.+........ ...+.+|+.++.+++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 667789999999999999874 578999998865432211 13578999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++|+||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999998653 4688999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCc-----eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 454 LLDHRDSH-----VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 454 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
........ ......|+..|+|||.+.+..++.++||||+|+++|||++|+.||+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 66532111 11224578999999999988899999999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=262.53 Aligned_cols=201 Identities=28% Similarity=0.413 Sum_probs=177.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
++|++.+.||+|++|.||+|... +++.|++|++..........++.+|++.+.+++|+|++++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999986 48999999987655434456899999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
+++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999998753 568999999999999999999999 8 9999999999999999999999999999876543
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
... .....++..|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 322 22345789999999999888999999999999999999999999744
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=272.48 Aligned_cols=203 Identities=29% Similarity=0.354 Sum_probs=174.4
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc--cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|+..+.||+|++|.||+|... +++.||+|.+....... ....+.+|++++..++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999976 48999999997654332 3456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++++|.+++... ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998642 235689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCc----------------------------eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSH----------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... ......||..|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 2110 01123578899999999988899999999999999999999999974
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-32 Score=263.53 Aligned_cols=200 Identities=28% Similarity=0.415 Sum_probs=169.4
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc----ccHHHHHHHHHHHhcccCCCccceeEEEec--CCee
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA----GGEVQFQTEVETISLAVHRNLLRLCGFCST--ENER 373 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 373 (540)
.+|+..+.||+|+||.||+|... .+..||+|+++..... .....+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888899999999999999874 5899999998643221 122358899999999999999999998865 3567
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++++||+++++|.+++.. ...+++.....++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999864 23588999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCC--ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 454 LLDHRDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 454 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
.+..... .......++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~ 210 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA 210 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcc
Confidence 6543211 11123458899999999998889999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=262.07 Aligned_cols=196 Identities=29% Similarity=0.464 Sum_probs=169.2
Q ss_pred CeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCChh
Q 009208 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVA 386 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~ 386 (540)
+.||+|+||.||++...+++.||+|.++..........+.+|++++++++|+||+++++++...+..++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46899999999999987799999999876554445567999999999999999999999999999999999999999999
Q ss_pred hhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCcee-ec
Q 009208 387 SRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT-TA 465 (540)
Q Consensus 387 ~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~-~~ 465 (540)
+++.+. ...+++.....++.+++.|+.|||++ +++||||+|+||+++.++.++|+|||++........... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 998653 23578999999999999999999999 999999999999999999999999999986542221111 11
Q ss_pred cccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 466 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
..++..|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 224667999999988889999999999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=264.55 Aligned_cols=190 Identities=23% Similarity=0.342 Sum_probs=159.4
Q ss_pred CeeeeccCccEEEEEeCC-------------CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCee
Q 009208 307 NILGRGGFGIVYKGCFSD-------------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 373 (540)
+.||+|+||.||+|++.. ...||+|.+.... ......|.+|+.++..++||||+++++++..+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 368999999999998532 2358899876543 23345788999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC-------eEE
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE-------AVV 446 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~-------~kl 446 (540)
++||||+++|+|..+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++. +++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999999888642 34689999999999999999999999 9999999999999987664 899
Q ss_pred cccccccccCCCCCceeeccccccccccccccc-cCCCCccCCeehhhHHHHHHH-hCCCCCCc
Q 009208 447 GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELI-TGQRALDF 508 (540)
Q Consensus 447 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~Dv~S~Gvil~ell-tg~~p~~~ 508 (540)
+|||++...... ....++..|+|||.+. ...++.++|||||||++|||+ +|+.||..
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999998754322 2234788999999886 466899999999999999998 58888864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=263.58 Aligned_cols=201 Identities=29% Similarity=0.362 Sum_probs=174.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|...+.||+|+||.||+|... +++.+++|.+..... .....+.+|++++++++||||+++++++...+..+++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 357888899999999999999875 578899999876542 245678999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++++|.+++... ...+++..+..++.|++.|+.|||+. +|+||||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 81 YCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 99999999988652 24688999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCceeeccccccccccccccccC---CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. ......++..|+|||.+... .++.++||||||+++|||+||+.||..
T Consensus 155 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~ 206 (262)
T cd06613 155 IA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206 (262)
T ss_pred hh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 21 22334578899999998776 789999999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=271.08 Aligned_cols=199 Identities=23% Similarity=0.380 Sum_probs=173.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.+|...+.||+|+||.||++... ++..||+|.+.... ......+.+|+.+++.++|||++++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 57888899999999999999864 67899999986433 23345688999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++.+ ..+++..+..++.+++.|+.|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999999864 2478999999999999999999999 99999999999999999999999999987654332
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
. ......+++.|+|||.+....++.++||||||+++||+++|+.||...
T Consensus 170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2 222345888999999998888999999999999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=265.48 Aligned_cols=201 Identities=28% Similarity=0.413 Sum_probs=172.0
Q ss_pred CCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCcc-----ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIA-----GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
+|+..+.||+|++|.||+|.. .+++.||+|.++..... .....+.+|++++++++|+||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999986 46899999998753311 123468999999999999999999999999999999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEcccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKL 454 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~ 454 (540)
|+||+++++|.+++.+ ..++++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999865 24688999999999999999999999 999999999999998775 599999999876
Q ss_pred cCCCCC---ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 455 LDHRDS---HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 455 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+..... .......++..|+|||.+.+..++.++||||+|+++++|++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 653311 1122345789999999998888999999999999999999999999743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=262.08 Aligned_cols=198 Identities=27% Similarity=0.428 Sum_probs=172.2
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc----cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI----AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
+|+..+.||+|++|.||+|... +++.|++|.+..... ......+.+|+++++.++|+||+++++++...+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999986 789999999865332 12335689999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
+||+++++|.+++.+. ..+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999998752 4588999999999999999999999 99999999999999999999999999988654
Q ss_pred CCCCceeeccccccccccccccccCC-CCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||..
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~ 204 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ 204 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 332 223345889999999987766 89999999999999999999999963
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=268.19 Aligned_cols=199 Identities=34% Similarity=0.518 Sum_probs=167.8
Q ss_pred CeeeeccCccEEEEEeCC-------CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 307 NILGRGGFGIVYKGCFSD-------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+.||+|+||.||+|...+ ++.+|+|.+..........++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998643 2579999887654344556799999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-----CeEEccccc
Q 009208 380 MPNGSVASRLRDHIH---GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-----EAVVGDFGL 451 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-----~~kl~Dfgl 451 (540)
+++|+|.+++.+... ....+++..+..++.|++.|++|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975322 224588999999999999999999998 999999999999999877 899999999
Q ss_pred ccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 452 AKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 452 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
++........ ......++..|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~ 216 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc
Confidence 9765432211 1122335788999999999999999999999999999998 9999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-33 Score=258.90 Aligned_cols=201 Identities=27% Similarity=0.355 Sum_probs=177.4
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccH--HHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGE--VQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|...+++|+|.||.|..++-+ .|+.+|+|++++...-... ..-..|-+++...+||.+..+--.++.++..++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 56777899999999999998865 6899999999886543322 23567999999999999999988899999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||..||.|.-+|.+ ...+++...+.+-..|+.||.|||++ +||.||+|.+|.|+|++|.+||+|||+++.- -
T Consensus 248 eyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I 319 (516)
T KOG0690|consen 248 EYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE-I 319 (516)
T ss_pred EEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc-c
Confidence 99999999888865 45689999999999999999999999 9999999999999999999999999999842 2
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.....+...+|||.|+|||++....|+..+|.|.+||++|||++|+.||...
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 2344567889999999999999999999999999999999999999999843
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-33 Score=252.67 Aligned_cols=196 Identities=26% Similarity=0.404 Sum_probs=167.5
Q ss_pred cCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEecCCeeEEEEecCCC
Q 009208 305 AKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 305 ~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
....+|.|..|.|+++.++ .|...|||.+.......+.+++...+.++..-. .|.||+.+|||..+...++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 3466999999999999986 589999999998776666677888888877664 8999999999999999999999984
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
..+...++.. ..++++...-++...+++||.||.++| +|+|||+||+|||+|+.|++|+||||++-++-++..+
T Consensus 175 ~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh- 248 (391)
T KOG0983|consen 175 TCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH- 248 (391)
T ss_pred HHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence 3555555542 456899999999999999999999886 9999999999999999999999999999877654433
Q ss_pred eecccccccccccccccc---CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 463 TTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
...+|.+.|||||.+.. ..|+.++||||||+.++||.||+.||..
T Consensus 249 -trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 249 -TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred -ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 34469999999999864 4689999999999999999999999974
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=270.29 Aligned_cols=199 Identities=23% Similarity=0.338 Sum_probs=167.8
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+|+..+.||+|+||.||+|... +|+.||+|+++..... .....+.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3677889999999999999975 6899999998754322 2234678899999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
++ ++|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 5788777542 34689999999999999999999999 99999999999999999999999999998654322
Q ss_pred CceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ......+++.|+|||++.+. .++.++|||||||++|||+||+.|+..
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 2 12234578999999998764 468999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=267.34 Aligned_cols=202 Identities=25% Similarity=0.300 Sum_probs=174.3
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEec--CCeeEEEEe
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST--ENERLLVYP 378 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV~e 378 (540)
+|...+.||.|++|.||++... +++.+|+|.+..........++.+|++++++++||||+++++++.. .+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5777889999999999999985 5889999998765444455679999999999999999999998864 346899999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++++|.+++.........+++.....++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999998765444455688999999999999999999999 9999999999999999999999999998755432
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. ....++..|+|||.+.+..++.++||||+|+++|||++|+.||+..
T Consensus 159 ~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 159 LA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 21 2344788999999999889999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=263.30 Aligned_cols=200 Identities=28% Similarity=0.407 Sum_probs=169.6
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC----ccccHHHHHHHHHHHhcccCCCccceeEEEecC--Cee
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN----IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NER 373 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 373 (540)
.+|.+.+.||+|+||.||+|... ++..||+|.+.... .......+.+|++++++++|+||+++++++... +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999874 58999999875321 122234688999999999999999999998654 457
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++|+||+++++|.+++.. ...+++.....++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999998864 23578999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC--CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 454 LLDHRD--SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 454 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
...... ........++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 210 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 654311 111123458899999999988889999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=273.37 Aligned_cols=199 Identities=22% Similarity=0.289 Sum_probs=164.7
Q ss_pred cCCeeeec--cCccEEEEEeC-CCcEEEEEEeccCCccc-cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 305 AKNILGRG--GFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 305 ~~~~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
+.++||+| +|++||++..+ +|+.||+|+++...... ....+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 67899999874 68999999987643322 2345778999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++|+|.+++..+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999986532 23589999999999999999999999 999999999999999999999999986543321111
Q ss_pred c------eeecccccccccccccccc--CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 461 H------VTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 461 ~------~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0 0112246788999999876 4588999999999999999999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=264.75 Aligned_cols=202 Identities=27% Similarity=0.375 Sum_probs=172.0
Q ss_pred CCCcCCeeeeccCccEEEEEeCC--CcEEEEEEeccCCc---------cccHHHHHHHHHHHhc-ccCCCccceeEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFSD--GALVAVKRLKDYNI---------AGGEVQFQTEVETISL-AVHRNLLRLCGFCST 369 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~ 369 (540)
+|++.+.||+|+||.||+|.... ++.+|+|.+..... .....++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999865 68899998864321 1122357788888864 799999999999999
Q ss_pred CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeeCCCCCeEEcc
Q 009208 370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDFEAVVGD 448 (540)
Q Consensus 370 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~D 448 (540)
.+..++||||+++++|.+++.........+++..++.++.|++.|+.|||+ . +++||||+|+||++++++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886543445678999999999999999999996 5 899999999999999999999999
Q ss_pred cccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 449 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 449 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
||.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence 99998655432 23344588999999999988899999999999999999999999964
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=262.28 Aligned_cols=200 Identities=29% Similarity=0.475 Sum_probs=173.8
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+++++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999865 6899999998765432 2455789999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++.. ...+++..+..++.++++|+.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999998864 23578899999999999999999999 99999999999999999999999999998765433
Q ss_pred Cceee---ccccccccccccccccCC---CCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTT---AVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~---~~~gt~~y~aPE~~~~~~---~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..... ...++..|+|||++.... .+.++||||||+++||+++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~ 208 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence 22211 345788999999998766 88999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=261.91 Aligned_cols=201 Identities=24% Similarity=0.362 Sum_probs=172.1
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEec-CCeeEEEEe
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCST-ENERLLVYP 378 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~e 378 (540)
+|++.+.||+|++|.||++..+ +++.||+|++..... ......+.+|++++++++|+|++++.+.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999875 578999999875432 2334568899999999999999999988764 446789999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++++|.+++.... ...+++..+..++.+++.|++|||+. +++||||||+||++++++.++|+|||++..+...
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999997532 34589999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. ......+++.|+|||++.+..++.++||||||++++||++|+.||+.
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 204 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 22 22334588999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=273.35 Aligned_cols=193 Identities=23% Similarity=0.347 Sum_probs=168.3
Q ss_pred CCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCC
Q 009208 306 KNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS 384 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 384 (540)
...||+|+||.||+|... +++.||+|.+.... ......+.+|+.++..+.||||+++++++...+..++|+||+++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 356999999999999875 68999999986543 2334568899999999999999999999999999999999999999
Q ss_pred hhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCceee
Q 009208 385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464 (540)
Q Consensus 385 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 464 (540)
|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++........ ...
T Consensus 105 L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 105 LTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred HHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 9987753 3588999999999999999999999 999999999999999999999999999875543221 123
Q ss_pred ccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 465 ~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
...|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 219 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 34589999999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=270.78 Aligned_cols=201 Identities=28% Similarity=0.522 Sum_probs=168.4
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCc----EEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
++|...+.||+|+||.||+|.+. +|+ .||+|.+..........++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677889999999999999864 343 57899887654444445789999999999999999999998754 4679
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
++||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 99999999999998653 33588999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 456 DHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 456 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 432221 1122335778999999988899999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=264.33 Aligned_cols=200 Identities=27% Similarity=0.336 Sum_probs=175.8
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
+|++.+.||.|+||.||+|... +++.||+|.+...... .....+.+|++++++++||||+++++.+......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999986 5899999998754322 234578999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++++|.+++... .++++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998653 4788999999999999999999998 9999999999999999999999999998865433
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||+..+
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 2 2233458899999999988889999999999999999999999998544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=269.53 Aligned_cols=200 Identities=25% Similarity=0.374 Sum_probs=171.1
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
++|+..+.||+|+||.||+|..+ +++.||+|++...... .....+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999986 5899999998654322 234568899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|++++++..+... ...+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999998876653 23589999999999999999999999 9999999999999999999999999998865443
Q ss_pred CCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. .......++..|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 2 22233457899999999865 4478899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=266.64 Aligned_cols=200 Identities=27% Similarity=0.395 Sum_probs=172.7
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+|.+.+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999975 689999999876543 23345789999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+ +++|.+++... ...+++..+..++.|+++||.|||+. +++|+||||+||++++++.++++|||.+.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998653 25689999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
........++..|+|||.+.+. .++.++||||+|++++||++|+.||..
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 2223344589999999998654 468999999999999999999888763
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=264.63 Aligned_cols=197 Identities=29% Similarity=0.417 Sum_probs=172.4
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
-|+..+.||+|+||.||+|... +++.||+|.+...........+.+|++.+.+++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667789999999999999864 688999999865443444557899999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++++|.+++.. ..+++..+..++.+++.|+.|||+. +++|+||+|+||++++++.++++|||++..+.....
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999998863 3588999999999999999999998 999999999999999999999999999876543221
Q ss_pred ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
......++..|+|||.+.....+.++|||||||++|||++|+.||.
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 202 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHS 202 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 1223457889999999988888999999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=264.81 Aligned_cols=198 Identities=28% Similarity=0.426 Sum_probs=172.2
Q ss_pred CCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhccc---CCCccceeEEEecCCeeEEEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV---HRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lV~ 377 (540)
.|+..+.||+|+||.||+|.. .+++.||+|.++.........++.+|++++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778999999999999997 4689999999876544445567889999999886 999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++++|.++++. ..+++.....++.+++.|+.|||+. +|+||||+|+||++++++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998864 2688999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... .....|+..|+|||.+... .++.++|||||||++|+|++|+.||..
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 204 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC
Confidence 3322 2334588999999988654 468999999999999999999999974
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=260.66 Aligned_cols=201 Identities=33% Similarity=0.513 Sum_probs=172.7
Q ss_pred CCcCCeeeeccCccEEEEEeCC-----CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 303 FSAKNILGRGGFGIVYKGCFSD-----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
|++.+.||+|+||.||++...+ +..||+|.++..........+.+|++.+..++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3566889999999999999754 48899999976654435668999999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999987532 11289999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
..........+++.|+|||.+.+..++.++||||+|++++||++ |+.||+.
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 42222222337789999999988889999999999999999998 8888863
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=268.16 Aligned_cols=204 Identities=31% Similarity=0.430 Sum_probs=173.0
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCC-----
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTEN----- 371 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~----- 371 (540)
++++|++.+.||+|++|.||+|..+ +++.+++|.+.... ....++.+|+.++.++ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4678999999999999999999985 57899999987543 2345789999999998 6999999999997644
Q ss_pred -eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccc
Q 009208 372 -ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450 (540)
Q Consensus 372 -~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 450 (540)
..++||||+++++|.+++.........+++..+..++.|+++||.|||+. +++||||+|+||++++++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 48999999999999998876443346789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccccccccc-----CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
++........ ......|+..|+|||++.. ..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 9876543222 2223458899999998753 3467899999999999999999999963
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=262.50 Aligned_cols=195 Identities=33% Similarity=0.500 Sum_probs=159.9
Q ss_pred CeeeeccCccEEEEEeC----CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEe-cCCeeEEEEecCC
Q 009208 307 NILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS-TENERLLVYPYMP 381 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lV~e~~~ 381 (540)
+.||+|+||.||+|.+. ++..||+|.+...........+.+|+.+++.++||||+++++++. .++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999863 245799999865433333457889999999999999999999875 4556889999999
Q ss_pred CCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc
Q 009208 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461 (540)
Q Consensus 382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 461 (540)
+|+|.+++.+. .....+..+..++.|+++|+.|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998753 23467788899999999999999998 9999999999999999999999999999755432111
Q ss_pred e---eeccccccccccccccccCCCCccCCeehhhHHHHHHHhC-CCCCC
Q 009208 462 V---TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG-QRALD 507 (540)
Q Consensus 462 ~---~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg-~~p~~ 507 (540)
. .....++..|+|||++....++.++||||||+++|||++| ..||.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 1 1123357789999999888899999999999999999995 55564
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=266.14 Aligned_cols=191 Identities=28% Similarity=0.382 Sum_probs=159.0
Q ss_pred eeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHh---cccCCCccceeEEEecCCeeEEEEecCC
Q 009208 308 ILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETIS---LAVHRNLLRLCGFCSTENERLLVYPYMP 381 (540)
Q Consensus 308 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~---~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 381 (540)
.||+|+||.||++... +++.||+|.+...... .....+.+|..++. ..+||||+.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 5899999998754322 22233445554443 3479999999999999999999999999
Q ss_pred CCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc
Q 009208 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461 (540)
Q Consensus 382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 461 (540)
+|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|||++........
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 9999998864 24689999999999999999999999 999999999999999999999999999875543221
Q ss_pred eeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 462 VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 462 ~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 198 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence 22358999999999864 5578999999999999999999999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=260.36 Aligned_cols=202 Identities=22% Similarity=0.351 Sum_probs=174.1
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+|+..+.||+|+||.||++... +|+.||+|.+..... .....++.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999875 688999999875432 23345789999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++... ....+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988642 123578999999999999999999998 99999999999999999999999999998654322
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
. ......|++.|+|||+..+...+.++|||||||++++|++|+.||...
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 2 122345888999999998888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=265.43 Aligned_cols=189 Identities=25% Similarity=0.332 Sum_probs=157.0
Q ss_pred eeeeccCccEEEEEeCC-------------------------CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccc
Q 009208 308 ILGRGGFGIVYKGCFSD-------------------------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362 (540)
Q Consensus 308 ~lG~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 362 (540)
.||+|+||.||+|.+.. ...||+|.+.... .....+|.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 58999999999997521 1358899886533 223346888999999999999999
Q ss_pred eeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 009208 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442 (540)
Q Consensus 363 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~ 442 (540)
+++++...+..++||||+++|+|..++... ...+++..+..++.|+++||+|||++ +|+||||||+||++++++
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 999999999999999999999999988642 34688999999999999999999999 999999999999998644
Q ss_pred -------CeEEcccccccccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHH-HhCCCCCCc
Q 009208 443 -------EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLEL-ITGQRALDF 508 (540)
Q Consensus 443 -------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~el-ltg~~p~~~ 508 (540)
.++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||+ ++|+.||..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 3799999988643221 12247888999998865 5689999999999999998 479999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=289.52 Aligned_cols=204 Identities=22% Similarity=0.332 Sum_probs=160.8
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCC--CcEEEEEEec--------------c--CCccccHHHHHHHHHHHhcccCCCc
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSD--GALVAVKRLK--------------D--YNIAGGEVQFQTEVETISLAVHRNL 360 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~--------------~--~~~~~~~~~~~~E~~~l~~l~h~nI 360 (540)
..++|.+.+.||+|+||+||++..+. +..+++|.+. + .........+.+|++++.+++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987542 2222222110 0 0011223468899999999999999
Q ss_pred cceeEEEecCCeeEEEEecCCCCChhhhcccc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC
Q 009208 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDH-IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD 439 (540)
Q Consensus 361 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~ 439 (540)
+++++++...+..++|++++. +++.+++... ..............++.|++.||+|||+. +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999985 5677766432 11122334566778999999999999999 999999999999999
Q ss_pred CCCCeEEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCC
Q 009208 440 EDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRAL 506 (540)
Q Consensus 440 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~ 506 (540)
.++.+||+|||+++.+............||+.|+|||++.+..++.++|||||||++|||++|+.++
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999876544333334456999999999999999999999999999999999998544
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=267.41 Aligned_cols=201 Identities=26% Similarity=0.401 Sum_probs=176.2
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
.++.|+..+.+|+|++|.||+|..+ ++..|++|.+..... ....+.+|++.+..++|+|++++++++...+..++|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566778889999999999999986 689999999876432 4557899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++++|.+++.... ..+++..+..++.++++||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999997632 3799999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~ 218 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR 218 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 221 12233478899999999888899999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-34 Score=259.03 Aligned_cols=217 Identities=27% Similarity=0.376 Sum_probs=176.1
Q ss_pred CCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhc-ccCCCccceeEEEecCCeeEEEEecCCCC
Q 009208 306 KNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRNLLRLCGFCSTENERLLVYPYMPNG 383 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 383 (540)
...||.|+||+|+|-..+ .|+..|||+++......+++++..|.+...+ -+.||||+++|.+..++..++.||.|. -
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 467999999999999875 6999999999988776777789988887654 468999999999999999999999995 4
Q ss_pred Chhhhccc-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 384 SVASRLRD-HIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 384 sL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|++.+-.. +...+..+++...-+|..-.++||.||.+.. .|||||+||+|||++..|.+|+||||++-.+..+- .
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--A 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--A 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH--H
Confidence 65543221 1122446888889999999999999999875 89999999999999999999999999987554322 2
Q ss_pred eeccccccccccccccccC--CCCccCCeehhhHHHHHHHhCCCCCCcccccccCCcHHHHHHHHhhcCCcch
Q 009208 463 TTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVCSHILSNQSSL 533 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~w~~~~~~~~~~~~ 533 (540)
.+.-+|...|||||.+... .|+.+|||||+|+.|+|+.||+.|++..+ ...+.+.+++..+.+.+
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~------svfeql~~Vv~gdpp~l 290 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD------SVFEQLCQVVIGDPPIL 290 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH------HHHHHHHHHHcCCCCee
Confidence 2344588999999999653 48899999999999999999999998433 13467777777776643
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-33 Score=270.53 Aligned_cols=195 Identities=25% Similarity=0.384 Sum_probs=170.4
Q ss_pred CCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcccc-HHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCC
Q 009208 306 KNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNG 383 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~g 383 (540)
.+++|+|.||+||-|..+ +|+.||||++.+...+.. +.++.+|+.++.++.||.||.+.--|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999974 799999999987665543 457899999999999999999999999999999999999655
Q ss_pred ChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC---CCeEEcccccccccCCCCC
Q 009208 384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED---FEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 384 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Dfgla~~~~~~~~ 460 (540)
-|.-.|.. +.+.+++.....++.||+.||+|||.+ +|+|+||||+|||+.+. -++||||||+|+++...
T Consensus 649 MLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 649 MLEMILSS---EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred HHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 44444443 356799999999999999999999999 99999999999999743 37999999999988653
Q ss_pred ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....+.|||.|+|||++.+..|...-||||.|||+|--++|..||+.
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 234567799999999999999999999999999999999999999983
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=264.96 Aligned_cols=203 Identities=29% Similarity=0.418 Sum_probs=172.7
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
+|+..+.||.|++|.||+|+.. +|+.||+|+++..........+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999985 589999999986554444556788999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++ +|.+++.... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 8888876532 234689999999999999999999998 999999999999999999999999999976543221
Q ss_pred ceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
......++..|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 12233478899999987654 56889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=262.39 Aligned_cols=199 Identities=29% Similarity=0.471 Sum_probs=169.0
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--c-------cHHHHHHHHHHHhcccCCCccceeEEEecCC
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--G-------GEVQFQTEVETISLAVHRNLLRLCGFCSTEN 371 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 371 (540)
+|...+.||+|+||.||+|... +|+.||+|.++..... . ..+.+.+|++++..++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3667789999999999999864 6899999988642111 0 1235788999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
..++|+||+++++|.+++++. ..+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999998753 4689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCc-eeeccccccccccccccccCC--CCccCCeehhhHHHHHHHhCCCCCC
Q 009208 452 AKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 452 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
+......... ......|+..|+|||.+.... ++.++||||||+++||+++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 213 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence 9765432111 123345889999999987654 7899999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=264.77 Aligned_cols=194 Identities=29% Similarity=0.384 Sum_probs=166.9
Q ss_pred eeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCCh
Q 009208 309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385 (540)
Q Consensus 309 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 385 (540)
||+|+||+||++... +|+.||+|.+..... ......+.+|++++.+++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999864 689999999865322 22234577899999999999999999999999999999999999999
Q ss_pred hhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCceeec
Q 009208 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465 (540)
Q Consensus 386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 465 (540)
.+++.... ...+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 99987532 24689999999999999999999999 99999999999999999999999999987654321 1223
Q ss_pred cccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 466 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 45788999999998888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=257.60 Aligned_cols=204 Identities=24% Similarity=0.380 Sum_probs=178.9
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+|...+.||+|+||.||++... ++..||+|++...... ....++.+|+++++.++|+|++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999975 5899999998765432 4455789999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++.+.......+++..+..++.+++.|+.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999986543456799999999999999999999999 99999999999999999999999999998665433
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.......|++.|+|||......++.++||||+|+++++|++|+.||+..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 2233446889999999998888999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=265.93 Aligned_cols=200 Identities=25% Similarity=0.344 Sum_probs=172.7
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+|++.+.||+|+||.||+|... +++.||+|+++.... ......+.+|++++++++|+||+++++++..++..++|+||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5788899999999999999976 578999999875432 23345789999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
++++.+..+... ...+++..+..++.+++.|+.|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 82 VERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 998777655543 34589999999999999999999999 99999999999999999999999999998765443
Q ss_pred CceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
........++..|+|||++... .++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3233345578999999999887 789999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=260.03 Aligned_cols=195 Identities=33% Similarity=0.493 Sum_probs=167.1
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
++|.+.+.||+|+||.||++.. .++.||+|.++... ....+.+|+.++..++|||++++++++... ..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4578889999999999999975 67889999986532 345789999999999999999999998654 579999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++++|.+++... ....+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 81 SKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999999999753 234688999999999999999999998 99999999999999999999999999987543211
Q ss_pred ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCcc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFG 509 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~~ 509 (540)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 12234678999999988899999999999999999998 99999743
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=267.32 Aligned_cols=204 Identities=24% Similarity=0.345 Sum_probs=168.7
Q ss_pred CCCcCCeeeeccCccEEEEEeCC---CcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecC--CeeE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFSD---GALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERL 374 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~ 374 (540)
+|.+.+.||+|+||.||+|.... ++.||+|.+..... ......+.+|+.++.+++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 36778899999999999999754 78999999876331 22234678899999999999999999999887 7899
Q ss_pred EEEecCCCCChhhhccccCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC----CCCeEEccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGR-PALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE----DFEAVVGDF 449 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~Df 449 (540)
+||||+++ ++.+.+....... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6766665433322 3789999999999999999999999 9999999999999999 999999999
Q ss_pred ccccccCCCCC--ceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 450 GLAKLLDHRDS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 450 gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
|++........ .......+++.|+|||.+.+. .++.++||||||++++||++|+.||...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 99986543322 112234578999999987664 5789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=252.63 Aligned_cols=204 Identities=24% Similarity=0.383 Sum_probs=170.4
Q ss_pred CHHHHHHHhcCCCcCCeeeeccCccEEEEE-eCCCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEec
Q 009208 292 TFKELRAATSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCST 369 (540)
Q Consensus 292 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 369 (540)
+|+++-+.++ +.||+|+|+.|--+. ..+|..+|||++.+. ....+.+..+|++++.+.+ |+||+++++++++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 3566655554 679999999998876 468999999999775 3445668899999999985 9999999999999
Q ss_pred CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC---CeEE
Q 009208 370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF---EAVV 446 (540)
Q Consensus 370 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl 446 (540)
+...|+|||-|.||+|.+++.++ .-+++..+..+.++|+.||.|||.+ +|.|||+||+|||-.+-. -+||
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred cceEEEEEecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence 99999999999999999988764 5699999999999999999999999 999999999999987544 4799
Q ss_pred cccccccccCCCC------Cceeeccccccccccccccc-----cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 447 GDFGLAKLLDHRD------SHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 447 ~Dfgla~~~~~~~------~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|||.+..-+.... .....+.+|+..|||||+.. ...|+.++|.||+|||+|-|++|..||..
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 9999876432211 11122345888999999863 34688999999999999999999999974
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=265.28 Aligned_cols=201 Identities=24% Similarity=0.369 Sum_probs=170.1
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+|+..+.||+|++|.||+|... +|+.||||+++.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999875 689999999875432 22334688999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+. ++|.+++... ....+++..+..++.|++.||+|||+. +++||||+|+||++++++.+|++|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 6888888643 235689999999999999999999998 99999999999999999999999999987654322
Q ss_pred CceeeccccccccccccccccCC-CCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
. ......+++.|+|||++.+.. ++.++||||||+++|||+||+.||...
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 2 122334788999999886644 588999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=264.89 Aligned_cols=196 Identities=23% Similarity=0.361 Sum_probs=169.8
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCC
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP 381 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 381 (540)
|...+.||+|++|.||++... +++.|++|+++... ......+.+|+.++..+.||||+++++++...+..++|+||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 444578999999999999864 68899999986433 2334568899999999999999999999999999999999999
Q ss_pred CCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc
Q 009208 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461 (540)
Q Consensus 382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 461 (540)
+++|.+++.. ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+........
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 9999998864 3588999999999999999999999 999999999999999999999999998875443221
Q ss_pred eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 462 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 22334589999999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=263.82 Aligned_cols=210 Identities=29% Similarity=0.434 Sum_probs=174.4
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEe
Q 009208 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCS 368 (540)
Q Consensus 291 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 368 (540)
.++.++..+...|++.+.||+|+||.||+|... +++.||+|.+.... ....++..|+.++.++ +|+||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 345566667788999999999999999999974 58899999986532 2335688899999888 6999999999985
Q ss_pred c------CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 009208 369 T------ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442 (540)
Q Consensus 369 ~------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~ 442 (540)
. .+..+++|||+++|+|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||+|+||++++++
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA 158 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 3 457899999999999999887532 34578888999999999999999999 999999999999999999
Q ss_pred CeEEcccccccccCCCCCceeeccccccccccccccc-----cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 443 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 443 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.++|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 159 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~ 228 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228 (282)
T ss_pred CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence 999999999875543221 122345899999999875 34578899999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=263.57 Aligned_cols=202 Identities=30% Similarity=0.456 Sum_probs=171.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-----CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEec--CCee
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST--ENER 373 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 373 (540)
+.|...+.||+|+||.||+|.+. .+..||||.++..........|.+|+++++.+.|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999864 3688999999865433245679999999999999999999999877 5578
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999753 23589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCce--eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 454 LLDHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 454 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
......... .....++..|+|||.+.+..++.++||||||+++|||+||+.|+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 214 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence 765322211 1122355679999999888899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=264.39 Aligned_cols=196 Identities=32% Similarity=0.411 Sum_probs=167.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
..|...+.||+|+||.||+|... +++.||+|.+...... ....++.+|++++..++||||+++.+++...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45778899999999999999875 6899999998654322 22346889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||++ |++.+++... ...+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 5777766532 34689999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCceeeccccccccccccccc---cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ....+++.|+|||++. ...++.++||||||+++|||+||+.||..
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 2 2235788999999874 35688999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=255.22 Aligned_cols=199 Identities=30% Similarity=0.445 Sum_probs=175.8
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
+|...+.||+|++|.||++... +++.+++|++..... .....+.+|++.+++++|+|++++++.+...+..++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 3677889999999999999986 689999999876543 34567999999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++++|.+++... ...+++..+..++.+++.|+.|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 80 SGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 999999988753 25689999999999999999999998 999999999999999999999999999987654332
Q ss_pred ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.....++..|+|||.+....++.++||||||+++++|++|+.||+..
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23345889999999998888999999999999999999999999743
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=261.86 Aligned_cols=192 Identities=29% Similarity=0.396 Sum_probs=159.4
Q ss_pred eeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHH---HhcccCCCccceeEEEecCCeeEEEEecCC
Q 009208 308 ILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVET---ISLAVHRNLLRLCGFCSTENERLLVYPYMP 381 (540)
Q Consensus 308 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~---l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 381 (540)
.||+|+||.||+|... +++.||+|.+...... .....+..|..+ +....||||+++.+++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999874 5889999998754322 122234444433 444579999999999999999999999999
Q ss_pred CCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc
Q 009208 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461 (540)
Q Consensus 382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 461 (540)
+|+|.+++.. ...+++..+..++.|+++|+.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 9999988864 34699999999999999999999998 999999999999999999999999999875543221
Q ss_pred eeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 462 VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 462 ~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||...
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 233589999999998754 5889999999999999999999999743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=264.92 Aligned_cols=199 Identities=28% Similarity=0.361 Sum_probs=169.4
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc----ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA----GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
+|+..+.||+|++|.||+|... +++.||+|+++..... .....+..|++++.+++|+||+++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677889999999999999975 6899999999765432 1234577899999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+ +|+|.+++... ...+++..+..++.|+++||.|||+. +|+||||+|+||+++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 99999998753 13689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||..
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 43222 223346788999998855 4578999999999999999999877763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=256.99 Aligned_cols=201 Identities=27% Similarity=0.449 Sum_probs=172.7
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+|+..+.||+|+||.||++... +++.+|+|.+..... ......+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999874 688999999875432 23345789999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEcccccccccCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla~~~~~~ 458 (540)
+++++|.+++.+. ....+++..+..++.++++|+.|||++ +++||||+|+||+++++ +.+|++|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999753 234589999999999999999999999 99999999999999855 46899999999866533
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. .....++..|+|||.+....++.++||||||+++|+|++|+.||+..
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 21 22345889999999998888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=262.89 Aligned_cols=189 Identities=23% Similarity=0.380 Sum_probs=158.0
Q ss_pred CeeeeccCccEEEEEeCC--------CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 307 NILGRGGFGIVYKGCFSD--------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
+.||+|+||.||+|.... ...||+|.+.... .....++.+|+.+++.+.|||++++++++..++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 368999999999998642 2348888875432 2334578899999999999999999999999899999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC--------eEEcccc
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE--------AVVGDFG 450 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~--------~kl~Dfg 450 (540)
|+++|+|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. ++++|||
T Consensus 80 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 80 YVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999999753 23689999999999999999999999 9999999999999987765 5999999
Q ss_pred cccccCCCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCC-CCCC
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQ-RALD 507 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~-~p~~ 507 (540)
++...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+.
T Consensus 154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~ 207 (258)
T cd05078 154 ISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS 207 (258)
T ss_pred cccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChh
Confidence 88754321 223478899999999764 5799999999999999999995 5554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=258.53 Aligned_cols=193 Identities=28% Similarity=0.356 Sum_probs=169.0
Q ss_pred eeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCCh
Q 009208 309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385 (540)
Q Consensus 309 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 385 (540)
||.|++|.||++... +++.||+|.+...... .....+.+|+++++.++||||+++++++...+..++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999985 4899999998754322 3345789999999999999999999999999999999999999999
Q ss_pred hhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCceeec
Q 009208 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465 (540)
Q Consensus 386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 465 (540)
.+++.+. ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 9998753 3588999999999999999999998 99999999999999999999999999998665432 1223
Q ss_pred cccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 466 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
..+++.|+|||.+....++.++|+||+|+++|||++|+.||....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 458899999999988889999999999999999999999997443
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=277.23 Aligned_cols=199 Identities=29% Similarity=0.461 Sum_probs=173.7
Q ss_pred CcCCeeeeccCccEEEEEeCC--C--cEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 304 SAKNILGRGGFGIVYKGCFSD--G--ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 304 ~~~~~lG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
...++||+|.||.|++|.|.. | ..||||.++.........+|.+|+.+|.+++|+|+++++|+..+ ....||+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 345789999999999999863 4 45999999987655566789999999999999999999999987 667899999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
.+.|||.+.|++ ..+..+.......++.|||.||.||..+ ++|||||..+|+|+-....+||+|||+.+-+....
T Consensus 192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999987 3456788899999999999999999999 99999999999999998899999999999876554
Q ss_pred Ccee--eccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 460 SHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 460 ~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.+.. ....-...|+|||.+....++.++|||+|||.+|||+| |+.||-.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G 318 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG 318 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC
Confidence 3322 22234678999999999999999999999999999999 7899963
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=262.91 Aligned_cols=207 Identities=27% Similarity=0.356 Sum_probs=176.4
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCcccc--HHHHHHHHHHHhcc-cCCCccceeEEEecCCeeE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGG--EVQFQTEVETISLA-VHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 374 (540)
...+|....+||+|+||.|..|..+. .+.+|||++++...-+. .+--+.|-++|+.. +-|.++++...++..+..|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 34678889999999999999998753 67899999987654222 22345677777765 5789999999999999999
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+||||+.||+|--++.+ -+.+.++.+..+|..||-||-+||++ +||+||||.+||++|.+|.+||+|||+++.
T Consensus 427 FVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999998766654 45688899999999999999999999 999999999999999999999999999984
Q ss_pred cCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcccccc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAAN 513 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~ 513 (540)
-- -....+.+.+|||.|+|||++..+.|+..+|.|||||++|||+.|++||+..++++
T Consensus 500 ni-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e 557 (683)
T KOG0696|consen 500 NI-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 557 (683)
T ss_pred cc-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 22 12344667889999999999999999999999999999999999999999765443
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=263.12 Aligned_cols=203 Identities=22% Similarity=0.285 Sum_probs=167.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhccc-CCCccceeEEEecCCe-----
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAV-HRNLLRLCGFCSTENE----- 372 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~----- 372 (540)
++|+..+.||+|+||.||+|... +++.||+|.++..... .....+.+|+.++..+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999975 6899999998654322 22346888999999995 6999999999876655
Q ss_pred eEEEEecCCCCChhhhccccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-CCCeEEcccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDFG 450 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfg 450 (540)
.++||||+++ +|.+++...... ...+++..+..++.||++||.|||+. +|+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 888888653322 34689999999999999999999999 9999999999999998 8899999999
Q ss_pred cccccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
+++........ .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 99865432221 122346889999998865 4578999999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=257.91 Aligned_cols=197 Identities=26% Similarity=0.332 Sum_probs=164.2
Q ss_pred HHHHHHhcCCCcCCee--eeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhc-ccCCCccceeEEEec
Q 009208 294 KELRAATSNFSAKNIL--GRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRNLLRLCGFCST 369 (540)
Q Consensus 294 ~~l~~~~~~~~~~~~l--G~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~ 369 (540)
.+.....++|.+.+.+ |+|+||.||++..+ ++..+|+|.+....... .|+..... .+||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEec
Confidence 3444445677777776 99999999999864 67889999986533211 12222222 269999999999999
Q ss_pred CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEcc
Q 009208 370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGD 448 (540)
Q Consensus 370 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~D 448 (540)
.+..++||||+++|+|.+++... ..+++..+..++.|+++|+.|||+. +++||||||+||+++.++ .++|+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence 99999999999999999998753 3789999999999999999999999 999999999999999988 999999
Q ss_pred cccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 449 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 449 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
||++....... ...++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 154 fg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 208 (267)
T PHA03390 154 YGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208 (267)
T ss_pred CccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 99987654322 23588999999999988899999999999999999999999973
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=268.80 Aligned_cols=200 Identities=22% Similarity=0.381 Sum_probs=167.0
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecC-----Cee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 373 (540)
.++|.+.+.||+|+||.||+|... +|+.||+|.++..........+.+|+.++.+++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467899999999999999999864 68999999987543333445688999999999999999999987543 357
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++|+||+++ ++.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 999999964 77776643 3689999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCc--eeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 454 LLDHRDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 454 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
........ ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 65432211 1123458899999998754 5689999999999999999999999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=263.12 Aligned_cols=200 Identities=24% Similarity=0.313 Sum_probs=169.5
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-cHHHHHHHHHHHhcccCCCccceeEEEecC--CeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV 376 (540)
++|+..+.||+|+||.||+|... +++.+|+|.++...... ....+.+|++++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788899999999999999986 58899999997543322 233577899999999999999999998777 889999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
+||++ ++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 5888888653 23689999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..... .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 158 SPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred CCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 43221 2233478899999998654 468999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=264.02 Aligned_cols=202 Identities=29% Similarity=0.378 Sum_probs=168.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-cHHHHHHHHHHHhcccCCCccceeEEEecC--CeeEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERLL 375 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 375 (540)
.++|++.+.||+|+||.||+|... +|+.||+|+++...... ....+.+|+.++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467889999999999999999975 58999999987543222 233567899999999999999999998754 56899
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||++ ++|.+++... ...+++..+..++.|+++|+.|||+. +++||||||+||++++++.+||+|||++...
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 4788887643 25689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
...... .....+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||...
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 159 GLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred CCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 543221 222335788999999865 45789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=260.34 Aligned_cols=200 Identities=28% Similarity=0.402 Sum_probs=169.6
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC-ccccHHHHHHHHHHHhcccCCCccceeEEEecC--CeeEEEEe
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN-IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERLLVYP 378 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~e 378 (540)
|++.+.||+|+||.||+|... +++.+|+|+++... .......+.+|++++.+++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999976 48899999998653 223345688999999999999999999999887 88999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++ +|.+++... ...+++..+..++.|+++|++|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9974 888877642 24689999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||+..
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~ 205 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3222233457889999998764 45789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=257.57 Aligned_cols=203 Identities=28% Similarity=0.407 Sum_probs=165.5
Q ss_pred CCcCCeeeeccCccEEEEEeC----CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCC------
Q 009208 303 FSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN------ 371 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 371 (540)
|.+.+.||+|+||.||+|.+. .++.||+|.++.... .....++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999863 368899999875432 223456889999999999999999999886432
Q ss_pred eeEEEEecCCCCChhhhccccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF 449 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 449 (540)
..++++||+++|+|.+++.... .....+++.....++.|++.|++|||+. +|+||||||+||++++++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875321 1123578999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 450 GLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 450 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
|.++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~ 218 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC
Confidence 999865432211 1122335678999999988889999999999999999999 8899864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=261.85 Aligned_cols=200 Identities=29% Similarity=0.391 Sum_probs=169.7
Q ss_pred CCCcCCeeeeccCccEEEEEe----CCCcEEEEEEeccCCc---cccHHHHHHHHHHHhcc-cCCCccceeEEEecCCee
Q 009208 302 NFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNI---AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENER 373 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 373 (540)
+|++.+.||+|++|.||++.. .+++.||||.++.... ......+.+|++++.++ .||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999875 2578899999875322 22234688999999999 599999999999989999
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++||||+++|+|.+++.. ...+++..+..++.|+++||.|||+. +++||||+|+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999998864 24588999999999999999999998 99999999999999999999999999988
Q ss_pred ccCCCCCceeeccccccccccccccccCC--CCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..............|+..|+|||...+.. .+.++||||||+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 65443332233345889999999987655 78899999999999999999999963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=261.70 Aligned_cols=204 Identities=27% Similarity=0.384 Sum_probs=170.3
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCC----
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN---- 371 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---- 371 (540)
...++|++.+.||+|+||.||+|..+ +|+.||+|+++.... ......+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678899999999999999999986 588999999875432 233456788999999999999999999987654
Q ss_pred ------eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeE
Q 009208 372 ------ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV 445 (540)
Q Consensus 372 ------~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 445 (540)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999976 676666542 34689999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 446 VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 446 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||+.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99999998765433222223346788999998765 4578999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=260.30 Aligned_cols=200 Identities=25% Similarity=0.367 Sum_probs=168.7
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
|+..+.||+|++|.||+|... +|..||+|++...... .....+.+|+++++.++|||++++++++...+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999875 6899999998754322 22346889999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
+ ++|.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 68998886532 24689999999999999999999998 999999999999999999999999999976543222
Q ss_pred ceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1222468899999987654 5688999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=275.29 Aligned_cols=197 Identities=25% Similarity=0.351 Sum_probs=166.8
Q ss_pred CCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCC
Q 009208 303 FSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP 381 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 381 (540)
|.+...||.|+||.||||..++ +-..|-|++... ....-.+|.-|+++|+.+.||+||++++.|+..+..+|..|||.
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 3455679999999999998765 344556665432 23444579999999999999999999999999999999999999
Q ss_pred CCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc
Q 009208 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461 (540)
Q Consensus 382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 461 (540)
||-.+..+-+. ...+++.++.-+++++++||.|||++ +|||||||..|||++-+|.++++|||.+..... ...
T Consensus 113 GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~q 185 (1187)
T KOG0579|consen 113 GGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQ 185 (1187)
T ss_pred CchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHh
Confidence 99998877553 45799999999999999999999999 999999999999999999999999999864332 223
Q ss_pred eeeccccccccccccccc-----cCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 462 VTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 462 ~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
....+.|||.|||||+.. ...|+.++||||||+.+.||..+.+|-.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh 236 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH 236 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc
Confidence 345677999999999864 4678999999999999999999998875
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=255.90 Aligned_cols=201 Identities=23% Similarity=0.366 Sum_probs=172.6
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+|...+.||+|+||.||+|... +|..||+|.+...... .....+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999975 5889999998654322 2345688999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEcccccccccCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHR 458 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~ 458 (540)
+++++|.+++.+. ....+++..+..++.++++|+.|||+. +++|+||||+||++++++ .++++|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999998753 233579999999999999999999999 999999999999999875 4699999999866543
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. ......|++.|+|||+.....++.++||||||+++|||++|+.||..
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 204 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22 22234588999999999888899999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=262.83 Aligned_cols=192 Identities=24% Similarity=0.378 Sum_probs=167.2
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCCh
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 385 (540)
..||+|+||.||++..+ +++.||+|++.... ......+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 56999999999999874 68999999985433 23455689999999999999999999999999999999999999999
Q ss_pred hhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCceeec
Q 009208 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465 (540)
Q Consensus 386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 465 (540)
.+++.. ..+++.....++.|++.|++|||+. +++||||+|+||++++++.++|+|||++........ ....
T Consensus 105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 987753 3578999999999999999999999 999999999999999999999999999876543221 1233
Q ss_pred cccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 466 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..|++.|+|||.+....++.++||||||+++|||++|+.||..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4588999999999888889999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=256.77 Aligned_cols=202 Identities=29% Similarity=0.387 Sum_probs=176.3
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+|++.+.||+|+||.||++... +++.+|+|.+..... .....++.+|+++++.++|+||+++.+++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999865 678999999876432 23345688999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++.+.......+++..+..++.+++.|++|||+. +++|+||+|+||++++++.+|++|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999876444456789999999999999999999999 99999999999999999999999999998765431
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.....+++.|+|||...+..++.++|+||||+++|||++|+.||+..
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 204 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 22344789999999998888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=261.69 Aligned_cols=202 Identities=26% Similarity=0.358 Sum_probs=165.8
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+|...+.||+|+||.||++... +++.||+|.+...........+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4455678999999999999875 589999999876544445567899999999996 99999999999999999999999
Q ss_pred CCCCChhhhccc-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 380 MPNGSVASRLRD-HIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 380 ~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
+.. ++.++... .......+++.....++.+++.||+|||+.. +++||||||+||++++++.++|+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 55443321 1112356899999999999999999999732 8999999999999999999999999999765432
Q ss_pred CCceeeccccccccccccccccC---CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. .....|+..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 21 1223588999999998776 689999999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=257.85 Aligned_cols=197 Identities=24% Similarity=0.285 Sum_probs=164.6
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEecC--CeeEEEEe
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTE--NERLLVYP 378 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lV~e 378 (540)
|.+.+.||+|+||.||+|... +++.||+|+++............+|+.++.++. |+|++++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999865 689999999876433333345567888898885 99999999999877 88999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|++ |++.+++... ...++|..+..++.|++.||+|||+. +++||||+|+||++++ +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 5888877642 24689999999999999999999999 9999999999999999 99999999999866432
Q ss_pred CCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. .....++..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 22 122347899999997644 55789999999999999999999999743
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=256.81 Aligned_cols=194 Identities=28% Similarity=0.388 Sum_probs=167.8
Q ss_pred eeeccCccEEEEEeCC-CcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCCh
Q 009208 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385 (540)
Q Consensus 309 lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 385 (540)
||+|+||.||++...+ |+.+++|.+...... .....+.+|++++.+++|+||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999864 899999998754322 3345788999999999999999999999999999999999999999
Q ss_pred hhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC-----
Q 009208 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS----- 460 (540)
Q Consensus 386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~----- 460 (540)
.+++.+. ..+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9998753 3689999999999999999999999 999999999999999999999999999875433211
Q ss_pred --ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 461 --HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 461 --~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.......++..|+|||.......+.++||||||+++||+++|+.||+..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 204 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE 204 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 1223345788999999998888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=259.95 Aligned_cols=202 Identities=23% Similarity=0.338 Sum_probs=167.3
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
++|+..+.||+|++|.||+|..+ +|+.||+|+++..... .....+.+|++++++++|+||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999975 6899999998654322 223468899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-CCCeEEcccccccccCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~~~~ 457 (540)
|++ +++.+++... ....+++.....++.|++.||+|||+. +++||||+|+||++++ ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 5787777542 223467888899999999999999999 9999999999999985 56799999999976543
Q ss_pred CCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
... ......+++.|+|||++.+. .++.++||||+|+++|+|+||+.||...
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 221 11233478899999988664 5789999999999999999999999643
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=254.34 Aligned_cols=199 Identities=30% Similarity=0.487 Sum_probs=174.6
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+|+..+.||+|++|.||++... +++.||+|.+...... .....+.+|++++.+++|+|++++++++...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999875 5789999999765432 2345789999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++... ..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999988653 5689999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. .....++..|+|||......++.++||||+|+++|+|++|+.||..
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 22 2334588999999999888889999999999999999999999963
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=250.77 Aligned_cols=205 Identities=25% Similarity=0.342 Sum_probs=169.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC-----CcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEec-CCe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD-----GALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCST-ENE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~ 372 (540)
...|+....||+|.||.||||.-++ ...+|+|+++...-. .-.....+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3568888999999999999996432 237999999865322 223457899999999999999999998876 778
Q ss_pred eEEEEecCCCCChhhhccccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC----CCeEEc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED----FEAVVG 447 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~ 447 (540)
.++++||.+. +|.+.++-+... ...++...+.+|..||+.|+.|||++ =|+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 9999999976 788877654322 24688999999999999999999999 89999999999999866 899999
Q ss_pred ccccccccCCCCCc--eeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 448 DFGLAKLLDHRDSH--VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 448 Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|||+++.+...-.. ....++-|..|.|||++.+. .||.+.||||.|||+.||+|-++-|..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 99999987654322 23456689999999999876 589999999999999999999987763
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=259.41 Aligned_cols=201 Identities=24% Similarity=0.394 Sum_probs=166.6
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~ 377 (540)
.++|.+.+.||+|+||.||+|...+ ++.||||.++.........++..|++++.+.. |+||+++++++......++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3567788999999999999999865 89999999976544444556777887776664 999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||++ +++.+.+... ...+++..+..++.++++|++|||+.. +|+||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 4666665432 237899999999999999999999732 899999999999999999999999999876543
Q ss_pred CCCceeeccccccccccccccccCC----CCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... ....++..|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 168 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 168 SKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 2221 2234788999999987554 78899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=265.74 Aligned_cols=199 Identities=25% Similarity=0.302 Sum_probs=168.3
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC-ccccHHHHHHHHHHHhcccCCCccceeEEEecC------
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN-IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE------ 370 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 370 (540)
...+|+..+.||+|+||.||+|... +|+.||+|.+.... ......++.+|++++.+++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3577999999999999999999875 68999999986432 222334677899999999999999999988643
Q ss_pred CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccc
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 450 (540)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 34699999996 577777653 278889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 9986543221 23345789999999999999999999999999999999999999744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=253.47 Aligned_cols=190 Identities=24% Similarity=0.332 Sum_probs=160.7
Q ss_pred CeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHH-hcccCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETI-SLAVHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||+|... +|+.||+|.++..... .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999874 5899999998754321 1122344555444 455899999999999999999999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 9999988642 4688999999999999999999998 999999999999999999999999999875432
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 195 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC
Confidence 2234588999999999888889999999999999999999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=250.48 Aligned_cols=201 Identities=31% Similarity=0.443 Sum_probs=175.3
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecC--CeeEEEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERLLVY 377 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV~ 377 (540)
+|...+.||+|++|.||+|... +++.|++|.+..... ......+.+|++.+++++|+||+++++.+... +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677789999999999999986 689999999876442 23345789999999999999999999999888 8899999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++++|.+++.+. ..+++..+..++.++++|+.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998753 3789999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.... ......++..|+|||.+.....+.++||||||+++++|++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 4321 123345889999999998888999999999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=265.11 Aligned_cols=202 Identities=27% Similarity=0.401 Sum_probs=167.7
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC-ccccHHHHHHHHHHHhcc-cCCCccceeEEEecC--Cee
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN-IAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE--NER 373 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~--~~~ 373 (540)
..++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|+.++.++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888899999999999999975 58899999886432 123334677899999999 999999999998653 367
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++||||++ ++|.+++.. ..++|..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 588888754 2688999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCC----ceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 454 LLDHRDS----HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 454 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
....... .......|+..|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 6543322 12233458899999998755 45788999999999999999999999743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=259.16 Aligned_cols=203 Identities=27% Similarity=0.395 Sum_probs=166.9
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCC------
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTEN------ 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 371 (540)
.++|...+.||+|+||.||+|... +++.||+|.+...... .....+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457888999999999999999975 6899999998654322 22345678999999999999999999987654
Q ss_pred --eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccc
Q 009208 372 --ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF 449 (540)
Q Consensus 372 --~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 449 (540)
..++||||+. ++|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 3499999996 4787777542 23689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc---eeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 450 GLAKLLDHRDSH---VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 450 gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
|++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 999865432211 11233478899999987664 4688999999999999999999999744
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=258.19 Aligned_cols=205 Identities=27% Similarity=0.392 Sum_probs=171.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccH------HHHHHHHHHHhcccCCCccceeEEEe-cCC
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGE------VQFQTEVETISLAVHRNLLRLCGFCS-TEN 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~ 371 (540)
.++|-..+.||+|||+.||||.. ...+.||||+-.......++ +...+|-++-..+.||-||++++|+. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 45677788999999999999985 46788999986543322222 24678999999999999999999996 456
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEcc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGD 448 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~D 448 (540)
.++-|+||++|.+|+-||+.+ ..+++..+..|+.||+.||.||.+. +++|||-||||.|||+-+ -|.+||.|
T Consensus 542 sFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 688999999999999999864 4688999999999999999999987 789999999999999864 46899999
Q ss_pred cccccccCCCCCc------eeecccccccccccccccc----CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 449 FGLAKLLDHRDSH------VTTAVRGTVGHIAPEYLST----GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 449 fgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
||++++++..... .+...+||..|++||.+.- ...+.|+||||.|||+|+++.|+.||...
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 9999998754322 3455679999999998743 35688999999999999999999999753
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=261.67 Aligned_cols=200 Identities=23% Similarity=0.328 Sum_probs=168.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCcccc-HHHHHHHHHHHhccc-CCCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~ 377 (540)
-..|++.+.||+||.++||++...+.+.+|+|++........ -..|.+|++.|.+++ |.+|+++++|...++..||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 356788899999999999999998889999998875443322 236999999999996 899999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||= .-+|..+|++.. ....+| .++.+..|++.|+.++|+. +|||.||||.|+|+-+ |.+||+|||+|..+..
T Consensus 440 E~G-d~DL~kiL~k~~--~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKK--SIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred ecc-cccHHHHHHhcc--CCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 965 568999998642 223445 7889999999999999999 9999999999998864 5999999999998876
Q ss_pred CCCc-eeeccccccccccccccccCC-----------CCccCCeehhhHHHHHHHhCCCCCC
Q 009208 458 RDSH-VTTAVRGTVGHIAPEYLSTGQ-----------SSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 458 ~~~~-~~~~~~gt~~y~aPE~~~~~~-----------~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
.... .....+||+.||+||.+.... .++++||||+|||+|+|+.|+.||.
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~ 573 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG 573 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence 5443 335567999999999985432 4678999999999999999999997
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=258.69 Aligned_cols=194 Identities=31% Similarity=0.425 Sum_probs=165.5
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
|...+.||+|+||.||+|... ++..||+|.+...... ....++.+|++++++++|+|++++++++..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 556788999999999999974 6899999998754322 2234688999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
++ |++.+.+... ...+++..+..++.+++.|+.|||+. +|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 97 5777776532 34689999999999999999999999 9999999999999999999999999998754322
Q ss_pred Cceeeccccccccccccccc---cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
....|++.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 2335889999999973 45688999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=293.77 Aligned_cols=200 Identities=30% Similarity=0.424 Sum_probs=171.2
Q ss_pred cCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
-+++....||.|.||.||-|.. .+|+..|+|.++..... .....+.+|+.++..++|||+|+.+|+-...+..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 4456678999999999999985 57999999998754432 223468899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
||++|+|.+.+.. ....++.....+..|++.|+.|||+. +||||||||.||+++.+|.+|.+|||.|..+...
T Consensus 1315 yC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999998864 23467778888999999999999999 9999999999999999999999999999877654
Q ss_pred CCce---eeccccccccccccccccCC---CCccCCeehhhHHHHHHHhCCCCCC
Q 009208 459 DSHV---TTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 459 ~~~~---~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
.... .....||+.|||||++.+.. ...+.||||+|||+.||+||+.||.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~ 1442 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWA 1442 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchh
Confidence 3221 23456999999999997654 4568899999999999999999997
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=257.31 Aligned_cols=201 Identities=19% Similarity=0.205 Sum_probs=152.0
Q ss_pred cCCCcCCeeeeccCccEEEEEeCC----CcEEEEEEeccCCcccc-H---------HHHHHHHHHHhcccCCCccceeEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGG-E---------VQFQTEVETISLAVHRNLLRLCGF 366 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~-~---------~~~~~E~~~l~~l~h~nIv~l~~~ 366 (540)
.+|.+.+.||+|+||.||+|...+ +..+|+|.......... + .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578899999999999999999754 34566665332221100 0 112233445566789999999997
Q ss_pred EecCC----eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 009208 367 CSTEN----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442 (540)
Q Consensus 367 ~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~ 442 (540)
+.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||+|||+. +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 65443 34677777643 55555443 22356888899999999999999999 999999999999999999
Q ss_pred CeEEcccccccccCCCCCc------eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 443 EAVVGDFGLAKLLDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 443 ~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.++|+|||+++.+...... ......||+.|+|||+..+..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999865432211 112245999999999999999999999999999999999999999743
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=256.39 Aligned_cols=202 Identities=28% Similarity=0.423 Sum_probs=174.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhccc-CCCccceeEEEecCCeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV 376 (540)
++|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+|.+++.+++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999975 689999999875332 223456889999999998 99999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++++|.+++.+. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999998753 3699999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCC-------------------ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 457 HRDS-------------------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 457 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.... .......++..|+|||......++.++||||||++++++++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 3221 1122345789999999998888999999999999999999999999743
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=284.67 Aligned_cols=232 Identities=28% Similarity=0.390 Sum_probs=174.6
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecC--------
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-------- 370 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-------- 370 (540)
..+|+..+.||+||||.|||++.+ ||+.+|||++.............+|++.+++++|||||+++....+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 456777889999999999999976 89999999998654333344688999999999999999876322100
Q ss_pred --------------------------------------------------------------------------------
Q 009208 371 -------------------------------------------------------------------------------- 370 (540)
Q Consensus 371 -------------------------------------------------------------------------------- 370 (540)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 009208 371 -------------------------------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419 (540)
Q Consensus 371 -------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH 419 (540)
...||=||||+.-++.+++++..... .....++++.+|++||.|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHH
Confidence 01357788888877777776532211 46678899999999999999
Q ss_pred hcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC----------------CCC-CceeeccccccccccccccccCC
Q 009208 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD----------------HRD-SHVTTAVRGTVGHIAPEYLSTGQ 482 (540)
Q Consensus 420 ~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~----------------~~~-~~~~~~~~gt~~y~aPE~~~~~~ 482 (540)
++ +||||||||.||++|++..+||+|||+|.... ... ....+..+||.-|+|||++.+..
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 99 99999999999999999999999999998621 001 11234556999999999997654
Q ss_pred ---CCccCCeehhhHHHHHHHh-----------------CCCCCC---cccccccCCcHHHHHHHHhhcCCcchhhhh
Q 009208 483 ---SSEKTDVFGFGILLLELIT-----------------GQRALD---FGRAANQRGVMLDWVCSHILSNQSSLDMVL 537 (540)
Q Consensus 483 ---~~~k~Dv~S~Gvil~ellt-----------------g~~p~~---~~~~~~~~~~~~~w~~~~~~~~~~~~~~l~ 537 (540)
|+.|+||||+|||++||+. |..|++ .......+..+++|+.++-...+|-+.-|+
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLYPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 9999999999999999974 344444 222222334566888887666666554443
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=255.33 Aligned_cols=198 Identities=27% Similarity=0.375 Sum_probs=168.5
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEecCCeeEEEEecC
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
|.+.+.||+|++|.||+|... +++.||+|++.............+|+..+.+++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999986 478999999876543333445667999999999 999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
+|+|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889998887532 24689999999999999999999998 999999999999999999999999999986543222
Q ss_pred ceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 461 HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....++..|+|||++.. ..++.++|+||||++++||++|+.||..
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~ 201 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG 201 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence 123447889999998754 4578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=262.66 Aligned_cols=204 Identities=25% Similarity=0.338 Sum_probs=170.3
Q ss_pred CHHHHHHHhcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEec
Q 009208 292 TFKELRAATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCST 369 (540)
Q Consensus 292 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 369 (540)
...++...+++|.+.+.||+|+||.||+|.. .+++.||+|+++.... ......+.+|++++.+++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456667789999999999999999999986 4689999999875321 2223467889999999999999999998754
Q ss_pred C------CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC
Q 009208 370 E------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443 (540)
Q Consensus 370 ~------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 443 (540)
. ...+++++++ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||++++++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 3 3467888876 7888887753 3589999999999999999999999 9999999999999999999
Q ss_pred eEEcccccccccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 444 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 444 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
+||+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999998754322 223457899999998866 4678999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=261.90 Aligned_cols=200 Identities=23% Similarity=0.350 Sum_probs=167.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEec----CCeeE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCST----ENERL 374 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~ 374 (540)
++|++.+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.++.+++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888999999999999999875 589999999875432 2334567889999999999999999988753 34679
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+|+||+. |+|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++..
T Consensus 85 lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999995 688888754 34589999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCCc---eeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 455 LDHRDSH---VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 455 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
....... ......|+..|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 214 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG 214 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence 5432211 1123468899999999865 4588999999999999999999999964
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=262.50 Aligned_cols=201 Identities=25% Similarity=0.304 Sum_probs=165.8
Q ss_pred cCCC-cCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-------------cHHHHHHHHHHHhcccCCCccceeE
Q 009208 301 SNFS-AKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-------------GEVQFQTEVETISLAVHRNLLRLCG 365 (540)
Q Consensus 301 ~~~~-~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~nIv~l~~ 365 (540)
++|. +.+.||+|+||.||+|... +++.||+|+++...... ....+.+|++++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3443 3477999999999999865 68999999986543222 1124778999999999999999999
Q ss_pred EEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeE
Q 009208 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV 445 (540)
Q Consensus 366 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 445 (540)
++...+..++||||++ |+|.+++.. ...+++.....++.|+++||+|||+. +++||||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999996 688888764 34688999999999999999999998 999999999999999999999
Q ss_pred EcccccccccCCCC-------------CceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 446 VGDFGLAKLLDHRD-------------SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 446 l~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
++|||.+....... ........+++.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999997654110 1111223468899999998764 4689999999999999999999999744
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=280.05 Aligned_cols=211 Identities=29% Similarity=0.416 Sum_probs=178.7
Q ss_pred HHHHHhcCCCcCCeeeeccCccEEEEEeC--------CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeE
Q 009208 295 ELRAATSNFSAKNILGRGGFGIVYKGCFS--------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCG 365 (540)
Q Consensus 295 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~ 365 (540)
.++...++..+.+.+|+|.||.|++|... ....||||.++..........+..|+++|..+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34445556667779999999999999853 14579999999877666677899999999987 6999999999
Q ss_pred EEecCCeeEEEEecCCCCChhhhccccC-----CC-----C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 009208 366 FCSTENERLLVYPYMPNGSVASRLRDHI-----HG-----R--PALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKA 433 (540)
Q Consensus 366 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----~~-----~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~ 433 (540)
+|...+..++|.||++.|+|.++|+... .. . ..++......++.|||.||+||++. ++|||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998754 00 1 2388999999999999999999999 999999999
Q ss_pred CceeeCCCCCeEEcccccccccCCCCCceeecccc--ccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 434 ANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG--TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 434 ~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+|||+.++..+||+|||+++..............| ...|||||.+....++.|+|||||||++||++| |..||..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999999999665544444333333 456999999999999999999999999999999 7788863
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=260.36 Aligned_cols=196 Identities=25% Similarity=0.357 Sum_probs=163.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecC------C
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE------N 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 371 (540)
..+|...+.||+|+||.||+|... +|+.||+|+++.... ......+.+|+++++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368888999999999999999964 689999999865322 22234688999999999999999999988654 3
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
..++|+||+.. ++..+.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999964 6655442 3588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~ 218 (342)
T cd07879 164 ARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218 (342)
T ss_pred CcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 87543221 23357889999999876 45889999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=252.01 Aligned_cols=198 Identities=26% Similarity=0.388 Sum_probs=165.7
Q ss_pred CCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCccc-cHHHHHHHHHHHhcc---cCCCccceeEEEecCCe-----
Q 009208 303 FSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAG-GEVQFQTEVETISLA---VHRNLLRLCGFCSTENE----- 372 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~----- 372 (540)
|++.+.||+|+||.||+|..+. ++.||+|+++...... ....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667899999999999999864 8999999997543222 233566787777655 69999999999987776
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.+++|||+. ++|.+++.... ...+++..+..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999997 48888886532 23589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..+..... .....++..|+|||++.+..++.++||||||+++|||++|+.||+.
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~ 208 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG 208 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence 87643322 1233478899999999988899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=260.23 Aligned_cols=200 Identities=23% Similarity=0.328 Sum_probs=168.8
Q ss_pred HHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC-ccccHHHHHHHHHHHhcccCCCccceeEEEec-CCee
Q 009208 297 RAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN-IAGGEVQFQTEVETISLAVHRNLLRLCGFCST-ENER 373 (540)
Q Consensus 297 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~ 373 (540)
...+++|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|++++.+++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999865 78999999876432 22334568899999999999999999998865 5578
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++|+||+ +++|.++++. ..+++.....++.|+++||+|||+. +|+||||+|+||++++++.++|+|||.+.
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 8999998 5688887753 3578888899999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 157 IQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred ccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 543221 23347889999998766 56899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=256.12 Aligned_cols=202 Identities=29% Similarity=0.390 Sum_probs=165.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-cHHHHHHHHHHHhcccCCCccceeEEEecCC------
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTEN------ 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 371 (540)
.++|.+.+.||+|+||.||+|... +++.||+|++....... ....+.+|++++..++|+||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468899999999999999999975 58999999986543222 2345788999999999999999999875433
Q ss_pred --eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccc
Q 009208 372 --ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF 449 (540)
Q Consensus 372 --~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 449 (540)
..++|+||+.+ ++...+... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46899999975 666666532 34699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc----------eeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 450 GLAKLLDHRDSH----------VTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 450 gla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|+++........ ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 999765432211 11223468889999987654 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=260.48 Aligned_cols=200 Identities=23% Similarity=0.349 Sum_probs=170.9
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCC-----eeE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN-----ERL 374 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~ 374 (540)
+|.+.+.||+|++|.||+|... +++.||+|++..... ....+.+.+|+++++.++|+||+++.+++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999975 489999999876432 333457899999999999999999999987765 789
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+||||++ ++|.+++.+ ...+++..+..++.+++.||+|||+. +|+||||||+||++++++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 478887764 23799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--ceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 455 LDHRDS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 455 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 654321 112334578899999999887 7899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=253.52 Aligned_cols=199 Identities=24% Similarity=0.351 Sum_probs=170.5
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
|...+.||+|++|.||+|... +++.+++|+++..... .....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999875 6899999998764422 33457889999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++ ++.+++... ...+++..+..++.++++|+.|||+. +|+|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 888887652 25789999999999999999999999 99999999999999999999999999998665433
Q ss_pred ceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.......++..|+|||.+.+. .++.++||||+|+++|+|+||+.||...
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 202 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 112234478899999998776 7899999999999999999999999643
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=258.07 Aligned_cols=194 Identities=32% Similarity=0.436 Sum_probs=164.7
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
|+..+.||+|+||.||+|... +++.||+|.+..... .....++.+|+++++.++|+|++++.+++...+..++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 556688999999999999975 578999999864322 22334688999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+. |++.+.+... ...+++..+..++.+++.|+.|||+. +++||||+|+||+++.++.++++|||++......
T Consensus 97 ~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 97 CL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred cC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 96 6887776532 34588999999999999999999998 9999999999999999999999999998765432
Q ss_pred Cceeeccccccccccccccc---cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
....+++.|+|||.+. ...++.++|||||||++|||++|+.||..
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 2234788999999974 35678899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=257.45 Aligned_cols=196 Identities=24% Similarity=0.259 Sum_probs=161.2
Q ss_pred CeeeeccCccEEEEEeCCCcEEEEEEeccCC-ccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCCh
Q 009208 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYN-IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 385 (540)
+.+|.|+++.||++.. +++.||+|+++... .......+.+|+++++.++|+||+++++++..++..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 4445555555666555 68999999987652 233445799999999999999999999999999999999999999999
Q ss_pred hhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC-----
Q 009208 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS----- 460 (540)
Q Consensus 386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~----- 460 (540)
.+++.... ...+++.....++.|+++||+|||+. +|+||||||+||+++.++.++++|||.+..+.....
T Consensus 87 ~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 87 EDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99997542 23588899999999999999999999 999999999999999999999999998865432111
Q ss_pred -ceeeccccccccccccccccC--CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 461 -HVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 461 -~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.......++..|+|||++... .++.++|||||||++|||++|+.||..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 111233477889999998663 578999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=263.10 Aligned_cols=202 Identities=26% Similarity=0.306 Sum_probs=178.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCc-EEEEEEeccCCcccc--HHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGA-LVAVKRLKDYNIAGG--EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~-~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
.++.....||-|+||.|-....+... ..|+|.+++....+. +.....|-.+|...+.|.||+++..+.++...|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34455678999999999999885544 388898876554333 235788999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
|-|-||.+.+.|++ ++.++..+...++..+.+|++|||.+ +||+|||||+|.++|.+|.+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999986 46799999999999999999999999 999999999999999999999999999998875
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcccc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA 511 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~ 511 (540)
. ..+.+++|||.|.|||++.+...+..+|.||+|+++|||++|++||...++
T Consensus 573 g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp 624 (732)
T KOG0614|consen 573 G--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP 624 (732)
T ss_pred C--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence 4 446778899999999999999999999999999999999999999985443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=250.78 Aligned_cols=201 Identities=25% Similarity=0.362 Sum_probs=168.3
Q ss_pred CCCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCC----ccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYN----IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
+|.+.+.||+|+||.||++.... +..+++|.++... ......++..|+.+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998753 4556666655322 122334577899999999999999999999988999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
+||+++++|.+++.+.......+++..+..++.|+++|+.|||+. +++|+||+|+||++++ +.++++|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999876544556799999999999999999999998 9999999999999985 569999999987654
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
... .......|++.|+|||......++.++|+||||+++|+|++|+.||.
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~ 206 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 322 22233458899999999988888999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=242.25 Aligned_cols=195 Identities=26% Similarity=0.334 Sum_probs=164.2
Q ss_pred hcCCCc-CCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEec----CCe
Q 009208 300 TSNFSA-KNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCST----ENE 372 (540)
Q Consensus 300 ~~~~~~-~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~ 372 (540)
+++|.+ .++||-|-.|.|-....+ .|+..|+|++.... ...+|+++--.. .|||||++++++.+ ...
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 444543 267999999999988765 68999999987543 346777766544 59999999998854 456
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDF 449 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Df 449 (540)
.++|||.|+||.|.+.+.++ +..++++..+..|+.||+.|+.|||+. +|.||||||+|+|+.. +-.+|++||
T Consensus 134 LLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence 78999999999999999864 567899999999999999999999999 9999999999999974 447899999
Q ss_pred ccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
|+|+.-... ......+-||.|.|||++...+|+..+|+||+||++|-|++|.+||.
T Consensus 209 GFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY 264 (400)
T KOG0604|consen 209 GFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_pred ccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence 999865532 22344568999999999999999999999999999999999999997
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=258.91 Aligned_cols=200 Identities=24% Similarity=0.359 Sum_probs=167.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC-ccccHHHHHHHHHHHhcccCCCccceeEEEecC-----Ce
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN-IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 372 (540)
..+|.+.+.||+|+||.||+|... +++.||||.++... .......+.+|+.++..++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 356888899999999999999864 68999999987532 222344678899999999999999999987644 34
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 688887754 34689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 453 KLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
....... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 211 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence 8654332 12233457889999998765 4688999999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=257.19 Aligned_cols=197 Identities=26% Similarity=0.335 Sum_probs=161.5
Q ss_pred Ceeeec--cCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRG--GFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
..||+| +||+||++... +|+.||+|.+...... ...+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 89999999874 7899999998754322 2235688999999999999999999999999999999999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
+++.+++.+.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999987642 23588999999999999999999998 99999999999999999999999998654322111100
Q ss_pred ------eeccccccccccccccccC--CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 463 ------TTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 463 ------~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 0112246679999998764 478999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=224.24 Aligned_cols=198 Identities=24% Similarity=0.356 Sum_probs=166.7
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcccc-HHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+|...+.||+|.||+|+||+.+ .++.||+|+++-....++ .....+|+-+++.++|+|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3555678999999999999865 589999999986543332 33578999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+.. +|..|.... ++.++.....+++.|+.+|+.++|+. ++.|||+||.|.|++.+|+.|++|||+++...-+-
T Consensus 83 cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 954 677766543 45789999999999999999999999 99999999999999999999999999999766432
Q ss_pred CceeeccccccccccccccccCC-CCccCCeehhhHHHHHHHhCCCCCC
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
.......-|..|.+|.++.+.. |++..|+||-|||+.|+...-.|.-
T Consensus 156 -rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf 203 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_pred -EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence 2344556799999999998765 7889999999999999987554543
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=245.34 Aligned_cols=193 Identities=34% Similarity=0.401 Sum_probs=168.7
Q ss_pred eeeccCccEEEEEeC-CCcEEEEEEeccCCccc--cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCCh
Q 009208 309 LGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385 (540)
Q Consensus 309 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL 385 (540)
||+|+||.||++... +++.+|+|.++...... ....+..|++++++++|+||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999975 58999999987654322 344789999999999999999999999999999999999999999
Q ss_pred hhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCceeec
Q 009208 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465 (540)
Q Consensus 386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~ 465 (540)
.+++... ..+++.....++.|+++|+.|+|+. +++|+||+|+||++++++.++|+|||++....... .....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 9998652 3689999999999999999999998 99999999999999999999999999998654332 12334
Q ss_pred cccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 466 ~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
..++..|+|||...+...+.++|+||||+++||+++|+.||+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 196 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAE 196 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 45889999999998888899999999999999999999999743
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=258.13 Aligned_cols=198 Identities=25% Similarity=0.358 Sum_probs=167.1
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCC-----
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN----- 371 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 371 (540)
..++|+..+.||+|+||.||+|... +|..||||+++.... ......+.+|++++.+++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4567999999999999999999864 689999999864321 223346889999999999999999999886543
Q ss_pred -eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccc
Q 009208 372 -ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450 (540)
Q Consensus 372 -~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 450 (540)
..++||||+ +++|.+++.. ..+++..+..++.|+++|++|||+. +|+||||||+||++++++.++++|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999999 7788877753 3589999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
++....... ....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||...
T Consensus 164 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 164 LARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred cccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 998654321 23357889999999876 45889999999999999999999999743
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=260.44 Aligned_cols=218 Identities=24% Similarity=0.339 Sum_probs=182.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCcccc--HHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGG--EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
..-|...+.||-|+||+|..+.- +....+|.|.+++...-.. ....+.|..||+.-..+-||+++-.|.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 35577788999999999999874 4467899999876542211 22478899999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|+|++||++-+.|.+ .+-+.+..++.++..+..|+++.|.. |+|||||||+|||||.+|.+||.|||++.-+.
T Consensus 708 MdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 999999999888865 35688999999999999999999999 99999999999999999999999999985221
Q ss_pred ---------CCCCc--------------------------------eeeccccccccccccccccCCCCccCCeehhhHH
Q 009208 457 ---------HRDSH--------------------------------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGIL 495 (540)
Q Consensus 457 ---------~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvi 495 (540)
..+.. .....+||+.|+|||++....++..+|.||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 00000 0113459999999999999999999999999999
Q ss_pred HHHHHhCCCCCCcccccccCCcHHHHHHH
Q 009208 496 LLELITGQRALDFGRAANQRGVMLDWVCS 524 (540)
Q Consensus 496 l~elltg~~p~~~~~~~~~~~~~~~w~~~ 524 (540)
||||+.|+.||-...+.+.+-.+..|-..
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~ 889 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNF 889 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhc
Confidence 99999999999877776666677788653
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=251.95 Aligned_cols=194 Identities=32% Similarity=0.429 Sum_probs=164.4
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
|...+.||+|+||.||+|+.. +++.|++|++...... .....+.+|+++++.++|||++++++++......++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999874 6889999998654322 2234688999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+. |++.+++... ...+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 5777776542 34689999999999999999999999 999999999999999999999999999864322
Q ss_pred Cceeeccccccccccccccc---cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~ 222 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12345889999999974 45688899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=250.62 Aligned_cols=199 Identities=29% Similarity=0.389 Sum_probs=169.9
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
|+..+.||+|++|.||+|... +++.||+|.++.... ......+.+|++++++++|+|++++++++...+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999986 489999999886542 223456789999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
+ ++|.+++.+.. ..+++..+..++.++++||+|||+. +|+||||+|+||++++++.++|+|||.++.......
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 58999987531 4689999999999999999999999 999999999999999999999999999986544322
Q ss_pred ceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
. .....++..|+|||.+... .++.++||||||+++||+++|+.||...
T Consensus 154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 1 2223467889999998776 7899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=262.66 Aligned_cols=205 Identities=21% Similarity=0.283 Sum_probs=156.3
Q ss_pred HhcCCCcCCeeeeccCccEEEEEe-----------------CCCcEEEEEEeccCCccccHH--------------HHHH
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCF-----------------SDGALVAVKRLKDYNIAGGEV--------------QFQT 347 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~~ 347 (540)
..++|.+.++||+|+||.||+|.. .+++.||||+++.... .... .+..
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-GVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-hhHHHHHhhhhhhhcccchhHH
Confidence 467899999999999999999964 2356899999865321 1111 2345
Q ss_pred HHHHHhcccCCCc-----cceeEEEec--------CCeeEEEEecCCCCChhhhccccCC--------------------
Q 009208 348 EVETISLAVHRNL-----LRLCGFCST--------ENERLLVYPYMPNGSVASRLRDHIH-------------------- 394 (540)
Q Consensus 348 E~~~l~~l~h~nI-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~-------------------- 394 (540)
|+.++.+++|.++ ++++++|.. .+..++||||+++|+|.++++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6777777776654 677787753 3568999999999999999874211
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCceeecccccccccc
Q 009208 395 GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474 (540)
Q Consensus 395 ~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~a 474 (540)
....++|..+..++.|+++||.|+|+. +|+||||||+||+++.++.+||+|||++..+............+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 112357888999999999999999999 99999999999999999999999999997654332222222335889999
Q ss_pred ccccccCCC----------------------CccCCeehhhHHHHHHHhCCC-CCC
Q 009208 475 PEYLSTGQS----------------------SEKTDVFGFGILLLELITGQR-ALD 507 (540)
Q Consensus 475 PE~~~~~~~----------------------~~k~Dv~S~Gvil~elltg~~-p~~ 507 (540)
||.+..... ..+.||||+||+++||++|.. ||.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 998754321 235799999999999999985 765
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-31 Score=243.08 Aligned_cols=203 Identities=26% Similarity=0.354 Sum_probs=168.2
Q ss_pred CCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCC-ccccHHHHHHHHHHHhcccCCCccceeEEEecC-----CeeEE
Q 009208 303 FSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYN-IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NERLL 375 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~~l 375 (540)
.+..+.||.|+||.||..+. ++|+.||.|++...- .-...+++.+|++++..++|.|++..++...-. .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34558899999999999887 479999999985422 223345789999999999999999998876543 35678
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
++|.|.. + |++.+-+...++-..++-+..||.+||.|||+. +|.||||||.|.|++.+...||||||+++..
T Consensus 135 ~TELmQS-D----LHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 135 LTELMQS-D----LHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHh-h----hhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccccc
Confidence 8898853 4 444444566788888899999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcccccc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAAN 513 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~ 513 (540)
+.+.....+...-|..|.|||++++. .|+...||||.|||+.||+..+..|....+.+
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq 265 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE 265 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH
Confidence 76665555566689999999999885 58999999999999999999999998554443
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=254.55 Aligned_cols=200 Identities=24% Similarity=0.311 Sum_probs=163.3
Q ss_pred CCCcCCeeeeccCccEEEEEeC-C--CcEEEEEEeccCCc-cccHHHHHHHHHHHhcc-cCCCccceeEEEecC----Ce
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-D--GALVAVKRLKDYNI-AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE----NE 372 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~--g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~----~~ 372 (540)
+|.+.+.||+|+||.||++... . +..||+|++..... ......+.+|++++.++ .||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999975 3 77899999864321 22345678899999998 599999999875432 45
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.++++||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688889886 688888753 34689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc---eeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 453 KLLDHRDSH---VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 453 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+.+...... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 865432211 1123458999999998765 46899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=238.14 Aligned_cols=222 Identities=25% Similarity=0.347 Sum_probs=185.1
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccH-HH-HHHHHHHHhcc-cCCCccceeEEEecCCeeE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGE-VQ-FQTEVETISLA-VHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~-~~-~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 374 (540)
...+|...++||+|+|++|..+.++ ..+.+|+|++++....+.+ .+ .+.|-.+..+. +||.+|-+..++..+...+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3467889999999999999999875 5788999999876543332 12 45666666654 7999999999999999999
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+|.||.+||+|--++ +.+..+++..+..+...|.-||.|||++ +||+||+|..|||+|..|.+|+.|+|+++.
T Consensus 328 fvieyv~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhc
Confidence 999999999975444 3456799999999999999999999999 999999999999999999999999999984
Q ss_pred cCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcccccccCCcHHHHHHHHhhc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVCSHILS 528 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~w~~~~~~~ 528 (540)
-- .....+.+.+|||.|+|||++.+..|...+|.|++||+++||+.|+.|||.....+....-.+++-++|-+
T Consensus 401 ~l-~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile 473 (593)
T KOG0695|consen 401 GL-GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE 473 (593)
T ss_pred CC-CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh
Confidence 22 23445677899999999999999999999999999999999999999999654555555555666665544
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=255.69 Aligned_cols=198 Identities=26% Similarity=0.384 Sum_probs=163.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecC---------
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--------- 370 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--------- 370 (540)
.+|...+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 57888899999999999999875 589999999865442 3445688999999999999999999776543
Q ss_pred -----CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-CCCCe
Q 009208 371 -----NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEA 444 (540)
Q Consensus 371 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~ 444 (540)
...++|+||++ ++|.+++.. ..+++.....++.|+++||.|||+. +|+||||||+||+++ +++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 35789999997 588877753 3588999999999999999999999 999999999999998 45678
Q ss_pred EEcccccccccCCCCCce--eecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 445 VVGDFGLAKLLDHRDSHV--TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 445 kl~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
+++|||.++......... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||..
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 221 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999998654322111 122347889999998654 5678899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=240.75 Aligned_cols=180 Identities=22% Similarity=0.235 Sum_probs=154.5
Q ss_pred ccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCChhhhcc
Q 009208 312 GGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390 (540)
Q Consensus 312 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~ 390 (540)
|.+|.||++... +++.||+|+++... .+.+|...+....||||+++++++...+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 899999999875 68999999987643 23445555556679999999999999999999999999999999986
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCceeecccccc
Q 009208 391 DHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470 (540)
Q Consensus 391 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~ 470 (540)
+. ..+++..+..++.|+++||.|||+. +|+||||||+||++++++.++++|||.+...... .....++.
T Consensus 78 ~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~ 146 (237)
T cd05576 78 KF----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVEN 146 (237)
T ss_pred Hh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCc
Confidence 53 3589999999999999999999998 9999999999999999999999999987655432 12234677
Q ss_pred ccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 471 ~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.|+|||.+....++.++||||+|+++|||++|+.|++.
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 89999999888899999999999999999999988763
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=273.08 Aligned_cols=146 Identities=31% Similarity=0.394 Sum_probs=130.5
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|.+.+.||+|+||.||+|... +++.||+|+++..... .....+.+|+.++..++|+||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999986 6899999998754322 22356889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
||+++++|.+++... ..+++..++.++.||+.||+|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998642 3588899999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=254.93 Aligned_cols=197 Identities=26% Similarity=0.350 Sum_probs=166.9
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCe----
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE---- 372 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---- 372 (540)
..++|...+.||+|++|.||+|... +++.||+|++..... ......+.+|+.++++++|+|++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567889999999999999999985 578999999865321 2233467789999999999999999988765554
Q ss_pred --eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccc
Q 009208 373 --RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450 (540)
Q Consensus 373 --~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 450 (540)
.++|+||+ +++|.+++.. ..+++..+..++.|+++|+.|||+. +|+||||||+||++++++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 6799888763 3689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99865432 223357889999999865 3678999999999999999999999964
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=237.08 Aligned_cols=218 Identities=25% Similarity=0.298 Sum_probs=183.9
Q ss_pred HHHHHHHhcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEE
Q 009208 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366 (540)
Q Consensus 293 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 366 (540)
..++....++++....+-+|.||+||+|.|. +.+.|-||.++....+-.-..+..|.-.+..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4466666677888889999999999999664 3566888988876655445568889988989999999999999
Q ss_pred Eec-CCeeEEEEecCCCCChhhhcccc----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC
Q 009208 367 CST-ENERLLVYPYMPNGSVASRLRDH----IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED 441 (540)
Q Consensus 367 ~~~-~~~~~lV~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~ 441 (540)
+.+ ....++.|.++.-|+|..||... ......++..+...++.|++.|++|||.. ++||.||..+|.++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 864 55688999999999999999832 22344678888999999999999999999 99999999999999999
Q ss_pred CCeEEcccccccccCCCCCceee-ccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCcccccc
Q 009208 442 FEAVVGDFGLAKLLDHRDSHVTT-AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFGRAAN 513 (540)
Q Consensus 442 ~~~kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~~~~~~ 513 (540)
.++||+|=.+++.+.+.+.+..+ .......||+||.+.+..|+..+|||||||++|||+| |+.|+...++.+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE 506 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH
Confidence 99999999999988777666543 3446789999999999999999999999999999998 899997665544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=256.75 Aligned_cols=208 Identities=27% Similarity=0.413 Sum_probs=177.6
Q ss_pred CHHHHHHHhcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEe-
Q 009208 292 TFKELRAATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCS- 368 (540)
Q Consensus 292 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~- 368 (540)
.++.+...++.|.+.++||.|.+|.||+++. ++++.+|+|++.... +...+...|.+++... .|||++.++|++.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3444555678889999999999999999985 478999999987643 4445678888888876 6999999999985
Q ss_pred ----cCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCe
Q 009208 369 ----TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA 444 (540)
Q Consensus 369 ----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 444 (540)
.+++.++|||||.+||..+.++... ...+.|..+.-|+..++.|+.+||.. .++|||||-.|||++.++.+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcE
Confidence 3578999999999999999998765 56799999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCceeecccccccccccccccc-----CCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 445 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 445 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
|+.|||++..++... .......||+.|||||++.- ..|+.++|+||+|++..||--|.+|+-
T Consensus 163 KLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~ 229 (953)
T KOG0587|consen 163 KLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC 229 (953)
T ss_pred EEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence 999999998776433 33445569999999999854 346789999999999999999999985
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=229.63 Aligned_cols=200 Identities=31% Similarity=0.433 Sum_probs=171.8
Q ss_pred CCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCC
Q 009208 303 FSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP 381 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~ 381 (540)
|...+.||+|++|.||++...+ ++.+|+|.+...........+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566889999999999999875 899999998865433245678999999999999999999999999899999999999
Q ss_pred CCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc
Q 009208 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461 (540)
Q Consensus 382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 461 (540)
+++|.+++.... ..+++.....++.++++++.+||+. +++|+|++|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999987532 1278999999999999999999999 9999999999999999999999999999876543211
Q ss_pred eeecccccccccccccc-ccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 462 VTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 462 ~~~~~~gt~~y~aPE~~-~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
......++..|++||.. ....++.++||||||++++||++|+.||+.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334578899999998 666778899999999999999999999963
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=249.68 Aligned_cols=198 Identities=24% Similarity=0.328 Sum_probs=169.5
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCccc-----cH--HHHHHHHHHHhccc---CCCccceeEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAG-----GE--VQFQTEVETISLAV---HRNLLRLCGFCS 368 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~-----~~--~~~~~E~~~l~~l~---h~nIv~l~~~~~ 368 (540)
..+|...+.+|+|+||.|+.|.++. ...|+||.+.+...-. ++ -..-.|+++|+.++ |+||++++++++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3568889999999999999999864 5789999887654211 11 13567999999998 999999999999
Q ss_pred cCCeeEEEEecCCC-CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEc
Q 009208 369 TENERLLVYPYMPN-GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG 447 (540)
Q Consensus 369 ~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 447 (540)
+++.+||+||-... -+|.+++.. ++.++++.+..|++|++-|+++||++ +|||||||-+||.++.+|-+||+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence 99999999997644 477777764 56799999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCceeeccccccccccccccccCCC-CccCCeehhhHHHHHHHhCCCCCC
Q 009208 448 DFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 448 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
|||.+...... ....++||.+|.|||++.+..| +..-|||++|+++|.++..+.||.
T Consensus 713 dfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999865433 3456679999999999998877 566799999999999999999986
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=252.12 Aligned_cols=192 Identities=27% Similarity=0.368 Sum_probs=162.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++.|.....+|.|+|+.|-++... +++..+||++.+.. .+-.+|+.++... .||||+++.+.+.+..+.++||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 567778888999999999988864 57889999987652 1235567666554 6999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee-CCCCCeEEcccccccccC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL-DEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl-~~~~~~kl~Dfgla~~~~ 456 (540)
|.+.++-+.+.+... +... ..+..|+.+|+.|+.|||++ ++||||+||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK----PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999887777642 2233 67778999999999999999 99999999999999 699999999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. ....+-|..|.|||++....|++++|+||||++||+|++|+.||..
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~ 515 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAA 515 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcccc
Confidence 43 2223468899999999999999999999999999999999999974
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=260.81 Aligned_cols=201 Identities=21% Similarity=0.262 Sum_probs=145.4
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-C----CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEE------E
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-D----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF------C 367 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~------~ 367 (540)
..++|.+.+.||+|+||.||+|.+. + +..||+|+++.... ...+..| .+....+.++..++.. +
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 4678999999999999999999975 4 68999999764321 1111111 1111222223222211 2
Q ss_pred ecCCeeEEEEecCCCCChhhhccccCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 009208 368 STENERLLVYPYMPNGSVASRLRDHIH----------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDV 431 (540)
Q Consensus 368 ~~~~~~~lV~e~~~~gsL~~~l~~~~~----------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl 431 (540)
......++|+||+++++|.+++..... .........+..++.|++.||.|||+. +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 456678999999999999998864210 001112344667999999999999999 9999999
Q ss_pred CCCceeeCC-CCCeEEcccccccccCCCCCceeeccccccccccccccccC----------------------CCCccCC
Q 009208 432 KAANILLDE-DFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG----------------------QSSEKTD 488 (540)
Q Consensus 432 k~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k~D 488 (540)
||+|||+++ ++.+||+|||+++.+............+|+.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999985 57999999999987655444444556789999999965322 2345679
Q ss_pred eehhhHHHHHHHhCCCCCC
Q 009208 489 VFGFGILLLELITGQRALD 507 (540)
Q Consensus 489 v~S~Gvil~elltg~~p~~ 507 (540)
||||||++|||+++..|++
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999887765
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=227.53 Aligned_cols=187 Identities=34% Similarity=0.468 Sum_probs=164.9
Q ss_pred cCccEEEEEeCC-CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCChhhhccc
Q 009208 313 GFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD 391 (540)
Q Consensus 313 ~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 391 (540)
+||.||+|...+ |+.+|+|++...........+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999864 8999999987655333256899999999999999999999999999999999999999999998865
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCceeeccccccc
Q 009208 392 HIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471 (540)
Q Consensus 392 ~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~ 471 (540)
. ..+++..+..++.++++++.|||+. +++|+||+|+||++++++.++++|||.+....... ......++..
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 2 2388999999999999999999999 99999999999999999999999999998765432 2234458889
Q ss_pred cccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 472 y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|++||......++.++||||||++++++++|+.||+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999888889999999999999999999999974
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-30 Score=229.71 Aligned_cols=201 Identities=28% Similarity=0.437 Sum_probs=162.6
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcccc-HHHHHHHHHHHhcccCCCccceeEEEec--------CC
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG-EVQFQTEVETISLAVHRNLLRLCGFCST--------EN 371 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------~~ 371 (540)
.|.....||+|.||+|++|+.+ .|+.||+|+.--.....+ ...-.+|++++..++|+|++.++..|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3445578999999999999875 477899987644332222 2356899999999999999999998853 23
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
..++|+++++. +|.-.|.+. ...++...+.++++++..||.|+|.. .|+|||+|+.|+|++.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 47999999976 666666543 35688899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCce---eecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 452 AKLLDHRDSHV---TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 452 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
++.+..+++.. .+..+-|..|.+||.+.+ ..|+++.|||.-|||+.||.||.+-+...
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn 232 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN 232 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC
Confidence 97665433222 122345899999999876 46899999999999999999999888743
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=217.56 Aligned_cols=195 Identities=20% Similarity=0.317 Sum_probs=165.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEecCC--eeEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTEN--ERLL 375 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~~~l 375 (540)
.++|++.+.+|+|.|++|+.|.. .+.+.++||.+++.. .+.+.+|++++..+. ||||++++++..++. ...+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 46788899999999999999984 578999999998643 567899999999997 999999999987654 4679
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-CCCeEEcccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDFGLAKL 454 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~ 454 (540)
|+||..+.++...- +.++...+..++.+++.||.|+|+. ||+|||+||.|+++|. .-..+++|+|+|.+
T Consensus 113 iFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence 99999998866543 3567778899999999999999999 9999999999999995 45799999999998
Q ss_pred cCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
+.+..... ....+..|.-||.+-. +.|+..-|+|||||++.+|+..+.||-.+.
T Consensus 183 YHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 183 YHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred cCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 87655432 2236778889998855 457889999999999999999999998653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=232.58 Aligned_cols=199 Identities=22% Similarity=0.292 Sum_probs=168.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccC--CC----ccceeEEEecCCe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH--RN----LLRLCGFCSTENE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~n----Iv~l~~~~~~~~~ 372 (540)
+.+|.+...+|+|.||.|-+.... .+..||||+++.. ...+..-.-|++++.++.+ |+ ++++.+++...++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 678889999999999999998865 4789999998753 2334456789999998842 33 6788888999999
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC------------
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE------------ 440 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~------------ 440 (540)
.+||+|.+ |-|+.++|.+. +..+++...++.++.|++++++|||+. +++|-||||+|||+-+
T Consensus 166 iCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred eEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCc
Confidence 99999988 66999999863 456789999999999999999999999 9999999999999831
Q ss_pred --------CCCeEEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 441 --------DFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 441 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
+..+|++|||.|....... ..++.|..|.|||++.+..++..+||||+||||.|+.||...|..-+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 3368999999998644322 45568999999999999999999999999999999999999998543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=255.21 Aligned_cols=196 Identities=30% Similarity=0.412 Sum_probs=160.1
Q ss_pred CCcCCeeeeccCcc-EEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEEecC
Q 009208 303 FSAKNILGRGGFGI-VYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 303 ~~~~~~lG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
|...+++|.|+-|+ ||+|.+ +|+.||||++-... ..-..+|+..+..- .|||||++++...++...||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 44557889999875 699999 78999999986432 23457899999877 5999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---C--CCeEEccccccccc
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---D--FEAVVGDFGLAKLL 455 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~--~~~kl~Dfgla~~~ 455 (540)
. -+|.+++...........-.....+..|+++|+++||+. +||||||||.||||+. + ..++|+|||+++.+
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5 599999976311111111144567889999999999998 9999999999999975 2 47899999999998
Q ss_pred CCCCCcee--eccccccccccccccccCCCCccCCeehhhHHHHHHHhC-CCCCC
Q 009208 456 DHRDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG-QRALD 507 (540)
Q Consensus 456 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg-~~p~~ 507 (540)
........ ....||-||+|||++....-+..+||||+||++|+.++| ++||.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC
Confidence 76554432 355699999999999999889999999999999999997 99996
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-27 Score=217.33 Aligned_cols=219 Identities=23% Similarity=0.268 Sum_probs=173.6
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccC-CccccHHHHHHHHHHHhcccCCCccceeEEEecC------Ce
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDY-NIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE------NE 372 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~ 372 (540)
.+|.-...+|.|.- .|..|... .++.||+|++... ......++-.+|...+..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34556677888887 56555543 5889999987532 2233345678899999999999999999988533 46
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.|+|||+|. ++|.+.+.- .++-.++..|..|+..|++|||+. +|+||||||+||++..+..+||.|||+|
T Consensus 96 ~y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 789999994 577777652 467788999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcccccccCCcHHHHHHHHhhcCCcc
Q 009208 453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVCSHILSNQSS 532 (540)
Q Consensus 453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~w~~~~~~~~~~~ 532 (540)
+.-+.. ...+....|..|.|||++.+..+.+.+||||.||++.||++|+--|.+ +..+.+|.+..-..+.+-
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g------~d~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG------KDHIDQWNKIIEQLGTPD 237 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC------chHHHHHHHHHHHhcCCC
Confidence 865433 344566789999999999998899999999999999999999999873 335667777665555554
Q ss_pred hhhhhc
Q 009208 533 LDMVLN 538 (540)
Q Consensus 533 ~~~l~~ 538 (540)
.....+
T Consensus 238 ~~F~~q 243 (369)
T KOG0665|consen 238 PSFMKQ 243 (369)
T ss_pred HHHHHH
Confidence 444433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-25 Score=203.82 Aligned_cols=184 Identities=38% Similarity=0.548 Sum_probs=159.8
Q ss_pred eeeccCccEEEEEeCC-CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCChhh
Q 009208 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVAS 387 (540)
Q Consensus 309 lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~ 387 (540)
||+|.+|.||++...+ ++.+++|++...........+.+|++.+..++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999998865433234579999999999999999999999999999999999999999999
Q ss_pred hccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-CCCeEEcccccccccCCCCCceeecc
Q 009208 388 RLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDFGLAKLLDHRDSHVTTAV 466 (540)
Q Consensus 388 ~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~~~~~~~~~~~~~ 466 (540)
++.... ..+++..+..++.++++++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 987531 4688999999999999999999999 9999999999999999 89999999999986654321 12234
Q ss_pred ccccccccccccccC-CCCccCCeehhhHHHHHH
Q 009208 467 RGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLEL 499 (540)
Q Consensus 467 ~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~el 499 (540)
.+...|++||..... ..+.++|+|++|++++++
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 478899999998877 788999999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=217.36 Aligned_cols=199 Identities=25% Similarity=0.386 Sum_probs=165.9
Q ss_pred HHHHhcCCCcCCeeeeccCccEEEEEeC----CCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEecC
Q 009208 296 LRAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTE 370 (540)
Q Consensus 296 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 370 (540)
.......|..+++||+|.|++||++.+. ..+.||+|.+.....+ ....+|++++..+. +.||+++.+++..+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 3445577889999999999999999864 3678999998765433 36889999999885 89999999999999
Q ss_pred CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-CCCCeEEccc
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDF 449 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Df 449 (540)
+...+|+||++.....++... ++...+..+...+..||.++|.+ |||||||||+|+|++ ..+.-.|.||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 999999999999998888764 56788999999999999999999 999999999999998 4567899999
Q ss_pred ccccccCCCC---------------------------------Cc----------eeeccccccccccccccccC-CCCc
Q 009208 450 GLAKLLDHRD---------------------------------SH----------VTTAVRGTVGHIAPEYLSTG-QSSE 485 (540)
Q Consensus 450 gla~~~~~~~---------------------------------~~----------~~~~~~gt~~y~aPE~~~~~-~~~~ 485 (540)
|+|...+... +. ..-..+||+||.|||++... .-++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 9987221000 00 00123499999999998765 4688
Q ss_pred cCCeehhhHHHHHHHhCCCCCC
Q 009208 486 KTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 486 k~Dv~S~Gvil~elltg~~p~~ 507 (540)
++||||.|||++.+++++.||-
T Consensus 258 aiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred ccceeeccceeehhhccccccc
Confidence 9999999999999999999996
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-26 Score=206.21 Aligned_cols=195 Identities=21% Similarity=0.350 Sum_probs=156.9
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEE-EecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGF-CSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~-~~~~~~~~lV 376 (540)
.+.|.+.+.+|+|.||.+-.+..+ ..+.+++|.+.... ...++|.+|...--.+ .|.||+.-+++ ++..+.++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 356888999999999999999986 46789999886543 3356788888654444 58999988765 5677888899
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC--CCCCeEEcccccccc
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD--EDFEAVVGDFGLAKL 454 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~Dfgla~~ 454 (540)
+||++.|+|.+-+.. ..+-+..-.+++.|+++|+.|+|++ ++||||||.+|||+- +..++|+||||..+.
T Consensus 101 qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccc
Confidence 999999998877653 3477888899999999999999999 999999999999984 455899999999875
Q ss_pred cCCCCCceeeccccccccccccccccC-----CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.+..- ....-+..|.+||..... ...+.+|||.||++++.++||+.||..
T Consensus 173 ~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 173 VGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred cCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 43211 122346789999986432 346789999999999999999999983
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=213.88 Aligned_cols=167 Identities=23% Similarity=0.214 Sum_probs=129.3
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeC--CCcEEEEEEeccCCc----cccHHHHHHHHHHHhcccCCCccceeEEEecCC
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNI----AGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN 371 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 371 (540)
...++|.+.+.||+|+||+||+|..+ +++.||||++..... ......|.+|++++.+++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34578999999999999999999875 578889998753311 1234568999999999999999853322 24
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceeeCCCCCeEEcccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDV-KAANILLDEDFEAVVGDFG 450 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl-k~~NILl~~~~~~kl~Dfg 450 (540)
..++||||+++++|.. +.. .. ...++.++++||.|||+. +|+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~-~~~----~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHL-ARP----HG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHH-hCc----cc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 6799999999999863 211 11 146788999999999999 9999999 9999999999999999999
Q ss_pred cccccCCCCCce-------eeccccccccccccccccC
Q 009208 451 LAKLLDHRDSHV-------TTAVRGTVGHIAPEYLSTG 481 (540)
Q Consensus 451 la~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 481 (540)
+++.+....... .....+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 998765432111 1245688899999998643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-25 Score=218.64 Aligned_cols=218 Identities=22% Similarity=0.226 Sum_probs=175.7
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhccc------CCCccce
Q 009208 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV------HRNLLRL 363 (540)
Q Consensus 291 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~l 363 (540)
+.+.|+ ....|.+....|+|-|++|.+|... .|+.||||+++..... .+.=+.|+++|.+++ --|.+++
T Consensus 424 v~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 424 VRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred Eehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 344444 3567888889999999999999875 4789999999764322 223467999999885 3478999
Q ss_pred eEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-C
Q 009208 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-F 442 (540)
Q Consensus 364 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~ 442 (540)
+..|...++++||+|-+ ..+|.+.|+.+ .....+....+..++.|+.-||..|... +|+|.||||.|||+++. .
T Consensus 500 ~r~F~hknHLClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHhhhcceeEEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 99999999999999987 45889988864 4455688899999999999999999998 99999999999999965 4
Q ss_pred CeEEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcccccccCCcHHHHH
Q 009208 443 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWV 522 (540)
Q Consensus 443 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~w~ 522 (540)
.+||||||.|....... .++..-+..|.|||++.+-.|+...|+||.||.||||.||+..|.... +-.|++..
T Consensus 575 iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T----NN~MLrl~ 647 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT----NNQMLRLF 647 (752)
T ss_pred eeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC----cHHHHHHH
Confidence 68999999998655332 233345678999999999999999999999999999999999997432 33456555
Q ss_pred HH
Q 009208 523 CS 524 (540)
Q Consensus 523 ~~ 524 (540)
+.
T Consensus 648 me 649 (752)
T KOG0670|consen 648 ME 649 (752)
T ss_pred HH
Confidence 43
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-25 Score=225.69 Aligned_cols=199 Identities=27% Similarity=0.352 Sum_probs=170.0
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|.....+|.|.||.||||+.. .++..|+|.++-.. .+...-.++|+-+++..+||||+.++|-+...+..+++||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 467888899999999999999975 68999999998654 2333457889999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+.+|+|.+.-+ ...++++.++...++...+|++|||++ +=+|||||-.||++++.+.+|++|||.+-.+...
T Consensus 93 ycgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred ecCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence 999999887544 356899999999999999999999999 8899999999999999999999999998755432
Q ss_pred CCceeecccccccccccccc---ccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 459 DSHVTTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
......+.||+.|||||+. ..+.|..++|||+.|+...|+-.-+.|..
T Consensus 166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf 216 (829)
T KOG0576|consen 166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF 216 (829)
T ss_pred -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc
Confidence 2223456799999999986 45678999999999999999877776653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=206.85 Aligned_cols=132 Identities=22% Similarity=0.330 Sum_probs=110.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhccc-----C---CCccceeEEEec-
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-----H---RNLLRLCGFCST- 369 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~l~~~~~~- 369 (540)
..+|.+.++||-|.|++||.+.. ++.+.||+|+.+... ...+.-..||++|.+++ | ..||+++++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 36788999999999999999986 457889999987642 33345688999998874 3 359999999864
Q ss_pred ---CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009208 370 ---ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438 (540)
Q Consensus 370 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl 438 (540)
..+.+||+|++ |.+|..+|... .-..++...+++|+.||+.||.|||.+| +|||-||||+|||+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45789999999 67888888753 2345888999999999999999999998 99999999999999
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.6e-23 Score=234.12 Aligned_cols=154 Identities=38% Similarity=0.673 Sum_probs=117.7
Q ss_pred chHHHHHHHHHHhcCCCCCccCCCCCCCCCCccceeeeecCCCcEEEecCCCCCCccccCccccCCCccCEEEcccCCCC
Q 009208 32 NYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAIL 111 (540)
Q Consensus 32 ~~~~~~l~~~k~~~~~~~~~~~~w~~~~~~~c~w~gv~c~~~~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~ 111 (540)
+.|+.||++||+++.+|.+.+.+|+ ++.+||.|.||+|+..++|+.|+|++|+++|.++..+..+++|+.|+|++|+++
T Consensus 28 ~~~~~~l~~~~~~~~~~~~~~~~w~-~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~ 106 (968)
T PLN00113 28 AEELELLLSFKSSINDPLKYLSNWN-SSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLS 106 (968)
T ss_pred HHHHHHHHHHHHhCCCCcccCCCCC-CCCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccC
Confidence 3689999999999999988899997 467899999999987789999999999999999999999999999999999999
Q ss_pred CCCCcccC-CCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCC
Q 009208 112 GPIPASLG-KLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188 (540)
Q Consensus 112 ~~~p~~~~-~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 188 (540)
|.+|..+. ++++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|..++++++|++|++++|.+++.+|.
T Consensus 107 ~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 182 (968)
T PLN00113 107 GPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182 (968)
T ss_pred CcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCCh
Confidence 88887655 777777777777777665553 2345555555555555555555555555555555555555544443
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-22 Score=214.62 Aligned_cols=160 Identities=40% Similarity=0.658 Sum_probs=127.6
Q ss_pred CCCCchHHHHHHHHHHhcCCCCCccCCCCCCCCCCc-----cceeeeecCC-----CcEEEecCCCCCCccccCccccCC
Q 009208 28 PAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPC-----SWRMITCSPD-----GYVSALGLPSQSLSGTLSPWIGNL 97 (540)
Q Consensus 28 ~~~~~~~~~~l~~~k~~~~~~~~~~~~w~~~~~~~c-----~w~gv~c~~~-----~~l~~l~l~~~~l~~~~~~~~~~l 97 (540)
......|..||+.+|.++.+|.. .+|+. +|| .|.||+|..+ ..++.|+|++|+++|.+|..+++|
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L 441 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL 441 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence 34566789999999999987642 48953 456 6999999632 258889999999999999999999
Q ss_pred CccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCC-ccccEEe
Q 009208 98 TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKI-ESLTLVD 176 (540)
Q Consensus 98 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l-~~L~~L~ 176 (540)
++|+.|+|++|+++|.+|..++.+++|+.|+|++|+|+|.+|+.++++++|+.|+|++|+++|.+|..+..+ .++.
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~--- 518 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRA--- 518 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCc---
Confidence 999999999999999999889999999999999999999999999999999999999999998888877543 1222
Q ss_pred cccCcccccCCCCCcccccccCCCCCcCCCCCCCC
Q 009208 177 LSYNNLSGSLPKISARTFKVTGNPLICGPKATNNC 211 (540)
Q Consensus 177 l~~N~l~~~~p~~~~~~~~~~~n~~~~~~~~~~~c 211 (540)
.+++.+|+.+|+.+....|
T Consensus 519 ----------------~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 519 ----------------SFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred ----------------eEEecCCccccCCCCCCCC
Confidence 3456677777875544444
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-22 Score=227.96 Aligned_cols=146 Identities=15% Similarity=0.136 Sum_probs=114.1
Q ss_pred ccC-CCccceeEEE-------ecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 009208 355 AVH-RNLLRLCGFC-------STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426 (540)
Q Consensus 355 l~h-~nIv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 426 (540)
..| +||.++++++ ......+.++||+ +++|.++|... ...+++..++.++.||++||+|||++ +|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 345 6888888877 2234567788887 66999999642 34699999999999999999999999 99
Q ss_pred EecCCCCCceeeCC-------------------CCCeEEcccccccccCCCCC---------------ceeecccccccc
Q 009208 427 IHRDVKAANILLDE-------------------DFEAVVGDFGLAKLLDHRDS---------------HVTTAVRGTVGH 472 (540)
Q Consensus 427 vH~Dlk~~NILl~~-------------------~~~~kl~Dfgla~~~~~~~~---------------~~~~~~~gt~~y 472 (540)
+||||||+|||++. ++.+|++|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566777777654221000 001123478899
Q ss_pred ccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 473 IAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 473 ~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
||||++.+..++.++|||||||++|||++|..|+.
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 99999999999999999999999999999998876
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=193.66 Aligned_cols=201 Identities=21% Similarity=0.239 Sum_probs=163.8
Q ss_pred CCCcCCeeeeccCccEEEEEeCCC--cEEEEEEeccCCccccHHHHHHHHHHHhcccC----CCccceeEEE-ecCCeeE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFSDG--ALVAVKRLKDYNIAGGEVQFQTEVETISLAVH----RNLLRLCGFC-STENERL 374 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~l~~~~-~~~~~~~ 374 (540)
+|.+.+.||+|+||.||++...+. ..+|+|.-......... .+..|+.++..+.+ +++..+++.. ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 788999999999999999997553 47888887654333333 57788888887762 5788888888 5777899
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-----CCeEEccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-----FEAVVGDF 449 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-----~~~kl~Df 449 (540)
+||+.+ |.+|.+...... ...++..+...|+.|++.+|+++|+. +++||||||.|+.+... ..+.+.||
T Consensus 98 iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 999977 789998665432 56799999999999999999999999 99999999999999854 46899999
Q ss_pred cccc--ccCCCCCc------e-eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 450 GLAK--LLDHRDSH------V-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 450 gla~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
|+++ .+...... . .....||..|.+++...+...+.+.|+||++-++.|+..|..||...
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 9998 33211111 1 12355999999999999999999999999999999999999999643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.4e-21 Score=191.19 Aligned_cols=201 Identities=34% Similarity=0.451 Sum_probs=170.7
Q ss_pred CCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccc--cHHHHHHHHHHHhcccCC-CccceeEEEecCCeeEEEEec
Q 009208 303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHR-NLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lV~e~ 379 (540)
|...+.+|.|+||.||++... ..+++|.+....... ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556788999999999999986 889999998765444 366799999999999988 799999999777778999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEcccccccccCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHR 458 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~ 458 (540)
+.++++.+++...... ..+.......+..+++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999766543211 3688899999999999999999999 999999999999999888 7999999999855543
Q ss_pred CCc-----eeecccccccccccccccc---CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 459 DSH-----VTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 459 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
... ......||..|+|||.+.. ..++...|+||+|++++++++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~ 214 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 322 2355679999999999987 57889999999999999999999997643
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=178.50 Aligned_cols=141 Identities=16% Similarity=0.186 Sum_probs=109.8
Q ss_pred CCeeeeccCccEEEEEeCCCcEEEEEEeccCCccc-c-------HHH-----------------HHHHHHHHhcccCCCc
Q 009208 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG-G-------EVQ-----------------FQTEVETISLAVHRNL 360 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-~-------~~~-----------------~~~E~~~l~~l~h~nI 360 (540)
...||+|+||.||+|...+|+.||||+++...... . ... ...|.+.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 36799999999999998889999999997643211 1 012 2349999999988877
Q ss_pred cceeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCceeeC
Q 009208 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL-HEQCDPKIIHRDVKAANILLD 439 (540)
Q Consensus 361 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~Dlk~~NILl~ 439 (540)
.....+.. ...++||||++++++...... ...+++.....++.|++.+|.|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 54443322 234899999998876544321 24688999999999999999999 687 999999999999998
Q ss_pred CCCCeEEcccccccccC
Q 009208 440 EDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 440 ~~~~~kl~Dfgla~~~~ 456 (540)
++.++|+|||++...+
T Consensus 153 -~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 -DGKLYIIDVSQSVEHD 168 (190)
T ss_pred -CCcEEEEEccccccCC
Confidence 4789999999997544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.8e-21 Score=173.40 Aligned_cols=205 Identities=20% Similarity=0.229 Sum_probs=166.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccC-CCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH-RNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lV~ 377 (540)
..+|...+.||.|+||.+|.|.. .+|+.||||.-+... ...++.-|.++++.++| ..|..+.-|..+.....+||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 46788999999999999999984 689999999854322 23367789999999876 66777777788888899999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC---CCCCeEEcccccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKL 454 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgla~~ 454 (540)
+.+ |-||.+...-. ...++..+.+-++.|++.-++|+|.+ ++|||||||+|.|+. .-..+.++|||+|+.
T Consensus 91 dLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhh
Confidence 988 77888876533 34688899999999999999999999 999999999999986 345789999999997
Q ss_pred cCCCCCc------eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCccccccc
Q 009208 455 LDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ 514 (540)
Q Consensus 455 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~~ 514 (540)
+.+.... ......||.+|.+-....+.+-+.+-|+=|+|.++...--|..||..-.....
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk 229 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK 229 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence 7543322 12334599999998887777778899999999999999999999996554443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-21 Score=178.61 Aligned_cols=172 Identities=10% Similarity=0.061 Sum_probs=132.9
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccH--H------HHHHHHHHHhcccCCCccceeEEEecC
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGE--V------QFQTEVETISLAVHRNLLRLCGFCSTE 370 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~--~------~~~~E~~~l~~l~h~nIv~l~~~~~~~ 370 (540)
...+|...+++|.|+||.||.... ++..+|+|.++........ . .+.+|++.+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357899999999999999999766 5778999999765422211 1 268999999999999999998885432
Q ss_pred --------CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 009208 371 --------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442 (540)
Q Consensus 371 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~ 442 (540)
+..++||||++|.+|.++.. ++. ....+++.++..+|.. +++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 35789999999999877632 222 2456999999999999 999999999999999988
Q ss_pred CeEEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHH
Q 009208 443 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELI 500 (540)
Q Consensus 443 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ell 500 (540)
++++|||..+........ ..+.....+..++|+||||+.+....
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988654321110 11344555668999999999876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.6e-20 Score=170.82 Aligned_cols=141 Identities=18% Similarity=0.186 Sum_probs=112.2
Q ss_pred CCeeeeccCccEEEEEeCCCcEEEEEEeccCCcccc-------------------------HHHHHHHHHHHhcccCCCc
Q 009208 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-------------------------EVQFQTEVETISLAVHRNL 360 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-------------------------~~~~~~E~~~l~~l~h~nI 360 (540)
...||+|++|.||+|...+|+.||||+++....... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999987899999999886431100 1123578999999999988
Q ss_pred cceeEEEecCCeeEEEEecCCCCChhhh-ccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceee
Q 009208 361 LRLCGFCSTENERLLVYPYMPNGSVASR-LRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILL 438 (540)
Q Consensus 361 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl 438 (540)
.....+... ..++||||++++++... +. ...++......++.+++.++.++|+ . +|+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 655544433 34899999998865433 32 2356778899999999999999999 8 99999999999999
Q ss_pred CCCCCeEEcccccccccCC
Q 009208 439 DEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 439 ~~~~~~kl~Dfgla~~~~~ 457 (540)
+ ++.++|+|||++..+..
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 78999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-21 Score=177.91 Aligned_cols=194 Identities=24% Similarity=0.379 Sum_probs=152.7
Q ss_pred CCeeeeccCccEEEEEeCCCcEEEEEEeccCC-ccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCC
Q 009208 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYN-IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS 384 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 384 (540)
..+|.+...|+.|+|+| .|..+++|+++... .....++|..|.-.++.+.||||+.++|.|..+....++..||+.||
T Consensus 195 ~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 35688899999999999 45666677776433 23334579999999999999999999999999999999999999999
Q ss_pred hhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCceee
Q 009208 385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464 (540)
Q Consensus 385 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~ 464 (540)
|+..|++. ..-.++-.++.+++.++|+|++|||+. .|-|.---+.+..|++|++.+++|+ .+-.++- ....
T Consensus 274 lynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfs-----fqe~ 344 (448)
T KOG0195|consen 274 LYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS-----FQEV 344 (448)
T ss_pred HHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceee-----eecc
Confidence 99999863 345678889999999999999999986 3344445689999999999998875 1111110 0011
Q ss_pred ccccccccccccccccCCC---CccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 465 AVRGTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 465 ~~~gt~~y~aPE~~~~~~~---~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
...-.|.||+||.++.... -..+|+|||++++|||.|.+-||..-
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl 392 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL 392 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC
Confidence 1224689999999976543 35789999999999999999999743
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-20 Score=171.23 Aligned_cols=106 Identities=26% Similarity=0.243 Sum_probs=93.8
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|.++++.. ...++|..+..++.|+++||+|||+. + ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6888888753 34699999999999999999999998 5 999999999999999 99998654422
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~ 106 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 2489999999999999999999999999999999999999963
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=164.81 Aligned_cols=185 Identities=18% Similarity=0.074 Sum_probs=138.9
Q ss_pred CcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCcccc---HHHHHHHHHHHhccc-CCCccceeEEEecCCeeEEEEec
Q 009208 304 SAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG---EVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 304 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~---~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.....|++|+||+||.+.. ++.+++.+.+........ ...+.+|++++.++. |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999997766 788888887765443211 225789999999995 4889999886 457999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCceeeCCCCCeEEcccccccccCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDV-KAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl-k~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
++|.+|.+.+.. ....++.++++++.++|+. +|+|||| ||+|||+++++.++|+|||++......
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999998654311 1135778999999999999 9999999 799999999999999999999854432
Q ss_pred CCc----e--------eeccccccccccccccccC-CCC-ccCCeehhhHHHHHHHhCCCCCC
Q 009208 459 DSH----V--------TTAVRGTVGHIAPEYLSTG-QSS-EKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 459 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
... . ......++.|++|+...-. ..+ ...+.++-|.-+|.++|+..|.-
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 210 0 1122357788888764322 222 45688899999999999998775
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=170.60 Aligned_cols=198 Identities=19% Similarity=0.268 Sum_probs=163.6
Q ss_pred cCCCcCCeeeeccCccEEEEE-eCCCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e 378 (540)
-.|.+.+.||+|+||.++.|+ +-+++.||||.=... ....++..|-+.++.+. .+.|..++-+-...-+..||+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk---S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK---SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc---CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 357788999999999999998 458999999974321 22236778888888775 5888888877777778889999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-----CCCeEEccccccc
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-----DFEAVVGDFGLAK 453 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~Dfgla~ 453 (540)
.+ |-||.+...=+ ...++..++..+|.|++.-++|+|++ .+|.|||||+|+||.. ...+.++|||+|+
T Consensus 105 LL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 88 77888766432 34689999999999999999999999 9999999999999973 3468999999999
Q ss_pred ccCCCCCc------eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 454 LLDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 454 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.+.+.... ......||.+||+-....+.+-+.+-|+=|+|-+++..+-|..||..
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 87654432 22345699999999999999999999999999999999999999984
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=158.54 Aligned_cols=137 Identities=19% Similarity=0.244 Sum_probs=104.9
Q ss_pred CcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcc-----cCCCccceeEEEecCC---e-eE
Q 009208 304 SAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-----VHRNLLRLCGFCSTEN---E-RL 374 (540)
Q Consensus 304 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~---~-~~ 374 (540)
...+.||+|+||.||. .-.++.. +||++.... ......+.+|++++..+ .||||++++|++.++. . ..
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3457899999999996 2223444 699886543 22355789999999999 5799999999998763 3 33
Q ss_pred EEEec--CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCceeeCC----CCCeEEc
Q 009208 375 LVYPY--MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL-LYLHEQCDPKIIHRDVKAANILLDE----DFEAVVG 447 (540)
Q Consensus 375 lV~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~ 447 (540)
+|+|| +++|+|.+++.+. .+++. ..++.+++.++ +|||+. +|+||||||+|||++. +..++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 5579999999642 35554 35577788777 999999 9999999999999974 3379999
Q ss_pred c-ccccc
Q 009208 448 D-FGLAK 453 (540)
Q Consensus 448 D-fgla~ 453 (540)
| ||...
T Consensus 152 Dg~G~~~ 158 (210)
T PRK10345 152 DNIGEST 158 (210)
T ss_pred ECCCCcc
Confidence 9 55443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.4e-20 Score=186.32 Aligned_cols=187 Identities=26% Similarity=0.309 Sum_probs=157.8
Q ss_pred eeeeccCccEEEEE----eCCCcEEEEEEeccCCcccc-HHHHHHHHHHHhccc-CCCccceeEEEecCCeeEEEEecCC
Q 009208 308 ILGRGGFGIVYKGC----FSDGALVAVKRLKDYNIAGG-EVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYPYMP 381 (540)
Q Consensus 308 ~lG~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~~ 381 (540)
.+|+|.||.|+... .+.|..+|.|..++...... +.....|..++..++ ||.++++...++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36899999998654 23577889888876543222 224567888888887 9999999999999999999999999
Q ss_pred CCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc
Q 009208 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461 (540)
Q Consensus 382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 461 (540)
+|.+...+.+ ...+++.....+...++-+++++|+. +|+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999888765 45688888889999999999999999 9999999999999999999999999999865432221
Q ss_pred eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 462 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
+||..|||||++. .....+|-||||++++||+||-.||..
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 6999999999987 567789999999999999999999984
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-18 Score=189.37 Aligned_cols=200 Identities=23% Similarity=0.246 Sum_probs=161.6
Q ss_pred HHHHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhccc---CCCccceeEEEecCC
Q 009208 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV---HRNLLRLCGFCSTEN 371 (540)
Q Consensus 295 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~ 371 (540)
+.+...+.|.+.+.+|+|+||+||+|...+|+.||+|+=+.....+ |--=.+++.+++ -+-|..+...+...+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 3444567788999999999999999999889999999977654332 211223334443 345666666677788
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-------CCCe
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-------DFEA 444 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-------~~~~ 444 (540)
.-++|+||.+.|+|.+++. ..+.++|.....++.++++-+++||.. +|||+||||+|.|+.. ...+
T Consensus 768 ~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred cceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence 8999999999999999886 456799999999999999999999999 9999999999999952 3468
Q ss_pred EEcccccccccCCC-CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCC
Q 009208 445 VVGDFGLAKLLDHR-DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRA 505 (540)
Q Consensus 445 kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p 505 (540)
+|+|||.+..+.-- +.......++|-++-.+|...++.++.++|.|.++-+++-|+.|+..
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99999998755422 22344556789999999999999999999999999999999999844
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.4e-19 Score=190.92 Aligned_cols=198 Identities=22% Similarity=0.272 Sum_probs=156.1
Q ss_pred CcCCeeeeccCccEEEEEeC-CCcEEEEEEec----cCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 304 SAKNILGRGGFGIVYKGCFS-DGALVAVKRLK----DYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 304 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~----~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
...+++|.|++|.|+..... ..+..+.|.++ .... ......+..|.-+-..+.|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999988777643 33444444433 1111 111112566777777889999998888877777766679
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++ +|...+... ..+....+..+++|+..|++|+|+. +|.|||+|++|++++.++.+||+|||.+....-
T Consensus 401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 999988652 3577788889999999999999999 999999999999999999999999999986554
Q ss_pred CCC---ceeeccccccccccccccccCCCCc-cCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RDS---HVTTAVRGTVGHIAPEYLSTGQSSE-KTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
... .......|+..|+|||++...+|.+ -.||||.|+++..|++|+.||-..
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a 528 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVA 528 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccc
Confidence 333 3456677999999999999998866 479999999999999999999754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.5e-18 Score=159.78 Aligned_cols=144 Identities=15% Similarity=0.139 Sum_probs=111.6
Q ss_pred CCCcCCeeeeccCccEEEEE--eCCCcEEEEEEeccCCccc-----------------------cHHHHHHHHHHHhccc
Q 009208 302 NFSAKNILGRGGFGIVYKGC--FSDGALVAVKRLKDYNIAG-----------------------GEVQFQTEVETISLAV 356 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~ 356 (540)
.|.+.+.||+|++|.||+|. ..+|+.||+|+++...... ....+..|.+.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46788999999999999998 5689999999987543110 0123568999999997
Q ss_pred CCC--ccceeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCC
Q 009208 357 HRN--LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK-IIHRDVKA 433 (540)
Q Consensus 357 h~n--Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~Dlk~ 433 (540)
+.. +.+++++ ...++||||++++++...... ...........++.|++.++.+||+. + |+||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 633 3333332 245899999999887765422 23455666788999999999999999 8 99999999
Q ss_pred CceeeCCCCCeEEcccccccccCC
Q 009208 434 ANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 434 ~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
+||+++ +++++++|||.+.....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCC
Confidence 999999 88999999999885543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=154.23 Aligned_cols=146 Identities=20% Similarity=0.137 Sum_probs=112.4
Q ss_pred HHHHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCcc---------------------ccHHHHHHHHHHHh
Q 009208 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA---------------------GGEVQFQTEVETIS 353 (540)
Q Consensus 295 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~ 353 (540)
++......|.+.+.||+|+||.||++..++|+.||||+++..... .....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 344444447788999999999999999888999999987643210 01123677888888
Q ss_pred cccCCC--ccceeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 009208 354 LAVHRN--LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDV 431 (540)
Q Consensus 354 ~l~h~n--Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl 431 (540)
.+.|++ +.+.++ ....++||||+++++|...... .....++.+++.++.++|+. +|+||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDL 151 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence 888774 344433 3456899999999998764321 23467889999999999998 9999999
Q ss_pred CCCceeeCCCCCeEEcccccccccCC
Q 009208 432 KAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 432 k~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+||++++++.++|+|||.+...+.
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=156.24 Aligned_cols=135 Identities=19% Similarity=0.258 Sum_probs=114.6
Q ss_pred CeeeeccCccEEEEEeCCCcEEEEEEeccCCccc-------cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG-------GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+.||+|++|.||+|.+ .|..|++|+........ ....+.+|++++..+.|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 77889999866432211 123578899999999999998888888778889999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
++|++|.+++... .+ .+..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999888542 12 7889999999999999999 999999999999999 78999999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.1e-17 Score=153.83 Aligned_cols=132 Identities=20% Similarity=0.284 Sum_probs=108.6
Q ss_pred eeeeccCccEEEEEeCCCcEEEEEEeccCCccc-------cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 308 ILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG-------GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 308 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
.||+|+||.||+|.+ +|..|++|......... ...++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999986 67889999865432111 1245778999999999988776666666777789999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
++++|.+.+... .. .++.+++.+|.++|+. +++|||++|+||+++ ++.++++|||.+...
T Consensus 80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998877531 00 7899999999999999 999999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-17 Score=176.56 Aligned_cols=141 Identities=18% Similarity=0.227 Sum_probs=113.4
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEe-ccC-Ccc-----ccHHHHHHHHHHHhcccCCCccceeEEEecCC
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRL-KDY-NIA-----GGEVQFQTEVETISLAVHRNLLRLCGFCSTEN 371 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~-~~~-~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 371 (540)
....|...+.||+|+||.||+|.+.+.. +++|+. ... ... ....++.+|++++..++|++++....++....
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3445567899999999999999885444 444432 211 111 11246889999999999999998888888878
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
..++||||+++++|.+++. ....++.++++++.|||+. +++|||+||+||++ +++.++|+|||+
T Consensus 410 ~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcc
Confidence 8899999999999988774 3467899999999999999 99999999999999 577999999999
Q ss_pred ccccC
Q 009208 452 AKLLD 456 (540)
Q Consensus 452 a~~~~ 456 (540)
++...
T Consensus 474 a~~~~ 478 (535)
T PRK09605 474 GKYSD 478 (535)
T ss_pred cccCC
Confidence 98643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.4e-18 Score=185.06 Aligned_cols=228 Identities=23% Similarity=0.255 Sum_probs=163.1
Q ss_pred CCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHH---HHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQF---QTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~---~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
++...+.+|++.|=+|.+|++++|. |+||++-+..-.-.-..| ..|++ ....+|||.+++.-+...+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5666788999999999999998888 889988654422222333 34444 556689999999888777778889999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc-CC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL-DH 457 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~-~~ 457 (540)
|..+ +|++.|.. ++-+...+.+-|+.|+..|+..+|.. +|+|||||.+|||++.=+=+.|+||..-+.. -+
T Consensus 102 yvkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9854 77777753 45677788888999999999999999 9999999999999999888999999765421 11
Q ss_pred CCCce-----eeccccccccccccccccC-----------CCCccCCeehhhHHHHHHHh-CCCCCCcccccccCC---c
Q 009208 458 RDSHV-----TTAVRGTVGHIAPEYLSTG-----------QSSEKTDVFGFGILLLELIT-GQRALDFGRAANQRG---V 517 (540)
Q Consensus 458 ~~~~~-----~~~~~gt~~y~aPE~~~~~-----------~~~~k~Dv~S~Gvil~ellt-g~~p~~~~~~~~~~~---~ 517 (540)
.++.. ..+.....-|+|||.+-.. ..+++-||||+||++.||++ |++||+..+--..+. .
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~ 253 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNAD 253 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCcc
Confidence 11111 1122234569999987431 15788999999999999987 799998432221111 1
Q ss_pred HHHHHHHHhhcCCcchhhhhccC
Q 009208 518 MLDWVCSHILSNQSSLDMVLNLL 540 (540)
Q Consensus 518 ~~~w~~~~~~~~~~~~~~l~~~~ 540 (540)
...-+-.-| ++.+.++||++||
T Consensus 254 ~~e~~Le~I-ed~~~Rnlil~Mi 275 (1431)
T KOG1240|consen 254 DPEQLLEKI-EDVSLRNLILSMI 275 (1431)
T ss_pred CHHHHHHhC-cCccHHHHHHHHH
Confidence 122222222 3457788888775
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.9e-17 Score=167.21 Aligned_cols=167 Identities=25% Similarity=0.420 Sum_probs=134.2
Q ss_pred HhcccCCCccceeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EecC
Q 009208 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI-IHRD 430 (540)
Q Consensus 352 l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i-vH~D 430 (540)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ....++|.....++++++.||.|+|.. +| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 3567899999999999999999999999999999999976 356799999999999999999999987 55 8999
Q ss_pred CCCCceeeCCCCCeEEcccccccccCC-CCCceeeccccccccccccccccC-------CCCccCCeehhhHHHHHHHhC
Q 009208 431 VKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEYLSTG-------QSSEKTDVFGFGILLLELITG 502 (540)
Q Consensus 431 lk~~NILl~~~~~~kl~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~k~Dv~S~Gvil~elltg 502 (540)
++++|.++|....+|++|||+...... ..........-..-|.|||.+... ..+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 999999999999999999999887642 111111222245679999998763 147789999999999999999
Q ss_pred CCCCCcccccccCCcHHHHHHH
Q 009208 503 QRALDFGRAANQRGVMLDWVCS 524 (540)
Q Consensus 503 ~~p~~~~~~~~~~~~~~~w~~~ 524 (540)
+.||+-.........++.+++.
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~ 176 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK 176 (484)
T ss_pred cCccccccccCChHHHHHHHHh
Confidence 9999854333322334444443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=3e-17 Score=157.25 Aligned_cols=199 Identities=25% Similarity=0.313 Sum_probs=130.1
Q ss_pred CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccC----------CCccceeEEEec
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVH----------RNLLRLCGFCST 369 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h----------~nIv~l~~~~~~ 369 (540)
+...+.||.|+++.||.++.. .|+.+|||.+..... ....+++.+|.-....+.+ -.++..++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999986 489999999864432 2234467777655555333 112222222211
Q ss_pred ---------C---C-----eeEEEEecCCCCChhhhccc---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 009208 370 ---------E---N-----ERLLVYPYMPNGSVASRLRD---HIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHR 429 (540)
Q Consensus 370 ---------~---~-----~~~lV~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~ 429 (540)
. . ..+++|+-+ .++|.+.+.. .......+....+..+..|+++.+++||.. +++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 1 1 235677777 4577776532 211122345566778889999999999999 99999
Q ss_pred CCCCCceeeCCCCCeEEcccccccccCCCCCceeecccccccccccccccc--------CCCCccCCeehhhHHHHHHHh
Q 009208 430 DVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST--------GQSSEKTDVFGFGILLLELIT 501 (540)
Q Consensus 430 Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~Dv~S~Gvil~ellt 501 (540)
||+|+|++++.+|.+.|+||+.....+. .......+..|.+||.... ..++.+.|.|++|+++|.|.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999987764332 1121335688999998643 247889999999999999999
Q ss_pred CCCCCCcc
Q 009208 502 GQRALDFG 509 (540)
Q Consensus 502 g~~p~~~~ 509 (540)
|+.||+..
T Consensus 246 ~~lPf~~~ 253 (288)
T PF14531_consen 246 GRLPFGLS 253 (288)
T ss_dssp SS-STCCC
T ss_pred ccCCCCCC
Confidence 99999854
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.6e-15 Score=134.00 Aligned_cols=135 Identities=18% Similarity=0.126 Sum_probs=114.5
Q ss_pred cCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccC--CCccceeEEEecCCeeEEEEecCCC
Q 009208 305 AKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH--RNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 305 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.+.+|+|.++.||++...+ ..+++|..+.... ...+.+|...+..++| .++.+++++...++..++++||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 35789999999999999844 7899999865432 4578999999999977 5888998888888889999999998
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+.+..+ +......++.+++++++++|.....+++|+|++|+||++++++.++++|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 876543 5567788899999999999986445799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.9e-16 Score=143.09 Aligned_cols=138 Identities=21% Similarity=0.218 Sum_probs=98.5
Q ss_pred CCeeeeccCccEEEEEeCCCcEEEEEEeccCCcccc-HHH----------------------HHHHHHHHhcccCCC--c
Q 009208 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-EVQ----------------------FQTEVETISLAVHRN--L 360 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-~~~----------------------~~~E~~~l~~l~h~n--I 360 (540)
.+.||+|+||.||+|...+|+.||||+++....... ... ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999988899999999875431111 111 134555555554432 3
Q ss_pred cceeEEEecCCeeEEEEecCCCCChhhh-ccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceee
Q 009208 361 LRLCGFCSTENERLLVYPYMPNGSVASR-LRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILL 438 (540)
Q Consensus 361 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl 438 (540)
.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. . +|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 333332 346899999999654322 22110 11 5678899999999999999 7 99999999999999
Q ss_pred CCCCCeEEcccccccccCC
Q 009208 439 DEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 439 ~~~~~~kl~Dfgla~~~~~ 457 (540)
+ ++.++++|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 88999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.2e-16 Score=170.37 Aligned_cols=195 Identities=24% Similarity=0.334 Sum_probs=133.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
..+|..++.|..|+||.||...++. .+..|.|. ++.+ .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~------lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN------LILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccc------hhhhc--cccccCCccee-----------------
Confidence 4678888999999999999998753 56677744 3221 01110 22222233332
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+-.+.++. .++++- +++.+++|+|+. +|+|||+||+|.+++.-|.+|+.|||+++..-..
T Consensus 136 ----gDc~tllk~----~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----GDCATLLKN----IGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----chhhhhccc----CCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 333333332 222222 237789999999 9999999999999999999999999998743110
Q ss_pred --------------CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcccccccCCcHH----H
Q 009208 459 --------------DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML----D 520 (540)
Q Consensus 459 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~----~ 520 (540)
..-....++||+.|+|||++....|..-+|.|++|+|+||.+-|+.||+.+.+++.-+.++ .
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~ 276 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 276 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence 0111234579999999999999999999999999999999999999999776666655554 4
Q ss_pred HHHHHhhcCCcchhhhhcc
Q 009208 521 WVCSHILSNQSSLDMVLNL 539 (540)
Q Consensus 521 w~~~~~~~~~~~~~~l~~~ 539 (540)
|-........+..+++.+|
T Consensus 277 wpE~dea~p~Ea~dli~~L 295 (1205)
T KOG0606|consen 277 WPEEDEALPPEAQDLIEQL 295 (1205)
T ss_pred ccccCcCCCHHHHHHHHHH
Confidence 4444333333444444443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1e-15 Score=147.03 Aligned_cols=144 Identities=24% Similarity=0.304 Sum_probs=106.4
Q ss_pred cCCCccceeEEEecC---------------------------CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHH
Q 009208 356 VHRNLLRLCGFCSTE---------------------------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408 (540)
Q Consensus 356 ~h~nIv~l~~~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 408 (540)
+|||||++.++|.+. ...|+||.-++ -+|.+|+... ..+.....-+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-----~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-----HRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-----CCchHHHHHHH
Confidence 699999998876432 24678888774 3778777542 34555677788
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCceeeC--CCC--CeEEcccccccccCCC-----CCceeeccccccccccccccc
Q 009208 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLD--EDF--EAVVGDFGLAKLLDHR-----DSHVTTAVRGTVGHIAPEYLS 479 (540)
Q Consensus 409 ~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~--~~~--~~kl~Dfgla~~~~~~-----~~~~~~~~~gt~~y~aPE~~~ 479 (540)
.|+.+|+.|||.+ +|.|||+|++|||+. +|. ...|+|||.+---+.. ........-|.-.-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 999999999999984 444 4689999976422211 011111223677889999975
Q ss_pred cCC------CCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 480 TGQ------SSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 480 ~~~------~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ...|+|.|+.|-+.||+++...||..
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 432 25699999999999999999999984
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.7e-15 Score=139.46 Aligned_cols=137 Identities=16% Similarity=0.163 Sum_probs=106.1
Q ss_pred CCeee-eccCccEEEEEeCCCcEEEEEEeccCCc------------cccHHHHHHHHHHHhcccCCCc--cceeEEEecC
Q 009208 306 KNILG-RGGFGIVYKGCFSDGALVAVKRLKDYNI------------AGGEVQFQTEVETISLAVHRNL--LRLCGFCSTE 370 (540)
Q Consensus 306 ~~~lG-~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~ 370 (540)
...|| .||.|+||+... ++..++||.+..... ......+.+|++++..+.|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 36788 899999999988 478899998854211 1123467889999999998885 6677765432
Q ss_pred C----eeEEEEecCCC-CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeE
Q 009208 371 N----ERLLVYPYMPN-GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV 445 (540)
Q Consensus 371 ~----~~~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 445 (540)
. ..++|+||+++ .+|.+++.+ .+++.. .+.+++.++.+||+. +|+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 688888753 234433 357899999999999 999999999999999988999
Q ss_pred Eccccccccc
Q 009208 446 VGDFGLAKLL 455 (540)
Q Consensus 446 l~Dfgla~~~ 455 (540)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999998753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.4e-16 Score=157.56 Aligned_cols=123 Identities=27% Similarity=0.392 Sum_probs=106.0
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
..++.|+++...+|.+||.... ....-++...+.++.|++.|++| + +.+|||+||.||....+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 5789999999999999997532 23457788999999999999999 6 899999999999999999999999999
Q ss_pred ccccCCCC-----CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh
Q 009208 452 AKLLDHRD-----SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501 (540)
Q Consensus 452 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt 501 (540)
........ ....+...||..||+||.+.+..|+.|+||||+|+|++|++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87665433 112234559999999999999999999999999999999998
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.2e-16 Score=131.85 Aligned_cols=129 Identities=26% Similarity=0.438 Sum_probs=109.2
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|.|++|.++ .+|+.+..|.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. .+|..|+.++.|+.|||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 47888999999999 88999999999999999999999 88999999999999999999999 99999999999999999
Q ss_pred cCccCCC-CCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCCcCC
Q 009208 154 NNNSLTG-SCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGP 205 (540)
Q Consensus 154 ~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~ 205 (540)
+.|+++. .+|..|..++.|+.|+|+.|.|.-.+|++.. +.+.+..|.++.-+
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~lp 166 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLSLP 166 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhhCc
Confidence 9999853 5788888888888888888888866666533 34556666655443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.2e-14 Score=143.83 Aligned_cols=147 Identities=22% Similarity=0.231 Sum_probs=103.0
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccc---------------------------------------c
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG---------------------------------------G 341 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---------------------------------------~ 341 (540)
..|+ .+.||+|++|.||+|++++|+.||||+.+...... .
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3344 36899999999999999999999999986532100 0
Q ss_pred HHHHHHHHHHHhccc----C-CCccceeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHH-HH
Q 009208 342 EVQFQTEVETISLAV----H-RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR-GL 415 (540)
Q Consensus 342 ~~~~~~E~~~l~~l~----h-~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-~l 415 (540)
+.+|.+|.+.+.+++ | +++.-..-+....+..++||||++|++|.+....... .. .+..++..+++ .+
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l 270 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFL 270 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHH
Confidence 113555666555542 3 3332222222334567999999999999887643111 12 23456666666 46
Q ss_pred HHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 416 ~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
..+|.. +++|+|+||.||+++++++++++|||++..+..
T Consensus 271 ~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 271 NQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 778887 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=7.9e-15 Score=156.47 Aligned_cols=216 Identities=26% Similarity=0.348 Sum_probs=166.8
Q ss_pred cCCCcCCeeeeccCccEEEEEeC--CCcEEEEEEeccCC-ccccHHHHHHHHHHHhccc-CCCccceeEEEecCCeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYN-IAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV 376 (540)
..|...+.||+|+|+.|-..... ....+|+|.+.... ..........|..+-..+. |+|++.+++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45666778999999999877653 34567777765443 1222233445777766676 99999999999999999999
Q ss_pred EecCCCCChhhhc-cccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCceeeCCCC-CeEEccccccc
Q 009208 377 YPYMPNGSVASRL-RDHIHGRPALDWARRKRIALGTARGLLYLH-EQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAK 453 (540)
Q Consensus 377 ~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~ 453 (540)
.+|.+++++.+.+ +.. ....+......+..|+..++.|+| .. ++.|||+||+|.++++.+ ..+++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999988887 332 224555677889999999999999 77 999999999999999999 99999999998
Q ss_pred ccCC--CCCceeecccc-ccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcccccccCCcHHHHHHH
Q 009208 454 LLDH--RDSHVTTAVRG-TVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVCS 524 (540)
Q Consensus 454 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~w~~~ 524 (540)
.+.. ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...... +....|...
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~ 246 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSN 246 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeeccc
Confidence 7665 23333345568 9999999998774 55788999999999999999999998654333 333455443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.4e-14 Score=139.46 Aligned_cols=123 Identities=28% Similarity=0.419 Sum_probs=105.9
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCcccc-CCCCcchhhc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG-DLGNLNYLRL 153 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~-~l~~L~~L~l 153 (540)
+++.||..+|-++ ++|+.++.+.+|.-|+|..|+|. .+| +|.++..|++|+++.|+|+ .+|...+ ++++|..|||
T Consensus 184 ~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDL 259 (565)
T KOG0472|consen 184 RLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDL 259 (565)
T ss_pred HHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeec
Confidence 4566677777666 78889999999999999999998 777 7999999999999999999 8888865 8999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc---ccccccCCCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA---RTFKVTGNPLI 202 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~---~~~~~~~n~~~ 202 (540)
..|+++ .+|+.++.+++|++||+|+|.|++.++++.. +.+.+.|||+-
T Consensus 260 RdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNPlr 310 (565)
T KOG0472|consen 260 RDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNLHLKFLALEGNPLR 310 (565)
T ss_pred cccccc-cCchHHHHhhhhhhhcccCCccccCCcccccceeeehhhcCCchH
Confidence 999999 8999999999999999999999988887754 56678999873
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.9e-14 Score=122.06 Aligned_cols=128 Identities=27% Similarity=0.445 Sum_probs=111.0
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCc-ccCCccccCCCCcchhhc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT-GEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~l~~L~~L~l 153 (540)
.++.|++.+|+|+ .+|..++.+++|+.|+++-|++. .+|..|+.++.|+.|||++|+++ ..+|..|..++.|+.|+|
T Consensus 57 nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl 134 (264)
T KOG0617|consen 57 NLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYL 134 (264)
T ss_pred hhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHh
Confidence 6888999999999 89999999999999999999999 89999999999999999999986 468999999999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCcCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPK 206 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~ 206 (540)
+.|.+. .+|..+++|++|+.|.+..|.+- ++|.... +.+.+.||.+.--++
T Consensus 135 ~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlpp 190 (264)
T KOG0617|consen 135 GDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPP 190 (264)
T ss_pred cCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecCh
Confidence 999999 88999999999999999999988 4444322 567788888755444
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.5e-13 Score=140.28 Aligned_cols=147 Identities=20% Similarity=0.188 Sum_probs=94.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCcc---------------------------------c-----
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIA---------------------------------G----- 340 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~---------------------------------~----- 340 (540)
...|+. +.+|+|++|.||+|++++ |+.||||+.++.... +
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455776 789999999999999987 999999998754210 0
Q ss_pred -cHHHHHHHHHHHhccc----CCCccceeEEEe-cCCeeEEEEecCCCCChhhh--ccccCCCCCCCCHHHHHHHHHHHH
Q 009208 341 -GEVQFQTEVETISLAV----HRNLLRLCGFCS-TENERLLVYPYMPNGSVASR--LRDHIHGRPALDWARRKRIALGTA 412 (540)
Q Consensus 341 -~~~~~~~E~~~l~~l~----h~nIv~l~~~~~-~~~~~~lV~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~~ia 412 (540)
.+.+|.+|..-+.+++ +.+.+.+-.++. .....++||||++|+++.+. +.........+.......++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 0112445555444442 333333333332 24567899999999998764 2211000011222222223333
Q ss_pred HHHHHHHhcCCCCeEecCCCCCceeeCCCC----CeEEcccccccccCC
Q 009208 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDF----EAVVGDFGLAKLLDH 457 (540)
Q Consensus 413 ~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Dfgla~~~~~ 457 (540)
+... +++|+|+||.||+++.++ +++++|||++..++.
T Consensus 276 -----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3344 999999999999999888 999999999887654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.7e-12 Score=114.44 Aligned_cols=130 Identities=20% Similarity=0.145 Sum_probs=96.2
Q ss_pred CeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCcc-ceeEEEecCCeeEEEEecCCCCCh
Q 009208 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL-RLCGFCSTENERLLVYPYMPNGSV 385 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~lV~e~~~~gsL 385 (540)
+.++.|.++.||++.. .+..|++|....... ....+.+|.+.+..+.+.+++ +++.+. ....++||||+++.++
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 5688999999999987 478899999765421 223567899999888765554 344433 3345899999999886
Q ss_pred hhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC--DPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 386 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
.+. . .....+..+++++++.||... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~--~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE--D----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--c----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 543 0 011345678999999999872 22369999999999999 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.7e-12 Score=140.51 Aligned_cols=93 Identities=40% Similarity=0.647 Sum_probs=89.5
Q ss_pred ccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecc
Q 009208 99 KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLS 178 (540)
Q Consensus 99 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 178 (540)
.++.|+|++|.++|.+|..++++++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+++|.+|+.+++|++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 58899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCc
Q 009208 179 YNNLSGSLPKISA 191 (540)
Q Consensus 179 ~N~l~~~~p~~~~ 191 (540)
+|+++|.+|....
T Consensus 499 ~N~l~g~iP~~l~ 511 (623)
T PLN03150 499 GNSLSGRVPAALG 511 (623)
T ss_pred CCcccccCChHHh
Confidence 9999999997643
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.1e-13 Score=137.13 Aligned_cols=114 Identities=30% Similarity=0.318 Sum_probs=77.7
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
.++.|+|+.|+++..-..++.+|+.|+.|+||+|.|....++++.-.++|++|+||+|+|+..-+.+|..|..|++|+|+
T Consensus 270 kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs 349 (873)
T KOG4194|consen 270 KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLS 349 (873)
T ss_pred ccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccc
Confidence 57778888888876666777778888888888888877777777777788888888888874444556666666666666
Q ss_pred CccCCCCCCccccCCccccEEecccCcccccCCC
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 188 (540)
+|+++-.-...|..+++|+.|||++|.|+..|.+
T Consensus 350 ~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED 383 (873)
T KOG4194|consen 350 HNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED 383 (873)
T ss_pred ccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec
Confidence 6666533333455555666666666655544443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.9e-13 Score=134.50 Aligned_cols=132 Identities=23% Similarity=0.329 Sum_probs=87.2
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCc---cccCCCCcchh
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD---SLGDLGNLNYL 151 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~---~~~~l~~L~~L 151 (540)
+++.|+|++|+|+..-+.+|..|..|++|+|+.|++...-...|..+++|+.|||++|.|+..+-+ .|..|++|+.|
T Consensus 318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL 397 (873)
T KOG4194|consen 318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL 397 (873)
T ss_pred cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence 566666666666655556666666666666666666655555666677777777777777655544 26667777777
Q ss_pred hccCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCCcCCC
Q 009208 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGPK 206 (540)
Q Consensus 152 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~~ 206 (540)
+|.+|+|....-.+|..+++|++|||.+|.|...-|+.+. +.+-+..-.++|+|.
T Consensus 398 ~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCq 456 (873)
T KOG4194|consen 398 RLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQ 456 (873)
T ss_pred eecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEecc
Confidence 7777777733345677777888888888877755555433 334455666778765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.3e-10 Score=105.91 Aligned_cols=138 Identities=15% Similarity=0.154 Sum_probs=99.2
Q ss_pred CeeeeccCccEEEEEeCC-------CcEEEEEEeccCCc---------------------cccHHHHH----HHHHHHhc
Q 009208 307 NILGRGGFGIVYKGCFSD-------GALVAVKRLKDYNI---------------------AGGEVQFQ----TEVETISL 354 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~---------------------~~~~~~~~----~E~~~l~~ 354 (540)
..||.|--+.||.|...+ +..+|||+++.... ...+..+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 568999999999998653 47999999753210 01122233 78888888
Q ss_pred ccC--CCccceeEEEecCCeeEEEEecCCCCChhh-hccccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecC
Q 009208 355 AVH--RNLLRLCGFCSTENERLLVYPYMPNGSVAS-RLRDHIHGRPALDWARRKRIALGTARGLLYL-HEQCDPKIIHRD 430 (540)
Q Consensus 355 l~h--~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~D 430 (540)
+.. -++.+++++ ...++||||+.++.+.. .+++ ..++......+..+++.+|..+ |.. ++||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 854 345555553 56789999998754422 2322 1244455677889999999999 777 999999
Q ss_pred CCCCceeeCCCCCeEEcccccccccCC
Q 009208 431 VKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 431 lk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
+++.||++++ +.+.|+|||-+...++
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCCC
Confidence 9999999974 6899999998876554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=9.6e-13 Score=126.78 Aligned_cols=132 Identities=27% Similarity=0.378 Sum_probs=114.9
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeC-CCCcccCCc-cccCCCCcchh
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN-NKFTGEIPD-SLGDLGNLNYL 151 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p~-~~~~l~~L~~L 151 (540)
...++|+|..|+|+...|.+|+.+++|+.||||+|+|+-+-|++|.+|.+|..|-+.+ |+|+ .+|. .|++|.+|+.|
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrL 145 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRL 145 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHH
Confidence 3689999999999977778999999999999999999999999999999998887665 9999 6665 59999999999
Q ss_pred hccCccCCCCCCccccCCccccEEecccCcccccCCCC------CcccccccCCCCCcCCCC
Q 009208 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI------SARTFKVTGNPLICGPKA 207 (540)
Q Consensus 152 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~------~~~~~~~~~n~~~~~~~~ 207 (540)
.+.-|++.-...+.|..|++|..|.+-.|.+. .++.. ..+.+.+.-|++.|.|..
T Consensus 146 llNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL 206 (498)
T KOG4237|consen 146 LLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNL 206 (498)
T ss_pred hcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccccccc
Confidence 99999999677788999999999999999998 44432 226678899999998753
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.5e-12 Score=131.77 Aligned_cols=80 Identities=29% Similarity=0.360 Sum_probs=44.3
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCc-ccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.++.||||+|+|+ ..|..+.+.+++-.|+||+|+|. .||. .|-+|+.|-+||||+|++. .+|+.+..|..|++|+|
T Consensus 104 dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~L 180 (1255)
T KOG0444|consen 104 DLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKL 180 (1255)
T ss_pred cceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhc
Confidence 4566666666665 55655555566666666666665 3333 3445555555566655555 45555554555555555
Q ss_pred cCcc
Q 009208 154 NNNS 157 (540)
Q Consensus 154 ~~N~ 157 (540)
++|.
T Consensus 181 s~NP 184 (1255)
T KOG0444|consen 181 SNNP 184 (1255)
T ss_pred CCCh
Confidence 4444
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.3e-10 Score=109.81 Aligned_cols=143 Identities=20% Similarity=0.257 Sum_probs=109.9
Q ss_pred CeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCC--CccceeEEEecC---CeeEEEEecCC
Q 009208 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR--NLLRLCGFCSTE---NERLLVYPYMP 381 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~---~~~~lV~e~~~ 381 (540)
+.++.|..+.||++...+|+.+++|.............+.+|.+++..+.+. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 5689999999999998777899999976543222344688999999998764 456677776553 25689999999
Q ss_pred CCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 009208 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC--------------------------------------- 422 (540)
Q Consensus 382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------- 422 (540)
+.++.+.+.. ..++......++.++++++.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9887765531 24677777888888888888888521
Q ss_pred --------------CCCeEecCCCCCceeeCC--CCCeEEcccccccc
Q 009208 423 --------------DPKIIHRDVKAANILLDE--DFEAVVGDFGLAKL 454 (540)
Q Consensus 423 --------------~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgla~~ 454 (540)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 56689999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.2e-10 Score=120.45 Aligned_cols=165 Identities=19% Similarity=0.234 Sum_probs=123.5
Q ss_pred CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHH
Q 009208 323 SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWA 402 (540)
Q Consensus 323 ~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~ 402 (540)
.++.+|.|..++.... .......+.++.++.+|||||++++......+..|+|+|-+. .|..++.+. ...
T Consensus 35 ~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE 104 (690)
T ss_pred ccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence 3688899988876553 223456788999999999999999999999999999999874 466666542 234
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCceeeccccccccccccccccCC
Q 009208 403 RRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482 (540)
Q Consensus 403 ~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 482 (540)
...-.+.||+.||.|||+.| +++|++|.-..|++++.|+.||++|.++........ ......---.|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 45567889999999999766 999999999999999999999999998864332111 011111122456666543322
Q ss_pred CCccCCeehhhHHHHHHHhC
Q 009208 483 SSEKTDVFGFGILLLELITG 502 (540)
Q Consensus 483 ~~~k~Dv~S~Gvil~elltg 502 (540)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 235999999999999999
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.4e-11 Score=110.02 Aligned_cols=105 Identities=34% Similarity=0.472 Sum_probs=43.3
Q ss_pred cEEEecCCCCCCccccCcccc-CCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccc-cCCCCcchhh
Q 009208 75 YVSALGLPSQSLSGTLSPWIG-NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSL-GDLGNLNYLR 152 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~-~~l~~L~~L~ 152 (540)
++++|+|++|.|+. + +.++ .+++|+.|+|++|.|+. ++ .+..+++|+.|+|++|+|+ .+++.+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 57889999999984 4 3455 68899999999999994 44 5888999999999999999 676655 4689999999
Q ss_pred ccCccCCCCC-CccccCCccccEEecccCcccc
Q 009208 153 LNNNSLTGSC-PESLSKIESLTLVDLSYNNLSG 184 (540)
Q Consensus 153 l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~ 184 (540)
|++|+|...- -..++.+++|+.|+|.+|+++.
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 9999997321 2457788999999999999873
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.1e-12 Score=124.62 Aligned_cols=111 Identities=33% Similarity=0.517 Sum_probs=90.8
Q ss_pred ccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccC
Q 009208 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSK 168 (540)
Q Consensus 89 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 168 (540)
-+|..+..+++|..|+|+||-+. .+|.+++.+..|+.||+|.|+|. .+|..+-.+..|+.+-.++|++....|..+.+
T Consensus 426 fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~n 503 (565)
T KOG0472|consen 426 FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKN 503 (565)
T ss_pred cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhh
Confidence 35555777888999999999888 78899999999999999999998 88888877778888888888888566666999
Q ss_pred CccccEEecccCcccccCCCCCc----ccccccCCCC
Q 009208 169 IESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPL 201 (540)
Q Consensus 169 l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~ 201 (540)
+.+|+.|||.+|.+...+|.+.. +.+.+.||||
T Consensus 504 m~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf 540 (565)
T KOG0472|consen 504 MRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF 540 (565)
T ss_pred hhhcceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence 99999999999999955554432 5678889987
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.5e-10 Score=98.84 Aligned_cols=132 Identities=20% Similarity=0.268 Sum_probs=101.9
Q ss_pred CeeeeccCccEEEEEeCCCcEEEEEEeccCCc--c-----ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNI--A-----GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
..+++|+-+.+|.+.+. |..+++|.-.+..- + -...+-.+|.+++.+.+--.|.-..-+..+++...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999874 44466665322111 1 1123467899999988877777777778888999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
++|..|.+.+... ...++..+-..+.-||.. +|+|+|+.++||.+..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999988888642 245677778888889999 999999999999998764 99999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.2e-10 Score=98.48 Aligned_cols=144 Identities=17% Similarity=0.191 Sum_probs=107.7
Q ss_pred cCCeeeeccCccEEEEEeCCCcEEEEEEeccCC-------ccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 305 AKNILGRGGFGIVYKGCFSDGALVAVKRLKDYN-------IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 305 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
....+-+|+-+.|+++.+ .|+...||.-.... ..-.+.+..+|.+.+.+++--.|.-..-++.+.....|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457889999999999998 67776666532111 1122346788999999987666666666677777778999
Q ss_pred ecCCC-CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC---CeEEccccccc
Q 009208 378 PYMPN-GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF---EAVVGDFGLAK 453 (540)
Q Consensus 378 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgla~ 453 (540)
||+++ -++.+++..... .+.........+..|-+.+.-||.. .|+|+||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99976 477888776432 2223333367889999999999999 999999999999997554 45899999986
Q ss_pred c
Q 009208 454 L 454 (540)
Q Consensus 454 ~ 454 (540)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4.3e-11 Score=113.07 Aligned_cols=152 Identities=22% Similarity=0.356 Sum_probs=118.7
Q ss_pred HhcccCCCccceeEEEec-----CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 009208 352 ISLAVHRNLLRLCGFCST-----ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426 (540)
Q Consensus 352 l~~l~h~nIv~l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 426 (540)
+-++.|.|||++..|..+ .....++.|||..|++.++|++.......+......+++.||..||.|||+ |.|+|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCcc
Confidence 344569999999998743 345789999999999999999877777788888899999999999999998 58999
Q ss_pred EecCCCCCceeeCCCCCeEEcccccccccCCC----CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhC
Q 009208 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHR----DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502 (540)
Q Consensus 427 vH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg 502 (540)
+|+++.-+-|++..++-+|+.---- ...... .........+-++|.|||+=.....+..+|||+||....||.-+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999998888743211 111110 01111122367899999987777778899999999999999887
Q ss_pred CCC
Q 009208 503 QRA 505 (540)
Q Consensus 503 ~~p 505 (540)
..-
T Consensus 279 Eiq 281 (458)
T KOG1266|consen 279 EIQ 281 (458)
T ss_pred eec
Confidence 743
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.5e-12 Score=133.46 Aligned_cols=123 Identities=37% Similarity=0.583 Sum_probs=109.9
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCc-ccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.++.|+|.+|.|+...-+.+.+..+|+.|+|++|+|. .+|+ .+.++..|++|+||+|+++ .+|..+.+++.|++|..
T Consensus 360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 6899999999999988889999999999999999999 5555 6788999999999999999 99999999999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccc-cCCCC----CcccccccCCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG-SLPKI----SARTFKVTGNPL 201 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~----~~~~~~~~~n~~ 201 (540)
.+|++. .+| .+..++.|+.+|+|.|+|+. .+|.. -.+.++++||.+
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 999999 888 89999999999999999984 23322 226789999985
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.12 E-value=6e-12 Score=127.61 Aligned_cols=106 Identities=29% Similarity=0.427 Sum_probs=58.2
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
++..+|||.|+|. .+|..+-++++|+.|+||+|+|+ .+........+|++|+||.|+++ .+|+.+++|++|+.|++.
T Consensus 223 NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n 299 (1255)
T KOG0444|consen 223 NLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYAN 299 (1255)
T ss_pred hhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhc
Confidence 4555566666665 55666666666666666666655 34444444555555555555555 555555555555555555
Q ss_pred CccCCC-CCCccccCCccccEEecccCccc
Q 009208 155 NNSLTG-SCPESLSKIESLTLVDLSYNNLS 183 (540)
Q Consensus 155 ~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~ 183 (540)
+|+++- -+|..+++|.+|+.+..++|++.
T Consensus 300 ~NkL~FeGiPSGIGKL~~Levf~aanN~LE 329 (1255)
T KOG0444|consen 300 NNKLTFEGIPSGIGKLIQLEVFHAANNKLE 329 (1255)
T ss_pred cCcccccCCccchhhhhhhHHHHhhccccc
Confidence 555431 24555555555555555555554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.2e-12 Score=117.08 Aligned_cols=121 Identities=33% Similarity=0.486 Sum_probs=100.5
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
.++++||++|.|+ .+..+..-++.++.|++|+|.|.. + ..+..|++|+.||||+|.++ .+..+-.+|.+.++|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 4788999999998 788888888999999999999984 3 34888999999999999999 777777788899999999
Q ss_pred CccCCCCCCccccCCccccEEecccCccc--------ccCCCCCcccccccCCCCCc
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS--------GSLPKISARTFKVTGNPLIC 203 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--------~~~p~~~~~~~~~~~n~~~~ 203 (540)
.|.|. .+ ..+.+|-+|..||+++|+|. |.+|.+ +.+.+.+||+.-
T Consensus 361 ~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCL--E~l~L~~NPl~~ 413 (490)
T KOG1259|consen 361 QNKIE-TL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCL--ETLRLTGNPLAG 413 (490)
T ss_pred hhhHh-hh-hhhHhhhhheeccccccchhhHHHhcccccccHH--HHHhhcCCCccc
Confidence 99987 33 46788889999999999987 455544 667888998743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1e-10 Score=119.78 Aligned_cols=200 Identities=23% Similarity=0.203 Sum_probs=152.2
Q ss_pred CCCcCCeeee--ccCccEEEEEe---CCCcEEEEEEeccCCc-cccHHHHHHHHHHHhccc-CCCccceeEEEecCCeeE
Q 009208 302 NFSAKNILGR--GGFGIVYKGCF---SDGALVAVKRLKDYNI-AGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERL 374 (540)
Q Consensus 302 ~~~~~~~lG~--G~~g~Vy~~~~---~~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 374 (540)
.|.+...+|. |.+|.||.+.. .++..+|+|+-+.... +.....=.+|......++ |+|.++........+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3556678999 99999999987 3678899998432211 122223345666666664 999999888888889999
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR----GLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDF 449 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Df 449 (540)
+-+|++. .++.++.+... ..++....+.+..+..+ |+.++|.. +++|-|+||.||+...+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 9999885 78877776532 22555666677777777 99999999 99999999999999998 89999999
Q ss_pred ccccccCCCCC----ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 450 GLAKLLDHRDS----HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 450 gla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
|+...+....- .......|...|++||.. +..++...|+||+|.++.+..++..+...+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 99987765431 112233588899999986 556788999999999999999998877644
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.5e-10 Score=83.90 Aligned_cols=59 Identities=46% Similarity=0.649 Sum_probs=27.1
Q ss_pred ccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCcc
Q 009208 99 KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNS 157 (540)
Q Consensus 99 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 157 (540)
+|++|+|++|+|+...+..|.++++|++|+|++|+++..-|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444443333344444444444444444443333344444444444444444
|
... |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.9e-10 Score=102.78 Aligned_cols=102 Identities=38% Similarity=0.568 Sum_probs=36.8
Q ss_pred ccCCCccCEEEcccCCCCCCCCcccC-CCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccc-cCCcc
Q 009208 94 IGNLTKLQSVLLQNNAILGPIPASLG-KLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESL-SKIES 171 (540)
Q Consensus 94 ~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~ 171 (540)
+.+..++++|+|++|.|+ .+. .++ .+.+|+.||||+|+|+ .++ .+..+++|++|++++|+|+ .+++.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 445667999999999999 443 566 5899999999999999 665 5888999999999999999 565555 46899
Q ss_pred ccEEecccCcccccCCCCC-------cccccccCCCC
Q 009208 172 LTLVDLSYNNLSGSLPKIS-------ARTFKVTGNPL 201 (540)
Q Consensus 172 L~~L~l~~N~l~~~~p~~~-------~~~~~~~~n~~ 201 (540)
|+.|++++|+|.. +-++. .+.+++.|||+
T Consensus 90 L~~L~L~~N~I~~-l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 90 LQELYLSNNKISD-LNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp --EEE-TTS---S-CCCCGGGGG-TT--EEE-TT-GG
T ss_pred CCEEECcCCcCCC-hHHhHHHHcCCCcceeeccCCcc
Confidence 9999999999983 22221 15678899987
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.1e-08 Score=98.81 Aligned_cols=142 Identities=14% Similarity=0.073 Sum_probs=103.3
Q ss_pred CeeeeccCccEEEEEeCCCcEEEEEEeccCCcc----------ccHHHHHHHHHHHhcccCCCc--cceeEEEec-----
Q 009208 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA----------GGEVQFQTEVETISLAVHRNL--LRLCGFCST----- 369 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~----- 369 (540)
+.+-......|++..+ +|+.+.||........ .....+.+|...+.++...+| .+++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 5566566666888776 7789999987543311 111247788888888754333 345555543
Q ss_pred CCeeEEEEecCCCC-ChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-------C
Q 009208 370 ENERLLVYPYMPNG-SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-------D 441 (540)
Q Consensus 370 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-------~ 441 (540)
....++|+|++++- +|.+++.+.. ..+.+......++.+++..+.-||.. +|+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23478999999886 7888875422 23445667788999999999999999 9999999999999985 4
Q ss_pred CCeEEcccccccc
Q 009208 442 FEAVVGDFGLAKL 454 (540)
Q Consensus 442 ~~~kl~Dfgla~~ 454 (540)
..+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998863
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.8e-10 Score=75.61 Aligned_cols=40 Identities=48% Similarity=0.933 Sum_probs=31.0
Q ss_pred chHHHHHHHHHHhcC-CCCCccCCCCCCC-CCCccceeeeec
Q 009208 32 NYEVVALVAVKNNLH-DPYNVLENWDITS-VDPCSWRMITCS 71 (540)
Q Consensus 32 ~~~~~~l~~~k~~~~-~~~~~~~~w~~~~-~~~c~w~gv~c~ 71 (540)
+.|++||++||+++. +|.+.+.+|+.++ .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 578999999999997 5778999999764 899999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1e-10 Score=117.88 Aligned_cols=103 Identities=33% Similarity=0.535 Sum_probs=63.4
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
.++.|||+.|+++ .+|..+..|+ |+.|-+++|+++ .+|+.++.+..|..||.|.|++. .+|..++.+.+|+.|.+.
T Consensus 122 ~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vr 197 (722)
T KOG0532|consen 122 ALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVR 197 (722)
T ss_pred HHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHh
Confidence 4666777777776 6666666665 677777777776 66667776667777777777776 666666666665555555
Q ss_pred CccCCCCCCccccCCccccEEecccCccc
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS 183 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 183 (540)
.|++. .+|..+..| .|..||+|.|+++
T Consensus 198 Rn~l~-~lp~El~~L-pLi~lDfScNkis 224 (722)
T KOG0532|consen 198 RNHLE-DLPEELCSL-PLIRLDFSCNKIS 224 (722)
T ss_pred hhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence 55544 344444433 2444455555554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.2e-10 Score=115.31 Aligned_cols=196 Identities=23% Similarity=0.226 Sum_probs=144.7
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC--CCcEEEEEEeccCCccccHH-HHHHHHHHHhcc-cCCCccceeEEEecCCeeE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAGGEV-QFQTEVETISLA-VHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 374 (540)
...+|..+..||.|.|+.|++...+ ++..+++|...........+ .-..|+.+...+ .|.++++...........+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4567888899999999999987753 57889999876543222222 224455555544 4888888777666666777
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAK 453 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla~ 453 (540)
+=-||+++++...... -...++...++.+..+++.++.++|+. .++|+|+||+||++.++ +.-++.|||.+.
T Consensus 343 ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence 9999999998776552 134577788899999999999999998 99999999999999986 788999999987
Q ss_pred ccCCCCCceeecccccccc-ccccccccCCCCccCCeehhhHHHHHHHhCCC
Q 009208 454 LLDHRDSHVTTAVRGTVGH-IAPEYLSTGQSSEKTDVFGFGILLLELITGQR 504 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~ 504 (540)
.+.... ......+..| .+|+......+-.+.|+||||.-+.|.+++..
T Consensus 416 ~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 416 RLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ccceec---ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 432111 1111123334 35555566678899999999999999999884
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.93 E-value=6.7e-09 Score=94.43 Aligned_cols=127 Identities=23% Similarity=0.272 Sum_probs=82.1
Q ss_pred cEEEEEeCCCcEEEEEEeccCCc------------cc-------------cHHHHHHHHHHHhcccCC--CccceeEEEe
Q 009208 316 IVYKGCFSDGALVAVKRLKDYNI------------AG-------------GEVQFQTEVETISLAVHR--NLLRLCGFCS 368 (540)
Q Consensus 316 ~Vy~~~~~~g~~vavK~~~~~~~------------~~-------------~~~~~~~E~~~l~~l~h~--nIv~l~~~~~ 368 (540)
.||.|...+|..+|||..+.... .. .+....+|.+.|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 38999998999999999754210 00 112467899999999766 45555544
Q ss_pred cCCeeEEEEecCC--CCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCceeeCCCCCeE
Q 009208 369 TENERLLVYPYMP--NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY-LHEQCDPKIIHRDVKAANILLDEDFEAV 445 (540)
Q Consensus 369 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~-LH~~~~~~ivH~Dlk~~NILl~~~~~~k 445 (540)
....+||||++ |..+.. |.+. .++......++.++...+.. +|.. +|+|+|+.+.||+++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~-l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPR-LKDV-----DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGC-HHHC-----GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhh-HHhc-----cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 24579999998 544433 3321 11123445677777775665 4677 99999999999999988 999
Q ss_pred EcccccccccC
Q 009208 446 VGDFGLAKLLD 456 (540)
Q Consensus 446 l~Dfgla~~~~ 456 (540)
++|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999887544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.7e-10 Score=82.49 Aligned_cols=61 Identities=49% Similarity=0.685 Sum_probs=55.2
Q ss_pred CcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcc
Q 009208 122 EKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNL 182 (540)
Q Consensus 122 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 182 (540)
++|++|+|++|+|+..-+..|.++++|++|++++|+++...|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999954446789999999999999999977778999999999999999986
|
... |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.9e-09 Score=116.45 Aligned_cols=117 Identities=26% Similarity=0.428 Sum_probs=82.3
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
..++.|+|++|.|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|+|
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 199 EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 36888888888888 5666554 58888888888888 5676554 46888888888888 7777664 47888888
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCC--cccccccCCCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS--ARTFKVTGNPLI 202 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--~~~~~~~~n~~~ 202 (540)
++|+|+ .+|..+. ++|+.|++++|+|++.++.+. ...+++.+|.+.
T Consensus 270 s~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp~sL~~L~Ls~N~Lt 317 (754)
T PRK15370 270 FHNKIS-CLPENLP--EELRYLSVYDNSIRTLPAHLPSGITHLNVQSNSLT 317 (754)
T ss_pred cCCccC-ccccccC--CCCcEEECCCCccccCcccchhhHHHHHhcCCccc
Confidence 888888 5676554 478888888888875322222 134455566553
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.6e-09 Score=117.92 Aligned_cols=53 Identities=30% Similarity=0.351 Sum_probs=26.4
Q ss_pred cccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCccc
Q 009208 123 KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183 (540)
Q Consensus 123 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 183 (540)
+|+.|+|++|+|+ .+|... ++|+.|++++|+|+ .+|... .+|+.|++++|+|+
T Consensus 383 ~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt 435 (788)
T PRK15387 383 GLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT 435 (788)
T ss_pred ccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc
Confidence 4555566666555 344322 34555555555555 344321 24455555555555
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.4e-08 Score=110.52 Aligned_cols=33 Identities=18% Similarity=0.402 Sum_probs=18.8
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCC
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAIL 111 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~ 111 (540)
+++.|++++|+|+ .+|.. +++|++|+|++|+|+
T Consensus 223 ~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt 255 (788)
T PRK15387 223 HITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT 255 (788)
T ss_pred CCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC
Confidence 4566666666666 34432 355666666666666
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.82 E-value=5.8e-09 Score=114.04 Aligned_cols=97 Identities=29% Similarity=0.465 Sum_probs=52.1
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
+++.|+|++|+|+ .+|..+. ++|+.|+|++|++. .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|+
T Consensus 221 nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls 291 (754)
T PRK15370 221 NIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVY 291 (754)
T ss_pred CCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECC
Confidence 5777777777777 4555442 35666666666665 4554443 35566666666665 4555442 355555555
Q ss_pred CccCCCCCCccccCCccccEEecccCccc
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS 183 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 183 (540)
+|+|+ .+|..+. ++|+.|++++|+++
T Consensus 292 ~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt 317 (754)
T PRK15370 292 DNSIR-TLPAHLP--SGITHLNVQSNSLT 317 (754)
T ss_pred CCccc-cCcccch--hhHHHHHhcCCccc
Confidence 55555 3443322 23444444444444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.3e-10 Score=119.93 Aligned_cols=206 Identities=19% Similarity=0.211 Sum_probs=141.9
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
...+.+.+.+-+-+|.++.+.-+.-. .|...+.|.......- ..-.....+-.+.-..+||-++...--+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 45567777788889999998876532 2333333333221100 00111222333333344565554443334456788
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+|++|..+++|...|+.. +..+..-.......+..+.+|||.. .+.|+|++|.|.+...++..++.|||....
T Consensus 881 L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence 999999999999988753 2445555566777788999999998 799999999999999999999999984321
Q ss_pred cC-------C--------------C-------C--CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCC
Q 009208 455 LD-------H--------------R-------D--SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 504 (540)
Q Consensus 455 ~~-------~--------------~-------~--~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~ 504 (540)
.. . . . ........||+.|.+||...+......+|.|++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 10 0 0 0 011223458999999999999999999999999999999999999
Q ss_pred CCCccc
Q 009208 505 ALDFGR 510 (540)
Q Consensus 505 p~~~~~ 510 (540)
||+...
T Consensus 1034 p~na~t 1039 (1205)
T KOG0606|consen 1034 PFNAET 1039 (1205)
T ss_pred CCCCcc
Confidence 998543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.2e-08 Score=91.75 Aligned_cols=136 Identities=21% Similarity=0.142 Sum_probs=95.9
Q ss_pred CCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCc---------------------cccHHHHHHHHHHHhcccCC--C
Q 009208 303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNI---------------------AGGEVQFQTEVETISLAVHR--N 359 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~---------------------~~~~~~~~~E~~~l~~l~h~--n 359 (540)
..+.+.||-|.-+.||.|...+|.++|||.-+.... .-.+...++|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345688999999999999999999999997432110 01123467888888888644 5
Q ss_pred ccceeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC
Q 009208 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD 439 (540)
Q Consensus 360 Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~ 439 (540)
+.+.++ .+...+||||+++-.|... +++-.....++..|.+-+..+-.. ||||+|+++-||+++
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~---------r~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRL---------RLDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCccc----cccceeeeehcccceeecc---------cCcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 555554 4677899999998664431 112223334444555544444456 999999999999999
Q ss_pred CCCCeEEcccccccc
Q 009208 440 EDFEAVVGDFGLAKL 454 (540)
Q Consensus 440 ~~~~~kl~Dfgla~~ 454 (540)
++|.+.++||=-+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999976543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.78 E-value=4.9e-08 Score=98.22 Aligned_cols=171 Identities=19% Similarity=0.219 Sum_probs=128.1
Q ss_pred cCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEe----cCCeeEEEEecCCC-CChh
Q 009208 313 GFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS----TENERLLVYPYMPN-GSVA 386 (540)
Q Consensus 313 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~lV~e~~~~-gsL~ 386 (540)
-..+.||+... +|..|++|+++..... .......-++.++++.|.|+|++..++. .+...++||+|+++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~-~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ-STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc-CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 34578888754 8999999999543321 1112345678889999999999999876 34568899999986 4666
Q ss_pred hhcccc-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 387 SRLRDH-----------IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 387 ~~l~~~-----------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
++-... .......++...+.++.|+..||.++|+. |+.-+-+.+++|+++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 543221 12234577889999999999999999999 9999999999999999999999999988776
Q ss_pred CCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCC
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRA 505 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p 505 (540)
..+.. |-+ +--.+-|.=.||.+++.|.||..-
T Consensus 444 ~~d~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPT---------------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCC---------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 64431 111 112456888899999999999644
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=3.7e-09 Score=102.43 Aligned_cols=92 Identities=25% Similarity=0.292 Sum_probs=76.1
Q ss_pred ccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCcc
Q 009208 92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIES 171 (540)
Q Consensus 92 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 171 (540)
..|.+|++|+.|+|++|+|+++-+.+|.++.+|++|+|..|+|...--..|.++..|++|+|.+|+|+..-|.+|..+.+
T Consensus 268 ~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~ 347 (498)
T KOG4237|consen 268 KCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFS 347 (498)
T ss_pred HHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccce
Confidence 35788888888888888888888888888888888888888888444556788888888888888888777888888888
Q ss_pred ccEEecccCccc
Q 009208 172 LTLVDLSYNNLS 183 (540)
Q Consensus 172 L~~L~l~~N~l~ 183 (540)
|..|+|-.|++.
T Consensus 348 l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 348 LSTLNLLSNPFN 359 (498)
T ss_pred eeeeehccCccc
Confidence 888888888775
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.8e-08 Score=105.15 Aligned_cols=147 Identities=22% Similarity=0.273 Sum_probs=97.8
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCcc---------------------c------------------c
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA---------------------G------------------G 341 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---------------------~------------------~ 341 (540)
..|+. +.|+.++-|.||+|++++|+.||||+.++.-.+ . .
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 34442 689999999999999999999999997543210 0 1
Q ss_pred HHHHHHHHHHHhccc-----CCCccceeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHH
Q 009208 342 EVQFQTEVETISLAV-----HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416 (540)
Q Consensus 342 ~~~~~~E~~~l~~l~-----h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~ 416 (540)
+-++.+|..-+.+++ .+++.-.--|....+...++|||++|-.+.+...-.. ...+ +..++..++++.-
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d---~k~ia~~~~~~f~ 278 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGID---RKELAELLVRAFL 278 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCC---HHHHHHHHHHHHH
Confidence 113555666665543 3443333333344677899999999998887743211 2233 3334444443221
Q ss_pred -HHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 417 -YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 417 -~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
.+=.. +++|.|.+|.||+++.++++.+.|||+...+++
T Consensus 279 ~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 279 RQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 12223 899999999999999999999999999886654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.2e-09 Score=110.23 Aligned_cols=110 Identities=26% Similarity=0.434 Sum_probs=100.8
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
-++.|-+++|+++ .+|+.++.+.+|..||.+.|.+. .+|..++.+.+|+.|.+..|++. .+|+.++.| .|..||+|
T Consensus 144 pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfS 219 (722)
T KOG0532|consen 144 PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFS 219 (722)
T ss_pred cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecc
Confidence 4788889999998 89999999999999999999999 88999999999999999999999 899999855 69999999
Q ss_pred CccCCCCCCccccCCccccEEecccCcccccCCCC
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 189 (540)
+|+++ .+|..|.+|+.|++|-|.+|+|+..+-++
T Consensus 220 cNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAqI 253 (722)
T KOG0532|consen 220 CNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQI 253 (722)
T ss_pred cCcee-ecchhhhhhhhheeeeeccCCCCCChHHH
Confidence 99999 99999999999999999999999443333
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.71 E-value=3.5e-08 Score=114.96 Aligned_cols=124 Identities=25% Similarity=0.301 Sum_probs=85.3
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
.++.|+|++|.|. .++..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|..++++++|+.|+++
T Consensus 612 ~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~ 689 (1153)
T PLN03210 612 NLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689 (1153)
T ss_pred CCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCC
Confidence 5677777777776 5666777777788888877654446663 7777788888887776555777777788888888887
Q ss_pred CccCCCCCCccccCCccccEEecccCcccccCCCCCc--ccccccCCCC
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA--RTFKVTGNPL 201 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~~~~~~n~~ 201 (540)
+|..-+.+|..+ ++++|+.|++++|...+.+|.... +.+.+.+|.+
T Consensus 690 ~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i 737 (1153)
T PLN03210 690 RCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAI 737 (1153)
T ss_pred CCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCcc
Confidence 764444677655 677777777777766656665432 3455666654
|
syringae 6; Provisional |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.1e-09 Score=100.42 Aligned_cols=124 Identities=23% Similarity=0.263 Sum_probs=97.7
Q ss_pred ceeeeecCC-----CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCC
Q 009208 65 WRMITCSPD-----GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP 139 (540)
Q Consensus 65 w~gv~c~~~-----~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 139 (540)
..-++|-+. ..++.|+++.|+|. .+.. +..|.+|+.||||+|.++ .+-..=.+|-+.+.|.|+.|.|. .+
T Consensus 293 ~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-~L- 367 (490)
T KOG1259|consen 293 GNLITQIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-TL- 367 (490)
T ss_pred ccchhhhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-hh-
Confidence 344566432 57999999999998 4443 888999999999999999 55555567889999999999998 44
Q ss_pred ccccCCCCcchhhccCccCCCC-CCccccCCccccEEecccCcccccCCCCCcccc
Q 009208 140 DSLGDLGNLNYLRLNNNSLTGS-CPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194 (540)
Q Consensus 140 ~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~ 194 (540)
..+.+|-+|..||+++|+|... --..+++|+.|++|.|.+|++.+ +|+...+.+
T Consensus 368 SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~-~vdYRTKVL 422 (490)
T KOG1259|consen 368 SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG-SVDYRTKVL 422 (490)
T ss_pred hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc-cchHHHHHH
Confidence 4588899999999999999731 12468999999999999999995 444433333
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.7e-09 Score=113.51 Aligned_cols=102 Identities=28% Similarity=0.438 Sum_probs=93.0
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
+++.|||++|.++ ..|..+..+.+|+.|+++.|.|. ..|.+..++.+|++|.|.+|++. .+|.++..+.+|+.|++|
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 5899999999988 88999999999999999999999 77889999999999999999999 999999999999999999
Q ss_pred CccCCCCCCccccCCccccEEecccC
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYN 180 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N 180 (540)
.|++. .+|..+..++.++.+.+++|
T Consensus 123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N 147 (1081)
T KOG0618|consen 123 FNHFG-PIPLVIEVLTAEEELAASNN 147 (1081)
T ss_pred hhccC-CCchhHHhhhHHHHHhhhcc
Confidence 99999 88888888888777777777
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.6e-07 Score=82.37 Aligned_cols=139 Identities=19% Similarity=0.129 Sum_probs=103.0
Q ss_pred eeeccCccEEEEEeCCCcEEEEEEeccCC-----ccccHHHHHHHHHHHhcccCCC--ccceeEEEe-c----CCeeEEE
Q 009208 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYN-----IAGGEVQFQTEVETISLAVHRN--LLRLCGFCS-T----ENERLLV 376 (540)
Q Consensus 309 lG~G~~g~Vy~~~~~~g~~vavK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~-~----~~~~~lV 376 (540)
-|+||-+.|++-.+ +|+.+-+|+-.... .+-++..|.+|...+.++...+ +.++. ++. . .-.-+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46789999999877 45578888864111 1446778999999999886433 33444 332 1 1235799
Q ss_pred EecCCC-CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC--eEEccccccc
Q 009208 377 YPYMPN-GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE--AVVGDFGLAK 453 (540)
Q Consensus 377 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~Dfgla~ 453 (540)
+|-+++ -+|.+++.+. ...+.+...+..+..++++.++-||.. ++.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997764 4888887542 123456777889999999999999999 9999999999999986666 9999999776
Q ss_pred c
Q 009208 454 L 454 (540)
Q Consensus 454 ~ 454 (540)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=9.3e-10 Score=113.87 Aligned_cols=124 Identities=32% Similarity=0.456 Sum_probs=98.1
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCcc-ccCCCCcchhhc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDS-LGDLGNLNYLRL 153 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~L~l 153 (540)
.+...+.+.|.|. .+..++.-++.|+.|+|++|+++.. +.+..|++|++|||++|.+. .+|.- -..+ .|+.|.+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeeee
Confidence 4667788888887 6777888889999999999999965 37889999999999999999 77763 3334 4999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCccccc--CCCC----CcccccccCCCCCcCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGS--LPKI----SARTFKVTGNPLICGP 205 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~----~~~~~~~~~n~~~~~~ 205 (540)
++|.++ .+ ..+.+|++|+.||+++|-|++- +-.+ ....+.|+|||+-|.+
T Consensus 240 rnN~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 240 RNNALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred cccHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 999998 44 4688999999999999988852 1111 1156789999998863
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1e-06 Score=86.82 Aligned_cols=193 Identities=17% Similarity=0.207 Sum_probs=124.0
Q ss_pred cCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEE----Ee--cCCe-eEEE
Q 009208 305 AKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGF----CS--TENE-RLLV 376 (540)
Q Consensus 305 ~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~----~~--~~~~-~~lV 376 (540)
..+.+|+|+.+.+|--- .-...+-|+++..... .. .+.++.|... .||-+-.-+.+ .. +.+. ..+.
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa-~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPA-AQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCch-HH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 45789999999999531 1112234665543211 11 1223334333 45543321111 11 1122 4566
Q ss_pred EecCCCCC-hhhhcc--ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 377 YPYMPNGS-VASRLR--DHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 377 ~e~~~~gs-L~~~l~--~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
|..+.+.. ...+.+ ...+.-+..+|...+..+..+|.+.+-||+. |.+-+|+.++|+|+++++.+.+.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 66665541 111111 1223345689999999999999999999998 99999999999999999999998854332
Q ss_pred ccCCCCCceeeccccccccccccccc-----cCCCCccCCeehhhHHHHHHHhC-CCCCCc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITG-QRALDF 508 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvil~elltg-~~p~~~ 508 (540)
.-. .........|...|.+||.-. +..-+...|-|.+||++++++.| ++||..
T Consensus 166 i~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 166 INA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 221 122233445899999999864 23457789999999999999987 999984
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.4e-09 Score=106.08 Aligned_cols=111 Identities=26% Similarity=0.346 Sum_probs=78.0
Q ss_pred CcEEEecCCCCCCccccCccccCCCc---cCEEEcccCCCCC----CCCcccCCC-CcccEEEeeCCCCccc----CCcc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTK---LQSVLLQNNAILG----PIPASLGKL-EKLQTLDLSNNKFTGE----IPDS 141 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~---L~~L~l~~N~l~~----~~p~~~~~l-~~L~~L~ls~N~l~~~----~p~~ 141 (540)
.+++.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 47888888888887666666655555 8888888888773 233345566 7888888888888732 3445
Q ss_pred ccCCCCcchhhccCccCCCC----CCccccCCccccEEecccCcccc
Q 009208 142 LGDLGNLNYLRLNNNSLTGS----CPESLSKIESLTLVDLSYNNLSG 184 (540)
Q Consensus 142 ~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 184 (540)
+..+++|++|++++|.+++. ++..+..+++|+.|++++|.+++
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 207 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTD 207 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccCh
Confidence 66677888888888888742 33345556688888888888763
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.58 E-value=6.1e-09 Score=104.24 Aligned_cols=128 Identities=30% Similarity=0.428 Sum_probs=91.3
Q ss_pred cEEEecCCCCCCcc----ccCccccCC-CccCEEEcccCCCCCC----CCcccCCCCcccEEEeeCCCCcc----cCCcc
Q 009208 75 YVSALGLPSQSLSG----TLSPWIGNL-TKLQSVLLQNNAILGP----IPASLGKLEKLQTLDLSNNKFTG----EIPDS 141 (540)
Q Consensus 75 ~l~~l~l~~~~l~~----~~~~~~~~l-~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~----~~p~~ 141 (540)
+++.|++++|.+++ .+...+..+ ++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++ .++..
T Consensus 109 ~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~ 188 (319)
T cd00116 109 SLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEG 188 (319)
T ss_pred cccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHH
Confidence 48999999998873 334456667 8899999999998843 34456677889999999999884 23445
Q ss_pred ccCCCCcchhhccCccCCCC----CCccccCCccccEEecccCccccc--------CCC--CCcccccccCCCCC
Q 009208 142 LGDLGNLNYLRLNNNSLTGS----CPESLSKIESLTLVDLSYNNLSGS--------LPK--ISARTFKVTGNPLI 202 (540)
Q Consensus 142 ~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~--------~p~--~~~~~~~~~~n~~~ 202 (540)
+..+++|+.|+|++|.+++. ++..+..+++|++|++++|++++. ++. ...+.+++.+|.+.
T Consensus 189 l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 189 LKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 56667899999999988743 334566788899999999988851 111 12255677777653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.2e-07 Score=85.51 Aligned_cols=106 Identities=19% Similarity=0.240 Sum_probs=82.7
Q ss_pred HHHHHHHHHHhcccCC--CccceeEEEecCC----eeEEEEecCCCC-ChhhhccccCCCCCCCCHHHHHHHHHHHHHHH
Q 009208 343 VQFQTEVETISLAVHR--NLLRLCGFCSTEN----ERLLVYPYMPNG-SVASRLRDHIHGRPALDWARRKRIALGTARGL 415 (540)
Q Consensus 343 ~~~~~E~~~l~~l~h~--nIv~l~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l 415 (540)
....+|...+..+... ...+++++..... ..++|+|++++- +|.+++.+.. ..+......++.++++.+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 3577888887777533 3456666665432 347999999884 7888886521 255667788999999999
Q ss_pred HHHHhcCCCCeEecCCCCCceeeCCCC---CeEEccccccccc
Q 009208 416 LYLHEQCDPKIIHRDVKAANILLDEDF---EAVVGDFGLAKLL 455 (540)
Q Consensus 416 ~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgla~~~ 455 (540)
.-||.. +|+|+|+++.|||++.+. .+.++||+.++..
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.7e-09 Score=89.70 Aligned_cols=110 Identities=23% Similarity=0.368 Sum_probs=82.5
Q ss_pred ecCCCcEEEecCCCCCCccccCc---cccCCCccCEEEcccCCCCCCCCcccCC-CCcccEEEeeCCCCcccCCccccCC
Q 009208 70 CSPDGYVSALGLPSQSLSGTLSP---WIGNLTKLQSVLLQNNAILGPIPASLGK-LEKLQTLDLSNNKFTGEIPDSLGDL 145 (540)
Q Consensus 70 c~~~~~l~~l~l~~~~l~~~~~~---~~~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~ls~N~l~~~~p~~~~~l 145 (540)
|+....+-.+||+++.|- .+++ .+....+|+..+|++|.+. ..|+.|.. .+.++.|+|++|+|+ .+|..+..+
T Consensus 23 cedakE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam 99 (177)
T KOG4579|consen 23 CEDAKELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAM 99 (177)
T ss_pred hHHHHHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhh
Confidence 444445666778887765 3443 3455567777788888888 55555544 457888888888888 888888888
Q ss_pred CCcchhhccCccCCCCCCccccCCccccEEecccCccc
Q 009208 146 GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183 (540)
Q Consensus 146 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 183 (540)
+.|+.|+++.|.+. ..|..+..|.+|-.|+..+|.+.
T Consensus 100 ~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 100 PALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred HHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 88888888888888 77777888888888888888776
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=6.9e-09 Score=86.15 Aligned_cols=110 Identities=18% Similarity=0.240 Sum_probs=89.3
Q ss_pred CcEEEecCCCCCCccccCcccc-CCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhh
Q 009208 74 GYVSALGLPSQSLSGTLSPWIG-NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 152 (540)
.+++.++|++|.+. .+|+.|. +.+.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|-.|+
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 47999999999999 5666554 4569999999999999 88999999999999999999999 8999999999999999
Q ss_pred ccCccCCCCCCccccCCccccEEecccCcccccCC
Q 009208 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187 (540)
Q Consensus 153 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 187 (540)
..+|.+. .+|..+..-+.+-..++.+|++.+.-|
T Consensus 130 s~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 130 SPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred CCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 9999998 676654333333444556666665444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.2e-08 Score=102.23 Aligned_cols=85 Identities=44% Similarity=0.620 Sum_probs=42.2
Q ss_pred CCCccCEEEcccCCCCCCCCcccCCCC-cccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccE
Q 009208 96 NLTKLQSVLLQNNAILGPIPASLGKLE-KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTL 174 (540)
Q Consensus 96 ~l~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 174 (540)
.++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|.....+++|+.
T Consensus 114 ~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~ 190 (394)
T COG4886 114 ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNN 190 (394)
T ss_pred cccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhh
Confidence 3344555555555555 3444444442 5555555555555 44444555555555555555555 44443334455555
Q ss_pred EecccCccc
Q 009208 175 VDLSYNNLS 183 (540)
Q Consensus 175 L~l~~N~l~ 183 (540)
|++++|+++
T Consensus 191 L~ls~N~i~ 199 (394)
T COG4886 191 LDLSGNKIS 199 (394)
T ss_pred eeccCCccc
Confidence 555555555
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.1e-07 Score=108.56 Aligned_cols=123 Identities=22% Similarity=0.237 Sum_probs=95.9
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
.++.|++.++.++ .+|..| ...+|+.|+|++|++. .+|..+..+++|+.|+|++|...+.+|. +..+++|+.|+|+
T Consensus 590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~ 665 (1153)
T PLN03210 590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLS 665 (1153)
T ss_pred ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEec
Confidence 4677777777776 667666 5788999999999988 6788888899999999998765557775 7889999999999
Q ss_pred CccCCCCCCccccCCccccEEecccCcccccCCCCC----cccccccCCCC
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS----ARTFKVTGNPL 201 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~----~~~~~~~~n~~ 201 (540)
+|.....+|..+.++++|+.|++++|+.-+.+|... .+.+++.||..
T Consensus 666 ~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~ 716 (1153)
T PLN03210 666 DCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSR 716 (1153)
T ss_pred CCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCC
Confidence 887666889999999999999999876555666532 14556777643
|
syringae 6; Provisional |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.45 E-value=6.7e-08 Score=99.90 Aligned_cols=126 Identities=30% Similarity=0.508 Sum_probs=102.7
Q ss_pred CcEEEecCCCCCCccccCccccCCC-ccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhh
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLT-KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 152 (540)
..++.|++.+|.++ .+++....++ +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.++.|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 36899999999999 7888888885 9999999999999 77778999999999999999999 8888887899999999
Q ss_pred ccCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCCc
Q 009208 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLIC 203 (540)
Q Consensus 153 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~ 203 (540)
+++|+++ .+|.....+..|+.|.+++|++...+..+.. ..+.+.+|++.+
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeee
Confidence 9999999 8888776777799999999964433332221 233466676654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.6e-06 Score=78.23 Aligned_cols=140 Identities=13% Similarity=0.134 Sum_probs=84.3
Q ss_pred CeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCC--ccceeEEEecCCeeEEEEecCCCCC
Q 009208 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN--LLRLCGFCSTENERLLVYPYMPNGS 384 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lV~e~~~~gs 384 (540)
..||+|..+.||+. .|..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 56899999999984 35567788876432 2335688999998876443 4566777777777889999999863
Q ss_pred -hhhhcc--------------c---cCCCC--CCCCHHHHHH-HHH----------HHHH-HHHHHHhc-CCCCeEecCC
Q 009208 385 -VASRLR--------------D---HIHGR--PALDWARRKR-IAL----------GTAR-GLLYLHEQ-CDPKIIHRDV 431 (540)
Q Consensus 385 -L~~~l~--------------~---~~~~~--~~l~~~~~~~-i~~----------~ia~-~l~~LH~~-~~~~ivH~Dl 431 (540)
+...+. + .++.- .......... +.. .+.+ ...+|... ..+.++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 211110 0 00000 0111111000 000 0011 12222211 1346789999
Q ss_pred CCCceeeCCCCCeEEccccccc
Q 009208 432 KAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 432 k~~NILl~~~~~~kl~Dfgla~ 453 (540)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999887 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.3e-06 Score=77.68 Aligned_cols=159 Identities=23% Similarity=0.272 Sum_probs=101.8
Q ss_pred ccccCHHHHHHHhcCCCcCCeee---eccCccEEEEEeCCCcEEEEEEeccCCccc------------------cHHH--
Q 009208 288 LKRYTFKELRAATSNFSAKNILG---RGGFGIVYKGCFSDGALVAVKRLKDYNIAG------------------GEVQ-- 344 (540)
Q Consensus 288 ~~~~~~~~l~~~~~~~~~~~~lG---~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~------------------~~~~-- 344 (540)
....+++.+....+...+.+..| +|.-+.||+|...++..+|||+++.....- +..+
T Consensus 32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv 111 (268)
T COG1718 32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV 111 (268)
T ss_pred hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence 34556667776666666665554 677778999998889999999986533110 1110
Q ss_pred ---HHHHHHHHhccc--CCCccceeEEEecCCeeEEEEecCCCC-ChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 009208 345 ---FQTEVETISLAV--HRNLLRLCGFCSTENERLLVYPYMPNG-SVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418 (540)
Q Consensus 345 ---~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~L 418 (540)
..+|..-|.++. +-.+.+.+++ ....+||||+... .-.-.|++. ++.......+..++++.+.-|
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~LkDv-----~~e~~e~~~~~~~~v~~~~~l 182 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLKDV-----PLELEEAEGLYEDVVEYMRRL 182 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcccC-----CcCchhHHHHHHHHHHHHHHH
Confidence 133444444443 2222333332 2456999999654 212223221 222225666777888888887
Q ss_pred HhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 419 H~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
-..+ ++||+||+.-|||+. ++.+.|+|||-|...+++
T Consensus 183 ~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 183 YKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred HHhc--CcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 7632 999999999999999 789999999998766543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.28 E-value=5.2e-06 Score=76.36 Aligned_cols=136 Identities=13% Similarity=0.116 Sum_probs=90.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHH---------HHHHHHHHhcccCC---CccceeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ---------FQTEVETISLAVHR---NLLRLCGFC 367 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~---------~~~E~~~l~~l~h~---nIv~l~~~~ 367 (540)
..+|...+++.......|.+-.. +|+.+++|..+..... .++. ..+++..+.+++.. ....++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 45677777777777777777666 6789999987754321 1221 23344444444322 223323322
Q ss_pred e-----cCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 009208 368 S-----TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442 (540)
Q Consensus 368 ~-----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~ 442 (540)
. .....+++|||++|..|.+... ++. .++..+++++.-+|+. |++|+|.+|+|++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-
Confidence 2 2245568999999988765432 222 2456677889999999 99999999999999965
Q ss_pred CeEEccccccc
Q 009208 443 EAVVGDFGLAK 453 (540)
Q Consensus 443 ~~kl~Dfgla~ 453 (540)
.++++||+..+
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 59999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.28 E-value=5.2e-07 Score=60.86 Aligned_cols=36 Identities=42% Similarity=0.636 Sum_probs=18.5
Q ss_pred ccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCc
Q 009208 99 KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT 135 (540)
Q Consensus 99 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 135 (540)
+|++|+|++|+|+ .+|..+++|++|+.|++++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4555555555555 34444555555555555555555
|
... |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.25 E-value=4.2e-07 Score=61.33 Aligned_cols=37 Identities=46% Similarity=0.766 Sum_probs=25.7
Q ss_pred CcccEEEeeCCCCcccCCccccCCCCcchhhccCccCC
Q 009208 122 EKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT 159 (540)
Q Consensus 122 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 159 (540)
++|++|+|++|+|+ .+|+.+.+|++|+.|++++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 46777777777777 66666777777777777777776
|
... |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.2e-07 Score=95.83 Aligned_cols=97 Identities=21% Similarity=0.427 Sum_probs=76.5
Q ss_pred HHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce--------eecccccccccccccccc
Q 009208 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV--------TTAVRGTVGHIAPEYLST 480 (540)
Q Consensus 409 ~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~ 480 (540)
.++++|+.|+|... ++||++|.|++|.++..+..||+.|+.+.......... ..-..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34559999999864 99999999999999999999999999876443321111 111224568999999999
Q ss_pred CCCCccCCeehhhHHHHHHH-hCCCCCC
Q 009208 481 GQSSEKTDVFGFGILLLELI-TGQRALD 507 (540)
Q Consensus 481 ~~~~~k~Dv~S~Gvil~ell-tg~~p~~ 507 (540)
...+.++|+||+||++|.+. .|+.-++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~ 211 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIA 211 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhh
Confidence 88999999999999999999 5665554
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=5.8e-06 Score=86.27 Aligned_cols=144 Identities=20% Similarity=0.221 Sum_probs=92.9
Q ss_pred CCeeeeccCccEEEEEeCCCcEEEEEEeccCCccc------------------------------------cHHHHHHHH
Q 009208 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG------------------------------------GEVQFQTEV 349 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~------------------------------------~~~~~~~E~ 349 (540)
.+.||.-+.|.||+|++++|+.||||+-++.-... .+.+|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36899999999999999999999999965422100 122466666
Q ss_pred HHHhcc----cCCCc---cceeEEE-ecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 009208 350 ETISLA----VHRNL---LRLCGFC-STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421 (540)
Q Consensus 350 ~~l~~l----~h~nI---v~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~ 421 (540)
+-..++ +|-+. |.+=.++ .......|+||||+|..+.+.-. +. +..++-. .++..+.++ |++..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~--i~-~~gi~~~---~i~~~l~~~--~~~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA--ID-KRGISPH---DILNKLVEA--YLEQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH--HH-HcCCCHH---HHHHHHHHH--HHHHH
Confidence 655443 35441 1122222 23457889999999997776421 11 1123333 344444432 33333
Q ss_pred CCCCeEecCCCCCceeeCC----CCCeEEcccccccccCC
Q 009208 422 CDPKIIHRDVKAANILLDE----DFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 422 ~~~~ivH~Dlk~~NILl~~----~~~~kl~Dfgla~~~~~ 457 (540)
...|++|+|=+|.||+++. ++++.+-|||+...+.+
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3348999999999999993 67899999999886654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.1e-07 Score=94.83 Aligned_cols=185 Identities=18% Similarity=0.136 Sum_probs=131.8
Q ss_pred CcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCC-ccceeEEEecCCeeEEEEecCCC
Q 009208 304 SAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN-LLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 304 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
...+..++|+++++||.+-...+....+.+... ....-++++|.+++||| .+..++-+..++..+++++++.+
T Consensus 245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred HHHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 334567899999999987543444445554332 34566889999999999 66666666667778899999988
Q ss_pred C-ChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc
Q 009208 383 G-SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461 (540)
Q Consensus 383 g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~ 461 (540)
+ +-..-. ......+...+...+...-.++++|+|+. .=+|+| ||+..+ +..+..||+...-+....
T Consensus 319 ~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 319 GRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred CccccccC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--
Confidence 7 211111 11122344444555666778899999987 458888 777766 588999999887665433
Q ss_pred eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 462 ~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
......+|+.++|||+.....+..+.|+||.|+--.++--|-+|-.
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 2344569999999999999999999999999987777777776653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.19 E-value=5.2e-07 Score=88.95 Aligned_cols=120 Identities=26% Similarity=0.262 Sum_probs=78.0
Q ss_pred ccceeeeecCCCcEEEecCCCCCCcc-ccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCC--
Q 009208 63 CSWRMITCSPDGYVSALGLPSQSLSG-TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP-- 139 (540)
Q Consensus 63 c~w~gv~c~~~~~l~~l~l~~~~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-- 139 (540)
|.|...+-..-.+++.|.|++|+|+. .+-.....+++|+.|+|..|..-+.-......+..|+.|||++|++- ..+
T Consensus 186 ~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~ 264 (505)
T KOG3207|consen 186 NFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQG 264 (505)
T ss_pred CCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccc
Confidence 34444433333567777777777763 22233455678888888887533233334455778888888888887 555
Q ss_pred ccccCCCCcchhhccCccCCC-CCCcc-----ccCCccccEEecccCccc
Q 009208 140 DSLGDLGNLNYLRLNNNSLTG-SCPES-----LSKIESLTLVDLSYNNLS 183 (540)
Q Consensus 140 ~~~~~l~~L~~L~l~~N~l~~-~~p~~-----~~~l~~L~~L~l~~N~l~ 183 (540)
.-.+.++.|+.|+++.+.+.. ..|+. ...+++|++|+++.|++.
T Consensus 265 ~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 265 YKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred cccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 346778888888888888763 23443 356778888888888885
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 540 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-106 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-105 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-38 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-22 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-22 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-22 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-22 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-22 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-22 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-22 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-22 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-22 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-22 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-22 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-10 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-10 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 6e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-05 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 472 bits (1216), Expect = e-165
Identities = 188/266 (70%), Positives = 217/266 (81%), Gaps = 2/266 (0%)
Query: 272 FFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVK 331
FFDV + DPEV LG LKR++ +EL+ A+ NFS KNILGRGGFG VYKG +DG LVAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 332 RLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD 391
RLK+ GGE+QFQTEVE IS+AVHRNLLRL GFC T ERLLVYPYM NGSVAS LR+
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 392 HIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451
+P LDW +R+RIALG+ARGL YLH+ CDPKIIHRDVKAANILLDE+FEAVVGDFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA 511
AKL+D++D+HVTTAVRGT+GHIAPEYLSTG+SSEKTDVFG+G++LLELITGQRA D R
Sbjct: 181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 512 ANQRGVML-DWVCSHILSNQSSLDMV 536
AN VML DWV +L + +V
Sbjct: 241 ANDDDVMLLDWVKG-LLKEKKLEALV 265
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 364 bits (937), Expect = e-124
Identities = 102/271 (37%), Positives = 152/271 (56%), Gaps = 20/271 (7%)
Query: 277 DQYDPEVSLGHLKRYTFKELRAATSNFSAK------NILGRGGFGIVYKGCFSDGALVAV 330
+ EVS ++F EL+ T+NF + N +G GGFG+VYKG + VAV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 331 KRLK---DYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVAS 387
K+L D + QF E++ ++ H NL+ L GF S ++ LVY YMPNGS+
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 388 RLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG 447
RL + G P L W R +IA G A G+ +LHE IHRD+K+ANILLDE F A +
Sbjct: 120 RLSC-LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKIS 175
Query: 448 DFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRAL 506
DFGLA+ + + +T+ + GT ++APE L G+ + K+D++ FG++LLE+ITG A+
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 507 DFGRAANQRGVMLDWVCSHILSNQSSLDMVL 537
D R ++LD I + +++ +
Sbjct: 235 DEHREPQ---LLLDIKE-EIEDEEKTIEDYI 261
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 331 bits (852), Expect = e-111
Identities = 96/243 (39%), Positives = 142/243 (58%), Gaps = 14/243 (5%)
Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTE 348
R +L AT+NF K ++G G FG VYKG DGA VA+KR + G +F+TE
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP-ESSQGIEEFETE 85
Query: 349 VETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA----LDWARR 404
+ET+S H +L+ L GFC NE +L+Y YM NG+ L+ H++G + W +R
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN----LKRHLYGSDLPTMSMSWEQR 141
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL-LDHRDSHVT 463
I +G ARGL YLH + IIHRDVK+ NILLDE+F + DFG++K + +H++
Sbjct: 142 LEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198
Query: 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVC 523
T V+GT+G+I PEY G+ +EK+DV+ FG++L E++ + A+ + +W
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN-LAEWAV 257
Query: 524 SHI 526
Sbjct: 258 ESH 260
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 7e-70
Identities = 66/248 (26%), Positives = 100/248 (40%), Gaps = 26/248 (10%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
L + + RG FG V+K VAVK + Q + EV ++
Sbjct: 18 NLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQ--SWQNEYEVYSLPG 74
Query: 355 AVHRNLLRLCGFC----STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
H N+L+ G S + + L+ + GS L D + + W IA
Sbjct: 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGS----LSDFLKANV-VSWNELCHIAET 129
Query: 411 TARGLLYLHE-------QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHV 462
ARGL YLHE P I HRD+K+ N+LL + A + DFGLA + + +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 463 TTAVRGTVGHIAPEYLSTG-----QSSEKTDVFGFGILLLELITGQRALDFGRAANQRGV 517
T GT ++APE L + + D++ G++L EL + A D G
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD-GPVDEYMLP 248
Query: 518 MLDWVCSH 525
+ + H
Sbjct: 249 FEEEIGQH 256
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-58
Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLC 364
K +G G FG V++ + G+ VAVK L + + V F EV + H N++
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIH---GRPALDWARRKRIALGTARGLLYLHEQ 421
G + +V Y+ GS L +H R LD RR +A A+G+ YLH
Sbjct: 101 GAVTQPPNLSIVTEYLSRGS----LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
+P I+HR++K+ N+L+D+ + V DFGL++L + + GT +APE L
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS-TFLSSKSAAGTPEWMAPEVLRDE 214
Query: 482 QSSEKTDVFGFGILLLELITGQ 503
S+EK+DV+ FG++L EL T Q
Sbjct: 215 PSNEKSDVYSFGVILWELATLQ 236
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-55
Identities = 66/245 (26%), Positives = 95/245 (38%), Gaps = 37/245 (15%)
Query: 292 TFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVET 351
E N ++GRG +G VYKG D VAVK N F E
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNI 58
Query: 352 ISLAV--HRNLLRLCGFC-----STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR 404
+ + H N+ R E LLV Y PNGS L ++ DW
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGS----LXKYLS-LHTSDWVSS 113
Query: 405 KRIALGTARGLLYLHE------QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH- 457
R+A RGL YLH P I HRD+ + N+L+ D V+ DFGL+ L
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 458 ------RDSHVTTAVRGTVGHIAPEYL-------STGQSSEKTDVFGFGILLLELITGQR 504
+ + + GT+ ++APE L + ++ D++ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 505 ALDFG 509
L G
Sbjct: 234 DLFPG 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 6e-55
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
+ ++GRG FG+V K + VA+K+++ + F E+ +S H N+++L G
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE---RKAFIVELRQLSRVNHPNIVKLYG 68
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGR---PALDWARRKRIALGTARGLLYLHEQC 422
C N LV Y GS L + +HG P A L ++G+ YLH
Sbjct: 69 ACL--NPVCLVMEYAEGGS----LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 423 DPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
+IHRD+K N+LL + + DFG A + T +G+ +APE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGS 178
Query: 482 QSSEKTDVFGFGILLLELITGQR 504
SEK DVF +GI+L E+IT ++
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRK 201
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-54
Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 306 KNILGRGGFGIVYKGCFSDGALVAVKRLK---DYNIAGGEVQFQTEVETISLAVHRNLLR 362
+ I+G GGFG VY+ + G VAVK + D +I+ + E + ++ H N++
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
L G C E LV + G L + G+ + A+ ARG+ YLH++
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGP----LNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEA 125
Query: 423 DPKIIHRDVKAANILLDEDFEAV--------VGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
IIHRD+K++NIL+ + E + DFGLA+ + G +A
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMA 182
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQ 503
PE + S+ +DV+ +G+LL EL+TG+
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 9e-54
Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 306 KNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEV------QFQTEVETISLAVHR 358
+ +G+GGFG+V+KG D ++VA+K L + G +FQ EV +S H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIALGTARGLLY 417
N+++L G N +V ++P G L + + + W+ + R+ L A G+ Y
Sbjct: 84 NIVKLYGLMH--NPPRMVMEFVPCGD----LYHRLLDKAHPIKWSVKLRLMLDIALGIEY 137
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAV-----VGDFGLAKLLDHRDSHVTTAVRGTVGH 472
+ +P I+HRD+++ NI L E V DFGL++ H + + G
Sbjct: 138 MQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQW 192
Query: 473 IAPEYLSTGQS--SEKTDVFGFGILLLELITGQR 504
+APE + + +EK D + F ++L ++TG+
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-52
Identities = 71/201 (35%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFC 367
+G G FG VYKG + VAVK L ++Q F+ EV + H N+L G+
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGR-PALDWARRKRIALGTARGLLYLHEQCDPKI 426
+ +V + S L H+H + + IA TARG+ YLH + I
Sbjct: 90 TAPQ-LAIVTQWCEGSS----LYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHR-DSHVTTAVRGTVGHIAPEYLSTGQS-- 483
IHRD+K+ NI L ED +GDFGLA SH + G++ +APE + S
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 484 -SEKTDVFGFGILLLELITGQ 503
S ++DV+ FGI+L EL+TGQ
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-51
Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLC 364
L G ++KG + G + VK LK + + + + F E + + H N+L +
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 365 GFCSTENERLL--VYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLLYLHE 420
G C + + +MP GS L + +H +D ++ + AL ARG+ +LH
Sbjct: 74 GACQSPPAPHPTLITHWMPYGS----LYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH- 128
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
+P I + + ++++DED A + + S + +APE L
Sbjct: 129 TLEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQK 182
Query: 481 GQS---SEKTDVFGFGILLLELITGQ 503
D++ F +LL EL+T +
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-51
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 21/214 (9%)
Query: 306 KNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
+LG+G FG K G ++ +K L ++ + F EV+ + H N+L+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
G + + Y+ G++ ++ W++R A A G+ YLH
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM--- 127
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLD-------------HRDSHVTTAVRGTVG 471
IIHRD+ + N L+ E+ VV DFGLA+L+ D V G
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITGQRA 505
+APE ++ EK DVF FGI+L E+I A
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-49
Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 25/213 (11%)
Query: 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLC 364
++G+G FG VY G + VA++ + +++ F+ EV H N++
Sbjct: 38 GELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGR-PALDWARRKRIALGTARGLLYLHEQCD 423
G C + ++ + L + LD + ++IA +G+ YLH +
Sbjct: 96 GACMSPPHLAIITSLCKGRT----LYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK-- 149
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH----RDSHVTTAVRGTVGHIAPEYLS 479
I+H+D+K+ N+ D + V+ DFGL + R G + H+APE +
Sbjct: 150 -GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 480 TGQS---------SEKTDVFGFGILLLELITGQ 503
S+ +DVF G + EL +
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-49
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 30/216 (13%)
Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV--HRNLLRLC 364
+G+G +G V++G + G VAVK + E + E E + + H N+L
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFI 68
Query: 365 GFCSTEN----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
T + L+ Y GS L D++ LD RI L A GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGS----LYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 421 -----QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV---TTAVRGTVGH 472
Q P I HRD+K+ NIL+ ++ + + D GLA + + + GT +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 473 IAPE------YLSTGQSSEKTDVFGFGILLLELITG 502
+APE + S ++ D++ FG++L E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-48
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV--HRNLLRLC 364
+G+G FG V++G + G VAVK E + E E + H N+L
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFI 102
Query: 365 GFCSTEN----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
+ +N + LV Y +GS L D+++ R + ++AL TA GL +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGS----LFDYLN-RYTVTVEGMIKLALSTASGLAHLHM 157
Query: 421 -----QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT---TAVRGTVGH 472
Q P I HRD+K+ NIL+ ++ + D GLA D + GT +
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 473 IAPEYL------STGQSSEKTDVFGFGILLLELITG 502
+APE L +S ++ D++ G++ E+
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 5e-48
Identities = 56/216 (25%), Positives = 86/216 (39%), Gaps = 30/216 (13%)
Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV--HRNLLRLC 364
+G+G +G V+ G + G VAVK A + E E + H N+L
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA----SWFRETEIYQTVLMRHENILGFI 97
Query: 365 GFCSTENER----LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
L+ Y NGS L D++ LD ++A + GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGS----LYDYLK-STTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 421 -----QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV---TTAVRGTVGH 472
Q P I HRD+K+ NIL+ ++ + D GLA + V GT +
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 473 IAPE------YLSTGQSSEKTDVFGFGILLLELITG 502
+ PE + QS D++ FG++L E+
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-45
Identities = 45/162 (27%), Positives = 80/162 (49%), Gaps = 8/162 (4%)
Query: 34 EVVALVAVKNNLHDPYNVLENWDI-TSVDPCSWRMITCSPDG---YVSALGLPSQSLSGT 89
+ AL+ +K +L +P L +W T +W + C D V+ L L +L
Sbjct: 7 DKQALLQIKKDLGNPTT-LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 90 --LSPWIGNLTKLQSVLLQN-NAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG 146
+ + NL L + + N ++GPIP ++ KL +L L +++ +G IPD L +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 147 NLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
L L + N+L+G+ P S+S + +L + N +SG++P
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 2/110 (1%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L + ++SG + ++ + L ++ NA+ G +P S+ L L + N+ +G I
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 139 PDSLGDLGNL-NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
PDS G L + ++ N LTG P + + + +L VDLS N L G
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDAS 214
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 35/124 (28%), Positives = 58/124 (46%), Gaps = 6/124 (4%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
L+G + P NL L V L N + G G + Q + L+ N ++ +G
Sbjct: 185 RLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGL 242
Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI----SARTFKVTGNP 200
NLN L L NN + G+ P+ L++++ L +++S+NNL G +P+ N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 201 LICG 204
+CG
Sbjct: 303 CLCG 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 30/105 (28%), Positives = 48/105 (45%), Gaps = 4/105 (3%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
L G S G+ Q + L N++ + +G + L LDL NN+ G +P L
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQ 266
Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNN-LSGS-LP 187
L L+ L ++ N+L G P+ ++ + + N L GS LP
Sbjct: 267 LKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPLP 310
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
+ +GRG FG V+ G +D LVAVK ++ + +F E + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
++RL G C+ + +V + G + LR L ++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLE 230
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI-----A 474
+ IHRD+ A N L+ E + DFG+++ D G + + A
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA--DGVYAA--SGGLRQVPVKWTA 283
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELIT 501
PE L+ G+ S ++DV+ FGILL E +
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFS 310
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-37
Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 308 ILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEV-QFQTEVETISLAVHRNLLRLCG 365
+GRG F VYKG VA L+D + E +F+ E E + H N++R
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 366 FC---STENERLLVYP-YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
+ +++ M +G++ + L+ + + +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 422 CDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
P IIHRD+K NI + +V +GD GLA L + AV GT +APE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
E DV+ FG+ +LE+ T +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-37
Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 306 KNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
LG G FG V + + G VAVK LK + + E+E + H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 361 LRLCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
++ G C+ + L+ ++P+GS+ L + + ++ ++ + A+ +G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYL 142
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI---AP 475
+ + +HRD+ A N+L++ + + +GDFGL K + D T + AP
Sbjct: 143 GSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYAP 198
Query: 476 EYLSTGQSSEKTDVFGFGILLLELIT 501
E L + +DV+ FG+ L EL+T
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 63/206 (30%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 306 KNILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
++G+G FG+VY G + D A A+K L F E + H N+L
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 362 RLCGFCSTENERLL-VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
L G + PYM +G + +R + L ARG+ YL E
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAE 142
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI-----AP 475
Q K +HRD+ A N +LDE F V DFGLA+ + R+ + + + A
Sbjct: 143 Q---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE--YYSVQQHRHARLPVKWTAL 197
Query: 476 EYLSTGQSSEKTDVFGFGILLLELIT 501
E L T + + K+DV+ FG+LL EL+T
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + VA+K L++ + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
+ ++ RL G C + L+ MP G + +R+H + + + A+G+
Sbjct: 75 DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGM 130
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTV 470
YL ++ +++HRD+ A N+L+ + DFGLAKLL + ++
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM- 186
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
A E + + ++DV+ +G+ + EL+T G +
Sbjct: 187 ---ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 68/205 (33%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 307 NILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G D AVK L G QF TE + H N+L
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 363 LCGFCS-TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
L G C +E L+V PYM +G + + +R+ L A+G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI-----APE 476
K +HRD+ A N +LDE F V DFGLA+ + ++ + + T + A E
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKTGAKLPVKWMALE 202
Query: 477 YLSTGQSSEKTDVFGFGILLLELIT 501
L T + + K+DV+ FG+LL EL+T
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 67/205 (32%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 307 NILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
++GRG FG VY G D AVK L G QF TE + H N+L
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 363 LCGFCS-TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
L G C +E L+V PYM +G + + +R+ L A+G+ +L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI-----APE 476
K +HRD+ A N +LDE F V DFGLA+ + ++ T + A E
Sbjct: 212 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWMALE 266
Query: 477 YLSTGQSSEKTDVFGFGILLLELIT 501
L T + + K+DV+ FG+LL EL+T
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 306 KNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQ---FQTEVETISLAVH 357
LG+G FG V + + G +VAVK+L+ E F+ E+E + H
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----STEEHLRDFEREIEILKSLQH 70
Query: 358 RNLLRLCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
N+++ G C + R L+ Y+P GS+ L+ H + +D + + +G+
Sbjct: 71 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGM 127
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI-- 473
YL + + IHRD+ NIL++ + +GDFGL K+L D I
Sbjct: 128 EYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFW 183
Query: 474 -APEYLSTGQSSEKTDVFGFGILLLELIT 501
APE L+ + S +DV+ FG++L EL T
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 60/195 (30%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
+E +V YM GS+ L+ L + +A A G+ Y+
Sbjct: 248 V-SEEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
+HRD++AANIL+ E+ V DFGLA+L++ + + + APE G+ + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 487 TDVFGFGILLLELIT 501
+DV+ FGILL EL T
Sbjct: 362 SDVWSFGILLTELTT 376
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-35
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 306 KNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQ---FQTEVETISLAVH 357
LG+G FG V + + G +VAVK+L+ E F+ E+E + H
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----STEEHLRDFEREIEILKSLQH 101
Query: 358 RNLLRLCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
N+++ G C + R L+ Y+P GS+ L+ H + +D + + +G+
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGM 158
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI-- 473
YL + + IHRD+ NIL++ + +GDFGL K+L D I
Sbjct: 159 EYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFW 214
Query: 474 -APEYLSTGQSSEKTDVFGFGILLLELIT 501
APE L+ + S +DV+ FG++L EL T
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-----VAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ +LG G FG V+KG + V +K ++D + + I
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
H +++RL G C + LV Y+P GS+ +R H R AL + A+G+
Sbjct: 73 DHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGM 128
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTV 470
YL E ++HR++ A N+LL + V DFG+A LL D + + ++
Sbjct: 129 YYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM- 184
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
A E + G+ + ++DV+ +G+ + EL+T G
Sbjct: 185 ---ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 63/209 (30%), Positives = 90/209 (43%), Gaps = 25/209 (11%)
Query: 306 KNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
LG G FG V C+ G +VAVK LK ++ E++ + H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 361 LRLCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
++ G C LV Y+P GS+ L H ++ A+ A G+ YL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYL 150
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TVGH 472
H Q IHRD+ A N+LLD D +GDFGLAK + + G
Sbjct: 151 HAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY--- 204
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELIT 501
APE L + +DV+ FG+ L EL+T
Sbjct: 205 -APECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-35
Identities = 60/195 (30%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
LG+G FG V+ G ++ VA+K LK ++ F E + + H L++L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
+E +V YM GS+ L+ L + +A A G+ Y+
Sbjct: 331 V-SEEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
+HRD++AANIL+ E+ V DFGLA+L++ + + + APE G+ + K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 487 TDVFGFGILLLELIT 501
+DV+ FGILL EL T
Sbjct: 445 SDVWSFGILLTELTT 459
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-34
Identities = 52/167 (31%), Positives = 77/167 (46%), Gaps = 16/167 (9%)
Query: 76 VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT 135
+ + S+ G SP N + + + N + G IP +G + L L+L +N +
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 136 GEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-RTF 194
G IPD +GDL LN L L++N L G P+++S + LT +DLS NNLSG +P++ TF
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETF 729
Query: 195 KVT---GNPLICGPKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHR 238
NP +CG PL D +SH
Sbjct: 730 PPAKFLNNPGLCGY------------PLPRCDPSNADGYAHHQRSHH 764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-34
Identities = 42/104 (40%), Positives = 57/104 (54%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
+G + P + N ++L S+ L N + G IP+SLG L KL+ L L N GEIP L
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
+ L L L+ N LTG P LS +L + LS N L+G +PK
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-33
Identities = 38/104 (36%), Positives = 59/104 (56%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
L G + + + L++++L N + G IP+ L L + LSNN+ TGEIP +G
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
L NL L+L+NNS +G+ P L SL +DL+ N +G++P
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-32
Identities = 43/103 (41%), Positives = 67/103 (65%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
LSGT+ +G+L+KL+ + L N + G IP L ++ L+TL L N TGEIP L +
Sbjct: 429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
NLN++ L+NN LTG P+ + ++E+L ++ LS N+ SG++P
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP 531
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-31
Identities = 42/112 (37%), Positives = 60/112 (53%), Gaps = 2/112 (1%)
Query: 79 LGLPSQSLSGTLSPWIGN--LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG 136
L L S + SG + P + LQ + LQNN G IP +L +L +L LS N +G
Sbjct: 373 LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSG 432
Query: 137 EIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
IP SLG L L L+L N L G P+ L +++L + L +N+L+G +P
Sbjct: 433 TIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 49/219 (22%), Positives = 86/219 (39%), Gaps = 59/219 (26%)
Query: 27 SPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPD------------- 73
+ E+ L++ K+ L D N+L +W ++ +PC++ +TC D
Sbjct: 6 PSQSLYREIHQLISFKDVLPDK-NLLPDWS-SNKNPCTFDGVTCRDDKVTSIDLSSKPLN 63
Query: 74 ---------------------------GYVSALG---------LPSQSLSGTLSP--WIG 95
G VS L SLSG ++ +G
Sbjct: 64 VGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLG 123
Query: 96 NLTKLQSVLLQNNAILGPIPASLG-KLEKLQTLDLSNNKFTGEIPDSL---GDLGNLNYL 151
+ + L+ + + +N + P S G KL L+ LDLS N +G G L +L
Sbjct: 124 SCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 183
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
++ N ++G +S+ +L +D+S NN S +P +
Sbjct: 184 AISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLG 220
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-30
Identities = 44/113 (38%), Positives = 57/113 (50%), Gaps = 3/113 (2%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L + LSG S I T+L+ + + +N +GPIP L+ LQ L L+ NKFTGEI
Sbjct: 228 LDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEI 285
Query: 139 PDSL-GDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
PD L G L L L+ N G+ P L + LS NN SG LP +
Sbjct: 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT 338
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-29
Identities = 36/111 (32%), Positives = 62/111 (55%), Gaps = 4/111 (3%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L + S + S + P++G+ + LQ + + N + G ++ +L+ L++S+N+F G I
Sbjct: 205 LDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI 263
Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLS-KIESLTLVDLSYNNLSGSLPK 188
P L +L YL L N TG P+ LS ++LT +DLS N+ G++P
Sbjct: 264 PPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP 312
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-28
Identities = 37/104 (35%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
L+G + + N T L + L NN + G IP +G+LE L L LSNN F+G IP LGD
Sbjct: 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536
Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
+L +L LN N G+ P ++ K ++ N ++G
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQSG----KIAANFIAGKRYV 576
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-28
Identities = 41/111 (36%), Positives = 56/111 (50%), Gaps = 4/111 (3%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGE 137
L + S G + P L LQ + L N G IP L G + L LDLS N F G
Sbjct: 252 LNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA 309
Query: 138 IPDSLGDLGNLNYLRLNNNSLTGSCP-ESLSKIESLTLVDLSYNNLSGSLP 187
+P G L L L++N+ +G P ++L K+ L ++DLS+N SG LP
Sbjct: 310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 37/113 (32%), Positives = 64/113 (56%), Gaps = 4/113 (3%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGE 137
L L G + P+ G+ + L+S+ L +N G +P +L K+ L+ LDLS N+F+GE
Sbjct: 299 LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE 358
Query: 138 IPDSLGDL-GNLNYLRLNNNSLTGSCPESLSKI--ESLTLVDLSYNNLSGSLP 187
+P+SL +L +L L L++N+ +G +L + +L + L N +G +P
Sbjct: 359 LPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP 411
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 21/112 (18%), Positives = 52/112 (46%), Gaps = 2/112 (1%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAIL--GPIPASLGKLEKLQTLDLSNNKFTG 136
+ + ++G +I N + N + G L +L ++++ + G
Sbjct: 563 GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGG 622
Query: 137 EIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
+ + G++ +L ++ N L+G P+ + + L +++L +N++SGS+P
Sbjct: 623 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 22/112 (19%), Positives = 42/112 (37%), Gaps = 6/112 (5%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L L + S SG + +G+ L + L N G IPA++ K + ++ N G+
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKR 574
Query: 139 PDSLGDLGNLNYLRL--NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
+ + G N G E L+++ + +++ G
Sbjct: 575 YVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP 626
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 306 KNILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNL 360
ILG G FG V +G VAVK +K N + E++ F +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 361 LRLCGFCSTEN-----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK--RIALGTAR 413
+RL G C + + +++ P+M G + + L + + + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRG 468
G+ YL + +HRD+ A N +L +D V DFGL+K + D + V+
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
A E L+ + K+DV+ FG+ + E+ T
Sbjct: 216 I----AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGA-----LVAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + VA+K L++ + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
+ ++ RL G C + L+ MP G + +R+H + + + A+G+
Sbjct: 75 DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGM 130
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTV 470
YL ++ +++HRD+ A N+L+ + DFGLAKLL + ++
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM- 186
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
A E + + ++DV+ +G+ + EL+T G +
Sbjct: 187 ---ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 306 KNILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNL 360
+LG+G FG V + VAVK LK IA +++ F E + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 361 LRLCGFCSTENER------LLVYPYMPNGSVASRLRDHIHGR--PALDWARRKRIALGTA 412
+L G + +++ P+M +G + + L G L R + A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VR 467
G+ YL + IHRD+ A N +L ED V DFGL++ + D + V+
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
A E L+ + +DV+ FG+ + E++T
Sbjct: 205 WL----ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 306 KNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
+ LG+G FG V + + GALVAVK+L+ + + FQ E++ + +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH-SGPDQQRDFQREIQILKALHSDFI 86
Query: 361 LRLCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
++ G + LV Y+P+G + L+ H R LD +R + +G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYL 143
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TVGH 472
+ + +HRD+ A NIL++ + + DFGLAKLL + G
Sbjct: 144 GSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY--- 197
Query: 473 IAPEYLSTGQSSEKTDVFGFGILLLELIT 501
APE LS S ++DV+ FG++L EL T
Sbjct: 198 -APESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-34
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
+ LG G FG+V G + VAVK +K+ +++ E +F E +T+ H L
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKL 65
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
++ G CS E +V Y+ NG + + LR H L+ ++ + G+ +L
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTVGHIAP 475
+ IHRD+ A N L+D D V DFG+ + + D +V++ V+ + AP
Sbjct: 123 H---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSVGTKFPVKWS----AP 174
Query: 476 EYLSTGQSSEKTDVFGFGILLLELIT 501
E + S K+DV+ FGIL+ E+ +
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-34
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 8/202 (3%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
++ + K+ LG G +G VY+G VAVK LK+ + +F E + H N
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 277
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
L++L G C+ E ++ +M G++ LR+ R + +A + + YL
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE 335
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
++ IHR++ A N L+ E+ V DFGL++L+ + + APE L+
Sbjct: 336 KK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 392
Query: 480 TGQSSEKTDVFGFGILLLELIT 501
+ S K+DV+ FG+LL E+ T
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIAT 414
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-34
Identities = 52/206 (25%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
+ + LG G FG+V G + VA+K +K+ +++ E +F E + + H L
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKL 81
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
++L G C+ + ++ YM NG + + LR+ R + + + YL
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTVGHIAP 475
+ + +HRD+ A N L+++ V DFGL++ + D + ++ VR + P
Sbjct: 139 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWS----PP 190
Query: 476 EYLSTGQSSEKTDVFGFGILLLELIT 501
E L + S K+D++ FG+L+ E+ +
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-34
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 21/209 (10%)
Query: 306 KNILGRGGFGIVYKGCFSDGA---LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG V +G + VA+K LK + E + + + ++R
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
L G C E +LV G + L R + + + + G+ YL E+
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK- 129
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TVGHIAPE 476
+HRD+ A N+LL A + DFGL+K L DS+ T G APE
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APE 183
Query: 477 YLSTGQSSEKTDVFGFGILLLELIT-GQR 504
++ + S ++DV+ +G+ + E ++ GQ+
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-34
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
S + +G G FG+V+ G + + VA+K +++ ++ E F E E + H L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKL 65
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
++L G C + LV +M +G ++ LR R + L G+ YL E
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTVGHIAP 475
+IHRD+ A N L+ E+ V DFG+ + + D + ++ V+ +P
Sbjct: 123 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSSTGTKFPVKWA----SP 174
Query: 476 EYLSTGQSSEKTDVFGFGILLLELIT 501
E S + S K+DV+ FG+L+ E+ +
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
LG G FG V+ ++ VAVK +K +++ F E + H L++L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA--FLAEANVMKTLQHDKLVKLHAV 251
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
T+ ++ +M GS+ L+ + + A G+ ++ ++
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 305
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI---APEYLSTGQS 483
IHRD++AANIL+ + DFGLA+++ + + TA G I APE ++ G
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 484 SEKTDVFGFGILLLELIT 501
+ K+DV+ FGILL+E++T
Sbjct: 363 TIKSDVWSFGILLMEIVT 380
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 47/215 (21%), Positives = 91/215 (42%), Gaps = 24/215 (11%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLAV 356
+ ILG G FG VY+G +++ VAVK K + +F +E +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
H ++++L G E ++ P G + L + + +L +L + +
Sbjct: 72 HPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMA 127
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TV 470
YL +HRD+ NIL+ +GDFGL++ ++ D A
Sbjct: 128 YLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE--DEDYYKASVTRLPIKWM- 181
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
+PE ++ + + +DV+ F + + E+++ G++
Sbjct: 182 ---SPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 308 ILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
+G G FG V++G + VA+K K+ +F E T+ H ++++L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
G TEN ++ G + S L+ + +LD A A + L YL +
Sbjct: 82 IGVI-TENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK-- 135
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TVGHIAPEY 477
+ +HRD+ A N+L+ + +GDFGL++ ++ DS A +G APE
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKLPIKWM----APES 188
Query: 478 LSTGQSSEKTDVFGFGILLLELIT-GQR 504
++ + + +DV+ FG+ + E++ G +
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 21/210 (10%)
Query: 306 KNILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL 361
+ I+G G G V G VA+K LK F +E + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
RL G + ++V YM NGS+ + LR H + + G G+ YL +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TVGHIAP 475
+HRD+ A N+L+D + V DFGL+++L+ T G T AP
Sbjct: 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----AP 223
Query: 476 EYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
E ++ S +DV+ FG+++ E++ G+R
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-33
Identities = 66/203 (32%), Positives = 93/203 (45%), Gaps = 26/203 (12%)
Query: 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLC 364
+G+G FG V G + G VAVK +K+ Q F E ++ H NL++L
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKN----DATAQAFLAEASVMTQLRHSNLVQLL 80
Query: 365 GFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
G E L +V YM GS+ LR GR L + +L + YL
Sbjct: 81 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN-- 136
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTVGHIAPEYL 478
+HRD+ A N+L+ ED A V DFGL +++ T V+ T APE L
Sbjct: 137 -NFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWT----APEAL 186
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
+ S K+DV+ FGILL E+ +
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYS 209
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-33
Identities = 69/217 (31%), Positives = 92/217 (42%), Gaps = 24/217 (11%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNIAGGEVQ--FQTEVETISL 354
+ LG G FG+V +G + VAVK LK ++ E F EV +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
HRNL+RL G T +V P GS+ RLR H + R A+ A G
Sbjct: 78 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEG 133
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------ 468
+ YL + + IHRD+ A N+LL +GDFGL + L D H
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
APE L T S +D + FG+ L E+ T GQ
Sbjct: 191 C----APESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 306 KNILGRGGFGIVYKGCFSDGA------LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
LG+G FG+VY+G VA+K + + ++F E + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDH------IHGRPALDWARRKRIALGTAR 413
++RL G S L++ M G + S LR ++ ++A A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
G+ YL+ K +HRD+ A N ++ EDF +GDFG+ + + D +G G +
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD----YYRKGGKGLL 202
Query: 474 -----APEYLSTGQSSEKTDVFGFGILLLELIT 501
+PE L G + +DV+ FG++L E+ T
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
LG G FG V+ G ++ VAVK LK +++ F E + H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA--FLAEANLMKQLQHQRL 70
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
+RL T+ ++ YM NGS+ L+ L + +A A G+ ++ E
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA------VRGTVGHIA 474
+ IHRD++AANIL+ + + DFGLA+L++ D+ T ++ T A
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWT----A 178
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELIT 501
PE ++ G + K+DV+ FGILL E++T
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 22/216 (10%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGA-----LVAVKRLKDYNIAGGEVQFQTEVETISLA 355
S + + ++G G FG VYKG + VA+K LK V F E +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
H N++RL G S +++ YM NG++ LR+ + + G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGM 160
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL-DHRDSHVTTA-----VRGT 469
YL +HRD+ A NIL++ + V DFGL+++L D ++ TT+ +R T
Sbjct: 161 KYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 217
Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
APE +S + + +DV+ FGI++ E++T G+R
Sbjct: 218 ----APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 66/203 (32%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
+G+G FG V G + G VAVK +K+ Q F E ++ H N
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN----DATAQAFLAEASVMTQLRHSN 247
Query: 360 LLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
L++L G E L +V YM GS+ LR GR L + +L + YL
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
+HRD+ A N+L+ ED A V DFGL K V+ T APE L
Sbjct: 306 EGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEAL 358
Query: 479 STGQSSEKTDVFGFGILLLELIT 501
+ S K+DV+ FGILL E+ +
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYS 381
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 3e-32
Identities = 59/249 (23%), Positives = 100/249 (40%), Gaps = 15/249 (6%)
Query: 262 WLRYRHNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGC 321
+ + D + P LK R + A LG G FG V +G
Sbjct: 299 ITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKR--DNLLIADIELGCGNFGSVRQGV 356
Query: 322 FSDGA---LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378
+ VA+K LK + E + + + ++RL G C +LV
Sbjct: 357 YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVME 415
Query: 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438
G + L R + + + + G+ YL E+ +HR++ A N+LL
Sbjct: 416 MAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLL 469
Query: 439 DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT--VGHIAPEYLSTGQSSEKTDVFGFGILL 496
A + DFGL+K L DS+ T G + APE ++ + S ++DV+ +G+ +
Sbjct: 470 VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 529
Query: 497 LELIT-GQR 504
E ++ GQ+
Sbjct: 530 WEALSYGQK 538
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 18/207 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL-VAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
++ + K+ LG G +G VY+G + +L VAVK LK+ + +F E + H N
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 70
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
L++L G C+ E ++ +M G++ LR+ R + +A + + YL
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE 128
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----VRGTVGHIA 474
++ IHRD+ A N L+ E+ V DFGL++L+ D++ A ++ T A
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWT----A 180
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELIT 501
PE L+ + S K+DV+ FG+LL E+ T
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-32
Identities = 49/206 (23%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 308 ILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
+G G FG V++G + VA+K K+ +F E T+ H ++++L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
G TEN ++ G + S L+ + +LD A A + L YL +
Sbjct: 457 IGVI-TENPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK-- 510
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA----VRGTVGHIAPEYLS 479
+ +HRD+ A N+L+ + +GDFGL++ ++ + + ++ APE ++
Sbjct: 511 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESIN 565
Query: 480 TGQSSEKTDVFGFGILLLELIT-GQR 504
+ + +DV+ FG+ + E++ G +
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVK 591
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-32
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 306 KNILGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLL 361
++++G G FG V K L A+KR+K+Y F E+E + L H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK------------RIAL 409
L G C L Y P+G++ LR +A A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
ARG+ YL ++ + IHRD+ A NIL+ E++ A + DFGL+ R V V+ T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS-----RGQEV--YVKKT 199
Query: 470 VGHI-----APEYLSTGQSSEKTDVFGFGILLLELIT 501
+G + A E L+ + +DV+ +G+LL E+++
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 308 ILGRGGFGIVYKGCFSDGAL---VAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNLLRL 363
LG G FG V KG + + VAVK LK + N + + E + + ++R+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
G C E+ +LV G L ++ + + + G+ YL E
Sbjct: 84 IGICEAES-WMLVMEMAELGP----LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES-- 136
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG------TVGHIAPEY 477
+HRD+ A N+LL A + DFGL+K L +++ G APE
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APEC 191
Query: 478 LSTGQSSEKTDVFGFGILLLELIT-GQR 504
++ + S K+DV+ FG+L+ E + GQ+
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 33/222 (14%)
Query: 306 KNILGRGGFGIVYKG--------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAV 356
LG G FG V + VAVK LKD +E+E + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK----------- 405
H+N++ L G C+ + ++ Y G++ LR + +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 406 -RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
ARG+ YL Q K IHRD+ A N+L+ E+ + DFGLA+ +++ D + T
Sbjct: 160 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 465 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
V+ APE L + ++DV+ FG+L+ E+ T
Sbjct: 217 TNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
+N S ++G G FG V G + VA+K LK F E +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
H N++RL G + ++V YM NGS+ S LR H + + G A G+
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMK 161
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL-DHRDSHVTTA-----VRGTV 470
YL + +HRD+ A NIL++ + V DFGL ++L D ++ TT +R T
Sbjct: 162 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT- 217
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQR 504
+PE ++ + + +DV+ +GI+L E+++ G+R
Sbjct: 218 ---SPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 32/221 (14%)
Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAVHR 358
LGRG FG V + + VAVK LK+ +E++ + + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 359 NLLRLCGFCSTENE-RLLVYPYMPNGSVASRLRDHIHGRPALDWARRK------------ 405
N++ L G C+ +++ + G++++ LR + A
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
+ A+G+ +L + K IHRD+ A NILL E + DFGLA+ + +V
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 466 -----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
++ APE + + ++DV+ FG+LL E+ +
Sbjct: 209 DARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 37/222 (16%)
Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
K LG G FG V+ D LVAVK LKD +A FQ E E ++ H +
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA-RKDFQREAELLTNLQHEH 78
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR------------- 406
+++ G C + ++V+ YM +G + LR H P +
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH---GPDAMILVDGQPRQAKGELGLSQM 135
Query: 407 --IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
IA A G++YL Q +HRD+ N L+ + +GDFG+++ + D +
Sbjct: 136 LHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 465 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
+R PE + + + ++DV+ FG++L E+ T
Sbjct: 193 GHTMLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 59/222 (26%), Positives = 91/222 (40%), Gaps = 33/222 (14%)
Query: 306 KNILGRGGFGIVYKG--------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAV 356
LG G FG V + VAVK LK +E+E + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR---------- 406
H+N++ L G C+ + ++ Y G++ L+ +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 407 --IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
A ARG+ YL + K IHRD+ A N+L+ ED + DFGLA+ + H D + T
Sbjct: 194 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 465 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
V+ APE L + ++DV+ FG+LL E+ T
Sbjct: 251 TNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 33/222 (14%)
Query: 306 KNILGRGGFGIVYKG--------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAV 356
LG G FG V + VAVK LKD +E+E + +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK----------- 405
H+N++ L G C+ + ++ Y G++ LR + +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 406 -RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
ARG+ YL Q K IHRD+ A N+L+ E+ + DFGLA+ +++ D + T
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 465 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
V+ APE L + ++DV+ FG+L+ E+ T
Sbjct: 263 TNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 51/219 (23%), Positives = 82/219 (37%), Gaps = 23/219 (10%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVK--RLKDYNIAGGEVQFQTEVE 350
E R + + +GRG FG V++ G AVK RL+ + E+
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELV 102
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
+ ++ L G + + GS+ ++ L R
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK---QMGC-LPEDRALYYLGQ 158
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTA---- 465
GL YLH + +I+H DVKA N+LL D + DFG A L +
Sbjct: 159 ALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 504
+ GT H+APE + K D++ ++L ++ G
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-31
Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 308 ILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
+LG+G +GIVY G +A+K + + + + E+ H+N+++ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQYLGS 87
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
S + +P GS+++ LR G + GL YLH+ +I
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 427 IHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-- 483
+HRD+K N+L++ + + DFG +K L + T GT+ ++APE + G
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY 202
Query: 484 SEKTDVFGFGILLLELITGQR 504
+ D++ G ++E+ TG+
Sbjct: 203 GKAADIWSLGCTIIEMATGKP 223
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 45/208 (21%), Positives = 96/208 (46%), Gaps = 7/208 (3%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGE--VQFQTEVETISLAVH 357
+NF + +GRG F VY+ C DG VA+K+++ +++ + E++ + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
N+++ +NE +V G ++ ++ + + + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
+H + +++HRD+K AN+ + +GD GL + + + + V GT +++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 478 LSTGQSSEKTDVFGFGILLLELITGQRA 505
+ + K+D++ G LL E+ Q
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-31
Identities = 64/241 (26%), Positives = 91/241 (37%), Gaps = 24/241 (9%)
Query: 278 QYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGA------LVAVK 331
++P N + LG G FG VY+G S VAVK
Sbjct: 7 HHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK 66
Query: 332 RLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD 391
L + E+ F E IS H+N++R G R ++ M G + S LR+
Sbjct: 67 TLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRE 126
Query: 392 H---IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAV 445
+L +A A G YL E IHRD+ A N LL A
Sbjct: 127 TRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183
Query: 446 VGDFGLAKLLDHRDSHVTTAVRGTVGHI-----APEYLSTGQSSEKTDVFGFGILLLELI 500
+GDFG+A+ + +G + PE G + KTD + FG+LL E+
Sbjct: 184 IGDFGMARDIYRAS----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
Query: 501 T 501
+
Sbjct: 240 S 240
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 47/222 (21%), Positives = 84/222 (37%), Gaps = 36/222 (16%)
Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
LG FG VYKG VA+K LKD +F+ E + H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR------------- 406
++ L G + + +++ Y +G + L P D
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMR---SPHSDVGSTDDDRTVKSALEPPDF 130
Query: 407 --IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
+ A G+ YL ++H+D+ N+L+ + + D GL + + D +
Sbjct: 131 VHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187
Query: 465 A-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
+R APE + G+ S +D++ +G++L E+ +
Sbjct: 188 GNSLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 35/221 (15%)
Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAVHR 358
LG G FG V + VAVK LK A + +E++ +S L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK------------- 405
N++ L G C+ L++ Y G + + LR L+
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRK---SRVLETDPAFAIANSTASTRDLL 167
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
+ A+G+ +L + IHRDV A N+LL A +GDFGLA+ + + +++
Sbjct: 168 HFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 466 -----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
V+ APE + + ++DV+ +GILL E+ +
Sbjct: 225 NARLPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 10/223 (4%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLAVHRN 359
++ +G G +G K SDG ++ K L ++ E Q +EV + H N
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 360 LLRLCG-FCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
++R N L +V Y G +AS + R LD R+ L
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 418 LHEQCDP--KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
H + D ++HRD+K AN+ LD +GDFGLA++L+H S T V GT +++P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSP 185
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVM 518
E ++ +EK+D++ G LL EL F A +Q+ +
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPP--F-TAFSQKELA 225
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 55/226 (24%), Positives = 85/226 (37%), Gaps = 41/226 (18%)
Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAVHR 358
LG G FG V + VAVK LK +E++ +S L H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK------------- 405
N++ L G C+ L++ Y G + + LR R + ++
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK---RDSFICSKTSPAIMEDDELALDL 144
Query: 406 ----RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
+ A+G+ +L + IHRD+ A NILL + DFGLA RD
Sbjct: 145 EDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA-----RDIK 196
Query: 462 VTTAVRGTVGHI------APEYLSTGQSSEKTDVFGFGILLLELIT 501
+ APE + + ++DV+ +GI L EL +
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 53/225 (23%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLAVHRN 359
+ +G G FG DG +K + ++ E + + EV ++ H N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-----ALDWARRKRIALGTARG 414
+++ +V Y G + R+ G LDW +
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQ------ICLA 137
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
L ++H++ KI+HRD+K+ NI L +D +GDFG+A++L+ + GT +++
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLS 193
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVML 519
PE + K+D++ G +L EL T + A F A + + ++L
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHA--F-EAGSMKNLVL 235
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 44/218 (20%), Positives = 86/218 (39%), Gaps = 29/218 (13%)
Query: 301 SNFSAKNILGRGGFGIVYKG--------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETI 352
+ LG+G F ++KG V +K L + E F +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFFEAASMM 66
Query: 353 SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
S H++L+ G C +E +LV ++ GS+ + L+ + + ++ + +A A
Sbjct: 67 SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLA 123
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV--------VGDFGLAKLLDHRDSHVTT 464
+ +L E +IH +V A NILL + + + D G++ + +
Sbjct: 124 AAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQE 179
Query: 465 AVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELIT 501
+ PE + ++ + TD + FG L E+ +
Sbjct: 180 RIPWV----PPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 36/221 (16%)
Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
K LG G FG V+ D LVAVK LK+ + + FQ E E +++ H++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-RQDFQREAELLTMLQHQH 104
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR------------- 406
++R G C+ L+V+ YM +G + LR H P
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH---GPDAKLLAGGEDVAPGPLGLGQLL 161
Query: 407 -IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
+A A G++YL +HRD+ N L+ + +GDFG+++ + D
Sbjct: 162 AVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YY 214
Query: 466 VRGTVGHI-----APEYLSTGQSSEKTDVFGFGILLLELIT 501
G + PE + + + ++DV+ FG++L E+ T
Sbjct: 215 RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 70/288 (24%), Positives = 103/288 (35%), Gaps = 52/288 (18%)
Query: 259 LLVWLRYRHNQQIFFDVNDQY----------DPEVSLGHLKR----------YTFKELRA 298
+ + + H+ + Y PE L L+ Y F +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTS 60
Query: 299 AT--------SNFSAKNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQ 344
+ N + LG G FG VY+G VAVK L + E+
Sbjct: 61 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 120
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH---IHGRPALDW 401
F E IS H+N++R G R ++ M G + S LR+ +L
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLLDHR 458
+A A G YL E IHRD+ A N LL A +GDFG+A+ +
Sbjct: 181 LDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237
Query: 459 DSHVTTAVRGTVGHI-----APEYLSTGQSSEKTDVFGFGILLLELIT 501
+G + PE G + KTD + FG+LL E+ +
Sbjct: 238 G----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 28/225 (12%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
++F LGRGGFG+V++ D A+KR++ N + EV+ ++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 360 LLRLCGFCSTENERLLVYP------------YMPNGSVASRLRDHIHGRPALDWARRKRI 407
++R +N + P ++ + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHI 123
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
L A + +LH + ++HRD+K +NI D VGDFGL +D + T
Sbjct: 124 FLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 468 -----------GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
GT +++PE + S K D+F G++L EL+
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 54/228 (23%), Positives = 87/228 (38%), Gaps = 40/228 (17%)
Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAVHR 358
+LG G FG V VAVK LK+ + +E++ ++ L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR------------ 406
N++ L G C+ L++ Y G + + LR + +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 407 -------IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
A A+G+ +L + +HRD+ A N+L+ + DFGLA RD
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA-----RD 221
Query: 460 SHVTTAVRGTVGHI------APEYLSTGQSSEKTDVFGFGILLLELIT 501
+ APE L G + K+DV+ +GILL E+ +
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 20/218 (9%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
++ LG GGF V DG A+KR+ + E + Q E + L H N+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-EAQREADMHRLFNHPNI 88
Query: 361 LRLCGFCSTE----NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
LRL +C E +E L+ P+ G++ + + L + + LG RGL
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR--------G 468
+H HRD+K NILL ++ + V+ D G A+
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 469 TVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQ 503
T+ + APE S E+TDV+ G +L ++ G+
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 49/228 (21%), Positives = 82/228 (35%), Gaps = 33/228 (14%)
Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQ-TEVETIS-LAV 356
T+ F +G G FG V+K DG + A+KR K + Q EV + L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 357 HRNLLRLCGFCSTENERLLVY-PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
H +++R E++ +L+ Y GS+A + ++ A K + L RGL
Sbjct: 70 HSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVV-------------------GDFGLAKLLD 456
Y+H ++H D+K +NI + GD G +
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 457 HRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
G +A E L + K D+F + ++ +
Sbjct: 186 SPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 38/227 (16%)
Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
LG G FG V K + VAVK LK+ +E + H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT-------- 411
+++L G CS + LL+ Y GS+ LR+ P + R +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 412 ------------ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
++G+ YL E K++HRD+ A NIL+ E + + DFGL++ + D
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 460 SHVTTA-----VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
S+V + V+ A E L + ++DV+ FG+LL E++T
Sbjct: 205 SYVKRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 53/230 (23%), Positives = 92/230 (40%), Gaps = 44/230 (19%)
Query: 306 KNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
+G G FG V++ + +VAVK LK+ A + FQ E ++ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK-------------- 405
+++L G C+ L++ YM G + LR P +
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSM---SPHTVCSLSHSDLSTRARVSSPGP 168
Query: 406 ---------RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456
IA A G+ YL E+ K +HRD+ N L+ E+ + DFGL++ +
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 457 HRDSHVTTAVRGTVGHI-----APEYLSTGQSSEKTDVFGFGILLLELIT 501
D I PE + + + ++DV+ +G++L E+ +
Sbjct: 226 SAD----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 46/221 (20%), Positives = 92/221 (41%), Gaps = 29/221 (13%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
+F ++G GGFG V+K DG +KR + + + EV+ ++ H N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR-----VKYNNEKAEREVKALAKLDHVN 65
Query: 360 LLRLCGFCSTENERLLVYP----------------YMPNGSVASRLRDHIHGRPALDWAR 403
++ G + + G++ + + A
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 404 RKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463
+ +G+ Y+H + K+I+RD+K +NI L + + +GDFGL L +
Sbjct: 126 E--LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180
Query: 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 504
+ GT+ +++PE +S+ ++ D++ G++L EL+
Sbjct: 181 SK--GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 57/210 (27%), Positives = 77/210 (36%), Gaps = 21/210 (10%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV--- 356
+F + LG G +G V+K DG L AVKR + + E S
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQ 115
Query: 357 HRNLLRLCGFCS-TENERLLVYPYM--PNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
H +RL + E L Y S+ G L A+ T
Sbjct: 116 HPCCVRL--EQAWEEGGIL--YLQTELCGPSLQQHCEAW--GAS-LPEAQVWGYLRDTLL 168
Query: 414 GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
L +LH Q ++H DVK ANI L +GDFGL L + G ++
Sbjct: 169 ALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYM 223
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
APE L G DVF G+ +LE+
Sbjct: 224 APELLQ-GSYGTAADVFSLGLTILEVACNM 252
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 63/239 (26%), Positives = 96/239 (40%), Gaps = 52/239 (21%)
Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
S+F +LG+G FG V K D A+K+++ +EV ++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK--LSTILSEVMLLASLNHQ 62
Query: 359 NLLRLCG-FCSTENERLLVYP------------YMPNGSVASRLRDHIHGRP-------A 398
++R + N + Y NG+ L D IH
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGT----LYDLIHSENLNQQRDEY 118
Query: 399 LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH- 457
R+ I L Y+H Q IIHRD+K NI +DE +GDFGLAK +
Sbjct: 119 WRLFRQ--ILEA----LSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 458 -------------RDSHVTTAVRGTVGHIAPEYLS-TGQSSEKTDVFGFGILLLELITG 502
++T+A+ GT ++A E L TG +EK D++ GI+ E+I
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-28
Identities = 55/213 (25%), Positives = 84/213 (39%), Gaps = 24/213 (11%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAVHRN 359
+F K++LG G G + D VAVKR+ + ++ A EVQ E H N
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRE-----SDEHPN 79
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
++R + + ++ + L+ + T GL +LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLH 135
Query: 420 EQCDPKIIHRDVKAANILLDEDFE-----AVVGDFGLAKLLDHRDS--HVTTAVRGTVGH 472
I+HRD+K NIL+ A++ DFGL K L + V GT G
Sbjct: 136 SL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 473 IAPEYLSTGQS---SEKTDVFGFGILLLELITG 502
IAPE LS + D+F G + +I+
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 33/208 (15%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVK-----RLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+GGF ++ + A K L + + E+ H++++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 105
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR--------G 414
GF + +V S+ + RRK + AR G
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHK------------RRKALTEPEARYYLRQIVLG 153
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
YLH ++IHRD+K N+ L+ED E +GDFGLA +++ GT +IA
Sbjct: 154 CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIA 209
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
PE LS S + DV+ G ++ L+ G
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVG 237
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 19/216 (8%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHR 358
++ + ++G G +V C VA+KR+ + + E++ +S H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHP 73
Query: 359 NLLRLCGFCS-TENERL-LVYPYMPNGSVASRLRD-HIHGRPALDWARRKRIAL---GTA 412
N++ + S + L LV + GSV ++ G IA
Sbjct: 74 NIVSY--YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT-VG 471
GL YLH+ IHRDVKA NILL ED + DFG++ L VR T VG
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 472 H---IAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
+APE + + K D++ FGI +EL TG
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 33/208 (15%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVK-----RLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+GGF ++ + A K L + + E+ H++++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVG 79
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR--------G 414
GF + +V S+ + RRK + AR G
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHK------------RRKALTEPEARYYLRQIVLG 127
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
YLH ++IHRD+K N+ L+ED E +GDFGLA +++ GT +IA
Sbjct: 128 CQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIA 183
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
PE LS S + DV+ G ++ L+ G
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVG 211
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVH 357
F+ +G+G FG V+KG +VA+K + D A E++ Q E+ +S
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDS 79
Query: 358 RNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
+ + G ++ +L ++ Y+ GS D + P LD + I +GL
Sbjct: 80 PYVTKYYG-SYLKDTKLWIIMEYLGGGSA----LDLLEPGP-LDETQIATILREILKGLD 133
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
YLH + K IHRD+KAAN+LL E E + DFG+A L T V GT +APE
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE 189
Query: 477 YLSTGQSSEKTDVFGFGILLLELITGQ 503
+ K D++ GI +EL G+
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGE 216
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 42/233 (18%), Positives = 76/233 (32%), Gaps = 31/233 (13%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQT 347
E + + ++LG G F VY+ D +K K N + Q
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ- 116
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR---- 403
+E + ++ ++ +N +LV G+ L + I+
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT----LLNAINLYKNTPEKVMPQG 172
Query: 404 -RKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL-----------DEDFEAVVGDFGL 451
A+ + +H+ +IIH D+K N +L D + D G
Sbjct: 173 LVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229
Query: 452 AKLLD-HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
+ + + TA T G E LS + + D FG + ++ G
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 16/202 (7%)
Query: 309 LGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEV---QFQTEVETISLAVHRNLLR 362
LG GG VY D L VA+K + E +F+ EV S H+N++
Sbjct: 19 LGGGGMSTVYLA--EDTILNIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
+ ++ LV Y+ + L ++I L G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPT----LSEYIESHGPLSVDTAINFTNQILDGIKHAHDM- 130
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ 482
+I+HRD+K NIL+D + + DFG+AK L T V GTV + +PE
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 483 SSEKTDVFGFGILLLELITGQR 504
+ E TD++ GI+L E++ G+
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEP 210
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 54/208 (25%), Positives = 83/208 (39%), Gaps = 32/208 (15%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVK-----RLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG+G F VY+ G VA+K + + + Q EV+ H ++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM---VQRVQNEVKIHCQLKHPSILE 75
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR--------G 414
L + N LV NG + ++ R K + AR G
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGE----MNRYLK-------NRVKPFSENEARHFMHQIITG 124
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
+LYLH I+HRD+ +N+LL + + DFGLA L T GT +I+
Sbjct: 125 MLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYIS 180
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
PE + ++DV+ G + L+ G
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIG 208
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 49/219 (22%), Positives = 80/219 (36%), Gaps = 23/219 (10%)
Query: 300 TSNFSAKNILGRG--GFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISLA 355
+ ++G+G V G V V+R+ + V F Q E+ L
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL---GTA 412
H N++ +NE +V +M GS + H IA G
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVL 138
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG-LAKLLDH--RDSHVTTAVRGT 469
+ L Y+H +HR VKA++IL+ D + + ++ H R V + +
Sbjct: 139 KALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 470 VGHI---APEYLSTGQS--SEKTDVFGFGILLLELITGQ 503
V + +PE L K+D++ GI EL G
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 60/205 (29%), Positives = 88/205 (42%), Gaps = 13/205 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVH 357
+F LG+G FG VY ++A+K L + AG E Q + EVE S H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
N+LRL G+ L+ Y P G+V L+ + D R A L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SK--FDEQRTATYITELANALSY 124
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
H + ++IHRD+K N+LL E + DFG + GT+ ++ PE
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-SRRTDLC--GTLDYLPPEM 178
Query: 478 LSTGQSSEKTDVFGFGILLLELITG 502
+ EK D++ G+L E + G
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 30/233 (12%), Positives = 61/233 (26%), Gaps = 40/233 (17%)
Query: 308 ILGRGGFGIVYKGC-FSDGALVAVK---------------------------RLKDYNIA 339
+LG+ + G V +K+ A
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 340 GGEVQFQTEVETISLAVHRNLLRLCGFCSTEN--ERLLVYPYM--PNGSVASRLRDHIHG 395
++F + + + ++R+ R +YP M + L H
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 396 RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455
+L R ++ L R L LH ++H ++ +I+LD+ + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 456 DHRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQ 503
A L + D + G+ + +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 27/242 (11%), Positives = 54/242 (22%), Gaps = 40/242 (16%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVK--RLKDYNIAGGEVQFQTEVET 351
L L G +V+ A+K + N +
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 352 ISLAVHRNLLRLCGFC--------------------------STENERLLVYPYMP--NG 383
+ + + LL+ P
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175
Query: 384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443
+ S L R + R L + ++H N+ + D
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGR 232
Query: 444 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELIT 501
++GD + A V + E+L ST + + + G+ + +
Sbjct: 233 LMLGDVSAL----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 502 GQ 503
Sbjct: 289 LF 290
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 26/210 (12%)
Query: 309 LGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEV---QFQTEVETISLAVHRNLLR 362
LG GG V+ D VAVK L+ ++A +F+ E + + H ++
Sbjct: 20 LGFGGMSEVHLA--RDLRDHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 363 L--CGFCSTENERLLVYPYMP----NGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
+ G PY+ +G LRD +H + R + + L
Sbjct: 77 VYDTG---EAETPAGPLPYIVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT--AVRGTVGHIA 474
+ H+ IIHRDVK ANI++ V DFG+A+ + + VT AV GT +++
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQR 504
PE ++DV+ G +L E++TG+
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 32/238 (13%), Positives = 67/238 (28%), Gaps = 51/238 (21%)
Query: 308 ILGRGGFGIVYKGC-FSDGALVAVK---------------------------RLKDYNIA 339
+LG+ + G V +K+ A
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 340 GGEVQFQTEVETISLAVHRNLLRLCGFCSTEN--ERLLVYPYM--PNGSVASRLRDHIHG 395
++F + + + ++R+ R +YP M + L H
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 396 RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455
+L R ++ L R L LH ++H ++ +I+LD+ + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQS-----------SEKTDVFGFGILLLELITG 502
R + G PE + + + D + G+++ +
Sbjct: 257 GAR-----VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 41/205 (20%), Positives = 74/205 (36%), Gaps = 27/205 (13%)
Query: 309 LGRGGFGIVYKGCFSDGAL----VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
+ GG G +Y D + V +K L A + E + ++ VH +++++
Sbjct: 88 IAHGGLGWIYLA--LDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 365 GFCSTENERLLVYPYM-----PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
F + Y+ S L+ + + A L L YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQS----LKRSKGQKLPVAEAIA--YLLEILPALSYLH 199
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
+++ D+K NI+L E+ + + D G ++ + GT G APE +
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPE-IV 249
Query: 480 TGQSSEKTDVFGFGILLLELITGQR 504
+ TD++ G L L
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLP 274
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 29/237 (12%)
Query: 284 SLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGE 342
L LR F ++G G +G VYKG G L A+K + ++ G E
Sbjct: 7 PARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDE 63
Query: 343 VQ-FQTEVETIS-LAVHRNLLR-----LCGFCSTENERL-LVYPYMPNGSVASRLRDHIH 394
+ + E+ + + HRN+ + +++L LV + GSV +++
Sbjct: 64 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 123
Query: 395 GRPALDWARRKRIAL---GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451
+W IA RGL +LH+ K+IHRD+K N+LL E+ E + DFG+
Sbjct: 124 NTLKEEW-----IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELITGQ 503
+ LD T + GT +APE ++ ++ + K+D++ GI +E+ G
Sbjct: 176 SAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 49/204 (24%), Positives = 81/204 (39%), Gaps = 20/204 (9%)
Query: 309 LGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEV---QFQTEVETISLAVHRNLLR 362
+GRGG G VY+ D VA+K + + ++ V + Q E T +++
Sbjct: 42 VGRGGMGDVYEA--EDTVRERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
+ F + + + + L + + L R I L H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVD----LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA- 153
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT--AVRGTVGHIAPEYLST 480
HRDVK NIL+ D A + DFG+A D +T GT+ ++APE S
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSE 209
Query: 481 GQSSEKTDVFGFGILLLELITGQR 504
++ + D++ +L E +TG
Sbjct: 210 SHATYRADIYALTCVLYECLTGSP 233
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 48/220 (21%), Positives = 85/220 (38%), Gaps = 36/220 (16%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKRLK----------------DYNIAGGEVQFQTEVETI 352
L +G F + C D A+K+ + +I F+ E++ I
Sbjct: 39 LNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 353 SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
+ + L G + +E ++Y YM N S + LD I +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDS----ILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 413 R--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
+ Y+H + + I HRDVK +NIL+D++ + DFG ++ + D +
Sbjct: 154 KCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKG 209
Query: 465 AVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITG 502
+ GT + PE+ S + K D++ GI L +
Sbjct: 210 SR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-25
Identities = 60/220 (27%), Positives = 88/220 (40%), Gaps = 30/220 (13%)
Query: 302 NFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
+ K LG GGFG V + G VA+K+ + ++ E++ + H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 361 LRLCGFCSTENE------RLLVYPYMPNGSVASRLRDHI--HGRPAL---DWARR--KRI 407
+ + LL Y G LR ++ R I
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGD----LRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV---VGDFGLAKLLDHRDSHVTT 464
+ L YLHE +IIHRD+K NI+L + + + D G AK LD T
Sbjct: 131 SSA----LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-GELCTE 182
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 504
V GT+ ++APE L + + D + FG L E ITG R
Sbjct: 183 FV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 58/197 (29%), Positives = 89/197 (45%), Gaps = 13/197 (6%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHRNLLRLCG 365
LG+G FG VY + ++A+K L + V Q + E+E S H N+LR+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK 425
+ L+ + P G + L+ H GR D R A L Y HE+ K
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKH--GR--FDEQRSATFMEELADALHYCHER---K 134
Query: 426 IIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE 485
+IHRD+K N+L+ E + DFG + H S + GT+ ++ PE + E
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRTMCGTLDYLPPEMIEGKTHDE 191
Query: 486 KTDVFGFGILLLELITG 502
K D++ G+L E + G
Sbjct: 192 KVDLWCAGVLCYEFLVG 208
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 43/230 (18%), Positives = 87/230 (37%), Gaps = 24/230 (10%)
Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQT 347
+ F+ + +S +G GG V++ + A+K + + ++
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 348 EVETISLAVHRNL--LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
E+ ++ + +RL + T+ +V N + S L+ +
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK--KKSIDPWERK-- 130
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL-DHRDSHVTT 464
+ +H+ I+H D+K AN L+ + + DFG+A + S V
Sbjct: 131 SYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 186
Query: 465 AVRGTVGHIAPEYL-----------STGQSSEKTDVFGFGILLLELITGQ 503
+ GTV ++ PE + S + S K+DV+ G +L + G+
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 25/126 (19%), Positives = 46/126 (36%), Gaps = 7/126 (5%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPI-PASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
+ L+ L+ + + N+ P +L L LDLS + P +
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI------SARTFKVT 197
L +L L +++N+ + SL ++D S N++ S + S +T
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551
Query: 198 GNPLIC 203
N C
Sbjct: 552 QNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 18/100 (18%), Positives = 36/100 (36%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
L S + +LQ + L I + L L TL L+ N +
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
L +L L +L + +++L +++++N +
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 7e-21
Identities = 24/110 (21%), Positives = 39/110 (35%), Gaps = 1/110 (0%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L L + +L+ L +++L N I + L LQ L
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 139 PDSLGDLGNLNYLRLNNNSLTG-SCPESLSKIESLTLVDLSYNNLSGSLP 187
+G L L L + +N + PE S + +L +DLS N +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-21
Identities = 22/110 (20%), Positives = 47/110 (42%), Gaps = 5/110 (4%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG-EIPDSLG 143
+ L+ LQ ++ + +G L+ L+ L++++N ++P+
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLV----DLSYNNLSGSLPKI 189
+L NL +L L++N + L + + L+ DLS N ++ P
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 23/105 (21%), Positives = 39/105 (37%), Gaps = 2/105 (1%)
Query: 85 SLSGTLSP-WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
S P L L + L + P + L LQ L++S+N F
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 515
Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIE-SLTLVDLSYNNLSGSLP 187
L +L L + N + S + L SL ++L+ N+ + +
Sbjct: 516 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-20
Identities = 24/103 (23%), Positives = 43/103 (41%), Gaps = 2/103 (1%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPAS-LGKLEKLQTLDLSNNKFTGEIPDSLGDLGN 147
T+S L +L+ + Q++ + S L L LD+S+ L +
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 148 LNYLRLNNNSLTGS-CPESLSKIESLTLVDLSYNNLSGSLPKI 189
L L++ NS + P+ +++ +LT +DLS L P
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-19
Identities = 28/111 (25%), Positives = 47/111 (42%), Gaps = 6/111 (5%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
+L+ + IG+L L+ + + +N I +P L L+ LDLS+NK L
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 144 DLGNLNY----LRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
L + L L+ N + P + +I L + L N S ++ K
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTC 220
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-19
Identities = 19/90 (21%), Positives = 33/90 (36%)
Query: 98 TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNS 157
+++ L N + S +LQ LDLS + + L +L+ L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 158 LTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
+ + S + SL + NL+
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLEN 117
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 7e-18
Identities = 23/108 (21%), Positives = 42/108 (38%), Gaps = 4/108 (3%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSL 142
S G + +L L+ + L N + G S L+ LDLS N + +
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF 392
Query: 143 GDLGNLNYLRLNNNSLTGSCPES-LSKIESLTLVDLSYNNLSGSLPKI 189
L L +L +++L S + +L +D+S+ + + I
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 29/126 (23%), Positives = 41/126 (32%), Gaps = 23/126 (18%)
Query: 86 LSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT---------- 135
+ LT + S L + I Q L+L N KF
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSL 327
Query: 136 ---------GEIPDSLGDLGNLNYLRLNNNSLT--GSCPESLSKIESLTLVDLSYNNLSG 184
G S DL +L +L L+ N L+ G C +S SL +DLS+N +
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
Query: 185 SLPKIS 190
Sbjct: 388 MSSNFL 393
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 14/97 (14%), Positives = 31/97 (31%), Gaps = 4/97 (4%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEK-LQTLDLSNNKFTGEIP--DS 141
+ + L LQ + N I+ L L L+L+ N F
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF 564
Query: 142 LGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLS 178
L + + L + + + P + + ++++
Sbjct: 565 LQWIKDQRQLLVEVERMECATPSDKQGM-PVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 16/91 (17%), Positives = 25/91 (27%), Gaps = 2/91 (2%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
NLT + L + L I L + + L + S +L L N
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVN 313
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSL 186
L ++ LT N +
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 344
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 16/109 (14%), Positives = 32/109 (29%), Gaps = 10/109 (9%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGE------IPDS 141
+ P +L + L+NN + + L L+ L +F E +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 142 LGDLGNLNYLRLNNNSLTGS---CPESLSKIESLTLVDLSYNNLSGSLP 187
L L NL L + + + +++ L +
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 17/121 (14%), Positives = 36/121 (29%), Gaps = 13/121 (10%)
Query: 85 SLSGTLSP-WIGNLTKLQSVLLQNNAILG------PIPASLGKLEKLQTLDLS---NNKF 134
S + I L L+ L ++L L L + + +
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 135 TGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
+I D L N++ L + ++ + S ++L P + ++
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQ-FPTLKLKSL 327
Query: 195 K 195
K
Sbjct: 328 K 328
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 42/214 (19%), Positives = 82/214 (38%), Gaps = 28/214 (13%)
Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNL--LRL 363
+G GG V++ + A+K + + ++ E+ ++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 364 CGFCSTENERLLVYPYM--PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
+ T+ +Y M N + S L+ + + +H+
Sbjct: 75 YDYEITDQY---IYMVMECGNIDLNSWLKK--KKSIDPWERK--SYWKNMLEAVHTIHQH 127
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL-DHRDSHVTTAVRGTVGHIAPEYL-- 478
I+H D+K AN L+ + + DFG+A + S V + GTV ++ PE +
Sbjct: 128 ---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 479 ---------STGQSSEKTDVFGFGILLLELITGQ 503
S + S K+DV+ G +L + G+
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 25/121 (20%), Positives = 44/121 (36%), Gaps = 9/121 (7%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT--- 135
T NL L V + N L +P L L ++Q ++++ N+
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289
Query: 136 -----GEIPDSLGDLGNLNYLRLNNNSL-TGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
+ + + + N+L T SL K++ L +++ YN L G LP
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF 349
Query: 190 S 190
Sbjct: 350 G 350
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-23
Identities = 21/115 (18%), Positives = 42/115 (36%), Gaps = 10/115 (8%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAIL--------GPIPASLGKLEKLQTLDLS 130
+ + + L ++ L ++Q + + N + A EK+Q + +
Sbjct: 254 VEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIG 313
Query: 131 NNKF-TGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
N T + SL + L L N L G + L ++L+YN ++
Sbjct: 314 YNNLKTFPVETSLQKMKKLGMLECLYNQLEGK-LPAFGSEIKLASLNLAYNQITE 367
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-21
Identities = 20/111 (18%), Positives = 41/111 (36%), Gaps = 14/111 (12%)
Query: 94 IGNLTKLQSVLLQNNAI-------LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG 146
+++ + ++ N I P+ + K + +++LSNN+ + +
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
Query: 147 NLNYLRLNNNSLTG-------SCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
L+ + L N LT E+ LT +DL +N L+
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFR 508
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 21/103 (20%), Positives = 41/103 (39%), Gaps = 2/103 (1%)
Query: 87 SGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG 146
+ + + + KL + N + G +P + G KL +L+L+ N+ T + G
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTE 377
Query: 147 NLNYLRLNNNSLTG-SCPESLSKIESLTLVDLSYNNLSGSLPK 188
+ L +N L + ++ +D SYN + K
Sbjct: 378 QVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGK 420
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-20
Identities = 23/113 (20%), Positives = 41/113 (36%), Gaps = 9/113 (7%)
Query: 80 GLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG--- 136
+ ++ L P + S+ L NN I L +++L N T
Sbjct: 416 SVDGKNFDP-LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPK 474
Query: 137 ----EIPDSLGDLGNLNYLRLNNNSLTGSCPE-SLSKIESLTLVDLSYNNLSG 184
+ ++ + L + L N LT + + + L +DLSYN+ S
Sbjct: 475 NSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK 527
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 8e-20
Identities = 17/113 (15%), Positives = 36/113 (31%), Gaps = 6/113 (5%)
Query: 76 VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT 135
+ + S ++ K + +N I + ++ +L KL+ + N+ F
Sbjct: 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFV 219
Query: 136 GEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
E + N Y + ++ LT V++ LP
Sbjct: 220 AENICEAWENENSEYAQQYKTE-----DLKWDNLKDLTDVEVYNCPNLTKLPT 267
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 8e-20
Identities = 20/137 (14%), Positives = 45/137 (32%), Gaps = 29/137 (21%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGP-------------------IPASLG 119
+G S +++ +S + LTKL+ + N+ +
Sbjct: 188 IGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWD 246
Query: 120 KLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT--------GSCPESLSKIES 171
L+ L +++ N ++P L L + + + N E
Sbjct: 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
Query: 172 LTLVDLSYNNL-SGSLP 187
+ ++ + YNNL + +
Sbjct: 307 IQIIYIGYNNLKTFPVE 323
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-19
Identities = 16/108 (14%), Positives = 43/108 (39%), Gaps = 8/108 (7%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTG------- 136
++ + + G +++++ +N + P + + +D S N+
Sbjct: 364 QITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD 423
Query: 137 EIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
+ + N++ + L+NN ++ E S L+ ++L N L+
Sbjct: 424 PLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 6e-19
Identities = 23/193 (11%), Positives = 55/193 (28%), Gaps = 43/193 (22%)
Query: 36 VALVAVKNNLHDP--------YNVLENWDITSVDPCSWRM---ITCSPDGYVSALGLPSQ 84
+AL + + L+ NW+ + + W ++ + +G V+ L L
Sbjct: 33 LALKEIWDALNGKNWSQQGFGTQPGANWN-FNKELDMWGAQPGVSLNSNGRVTGLSLEGF 91
Query: 85 SLSGTLSPWIGNLTKL----------------------------QSVLLQNNAILGPIPA 116
SG + IG LT+L +
Sbjct: 92 GASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVD 151
Query: 117 SLGKLE--KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTL 174
+ + L ++++ I S + +N++T +++ ++ L
Sbjct: 152 YDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQ 210
Query: 175 VDLSYNNLSGSLP 187
+ +
Sbjct: 211 FYMGNSPFVAENI 223
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 17/101 (16%), Positives = 31/101 (30%), Gaps = 10/101 (9%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN------NKFTGEIPDSLGDLGN 147
L L + L N+ P L+ + N N+ E P+ + +
Sbjct: 509 ATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567
Query: 148 LNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
L L++ +N + + I L D+ N
Sbjct: 568 LTQLQIGSNDIRKVNEKITPNISVL---DIKDNPNISIDLS 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 14/101 (13%), Positives = 29/101 (28%), Gaps = 9/101 (8%)
Query: 89 TLSPWIGNLTKLQS------VLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSL 142
N + L+ Q N L P + L L + +N + + +
Sbjct: 527 KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI 585
Query: 143 GDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
N++ L + +N + + L Y+
Sbjct: 586 --TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 28/190 (14%), Positives = 52/190 (27%), Gaps = 35/190 (18%)
Query: 34 EVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPW 93
V ++ Y L+ W AL + S G +
Sbjct: 17 IVPIKLSRTAEYIKDYLALKEI---------WD-----------ALNGKNWSQQGFGTQP 56
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
N + + + SL ++ L L +G +PD++G L L L L
Sbjct: 57 GANWNFNKELDMWGA----QPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLAL 112
Query: 154 NNNSLTG----SCPESLSKIESLTLVDLSYNNLSGSLPKISAR-------TFKVTGNPLI 202
++ P+ +S S + + R + +P
Sbjct: 113 GSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQ 172
Query: 203 CGPKATNNCT 212
K ++ T
Sbjct: 173 KSIKKSSRIT 182
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 8/81 (9%), Positives = 18/81 (22%), Gaps = 3/81 (3%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
I L + + +N I + + + LD+ +N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISID 603
Query: 139 PDSLGDLGNLNYLRLNNNSLT 159
+ L +
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQ 624
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 293 FKELRAATSN------FSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQF 345
++LR+ S ++ +G+G G VY + G VA++++ + +
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELI 64
Query: 346 QTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
E+ + + N++ +E +V Y+ GS L D + +D +
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETC-MDEGQIA 119
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
+ + L +LH ++IHRD+K+ NILL D + DFG + S +T
Sbjct: 120 AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
V GT +APE ++ K D++ GI+ +E+I G+
Sbjct: 177 V-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 13/206 (6%)
Query: 300 TSNFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
F LG G +G VYK G +VA+K++ + + E+ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDLQEIIKEISIMQQCDSP 84
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIALGTARGLLY 417
++++ G + +V Y GSV+ D I R L I T +GL Y
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVS----DIIRLRNKTLTEDEIATILQSTLKGLEY 140
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
LH + IHRD+KA NILL+ + A + DFG+A L + T + GT +APE
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEV 196
Query: 478 LSTGQSSEKTDVFGFGILLLELITGQ 503
+ + D++ GI +E+ G+
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 41/216 (18%), Positives = 82/216 (37%), Gaps = 32/216 (14%)
Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNL--LRL 363
+G GG V++ + A+K + + ++ E+ ++ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 364 CGFCSTENERLLVYPYM--PNGSVASRLRDHIHGRPALDWARR--KRIALGTARGLLYLH 419
+ T+ +Y M N + S L+ + K + + +H
Sbjct: 122 YDYEITDQY---IYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLE----AVHTIH 172
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL-DHRDSHVTTAVRGTVGHIAPEYL 478
+ I+H D+K AN L+ + + DFG+A + S V + G V ++ PE +
Sbjct: 173 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 479 S-----------TGQSSEKTDVFGFGILLLELITGQ 503
+ S K+DV+ G +L + G+
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 59/234 (25%), Positives = 92/234 (39%), Gaps = 45/234 (19%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAVHR 358
+ ++ ILG G G V G VAVKR+ +IA E++ TE H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTE-----SDDHP 69
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR-------KRIALGT 411
N++R +T+ + N + L+D + + D + +
Sbjct: 70 NVIRYYCSETTDRFLYIALELC-NLN----LQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLD-------------EDFEAVVGDFGLAKLLDHR 458
A G+ +LH KIIHRD+K NIL+ E+ ++ DFGL K LD
Sbjct: 125 ASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 459 DSHVTTAVR---GTVGHIAPEYLSTGQS-------SEKTDVFGFGILLLELITG 502
S T + GT G APE L + + D+F G + +++
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 46/224 (20%), Positives = 81/224 (36%), Gaps = 35/224 (15%)
Query: 302 NFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
+ +ILG+G V++G G L A+K + + E E + H+N+
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 361 LRLCGFCSTENERL--LVYPYMPNGSVASRLRDHI--HGRPAL---DWARR--KRIALGT 411
++L R L+ + P GS L + + +
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGS----LYTVLEEPSNAYGLPESEFLIVLRDVV--- 122
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILL--DEDFEAVV--GDFGLAKLLDHRDSHVTTAVR 467
G+ +L E I+HR++K NI+ ED ++V DFG A+ L+ D +
Sbjct: 123 -GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY- 176
Query: 468 GTVGHIAPEYLSTGQS--------SEKTDVFGFGILLLELITGQ 503
GT ++ P+ D++ G+ TG
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
LG G G+V+K G ++A K + Q E++ + ++ G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 368 STENERLLVYPYMPNGSVAS------RLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
++ E + +M GS+ R+ + I G+ +++ +GL YL E+
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK----------VSIAVIKGLTYLREK 150
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
KI+HRDVK +NIL++ E + DFG++ L DS + V GT +++PE L
Sbjct: 151 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGT 205
Query: 482 QSSEKTDVFGFGILLLELITGQ 503
S ++D++ G+ L+E+ G+
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGR 227
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 55/219 (25%), Positives = 83/219 (37%), Gaps = 28/219 (12%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLLRLCGF 366
L GGF VY+ G A+KRL EV + L+ H N+++ C
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK-NRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 367 CSTENER-------LLVYPYMPNGSVASRL-RDHIHGRPALDWARRKRIALGTARGLLYL 418
S E L+ + G + L + G + D + I T R + ++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK--IFYQTCRAVQHM 152
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA-----------VR 467
H Q P IIHRD+K N+LL + DFG A + H + +A
Sbjct: 153 HRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 468 GTVGHIAPEYLSTGQS---SEKTDVFGFGILLLELITGQ 503
T + PE + + EK D++ G +L L Q
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 46/224 (20%), Positives = 81/224 (36%), Gaps = 35/224 (15%)
Query: 302 NFSAKNILGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
+ +ILG+G V++G G L A+K + + E E + H+N+
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 361 LRLCGFCSTENERL--LVYPYMPNGSVASRLRDHI--HGRPAL---DWARR--KRIALGT 411
++L R L+ + P GS L + + + G
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGS----LYTVLEEPSNAYGLPESEFLIVLRDVVGG- 124
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILL--DEDFEAVV--GDFGLAKLLDHRDSHVTTAVR 467
+ +L E I+HR++K NI+ ED ++V DFG A+ L+ D +
Sbjct: 125 ---MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY- 176
Query: 468 GTVGHIAPEYLSTGQS--------SEKTDVFGFGILLLELITGQ 503
GT ++ P+ D++ G+ TG
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 50/208 (24%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 303 FSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNL 360
+ LG G FG VYK GAL A K ++ + E++ + E+E ++ H +
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHPYI 78
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
++L G + + ++ + P G+V + + + G L + + + L +LH
Sbjct: 79 VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHS 135
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
+ +IIHRD+KA N+L+ + + + DFG++ + + GT +APE +
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMC 191
Query: 481 GQSSE-----KTDVFGFGILLLELITGQ 503
+ K D++ GI L+E+ +
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 14/228 (6%)
Query: 284 SLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGE 342
S G LK + + +GRG +G V K G ++AVKR+ + E
Sbjct: 5 SSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKE 63
Query: 343 V-QFQTEVETI-SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA-L 399
Q +++ + + +++ G E + + M + S + +
Sbjct: 64 QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVI 122
Query: 400 DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
+I L T + L +L E KIIHRD+K +NILLD + DFG++ L
Sbjct: 123 PEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180
Query: 460 SHVTTAVRGTVGHIAPEYLSTGQS----SEKTDVFGFGILLLELITGQ 503
+ A G ++APE + S ++DV+ GI L EL TG+
Sbjct: 181 AKTRDA--GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 49/205 (23%), Positives = 85/205 (41%), Gaps = 11/205 (5%)
Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
+ +G G GIV G VAVK + D EV + H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRELLFNEVVIMRDYQHF 102
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
N++ + E ++ ++ G+ L D + L+ + + + L YL
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGA----LTDIVSQVR-LNEEQIATVCEAVLQALAYL 157
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
H Q +IHRD+K+ +ILL D + DFG + + V GT +APE +
Sbjct: 158 HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVI 213
Query: 479 STGQSSEKTDVFGFGILLLELITGQ 503
S + + D++ GI+++E++ G+
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 15/203 (7%)
Query: 309 LGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEV-QFQTEVETISLAV--HRNLLRLC 364
LGRG +G+V K G ++AVKR+ + E + +++ IS+ +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLD-ISMRTVDCPFTVTFY 72
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDP 424
G E + + M + S+ + I + +IA+ + L +LH +
Sbjct: 73 GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL-- 129
Query: 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS- 483
+IHRDVK +N+L++ + + DFG++ L D G ++APE ++ +
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 484 ---SEKTDVFGFGILLLELITGQ 503
S K+D++ GI ++EL +
Sbjct: 188 KGYSVKSDIWSLGITMIELAILR 210
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 63/210 (30%), Positives = 90/210 (42%), Gaps = 18/210 (8%)
Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLK-DYNIAGGEVQ-FQTEVETISLAV 356
FS +G G FG VY + +VA+K++ + + Q EV +
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
H N ++ G E+ LV Y GS + L H + L + G +GL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLA 168
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
YLH +IHRDVKA NILL E +GDFG A ++ +S V GT +APE
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPE 220
Query: 477 YLSTGQSSE---KTDVFGFGILLLELITGQ 503
+ + K DV+ GI +EL +
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 1e-21
Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 35/243 (14%)
Query: 271 IFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVY----KGCFSDGA 326
I+F+ Q+ + + + TF++ R +LG+GGFG V + G
Sbjct: 165 IYFNRFLQWKW-LERQPVTKNTFRQYR----------VLGKGGFGEVCACQVRA---TGK 210
Query: 327 LVAVKRL-KDYNIAGGEVQF-QTEVETISLAVHRNLLRLCGFCSTENERL-LVYPYMPNG 383
+ A K+L K E + + R ++ L + + L LV M G
Sbjct: 211 MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGG 269
Query: 384 SVASRLRDHIH--GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED 441
L+ HI+ G+ AR A GL LH + +I++RD+K NILLD+
Sbjct: 270 D----LKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDH 322
Query: 442 FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELI 500
+ D GLA + + GTVG++APE + + + D + G LL E+I
Sbjct: 323 GHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMI 379
Query: 501 TGQ 503
GQ
Sbjct: 380 AGQ 382
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-21
Identities = 62/219 (28%), Positives = 89/219 (40%), Gaps = 33/219 (15%)
Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQF-QTEVETISL 354
F +LGRGGFG V+ K G L A K+L K Q E + ++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 355 AVHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
R ++ L + L LV M G +R HI+ A
Sbjct: 242 VHSRFIVSL-AYAFETKTDLCLVMTIMNGGD----IRYHIYNVDE----DNPGFQEPRAI 292
Query: 414 --------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
GL +LH++ II+RD+K N+LLD+D + D GLA L +
Sbjct: 293 FYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY 349
Query: 466 VRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
GT G +APE L G+ + + D F G+ L E+I +
Sbjct: 350 A-GTPGFMAPELL-LGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-21
Identities = 24/120 (20%), Positives = 40/120 (33%), Gaps = 11/120 (9%)
Query: 81 LPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG---- 136
NL L V L N + +P L L +LQ+L+++ N+
Sbjct: 474 SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQL 533
Query: 137 -----EIPDSLGDLGNLNYLRLNNNSLTGSCPE-SLSKIESLTLVDLSYNNLSGSLPKIS 190
+ D + + N+L SL K+ L L+D +N + L
Sbjct: 534 KADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFG 592
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 1e-18
Identities = 25/125 (20%), Positives = 38/125 (30%), Gaps = 28/125 (22%)
Query: 88 GTLSPWIGNLTKLQSVLLQNNAI-------------------LGPIPASLGKLEKLQTLD 128
+S I LTKLQ + N+ S L+ L ++
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE 497
Query: 129 LSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTG---------SCPESLSKIESLTLVDLSY 179
L N ++PD L DL L L + N + + + + Y
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557
Query: 180 NNLSG 184
NNL
Sbjct: 558 NNLEE 562
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 3e-17
Identities = 25/109 (22%), Positives = 45/109 (41%), Gaps = 4/109 (3%)
Query: 82 PSQSLSGTLSPWIGNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPD 140
++ L+ K+Q + N + P ASL K+ KL LD +NK +
Sbjct: 532 QLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLE 589
Query: 141 SLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
+ G L L+L+ N + + + + + + S+N L +P I
Sbjct: 590 AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNI 637
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 5e-17
Identities = 22/123 (17%), Positives = 47/123 (38%), Gaps = 15/123 (12%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAI-------LGPIPASLGKLEKLQTLDLSN 131
+ L + + + + +++L NN + L P + L T+DL
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRF 737
Query: 132 NKFTGEIPDSL--GDLGNLNYLRLNNNSLTG--SCPESLSKIESLTL---VDLSYNNLSG 184
NK T + D L L+ + ++ N + + P + S++++ + D N +
Sbjct: 738 NKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILR 796
Query: 185 SLP 187
P
Sbjct: 797 QWP 799
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 18/124 (14%), Positives = 39/124 (31%), Gaps = 17/124 (13%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL------SNNKFTGEIPDSLGDLGN 147
L L ++ + N P +L+ + N+ + P + +
Sbjct: 749 ATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPS 807
Query: 148 LNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNL-SGSLP------KISARTFKVTGNP 200
L L++ +N + E L+ L ++D++ N S + +
Sbjct: 808 LIQLQIGSNDIR-KVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
Query: 201 LICG 204
I G
Sbjct: 865 DIRG 868
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 3e-16
Identities = 20/137 (14%), Positives = 42/137 (30%), Gaps = 20/137 (14%)
Query: 76 VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT 135
+ + + K + N + I ++ +L KLQ + +N+ FT
Sbjct: 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNR-ITFISKAIQRLTKLQIIYFANSPFT 461
Query: 136 G-------------------EIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVD 176
S +L +L + L N P+ L + L ++
Sbjct: 462 YDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLN 521
Query: 177 LSYNNLSGSLPKISART 193
++ N + + T
Sbjct: 522 IACNRGISAAQLKADWT 538
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 3e-16
Identities = 21/106 (19%), Positives = 36/106 (33%), Gaps = 13/106 (12%)
Query: 94 IGNLTKLQSVLLQNNAILG-----PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
++ + SV N I K T+ LS N+ + +
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI 699
Query: 149 NYLRLNNNSLT-------GSCPESLSKIESLTLVDLSYNNLSGSLP 187
+ + L+NN +T + LT +DL +N L+ SL
Sbjct: 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLS 744
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 9e-16
Identities = 23/103 (22%), Positives = 39/103 (37%), Gaps = 5/103 (4%)
Query: 91 SPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG-DLGNLN 149
S + + KL + +N + + + G KL L L N+ EIP+ +
Sbjct: 566 SASLQKMVKLGLLDCVHNK-VRHLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVE 622
Query: 150 YLRLNNNSLTGSCPE-SLSKIESLTLVDLSYNNLSGSLPKISA 191
L ++N L + + + VD SYN + IS
Sbjct: 623 GLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISC 665
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 16/107 (14%), Positives = 42/107 (39%), Gaps = 8/107 (7%)
Query: 89 TLSPWIG-NLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG 146
+ +++ + +N + P + + + ++D S NK E + +
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
Query: 147 -----NLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
N + + L+ N + E + ++ + LS N ++ S+P+
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPE 714
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 24/106 (22%), Positives = 36/106 (33%), Gaps = 9/106 (8%)
Query: 91 SPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT-------GEIPDSLG 143
S +V L N I + T+ LSNN T +
Sbjct: 666 SMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725
Query: 144 DLGNLNYLRLNNNSLTGSCPE-SLSKIESLTLVDLSYNNLSGSLPK 188
+ L + L N LT + + + L+ +D+SYN S S P
Sbjct: 726 NTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPT 770
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-15
Identities = 23/106 (21%), Positives = 41/106 (38%), Gaps = 10/106 (9%)
Query: 92 PWIGNLTKLQSVLLQNNAILGPIPASLGK-LEKLQTLDLSNNKFTGEIPD--SLGDLGNL 148
G KL + L N I IP ++++ L S+NK IP+ + + +
Sbjct: 589 EAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVM 646
Query: 149 NYLRLNNNSLTG-----SCPESLSKIESLTLVDLSYNNLSGSLPKI 189
+ + N + SC K + + V LSYN + ++
Sbjct: 647 GSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTEL 692
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 18/193 (9%), Positives = 51/193 (26%), Gaps = 33/193 (17%)
Query: 42 KNNLHDPYNVLENWDITSVDPCSWRM---ITCSPDGYVSALGLPSQSLSGTLSPWIGNLT 98
+ + NW+ + + W + +G V+ L L G + IG LT
Sbjct: 289 YSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLT 347
Query: 99 KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP-DSLGDLGNLNYLRLNNNS 157
+L+ + ++ + + ++ L LN L ++
Sbjct: 348 ELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDA 407
Query: 158 LTGSC----------------------------PESLSKIESLTLVDLSYNNLSGSLPKI 189
+ + +++ ++ L ++ + + + +
Sbjct: 408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV 467
Query: 190 SARTFKVTGNPLI 202
Sbjct: 468 DWEDANSDYAKQY 480
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 4e-13
Identities = 22/196 (11%), Positives = 52/196 (26%), Gaps = 27/196 (13%)
Query: 36 VALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIG 95
+ L + D + W+ + T + + W
Sbjct: 259 IQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINN--------------TIHSLNW-- 302
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
+ + + L ++ L L+ G +PD++G L L L
Sbjct: 303 ------NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGT 356
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVF 215
+S T S + + + + + + K+ + + + +
Sbjct: 357 HSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMF-----LDYDQRLNLSDLLQDAINRN 411
Query: 216 PEPLSLPPNGLKDQSD 231
PE + + D
Sbjct: 412 PEMKPIKKDSRISLKD 427
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 25/170 (14%), Positives = 51/170 (30%), Gaps = 26/170 (15%)
Query: 77 SALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG 136
+ + + + + LQ + +N + S L+ Q + N+ T
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQ-IGNLTNRITF 439
Query: 137 EIPDSLGDLGNLNYLRLNNNSLTGSC-------------------PESLSKIESLTLVDL 177
I ++ L L + N+ T S S ++ LT V+L
Sbjct: 440 -ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498
Query: 178 SYNNLSGSLPK-----ISARTFKVTGNPLICGPKATNNCTAVFPEPLSLP 222
LP ++ + N I + + T + + + P
Sbjct: 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGP 548
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 12/87 (13%), Positives = 25/87 (28%), Gaps = 5/87 (5%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT-GE 137
+ I L + + +N I + L +L LD+++N +
Sbjct: 787 RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISID 843
Query: 138 IPDSLGDLGNLNY-LRLNNNSLTGSCP 163
+ + Y L + C
Sbjct: 844 VTSVCPYIEAGMYVLLYDKTQDIRGCD 870
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 2e-21
Identities = 63/240 (26%), Positives = 97/240 (40%), Gaps = 29/240 (12%)
Query: 272 FFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAV 330
F Q+ HL F R I+GRGGFG VY +D G + A+
Sbjct: 170 KFTRFCQWKNVELNIHLTMNDFSVHR----------IIGRGGFGEVYGCRKADTGKMYAM 219
Query: 331 KRL-KDYNIAGGEVQF-QTE---VETISLAVHRNLLRLCGFCSTENERL-LVYPYMPNGS 384
K L K E + +S ++ + + ++L + M G
Sbjct: 220 KCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGD 278
Query: 385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA 444
L H+ A + A GL ++H + +++RD+K ANILLDE
Sbjct: 279 ----LHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHV 331
Query: 445 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
+ D GLA + H +V GT G++APE L G + + + D F G +L +L+ G
Sbjct: 332 RISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 52/224 (23%), Positives = 98/224 (43%), Gaps = 29/224 (12%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEV-QFQTEVET 351
+ +A ++ +G G G V+K F G ++AVK++ + E + +++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDV 76
Query: 352 I-SLAVHRNLLRLCGFCSTENERLLVYPYMPNGS------VASRLRDHIHGRPALDWARR 404
+ +++ G T + + M + + + + I G+
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK-------- 128
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
+ + + L YL E+ +IHRDVK +NILLDE + + DFG++ L + +
Sbjct: 129 --MTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS 184
Query: 465 AVRGTVGHIAPEYLSTGQSSE-----KTDVFGFGILLLELITGQ 503
A G ++APE + ++ + DV+ GI L+EL TGQ
Sbjct: 185 A--GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-21
Identities = 30/113 (26%), Positives = 45/113 (39%), Gaps = 2/113 (1%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L L S S+ + L ++ L +N + + +LE LQ L LSNNK
Sbjct: 102 LHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK 161
Query: 139 PDSLGDLGN--LNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
+ L N L L L++N + P I L + L+ L SL +
Sbjct: 162 SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK 214
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 9e-21
Identities = 34/137 (24%), Positives = 55/137 (40%), Gaps = 4/137 (2%)
Query: 54 NWDITSVDPCSWRMITCSPDG---YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAI 110
D CS +T PD ++ L L L + ++L S+ + N I
Sbjct: 3 TVSHEVAD-CSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 111 LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIE 170
P KL L+ L+L +N+ + + NL L L +NS+ K +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 171 SLTLVDLSYNNLSGSLP 187
+L +DLS+N LS +
Sbjct: 122 NLITLDLSHNGLSSTKL 138
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-20
Identities = 29/137 (21%), Positives = 51/137 (37%), Gaps = 14/137 (10%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNN--------AILGPIPASLGKLEKLQTLDLSNNKFTG 136
+++ + L KL+ + LQ+N A G L L L L+L +N F
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
Query: 137 EIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI------S 190
+ DL L + L N+L + SL ++L N ++ K+ +
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 191 ARTFKVTGNPLICGPKA 207
+ NP C ++
Sbjct: 611 LTELDMRFNPFDCTCES 627
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-20
Identities = 22/116 (18%), Positives = 44/116 (37%), Gaps = 4/116 (3%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
++S L L+ + LQ+N + + L L L +N +
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNP 200
NL L L++N L+ + + ++E+L + LS N + + + + N
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA----LKSEELDIFANS 171
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 21/111 (18%), Positives = 41/111 (36%), Gaps = 1/111 (0%)
Query: 81 LPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD 140
L + G ++ L+ L + L++N L +L+ +DL N
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 141 SLGDLGNLNYLRLNNNSLTGSCPESLSKIE-SLTLVDLSYNNLSGSLPKIS 190
+ +L L L N +T + +LT +D+ +N + I+
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIA 629
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 30/105 (28%), Positives = 42/105 (40%), Gaps = 2/105 (1%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
LS T L + L +N+I K + L TLDLS+N + +
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIE--SLTLVDLSYNNLSGSLP 187
L NL L L+NN + E L SL ++LS N + P
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSP 188
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-18
Identities = 27/108 (25%), Positives = 45/108 (41%), Gaps = 3/108 (2%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPAS-LGKLEKLQTLDLSNNKFTGEIPDSLG 143
+S S L L+ + L N I + LE + + LS NK+ +S
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFA 451
Query: 144 DLGNLNYLRLNNNSLTG--SCPESLSKIESLTLVDLSYNNLSGSLPKI 189
+ +L L L +L S P + +LT++DLS NN++ +
Sbjct: 452 LVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 33/110 (30%), Positives = 43/110 (39%), Gaps = 5/110 (4%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLG--KLEKLQTLDLSNNKFTGEIPDSL 142
LS T L LQ +LL NN I L L+ L+LS+N+ P
Sbjct: 132 GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191
Query: 143 GDLGNLNYLRLNNNSLTGSCPESLSKIE---SLTLVDLSYNNLSGSLPKI 189
+G L L LNN L S E L S+ + LS + LS +
Sbjct: 192 HAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-17
Identities = 24/113 (21%), Positives = 44/113 (38%), Gaps = 4/113 (3%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNN--KFTG 136
+ SL L L+ + +++N I G L L+ L LSN+
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369
Query: 137 EIPDSLGDLGN--LNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
++ L + L+ L L N ++ ++ S + L ++DL N + L
Sbjct: 370 LTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 28/122 (22%), Positives = 44/122 (36%), Gaps = 11/122 (9%)
Query: 79 LGLPSQSLSGTLSPWIGNL--TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG 136
L L + LS T + L T L + L N + S L +L+ L N
Sbjct: 227 LSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286
Query: 137 EIPDSLGDLGNLNYLRLNNN---------SLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
SL L N+ YL L + SL S ++ L +++ N++ G
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346
Query: 188 KI 189
+
Sbjct: 347 NM 348
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 8e-17
Identities = 26/114 (22%), Positives = 41/114 (35%), Gaps = 10/114 (8%)
Query: 86 LSGTLSPWIGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
+ LQ ++L+ A+ + P+ L L LDLSNN D L
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE 501
Query: 144 DLGNLNYLRLNNNSLT--------GSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
L L L L +N+L G L + L +++L N ++
Sbjct: 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEV 555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 28/121 (23%), Positives = 49/121 (40%), Gaps = 10/121 (8%)
Query: 85 SLSGTLSPWIG---NLTKLQSVLLQNNAILGPIPASLGKLE--KLQTLDLSNNKFTGEIP 139
L +L+ + T ++++ L N+ + + L+ L LDLS N
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 140 DSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG-----SLPKISARTF 194
DS L L Y L N++ SL + ++ ++L + SLPKI +F
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325
Query: 195 K 195
+
Sbjct: 326 Q 326
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-16
Identities = 24/110 (21%), Positives = 40/110 (36%), Gaps = 5/110 (4%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAI-LGPIPASLGK---LEKLQTLDLSNNKFTGEIPD 140
+ G S L L+ + L N+ L + L L+L+ NK + D
Sbjct: 340 DIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESD 399
Query: 141 SLGDLGNLNYLRLNNNSLTGSCP-ESLSKIESLTLVDLSYNNLSGSLPKI 189
+ LG+L L L N + + +E++ + LSYN
Sbjct: 400 AFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS 449
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 23/116 (19%), Positives = 47/116 (40%), Gaps = 13/116 (11%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNN---------AILGPIPASLGKLEKLQTLDLSNNKFT 135
++ S + L ++ + L+ + ++ S L+ L+ L++ +N
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP 342
Query: 136 GEIPDSLGDLGNLNYLRLNNN--SLTGSCPESLS--KIESLTLVDLSYNNLSGSLP 187
G + L NL YL L+N+ SL E+ L +++L+ N +S
Sbjct: 343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 15/210 (7%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVH 357
+ + LG G +G V A+K ++ +++ EV + L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
N+++L F + LV G L D I R + I G+ Y
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 418 LHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
LH+ I+HRD+K N+LL ++D + DFGL+ + + + GT +IA
Sbjct: 152 LHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIA 206
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQR 504
PE L + EK DV+ G++L L+ G
Sbjct: 207 PEVLR-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 61/247 (24%), Positives = 102/247 (41%), Gaps = 37/247 (14%)
Query: 282 EVSLGH--LKRYTFKELRAATSNFSAKNI---------LGRGGFGIVYKGCF--SDGALV 328
E++L K + F +L + K + LG G G V F V
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL-AFERKTCKKV 163
Query: 329 AVKRLKDYNIAGGEVQ-------FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMP 381
A++ + A G + +TE+E + H ++++ F E+ +V M
Sbjct: 164 AIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELME 222
Query: 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL--- 438
G L D + G L A K + YLHE IIHRD+K N+LL
Sbjct: 223 GGE----LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQ 275
Query: 439 DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS---SEKTDVFGFGIL 495
+ED + DFG +K+L ++ + + GT ++APE L + + + D + G++
Sbjct: 276 EEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
Query: 496 LLELITG 502
L ++G
Sbjct: 334 LFICLSG 340
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-20
Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 16/209 (7%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGE--VQFQTEVETISLAV 356
+ + + +LG+G FG V G AVK + + EV+ +
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
H N+++L F + LV G L D I R RI G+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQVLSGIT 140
Query: 417 YLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
Y+H+ KI+HRD+K N+LL +D + DFGL+ + S GT +I
Sbjct: 141 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYI 195
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITG 502
APE L G EK DV+ G++L L++G
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSG 223
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 49/199 (24%), Positives = 78/199 (39%), Gaps = 21/199 (10%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVK--------RLKDYNIAGGEVQFQTEV 349
N+ K ILGRG +V + C AVK + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRR-CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 350 ETI-SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
+ + ++ H N+++L T LV+ M G L D++ + L ++I
Sbjct: 75 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE----LFDYLTEKVTLSEKETRKIM 130
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG 468
+ LH+ I+HRD+K NILLD+D + DFG + LD + G
Sbjct: 131 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREVC-G 185
Query: 469 TVGHIAPEYLSTGQSSEKT 487
T ++APE + +
Sbjct: 186 TPSYLAPEIIECSMNDNHP 204
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 29/210 (13%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVK-----RLKDYNIAGGEVQFQTEVETISL----AVHR 358
LG+GGFG V+ G +D VA+K R+ ++ V EV + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARR--KRIALGTARG 414
++RL + T+ +LV L D+I G +R ++
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQ---DLFDYITEKGPLGEGPSRCFFGQVV----AA 151
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
+ + H + ++HRD+K NIL+D + DFG LL D T GT +
Sbjct: 152 IQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD-GTRVYS 205
Query: 474 APEYLSTGQ-SSEKTDVFGFGILLLELITG 502
PE++S Q + V+ GILL +++ G
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCG 235
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 57/253 (22%), Positives = 85/253 (33%), Gaps = 55/253 (21%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVK----RLKDYNIAGGEVQFQTEVETIS 353
+ K +G+G +G+V A+ A+K + +TEV +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRV-AIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413
H N+ RL E LV G + +L I + +
Sbjct: 84 KLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 414 ------------------------------------GLLYLHEQCDPKIIHRDVKAANIL 437
L YLH Q I HRD+K N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFL 200
Query: 438 L--DEDFEAVVGDFGLAKLLDHRDSH----VTTAVRGTVGHIAPEYLSTGQSS--EKTDV 489
++ FE + DFGL+K ++ +TT GT +APE L+T S K D
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDA 259
Query: 490 FGFGILLLELITG 502
+ G+LL L+ G
Sbjct: 260 WSAGVLLHLLLMG 272
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 25/127 (19%), Positives = 47/127 (37%), Gaps = 6/127 (4%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPAS-LGKLEKLQTLDLSNNKFTGEIPDSLG 143
+ LT L ++ + N+ ++ L LDLS +
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494
Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI-----SARTFKVTG 198
L L L +++N+L +++ SL+ +D S+N + S + S F +T
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
Query: 199 NPLICGP 205
N + C
Sbjct: 555 NSVACIC 561
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 18/90 (20%), Positives = 34/90 (37%)
Query: 95 GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
N ++LQ + L I + L L L L+ N P S L +L L
Sbjct: 53 SNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAV 112
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
L + ++ +L +++++N +
Sbjct: 113 ETKLASLESFPIGQLITLKKLNVAHNFIHS 142
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 34/137 (24%), Positives = 52/137 (37%), Gaps = 13/137 (9%)
Query: 68 ITCSPDGYVSALGLPS-QSLS------GTLSPWIGNLTKLQSVLLQNNAILGPIPAS-LG 119
++ S S LG S + L +S L +LQ + Q++ + S
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFL 421
Query: 120 KLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGS-CPESLSKIESLTLVDLS 178
LEKL LD+S + L +LN L++ NS + + +LT +DLS
Sbjct: 422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLS 481
Query: 179 YNNLSGSLPKISARTFK 195
L IS F
Sbjct: 482 KCQLEQ----ISWGVFD 494
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 26/116 (22%), Positives = 43/116 (37%), Gaps = 6/116 (5%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
L+ S IG L L+ + + +N I +PA L L +DLS N + L
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174
Query: 144 DLGNLN----YLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
L L ++ N + ++ I L + L N S ++ K +
Sbjct: 175 FLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLA 229
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 27/106 (25%), Positives = 41/106 (38%), Gaps = 4/106 (3%)
Query: 87 SGTLSPWIGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
G++S L L + L NA+ G S L+ LDLS N + +
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMG 397
Query: 145 LGNLNYLRLNNNSLTGSCPES-LSKIESLTLVDLSYNNLSGSLPKI 189
L L +L +++L S +E L +D+SY N I
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 25/95 (26%), Positives = 37/95 (38%), Gaps = 5/95 (5%)
Query: 95 GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG--NLNYLR 152
+L L+S+ L N I L L LDLS N + S DLG +L +L
Sbjct: 325 LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382
Query: 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
L+ N + +E L +D ++ L
Sbjct: 383 LSFNGAIIM-SANFMGLEELQHLDFQHSTLKRVTE 416
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 17/100 (17%), Positives = 39/100 (39%), Gaps = 4/100 (4%)
Query: 88 GTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGN 147
G+L+P I + + + + + +P + + +DLS N S +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 148 LNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
L +L L+ + ++ + L+ + L+ N + P
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSP 97
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 26/116 (22%), Positives = 38/116 (32%), Gaps = 8/116 (6%)
Query: 87 SGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL----QTLDLSNNKFTGEIPDSL 142
S L + NLT L V L N I L L + +LD+S N I D
Sbjct: 142 SCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQA 200
Query: 143 GDLGNLNYLRLNNNSLTGSCPE-SLSKIESLTLVDLSYNNLSG--SLPKISARTFK 195
L+ L L N + + + L + L + L +L +
Sbjct: 201 FQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIME 256
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 13/86 (15%), Positives = 24/86 (27%), Gaps = 5/86 (5%)
Query: 105 LQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPE 164
L L + + L+ + + L + L
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTL 325
Query: 165 SLSKIESLTLVDLSYNNLSGSLPKIS 190
L ++SL L+ N S S K++
Sbjct: 326 DLPFLKSL---TLTMNKGSISFKKVA 348
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 23/111 (20%), Positives = 31/111 (27%), Gaps = 12/111 (10%)
Query: 87 SGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP-DSLGDL 145
L N S+ + N I I + KL L L N + I L +L
Sbjct: 170 VNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNL 228
Query: 146 GNLNYLRLNNNSLTG---------SCPESLSKIESLTLVDLSYNNLSGSLP 187
L+ RL S E L + L+Y N
Sbjct: 229 AGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEF-RLTYTNDFSDDI 278
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 14/99 (14%), Positives = 27/99 (27%), Gaps = 10/99 (10%)
Query: 94 IGNLTKLQSVLLQNNAILG------PIPASLGKLEKLQT--LDLSNNKFTGEIPDSLGDL 145
+ NL L L P+ + L + L+ + L
Sbjct: 225 LQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCL 284
Query: 146 GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
N++ + L S+ E + K + + L
Sbjct: 285 ANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ 321
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 35/138 (25%), Positives = 59/138 (42%), Gaps = 21/138 (15%)
Query: 379 YMPNGSVASRLRDHIHGRPALDWARRK---RIALGTARGLLYLHEQCDPKIIHRDVKAAN 435
+ L+D ++ R +L+ I + A + +LH + ++HRD+K +N
Sbjct: 142 LCRKEN----LKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSN 194
Query: 436 ILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR-----------GTVGHIAPEYLSTGQSS 484
I D VGDFGL +D + T GT +++PE + S
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYS 254
Query: 485 EKTDVFGFGILLLELITG 502
K D+F G++L EL+
Sbjct: 255 HKVDIFSLGLILFELLYS 272
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 17/72 (23%), Positives = 32/72 (44%), Gaps = 1/72 (1%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
++F +GRGGFG+V++ D A+KR++ N + EV+ ++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 360 LLRLCGFCSTEN 371
++R
Sbjct: 66 IVRYFNAWLETP 77
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 49/215 (22%), Positives = 82/215 (38%), Gaps = 25/215 (11%)
Query: 293 FKELRAATSNFSA----KNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQ 346
++L + F+ K +G G + + + C + AVK + E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKR-CIHKATNMEFAVKIIDKSKRDPTE---- 64
Query: 347 TEVETISLAV-HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
E+E + H N++ L +V M G L D I +
Sbjct: 65 -EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE----LLDKILRQKFFSEREAS 119
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAV-VGDFGLAKLLDHRDSH 461
+ + + YLH Q ++HRD+K +NIL + E++ + DFG AK L +
Sbjct: 120 AVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 496
+ T T +APE L D++ G+LL
Sbjct: 177 LMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVH 357
++ +LG+G FG V K AVK + + + EVE + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
N+++L + +V G L D I R RI G+ Y
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 418 LHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
+H+ I+HRD+K NILL ++D + + DFGL+ +++ + + GT +IA
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRI-GTAYYIA 191
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITG 502
PE L G EK DV+ G++L L++G
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVILYILLSG 218
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 5e-19
Identities = 50/224 (22%), Positives = 92/224 (41%), Gaps = 26/224 (11%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQ-FQT 347
K++R +F ++GRG FG V K + A+K L K + E F+
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFRE 123
Query: 348 EVETISLAVHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWAR--R 404
E + + + + L + ++ L LV Y G + + L R + AR
Sbjct: 124 ERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYL 181
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
+ + + +H+ +HRD+K NIL+D + + DFG L + ++
Sbjct: 182 AEMVIA----IDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234
Query: 465 AVRGTVGHIAPEYLSTGQSSEKT-----DVFGFGILLLELITGQ 503
GT +I+PE L + + D + G+ + E++ G+
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 29/209 (13%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVK-----RLKDYNIAGGEVQFQTEVETISLAVHR--NL 360
LG GGFG VY G SD VA+K R+ D+ + EV + +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 361 LRLCGFCSTENERLLVYPY-MPNGSVASRLRDHI--HGRPALDWARR--KRIALGTARGL 415
+RL + + +L+ P L D I G + AR ++ +
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQD----LFDFITERGALQEELARSFFWQVL----EAV 162
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
+ H ++HRD+K NIL+D + + + DFG LL +D+ T GT +
Sbjct: 163 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD-GTRVYSP 216
Query: 475 PEYLSTGQ-SSEKTDVFGFGILLLELITG 502
PE++ + V+ GILL +++ G
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCG 245
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 9e-19
Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 18/211 (8%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
F K LG G FG V+ S G +K + Q + E+E + H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR----G 414
N++++ + +V G L + I A A + +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGG----ELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 415 LLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
L Y H Q ++H+D+K NIL + DFGLA+L D H T A GT
Sbjct: 137 LAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEHSTNAA-GTAL 191
Query: 472 HIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
++APE + K D++ G+++ L+TG
Sbjct: 192 YMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 45/197 (22%), Positives = 77/197 (39%), Gaps = 19/197 (9%)
Query: 306 KNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLLR 362
LG G F I K C AVK + A Q E+ + H N+++
Sbjct: 16 DKPLGEGSFSICRK-CVHKKSNQAFAVKIISKRMEA----NTQKEITALKLCEGHPNIVK 70
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
L + LV + G L + I + I + ++H+
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGE----LFERIKKKKHFSETEASYIMRKLVSAVSHMHDV- 125
Query: 423 DPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
++HRD+K N+L +++ E + DFG A+L + + T T+ + APE L+
Sbjct: 126 --GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLN 182
Query: 480 TGQSSEKTDVFGFGILL 496
E D++ G++L
Sbjct: 183 QNGYDESCDLWSLGVIL 199
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 26/219 (11%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLK------------DYNIAGGEVQFQ 346
++ LG G +G V + + A+K +K + NI +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 347 TEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
E+ + H N+++L + LV + G L + I R D
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFDECDAAN 150
Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVT 463
I G+ YLH+ I+HRD+K NILL + + DFGL+ D +
Sbjct: 151 IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK-DYKLR 206
Query: 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
+ GT +IAPE L + +EK DV+ G+++ L+ G
Sbjct: 207 DRL-GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCG 243
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 48/198 (24%), Positives = 81/198 (40%), Gaps = 20/198 (10%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVK-------RLKDYNIAGGEVQFQTEVET 351
+ K+++GRG +V + + G AVK RL + + E
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH- 151
Query: 352 I--SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
I +A H +++ L + + LV+ M G L D++ + AL + I
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE----LFDYLTEKVALSEKETRSIMR 207
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
+ +LH I+HRD+K NILLD++ + + DFG + L+ + GT
Sbjct: 208 SLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-GEKLRELC-GT 262
Query: 470 VGHIAPEYLSTGQSSEKT 487
G++APE L
Sbjct: 263 PGYLAPEILKCSMDETHP 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 57/226 (25%), Positives = 88/226 (38%), Gaps = 28/226 (12%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEV-QFQT 347
KE+R +F ++GRG F V K G + A+K + K + GEV F+
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 348 EVETISLAVHRNLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWAR--R 404
E + + R + +L F + L LV Y G + + L R + AR
Sbjct: 111 ERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYL 168
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
I + + +H +HRD+K NILLD + DFG L + +
Sbjct: 169 AEIVMA----IDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFG-------FGILLLELITGQ 503
GT +++PE L T +G G+ E+ GQ
Sbjct: 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAV 356
++ +LG+G FG V K C AVK + + + EVE +
Sbjct: 21 AERYNIVCMLGKGSFGEVLK-CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
H N+++L + +V G L D I R RI G+
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 417 YLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHI 473
Y+H+ I+HRD+K NILL ++D + + DFGL+ ++ + + GT +I
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRI-GTAYYI 190
Query: 474 APEYLSTGQSSEKTDVFGFG----ILL 496
APE L G EK DV+ G ILL
Sbjct: 191 APEVLR-GTYDEKCDVWSAGVILYILL 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 50/221 (22%), Positives = 81/221 (36%), Gaps = 34/221 (15%)
Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEV--- 343
Y E ++G+G F +V + C G AVK +
Sbjct: 24 DVYELCE------------VIGKGPFSVVRR-CINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 344 -QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWA 402
+ E + H +++ L S++ +V+ +M L I R +
Sbjct: 71 EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFV 126
Query: 403 RRKRIALGTARGLL----YLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLL 455
+ +A R +L Y H+ IIHRDVK +LL + +G FG+A L
Sbjct: 127 YSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183
Query: 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 496
V GT +APE + + DV+G G++L
Sbjct: 184 GESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 33/218 (15%)
Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQF-QTEVETISL 354
+F ILG G F V + A+K L K + I +V + E + +S
Sbjct: 30 EDFKFGKILGEGSFSTVVLAREL---ATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR- 413
H ++L + + Y NG + +R + R
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR------------KIGSFDETCTRF 134
Query: 414 -------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA- 465
L YLH + IIHRD+K NILL+ED + DFG AK+L
Sbjct: 135 YTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 191
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
GT +++PE L+ + + +D++ G ++ +L+ G
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 51/234 (21%), Positives = 90/234 (38%), Gaps = 19/234 (8%)
Query: 277 DQYDPEVSLGHLKRYTFKELRAATSNFSAK----NILGRGGFGIVYKGCF--SDGALVAV 330
+ YD K+Y + + + LG G FG+V++ C + G +
Sbjct: 24 NDYDKFYE-DIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHR-CVEKATGRVFVA 81
Query: 331 KRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLR 390
K + + E+ ++ H L+ L + E +L+ ++ G + R+
Sbjct: 82 KFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 140
Query: 391 DHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL--DEDFEAVVGD 448
+ + R A GL ++HE I+H D+K NI+ + + D
Sbjct: 141 AEDYKMSEAEVINYMRQACE---GLKHMHEH---SIVHLDIKPENIMCETKKASSVKIID 194
Query: 449 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
FGLA L+ D V T APE + TD++ G+L L++G
Sbjct: 195 FGLATKLNP-DEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-18
Identities = 35/118 (29%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 94 IGNLTKLQSVLLQNNAILGPI---PASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNY 150
L LQ + LQ N SL L +L+ L LS + + L +N+
Sbjct: 445 FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNH 504
Query: 151 LRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI-----SARTFKVTGNPLIC 203
+ L++N LT S E+LS ++ + L +L+ N++S LP + RT + NPL C
Sbjct: 505 VDLSHNRLTSSSIEALSHLKGIYL-NLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-17
Identities = 18/102 (17%), Positives = 37/102 (36%), Gaps = 2/102 (1%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
L + L+ + I L + L++L L +N +
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLV--DLSYNNLSG 184
L L NN++ E +S ++ T + +L+ N+++G
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 17/91 (18%), Positives = 30/91 (32%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
L L + L I + +L TL L+ N +L L +L
Sbjct: 53 FSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
++ L ++L + L N++S
Sbjct: 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 19/125 (15%), Positives = 43/125 (34%), Gaps = 7/125 (5%)
Query: 95 GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
+ +L +++L N ++ +L + L+ L + L + L L L
Sbjct: 78 QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS-------GSLPKISARTFKVTGNPLICGPKA 207
+N ++ E L ++D N + SL + + + + GN +
Sbjct: 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPG 197
Query: 208 TNNCT 212
+
Sbjct: 198 AFDSA 202
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-16
Identities = 25/109 (22%), Positives = 43/109 (39%), Gaps = 2/109 (1%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
+ + +S + + ++ ++S+ LQ + + LQ LDL+ + E+
Sbjct: 236 EDMDDEDISPAVFEGLCEMS-VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-EL 293
Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
P L L L L L+ N C S S SLT + + N L
Sbjct: 294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 6e-16
Identities = 17/96 (17%), Positives = 31/96 (32%), Gaps = 4/96 (4%)
Query: 100 LQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT 159
+ + N + + +L L LDL+ + D+ L+ L L N L
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 160 GSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
+LS ++L + +S I
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISS----IDFIPLH 126
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-16
Identities = 25/102 (24%), Positives = 43/102 (42%), Gaps = 2/102 (1%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
S + LQ + L + +P+ L L L+ L LS NKF S +
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASN 323
Query: 145 LGNLNYLRLNNNSLTGS-CPESLSKIESLTLVDLSYNNLSGS 185
+L +L + N+ L +E+L +DLS++++ S
Sbjct: 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS 365
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 8e-16
Identities = 20/102 (19%), Positives = 44/102 (43%), Gaps = 1/102 (0%)
Query: 84 QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
+ + + L +L+ ++L + + L+ + +DLS+N+ T ++L
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521
Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGS 185
L + YL L +N ++ P L + ++L N L +
Sbjct: 522 HLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 24/109 (22%), Positives = 45/109 (41%), Gaps = 4/109 (3%)
Query: 85 SLSGTLSPW-IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDS 141
+ L + NL L+ + L ++ I L L LQ+L+LS N+ ++
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395
Query: 142 LGDLGNLNYLRLNNNSLTGSCPES-LSKIESLTLVDLSYNNLSGSLPKI 189
+ L L L L +S + L +++LS++ L S ++
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL 444
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 25/94 (26%), Positives = 41/94 (43%), Gaps = 3/94 (3%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI---PDSLGDLGNLNY 150
NL L+ + L ++ + L LQ L+L N F +SL LG L
Sbjct: 421 FQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI 480
Query: 151 LRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
L L+ L+ + + ++ + VDLS+N L+
Sbjct: 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS 514
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 21/115 (18%), Positives = 37/115 (32%), Gaps = 8/115 (6%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
+ +L+ + L + + L L+ L+LS++
Sbjct: 387 EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446
Query: 144 DLGNLNYLRLNNNSLTG---SCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
L L +L L N SL + L ++ LS+ +LS I F
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS----IDQHAFT 497
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 24/119 (20%), Positives = 37/119 (31%), Gaps = 9/119 (7%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQ--TLDLSNNKFTGEIPDSL 142
+S P KL+ + QNNAI + L++ +L+L+ N I
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGA 198
Query: 143 GDLGNLNYLRLNNNSLTGSCPESLS--KIESLTLVDLSYNNLSGSLPKISARTFKVTGN 199
D L + L I+SL L + IS F+
Sbjct: 199 FDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE----DISPAVFEGLCE 253
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 15/100 (15%), Positives = 29/100 (29%), Gaps = 4/100 (4%)
Query: 88 GTLSPWIGNLTKLQSVLLQNNAILGPIPASLG--KLEKLQTLDLSNNKFTGEIPDSLGDL 145
+ P + QS+ L I L ++ L + P L
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 146 GNLN--YLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
++ + L + + L +DL+ +LS
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS 291
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 16/69 (23%), Positives = 30/69 (43%), Gaps = 1/69 (1%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+L + V L +N + +L L+ + L+L++N + +P L L + L
Sbjct: 496 FTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINL 554
Query: 154 NNNSLTGSC 162
N L +C
Sbjct: 555 RQNPLDCTC 563
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 6e-18
Identities = 48/213 (22%), Positives = 85/213 (39%), Gaps = 27/213 (12%)
Query: 300 TSNFSAK----NILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQ-FQTEVETIS 353
+ F+ + LG+G F +V + G A + ++ + Q + E
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL---DWARRKRIALG 410
L H N++RL S E L++ + G L + I R D + + L
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQQILE 121
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
+L+ H+ ++HR++K N+LL + + DFGLA ++
Sbjct: 122 ---AVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA- 174
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFG----ILL 496
GT G+++PE L + D++ G ILL
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 7e-18
Identities = 49/217 (22%), Positives = 86/217 (39%), Gaps = 27/217 (12%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVK-----RLKDYNIAGGEVQFQTEVETI 352
+ LG G F IV K C S G A K + + + + EV +
Sbjct: 11 EDFYDIGEELGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 353 SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL---DWARRKRIAL 409
+H N++ L + +L+ + G L D + + +L + + L
Sbjct: 70 RQVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQIL 125
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAV-VGDFGLAKLLDHRDSHVTTA 465
G+ YLH + KI H D+K NI+L + + + DFGLA ++
Sbjct: 126 D---GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNI 178
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
GT +APE ++ + D++ G++ L++G
Sbjct: 179 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 54/229 (23%), Positives = 88/229 (38%), Gaps = 53/229 (23%)
Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
+F +G+G FG V + A+K + K + EV+ E
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVR-NVFKE----- 65
Query: 356 VHRNLLR------LCG--FCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
+++ L + + E + +V + G LR H+ +
Sbjct: 66 --LQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGD----LRYHLQ--------QNVH 111
Query: 407 IALGTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458
T + L YL Q +IIHRD+K NILLDE + DF +A +L
Sbjct: 112 FKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168
Query: 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKT---DVFGFGILLLELITGQR 504
T A GT ++APE S+ + + + D + G+ EL+ G+R
Sbjct: 169 TQITTMA--GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 21/101 (20%), Positives = 40/101 (39%), Gaps = 3/101 (2%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN-NKFTGEIPDSLGDLGN 147
L P I +L KL+ + L+ L P G L+ L L + + +P + L
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQ 278
Query: 148 LNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
L L L P ++++ + ++ + +L L +
Sbjct: 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILVP-PHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 20/102 (19%), Positives = 40/102 (39%), Gaps = 5/102 (4%)
Query: 89 TLSPWIGNLT--KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG 146
+ + + T ++ L++ L P +L LQ + + E+PD++
Sbjct: 70 ATADLLEDATQPGRVALELRSVP-LPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127
Query: 147 NLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
L L L N L + P S++ + L + + LP+
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPE 168
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 27/109 (24%), Positives = 48/109 (44%), Gaps = 12/109 (11%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG----- 143
L + L+++ L N L +PAS+ L +L+ L + E+P+ L
Sbjct: 118 ELPDTMQQFAGLETLTLARNP-LRALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 144 ----DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
L NL LRL + S P S++ +++L + + + LS +L
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGP 223
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 26/108 (24%), Positives = 44/108 (40%), Gaps = 2/108 (1%)
Query: 81 LPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD 140
LP S S L LQS+ L+ I +PAS+ L+ L++L + N+ + +
Sbjct: 166 LPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGP 223
Query: 141 SLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
++ L L L L + + P L + L + +LP
Sbjct: 224 AIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPL 271
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 15/81 (18%), Positives = 32/81 (39%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L L + P G L+ ++L++ + L +P + +L +L+ LDL +
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 139 PDSLGDLGNLNYLRLNNNSLT 159
P + L + + +
Sbjct: 294 PSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 19/125 (15%), Positives = 34/125 (27%), Gaps = 8/125 (6%)
Query: 68 ITCSPDGYVSALGLPSQSLSG--TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQ 125
+ S + + G + G L P+ L++ Q + Q
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS-AWRQANSNNPQ 59
Query: 126 TLDLSNNKFTGEIPDSLGDL--GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
+ D L D L L + L P+ ++ L + + L
Sbjct: 60 IETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117
Query: 184 GSLPK 188
LP
Sbjct: 118 -ELPD 121
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 32/218 (14%)
Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQ-F 345
Y KE LG+G F +V + C + G A K + ++ + Q
Sbjct: 29 DNYDVKE------------ELGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKL 75
Query: 346 QTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
+ E H N++RL E+ LV+ + G L + I R A
Sbjct: 76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS 131
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHV 462
+ Y H I+HR++K N+LL + + DFGLA ++ DS
Sbjct: 132 HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEA 186
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG----ILL 496
GT G+++PE L S+ D++ G ILL
Sbjct: 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQ 346
K + F E +LG G F V+ G L A+K +K + A + +
Sbjct: 9 KTFIFME------------VLGSGAFSEVFL-VKQRLTGKLFALKCIKK-SPAFRDSSLE 54
Query: 347 TEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
E+ + H N++ L + LV + G L D I R
Sbjct: 55 NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDASL 110
Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVT 463
+ + YLHE I+HRD+K N+L +E+ + ++ DFGL+K+ + ++
Sbjct: 111 VIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIMS 165
Query: 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFG----ILL 496
TA GT G++APE L+ S+ D + G ILL
Sbjct: 166 TAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 24/211 (11%)
Query: 300 TSNFSAK----NILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQ-FQTEVETI 352
++ FS LG+G F +V + C + G A K + ++ + Q + E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 59
Query: 353 SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
H N++RL E+ LV+ + G L + I R A
Sbjct: 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQIL 115
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGT 469
+ Y H I+HR++K N+LL + + DFGLA ++ DS GT
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGT 170
Query: 470 VGHIAPEYLSTGQSSEKTDVFGFG----ILL 496
G+++PE L S+ D++ G ILL
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 27/217 (12%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVK-----RLKDYNIAGGEVQFQTEVETI 352
++ LG G F IV K C G A K RL + + EV +
Sbjct: 4 EDHYEMGEELGSGQFAIVRK-CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 353 SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL---DWARRKRIAL 409
H N++ L + + +L+ + G L D + + +L + + + L
Sbjct: 63 REIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEATQFLKQIL 118
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILL----DEDFEAVVGDFGLAKLLDHRDSHVTTA 465
G+ YLH + +I H D+K NI+L + + DFG+A ++ +
Sbjct: 119 D---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA-GNEFKNI 171
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
GT +APE ++ + D++ G++ L++G
Sbjct: 172 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 51/228 (22%), Positives = 85/228 (37%), Gaps = 37/228 (16%)
Query: 294 KELRAATSNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQ-FQT 347
++LR ++ ++GRG FG V K + A+K L K I + F
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWE 118
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
E + ++ A +++L + +V YMP G + + + +
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS-------------NYDV 165
Query: 408 ALGTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
AR L +H IHRDVK N+LLD+ + DFG ++
Sbjct: 166 PEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222
Query: 460 SHVTTAVRGTVGHIAPEYLSTGQSSEK----TDVFGFGILLLELITGQ 503
GT +I+PE L + D + G+ L E++ G
Sbjct: 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 49/217 (22%), Positives = 86/217 (39%), Gaps = 27/217 (12%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVK-----RLKDYNIAGGEVQFQTEVETI 352
+ LG G F IV K C S G A K + + + + EV +
Sbjct: 11 EDFYDIGEELGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 353 SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL---DWARRKRIAL 409
+H N++ L + +L+ + G L D + + +L + + L
Sbjct: 70 RQVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQIL 125
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAV-VGDFGLAKLLDHRDSHVTTA 465
G+ YLH + KI H D+K NI+L + + + DFGLA ++
Sbjct: 126 D---GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNI 178
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
GT +APE ++ + D++ G++ L++G
Sbjct: 179 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 302 NFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN 359
S ILG G FG V+K C + G +A K +K + E + + E+ ++ H N
Sbjct: 90 TVSKTEILGGGRFGQVHK-CEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHAN 147
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
L++L ++N+ +LV Y+ G + R+ D + LD + G+ ++H
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE---GIRHMH 204
Query: 420 EQCDPKIIHRDVKAANILL--DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
+ I+H D+K NIL + + + DFGLA+ R+ + GT +APE
Sbjct: 205 QM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNF-GTPEFLAPEV 259
Query: 478 LSTGQSSEKTDVFGFGILLLELITG 502
++ S TD++ G++ L++G
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 26/204 (12%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVK-----RLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
+G+G F V G VA+K +L ++ + EV + + H N+++
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ----KLFREVRIMKILNHPNIVK 78
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRKRIALGTARGLLYLHE 420
L TE L+ Y G + D++ HGR AR K + +A + Y H+
Sbjct: 79 LFEVIETEKTLYLIMEYASGG----EVFDYLVAHGRMKEKEARSKFRQIVSA--VQYCHQ 132
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
+ I+HRD+KA N+LLD D + DFG + + G + APE
Sbjct: 133 KR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFC-GAPPYAAPELFQ- 186
Query: 481 GQSSE--KTDVFGFGILLLELITG 502
G+ + + DV+ G++L L++G
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSG 210
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 47/194 (24%), Positives = 71/194 (36%), Gaps = 23/194 (11%)
Query: 306 KNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLLR 362
+++LG G V C AVK ++ + EVE + HRN+L
Sbjct: 18 EDVLGEGAHARVQT-CINLITSQEYAVKIIEKQPGHIRS-RVFREVEMLYQCQGHRNVLE 75
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
L F E+ LV+ M GS + HIH R + + A L +LH +
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGS----ILSHIHKRRHFNELEASVVVQDVASALDFLHNK- 130
Query: 423 DPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHV-------TTAVRGTVGH 472
I HRD+K NIL ++ + DF L + T G+ +
Sbjct: 131 --GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEY 187
Query: 473 IAPEYLSTGQSSEK 486
+APE +
Sbjct: 188 MAPEVVEAFSEEAS 201
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-17
Identities = 56/203 (27%), Positives = 84/203 (41%), Gaps = 22/203 (10%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
LG G +G V VAVK + + E+ + H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 368 STENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRK---RIALGTARGLLYLHEQC 422
N + L Y G L D I A+R +A G++YLH
Sbjct: 75 REGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGI- 124
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH--RDSHVTTAVRGTVGHIAPEYLS- 479
I HRD+K N+LLDE + DFGLA + + R+ + GT+ ++APE L
Sbjct: 125 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKR 181
Query: 480 TGQSSEKTDVFGFGILLLELITG 502
+E DV+ GI+L ++ G
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG 204
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 48/202 (23%), Positives = 79/202 (39%), Gaps = 27/202 (13%)
Query: 306 KNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
K +LG G G V + CF G A+K L D A EV + + +++ +
Sbjct: 34 KQVLGLGVNGKVLE-CFHRRTGQKCALKLLYDSPKARQEVDHHWQ-----ASGGPHIVCI 87
Query: 364 CGFCSTENER----LLVYPYMPNGSVASRLRDHIHGRPALDWARRK--RIALGTARGLLY 417
+ L++ M G L I R + R+ I + +
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGE----LFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 418 LHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
LH I HRDVK N+L ++D + DFG AK + + T T ++A
Sbjct: 144 LHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT--QNALQTPC-YTPYYVA 197
Query: 475 PEYLSTGQSSEKTDVFGFGILL 496
PE L + + D++ G+++
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIM 219
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 51/208 (24%), Positives = 79/208 (37%), Gaps = 27/208 (12%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVK-----RLKDYNIAGGEV--QFQTEVETISLAVHRNL 360
LG G FG V+ V VK ++ + + E+ +S H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRK--RIALGTARGLL 416
+++ + LV +G L I H R A ++
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLDEPLASYIFRQLVSAVG---- 144
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
YL + IIHRD+K NI++ EDF + DFG A L R T GT+ + APE
Sbjct: 145 YLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTFC-GTIEYCAPE 199
Query: 477 YLSTGQSSE--KTDVFGFGILLLELITG 502
L G + +++ G+ L L+
Sbjct: 200 VLM-GNPYRGPELEMWSLGVTLYTLVFE 226
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 5e-17
Identities = 53/230 (23%), Positives = 95/230 (41%), Gaps = 14/230 (6%)
Query: 277 DQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLK 334
D Y ++ + + + ++ LG G FG+V++ + G A K +
Sbjct: 133 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHR-VTERATGNNFAAKFVM 191
Query: 335 DYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH 394
+ + E + E++T+S+ H L+ L +NE +++Y +M G + ++ D +
Sbjct: 192 TPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 250
Query: 395 GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVV--GDFGLA 452
+ R GL ++HE +H D+K NI+ + DFGL
Sbjct: 251 KMSEDEAVEYMRQVCK---GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLT 304
Query: 453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
LD + S V GT APE TD++ G+L L++G
Sbjct: 305 AHLDPKQS-VKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 6e-17
Identities = 46/216 (21%), Positives = 78/216 (36%), Gaps = 31/216 (14%)
Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQT 347
+ YT + +GRG +G V A K++ Y + + +F+
Sbjct: 9 QYYTLEN------------TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQ 55
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
E+E + H N++RL + LV G L + + + + RI
Sbjct: 56 EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARI 111
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTT 464
+ Y H+ + HRD+K N L D + DFGLA +
Sbjct: 112 MKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMR 166
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFG----ILL 496
GT +++P+ L G + D + G +LL
Sbjct: 167 TKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLL 201
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 8e-17
Identities = 29/113 (25%), Positives = 52/113 (46%), Gaps = 11/113 (9%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ NL++L + + N I + L KL+ L++ +N+ + L +L LN L L
Sbjct: 239 LANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFL 294
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS-----GSLPKISARTFKVTGNPL 201
NNN L E + + +LT + LS N+++ SL K+ + +
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKM--DSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 24/90 (26%), Positives = 43/90 (47%), Gaps = 4/90 (4%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ +LTKL+ + + +N I L L +L +L L+NN+ E + +G L NL L L
Sbjct: 261 VKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
+ N +T L+ + + D + +
Sbjct: 319 SQNHITDI--RPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 2e-14
Identities = 27/91 (29%), Positives = 41/91 (45%), Gaps = 6/91 (6%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
I NLT L S+ L N I P L L L N+ T P + ++ LN L++
Sbjct: 173 IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
NN +T L+ + LT +++ N +S
Sbjct: 229 GNNKITDL--SPLANLSQLTWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 8e-14
Identities = 23/91 (25%), Positives = 39/91 (42%), Gaps = 5/91 (5%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ NLTK+ S+ L N L + L + L L ++ +K P + +L +L L L
Sbjct: 128 LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSL 184
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
N N + L+ + SL N ++
Sbjct: 185 NYNQIEDI--SPLASLTSLHYFTAYVNQITD 213
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 9e-14
Identities = 20/94 (21%), Positives = 38/94 (40%), Gaps = 5/94 (5%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ NL KL ++ + N I ++L L L+ L L+ + + L +L + L L
Sbjct: 84 LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNL 139
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
N LS + L + ++ + + P
Sbjct: 140 GANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTP 172
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 7e-13
Identities = 23/123 (18%), Positives = 50/123 (40%), Gaps = 11/123 (8%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
L + +++ + I + L L+ L+L+ N+ T P L +L L L +
Sbjct: 40 QEELESITKLVVAGEKVAS-IQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYI 95
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGPKATN 209
N +T +L + +L + L+ +N+S + ++ + + N + +
Sbjct: 96 GTNKITD--ISALQNLTNLRELYLNEDNIS-DISPLANLTKMYSLNLGANHNLSDLSPLS 152
Query: 210 NCT 212
N T
Sbjct: 153 NMT 155
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 4e-12
Identities = 22/90 (24%), Positives = 39/90 (43%), Gaps = 6/90 (6%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+L + +LQ ++ + +LE + L ++ K I + L NL YL L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNL 73
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
N N +T LS + LT + + N ++
Sbjct: 74 NGNQITD--ISPLSNLVKLTNLYIGTNKIT 101
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 9e-09
Identities = 11/88 (12%), Positives = 29/88 (32%), Gaps = 6/88 (6%)
Query: 100 LQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT 159
++ I P L + L T + +L ++ L + +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 160 GSCPESLSKIESLTLVDLSYNNLSGSLP 187
+ + + +L ++L+ N ++ P
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP 83
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 50/217 (23%), Positives = 83/217 (38%), Gaps = 27/217 (12%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVK-----RLKDYNIAGGEVQFQTEVETI 352
+ LG G F +V K C S G A K R K + EV +
Sbjct: 10 DDYYDTGEELGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 353 SLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL---DWARRKRIAL 409
H N++ L + + +L+ + G L D + + +L + + L
Sbjct: 69 KEIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLKQIL 124
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILL----DEDFEAVVGDFGLAKLLDHRDSHVTTA 465
G+ YLH +I H D+K NI+L + DFGLA +D +
Sbjct: 125 N---GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNI 177
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
GT +APE ++ + D++ G++ L++G
Sbjct: 178 F-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 19/205 (9%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVK---RLKDYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
LG G +G V + S+ AVK + K I GE + E++ + H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 365 GFCSTENER--LLVYPYMPNGSVASRLRDHI-HGRPALDWARRKRIALGTARGLLYLHEQ 421
E ++ +V Y G + D + R + A L GL YLH Q
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEKRFPVCQAHGYFCQL--IDGLEYLHSQ 128
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR--DSHVTTAVRGTVGHIAPEYLS 479
I+H+D+K N+LL + G+A+ L D T+ +G+ PE +
Sbjct: 129 ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPEIAN 184
Query: 480 TGQ--SSEKTDVFGFGILLLELITG 502
S K D++ G+ L + TG
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 26/212 (12%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQ-------FQTEVE 350
+ LG G G V F VA+K + A G + +TE+E
Sbjct: 9 RDEYIMSKTLGSGACGEVKL-AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 351 TISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
+ H ++++ F E+ +V M G L D + G L A K
Sbjct: 68 ILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQ 122
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
+ YLHE IIHRD+K N+LL +ED + DFG +K+L ++ + +
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLC 177
Query: 468 GTVGHIAPEYLSTGQS---SEKTDVFGFGILL 496
GT ++APE L + + + D + G++L
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 26/222 (11%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R F + + G+G FG V G S G VA+K+ ++D E+Q ++ +++
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAV 75
Query: 355 AVHRNLLRLCGFCSTENER-------LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
H N+++L + T ER +V Y+P+ ++ R++ + A K
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVF 134
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLDHRDSHVTTAV 466
R + LH + HRD+K N+L++ D + DFG AK L + +V
Sbjct: 135 LFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193
Query: 467 ----RGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
R APE + Q + D++ G + E++ G+
Sbjct: 194 SRYYR------APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 56/203 (27%), Positives = 84/203 (41%), Gaps = 22/203 (10%)
Query: 309 LGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
LG G +G V VAVK + + E+ + H N+++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 368 STENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRK---RIALGTARGLLYLHEQC 422
N + L Y G L D I A+R +A G++YLH
Sbjct: 75 REGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHGI- 124
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH--RDSHVTTAVRGTVGHIAPEYLS- 479
I HRD+K N+LLDE + DFGLA + + R+ + GT+ ++APE L
Sbjct: 125 --GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKR 181
Query: 480 TGQSSEKTDVFGFGILLLELITG 502
+E DV+ GI+L ++ G
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAG 204
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKR-LKDYNIAGGEVQFQTEVETISL 354
R +++ ++G G FG+VY+ G LVA+K+ L+D E+Q +++
Sbjct: 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD---- 105
Query: 355 AVHRNLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
H N++RL F + E+ LV Y+P +V R + + L K
Sbjct: 106 --HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAV- 466
R L Y+H I HRD+K N+LLD D + + DFG AK L + +V+
Sbjct: 163 YQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219
Query: 467 ---RGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
R APE + + DV+ G +L EL+ GQ
Sbjct: 220 RYYR------APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 57/242 (23%), Positives = 92/242 (38%), Gaps = 37/242 (15%)
Query: 277 DQYDPEVSLGHLKRYTFKELRAAT-SNFSAKNILGRGGFGIVY----KGCFSDGALVAVK 331
++ + LK++ A F LG G FG V K G A+K
Sbjct: 16 KEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMK 72
Query: 332 RL-KDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRL 389
L K + +++ E + L++L + +V Y+ G + S L
Sbjct: 73 ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 390 RDHIHGRPALDWARRKRIALGTAR--------GLLYLHEQCDPKIIHRDVKAANILLDED 441
R R R + AR YLH +I+RD+K N+L+D+
Sbjct: 133 R------------RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQ 177
Query: 442 FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
V DFG AK + R T + GT +APE + + ++ D + G+L+ E+
Sbjct: 178 GYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 502 GQ 503
G
Sbjct: 234 GY 235
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 24/114 (21%), Positives = 48/114 (42%), Gaps = 6/114 (5%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI-PDSLGDLGNLNYLRLN 154
+L L + + + L L+ L ++ N F PD +L NL +L L+
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS----GSLPKISA-RTFKVTGNPLIC 203
L P + + + SL +++++ N L G ++++ + + NP C
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 532
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 23/129 (17%), Positives = 42/129 (32%), Gaps = 4/129 (3%)
Query: 58 TSVDPCSWRMITCSPDG---YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPI 114
+ C PD L L L S + +LQ + L I
Sbjct: 10 ITYQ-CMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68
Query: 115 PASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTL 174
+ L L TL L+ N + L +L L +L + +++L
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 175 VDLSYNNLS 183
+++++N +
Sbjct: 129 LNVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 25/109 (22%), Positives = 46/109 (42%), Gaps = 6/109 (5%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPAS-LGKLEKLQTLDLSNNKFTGEIPDSLGDLGN 147
T+S L +L+ + Q++ + S L L LD+S+ L +
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 148 LNYLRLNNNSLTGS-CPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
L L++ NS + P+ +++ +LT +DLS L ++S F
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE----QLSPTAFN 491
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 24/108 (22%), Positives = 48/108 (44%), Gaps = 9/108 (8%)
Query: 93 WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT-GEIPDSLGDLGNLNYL 151
L+ LQ ++ + +G L+ L+ L++++N ++P+ +L NL +L
Sbjct: 95 AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154
Query: 152 RLNNNSLTGSCPESLSKIESLTLV----DLSYNNLSGSLPKISARTFK 195
L++N + L + + L+ DLS N ++ I FK
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN----FIQPGAFK 198
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 22/95 (23%), Positives = 37/95 (38%), Gaps = 1/95 (1%)
Query: 96 NLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
L+ L+ + + N+ +L L LDLS + P + L +L L +
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMA 502
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
+N L ++ SL + L N S P+I
Sbjct: 503 SNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 29/115 (25%), Positives = 48/115 (41%), Gaps = 6/115 (5%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAIL-GPIPASLGKLEKLQTLDLSNNKFTGE 137
L +L+ + IG+L L+ + + +N I +P L L+ LDLS+NK
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 138 IPDSLGDLGNLNY----LRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
L L + L L+ N + P + +I L + L N S ++ K
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMK 218
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 19/80 (23%), Positives = 30/80 (37%), Gaps = 1/80 (1%)
Query: 85 SLSGTLSPWI-GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
S P I L L + L + P + L LQ L++++N+
Sbjct: 456 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFD 515
Query: 144 DLGNLNYLRLNNNSLTGSCP 163
L +L + L+ N SCP
Sbjct: 516 RLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 27/93 (29%), Positives = 42/93 (45%), Gaps = 8/93 (8%)
Query: 97 LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN 156
Q + L N P KL+ L+ L ++NK S DL +L +L L+ N
Sbjct: 303 NFGWQHLELVNCKFGQ-FPT--LKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRN 357
Query: 157 SLT--GSCPESLSKIESLTLVDLSYNNLSGSLP 187
L+ G C +S SL +DLS+N + ++
Sbjct: 358 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMS 389
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 22/109 (20%), Positives = 37/109 (33%), Gaps = 12/109 (11%)
Query: 94 IGNLTKLQSVL----LQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD-SLGDLGNL 148
+ L ++ + L N + I K +L L L NN + + + L L
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGL 227
Query: 149 NYLRL------NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA 191
RL N +L +L + +LT+ + L L I
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 15/107 (14%), Positives = 32/107 (29%), Gaps = 5/107 (4%)
Query: 84 QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
+ + + NLT + L + L I L + + L + + D
Sbjct: 244 EKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSY 302
Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
+ +L L N L ++ L + N + ++
Sbjct: 303 NF-GWQHLELVNCKFGQFPTLKLKSLKRL---TFTSNKGGNAFSEVD 345
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 14/105 (13%), Positives = 30/105 (28%), Gaps = 10/105 (9%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDL------SNNKFTGEIPDS 141
+ P +L + L+NN + + L L+ L + +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 142 LGDLGNLNYLRLNNNSLTGSC---PESLSKIESLTLVDLSYNNLS 183
L L NL L + + + +++ L +
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 6e-16
Identities = 28/204 (13%), Positives = 55/204 (26%), Gaps = 44/204 (21%)
Query: 309 LGRGGFGIVYKGCFSDGAL---VAVKRLK-DYNIAGGEVQ-FQTEVETISLAVHRNLLRL 363
G ++ D AL VA+ + + +Q + +S + R+
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCD 423
T L+V ++ GS L++ P+ A R A H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGS----LQEVADTSPSPVGAIR--AMQSLAAAADAAHRA-- 148
Query: 424 PKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS 483
+ + + + D + V+ + +
Sbjct: 149 -GVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQ------------------------- 182
Query: 484 SEKTDVFGFGILLLELITGQRALD 507
D+ G G L L+ + L
Sbjct: 183 ---DDIRGIGASLYALLVNRWPLP 203
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-16
Identities = 17/97 (17%), Positives = 39/97 (40%), Gaps = 2/97 (2%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
I ++ + + N P + L L+ L + T + +L L +L L +
Sbjct: 62 IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
++++ S ++ + + +DLSYN + +
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLK 156
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-13
Identities = 18/91 (19%), Positives = 34/91 (37%), Gaps = 3/91 (3%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ LT L + + ++A I + L K+ ++DLS N +I L L L L +
Sbjct: 108 LSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNI 166
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
+ + + L + + G
Sbjct: 167 QFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-12
Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 8/97 (8%)
Query: 94 IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
+ L + L N + L + ++ L ++N T P + L NL L
Sbjct: 40 EAQMNSLTYITLANINVTDLTG----IEYAHNIKDLTINNIHATNYNP--ISGLSNLERL 93
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
R+ +T +LS + SLTL+D+S++ S+
Sbjct: 94 RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 9e-09
Identities = 14/93 (15%), Positives = 35/93 (37%), Gaps = 7/93 (7%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
+ LL ++ I + ++ L + L+N T ++ + N+ L +NN
Sbjct: 21 TFKAYLNGLLGQSST-ANI--TEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
T +S + +L + + +++
Sbjct: 76 IHATNY--NPISGLSNLERLRIMGKDVTSDKIP 106
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-16
Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 47/228 (20%)
Query: 301 SNFSAKNILGRGGFGIVY---KGCFSD-GALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
NF +LG G +G V+ K D G L A+K L K + + T E
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE----- 108
Query: 356 VHRNLLRLCG---------FCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
R +L + +L L+ Y+ G + + L +R+
Sbjct: 109 --RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS------------QRE 154
Query: 406 RIALGTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457
R + L +LH+ II+RD+K NILLD + V+ DFGL+K
Sbjct: 155 RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211
Query: 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV--FGFGILLLELITGQ 503
++ GT+ ++AP+ + G S V + G+L+ EL+TG
Sbjct: 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 25/206 (12%)
Query: 309 LGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQ-FQTEVETI-SLAVHRNLLRLC 364
LGRG F +V + C S G A K LK E+ + ++ L
Sbjct: 37 LGRGKFAVVRQ-CISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA-----LDWARRKRIALGTARGLLYLH 419
+E +L+ Y G + A D R + L G+ YLH
Sbjct: 96 EVYENTSEIILILEYAAGGE----IFSLCLPELAEMVSENDVIRLIKQILE---GVYYLH 148
Query: 420 EQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPE 476
+ I+H D+K NILL + + DFG+++ + H + + GT ++APE
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH-ACELREIM-GTPEYLAPE 203
Query: 477 YLSTGQSSEKTDVFGFGILLLELITG 502
L+ + TD++ GI+ L+T
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 8e-16
Identities = 56/224 (25%), Positives = 94/224 (41%), Gaps = 37/224 (16%)
Query: 297 RAATSNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVET 351
+A S F +LG+G FG V+ L A+K L K V+ + E +
Sbjct: 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 352 ISLAVHRNLLRLCGFCS--TENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
+ H +++L + TE +L L+ ++ G L + +
Sbjct: 80 LVEVNHPFIVKL--HYAFQTE-GKLYLILDFLRGGD----LFTRLS--------KEVMFT 124
Query: 409 LGTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460
+ L +LH II+RD+K NILLDE+ + DFGL+K
Sbjct: 125 EEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHE 180
Query: 461 HVTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
+ GTV ++APE + + ++ D + FG+L+ E++TG
Sbjct: 181 KKAYSFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKR-LKDYNIAGGEVQFQTEVETISLAVHR 358
++ ++G G FG+V++ + VA+K+ L+D E+Q V+ H
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVK------HP 92
Query: 359 NLLRLCGFCSTENERL------LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTA 412
N++ L F + ++ LV Y+P +V R + + + K
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV-VGDFGLAKLLDHRDSHVTTAV----R 467
R L Y+H I HRD+K N+LLD + + DFG AK+L + +V+ R
Sbjct: 152 RSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR 208
Query: 468 GTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
APE + + + D++ G ++ EL+ GQ
Sbjct: 209 ------APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 1e-15
Identities = 71/247 (28%), Positives = 102/247 (41%), Gaps = 24/247 (9%)
Query: 267 HNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIV----YKGCF 322
+I + + R ++F+ +LG+G FG V KG
Sbjct: 307 ERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG-- 364
Query: 323 SDGALVAVKRL-KDYNIAGGEVQFQTEVETISLAVHRN---LLRLCGFCSTENERL-LVY 377
L AVK L KD I +V+ T VE LA+ L +L C +RL V
Sbjct: 365 -TDELYAVKILKKDVVIQDDDVE-CTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVM 421
Query: 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANIL 437
Y+ G L HI A A GL +L + II+RD+K N++
Sbjct: 422 EYVNGGD----LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVM 474
Query: 438 LDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILL 496
LD + + DFG+ K + D T GT +IAPE + Q K+ D + FG+LL
Sbjct: 475 LDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLL 532
Query: 497 LELITGQ 503
E++ GQ
Sbjct: 533 YEMLAGQ 539
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 24/213 (11%)
Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
+ F +LG+G FG V K G A+K L K+ +A EV T E L
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVA-HTLTENRVLQ 203
Query: 356 VHRN--LLRLCGFCS--TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
R+ L L S T + V Y G L H+ R +
Sbjct: 204 NSRHPFLTAL--KYSFQTHDRLCFVMEYANGGE----LFFHLSRERVFSEDRARFYGAEI 257
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
L YLH + + +++RD+K N++LD+D + DFGL K +D GT
Sbjct: 258 VSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPE 314
Query: 472 HIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
++APE L + D +G G+++ E++ G+
Sbjct: 315 YLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 48/202 (23%), Positives = 79/202 (39%), Gaps = 26/202 (12%)
Query: 306 KNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
+LG G G V + F A+K L+D A EV+ + +++R+
Sbjct: 67 SQVLGLGINGKVLQ-IFNKRTQEKFALKMLQDCPKARREVELHWR-----ASQCPHIVRI 120
Query: 364 CGFC----STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK--RIALGTARGLLY 417
+ L+V + G L I R + R+ I + Y
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 418 LHEQCDPKIIHRDVKAANILL-DEDFEAVV--GDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
LH I HRDVK N+L + A++ DFG AK + +TT T ++A
Sbjct: 177 LHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS-HNSLTTPC-YTPYYVA 231
Query: 475 PEYLSTGQSSEKTDVFGFGILL 496
PE L + + D++ G+++
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIM 253
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 3e-15
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 36/217 (16%)
Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQ-FQTEVETISL 354
+F LG G FG V+ + +G A+K L K+ + +V+ E +S+
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR- 413
H ++R+ G + ++ Y+ G + S LR + +R A+
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR------------KSQRFPNPVAKF 110
Query: 414 -------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV 466
L YLH + II+RD+K NILLD++ + DFG AK + T +
Sbjct: 111 YAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTL 163
Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
GT +IAPE +ST ++ D + FGIL+ E++ G
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 58/219 (26%), Positives = 86/219 (39%), Gaps = 38/219 (17%)
Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQT 347
+ + LGRG IVY+ A+K LK + +T
Sbjct: 53 DFFEVES------------ELGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVRT 97
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL---DWARR 404
E+ + H N+++L T E LV + G L D I + D A
Sbjct: 98 EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE----LFDRIVEKGYYSERDAADA 153
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSH 461
+ L + YLHE I+HRD+K N+L D + DFGL+K+++H
Sbjct: 154 VKQILE---AVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-QVL 206
Query: 462 VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFG----ILL 496
+ T GT G+ APE L + D++ G ILL
Sbjct: 207 MKTVC-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILL 244
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 4/96 (4%)
Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTA 465
+ A+G+ +L + K IHRD+ A NILL E + DFGLA+ + +V
Sbjct: 198 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT 501
R + +APE + + ++DV+ FG+LL E+ +
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 55/236 (23%), Positives = 91/236 (38%), Gaps = 60/236 (25%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVK-------------------------RLKDYNIAGGE 342
+G+G +G+V +D A+K G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 343 VQFQTEVETISLAVHRNLLRLCGF----CSTENERLLVYPYMPNGSVASRLRDHIHGRPA 398
Q E+ + H N+++L E+ +V+ + G V
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV------------- 125
Query: 399 LDWARRKRIALGTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450
++ K ++ AR G+ YLH Q KIIHRD+K +N+L+ ED + DFG
Sbjct: 126 MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGQ 503
++ D+ ++ V GT +APE LS + S + DV+ G+ L + GQ
Sbjct: 183 VSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 45/212 (21%), Positives = 82/212 (38%), Gaps = 25/212 (11%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAV 356
+ LGRG FGIV++ C S K +K + G + + E+ +++A
Sbjct: 4 YEKYMIAEDLGRGEFGIVHR-CVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIAR 59
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA----LDWARRKRIALGTA 412
HRN+L L + E ++++ ++ + + I+ +
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCE-- 113
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILL--DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
L +LH I H D++ NI+ + +FG A+ L D+
Sbjct: 114 -ALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-TAP 167
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
+ APE S TD++ G L+ L++G
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 33/224 (14%)
Query: 299 ATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQF-QTEVETISL-- 354
ATS + +G G +G VYK G VA+K ++ N GG + V ++L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 355 ----AVHRNLLRLCGFCSTENERL-----LVYPYMPNGSVASRLRDHI--HGRPALDWAR 403
H N++RL C+T LV+ ++ LR ++ P L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-----QDLRTYLDKAPPPGLPAET 121
Query: 404 RKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL--LDHRDSH 461
K + RGL +LH I+HRD+K NIL+ + DFGLA++ +
Sbjct: 122 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
Query: 462 --VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
VT R APE L + D++ G + E+ +
Sbjct: 179 VVVTLWYR------APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 68/223 (30%), Positives = 97/223 (43%), Gaps = 44/223 (19%)
Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
NF +LG+G FG V K G L AVK L KD + +V+ T E L+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVE-CTMTEKRILS 78
Query: 356 VHRN---LLRLCGFCS--TENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
+ RN L +L FC T +RL V ++ G L HI + +R
Sbjct: 79 LARNHPFLTQL--FCCFQTP-DRLFFVMEFVNGGD----LMFHIQ--------KSRRFDE 123
Query: 410 GTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
AR L++LH++ II+RD+K N+LLD + + DFG+ K +
Sbjct: 124 ARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGV 179
Query: 462 VTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
T GT +IAPE L D + G+LL E++ G
Sbjct: 180 TTATFCGTPDYIAPEIL-QEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 68/223 (30%), Positives = 98/223 (43%), Gaps = 44/223 (19%)
Query: 301 SNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
+F +LG+G FG V +K A+K L KD + +V+ T VE L+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVE-CTMVEKRVLS 72
Query: 356 VHRN---LLRLCGFCS--TENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
+ L + FC+ T+ E L V Y+ G L HI + L
Sbjct: 73 LAWEHPFLTHM--FCTFQTK-ENLFFVMEYLNGGD----LMYHIQ--------SCHKFDL 117
Query: 410 GTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
A GL +LH + I++RD+K NILLD+D + DFG+ K +
Sbjct: 118 SRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDA 173
Query: 462 VTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
T GT +IAPE L GQ + D + FG+LL E++ GQ
Sbjct: 174 KTNTFCGTPDYIAPEIL-LGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 17/90 (18%), Positives = 36/90 (40%), Gaps = 2/90 (2%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
N + + + ++++ + + ++ LDLS N + L L L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
++N L L + +L +DL+ N +
Sbjct: 66 SSNVLYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 7e-14
Identities = 29/117 (24%), Positives = 47/117 (40%), Gaps = 11/117 (9%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
+ SL L+ + ++ + L N + A L KL+ L+LS+N E
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ET 73
Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
D L L L L LNNN + L S+ + + NN+S ++S +
Sbjct: 74 LD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS----RVSCSRGQ 120
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 19/124 (15%), Positives = 41/124 (33%), Gaps = 9/124 (7%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
KL+++ L +N + + + + L NNK I +L NL + L
Sbjct: 189 VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRG 246
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVF 215
N ++ + ++ ++ K++ + + P + C
Sbjct: 247 NGFHCGTLRDF-FSKNQRVQTVAKQ----TVKKLTGQNEEECTVPTL--GHYGAYCCEDL 299
Query: 216 PEPL 219
P P
Sbjct: 300 PAPF 303
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 18/90 (20%), Positives = 35/90 (38%), Gaps = 8/90 (8%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ +L+ L+++ L NN + L ++TL +NN + + S + L
Sbjct: 76 LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYL 127
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
NN +T + +DL N +
Sbjct: 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 19/96 (19%), Positives = 39/96 (40%), Gaps = 5/96 (5%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ ++++ NN I + S + + + L+NNK T G + YL L
Sbjct: 95 LLVGPSIETLHAANNNI-SRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 154 NNNSLTG-SCPESLSKIESLTLVDLSYNNLSGSLPK 188
N + + E + ++L ++L YN + +
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG 186
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 13/149 (8%), Positives = 40/149 (26%), Gaps = 10/149 (6%)
Query: 52 LENWDITSVDPCSWRMITCSPDGYVSALGLPSQS---LSGTLSPWIGNLTKLQSVLLQNN 108
+N + +V + + +T + + L +P+ L L+
Sbjct: 259 SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALL 318
Query: 109 AI----LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCP- 163
+ + + + +D ++ I L +L
Sbjct: 319 SGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSN 378
Query: 164 --ESLSKIESLTLVDLSYNNLSGSLPKIS 190
+ ++++ + L + + S
Sbjct: 379 GRRAHAELDGTLQQAVGQIELQHATEEQS 407
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 7/126 (5%), Positives = 25/126 (19%), Gaps = 6/126 (4%)
Query: 81 LPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL-----QTLDLSNNKFT 135
+ Q++ T +L L L ++
Sbjct: 267 VAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE 326
Query: 136 GEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
+ + + + + ++ ++ L + +
Sbjct: 327 -RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAE 385
Query: 196 VTGNPL 201
+ G
Sbjct: 386 LDGTLQ 391
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 12/58 (20%), Positives = 22/58 (37%), Gaps = 4/58 (6%)
Query: 138 IPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
I + + ++ ++SL + ++ +DLS N LS ISA
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ----ISAADLA 55
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ NLT L+ + + +N + L KL L++L +NN+ + P LG L NL+ L L
Sbjct: 173 LANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSL 228
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
N N L +L+ + +LT +DL+ N +S P
Sbjct: 229 NGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 260
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 24/99 (24%), Positives = 42/99 (42%), Gaps = 7/99 (7%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
+SP + LT L ++ L N + P + L+ L L L N + P + L L
Sbjct: 279 NISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKL 333
Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
L NN ++ SL+ + ++ + +N +S P
Sbjct: 334 QRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 28/94 (29%), Positives = 43/94 (45%), Gaps = 6/94 (6%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+G LT L + L N + L L L LDL+NN+ + P L L L L+L
Sbjct: 217 LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 272
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
N ++ L+ + +LT ++L+ N L P
Sbjct: 273 GANQISNI--SPLAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 33/94 (35%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ NLTKL +L+ NN I P L L L L L NN+ T P L +L NLN L L
Sbjct: 86 LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLEL 141
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
++N+++ +LS + SL + N ++ P
Sbjct: 142 SSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP 172
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 21/99 (21%), Positives = 43/99 (43%), Gaps = 5/99 (5%)
Query: 92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
+ NLT + + +N I P L L ++ L L++ +T + ++ N +
Sbjct: 347 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTV 404
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
+ +L P ++S S T D+++N S ++S
Sbjct: 405 KNVTGALI--APATISDGGSYTEPDITWNLPS-YTNEVS 440
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 27/91 (29%), Positives = 41/91 (45%), Gaps = 7/91 (7%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ NLT L + L NN I P L L L L+LS+N + +L L +L L
Sbjct: 108 LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF 163
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
N + L+ + +L +D+S N +S
Sbjct: 164 GNQVTD---LKPLANLTTLERLDISSNKVSD 191
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 23/106 (21%), Positives = 46/106 (43%), Gaps = 8/106 (7%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L +++ T+S +L ++ ++ I + L L ++ SNN+ T
Sbjct: 29 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDIT 84
Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
P L +L L + +NNN + L+ + +LT + L N ++
Sbjct: 85 P--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD 126
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 16/91 (17%), Positives = 32/91 (35%), Gaps = 6/91 (6%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
L + +L + + L+++ TL D + L NL +
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINF 75
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
+NN LT L + L + ++ N ++
Sbjct: 76 SNNQLTDI--TPLKNLTKLVDILMNNNQIAD 104
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 13/83 (15%), Positives = 29/83 (34%), Gaps = 6/83 (7%)
Query: 102 SVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGS 161
+ + Q+ I L + L T + DL + L+ + +
Sbjct: 6 ATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS- 60
Query: 162 CPESLSKIESLTLVDLSYNNLSG 184
+ + + +LT ++ S N L+
Sbjct: 61 -IDGVEYLNNLTQINFSNNQLTD 82
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 8e-15
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVK-----RLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG V G G VAVK +++ ++ G + + E++ + L H ++++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVG---KIKREIQNLKLFRHPHIIK 75
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRK--RIALGTARGLLYL 418
L ST + +V Y+ G L D+I HGR ARR +I Y
Sbjct: 76 LYQVISTPTDFFMVMEYVSGG----ELFDYICKHGRVEEMEARRLFQQILSAVD----YC 127
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
H ++HRD+K N+LLD A + DFGL+ ++ + T+ G+ + APE +
Sbjct: 128 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC-GSPNYAAPEVI 182
Query: 479 S-TGQSSEKTDVFGFGILLLELITG 502
S + + D++ G++L L+ G
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCG 207
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 18/94 (19%), Positives = 37/94 (39%), Gaps = 3/94 (3%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
N + + + ++++ + + ++ LDLS N + L L L L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
++N L L + +L +DL+ N + L
Sbjct: 66 SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL 96
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 29/117 (24%), Positives = 47/117 (40%), Gaps = 11/117 (9%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
+ SL L+ + ++ + L N + A L KL+ L+LS+N E
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ET 73
Query: 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
D L L L L LNNN + L S+ + + NN+S ++S +
Sbjct: 74 LD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS----RVSCSRGQ 120
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 19/133 (14%), Positives = 39/133 (29%), Gaps = 10/133 (7%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
+ + KL+++ L +N + + + + L NNK I +L NL
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239
Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKAT 208
+ L N ++ + ++ + L + V
Sbjct: 240 EHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHY-----G 292
Query: 209 NNCTAVFPEPLSL 221
C P P +
Sbjct: 293 AYCCEDLPAPFAD 305
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 19/96 (19%), Positives = 39/96 (40%), Gaps = 5/96 (5%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ ++++ NN I + S + + + L+NNK T G + YL L
Sbjct: 95 LLVGPSIETLHAANNNI-SRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 154 NNNSLTG-SCPESLSKIESLTLVDLSYNNLSGSLPK 188
N + + E + ++L ++L YN + +
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG 186
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 19/90 (21%), Positives = 36/90 (40%), Gaps = 8/90 (8%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ +L+ L+++ L NN + L ++TL +NN + + S G + L
Sbjct: 76 LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRGQ--GKKNIYL 127
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
NN +T + +DL N +
Sbjct: 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 12/58 (20%), Positives = 23/58 (39%), Gaps = 4/58 (6%)
Query: 138 IPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
I + + ++ ++SL + ++ +DLS N LS +ISA
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS----QISAADLA 55
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 9e-15
Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 36/218 (16%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG-------EVQFQTEVETIS 353
+ +G G +G+VYK S G +VA+KR++ G E+ E+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH--- 77
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA-LDWARRKRIALGTA 412
H N++ L +E LV+ +M L+ + L ++ K
Sbjct: 78 ---HPNIVSLIDVIHSERCLTLVFEFME-----KDLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-----R 467
RG+ + H+ +I+HRD+K N+L++ D + DFGLA+ T V R
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR 186
Query: 468 GTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
AP+ L S S+ D++ G + E+ITG+
Sbjct: 187 ------APDVLMGSKKYSTS-VDIWSIGCIFAEMITGK 217
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 39/222 (17%)
Query: 301 SNFSAKNILGRGGFGIVY---KGCFSD-GALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
F +LG+GG+G V+ K ++ G + A+K L K + + T+ E L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 356 VHRN--LLRLCGFCS--TENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
++ ++ L + T +L L+ Y+ G L + R
Sbjct: 77 EVKHPFIVDL--IYAFQTG-GKLYLILEYLSGGE----LFMQLE--------REGIFMED 121
Query: 411 TAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462
TA L +LH++ II+RD+K NI+L+ + DFGL K D V
Sbjct: 122 TACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTV 177
Query: 463 TTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
T GT+ ++APE L + D + G L+ +++TG
Sbjct: 178 THTFCGTIEYMAPEIL-MRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 60/221 (27%), Positives = 91/221 (41%), Gaps = 41/221 (18%)
Query: 301 SNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
++F +LG+G FG V K G A+K L K+ IA EV T E+ L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVA-HTVTESRVLQ 60
Query: 356 VHRN--LLRLCGFCS--TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
R+ L L + T + V Y G L H+ R +
Sbjct: 61 NTRHPFLTAL--KYAFQTHDRLCFVMEYANGGE----LFFHLS--------RERVFTEER 106
Query: 412 AR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463
AR L YLH + +++RD+K N++LD+D + DFGL K D
Sbjct: 107 ARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATM 162
Query: 464 TAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
GT ++APE L + D +G G+++ E++ G+
Sbjct: 163 KTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 58/257 (22%), Positives = 99/257 (38%), Gaps = 44/257 (17%)
Query: 267 HNQQIFFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVY----KGCF 322
N + + E + + +F ++GRG + V K
Sbjct: 18 ENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKK-- 75
Query: 323 SDGALVAVKRL-KDYNIAGGEVQFQTEVETISLAVHRN---LLRLCGFCS--TENERL-L 375
+ A++ + K+ ++ + E N L+ L TE RL
Sbjct: 76 -TDRIYAMRVVKKELVNDDEDID-WVQTEKHVFEQASNHPFLVGL--HSCFQTE-SRLFF 130
Query: 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR--------GLLYLHEQCDPKII 427
V Y+ G L H+ R++++ AR L YLHE+ II
Sbjct: 131 VIEYVNGGD----LMFHMQ--------RQRKLPEEHARFYSAEISLALNYLHER---GII 175
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKT 487
+RD+K N+LLD + + D+G+ K R T+ GT +IAPE L G+ +
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEIL-RGEDYGFS 233
Query: 488 -DVFGFGILLLELITGQ 503
D + G+L+ E++ G+
Sbjct: 234 VDWWALGVLMFEMMAGR 250
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 62/223 (27%), Positives = 91/223 (40%), Gaps = 44/223 (19%)
Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
S+F ++G+G FG V K + AVK L K + E + E L
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEK-HIMSERNVLL 93
Query: 356 VHRN---LLRLCGFCS--TENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
+ L+ L S T ++L V Y+ G L H+ R +
Sbjct: 94 KNVKHPFLVGL--HFSFQTA-DKLYFVLDYINGGE----LFYHLQ--------RERCFLE 138
Query: 410 GTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
AR L YLH I++RD+K NILLD V+ DFGL K + +
Sbjct: 139 PRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNS 194
Query: 462 VTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
T+ GT ++APE L Q ++T D + G +L E++ G
Sbjct: 195 TTSTFCGTPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 69/221 (31%), Positives = 98/221 (44%), Gaps = 40/221 (18%)
Query: 301 SNFSAKNILGRGGFGIV----YKGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
++F+ +LG+G FG V KG L AVK L KD I +V+ T VE LA
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVE-CTMVEKRVLA 75
Query: 356 VHRN---LLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
+ L +L C +RL V Y+ G L HI + R
Sbjct: 76 LPGKPPFLTQL-HSCFQTMDRLYFVMEYVNGGD----LMYHIQ--------QVGRFKEPH 122
Query: 412 AR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463
A GL +L + II+RD+K N++LD + + DFG+ K + D T
Sbjct: 123 AVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTT 178
Query: 464 TAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
GT +IAPE + Q K+ D + FG+LL E++ GQ
Sbjct: 179 KTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 49/227 (21%), Positives = 84/227 (37%), Gaps = 49/227 (21%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVE----T---- 351
+ LG G +G VYK VA+KR++ + E E T
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR----------LEHEEEGVPGTAIRE 83
Query: 352 ISL---AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIA 408
+SL HRN++ L + L++ Y + L+ ++ P + K
Sbjct: 84 VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-----NDLKKYMDKNPDVSMRVIKSFL 138
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG-----DFGLAKLL---DHRDS 460
G+ + H + + +HRD+K N+LL + DFGLA+ + +
Sbjct: 139 YQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195
Query: 461 H--VTTAVRGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
H +T R PE L S S+ D++ + E++
Sbjct: 196 HEIITLWYR------PPEILLGSRHYSTS-VDIWSIACIWAEMLMKT 235
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 301 SNFSAKNILGRGGFGIVY----KGCFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLA 355
+F ++GRG + V K + A+K + K+ ++ + E
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDID-WVQTEKHVFE 64
Query: 356 VHRN---LLRLCGFCS--TENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
N L+ L TE RL V Y+ G L H+ R++++
Sbjct: 65 QASNHPFLVGL--HSCFQTE-SRLFFVIEYVNGGD----LMFHMQ--------RQRKLPE 109
Query: 410 GTAR--------GLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH 461
AR L YLHE+ II+RD+K N+LLD + + D+G+ K R
Sbjct: 110 EHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGD 165
Query: 462 VTTAVRGTVGHIAPEYLSTGQSSEKT-DVFGFGILLLELITGQ 503
T+ GT +IAPE L G+ + D + G+L+ E++ G+
Sbjct: 166 TTSTFCGTPNYIAPEIL-RGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 295 ELRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQF-QTEVETI 352
++++ + + LG G F VYK + +VA+K++K + + + +T + I
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 353 SL---AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIA 408
L H N++ L ++ LV+ +M + L I L + K
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFME-----TDLEVIIKDNSLVLTPSHIKAYM 118
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453
L T +GL YLH+ I+HRD+K N+LLDE+ + DFGLAK
Sbjct: 119 LMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 22/116 (18%), Positives = 47/116 (40%), Gaps = 8/116 (6%)
Query: 92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
W+ N L V L N + + K+++L+ L +SNN+ + + L L
Sbjct: 242 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS----GSLPKISARTFKVTGNPLIC 203
L++N L + + + L + L +N++ + + + ++ N C
Sbjct: 301 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTL--KNLTLSHNDWDC 353
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 20/118 (16%), Positives = 44/118 (37%), Gaps = 6/118 (5%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
+ + Q+ L + V +N+ + A L +++ L+L++ + EI
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EI 84
Query: 139 P-DSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
+ + L + N++ P + LT++ L N+LS + F
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS----SLPRGIFH 138
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 20/101 (19%), Positives = 36/101 (35%), Gaps = 4/101 (3%)
Query: 95 GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
+ +++ + L + I + +Q L + N P ++ L L L
Sbjct: 66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
N L+ LT + +S NNL +I TF+
Sbjct: 126 RNDLSSLPRGIFHNTPKLTTLSMSNNNLE----RIEDDTFQ 162
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 22/94 (23%), Positives = 40/94 (42%), Gaps = 4/94 (4%)
Query: 95 GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
+L + LQ+N + L L +DLS N+ + + L L ++
Sbjct: 223 PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 280
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
NN L + I +L ++DLS+N+L + +
Sbjct: 281 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVER 312
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 21/89 (23%), Positives = 44/89 (49%), Gaps = 8/89 (8%)
Query: 95 GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
N KL ++ + NN + + LQ L LS+N+ T + SL + +L + ++
Sbjct: 138 HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVS 194
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS 183
N L+ +L+ ++ +D S+N+++
Sbjct: 195 YNLLS-----TLAIPIAVEELDASHNSIN 218
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 30/106 (28%), Positives = 46/106 (43%), Gaps = 3/106 (2%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
N+ L ++L+ N + KL TL +SNN D+ +L L+L++
Sbjct: 115 NVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSS 174
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPL 201
N LT LS I SL ++SYN LS I+ + N +
Sbjct: 175 NRLTHV---DLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSI 217
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 16/90 (17%), Positives = 37/90 (41%), Gaps = 5/90 (5%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
L+ + + L+ + L +N +L + + + ++L+ L L +N + L L
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTL 341
Query: 149 NYLRLNNNSLTGSCPESL-SKIESLTLVDL 177
L L++N + +L + + D
Sbjct: 342 KNLTLSHNDWDCNSLRALFRNVARPAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 9/100 (9%), Positives = 26/100 (26%), Gaps = 4/100 (4%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
V + L + + N+ L + L LN+
Sbjct: 19 YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 78
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
+ + + ++ + + +N + + F+
Sbjct: 79 LQIEEIDTYAFAYAHTIQKLYMGFNAIR----YLPPHVFQ 114
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 11/88 (12%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
T LQ++ L +N + + SL + L ++S N + +L + L ++
Sbjct: 163 ATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASH 214
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS 183
NS+ ++ L L +NNL+
Sbjct: 215 NSINVVRGPVNVELTIL---KLQHNNLT 239
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 10/82 (12%), Positives = 24/82 (29%), Gaps = 4/82 (4%)
Query: 114 IPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLT 173
I ++L + + L N + N+++ L +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 174 LVDLSYNNLSGSLPKISARTFK 195
L++L+ + +I F
Sbjct: 73 LLNLNDLQIE----EIDTYAFA 90
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 4e-14
Identities = 47/225 (20%), Positives = 87/225 (38%), Gaps = 45/225 (20%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVE----T----I 352
+ +G G +G V+K +VA+KR++ + E + I
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR----------LDDDDEGVPSSALREI 52
Query: 353 SL---AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA-LDWARRKRIA 408
L H+N++RL ++ + LV+ + L+ + LD K
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-----QDLKKYFDSCNGDLDPEIVKSFL 107
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-- 466
+GL + H + ++HRD+K N+L++ + E + +FGLA+ + V
Sbjct: 108 FQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVT 164
Query: 467 ---RGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQRAL 506
R P+ L + S+ D++ G + EL R L
Sbjct: 165 LWYR------PPDVLFGAKLYSTS-IDMWSAGCIFAELANAGRPL 202
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 5e-14
Identities = 22/116 (18%), Positives = 47/116 (40%), Gaps = 8/116 (6%)
Query: 92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
W+ N L V L N + + K+++L+ L +SNN+ + + L L
Sbjct: 248 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 306
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS----GSLPKISARTFKVTGNPLIC 203
L++N L + + + L + L +N++ + + + ++ N C
Sbjct: 307 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTL--KNLTLSHNDWDC 359
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 21/126 (16%), Positives = 45/126 (35%), Gaps = 6/126 (4%)
Query: 70 CSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL 129
D + + Q+ L + V +N+ + A L +++ L+L
Sbjct: 23 LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNL 82
Query: 130 SNNKFTGEIP-DSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
++ + EI + + L + N++ P + LT++ L N+LS
Sbjct: 83 NDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS----S 137
Query: 189 ISARTF 194
+ F
Sbjct: 138 LPRGIF 143
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 20/101 (19%), Positives = 36/101 (35%), Gaps = 4/101 (3%)
Query: 95 GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
+ +++ + L + I + +Q L + N P ++ L L L
Sbjct: 72 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
N L+ LT + +S NNL +I TF+
Sbjct: 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLE----RIEDDTFQ 168
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 22/94 (23%), Positives = 40/94 (42%), Gaps = 4/94 (4%)
Query: 95 GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
+L + LQ+N + L L +DLS N+ + + L L ++
Sbjct: 229 PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 286
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
NN L + I +L ++DLS+N+L + +
Sbjct: 287 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVER 318
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 31/107 (28%), Positives = 46/107 (42%), Gaps = 5/107 (4%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDS-LGDLGNLNYLRLN 154
N+ L ++L+ N + KL TL +SNN I D +L L+L+
Sbjct: 121 NVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS 179
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPL 201
+N LT SL I SL ++SYN LS I+ + N +
Sbjct: 180 SNRLT-HVDLSL--IPSLFHANVSYNLLSTLAIPIAVEELDASHNSI 223
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 16/93 (17%), Positives = 38/93 (40%), Gaps = 5/93 (5%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
L+ + + L+ + L +N +L + + + ++L+ L L +N + L L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTL 347
Query: 149 NYLRLNNNSLTGSCPESL-SKIESLTLVDLSYN 180
L L++N + +L + + D +
Sbjct: 348 KNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 11/88 (12%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
T LQ++ L +N + + SL + L ++S N + +L + L ++
Sbjct: 169 ATTSLQNLQLSSNRLTH-VDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASH 220
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS 183
NS+ ++ L L +NNL+
Sbjct: 221 NSINVVRGPVNVELTIL---KLQHNNLT 245
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 9/100 (9%), Positives = 26/100 (26%), Gaps = 4/100 (4%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
V + L + + N+ L + L LN+
Sbjct: 25 YDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLND 84
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
+ + + ++ + + +N + + F+
Sbjct: 85 LQIEEIDTYAFAYAHTIQKLYMGFNAIR----YLPPHVFQ 120
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 302 NFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISL---AVH 357
+ + LG G + VYKG LVA+K ++ + G T + +SL H
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC---TAIREVSLLKDLKH 59
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA-LDWARRKRIALGTARGLL 416
N++ L TE LV+ Y+ L+ ++ ++ K RGL
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLD-----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-----RGTVG 471
Y H Q K++HRD+K N+L++E E + DFGLA+ V R
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR---- 167
Query: 472 HIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
P+ L ST S++ D++G G + E+ TG+
Sbjct: 168 --PPDILLGSTDYSTQ-IDMWGVGCIFYEMATGR 198
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVK-----RLKDYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG V G G VAVK +++ ++ G + + E++ + L H ++++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVG---KIRREIQNLKLFRHPHIIK 80
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRK--RIALGTARGLLYL 418
L ST ++ +V Y+ G L D+I +GR +RR +I G Y
Sbjct: 81 LYQVISTPSDIFMVMEYVSGG----ELFDYICKNGRLDEKESRRLFQQILSGVD----YC 132
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
H ++HRD+K N+LLD A + DFGL+ ++ + T+ G+ + APE +
Sbjct: 133 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC-GSPNYAAPEVI 187
Query: 479 S-TGQSSEKTDVFGFGILLLELITG 502
S + + D++ G++L L+ G
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCG 212
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-14
Identities = 30/115 (26%), Positives = 51/115 (44%), Gaps = 9/115 (7%)
Query: 96 NLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
L LQ + LQ+NA+ +P + L L L L N+ + + L +L+ L L+
Sbjct: 127 GLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK------ISARTFKVTGNPLIC 203
N + P + + L + L NNLS +LP + + ++ NP +C
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVC 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 26/102 (25%), Positives = 43/102 (42%), Gaps = 7/102 (6%)
Query: 96 NLTKLQSVLLQNNAILGPIPAS-LGKLEKLQTLDLSNNKFTGEIP-DSLGDLGNLNYLRL 153
L L+ + L +NA L + + L +L TL L E+ L L YL L
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYL 136
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
+N+L ++ + +LT + L N +S + R F+
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRIS----SVPERAFR 174
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 24/100 (24%), Positives = 38/100 (38%), Gaps = 5/100 (5%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP-DSLGDLGNLNYLRLN 154
L + L +N + A+ L L+ LDLS+N + + LG L+ L L+
Sbjct: 54 ACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
L P + +L + L N L + TF
Sbjct: 114 RCGLQELGPGLFRGLAALQYLYLQDNALQ----ALPDDTF 149
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 21/98 (21%), Positives = 32/98 (32%), Gaps = 5/98 (5%)
Query: 98 TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNS 157
Q + L N I AS L L L +N + L L L L++N+
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 158 -LTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
L P + + L + L L ++ F
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ----ELGPGLF 125
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 22/67 (32%), Positives = 30/67 (44%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L L +LL N + P + L +L TL L N + ++L L L YLRLN+
Sbjct: 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND 234
Query: 156 NSLTGSC 162
N C
Sbjct: 235 NPWVCDC 241
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 19/81 (23%), Positives = 31/81 (38%), Gaps = 5/81 (6%)
Query: 114 IPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLT 173
+P + Q + L N+ + S NL L L++N L + + + L
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 174 LVDLSYNNLSGSLPKISARTF 194
+DLS N L + TF
Sbjct: 84 QLDLSDNAQ---LRSVDPATF 101
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 25/207 (12%)
Query: 307 NILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQT--EVETISLAVHRNLLRL 363
++G G +G+V K G +VA+K+ + + V+ E++ + H NL+ L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKM-VKKIAMREIKLLKQLRHENLVNL 89
Query: 364 CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIALGTARGLLYLHEQC 422
C + LV+ ++ + D + P LD+ ++ G+ + H
Sbjct: 90 LEVCKKKKRWYLVFEFVD-----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH- 143
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-----RGTVGHIAPEY 477
IIHRD+K NIL+ + + DFG A+ L V R APE
Sbjct: 144 --NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR------APEL 195
Query: 478 L-STGQSSEKTDVFGFGILLLELITGQ 503
L + + DV+ G L+ E+ G+
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 50/230 (21%), Positives = 89/230 (38%), Gaps = 51/230 (22%)
Query: 301 SNFSAKNILGRGGFGIVYKG--CFSDGALVAVKRLKDYNIAGGEVQFQTEVE----T--- 351
+ +G G +G V+K + G VA+KR++ QT E +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR----------VQTGEEGMPLSTIR 60
Query: 352 -ISL------AVHRNLLRLCGFCSTENERL-----LVYPYMPNGSVASRLRDHI--HGRP 397
+++ H N++RL C+ LV+ ++ L ++ P
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-----QDLTTYLDKVPEP 115
Query: 398 ALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL--L 455
+ K + RGL +LH +++HRD+K NIL+ + + DFGLA++
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172
Query: 456 DHRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
+ VT R APE L + D++ G + E+ +
Sbjct: 173 QMALTSVVVTLWYR------APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 1e-13
Identities = 50/221 (22%), Positives = 93/221 (42%), Gaps = 44/221 (19%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVE----T----IS 353
+ +G G +G+VYK + G A+K+++ + E E T IS
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR----------LEKEDEGIPSTTIREIS 52
Query: 354 L---AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPA-LDWARRKRIAL 409
+ H N+++L T+ +LV+ ++ L+ + L+ K L
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-----QDLKKLLDVCEGGLESVTAKSFLL 107
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV--- 466
G+ Y H++ +++HRD+K N+L++ + E + DFGLA+ T +
Sbjct: 108 QLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL 164
Query: 467 --RGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
R AP+ L S S+ D++ G + E++ G
Sbjct: 165 WYR------APDVLMGSKKYSTT-IDIWSVGCIFAEMVNGT 198
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 29/115 (25%), Positives = 48/115 (41%), Gaps = 11/115 (9%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L L+ + L I +P L L L+ L++S N F P S L +L L + N
Sbjct: 194 GLFNLKYLNLGMCNIKD-MPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS-------GSLPKISARTFKVTGNPLIC 203
+ ++ + + SL ++L++NNLS L + + NP C
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYL--VELHLHHNPWNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 21/98 (21%), Positives = 34/98 (34%), Gaps = 4/98 (4%)
Query: 98 TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNS 157
+ + + L N I + L L+ L L N + L +LN L L +N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 158 LTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
LT + + L + L N + I + F
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRNNPIE----SIPSYAFN 168
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 24/101 (23%), Positives = 43/101 (42%), Gaps = 7/101 (6%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN-NKFTGEIPDSLGDLGNLNYLRLN 154
L+KL+ + L+NN I + ++ L LDL K + L NL YL L
Sbjct: 145 YLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
++ +L+ + L +++S N+ +I +F
Sbjct: 205 MCNIKD--MPNLTPLVGLEELEMSGNHFP----EIRPGSFH 239
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 19/91 (20%), Positives = 39/91 (42%)
Query: 92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
P + L L+ + + N P S L L+ L + N++ + ++ L +L L
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNL 182
L +N+L+ + + + L + L +N
Sbjct: 272 NLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 19/97 (19%), Positives = 38/97 (39%), Gaps = 7/97 (7%)
Query: 99 KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSL 158
+ V+ + +P + + L+L N D+ L +L L+L NS+
Sbjct: 55 QFSKVVCTRRGLSE-VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 159 TGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
+ + + SL ++L N L+ I + F+
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT----VIPSGAFE 144
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 15/67 (22%), Positives = 28/67 (41%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L+ L+ + + N+ + + L L L+L++N + D L L L L++
Sbjct: 240 GLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHH 299
Query: 156 NSLTGSC 162
N C
Sbjct: 300 NPWNCDC 306
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 29/154 (18%), Positives = 60/154 (38%), Gaps = 14/154 (9%)
Query: 57 ITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPA 116
I ++ S++ + + L + T++P L S+ + + +
Sbjct: 188 INAIRDYSFKRLY-----RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYL 242
Query: 117 SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVD 176
++ L L+ L+LS N + L +L L ++L L P + + L +++
Sbjct: 243 AVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLN 302
Query: 177 LSYNNLS-------GSLPKISARTFKVTGNPLIC 203
+S N L+ S+ + T + NPL C
Sbjct: 303 VSGNQLTTLEESVFHSVGNL--ETLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 21/103 (20%), Positives = 44/103 (42%), Gaps = 4/103 (3%)
Query: 93 WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152
+ +L L + L++ I S +L +L+ L++S+ + + + NL L
Sbjct: 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLS 230
Query: 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
+ + +LT ++ + L ++LSYN +S I
Sbjct: 231 ITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS----TIEGSMLH 269
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 21/103 (20%), Positives = 44/103 (42%), Gaps = 2/103 (1%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD-SLGDLGNLNYLRLN 154
+L L+S+ + +N ++ + L L+ L L T IP +L L L LRL
Sbjct: 126 DLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLR 184
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVT 197
+ ++ S ++ L ++++S+ ++ +T
Sbjct: 185 HLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 26/99 (26%), Positives = 40/99 (40%), Gaps = 4/99 (4%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
NL L+++ L++N + L L LD+S NK + DL NL L + +
Sbjct: 78 NLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
N L + S + SL + L NL+ I
Sbjct: 138 NDLVYISHRAFSGLNSLEQLTLEKCNLT----SIPTEAL 172
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 16/100 (16%), Positives = 35/100 (35%), Gaps = 4/100 (4%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L L+ + L+ + +L L L L L + S L L L +++
Sbjct: 150 GLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
+ + +LT + +++ NL+ + +
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLT----AVPYLAVR 245
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 27/142 (19%), Positives = 48/142 (33%), Gaps = 26/142 (18%)
Query: 54 NWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGP 113
+ +V C + P+G +P+ L L N I
Sbjct: 10 SAQDRAVL-CHRKRFVAVPEG------IPT------------ETRLLD---LGKNRIKTL 47
Query: 114 IPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLT 173
L+ L+L+ N + P + +L NL L L +N L + + +LT
Sbjct: 48 NQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLT 107
Query: 174 LVDLSYNNLSGSLPKISARTFK 195
+D+S N + + F+
Sbjct: 108 KLDISENKIV----ILLDYMFQ 125
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 19/67 (28%), Positives = 30/67 (44%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L +LQ + L + P + L L+ L++S N+ T +GNL L L++
Sbjct: 270 ELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDS 329
Query: 156 NSLTGSC 162
N L C
Sbjct: 330 NPLACDC 336
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 56/233 (24%), Positives = 92/233 (39%), Gaps = 37/233 (15%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQT---- 347
EL A S ++ + + G +G V G S+G VA+KR+ + G V
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 348 -----EVETISLAVHRNLLRLCG-FCSTENERL----LVYPYMPNGSVASRLRDHIH-GR 396
E+ ++ H N+L L F E + LV M + L IH R
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQR 128
Query: 397 PALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456
+ + GL LHE ++HRD+ NILL ++ + + DF LA+
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDT 185
Query: 457 HRDSHVTTAV-----RGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELITGQ 503
D++ T V R APE + ++ D++ G ++ E+ +
Sbjct: 186 A-DANKTHYVTHRWYR------APELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 51/213 (23%), Positives = 84/213 (39%), Gaps = 37/213 (17%)
Query: 307 NILGRGGFGIVYKGCFSD-GALVAVK--RLKDYN-----IAGGEVQFQTEVETISLAVHR 358
+G G +G+V+K D G +VA+K + + IA E++ +++ H
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK------HP 62
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIALGTARGLLY 417
NL+ L + LV+ Y + + + K I T + + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCD-----HTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-----RGTVGH 472
H+ IHRDVK NIL+ + + DFG A+LL + V R
Sbjct: 118 CHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR----- 169
Query: 473 IAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
+PE L T DV+ G + EL++G
Sbjct: 170 -SPELLVGDTQYGPP-VDVWAIGCVFAELLSGV 200
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 23/91 (25%), Positives = 40/91 (43%), Gaps = 4/91 (4%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ L + + L +N + +P +L L L+ L S+N + + +L L L L
Sbjct: 459 LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLL 515
Query: 154 NNNSLTG-SCPESLSKIESLTLVDLSYNNLS 183
NN L + + L L L++L N+L
Sbjct: 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 9e-12
Identities = 25/132 (18%), Positives = 50/132 (37%), Gaps = 15/132 (11%)
Query: 93 WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152
++ + L + + + L +L + LDLS+N+ +P +L L L L+
Sbjct: 436 LKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQ 492
Query: 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLS--------GSLPKISARTFKVTGNPLICG 204
++N+L + ++ + L + L N L S P++ + GN L
Sbjct: 493 ASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRL--VLLNLQGNSLCQE 548
Query: 205 PKATNNCTAVFP 216
+ P
Sbjct: 549 EGIQERLAEMLP 560
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 4e-07
Identities = 20/85 (23%), Positives = 32/85 (37%), Gaps = 4/85 (4%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG-EIPDSLGDLGN 147
L P + L L+ + +NA+ + + L +LQ L L NN+ L
Sbjct: 477 ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534
Query: 148 LNYLRLNNNSLTGSCPESLSKIESL 172
L L L NSL ++ +
Sbjct: 535 LVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 37/201 (18%), Positives = 66/201 (32%), Gaps = 30/201 (14%)
Query: 95 GNLTKLQSVLLQNNAILGPIPASL-----GKLEKLQTLDLSNNKFTGEIPDSLGDLGNLN 149
L+ + L N + L L LQ L L++N P L L
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507
Query: 150 YLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI--SARTFKVTGNPLICG--- 204
L LN+N LT L +L ++D+S N L P + S +T N IC
Sbjct: 508 GLSLNSNRLTVLSHNDLPA--NLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565
Query: 205 --------------PKATNNCTAVFPEPLS----LPPNGLKDQSDSGTKSHRVAVALGAS 246
+ V+P+ S + + KS + ++ + +
Sbjct: 566 STFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCT 625
Query: 247 FGAAFFVIIVVGLLVWLRYRH 267
F++ ++ + + +
Sbjct: 626 VTLTLFLMTILTVTKFRGFCF 646
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 29/128 (22%), Positives = 55/128 (42%), Gaps = 9/128 (7%)
Query: 69 TCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLD 128
+CS DG ++ +L+ L + +LL N I +S LE+LQ L+
Sbjct: 1 SCSFDGRIAFYR--FCNLTQVPQ----VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLE 54
Query: 129 LSNNKFTGEI-PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
L + I ++ +L NL L L ++ + P++ + L + L + LS ++
Sbjct: 55 LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAV- 113
Query: 188 KISARTFK 195
+ F+
Sbjct: 114 -LKDGYFR 120
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 22/88 (25%), Positives = 36/88 (40%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L L+ + L N I + L+ LQ L+LS N + L + Y+ L
Sbjct: 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS 183
N + ++ +E L +DL N L+
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 25/91 (27%), Positives = 41/91 (45%), Gaps = 3/91 (3%)
Query: 96 NLTKLQSVLLQNNAILGPI-PASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
L +LQ + L + I + L L+ LDL ++K PD+ L +L LRL
Sbjct: 46 FLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLY 105
Query: 155 NNSLTGSC--PESLSKIESLTLVDLSYNNLS 183
L+ + +++LT +DLS N +
Sbjct: 106 FCGLSDAVLKDGYFRNLKALTRLDLSKNQIR 136
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 23/112 (20%), Positives = 39/112 (34%), Gaps = 5/112 (4%)
Query: 93 WIGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTG-EIPDSLGDLGNLN 149
L L + L + L+ L LDLS N+ + S G L +L
Sbjct: 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLK 151
Query: 150 YLRLNNNSLTGSCPESLSKIESLTL--VDLSYNNLSGSLPKISARTFKVTGN 199
+ ++N + C L ++ TL L+ N+L + + N
Sbjct: 152 SIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRN 203
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 26/114 (22%), Positives = 43/114 (37%), Gaps = 9/114 (7%)
Query: 93 WIGNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG--NLN 149
+ NL L + L N I + S GKL L+++D S+N+ L L L+
Sbjct: 118 YFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLS 177
Query: 150 YLRLNNNSLTGSCPESLSKIE------SLTLVDLSYNNLSGSLPKISARTFKVT 197
+ L NSL K L ++D+S N + + + +
Sbjct: 178 FFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 21/99 (21%), Positives = 42/99 (42%), Gaps = 4/99 (4%)
Query: 97 LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN 156
+ ++ + L + + L+ L+ L+L+ NK ++ L NL L L+ N
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324
Query: 157 SLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
L + + + +DL N+++ I +TFK
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIA----IIQDQTFK 359
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 22/103 (21%), Positives = 40/103 (38%), Gaps = 11/103 (10%)
Query: 100 LQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSL-GDLGNLNYLRLNNNS 157
+ L N + I L ++ LQ L L+ N+F+ D + +L L L N
Sbjct: 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462
Query: 158 LTGS-----CPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
L + C + + L ++ L++N L+ + F
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLN----SLPPGVFS 501
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 17/103 (16%), Positives = 38/103 (36%), Gaps = 6/103 (5%)
Query: 95 GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG--NLNYLR 152
GN + +NAI SL + + ++ L ++ +L
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272
Query: 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
L++ + ++ L +++L+YN ++ KI+ F
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKIN----KIADEAFY 311
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 21/89 (23%), Positives = 39/89 (43%), Gaps = 10/89 (11%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L KLQ++ L++NA+ ++ + + + LS NK +L N + L+
Sbjct: 360 FLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSE 410
Query: 156 NSLTGSCPES-LSKIESLTLVDLSYNNLS 183
N L L ++ L ++ L+ N S
Sbjct: 411 NRLENLDILYFLLRVPHLQILILNQNRFS 439
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 29/115 (25%), Positives = 48/115 (41%), Gaps = 11/115 (9%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L+ L+ + L + IP L L KL LDLS N + P S L +L L +
Sbjct: 183 GLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS-------GSLPKISARTFKVTGNPLIC 203
+ + + ++SL ++L++NNL+ L + + NP C
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHL--ERIHLHHNPWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 25/98 (25%), Positives = 35/98 (35%), Gaps = 4/98 (4%)
Query: 98 TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNS 157
T + + L N I S L L+ L LS N + L NLN L L +N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 158 LTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
LT + + L + L N + I + F
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIE----SIPSYAFN 157
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 30/101 (29%), Positives = 47/101 (46%), Gaps = 7/101 (6%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP-DSLGDLGNLNYLRLN 154
L+KL+ + L+NN I + ++ L+ LDL K I + L NL YL L
Sbjct: 134 YLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
+L +L+ + L +DLS N+LS I +F+
Sbjct: 194 MCNLRE--IPNLTPLIKLDELDLSGNHLS----AIRPGSFQ 228
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 21/91 (23%), Positives = 39/91 (42%)
Query: 92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
P + L KL + L N + P S L LQ L + ++ ++ +L +L +
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNL 182
L +N+LT + + + L + L +N
Sbjct: 261 NLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 18/97 (18%), Positives = 37/97 (38%), Gaps = 7/97 (7%)
Query: 99 KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSL 158
+ V+ L +P + + L+L N+ +S L +L L+L+ N +
Sbjct: 44 QFSKVICVRKN-LREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 159 TGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
+ + + +L ++L N L+ I F
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT----TIPNGAFV 133
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 29/171 (16%), Positives = 51/171 (29%), Gaps = 33/171 (19%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L LQ + + + I + L+ L ++L++N T D L +L + L++
Sbjct: 229 GLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHH 288
Query: 156 NSLTGSC-------------------------PESLSKIESLTLVDLSYNNLSGSLPKIS 190
N +C P +L + +L N + P I
Sbjct: 289 NPWNCNCDILWLSWWIKDMAPSNTACCARCNTPPNLKG---RYIGELDQNYFTCYAPVIV 345
Query: 191 ARTFKVTGNPLICGPKATNNCTAVFPEPLS--LPPNGLKDQSDSGTKSHRV 239
+ + G A C A + PNG + V
Sbjct: 346 EPPADLN---VTEGMAAELKCRASTSLTSVSWITPNGTVMTHGAYKVRIAV 393
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 25/150 (16%), Positives = 53/150 (35%), Gaps = 7/150 (4%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152
NLT LQ++ + N I L L L++ SL + ++++L
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSG------SLPKISARTFKVTGNPLICGPK 206
L+ + + S+ ++L NL+ + ++S+ K+ + +
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238
Query: 207 ATNNCTAVFPEPLSLPPNGLKDQSDSGTKS 236
+ N + L L D + +G
Sbjct: 239 SFNELLKLLRYILELSEVEFDDCTLNGLGD 268
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 25/102 (24%), Positives = 45/102 (44%), Gaps = 6/102 (5%)
Query: 84 QSLSGTLSPWIGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDS 141
S G LQ+++L N + + L L+ L +LD+S N F +PDS
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDS 405
Query: 142 LGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
+ +L L++ + + + +L ++D+S NNL
Sbjct: 406 CQWPEKMRFLNLSSTGIR-VVKTCIPQ--TLEVLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 27/134 (20%), Positives = 48/134 (35%), Gaps = 33/134 (24%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L L S+ + N P+P S EK++ L+LS+ + + L L ++N
Sbjct: 385 TLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSN 440
Query: 156 NSLTGSCPESLSKIE-------------------SLTLVDLSYNNLS-------GSLPKI 189
N+L S L +++ L ++ +S N L L +
Sbjct: 441 NNLD-SFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSL 499
Query: 190 SARTFKVTGNPLIC 203
+ + NP C
Sbjct: 500 --QKIWLHTNPWDC 511
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 22/89 (24%), Positives = 37/89 (41%)
Query: 95 GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
G ++S+ L N I L LQ L L +++ D+ LG+L +L L+
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS 183
+N L+ + SL ++L N
Sbjct: 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 1/98 (1%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ LQ ++L+++ I + L L+ LDLS+N + G L +L YL L
Sbjct: 46 LRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105
Query: 154 NNNSLTG-SCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
N + +L + + + +I
Sbjct: 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRID 143
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 18/98 (18%), Positives = 38/98 (38%), Gaps = 4/98 (4%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
++ + + + + LEK++ + + N+K L +L +L L+
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343
Query: 156 NSLTGSCPES---LSKIESLTLVDLSYNNLSGSLPKIS 190
N + ++ SL + LS N+L S+ K
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTG 380
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 20/88 (22%), Positives = 34/88 (38%), Gaps = 6/88 (6%)
Query: 95 GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
L+ + + NN L L +LQ L +S NK +PD+ L ++++
Sbjct: 428 CIPQTLEVLDVSNNN-LDSFSLFL---PRLQELYISRNKLK-TLPDASL-FPVLLVMKIS 481
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNL 182
N L ++ SL + L N
Sbjct: 482 RNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 15/68 (22%), Positives = 27/68 (39%), Gaps = 2/68 (2%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L +LQ + + N + +P + L + +S N+ L +L + L+
Sbjct: 449 FLPRLQELYISRNKLKT-LPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506
Query: 156 NSLTGSCP 163
N SCP
Sbjct: 507 NPWDCSCP 514
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 9/112 (8%), Positives = 30/112 (26%), Gaps = 11/112 (9%)
Query: 93 WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152
+ ++ + + L + + L ++ L+L + L + ++
Sbjct: 167 SLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226
Query: 153 LNNNSLTG----------SCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
+ + ++ + D + N L G +
Sbjct: 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGL-GDFNPSESDVV 277
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 15/74 (20%), Positives = 26/74 (35%), Gaps = 7/74 (9%)
Query: 122 EKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNN 181
+ D + FT IP L + L L+ N +T L +L ++ L +
Sbjct: 5 DASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 182 LSGSLPKISARTFK 195
++ I F
Sbjct: 62 IN----TIEGDAFY 71
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 55/203 (27%), Positives = 80/203 (39%), Gaps = 25/203 (12%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
+G G FG+ LVAVK ++ VQ E+ H N++R
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIVRFKEVI 85
Query: 368 STENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRK---RIALGTARGLLYLHEQC 422
T ++ Y G L + I GR + D AR ++ G+ Y H
Sbjct: 86 LTPTHLAIIMEYASGGE----LYERICNAGRFSEDEARFFFQQLLS-----GVSYCHSM- 135
Query: 423 DPKIIHRDVKAANILLDEDFEAV--VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS- 479
+I HRD+K N LLD + DFG +K S + V GT +IAPE L
Sbjct: 136 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTV-GTPAYIAPEVLLR 191
Query: 480 TGQSSEKTDVFGFGILLLELITG 502
+ DV+ G+ L ++ G
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVG 214
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 56/240 (23%), Positives = 89/240 (37%), Gaps = 67/240 (27%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVE----T---- 351
S + +G+G FG V+K G VA+K++ + E E T
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL----------MENEKEGFPITALRE 66
Query: 352 ISL---AVHRNLLRLCGFCSTENERL--------LVYPYMPNGSVASRLRDH------IH 394
I + H N++ L C T+ LV+ + +H +
Sbjct: 67 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC----------EHDLAGLLSN 116
Query: 395 GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454
+ KR+ GL Y+H KI+HRD+KAAN+L+ D + DFGLA+
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173
Query: 455 ----LDHRDSHVTTAV-----RGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
+ + + T V R PE L D++G G ++ E+ T
Sbjct: 174 FSLAKNSQPNRYTNRVVTLWYR------PPELLLGERDYGPP-IDLWGAGCIMAEMWTRS 226
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 6e-13
Identities = 26/113 (23%), Positives = 40/113 (35%), Gaps = 9/113 (7%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP----D 140
+ L W+ L+ + + L + L TLDLS+N GE
Sbjct: 138 AWLAELQQWL--KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195
Query: 141 SLGDLGNLNYLRLNNN---SLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
L L L N + +G C + L +DLS+N+L + S
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 6e-10
Identities = 32/124 (25%), Positives = 49/124 (39%), Gaps = 10/124 (8%)
Query: 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKL--EKLQTLDLSNN 132
V A +PS+ L G L + ++ LQ + L+N + G P L + L L+L N
Sbjct: 74 TVRAARIPSRILFGALR--VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131
Query: 133 KFTGEIPDSLGDLGN-----LNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
+ L +L L L + E + +L+ +DLS N G
Sbjct: 132 SWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 188 KISA 191
ISA
Sbjct: 191 LISA 194
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 9e-10
Identities = 23/103 (22%), Positives = 42/103 (40%), Gaps = 6/103 (5%)
Query: 84 QSLSGTLSPWIGNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSL 142
++ SG S +LQ + L +N++ S +L +L+LS ++P L
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272
Query: 143 GDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGS 185
L+ L L+ N L + S ++ + + L N S
Sbjct: 273 PA--KLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 26/131 (19%), Positives = 48/131 (36%), Gaps = 15/131 (11%)
Query: 76 VSALGLPSQSLSGTLSPWIGNLT--KLQSVLLQNNAILGPIPASLGKL-----EKLQTLD 128
+ L L + ++GT P + T L + L+N + A L +L L+ L
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLS 155
Query: 129 LSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGS-------CPESLSKIESLTLVDLSYNN 181
++ + + L+ L L++N G CP ++ L L +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 182 LSGSLPKISAR 192
SG ++A
Sbjct: 216 PSGVCSALAAA 226
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 8e-08
Identities = 20/106 (18%), Positives = 36/106 (33%), Gaps = 4/106 (3%)
Query: 84 QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIP-ASLGKLEKLQTLDLSNNKFTGEIPDS- 141
L G L+ +L + + + K L+ L + + I
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88
Query: 142 --LGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGS 185
+ + L L L N +TG+ P L + L L+ N+S +
Sbjct: 89 LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 45/228 (19%)
Query: 298 AATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVE-----T 351
+++S F LG G + VYKG + G VA+K +K + E T
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK------------LDSEEGTPST 49
Query: 352 ----ISL---AVHRNLLRLCGFCSTENERLLVYPYMPN--GSVASRLRDHIHGRPALDWA 402
ISL H N++RL TEN+ LV+ +M N R L+
Sbjct: 50 AIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRG-LELN 108
Query: 403 RRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462
K +GL + HE KI+HRD+K N+L+++ + +GDFGLA+ +
Sbjct: 109 LVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165
Query: 463 TTAV-----RGTVGHIAPEYL--STGQSSEKTDVFGFGILLLELITGQ 503
++ V R AP+ L S S+ D++ G +L E+ITG+
Sbjct: 166 SSEVVTLWYR------APDVLMGSRTYSTS-IDIWSCGCILAEMITGK 206
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQT--EVETISLAVHRNLLRLCG 365
LG G FG V + VA+K + + ++ + E+ + L H ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDHI--HGRPALDWARRK--RIALGTARGLLYLHEQ 421
+T + ++V Y L D+I R D RR +I Y H
Sbjct: 77 VITTPTDIVMVIEY-----AGGELFDYIVEKKRMTEDEGRRFFQQIICAIE----YCHRH 127
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
KI+HRD+K N+LLD++ + DFGL+ ++ + + T+ G+ + APE ++ G
Sbjct: 128 ---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTSC-GSPNYAAPEVIN-G 181
Query: 482 QSSE--KTDVFGFGILLLELITG 502
+ + DV+ GI+L ++ G
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVG 204
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 47/244 (19%), Positives = 80/244 (32%), Gaps = 50/244 (20%)
Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKR-------------------------L 333
+ +S LG G FGIV + G A+K+ L
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKL 65
Query: 334 KDY------NIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL--LVYPYMPNGSV 385
DY + N + + ++ Y+P+ ++
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TL 124
Query: 386 ASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEA 444
L+ I ++ R + ++H I HRD+K N+L++ +D
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTL 181
Query: 445 VVGDFGLAKLLDHRDSHVTTAV----RGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLEL 499
+ DFG AK L + V R APE L + + D++ G + EL
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYR------APELMLGATEYTPSIDLWSIGCVFGEL 235
Query: 500 ITGQ 503
I G+
Sbjct: 236 ILGK 239
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 35/202 (17%), Positives = 66/202 (32%), Gaps = 19/202 (9%)
Query: 58 TSVDPCSWRMITCSPD--GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIP 115
+ C R + P+ +V+ + L S++ L LQ + ++ I
Sbjct: 13 YNAI-CINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR 71
Query: 116 A-SLGKLEKLQTLDLSNNKFTGEIPDS-LGDLGNLNYLRLNNNSLTGSC--PESLSKIES 171
+ L L L L N+F ++ L NL L L +L G+ + S
Sbjct: 72 NNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS 130
Query: 172 LTLVDLSYNNLS--------GSLPKISARTFKVTGNPLICGPKAT-NNCTAVFPEPLSLP 222
L ++ L NN+ ++ + +T N + + N L L
Sbjct: 131 LEMLVLRDNNIKKIQPASFFLNMRRF--HVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS 188
Query: 223 PNGLKDQSDSGTKSHRVAVALG 244
L+D ++ +
Sbjct: 189 SITLQDMNEYWLGWEKCGNPFK 210
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 32/170 (18%), Positives = 58/170 (34%), Gaps = 16/170 (9%)
Query: 43 NNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWI-GNLTKLQ 101
+N ++ + + + D +++ + S V L + L + + T L+
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASG---VKTCDLSKSKIF-ALLKSVFSHFTDLE 302
Query: 102 SVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTG 160
+ L N I I + L L L+LS N +L L L L+ N +
Sbjct: 303 QLTLAQNEI-NKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA 361
Query: 161 SCPESLSKIESLTLVDLSYNNLS-------GSLPKISARTFKVTGNPLIC 203
+S + +L + L N L L + + NP C
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQ--KIWLHTNPWDC 409
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 23/73 (31%), Positives = 33/73 (45%), Gaps = 4/73 (5%)
Query: 96 NLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRL 153
NL KL+ + L N I + S L L+ L L N+ +PD + D L +L + L
Sbjct: 345 NLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWL 402
Query: 154 NNNSLTGSCPESL 166
+ N SCP
Sbjct: 403 HTNPWDCSCPRID 415
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 25/104 (24%), Positives = 44/104 (42%), Gaps = 13/104 (12%)
Query: 96 NLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG--NLNYL 151
LT L+ ++L++N I + P + + LDL+ NK + L + + L
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASF-FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL 185
Query: 152 RLNNNSLTGSCPESLSKIE--------SLTLVDLSYNNLSGSLP 187
RL++ +L L + S+T +DLS N S+
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMA 229
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 16/107 (14%), Positives = 31/107 (28%), Gaps = 16/107 (14%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLN-----Y 150
L+ + + + + K + TLDLS N F + D
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 151 LRLNNNSLTGSCPESLSKIE----------SLTLVDLSYNNLSGSLP 187
L + N + + + + DLS + + +L
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALL 291
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 26/100 (26%), Positives = 40/100 (40%), Gaps = 6/100 (6%)
Query: 96 NLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
LT L S+LL +N + I + + + L+ LDLS+N DL L L L
Sbjct: 62 RLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
NN + + + L + LS N +S +
Sbjct: 121 NNHIVVVDRNAFEDMAQLQKLYLSQNQIS----RFPVELI 156
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 28/112 (25%), Positives = 42/112 (37%), Gaps = 22/112 (19%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP----DSLGDLGNLNYL 151
+L L+ +LL NN I+ + + +LQ L LS N+ + P L L L
Sbjct: 110 DLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLL 168
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLIC 203
L++N L L K+ + L +N NPL C
Sbjct: 169 DLSSNKLKKLPLTDLQKLPAWVKNGLYLHN-----------------NPLEC 203
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 26/100 (26%), Positives = 43/100 (43%), Gaps = 5/100 (5%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L L +++L NN I + L KLQ L +S N EIP +L +L LR+++
Sbjct: 76 GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHD 132
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
N + S + ++ +++ N L S F
Sbjct: 133 NRIRKVPKGVFSGLRNMNCIEMGGNPLENS--GFEPGAFD 170
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 30/108 (27%), Positives = 44/108 (40%), Gaps = 7/108 (6%)
Query: 95 GNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
L + L +N I I L + KL L L +N+ SL L L L L
Sbjct: 190 DLPETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHL 248
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPL 201
+NN L+ P L ++ L +V L NN++ K+ F G +
Sbjct: 249 DNNKLS-RVPAGLPDLKLLQVVYLHTNNIT----KVGVNDFCPVGFGV 291
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 19/101 (18%), Positives = 34/101 (33%), Gaps = 10/101 (9%)
Query: 97 LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI--PDSLGDLGNLNYLRLN 154
+ L + + +N I L + +++ N P + L LNYLR++
Sbjct: 122 PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRIS 180
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
LTG + + L L +N + I
Sbjct: 181 EAKLTGIPKDLPETLNEL---HLDHNKIQ----AIELEDLL 214
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 19/94 (20%), Positives = 33/94 (35%), Gaps = 11/94 (11%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDS-------LGDLGNL 148
L L+ + L NN + +PA L L+ LQ + L N T ++ +
Sbjct: 239 FLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296
Query: 149 NYLRLNNNSLTGSC--PESLSKIESLTLVDLSYN 180
N + L NN + P + + +
Sbjct: 297 NGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 7/96 (7%)
Query: 100 LQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT 159
L+ V + L +P + LDL NN + D L +L L L NN ++
Sbjct: 35 LRVVQCSDLG-LKAVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 160 GSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
++ S + L + +S N+L +I
Sbjct: 92 KIHEKAFSPLRKLQKLYISKNHLV----EIPPNLPS 123
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 14/77 (18%), Positives = 26/77 (33%), Gaps = 10/77 (12%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPAS-------LGKLEKLQTLDLSNNKFT-GEI-P 139
+ + +L LQ V L N I + + K + L NN E+ P
Sbjct: 255 RVPAGLPDLKLLQVVYLHTNNI-TKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313
Query: 140 DSLGDLGNLNYLRLNNN 156
+ + + ++ N
Sbjct: 314 ATFRCVTDRLAIQFGNY 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 24/113 (21%), Positives = 40/113 (35%), Gaps = 12/113 (10%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
L +L + NN + L L L T+ NN +PD +L
Sbjct: 209 KLPDLPLSLESIV---AGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPP---SL 259
Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPL 201
L + +N LT PE + L + + ++ LS P + + N +
Sbjct: 260 EALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNL--YYLNASSNEI 309
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 30/126 (23%), Positives = 44/126 (34%), Gaps = 14/126 (11%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
L +L + NN L +P L L L + NN ++PD +L
Sbjct: 167 KLPDLPPSLEFIA---AGNNQ-LEELP-ELQNLPFLTAIYADNNSLK-KLPDL---PLSL 217
Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI--SARTFKVTGNPLICGPK 206
+ NN L L + LT + N L +LP + S V N L P+
Sbjct: 218 ESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDLPE 274
Query: 207 ATNNCT 212
+ T
Sbjct: 275 LPQSLT 280
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 25/112 (22%), Positives = 44/112 (39%), Gaps = 19/112 (16%)
Query: 90 LSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDL---- 145
++P + T LQ L ++ L +P ++ + +++ P G+
Sbjct: 3 INPRNVSNTFLQEPLRHSSN-LTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 146 ---------GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
+ L LNN L+ S PE +ESL S N+L+ LP+
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPE 108
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 25/127 (19%), Positives = 43/127 (33%), Gaps = 25/127 (19%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L L + LS +L +L L N+ L +P L+ L + + +
Sbjct: 76 LELNNLGLS-SLPELPPHLESLV---ASCNS-LTELPELPQSLKSLLVDNNNLKALSDLP 130
Query: 139 P---------------DSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
P L + L + ++NNSL P+ +E + N L
Sbjct: 131 PLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLE 186
Query: 184 GSLPKIS 190
LP++
Sbjct: 187 -ELPELQ 192
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 28/115 (24%), Positives = 40/115 (34%), Gaps = 24/115 (20%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKL--------------EKLQTLDLSNNKF 134
L +LT L + L +P +L L L+ L++SNNK
Sbjct: 271 DLPELPQSLTFLDVSENIFSG-LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL 329
Query: 135 TGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
E+P L L + N L PE ++ L + YN L P I
Sbjct: 330 I-ELPAL---PPRLERLIASFNHLA-EVPELPQNLKQL---HVEYNPLR-EFPDI 375
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 18/110 (16%), Positives = 36/110 (32%), Gaps = 22/110 (20%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAI--LGPIPASLGKLE-------------KLQTLDLSNNK 133
+ NL +L ++ N + IP S+ L L+ L + N
Sbjct: 351 EVPELPQNLKQLH---VEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNP 407
Query: 134 FTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
E PD ++ LR+N+ + + + L +++
Sbjct: 408 LR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 21/121 (17%), Positives = 32/121 (26%), Gaps = 28/121 (23%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDL--- 145
L L +L N L +P L + L + N E PD +
Sbjct: 331 ELPALPPRLERLI---ASFNH-LAEVPELPQNL---KQLHVEYNPLR-EFPDIPESVEDL 382
Query: 146 -------------GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISAR 192
NL L + N L P+ +E L ++ +
Sbjct: 383 RMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDL---RMNSERVVDPYEFAHET 438
Query: 193 T 193
T
Sbjct: 439 T 439
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 1e-11
Identities = 48/268 (17%), Positives = 82/268 (30%), Gaps = 71/268 (26%)
Query: 264 RYRHNQQIFFDVNDQYDPEVSLGHLKRY-TFKELRAATSNF-SAKNIL--GRGGFGIVYK 319
Y + ++ N + ++ R + +LR A AKN+L G G G K
Sbjct: 111 MYIEQRDRLYNDNQVFAK----YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---K 163
Query: 320 GCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL----- 374
VA+ Y + + + ++ ++L C++ L
Sbjct: 164 TW------VALDVCLSYKV---QCKMDFKIFWLNL----------KNCNSPETVLEMLQK 204
Query: 375 LVYPYMPNGSV----ASRLRDHIHGRPALDWARRKRIALGT---ARGLLYLHEQCDPKII 427
L+Y PN + +S ++ IH R L + LL L + K
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIH-----SIQAELRRLLKSKPYENCLLVLLNVQNAKAW 259
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRG-TVGHIAPEYLSTGQSSEK 486
F + LL R VT + T HI+ ++ S + ++
Sbjct: 260 ------------NAF-----NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE 302
Query: 487 TDVFGFGILLLELITGQRALDFGRAANQ 514
LL R D R
Sbjct: 303 VKS------LLLKYLDCRPQDLPREVLT 324
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 1e-06
Identities = 72/442 (16%), Positives = 134/442 (30%), Gaps = 142/442 (32%)
Query: 8 FW-------RVGFLVLALIDICY--------ATLSPAGINYEVVALVAVKNNL--HDPYN 50
FW ++ L + Y + + I + ++ A L PY
Sbjct: 185 FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244
Query: 51 ----VLEN-WDITSVDP----CSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQ 101
VL N + + + C +++ + V+ + + +L LT +
Sbjct: 245 NCLLVLLNVQNAKAWNAFNLSC--KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE 302
Query: 102 SV-LLQNNAILGPIPASLGKLEKLQT--LDLSNNKFTGEIPDSLGDLGNL--NYLRLNNN 156
LL L P L E L T LS I +S+ D N+ +N +
Sbjct: 303 VKSLLLK--YLDCRPQDL-PREVLTTNPRRLS------IIAESIRDGLATWDNWKHVNCD 353
Query: 157 SLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTAVFP 216
LT T+++ S N L P + F +VFP
Sbjct: 354 KLT-------------TIIESSLNVLE---PAEYRKMFD--------------RL-SVFP 382
Query: 217 EPLSLPPNGLK---------DQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVWLRYR- 266
+P L D K H+ ++ + + ++L +
Sbjct: 383 PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI-----PSIYLELKV 437
Query: 267 --------HNQQI-------FFDVNDQYDPEVS------LG-HLKR-------------- 290
H + FD +D P + +G HLK
Sbjct: 438 KLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVF 497
Query: 291 --YTF--KELRAATSNFSAK----NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGE 342
+ F +++R ++ ++A N L + F YK D + +
Sbjct: 498 LDFRFLEQKIRHDSTAWNASGSILNTLQQLKF---YKPYICDNDPKYERLVNAI------ 548
Query: 343 VQFQTEVETISL-AVHRNLLRL 363
+ F ++E + + + +LLR+
Sbjct: 549 LDFLPKIEENLICSKYTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 2e-05
Identities = 67/497 (13%), Positives = 134/497 (26%), Gaps = 167/497 (33%)
Query: 12 GFLVLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITC- 70
FL+ + S Y + ++ L++ V ++++ + P ++
Sbjct: 92 KFLMSPIKTEQRQP-SMMTRMY-----IEQRDRLYNDNQVFAKYNVSRLQP-YLKLRQAL 144
Query: 71 ---SPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVL----LQNNAILGPIP-----ASL 118
P V G+ G G K + + + + + +L
Sbjct: 145 LELRPAKNVLIDGVL-----G-----SG---K--TWVALDVCLSYKVQCKMDFKIFWLNL 189
Query: 119 GK-------LEKLQTL-------DLSNNKFTGEIPDSLGDL-GNLNYL---RLNNNSL-- 158
LE LQ L S + + I + + L L + N L
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249
Query: 159 -------------TGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICG- 204
SC L+ + ++ L +A T ++ +
Sbjct: 250 LLNVQNAKAWNAFNLSCK---------ILLTTRFKQVTDFL--SAATTTHISLDHHSMTL 298
Query: 205 -PKATNNCTAVFPEPLSLPPNGLKDQSDSGTKSHRVAVALGASFGAAFFVIIVVGLLVWL 263
P ++ + L P L + + + +++ + I GL W
Sbjct: 299 TPDEV---KSLLLKYLDCRPQDLPREVLTT---NPRRLSI---IAES----IRDGLATWD 345
Query: 264 RYRHNQQIFFDVNDQYDP--EVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGC 321
++H D+ E SL L+ ++++ F +
Sbjct: 346 NWKHVN------CDKLTTIIESSLNVLEPAEYRKM------FDR--------LSV----- 380
Query: 322 FSDGALVAVKRLKDY--NIAGGEVQ-FQTEVETISLA----------VHRNLLRLCGFCS 368
F A + L ++ +V ++ SL + L L
Sbjct: 381 FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK--VK 438
Query: 369 TENE----RLLV--YP----YMPNGSVASRLRD----HI--HGRPA-------------- 398
ENE R +V Y + + + L HI H +
Sbjct: 439 LENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL 498
Query: 399 -LDWARRKRIALGTARG 414
+ +K TA
Sbjct: 499 DFRFLEQKIRHDSTAWN 515
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 24/116 (20%), Positives = 49/116 (42%), Gaps = 13/116 (11%)
Query: 96 NLTKLQSVLLQNNAIL-GPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
+ LQ + + N++ + L +L++S+N T I L + L L+
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLH 429
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS-------GSLPKISARTFKVTGNPLIC 203
+N + S P+ + K+E+L ++++ N L L + + + NP C
Sbjct: 430 SNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSL--QKIWLHTNPWDC 482
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 23/94 (24%), Positives = 37/94 (39%), Gaps = 4/94 (4%)
Query: 98 TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNS 157
K + + N I + + L KL+ L +S+N+ L YL L++N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 158 LTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA 191
L S +L +DLS+N +LP
Sbjct: 81 LVKI---SCHPTVNLKHLDLSFNAFD-ALPICKE 110
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 20/113 (17%), Positives = 44/113 (38%), Gaps = 5/113 (4%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
++ + NN + + + G L +L+TL L N+ E+
Sbjct: 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-EL 363
Query: 139 PDSLG---DLGNLNYLRLNNNSLTGSCPESL-SKIESLTLVDLSYNNLSGSLP 187
+ +L L ++ NS++ + S +SL +++S N L+ ++
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 26/133 (19%), Positives = 39/133 (29%), Gaps = 3/133 (2%)
Query: 95 GNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLN-YLR 152
L+ + L NA PI G + +L+ L LS + L L
Sbjct: 87 HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146
Query: 153 LNNNSLTGSCPESLSKIESLTL-VDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNC 211
L PE L + +L + N + +S +T I N C
Sbjct: 147 LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC 206
Query: 212 TAVFPEPLSLPPN 224
+ L N
Sbjct: 207 SYFLSILAKLQTN 219
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 16/95 (16%), Positives = 32/95 (33%), Gaps = 1/95 (1%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
+L L + ++ P + + + + + +L +N
Sbjct: 274 SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
N LT + E+ + L + L N L L KI+
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLK-ELSKIA 367
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 21/68 (30%), Positives = 36/68 (52%), Gaps = 3/68 (4%)
Query: 97 LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD-SLGDLGNLNYLRLNN 155
+++ + L +N I IP + KLE LQ L++++N+ +PD L +L + L+
Sbjct: 420 PPRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHT 477
Query: 156 NSLTGSCP 163
N SCP
Sbjct: 478 NPWDCSCP 485
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 22/151 (14%), Positives = 44/151 (29%), Gaps = 8/151 (5%)
Query: 50 NVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNL---TKLQSVLLQ 106
N+ + + + +S L L + + I L T + +
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSIS 255
Query: 107 NNAILGPI-----PASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGS 161
N + G + S L+ L + ++ F N+N +
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315
Query: 162 CPESLSKIESLTLVDLSYNNLSGSLPKISAR 192
SKI +D S N L+ ++ +
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGH 346
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 38/159 (23%), Positives = 57/159 (35%), Gaps = 24/159 (15%)
Query: 306 KNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRL 363
+LG G G V + F A+K L+D A EV+ + +++R+
Sbjct: 23 SQVLGLGINGKVLQ-IFNKRTQEKFALKMLQDCPKARREVELHWR-----ASQCPHIVRI 76
Query: 364 CGFC----STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK--RIALGTARGLLY 417
+ L+V + G L I R + R+ I + Y
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 418 LHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAK 453
LH I HRDVK N+L + + DFG AK
Sbjct: 133 LHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 48/224 (21%)
Query: 309 LGRGGFGIVYKGCFSD---GALVAVKRLKDYNI---AGGEVQFQTEVETISLAVHRNLLR 362
+GRG +G VYK D A+K+++ I A E+ E++ H N++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELK------HPNVIS 82
Query: 363 LCG-FCSTENERL-LVYPYMPNGSVASRLRDHIHGRPA-----LDWARRKRIALGTARGL 415
L F S + ++ L++ Y + + ++ H + L K + G+
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAV----VGDFGLA-------KLLDHRDSHVTT 464
YLH ++HRD+K ANIL+ + + D G A K L D V T
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 465 AVRGTVGHI---APEYL--STGQSSEKTDVFGFGILLLELITGQ 503
APE L + + D++ G + EL+T +
Sbjct: 199 --------FWYRAPELLLGARHYTKA-IDIWAIGCIFAELLTSE 233
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 24/132 (18%), Positives = 44/132 (33%), Gaps = 14/132 (10%)
Query: 96 NLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
+LTKLQ + + N I L L+ L++ + P SL + N+++L L+
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSG----SLPKISARTFK---------VTGNPL 201
+ S+ ++L +L L + +T L
Sbjct: 207 MKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266
Query: 202 ICGPKATNNCTA 213
K N +
Sbjct: 267 FQVMKLLNQISG 278
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 18/123 (14%), Positives = 44/123 (35%), Gaps = 18/123 (14%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG----EIP----DSLGDLGN 147
++ + ++L + + + ++ L+L + E+ +SL
Sbjct: 196 SIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT 255
Query: 148 LNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG-------SLPKISARTFKVTGNP 200
+++ + SL + L++I L ++ S N L L + + + NP
Sbjct: 256 FRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSL--QKIWLHTNP 312
Query: 201 LIC 203
C
Sbjct: 313 WDC 315
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 23/122 (18%), Positives = 41/122 (33%), Gaps = 29/122 (23%)
Query: 96 NLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFT------------------- 135
+L L+ + L N L + +S L L L+L N +
Sbjct: 98 SLGSLEHLDLSYNY-LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV 156
Query: 136 ------GEIPD-SLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
+I L L L ++ + L P+SL I++++ + L L +
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLE 215
Query: 189 IS 190
I
Sbjct: 216 IF 217
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 17/85 (20%), Positives = 34/85 (40%), Gaps = 3/85 (3%)
Query: 80 GLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP 139
LS + + ++V + + ++ + L ++ L L+ S N+ +P
Sbjct: 236 TFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VP 293
Query: 140 DS-LGDLGNLNYLRLNNNSLTGSCP 163
D L +L + L+ N SCP
Sbjct: 294 DGIFDRLTSLQKIWLHTNPWDCSCP 318
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 26/71 (36%), Positives = 37/71 (52%), Gaps = 4/71 (5%)
Query: 124 LQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
+++LDLSNN+ T L NL L L +N + +S S + SL +DLSYN LS
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113
Query: 184 GSLPKISARTF 194
+S+ F
Sbjct: 114 ----NLSSSWF 120
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 28/106 (26%), Positives = 45/106 (42%), Gaps = 9/106 (8%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L L + L N+I SL L+ L L+NNK ++P L D + + L+N
Sbjct: 214 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 272
Query: 156 NSLTG------SCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
N+++ P +K S + V L N + +I TF+
Sbjct: 273 NNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW--EIQPSTFR 316
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 33/104 (31%), Positives = 43/104 (41%), Gaps = 5/104 (4%)
Query: 95 GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
G L + L N I ASL L L L LS N + SL + +L L LN
Sbjct: 189 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 248
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTG 198
NN L P L+ + + +V L NN+S I + F G
Sbjct: 249 NNKLV-KVPGGLADHKYIQVVYLHNNNIS----AIGSNDFCPPG 287
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 23/102 (22%), Positives = 44/102 (43%), Gaps = 9/102 (8%)
Query: 96 NLTKLQSVLLQNNAI-LGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
L ++ V L N + I + ++KL + +++ T IP L +L L L
Sbjct: 143 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHL 199
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
+ N +T SL + +L + LS+N++S + +
Sbjct: 200 DGNKITKVDAASLKGLNNLAKLGLSFNSIS----AVDNGSLA 237
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 27/95 (28%), Positives = 39/95 (41%), Gaps = 7/95 (7%)
Query: 100 LQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT 159
+ LQNN I L+ L TL L NNK + P + L L L L+ N L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 160 GSCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
PE + K +L + + N ++ K+ F
Sbjct: 114 -ELPEKMPK--TLQELRVHENEIT----KVRKSVF 141
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 17/101 (16%), Positives = 37/101 (36%), Gaps = 9/101 (8%)
Query: 97 LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI--PDSLGDLGNLNYLRLN 154
LQ + + N I + L ++ ++L N + + L+Y+R+
Sbjct: 120 PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
+ ++T + L L N ++ K+ A + K
Sbjct: 180 DTNITTIPQGLPPSLTEL---HLDGNKIT----KVDAASLK 213
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 17/94 (18%), Positives = 34/94 (36%), Gaps = 11/94 (11%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDS-------LGDLGNL 148
N L+ + L NN ++ +P L + +Q + L NN + I + +
Sbjct: 238 NTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASY 295
Query: 149 NYLRLNNNSLTGSC--PESLSKIESLTLVDLSYN 180
+ + L +N + P + + V L
Sbjct: 296 SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 26/96 (27%), Positives = 40/96 (41%), Gaps = 7/96 (7%)
Query: 100 LQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT 159
L+ V + L +P L LDL NNK T +L NL+ L L NN ++
Sbjct: 33 LRVVQCSDLG-LEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 160 GSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
P + + + L + LS N L ++ + K
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK----ELPEKMPK 121
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 15/76 (19%), Positives = 25/76 (32%), Gaps = 8/76 (10%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAI------LGPIPASLGKLEKLQTLDLSNNKFT-GEI-PD 140
+ + + +Q V L NN I P K + L +N EI P
Sbjct: 254 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
Query: 141 SLGDLGNLNYLRLNNN 156
+ + ++L N
Sbjct: 314 TFRCVYVRAAVQLGNY 329
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 17/158 (10%)
Query: 58 TSVDPCSWRMITCSPDG---YVSALGLPSQSLSGTLSPWI-GNLTKLQSVLLQNNAILGP 113
VD C + +T P ++ + L ++ + P KL+ + L NN +
Sbjct: 14 NIVD-CRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQ-ISE 70
Query: 114 IPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNNNSLTGSCPESLSKIES 171
+ + L L +L L NK T E+P SL + L +L L LN N + ++ + +
Sbjct: 71 LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHN 129
Query: 172 LTLVDLSYNNLSGSLPK------ISARTFKVTGNPLIC 203
L L+ L N L ++ K + +T + NP IC
Sbjct: 130 LNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQNPFIC 166
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 16/68 (23%), Positives = 24/68 (35%), Gaps = 2/68 (2%)
Query: 96 NLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
L LQ +LL N + + + L L L L +NK + L + + L
Sbjct: 102 GLFSLQLLLLNANK-INCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLA 160
Query: 155 NNSLTGSC 162
N C
Sbjct: 161 QNPFICDC 168
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 34/135 (25%), Positives = 52/135 (38%), Gaps = 35/135 (25%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL-----------------QTLDLSN 131
+L L +L + +N L +P +L KL + L +S
Sbjct: 175 SLPMLPSGLQELS---VSDNQ-LASLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSG 230
Query: 132 NKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK--- 188
N+ T +P +L L ++ N LT S P S + SL + N L+ LP+
Sbjct: 231 NRLT-SLPVLPSELKELM---VSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLI 281
Query: 189 --ISARTFKVTGNPL 201
S T + GNPL
Sbjct: 282 HLSSETTVNLEGNPL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 21/116 (18%), Positives = 37/116 (31%), Gaps = 10/116 (8%)
Query: 97 LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN 156
+ + + L +P L + TL + +N T +P L L ++ N
Sbjct: 39 NNGNAVLNVGESG-LTTLPDCLPA--HITTLVIPDNNLT-SLPALPP---ELRTLEVSGN 91
Query: 157 SLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCT 212
LT S P + L++ +L + + GN L P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALPSGL--CKLWIFGNQLTSLPVLPPGLQ 144
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 27/124 (21%), Positives = 42/124 (33%), Gaps = 25/124 (20%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L +P +L+ +L L L+ + N L +P L +L +
Sbjct: 66 LVIPDNNLT-SLPALPPELRTLE---VSGNQ-LTSLPVLPPGLLELSIFSNPLTHLP-AL 119
Query: 139 PDSLGDL--------------GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
P L L L L +++N L S P S++ L N L+
Sbjct: 120 PSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA-SLPALPSELCKL---WAYNNQLT- 174
Query: 185 SLPK 188
SLP
Sbjct: 175 SLPM 178
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 26/113 (23%), Positives = 45/113 (39%), Gaps = 14/113 (12%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
+L L +L + +N + +PA +L KL NN+ T +P L
Sbjct: 135 SLPVLPPGLQELS---VSDNQLAS-LPALPSELCKL---WAYNNQLT-SLPML---PSGL 183
Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPL 201
L +++N L S P S++ L + +L + + V+GN L
Sbjct: 184 QELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGL--KELIVSGNRL 233
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 15/91 (16%), Positives = 30/91 (32%), Gaps = 4/91 (4%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
+L L L + N L +P SL L T++L N + +L ++ +
Sbjct: 255 SLPMLPSGLLSLS---VYRNQ-LTRLPESLIHLSSETTVNLEGNPLSERTLQALREITSA 310
Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSY 179
+ + + +L L +
Sbjct: 311 PGYSGPIIRFDMAGASAPRETRALHLAAADW 341
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 23/116 (19%), Positives = 36/116 (31%), Gaps = 27/116 (23%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL-----------------QTLDLSN 131
L L + NN L +P LE L + LD+S
Sbjct: 134 MLPELPALLEYIN---ADNNQ-LTMLPELPTSLEVLSVRNNQLTFLPELPESLEALDVST 189
Query: 132 NKFTGEIPDSLGDLGNL----NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
N +P + + R N +T PE++ ++ + L N LS
Sbjct: 190 NLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS 243
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 27/129 (20%), Positives = 45/129 (34%), Gaps = 12/129 (9%)
Query: 84 QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
K N + + L + + L L+ + +PD+L
Sbjct: 23 SGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLPDNLP 79
Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI--SARTFKVTGNPL 201
+ L + N+L S PE + +E L D N LS +LP++ S + V N L
Sbjct: 80 P--QITVLEITQNALI-SLPELPASLEYL---DACDNRLS-TLPELPASLKHLDVDNNQL 132
Query: 202 ICGPKATNN 210
P+
Sbjct: 133 TMLPELPAL 141
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 32/99 (32%), Positives = 44/99 (44%), Gaps = 16/99 (16%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
TL +L L + NN L +P LE + + NN+ T +P+ +L
Sbjct: 114 TLPELPASLKHLD---VDNNQ-LTMLPELPALLEYI---NADNNQLT-MLPEL---PTSL 162
Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
L + NN LT PE ESL +D+S N L SLP
Sbjct: 163 EVLSVRNNQLT-FLPELP---ESLEALDVSTNLLE-SLP 196
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 14/104 (13%), Positives = 27/104 (25%), Gaps = 7/104 (6%)
Query: 89 TLSPWIGNLTKLQSVL----LQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
+L + + N I IP ++ L+ T+ L +N + I +SL
Sbjct: 194 SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQ 252
Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188
+ + L D +
Sbjct: 253 QTAQPDYHGPRIYFS--MSDGQQNTLHRPLADAVTAWFPENKQS 294
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 34/158 (21%), Positives = 62/158 (39%), Gaps = 16/158 (10%)
Query: 58 TSVDPCSWRMITCSPDG---YVSALGLPSQSLSGTLSPWIG--NLTKLQSVLLQNNAILG 112
T+VD CS + + P+ Y + L L + + L L +L+ + NN I
Sbjct: 14 TTVD-CSNQKLNKIPEHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITD 71
Query: 113 PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESL 172
+ + + L++N+ L +L L L +N +T +S + S+
Sbjct: 72 IEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSV 131
Query: 173 TLVDLSYNNLSG-------SLPKISARTFKVTGNPLIC 203
L+ L N ++ +L +S T + NP C
Sbjct: 132 RLLSLYDNQITTVAPGAFDTLHSLS--TLNLLANPFNC 167
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 17/68 (25%), Positives = 33/68 (48%), Gaps = 2/68 (2%)
Query: 96 NLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
L L++++L++N + + S L ++ L L +N+ T P + L +L+ L L
Sbjct: 103 GLESLKTLMLRSNR-ITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLL 161
Query: 155 NNSLTGSC 162
N +C
Sbjct: 162 ANPFNCNC 169
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 51/220 (23%), Positives = 80/220 (36%), Gaps = 36/220 (16%)
Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQT---------EV 349
+ +G G GIV VA+K+L FQ E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR--------PFQNQTHAKRAYREL 75
Query: 350 ETISLAVHRNLLRL------CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR 403
+ H+N++ L + +V M + L I LD R
Sbjct: 76 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-----ANLCQVIQME--LDHER 128
Query: 404 RKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463
+ G+ +LH IIHRD+K +NI++ D + DFGLA+ S +
Sbjct: 129 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMM 183
Query: 464 TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
T T + APE + E D++ G ++ E+I G
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 7e-11
Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 10/92 (10%)
Query: 94 IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
+ NL L + L N I L L L+KL++L L +N + +I + L L L L
Sbjct: 83 LTNLKNLGWLFLDENKIKDLSS----LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESL 136
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
L NN +T LS++ L + L N +S
Sbjct: 137 YLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 8e-10
Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ +L +L+S+ L NN I L +L KL TL L +N+ + +I L L L L L
Sbjct: 127 LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYL 182
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
+ N ++ +L+ +++L +++L
Sbjct: 183 SKNHIS--DLRALAGLKNLDVLELFSQECL 210
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 24/92 (26%), Positives = 38/92 (41%), Gaps = 10/92 (10%)
Query: 94 IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
I L + + L N + + P L L+ L L L NK ++ SL DL L L
Sbjct: 61 IQYLPNVTKLFLNGNKLTDIKP----LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSL 114
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
L +N ++ L + L + L N ++
Sbjct: 115 SLEHNGIS--DINGLVHLPQLESLYLGNNKIT 144
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 23/92 (25%), Positives = 41/92 (44%), Gaps = 10/92 (10%)
Query: 94 IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
L + ++ N+ I + + L + L L+ NK T +I L +L NL +L
Sbjct: 39 QNELNSIDQIIANNSDIKSVQG----IQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWL 92
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
L+ N + SL ++ L + L +N +S
Sbjct: 93 FLDENKIK--DLSSLKDLKKLKSLSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 16/88 (18%), Positives = 35/88 (39%), Gaps = 6/88 (6%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
+ L+ ++ + +L + + +N+ + + L N+ L LN
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS 183
N LT P L+ +++L + L N +
Sbjct: 75 NKLTDIKP--LTNLKNLGWLFLDENKIK 100
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 11/86 (12%), Positives = 33/86 (38%), Gaps = 10/86 (11%)
Query: 100 LQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNS 157
+ + + I + P + +L T + +L +++ + NN+
Sbjct: 1 MGETITVSTPIKQIFPDD----AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD 54
Query: 158 LTGSCPESLSKIESLTLVDLSYNNLS 183
+ + + + ++T + L+ N L+
Sbjct: 55 IKSV--QGIQYLPNVTKLFLNGNKLT 78
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 20/90 (22%), Positives = 39/90 (43%), Gaps = 4/90 (4%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ LTKLQ++ L N I +L L+ L L+L + + + + +L N ++
Sbjct: 171 LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKN 228
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
+ SL PE +S ++ ++
Sbjct: 229 TDGSLV--TPEIISDDGDYEKPNVKWHLPE 256
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 34/202 (16%), Positives = 75/202 (37%), Gaps = 31/202 (15%)
Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVET------I 352
+ ++++G G +G V + + +VA+K++ F+ ++ I
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR--------VFEDLIDCKRILREI 103
Query: 353 SL---AVHRNLLRLCGFCSTENERL-----LVYPYMPNGSVASRLRDHIHGRPALDWARR 404
++ H +++++ ++ +V S + L
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-----SDFKKLFRTPVYLTELHI 158
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
K + G+ Y+H I+HRD+K AN L+++D V DFGLA+ +D+ ++ +
Sbjct: 159 KTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 465 AVRGTVGHIAPEYLSTGQSSEK 486
+ K
Sbjct: 216 LPISPREDDMNLVTFPHTKNLK 237
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 23/114 (20%), Positives = 46/114 (40%), Gaps = 10/114 (8%)
Query: 84 QSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSL 142
++S L +L+ + Q++ + S+ L L LD+S+
Sbjct: 91 ITMSSNFL----GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 146
Query: 143 GDLGNLNYLRL-NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
L +L L++ N+ P+ +++ +LT +DLS L ++S F
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE----QLSPTAFN 196
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 24/98 (24%), Positives = 44/98 (44%), Gaps = 7/98 (7%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT--GEIPDSLGDLGNLNYLRL 153
+ T+L+ L++N + KL +L L LS+N + G S +L YL L
Sbjct: 29 SATRLE---LESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA 191
+ N + + + +E L +D ++NL + + S
Sbjct: 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSV 121
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 21/89 (23%), Positives = 36/89 (40%), Gaps = 1/89 (1%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L L + L + P + L LQ L++S+N F L +L L +
Sbjct: 173 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 232
Query: 156 NSLTGSCPESLSKI-ESLTLVDLSYNNLS 183
N + S + L SL ++L+ N+ +
Sbjct: 233 NHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 21/89 (23%), Positives = 36/89 (40%), Gaps = 6/89 (6%)
Query: 101 QSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT- 159
+ + L +P + L+L +NK L L L L++N L+
Sbjct: 10 TEIRCNSKG-LTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 160 -GSCPESLSKIESLTLVDLSYNNLSGSLP 187
G C +S SL +DLS+N + ++
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-TMS 94
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 17/69 (24%), Positives = 25/69 (36%), Gaps = 1/69 (1%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDL-GNLNYLRLN 154
+L+ LQ + + +N L LQ LD S N L +L +L L
Sbjct: 197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 256
Query: 155 NNSLTGSCP 163
N +C
Sbjct: 257 QNDFACTCE 265
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 6/90 (6%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ LT LQ + + N + P L L KL TL +NK + +I L L NL + L
Sbjct: 147 LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHL 202
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
NN ++ L+ +L +V L+ ++
Sbjct: 203 KNNQISDV--SPLANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 25/115 (21%), Positives = 47/115 (40%), Gaps = 13/115 (11%)
Query: 92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
+ L+ LQ + L N I I L L LQ L + N + + ++ L +L L L
Sbjct: 123 TPLAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTL 178
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS-----GSLPKISARTFKVTGNPL 201
+ ++N ++ L+ + +L V L N +S + + +T +
Sbjct: 179 KADDNKISDI--SPLASLPNLIEVHLKNNQISDVSPLANTSNL--FIVTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 22/90 (24%), Positives = 41/90 (45%), Gaps = 6/90 (6%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ L L + L++N I P L L K+ L+LS N ++ L ++ L L
Sbjct: 59 VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDL 114
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
+ +T P L+ + +L ++ L N ++
Sbjct: 115 TSTQITDVTP--LAGLSNLQVLYLDLNQIT 142
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 19/88 (21%), Positives = 32/88 (36%), Gaps = 6/88 (6%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L + + + + L+ + TL T I + L NL L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS 183
N +T L + +T ++LS N L
Sbjct: 73 NQITD--LAPLKNLTKITELELSGNPLK 98
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 17/90 (18%), Positives = 41/90 (45%), Gaps = 6/90 (6%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+L + ++ + I + L L L+L +N+ T ++ L +L + L L
Sbjct: 37 QADLDGITTLSAFGTGVTT-IEG-VQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELEL 92
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
+ N L +++ ++S+ +DL+ ++
Sbjct: 93 SGNPLKN--VSAIAGLQSIKTLDLTSTQIT 120
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 20/90 (22%), Positives = 37/90 (41%), Gaps = 4/90 (4%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ +L L V L+NN I P L L + L+N T + +L N ++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKG 248
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
+ + P ++S + +L++N S
Sbjct: 249 PSGAPI--APATISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 14/80 (17%), Positives = 27/80 (33%), Gaps = 6/80 (7%)
Query: 104 LLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCP 163
+ Q AI P L + + T + DL + L +T
Sbjct: 3 ITQPTAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI-- 56
Query: 164 ESLSKIESLTLVDLSYNNLS 183
E + + +L ++L N ++
Sbjct: 57 EGVQYLNNLIGLELKDNQIT 76
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 54/254 (21%), Positives = 90/254 (35%), Gaps = 39/254 (15%)
Query: 269 QQIFFDVNDQYDPEVSLGHLKRYTFKELRAA---TSNFSAKNILGRGGFGIVYKG-CFSD 324
Q + Y+ S + Y+ + + + +G G GIV
Sbjct: 27 QVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL 86
Query: 325 GALVAVKRLKDYNIAGGEVQFQT---------EVETISLAVHRNLLRL------CGFCST 369
VA+K+L FQ E+ + H+N++ L
Sbjct: 87 DRNVAIKKLSR--------PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138
Query: 370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHR 429
+ LV M + L I LD R + G+ +LH IIHR
Sbjct: 139 FQDVYLVMELMD-----ANLCQVIQME--LDHERMSYLLYQMLCGIKHLH---SAGIIHR 188
Query: 430 DVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDV 489
D+K +NI++ D + DFGLA+ S + T T + APE + E D+
Sbjct: 189 DLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDI 246
Query: 490 FGFGILLLELITGQ 503
+ G ++ E++ +
Sbjct: 247 WSVGCIMGEMVRHK 260
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 24/130 (18%), Positives = 45/130 (34%), Gaps = 16/130 (12%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ + T+L + Q I L + KL L L+N + T E+ + L L
Sbjct: 293 VTHNTQLYLLDCQAAGI---TELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSC 346
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCTA 213
N + + KI +L + ++PK + +T +
Sbjct: 347 VNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVS-------PDLLD 396
Query: 214 VFPEPLSLPP 223
F P+++ P
Sbjct: 397 QFGNPMNIEP 406
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 21/99 (21%), Positives = 38/99 (38%), Gaps = 10/99 (10%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
+ T+L ++ N I + + + L L+ N T ++ L L
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKI---TELDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQL 214
Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
+L ++N LT ++ + LT D S N L+ L
Sbjct: 215 TFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT-ELD 249
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 24/90 (26%), Positives = 39/90 (43%), Gaps = 9/90 (10%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
I LT L ++ +N I + L + L L +NK T + + L L YL
Sbjct: 60 IEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNC 113
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
+ N LT +S+ LT ++ + N L+
Sbjct: 114 DTNKLTKL---DVSQNPLLTYLNCARNTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 24/99 (24%), Positives = 42/99 (42%), Gaps = 8/99 (8%)
Query: 85 SLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144
+ T + L L S+ N++I + + KL L L ++N T + L
Sbjct: 29 EMQATDTISEEQLATLTSLDCHNSSITD-MTG-IEKLTGLTKLICTSNNIT-TLD--LSQ 83
Query: 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
NL YL ++N LT ++ + LT ++ N L+
Sbjct: 84 NTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT 119
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 22/94 (23%), Positives = 33/94 (35%), Gaps = 9/94 (9%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ T L + +N + + + L KL L+ NK T + L YL
Sbjct: 81 LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNC 134
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
N+LT +S LT +D N L
Sbjct: 135 ARNTLT---EIDVSHNTQLTELDCHLNKKITKLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 18/90 (20%), Positives = 28/90 (31%), Gaps = 8/90 (8%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ LT+L N + + S L KL TL EI L L Y +
Sbjct: 229 VTPLTQLTYFDCSVNPL-TELDVS--TLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQA 282
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
++ L L+D ++
Sbjct: 283 EGCRKI--KELDVTHNTQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 15/90 (16%), Positives = 32/90 (35%), Gaps = 8/90 (8%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ L + N + + +L LD NK ++ + L L
Sbjct: 123 VSQNPLLTYLNCARNTL---TEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDC 177
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
+ N +T +S+ + L ++ NN++
Sbjct: 178 SFNKITEL---DVSQNKLLNRLNCDTNNIT 204
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 19/84 (22%), Positives = 34/84 (40%), Gaps = 5/84 (5%)
Query: 100 LQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLT 159
S + + S +L L +LD N+ T ++ + L L L +N++T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT 77
Query: 160 GSCPESLSKIESLTLVDLSYNNLS 183
LS+ +LT + N L+
Sbjct: 78 T---LDLSQNTNLTYLACDSNKLT 98
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 17/101 (16%), Positives = 35/101 (34%), Gaps = 7/101 (6%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ + TKL+S+ N I S+GK+ L + + +P +L
Sbjct: 335 VSHNTKLKSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVS 391
Query: 154 NNN-SLTG---SCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
+ G + + +++ NLS P ++
Sbjct: 392 PDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVT 432
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 48/226 (21%)
Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQT---------EV 349
+ + +G G +G V GA VA+K+L FQ+ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--------PFQSELFAKRAYREL 75
Query: 350 ETISLAVHRNLLRL------CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR 403
+ H N++ L + LV P+M + L + L R
Sbjct: 76 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-----TDLGKLMKHEK-LGEDR 129
Query: 404 RKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463
+ + +GL Y+H IIHRD+K N+ ++ED E + DFGLA+ DS +T
Sbjct: 130 IQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMT 183
Query: 464 TAV-----RGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELITGQ 503
V R APE L+ + ++ D++ G ++ E+ITG+
Sbjct: 184 GYVVTRWYR------APEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 52/226 (23%), Positives = 93/226 (41%), Gaps = 49/226 (21%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQT---------EV 349
+ + +G G +G V G VA+K+L FQ+ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--------PFQSEIFAKRAYREL 74
Query: 350 ETISLAVHRNLLRL------CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR 403
+ H N++ L + LV P+M + L+ + + +
Sbjct: 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----TDLQKIMGLK--FSEEK 127
Query: 404 RKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT 463
+ + +GL Y+H ++HRD+K N+ ++ED E + DFGLA+ H D+ +T
Sbjct: 128 IQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMT 181
Query: 464 TAV-----RGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
V R APE LS ++ D++ G ++ E++TG+
Sbjct: 182 GYVVTRWYR------APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 19/96 (19%), Positives = 43/96 (44%), Gaps = 5/96 (5%)
Query: 96 NLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIP-DSLGDLGNLNYLRL 153
NL + + + + L + + S L K+ +++ N + I D+L +L L +L +
Sbjct: 53 NLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGI 112
Query: 154 NNNSLTGSCPE--SLSKIESLTLVDLSYNNLSGSLP 187
N L P+ + + +++++ N S+P
Sbjct: 113 FNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIP 147
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 22/98 (22%), Positives = 44/98 (44%), Gaps = 6/98 (6%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASL--GKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
+ + + + +N + IP + G + TL L NN FT + + L+ +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184
Query: 152 RL-NNNSLTGSCPESLSKIES-LTLVDLSYNNLSGSLP 187
L N LT ++ + S +L+D+S +++ +LP
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALP 221
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 22/106 (20%), Positives = 43/106 (40%), Gaps = 13/106 (12%)
Query: 96 NLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIP-DSLGDLGN-LNYLR 152
L L+ + + N + P + + L++++N + IP ++ L N L+
Sbjct: 103 ELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLK 162
Query: 153 LNNNSLTGSCPE---SLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
L NN T S + +K++++ L+ N L I F
Sbjct: 163 LYNNGFT-SVQGYAFNGTKLDAV---YLNKNKY---LTVIDKDAFG 201
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 19/70 (27%), Positives = 26/70 (37%), Gaps = 5/70 (7%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASL--GKLEKLQTLDLSNNKFTGEIPDSLGDLG 146
++ + N TKL +V L N L I G LD+S T +P L
Sbjct: 170 SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LE 226
Query: 147 NLNYLRLNNN 156
+L L N
Sbjct: 227 HLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 14/74 (18%), Positives = 29/74 (39%), Gaps = 6/74 (8%)
Query: 124 LQTLDLSNNKFTGEIP-DSLGDLGNLNYLRLN-NNSLTGSCPESLSKIESLTLVDLSYNN 181
QTL L IP + +L N++ + ++ + +L S + +T +++
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 182 LSGSLPKISARTFK 195
+L I K
Sbjct: 92 ---NLTYIDPDALK 102
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 28/92 (30%), Positives = 43/92 (46%), Gaps = 10/92 (10%)
Query: 94 IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
+ NL L + L N + L L L+KL++L L +N + +I + L L L L
Sbjct: 86 LANLKNLGWLFLDENKVKDLSS----LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESL 139
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
L NN +T LS++ L + L N +S
Sbjct: 140 YLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ +L +L+S+ L NN I L +L KL TL L +N+ + +I L L L L L
Sbjct: 130 LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYL 185
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
+ N ++ +L+ +++L +++L
Sbjct: 186 SKNHISD--LRALAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 24/92 (26%), Positives = 38/92 (41%), Gaps = 10/92 (10%)
Query: 94 IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
I L + + L N + + P L L+ L L L NK ++ SL DL L L
Sbjct: 64 IQYLPNVTKLFLNGNKLTDIKP----LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSL 117
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
L +N ++ L + L + L N ++
Sbjct: 118 SLEHNGIS--DINGLVHLPQLESLYLGNNKIT 147
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 23/92 (25%), Positives = 41/92 (44%), Gaps = 10/92 (10%)
Query: 94 IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
L + ++ N+ I + + L + L L+ NK T +I L +L NL +L
Sbjct: 42 QNELNSIDQIIANNSDIKSVQG----IQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWL 95
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
L+ N + SL ++ L + L +N +S
Sbjct: 96 FLDENKVK--DLSSLKDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 16/88 (18%), Positives = 35/88 (39%), Gaps = 6/88 (6%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
+ L+ ++ + +L + + +N+ + + L N+ L LN
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS 183
N LT P L+ +++L + L N +
Sbjct: 78 NKLTDIKP--LANLKNLGWLFLDENKVK 103
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 21/92 (22%), Positives = 39/92 (42%), Gaps = 8/92 (8%)
Query: 94 IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
+ LTKLQ++ L N I L L L+ L L+L + + + + +L N +
Sbjct: 174 LAGLTKLQNLYLSKNHISDLRA----LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 229
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
+ + SL PE +S ++ ++
Sbjct: 230 KNTDGSLV--TPEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 10/80 (12%), Positives = 29/80 (36%), Gaps = 6/80 (7%)
Query: 104 LLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCP 163
+ I + +L T + +L +++ + NN+ +
Sbjct: 8 ITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-- 61
Query: 164 ESLSKIESLTLVDLSYNNLS 183
+ + + ++T + L+ N L+
Sbjct: 62 QGIQYLPNVTKLFLNGNKLT 81
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 1e-09
Identities = 34/218 (15%), Positives = 56/218 (25%), Gaps = 45/218 (20%)
Query: 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVK--RLKDYNIAGGEVQFQTE 348
F T +G G FG V++ +D VA+K ++ ++ G Q E
Sbjct: 11 VPFSHCLP-TEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFE 68
Query: 349 --VETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRD--------------- 391
+ I ++ +LL TE L + GS L
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 392 ----------------------HIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHR 429
A K I L + HR
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHR 186
Query: 430 DVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
D+ N+LL + + K + ++
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 26/107 (24%), Positives = 49/107 (45%), Gaps = 13/107 (12%)
Query: 96 NLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTG-EIPDSLGDLGNLNYLR 152
L+ LQ ++ + L P G L+ L+ L++++N ++P+ +L NL +L
Sbjct: 98 GLSSLQKLVAVETNLASLENFPI--GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155
Query: 153 LNNNSLTGSCPESLSKIESLTLV----DLSYNNLSGSLPKISARTFK 195
L++N + L + + L+ DLS N ++ I FK
Sbjct: 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN----FIQPGAFK 198
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 19/100 (19%), Positives = 36/100 (36%), Gaps = 5/100 (5%)
Query: 96 NLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
+ +LQ + L I I L L TL L+ N + L +L L
Sbjct: 50 SFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
+L + +++L +++++N + S F
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQ-SFK--LPEYF 145
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 24/89 (26%), Positives = 34/89 (38%), Gaps = 5/89 (5%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQ----TLDLSNNKFTGEIPDSLGDLGNLNYL 151
NLT L+ + L +N I L L ++ +LDLS N I L L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKEL 205
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYN 180
L+ N L ++ SL + L N
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 16/72 (22%), Positives = 26/72 (36%), Gaps = 5/72 (6%)
Query: 96 NLTKLQSVL----LQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
L ++ + L N + I K +L+ L L N+ L +L +
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKI 229
Query: 152 RLNNNSLTGSCP 163
L+ N SCP
Sbjct: 230 WLHTNPWDCSCP 241
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 32/120 (26%), Positives = 49/120 (40%), Gaps = 6/120 (5%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148
+L L L + + N + +L L +LQ L L N+ P L L
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL 150
Query: 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK-----ISARTFKVTGNPLIC 203
L L NN+LT L+ +E+L + L N+L ++PK + GNP +C
Sbjct: 151 EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 23/92 (25%), Positives = 32/92 (34%), Gaps = 6/92 (6%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
+ V L +P L + L LS N +L L L L+
Sbjct: 8 KVASHLEVNCDKRN-LTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
LT + + L +DLS+N L SLP
Sbjct: 65 AELTK--LQVDGTLPVLGTLDLSHNQLQ-SLP 93
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 54/223 (24%), Positives = 89/223 (39%), Gaps = 42/223 (18%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQT---------EV 349
+ + +G G +G V + G VAVK+L FQ+ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--------PFQSIIHAKRTYREL 79
Query: 350 ETISLAVHRNLLRL------CGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWAR 403
+ H N++ L N+ LV M + L + + + L
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQK-LTDDH 133
Query: 404 RKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR--DSH 461
+ + RGL Y+H IIHRD+K +N+ ++ED E + DFGLA+
Sbjct: 134 VQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV 190
Query: 462 VTTAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
T R APE L+ ++ D++ G ++ EL+TG+
Sbjct: 191 ATRWYR------APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 48/243 (19%), Positives = 87/243 (35%), Gaps = 53/243 (21%)
Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVET------I 352
N+ K+++GRG +G VY + VA+K++ F+ ++ I
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR--------MFEDLIDCKRILREI 76
Query: 353 SL---AVHRNLLRLCGFCSTENERL-----LVYPYMPNGSVASRLRDHIHGRPALDWARR 404
++ ++RL ++ +V S L+ L
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-----SDLKKLFKTPIFLTEEHI 131
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
K I G ++HE IIHRD+K AN LL++D V DFGLA+ ++
Sbjct: 132 KTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 465 AVRGTVGHI---------------------APEYLSTGQS-SEKTDVFGFGILLLELITG 502
APE + ++ ++ D++ G + EL+
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 503 QRA 505
++
Sbjct: 249 LQS 251
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 53/238 (22%), Positives = 92/238 (38%), Gaps = 51/238 (21%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETI------ 352
+ LG+G +GIV+K G +VAVK++ D FQ +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--------AFQNSTDAQRTFREI 59
Query: 353 ----SLAVHRNLLRLCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKR 406
L+ H N++ L +N+R LV+ YM + L I L+ ++
Sbjct: 60 MILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-----TDLHAVIRANI-LEPVHKQY 113
Query: 407 IALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV 466
+ + + YLH ++HRD+K +NILL+ + V DFGL++ +
Sbjct: 114 VVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 467 RGTVGHI--------------------APEYLSTGQS-SEKTDVFGFGILLLELITGQ 503
+ APE L ++ D++ G +L E++ G+
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 26/127 (20%), Positives = 58/127 (45%), Gaps = 12/127 (9%)
Query: 84 QSLSGTLSPWIGNLTKLQSVLLQNNAIL-GPIPASLGKLEKLQTLDLSNNKFTGEIPDSL 142
++ + N++ L+++ + N++ + E + L+LS+N TG + L
Sbjct: 390 KNFFKV-ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL 448
Query: 143 GDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK------ISARTFKV 196
+ L L+NN + S P+ ++ +++L ++++ N L S+P S + +
Sbjct: 449 --PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWL 504
Query: 197 TGNPLIC 203
NP C
Sbjct: 505 HDNPWDC 511
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 16/89 (17%), Positives = 30/89 (33%), Gaps = 1/89 (1%)
Query: 105 LQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPE 164
++N L A ++ LS + + +L N T S +
Sbjct: 312 VKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQ 371
Query: 165 SLSKIESLTLVDLSYNNLSGSLPKISART 193
S ++ L + L N L + K++ T
Sbjct: 372 GCSTLKRLQTLILQRNGLK-NFFKVALMT 399
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 19/91 (20%), Positives = 38/91 (41%), Gaps = 8/91 (8%)
Query: 96 NLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
L++L+ + L +N + + + + L+ LD+S+N+ I + +L +L L+
Sbjct: 74 FLSELRVLRLSHN-RIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLS 129
Query: 155 NNSLTGSCPES--LSKIESLTLVDLSYNNLS 183
N P + LT + LS
Sbjct: 130 FNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR 159
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 20/162 (12%), Positives = 45/162 (27%), Gaps = 11/162 (6%)
Query: 44 NLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSV 103
+L L + + + + V+ + + ++ +
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281
Query: 104 LLQNNAILGPIP-----ASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSL 158
+ N I I S L+ L + N F +N L+ +
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 159 TG---SCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVT 197
CP S S L + + N + S+ + + ++
Sbjct: 342 PFIHMVCPPSPSSFTFL---NFTQNVFTDSVFQGCSTLKRLQ 380
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 16/74 (21%), Positives = 29/74 (39%), Gaps = 7/74 (9%)
Query: 114 IPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLT 173
+P + L LS N + + L L LRL++N + + L
Sbjct: 50 LPPRT------KALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLE 103
Query: 174 LVDLSYNNLSGSLP 187
+D+S+N L ++
Sbjct: 104 YLDVSHNRLQ-NIS 116
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 23/95 (24%), Positives = 35/95 (36%), Gaps = 2/95 (2%)
Query: 95 GNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG-NLNYLR 152
+ L+ + L N P+ G L KL L LS KF + L + L
Sbjct: 118 CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLD 177
Query: 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
L + + G ESL + L + + N S+
Sbjct: 178 LVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ 212
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 20/72 (27%), Positives = 35/72 (48%), Gaps = 6/72 (8%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD-SLGDLGNLNYLRLN 154
+ L L NN + IP + L+ LQ L++++N+ +PD L +L Y+ L+
Sbjct: 451 KVKVLD---LHNNR-IMSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLH 505
Query: 155 NNSLTGSCPESL 166
+N +CP
Sbjct: 506 DNPWDCTCPGIR 517
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 26/116 (22%), Positives = 49/116 (42%), Gaps = 15/116 (12%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ L + + L N I I +SL +E L+ L L N +I + L L +
Sbjct: 44 LSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS--------GSLPKISARTFKVTGNPL 201
+ N + + + K+ +L ++ +S N ++ +L K+ + GNPL
Sbjct: 101 SYNQI--ASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKL--EDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 23/90 (25%), Positives = 39/90 (43%), Gaps = 6/90 (6%)
Query: 96 NLTKLQSVLLQN--NAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
T+ + V L I + A+L L+ + L LS N +I SL + NL L L
Sbjct: 21 VATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSL 77
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
N + + ++L + +SYN ++
Sbjct: 78 GRNLIK-KIENLDAVADTLEELWISYNQIA 106
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 25/83 (30%), Positives = 34/83 (40%), Gaps = 9/83 (10%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFT--GEIPDSLGD 144
+ L+ + + N I L + KL L+ L +SNNK T GEI D L
Sbjct: 84 KIENLDAVADTLEELWISYNQIASLSG----IEKLVNLRVLYMSNNKITNWGEI-DKLAA 138
Query: 145 LGNLNYLRLNNNSLTGSCPESLS 167
L L L L N L E+ +
Sbjct: 139 LDKLEDLLLAGNPLYNDYKENNA 161
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 45/228 (19%), Positives = 91/228 (39%), Gaps = 48/228 (21%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQT---------EV 349
++ + +G G +G+V + VA+K++ F+ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---------FEHQTYCQRTLREI 76
Query: 350 ETISLAVHRNLLRLCG-FCSTENERL----LVYPYMPNGSVASRLRDHIHGRPALDWARR 404
+ + H N++ + + E++ +V M + L + + L
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLLKTQH-LSNDHI 130
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH--- 461
RGL Y+H ++HRD+K +N+LL+ + + DFGLA++ D H
Sbjct: 131 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 462 -----VTTAVRGTVGHIAPEY-LSTGQSSEKTDVFGFGILLLELITGQ 503
T R APE L++ ++ D++ G +L E+++ +
Sbjct: 188 LTEYVATRWYR------APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 49/137 (35%), Positives = 69/137 (50%), Gaps = 13/137 (9%)
Query: 58 TSVDPCSWRMITCSPDG---YVSALGLPSQSLSGTLSPWI-GNLTKLQSVLLQNNAILGP 113
SVD CS + +T P L L S LS +L LTKL+ + L +N L
Sbjct: 19 NSVD-CSSKKLTAIPSNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNK-LQT 75
Query: 114 IPASL-GKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNNNSLTGSCPESL-SKIE 170
+PA + +L+ L+TL +++NK +P + D L NL LRL+ N L S P + +
Sbjct: 76 LPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLT 133
Query: 171 SLTLVDLSYNNLSGSLP 187
LT + L YN L SLP
Sbjct: 134 KLTYLSLGYNELQ-SLP 149
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 30/116 (25%), Positives = 46/116 (39%), Gaps = 11/116 (9%)
Query: 96 NLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRL 153
L L + L N + +P + L KL L L N+ +P + D L +L LRL
Sbjct: 107 QLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRL 164
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK------ISARTFKVTGNPLIC 203
NN L + K+ L + L N L +P+ + ++ NP C
Sbjct: 165 YNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQENPWDC 219
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 7/95 (7%)
Query: 96 NLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRL 153
L L+++ + +N L +P + +L L L L N+ +P + D L L YL L
Sbjct: 83 ELKNLETLWVTDNK-LQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSL 140
Query: 154 NNNSLTGSCPESL-SKIESLTLVDLSYNNLSGSLP 187
N L S P+ + K+ SL + L N L +P
Sbjct: 141 GYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVP 173
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 22/72 (30%), Positives = 32/72 (44%), Gaps = 2/72 (2%)
Query: 96 NLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
LT L+ + L NN L +P KL +L+TL L NN+ + L L L+L
Sbjct: 155 KLTSLKELRLYNNQ-LKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213
Query: 155 NNSLTGSCPESL 166
N +C +
Sbjct: 214 ENPWDCTCNGII 225
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 59/236 (25%), Positives = 91/236 (38%), Gaps = 55/236 (23%)
Query: 300 TSNFSAKNILGRGGFGIVYKGCFSD-GALVAVK---------------------RLKDYN 337
S + LG GG G+V+ +D VA+K RL N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 338 IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP 397
I +V I L G + N +V YM + L + + P
Sbjct: 70 I--------VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-----TDLANVLEQGP 116
Query: 398 ALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLD 456
L + RGL Y+H ++HRD+K AN+ ++ ED +GDFGLA+++D
Sbjct: 117 -LLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 457 HRDSH--------VTTAVRGTVGHIAPE-YLSTGQSSEKTDVFGFGILLLELITGQ 503
SH VT R +P LS ++ D++ G + E++TG+
Sbjct: 173 PHYSHKGHLSEGLVTKWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 8e-09
Identities = 24/130 (18%), Positives = 40/130 (30%), Gaps = 8/130 (6%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152
+ L + ++N L + L L +L+ L + + PD+ L+ L
Sbjct: 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86
Query: 153 LNNNSLTGSCPESLSKIESLTLVDLSYN------NLSGSLPKISARTFKVTGNPLICGPK 206
L+ N+L S + SL + LS N L V L C +
Sbjct: 87 LSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQ 145
Query: 207 ATNNCTAVFP 216
Sbjct: 146 GPLAHMPNAS 155
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 23/88 (26%), Positives = 37/88 (42%), Gaps = 6/88 (6%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L + L NN + L L+ L+ L + NNK I LG L L L L+
Sbjct: 104 PSACLSRLFLDNNELRDTDS--LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHG 159
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS 183
N +T L++++ + +DL+
Sbjct: 160 NEIT--NTGGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 14/90 (15%), Positives = 31/90 (34%), Gaps = 6/90 (6%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
L L ++ + +L +Q + N+ + + NL L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHL 70
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
++N ++ L + L + ++ N L
Sbjct: 71 SHNQIS--DLSPLKDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 24/92 (26%), Positives = 38/92 (41%), Gaps = 11/92 (11%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
L+ +Q+ N+ I + L+ L LS+N+ + ++ L DL L L +
Sbjct: 37 QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSV 92
Query: 154 NNNSLTGSCPESLSKIESLTLV--DLSYNNLS 183
N N L +L+ I S L L N L
Sbjct: 93 NRNRLK-----NLNGIPSACLSRLFLDNNELR 119
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 19/91 (20%), Positives = 35/91 (38%), Gaps = 8/91 (8%)
Query: 94 IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
+ +L L+ + ++NN + + LG L KL+ LDL N+ T L L +N++
Sbjct: 124 LIHLKNLEILSIRNNKLKSIVM----LGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWI 177
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNL 182
L + ++ V
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 21/97 (21%), Positives = 38/97 (39%), Gaps = 5/97 (5%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+G L+KL+ + L N I L +L+K+ +DL+ K E +L N ++
Sbjct: 146 LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKD 203
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS 190
+ P +S S + L ++S
Sbjct: 204 PDGRWI--SPYYISNGGSYVDGCVL-WELPVYTDEVS 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 15/94 (15%), Positives = 33/94 (35%), Gaps = 3/94 (3%)
Query: 96 NLTKLQSVLLQNNAILGPIP--ASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ + + +Q+N + I + +G + L L+ N +
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
+NN+L + ++D+S + SLP
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIH-SLP 218
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 18/94 (19%), Positives = 37/94 (39%), Gaps = 6/94 (6%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP-DSLGDLGNLNYLRL- 153
N +L+ + + L+ +++S N I D +L L+ +R+
Sbjct: 31 NAIELR---FVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
N+L PE+ + +L + +S + LP
Sbjct: 88 KANNLLYINPEAFQNLPNLQYLLISNTGIK-HLP 120
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 22/108 (20%), Positives = 36/108 (33%), Gaps = 9/108 (8%)
Query: 96 NLTKLQSVLLQNNAILGPIPAS-LGKLEKLQTLDLSNNKFTGEIPD-SLGDLGNLNYLRL 153
NL KL + ++ L I L LQ L +SN +PD L +
Sbjct: 77 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDI 135
Query: 154 N-NNSLTGSCPESLSKIES-LTLVDLSYNNLSGSLPKISARTFKVTGN 199
N ++ S + ++ L+ N + +I F T
Sbjct: 136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQ----EIHNSAFNGTQL 179
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 16/107 (14%), Positives = 30/107 (28%), Gaps = 2/107 (1%)
Query: 98 TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP-DSLGDLGNLNYLRLNNN 156
+ + L N I ++ + + NN E+P D L ++
Sbjct: 154 FESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRT 212
Query: 157 SLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLIC 203
+ L ++ L +L K+ A P C
Sbjct: 213 RIHSLPSYGLENLKKLRARSTYNLKKLPTLEKLVALMEASLTYPSHC 259
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-08
Identities = 34/134 (25%), Positives = 53/134 (39%), Gaps = 18/134 (13%)
Query: 58 TSVDPCSWRMITCSPDG---YVSALGLPSQSLSGTLSPW--IGNLTKLQSVLLQNNAILG 112
T+VD C+ R + P + + L L L +S G L L + L+ N + G
Sbjct: 11 TTVD-CTGRGLKEIPRDIPLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTG 68
Query: 113 PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNNNSLTGSCPE----SLS 167
P + +Q L L NK EI + + L L L L +N ++ L+
Sbjct: 69 IEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLN 126
Query: 168 KIESLTLVDLSYNN 181
+ SL L +N
Sbjct: 127 SLTSLNL----ASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 16/69 (23%), Positives = 32/69 (46%), Gaps = 4/69 (5%)
Query: 96 NLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRL 153
+ +Q + L N + I + L +L+TL+L +N+ + + + L +L L L
Sbjct: 76 GASHIQELQLGENK-IKEISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNL 133
Query: 154 NNNSLTGSC 162
+N +C
Sbjct: 134 ASNPFNCNC 142
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 15/102 (14%)
Query: 413 RGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472
R + LH +IHRD+K +N+L++ + + V DFGLA+++D + + G
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE-SAADNSEPTGQQSG 178
Query: 473 I----------APEY-LSTGQSSEKTDVFGFGILLLELITGQ 503
+ APE L++ + S DV+ G +L EL +
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-07
Identities = 22/89 (24%), Positives = 41/89 (46%), Gaps = 3/89 (3%)
Query: 96 NLTKLQSVLLQNNAI-LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
+ ++ ++L N+ G + + E+L+ L N T I + L L L L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS 183
+N ++G K +LT ++LS N +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-07
Identities = 25/90 (27%), Positives = 43/90 (47%), Gaps = 7/90 (7%)
Query: 94 IGNLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
+L+ + N + + +P KL KL+ L+LS+N+ +G + NL +L
Sbjct: 38 TDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93
Query: 152 RLNNNSLTG-SCPESLSKIESLTLVDLSYN 180
L+ N + S E L K+E+L +DL
Sbjct: 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-06
Identities = 21/67 (31%), Positives = 30/67 (44%), Gaps = 1/67 (1%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG-EIPDSLGDLGNLNYLR 152
+ L KL+ + L +N + G + K L L+LS NK + L L NL L
Sbjct: 60 LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119
Query: 153 LNNNSLT 159
L N +T
Sbjct: 120 LFNCEVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-07
Identities = 29/103 (28%), Positives = 45/103 (43%), Gaps = 11/103 (10%)
Query: 85 SLSGTLSPWIGNL----TKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFTGEI 138
L G P I NL + ++ +N I L P L +L+TL ++NN+
Sbjct: 25 DLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLKTLLVNNNRICRIG 80
Query: 139 PDSLGDLGNLNYLRLNNNSLTG-SCPESLSKIESLTLVDLSYN 180
L +L L L NNSL + L+ ++SLT + + N
Sbjct: 81 EGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 22/89 (24%), Positives = 41/89 (46%), Gaps = 5/89 (5%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGK-LEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154
N + + + L+ I P+ +LG L++ +D S+N+ ++ D L L L +N
Sbjct: 17 NAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVN 72
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS 183
NN + + LT + L+ N+L
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-07
Identities = 23/88 (26%), Positives = 36/88 (40%), Gaps = 4/88 (4%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
+ +L VL + G I + L+ L L N + +L L L L L+
Sbjct: 25 AVREL--VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSE 80
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLS 183
N + G K+ +LT ++LS N L
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 30/99 (30%), Positives = 46/99 (46%), Gaps = 3/99 (3%)
Query: 83 SQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSL 142
+S G + L+ + L N ++ ++L KL KL+ L+LS N+ G +
Sbjct: 34 CKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENRIFGGLDMLA 91
Query: 143 GDLGNLNYLRLNNNSLTG-SCPESLSKIESLTLVDLSYN 180
L NL +L L+ N L S E L K+E L +DL
Sbjct: 92 EKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 22/68 (32%), Positives = 30/68 (44%), Gaps = 3/68 (4%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT--GEIPDSLGDLGNLNYL 151
+ L KL+ + L N I G + KL L L+LS NK + + L L L L
Sbjct: 67 LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSL 125
Query: 152 RLNNNSLT 159
L N +T
Sbjct: 126 DLFNCEVT 133
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 31/139 (22%), Positives = 59/139 (42%), Gaps = 16/139 (11%)
Query: 56 DITSVDPCSWRMITCSP--DGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGP 113
+ + + +T + + S + + + I L ++ + L N +
Sbjct: 20 ETIKAN-LKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKL--- 75
Query: 114 IPASLG---KLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNNNSLTGSCPESL-SK 168
+ +L L L L+ N+ +P+ + D L NL L L N L S P+ + K
Sbjct: 76 --HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDK 131
Query: 169 IESLTLVDLSYNNLSGSLP 187
+ +LT ++L++N L SLP
Sbjct: 132 LTNLTYLNLAHNQLQ-SLP 149
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 27/90 (30%), Positives = 41/90 (45%), Gaps = 11/90 (12%)
Query: 97 LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNN 155
LT L + L +N + KL L LDLS N+ +P+ + D L L LRL
Sbjct: 132 LTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQ 190
Query: 156 NSLTGSCPE----SLSKIESLTLVDLSYNN 181
N L S P+ L+ ++ + L ++N
Sbjct: 191 NQLK-SVPDGVFDRLTSLQYIWL----HDN 215
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 5/88 (5%)
Query: 96 NLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRL 153
+LT+L + L N + +P+ + +L KL+ L L+ N+ IP D L NL L L
Sbjct: 105 HLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSL 162
Query: 154 NNNSLTGSCPESLSKIESLTLVDLSYNN 181
+ N L + ++ L + L + N
Sbjct: 163 STNQLQSVPHGAFDRLGKLQTITL-FGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 26/88 (29%), Positives = 36/88 (40%), Gaps = 3/88 (3%)
Query: 101 QSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTG 160
+ + LQ+ + A+ L KL L+L N+ DL L L L NN L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 161 SCPESL-SKIESLTLVDLSYNNLSGSLP 187
S P + + L + L N L SLP
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLP 123
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 29/72 (40%), Positives = 34/72 (47%), Gaps = 4/72 (5%)
Query: 97 LTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLN 154
LTKL+ + L N L IPA KL LQTL LS N+ +P D LG L + L
Sbjct: 130 LTKLKELRLNTNQ-LQSIPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLF 187
Query: 155 NNSLTGSCPESL 166
N S E L
Sbjct: 188 GNQFDCSRCEIL 199
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 49/236 (20%), Positives = 79/236 (33%), Gaps = 69/236 (29%)
Query: 308 ILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
LG G F V+ + VA+K ++ + E+ LL+
Sbjct: 26 KLGWGHFSTVWL-AKDMVNNTHVAMKIVR--GDKVYTEAAEDEI---------KLLQRV- 72
Query: 366 FCSTENERLLVYPYMPNGSVASRLRDH--------IH--------GRPALDWARR----- 404
N+ + +L DH +H G L ++
Sbjct: 73 -----NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 127
Query: 405 ------KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE------DFEAVVGDFGLA 452
K+I+ GL Y+H +C IIH D+K N+L++ + + D G A
Sbjct: 128 IPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
Query: 453 KLLDHRDSHVTTAV-----RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
D H T ++ R +PE L D++ L+ ELITG
Sbjct: 186 CWYDE---HYTNSIQTREYR------SPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 43/219 (19%), Positives = 77/219 (35%), Gaps = 34/219 (15%)
Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETI------ 352
++ LGRG + V++ ++ V VK LK + +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----------KKKIKREIKIL 84
Query: 353 -SLAVHRNLLRLCGFCSTENER--LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
+L N++ L R LV+ ++ N + + L +
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNN----TDFKQLY---QTLTDYDIRFYMY 137
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLDHRDSHVTTAVRG 468
+ L Y H I+HRDVK N+++D E + + D+GLA+ + V
Sbjct: 138 EILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRV-A 192
Query: 469 TVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRAL 506
+ PE L Q D++ G +L +I +
Sbjct: 193 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.6 bits (117), Expect = 1e-06
Identities = 17/101 (16%), Positives = 36/101 (35%), Gaps = 13/101 (12%)
Query: 96 NLTKLQSVLLQNNAILGPIPASL------GKLEKLQTLDLSNNKFTGEIPDSLGD---LG 146
NL KL + + + L+ L + + + + + + L
Sbjct: 220 NLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP 279
Query: 147 NLNYLRLNNNSLTGS----CPESLSKIESLTLVDLSYNNLS 183
L + ++ LT + + KI+ L +++ YN LS
Sbjct: 280 QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.6 bits (117), Expect = 1e-06
Identities = 14/81 (17%), Positives = 33/81 (40%), Gaps = 7/81 (8%)
Query: 95 GNLTKLQSVLLQNNAILGPIPASLGK---LEKLQTLDLSNNKFTGE----IPDSLGDLGN 147
L+ + + + + + L +L+T+D+S T E + D + + +
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308
Query: 148 LNYLRLNNNSLTGSCPESLSK 168
L ++ + N L+ + L K
Sbjct: 309 LKFINMKYNYLSDEMKKELQK 329
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 35/168 (20%), Positives = 56/168 (33%), Gaps = 34/168 (20%)
Query: 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
+G GGFG++Y + A +K G E L ++ + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG----PLFSE---LKFYQRVAKKDCIK 97
Query: 368 STENERLLVYPYMPN----GSVASRLRDH------IHGRPALD--WARRKRIALGT---- 411
+ L Y +P G + R + G L + T
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLG-IDLQKISGQNGTFKKSTVLQL 156
Query: 412 ARGLL----YLHEQCDPKIIHRDVKAANILLDEDFEAVV--GDFGLAK 453
+L Y+HE +H D+KAAN+LL V D+GL+
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 33/176 (18%), Positives = 60/176 (34%), Gaps = 47/176 (26%)
Query: 309 LGRGGFGIVYKGC---------FSDGALVAVK----------RLKDYNIAGGEVQFQTEV 349
R GI+Y+ ++K + A +Q
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 350 ETISLAVHRNLLRLCGFCSTENE-RLLVYPYM-PNGSVASRLRDHIHGRPALDWARRKRI 407
+ S + GF +++ R LV P + + L+ ALD + + +
Sbjct: 110 KLYSTP-LLAIPTCMGFGVHQDKYRFLVLPSLGRS------LQS------ALDVSPKHVL 156
Query: 408 ALGT----ARGLL----YLHEQCDPKIIHRDVKAANILLDEDFEAVV--GDFGLAK 453
+ + A LL +LHE +H +V A NI +D + ++ V +G A
Sbjct: 157 SERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 27/90 (30%), Positives = 43/90 (47%), Gaps = 12/90 (13%)
Query: 97 LTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
LT+L + L N L +P+++ +L L+ L + NK T E+P + L +L +L L+
Sbjct: 87 LTQLTVLDLGTNQ-LTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQ 144
Query: 156 NSLTGSCPE----SLSKIESLTLVDLSYNN 181
N L S P LS + L + N
Sbjct: 145 NQLK-SIPHGAFDRLSSLTHAYL----FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 27/98 (27%), Positives = 37/98 (37%), Gaps = 15/98 (15%)
Query: 98 TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT---GEIPDSLGDLGNLNYLRLN 154
T Q + L +N I P L L+ L L +N+ + DS L L L L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDS---LTQLTVLDLG 96
Query: 155 NNSLTGSCPE----SLSKIESLTLVDLSYNNLSGSLPK 188
N LT P L L + + N L+ LP+
Sbjct: 97 TNQLT-VLPSAVFDRLVH---LKELFMCCNKLT-ELPR 129
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 7e-06
Identities = 26/90 (28%), Positives = 41/90 (45%), Gaps = 11/90 (12%)
Query: 97 LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNN 155
LT L + L N + KL +L+ L L+ N+ +PD + D L L LRL
Sbjct: 75 LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQ 133
Query: 156 NSLTGSCPE----SLSKIESLTLVDLSYNN 181
N L S P+ L+ ++ + L ++N
Sbjct: 134 NQLK-SVPDGVFDRLTSLQYIWL----HDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 26/96 (27%), Positives = 42/96 (43%), Gaps = 11/96 (11%)
Query: 98 TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNNN 156
+ + L+ N++ +L L L L NK +P+ + + L +L YL L+ N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86
Query: 157 SLTGSCPE----SLSKIESLTLVDLSYNNLSGSLPK 188
L S P L++ L + L+ N L SLP
Sbjct: 87 QLQ-SLPNGVFDKLTQ---LKELALNTNQLQ-SLPD 117
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 30/137 (21%), Positives = 46/137 (33%), Gaps = 41/137 (29%)
Query: 97 LTKLQSVLLQNNAI----LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG------ 146
L + Q V L + + I ++L L L+L +N LGD+G
Sbjct: 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN--------ELGDVGVHCVLQ 78
Query: 147 -------NLNYLRLNNNSLTGSC----PESLSKIESLTLVDLSYNNLSGSLPKISARTFK 195
+ L L N LTG+ +L + +L + LS N L +
Sbjct: 79 GLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA---------- 128
Query: 196 VTGNPLICGPKATNNCT 212
G L+C C
Sbjct: 129 --GLQLLCEGLLDPQCR 143
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 25/101 (24%), Positives = 45/101 (44%), Gaps = 13/101 (12%)
Query: 98 TKLQSVLLQNNAI----LGPIPASLGKLEKLQTLDLSNNKFTGE----IPDSLGDLG-NL 148
K+Q + LQN + G + ++L L LQ L LS+N + + L D L
Sbjct: 85 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRL 144
Query: 149 NYLRLNNNSLTGSCPESLSKI----ESLTLVDLSYNNLSGS 185
L+L SL+ + E L+ + + +S N+++ +
Sbjct: 145 EKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEA 185
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 22/101 (21%), Positives = 43/101 (42%), Gaps = 13/101 (12%)
Query: 98 TKLQSVLLQNNAI----LGPIPASLGKLEKLQTLDLSNNKFTGE----IPDSLGDLG-NL 148
++L+++ + I G + L E L+ L L+ N+ E + ++L + G L
Sbjct: 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL 315
Query: 149 NYLRLNNNSLTGSCPESLSKI----ESLTLVDLSYNNLSGS 185
L + + S T +C S + L + +S N L +
Sbjct: 316 ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 14/67 (20%), Positives = 29/67 (43%), Gaps = 5/67 (7%)
Query: 124 LQTLDLSNNKFTGE-IPDSLGDLGNLNYLRLNNNSLTGSCPESLSKI----ESLTLVDLS 178
+Q+LD+ + + + L L +RL++ LT + + +S +L ++L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 179 YNNLSGS 185
N L
Sbjct: 65 SNELGDV 71
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 19/103 (18%), Positives = 37/103 (35%), Gaps = 13/103 (12%)
Query: 96 NLTKLQSVLLQNNAI----LGPIPASLGKLEKLQTLDLSNNKFTGE-----IPDSLGDLG 146
+ +L+++ L++ + + + L+ L L +NK P L
Sbjct: 197 SPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSS 256
Query: 147 NLNYLRLNNNSLTGSCPESLSKI----ESLTLVDLSYNNLSGS 185
L L + +T L ++ ESL + L+ N L
Sbjct: 257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 36/179 (20%), Positives = 59/179 (32%), Gaps = 53/179 (29%)
Query: 309 LGRGGFGIVYKGCFSDGALVAVKR-----------------LKDYNIAGGEVQFQTEVET 351
+G+GGFG +Y + V LK Y A E
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKP-------EQ 95
Query: 352 ISLAVHRNLLRLCGFCS-----TENERLLVYPYMPNGSVASRLRDHIHGRP---ALDWAR 403
I + L+ G ++ Y +M + R G +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRF-----GSDLQKIYEANA 146
Query: 404 RK-------RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVV--GDFGLAK 453
++ +++L L Y+HE +H D+KA+N+LL+ V D+GLA
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 29/89 (32%), Positives = 40/89 (44%), Gaps = 11/89 (12%)
Query: 98 TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNNN 156
T Q + L +N I P +L +L LDL NN+ T +P + D L L L LN+N
Sbjct: 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88
Query: 157 SLTGSCPE----SLSKIESLTLVDLSYNN 181
L S P +L + + L NN
Sbjct: 89 QLK-SIPRGAFDNLKSLTHIWL----LNN 112
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 23/105 (21%), Positives = 39/105 (37%), Gaps = 15/105 (14%)
Query: 94 IGNLTKLQSVLLQNNAI-----LGPIPASLGKLEKLQTLDLSNNKFTGE----IPDSLGD 144
+ L +V + N I + L ++L+ LDL +N FT + +L
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242
Query: 145 LGNLNYLRLNNNSLTGSCPESLSKI------ESLTLVDLSYNNLS 183
NL L LN+ L+ ++ L + L YN +
Sbjct: 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 23/116 (19%), Positives = 37/116 (31%), Gaps = 27/116 (23%)
Query: 94 IGNLTKLQSVLLQNNAI----------LGPIPASLGKLEKLQTLDLSNNKFTGE----IP 139
I + L+ + L + +L K KL T+ LS+N F +
Sbjct: 56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115
Query: 140 DSLGDLGNLNYLRLNNNSLTGSCPESLSKI-------------ESLTLVDLSYNNL 182
D L L +L L+NN L +++ L + N L
Sbjct: 116 DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 18/108 (16%), Positives = 38/108 (35%), Gaps = 19/108 (17%)
Query: 94 IGNLTKLQSVLLQNNAI----LGPIPASLGKLEKLQTLDLSNNKFTGE----IPDSLGDL 145
+ + ++ L+ +AI + A L + + ++ + LS N E + +++
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 146 GNLNYLRLNNNSLTGSCPE----------SLSKIESLTLVDLSYNNLS 183
+L ++ E +L K L V LS N
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 107
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 22/75 (29%), Positives = 35/75 (46%), Gaps = 8/75 (10%)
Query: 114 IPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLT 173
IP + L L N+FT +P L + +L + L+NN ++ +S S + L
Sbjct: 29 IPRDV------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81
Query: 174 LVDLSYNNLSGSLPK 188
+ LSYN L +P
Sbjct: 82 TLILSYNRLR-CIPP 95
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 20/69 (28%), Positives = 34/69 (49%), Gaps = 4/69 (5%)
Query: 96 NLTKLQSVLLQNNAILGPIPASL-GKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRL 153
N+T+L +++L N L IP L+ L+ L L N + +P+ + L L++L +
Sbjct: 76 NMTQLLTLILSYNR-LRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAI 133
Query: 154 NNNSLTGSC 162
N L C
Sbjct: 134 GANPLYCDC 142
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 8e-05
Identities = 31/89 (34%), Positives = 39/89 (43%), Gaps = 11/89 (12%)
Query: 98 TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD-LGNLNYLRLNNN 156
T Q + L NN I P L LQ L ++NK T IP + D L L L LN+N
Sbjct: 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDN 91
Query: 157 SLTGSCPE----SLSKIESLTLVDLSYNN 181
L S P +L + + L YNN
Sbjct: 92 HLK-SIPRGAFDNLKSLTHIYL----YNN 115
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 30/151 (19%), Positives = 44/151 (29%), Gaps = 59/151 (39%)
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILL-------------------------- 438
K+I +GL YLH +C +IIH D+K NILL
Sbjct: 149 KKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 439 -----------------------DEDFEAVVGDFGLAKLLDHRDSHV--TTAVRGTVGHI 473
E + + D G A + + T R
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR------ 260
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQR 504
+ E L + D++ + EL TG
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDY 291
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 22/73 (30%), Positives = 37/73 (50%), Gaps = 6/73 (8%)
Query: 96 NLTKLQSVLLQNNAI--LGPIPASLGKLEKLQTLDLSNNKFT--GEIPDSLGDLGNLNYL 151
N+ +L S+ L NN + L + + + K L+ L+LS N+ E+ D + L L L
Sbjct: 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSEREL-DKIKGL-KLEEL 225
Query: 152 RLNNNSLTGSCPE 164
L+ NSL + +
Sbjct: 226 WLDGNSLCDTFRD 238
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 51/244 (20%), Positives = 90/244 (36%), Gaps = 38/244 (15%)
Query: 276 NDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRL 333
ND YD + ++ + +++G+G FG V K + + VA+K +
Sbjct: 34 NDGYDDDN--YDYIVKNGEKW---MDRYEIDSLIGKGSFGQVVK-AYDRVEQEWVAIKII 87
Query: 334 KD----YNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM-PNGSVASR 388
K+ N A EV+ + + ++ L N LV+ + N
Sbjct: 88 KNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN------ 141
Query: 389 LRDHI--HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV- 445
L D + + ++ A LL+L + IIH D+K NILL +
Sbjct: 142 LYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI 200
Query: 446 -VGDFGLAKLLDHRDSHVTTAV-----RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 499
+ DFG + + + R +PE L D++ G +L+E+
Sbjct: 201 KIVDFGSSC---QLGQRIYQYIQSRFYR------SPEVLLGMPYDLAIDMWSLGCILVEM 251
Query: 500 ITGQ 503
TG+
Sbjct: 252 HTGE 255
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 5e-04
Identities = 24/79 (30%), Positives = 33/79 (41%), Gaps = 15/79 (18%)
Query: 114 IPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPE----SLSKI 169
IP+S L+L +NK L L L L+ N + S P+ L+K
Sbjct: 26 IPSSA------TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK- 77
Query: 170 ESLTLVDLSYNNLSGSLPK 188
LT++ L N L SLP
Sbjct: 78 --LTILYLHENKLQ-SLPN 93
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 48/222 (21%), Positives = 82/222 (36%), Gaps = 55/222 (24%)
Query: 308 ILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAVH-----RN 359
++G+G FG V K + VA+K ++ N Q E+ + L N
Sbjct: 104 VIGKGSFGQVVK-AYDHKVHQHVALKMVR--NEKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 360 LLRLCGF-------CSTENERLLVYPYM-PNGSVASRLRDHI---HGRPALDWARRKRIA 408
++ + C + + + N L + I + ++ A
Sbjct: 161 VIHMLENFTFRNHIC-------MTFELLSMN------LYELIKKNKFQG-FSLPLVRKFA 206
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV--VGDFGLAKLLDHRDSHVTTAV 466
+ L LH+ +IIH D+K NILL + + V DFG + + V T +
Sbjct: 207 HSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC---YEHQRVYTYI 260
Query: 467 -----RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
R APE + + D++ G +L EL+TG
Sbjct: 261 QSRFYR------APEVILGARYGMPIDMWSLGCILAELLTGY 296
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 540 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.98 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.9 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.89 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.88 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.86 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.85 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.78 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.76 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.74 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.74 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.74 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.72 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.71 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.71 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.71 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.71 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.71 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.7 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.69 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.69 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.66 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.66 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.66 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.65 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.63 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.63 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.62 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.62 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.62 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.62 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.61 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.61 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.61 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.6 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.6 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.6 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.6 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.6 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.6 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.6 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.6 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.6 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.6 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.59 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.58 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.58 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.58 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.58 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.58 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.57 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.56 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.56 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.56 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.55 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.55 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.54 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.54 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.53 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.53 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.53 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.52 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.51 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.51 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.51 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.5 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.5 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.5 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.5 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.5 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.5 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.5 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.48 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.48 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.48 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.48 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.47 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.47 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.46 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.46 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.46 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.45 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.45 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.45 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.44 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.43 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.43 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.42 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.42 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.42 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.42 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.42 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.41 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.39 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.39 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.38 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.38 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.37 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.36 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.35 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.34 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.34 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.33 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.32 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.3 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.29 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.28 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.27 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.26 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.25 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.22 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.22 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.22 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.17 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.17 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.15 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.14 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.1 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.1 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.1 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.1 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.09 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.94 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.88 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.87 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.78 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.73 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.72 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.71 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.62 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.55 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.52 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.51 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.42 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.29 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.21 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.18 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.11 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.11 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.01 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.01 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.98 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.95 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.84 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.76 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.75 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.65 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.64 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.55 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.53 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.46 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.41 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.3 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.26 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.22 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.15 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.13 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.11 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.09 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.87 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.82 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.79 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.68 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.68 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.6 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.48 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.33 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 96.21 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 95.89 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.8 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 95.09 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.82 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.01 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 93.83 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 92.14 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.99 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 89.37 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.12 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.35 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.49 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 82.3 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 81.1 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=388.24 Aligned_cols=204 Identities=28% Similarity=0.474 Sum_probs=177.1
Q ss_pred cCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
++|.+.+.||+|+||+||+|++. ++..||||+++... ....++|.+|++++++++|||||+++|+|.+++..+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 56778899999999999999874 47889999997643 344568999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhccccC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeE
Q 009208 375 LVYPYMPNGSVASRLRDHI---------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV 445 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 445 (540)
+|||||++|+|.++|+... .....++|..+..++.||++||+|||++ +|+||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 9999999999999997531 2245799999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCCCCCce-eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 446 VGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 446 l~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
|+|||+|+......... .....||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~ 233 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 233 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999998765433322 233468999999999999999999999999999999999 8999974
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=388.79 Aligned_cols=204 Identities=23% Similarity=0.357 Sum_probs=177.6
Q ss_pred CCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
++.+.+.||+|+||+||+|.+. +++.||||+++........++|.+|+.++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3556688999999999999873 4688999999876555567789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC
Q 009208 376 VYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 443 (540)
|||||++|+|.++|+.... ....++|..+..|+.|||+||+|||++ +||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 9999999999999965321 124699999999999999999999999 9999999999999999999
Q ss_pred eEEcccccccccCCCCC-ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 444 AVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 444 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~ 250 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 250 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC
Confidence 99999999987644322 22345569999999999999999999999999999999999 8999974
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=387.89 Aligned_cols=204 Identities=28% Similarity=0.489 Sum_probs=171.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
++|.+.+.||+|+||+||+|+++ +++.||||+++... ....++|.+|++++++++|||||+++|+|.+.+..+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45667789999999999999874 47889999997643 344568999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhccccCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC
Q 009208 375 LVYPYMPNGSVASRLRDHIH-----------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 443 (540)
||||||++|+|.++|+.... ...+++|..+..|+.||++||+|||+. +||||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 99999999999999976422 235699999999999999999999999 9999999999999999999
Q ss_pred eEEcccccccccCCCCC-ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 444 AVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 444 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~ 263 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 263 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC
Confidence 99999999987654332 23345679999999999999999999999999999999999 8999974
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=381.35 Aligned_cols=200 Identities=33% Similarity=0.492 Sum_probs=168.5
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.+++.+.+.||+|+||+||+|++++ .||||+++.... .....+|.+|++++++++|||||+++|+|.. +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3567788999999999999998753 699999875432 2334579999999999999999999998864 56899999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
||++|+|.++|+.. ...++|..+..|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999999753 45799999999999999999999999 9999999999999999999999999999876533
Q ss_pred C-Cceeecccccccccccccccc---CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 D-SHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~-~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ........||+.|||||++.. ..++.++|||||||++|||+||+.||..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~ 239 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH 239 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC
Confidence 2 223345679999999999864 3589999999999999999999999974
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=386.32 Aligned_cols=203 Identities=23% Similarity=0.360 Sum_probs=174.4
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
++|.+.+.||+|+||+||+|... +|+.||||+++..... .....+.+|++++++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57889999999999999999975 6999999999765432 334579999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.++|... ....+++..+..++.||+.||+|||++ +||||||||+|||+++++.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999753 245689999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
. .......||+.|||||++.+..|+.++||||+||++|||+||+.||...
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 228 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 1 2234557999999999999999999999999999999999999999743
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=382.80 Aligned_cols=202 Identities=26% Similarity=0.390 Sum_probs=181.3
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|.+.+.||+|+||+||+|+.. +|+.||||++++... ......+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56899999999999999999975 689999999975432 233567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++++. +.+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999999763 4699999999999999999999999 999999999999999999999999999998754
Q ss_pred CC-CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. .......+||+.|||||++.+..|+.++||||+||++|||+||+.||...
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 33 23345668999999999999999999999999999999999999999743
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=387.54 Aligned_cols=198 Identities=24% Similarity=0.361 Sum_probs=178.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+.|+..+.||+|+||+||+|..+ +|+.||||+++.... .....+.+|++++++++|||||++++++.+++..||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 45788899999999999999975 699999999975442 3344688999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++|+|.+++.+ ..+++..+..++.||+.||+|||++ +||||||||+|||+++++.+||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999999864 3589999999999999999999999 99999999999999999999999999998775433
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||..
T Consensus 225 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 272 (346)
T 4fih_A 225 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 272 (346)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2 33456799999999999999999999999999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=381.47 Aligned_cols=195 Identities=25% Similarity=0.297 Sum_probs=171.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+.|...+.||+|+||.||+|..+ +|+.||||+++.... ..+|++++++++|||||++++++.+++..+|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45777889999999999999975 689999999976432 24799999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEcccccccccCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLLDHR 458 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~~~~ 458 (540)
+++|+|.++|++. ..+++..+..++.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+.+...
T Consensus 132 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 9999999999763 4699999999999999999999999 999999999999999887 6999999999977543
Q ss_pred CCc----eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSH----VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||..
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 258 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 221 12335699999999999999999999999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=388.48 Aligned_cols=198 Identities=24% Similarity=0.361 Sum_probs=178.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+.|+..+.||+|+||.||+|... +|+.||||+++.... .....+.+|+++|++++|||||++++++.+++..||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 56888999999999999999975 699999999976542 3344689999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
|++|+|.++++. ..+++..+..++.||+.||+|||++ +||||||||+|||+++++.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999999864 3589999999999999999999999 99999999999999999999999999998775433
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. .....+||+.|||||++.+..|+.++|||||||++|||++|+.||..
T Consensus 302 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 349 (423)
T 4fie_A 302 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 349 (423)
T ss_dssp C-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred c-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2 33456799999999999999999999999999999999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=366.46 Aligned_cols=196 Identities=29% Similarity=0.445 Sum_probs=168.2
Q ss_pred CcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEec----CCeeEEEE
Q 009208 304 SAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCST----ENERLLVY 377 (540)
Q Consensus 304 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lV~ 377 (540)
...+.||+|+||+||+|... ++..||+|++...... .....|.+|++++++++|||||++++++.. ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45567999999999999975 5899999999764432 334579999999999999999999999864 34579999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-CCCCeEEcccccccccC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~ 456 (540)
|||++|+|.+++++. ..+++..+..++.||++||+|||++ .++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999763 4699999999999999999999998 12399999999999998 47899999999998644
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. ......||+.|||||++.+ .|+.++|||||||++|||+||+.||..
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 32 2345679999999998865 699999999999999999999999963
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=377.57 Aligned_cols=201 Identities=28% Similarity=0.371 Sum_probs=170.8
Q ss_pred cCCCcCCeeeeccCccEEEEEeC----CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
++|++.+.||+|+||+||+|+.. .++.||||+++..... ....++.+|++++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56899999999999999999852 4789999999754322 233468899999999999999999999999999999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||+++|+|.+++.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999999763 4699999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.... .......||+.|||||++.+..|+.++||||+||++|||+||+.||...
T Consensus 177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 4322 2234567999999999999999999999999999999999999999743
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=363.10 Aligned_cols=198 Identities=24% Similarity=0.427 Sum_probs=163.0
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|++.+.||+|+||+||+|... +|+.||+|+++.... ......+.+|++++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999974 699999999976432 233457999999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+ +|+|.+++.+ ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6899999875 35799999999999999999999999 999999999999999999999999999986653
Q ss_pred CCCceeeccccccccccccccccCCC-CccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. ......||+.|||||++.+..+ +.++||||+||++|||+||+.||+.
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~ 214 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence 22 2344679999999999988776 5899999999999999999999974
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=380.14 Aligned_cols=215 Identities=26% Similarity=0.359 Sum_probs=185.8
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccCccEEEEEeCC------CcEEEEEEeccCCccccHHHHHHHHHHHhcccC-CCccce
Q 009208 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVH-RNLLRL 363 (540)
Q Consensus 291 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l 363 (540)
+..++++...++|.+.+.||+|+||+||+|.+.. ++.||||.++........++|.+|++++.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4455666677899999999999999999998642 468999999876655556789999999999976 899999
Q ss_pred eEEEecC-CeeEEEEecCCCCChhhhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 009208 364 CGFCSTE-NERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRD 430 (540)
Q Consensus 364 ~~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~D 430 (540)
+|+|..+ +..++|||||++|+|.++|+.... ....++|..+..++.|||+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999765 568999999999999999975321 134589999999999999999999999 999999
Q ss_pred CCCCceeeCCCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 431 VKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 431 lk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
|||+|||+++++.+||+|||+|+.+...... ......||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544333 3445679999999999999999999999999999999998 9999974
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=369.41 Aligned_cols=199 Identities=27% Similarity=0.402 Sum_probs=164.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCC----eeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN----ERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lV 376 (540)
.+|.+.+.||+|+||+||+|++ +|+.||||+++... .....+..|+..+.+++|||||+++|+|..++ ..+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 3567788999999999999998 68999999997532 11223345666667889999999999997654 57999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ-----CDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
||||++|+|.++|++ ..++|..+.+++.|+++||+|||++ +.++|+||||||+|||+++++.+||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999975 3589999999999999999999976 356899999999999999999999999999
Q ss_pred ccccCCCCCce---eeccccccccccccccccC------CCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 452 AKLLDHRDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 452 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
++......... .....||+.|||||++.+. .++.++|||||||++|||+||+.||.
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 98765543322 2345699999999998754 46789999999999999999988775
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=361.10 Aligned_cols=200 Identities=26% Similarity=0.401 Sum_probs=163.3
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCC--------
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN-------- 371 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-------- 371 (540)
++|++.+.||+|+||+||+|..+ +|+.||||+++..........+.+|++++++++|||||++++++...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45888999999999999999975 689999999986554455567999999999999999999999986543
Q ss_pred ----eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEc
Q 009208 372 ----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG 447 (540)
Q Consensus 372 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 447 (540)
..++||||+++|+|.+++.... .....++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999997532 223467788899999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCc-----------eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 448 DFGLAKLLDHRDSH-----------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 448 Dfgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
|||+|+.+...... .....+||+.|||||++.+..|+.++|||||||++|||++ ||.
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 99999876543221 1223569999999999999999999999999999999996 776
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=359.85 Aligned_cols=201 Identities=21% Similarity=0.336 Sum_probs=171.8
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEec------CCe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCST------ENE 372 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~ 372 (540)
++|.+.+.||+|+||+||+|... +|+.||||+++.... ......+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 56889999999999999999975 699999999975432 2334568899999999999999999998754 357
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.|||||||+ |+|.+++.+ ...+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999996 678888864 45799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC---CceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 453 KLLDHRD---SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 453 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+.+.... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~ 266 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK 266 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence 8764321 2223456799999999998775 5699999999999999999999999754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=351.63 Aligned_cols=254 Identities=72% Similarity=1.152 Sum_probs=210.2
Q ss_pred cCCCCCCCccccCcccccCHHHHHHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHh
Q 009208 274 DVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETIS 353 (540)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~ 353 (540)
+.....++....+....+++.++....++|...+.||+|+||.||+|...+|+.||||+++..........+.+|++++.
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~ 82 (326)
T 3uim_A 3 DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMIS 82 (326)
T ss_dssp ------------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGG
T ss_pred CCCcccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHH
Confidence 33445566666777889999999999999999999999999999999988899999999987554444447899999999
Q ss_pred cccCCCccceeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 009208 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKA 433 (540)
Q Consensus 354 ~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~ 433 (540)
.++||||+++++++...+..++||||+++|+|.++++........+++..+..++.|++.||+|||+.+.++|+||||||
T Consensus 83 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp 162 (326)
T 3uim_A 83 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 162 (326)
T ss_dssp TCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSG
T ss_pred hccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCch
Confidence 99999999999999999999999999999999999987666667799999999999999999999998888999999999
Q ss_pred CceeeCCCCCeEEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcccccc
Q 009208 434 ANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAAN 513 (540)
Q Consensus 434 ~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~ 513 (540)
+||++++++.+||+|||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||+......
T Consensus 163 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (326)
T 3uim_A 163 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242 (326)
T ss_dssp GGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred hhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence 99999999999999999998776555555556679999999999988899999999999999999999999997433222
Q ss_pred -cCCcHHHHHHHHhh
Q 009208 514 -QRGVMLDWVCSHIL 527 (540)
Q Consensus 514 -~~~~~~~w~~~~~~ 527 (540)
......+|+.....
T Consensus 243 ~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 243 DDDVMLLDWVKGLLK 257 (326)
T ss_dssp TSCSBHHHHHTTTTS
T ss_pred ccchhHHHHHHHHhh
Confidence 23334466665444
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=351.46 Aligned_cols=199 Identities=23% Similarity=0.382 Sum_probs=171.0
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeC----CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCe
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENE 372 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 372 (540)
...+.|.+.+.||+|+||+||+|+.+ .++.||+|++.... ...++.+|++++..+ .||||+++++++.+++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 34578999999999999999999853 46889999986543 345688999999988 69999999999999999
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGL 451 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgl 451 (540)
.++||||+++|+|.+++. .+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 95 ~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 999999999999999884 388999999999999999999999 99999999999999876 7999999999
Q ss_pred ccccCCCCC---------------------------ceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCC
Q 009208 452 AKLLDHRDS---------------------------HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQ 503 (540)
Q Consensus 452 a~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~ 503 (540)
|+....... ......+||+.|+|||++.+. .++.++||||+||++|||+||+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 986543211 112334699999999999775 5899999999999999999999
Q ss_pred CCCCcc
Q 009208 504 RALDFG 509 (540)
Q Consensus 504 ~p~~~~ 509 (540)
.||..+
T Consensus 245 ~Pf~~~ 250 (361)
T 4f9c_A 245 YPFYKA 250 (361)
T ss_dssp SSSSCC
T ss_pred CCCCCC
Confidence 999644
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=370.93 Aligned_cols=200 Identities=29% Similarity=0.393 Sum_probs=173.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHH---HHHHHhcccCCCccceeEEEecCCee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQT---EVETISLAVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~ 373 (540)
.++|.+.++||+|+||+||+|..+ +|+.||+|++++... ........+ +++++..++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367899999999999999999975 699999999975322 122223333 46667788999999999999999999
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
|+||||++||+|.++|.+. +.+++..+..++.||+.||+|||++ +||||||||+|||++++|.+||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 9999999999999999763 4699999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.+.... ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||...
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 765432 344679999999999975 57899999999999999999999999743
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=360.25 Aligned_cols=200 Identities=24% Similarity=0.383 Sum_probs=178.9
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|.+.+.||+|+||.||+|..+ +|+.||+|+++... ......+.+|+++|+.++|||||++++++.+++..++|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 367999999999999999999975 68999999997644 3334578999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC--CCeEEcccccccccC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED--FEAVVGDFGLAKLLD 456 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~Dfgla~~~~ 456 (540)
||++|+|.++|.+. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.+.
T Consensus 235 ~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 235 FMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred ecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 99999999998642 35699999999999999999999999 99999999999999854 899999999999876
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ......||+.|||||++.+..|+.++||||+||++|||++|+.||..
T Consensus 309 ~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~ 358 (573)
T 3uto_A 309 PKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 358 (573)
T ss_dssp TTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 433 33455799999999999999999999999999999999999999974
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=347.02 Aligned_cols=212 Identities=22% Similarity=0.329 Sum_probs=183.9
Q ss_pred HHHHHHHhcCCCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEec
Q 009208 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCST 369 (540)
Q Consensus 293 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 369 (540)
+.+++...++|.+.+.||+|+||+||+|..++ ++.||+|+++..... .....+.+|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44555667899999999999999999999864 789999999753211 112248899999999999999999999999
Q ss_pred CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccc
Q 009208 370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF 449 (540)
Q Consensus 370 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 449 (540)
.+..++||||+++|+|.+++.+. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999752 35699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeccccccccccccccc-----cCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
|+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 999876654444445567999999999987 4578999999999999999999999997543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=325.27 Aligned_cols=227 Identities=41% Similarity=0.731 Sum_probs=192.4
Q ss_pred CHHHHHHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCC
Q 009208 292 TFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN 371 (540)
Q Consensus 292 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 371 (540)
++.++...+++|...+.||+|+||.||+|..++++.||||++.... ......+.+|++++..++||||+++++++...+
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 3444555778999999999999999999999889999999987653 344567999999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
..++||||+++|+|.+++.........++|..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999976544445699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCC-CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcccccccCCcHHHHHH
Q 009208 452 AKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVC 523 (540)
Q Consensus 452 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~~~~~~~~w~~ 523 (540)
++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||....+.+ .....+|..
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~-~~~~~~~~~ 257 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNLAEWAV 257 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS-CCCHHHHTH
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH-HHHHHHHhh
Confidence 98654322 222334458999999999998999999999999999999999999998544332 223445544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=341.33 Aligned_cols=210 Identities=22% Similarity=0.347 Sum_probs=181.8
Q ss_pred HHHHHHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEec
Q 009208 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCST 369 (540)
Q Consensus 293 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 369 (540)
+.+++...++|.+.+.||+|+||.||+|..+ +++.||+|+++.... ......+.+|++++..++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3445556788999999999999999999986 589999999865321 1122357899999999999999999999999
Q ss_pred CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccc
Q 009208 370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF 449 (540)
Q Consensus 370 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 449 (540)
.+..++||||+++|+|.+++++ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 9999999999999999999875 2589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeccccccccccccccccCC----CCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ----SSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
|+++..............||+.|+|||++.... ++.++|||||||++|||++|+.||...+
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 999876654433344667999999999997655 7899999999999999999999997543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=340.61 Aligned_cols=213 Identities=23% Similarity=0.323 Sum_probs=183.8
Q ss_pred CHHHHHHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEe
Q 009208 292 TFKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCS 368 (540)
Q Consensus 292 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 368 (540)
.+++.+...++|.+.+.||+|+||.||++..+ +|+.||+|++++... ......+.+|.+++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455556788999999999999999999985 689999999975321 111234789999999999999999999999
Q ss_pred cCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcc
Q 009208 369 TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD 448 (540)
Q Consensus 369 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 448 (540)
+.+..++||||+++|+|.+++.+. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999753 23689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeeccccccccccccccc-------cCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 449 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS-------TGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 449 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
||+++..............||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 9999877654433344567999999999987 3568999999999999999999999997543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=314.46 Aligned_cols=199 Identities=23% Similarity=0.377 Sum_probs=178.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
..+|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc-ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 46788999999999999999986 468999999987554 3345678999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.+++.+. .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 99999999999752 589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 218 (297)
T 3fxz_A 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (297)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 32 23345699999999999999999999999999999999999999974
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=321.84 Aligned_cols=211 Identities=23% Similarity=0.327 Sum_probs=184.9
Q ss_pred cccCHHHHHHHhcC----------CCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccC
Q 009208 289 KRYTFKELRAATSN----------FSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH 357 (540)
Q Consensus 289 ~~~~~~~l~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h 357 (540)
..+++++++.+++. |...+.||+|+||.||+|... +|+.||||+++... ......+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCC
Confidence 45778888877765 566679999999999999986 69999999997644 3445678999999999999
Q ss_pred CCccceeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 009208 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANIL 437 (540)
Q Consensus 358 ~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIL 437 (540)
|||+++++++...+..++||||+++|+|.+++.+ ..+++..+..++.|+++||.|||+. +|+||||||+||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999998864 3589999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 438 LDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 438 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~ 244 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD 244 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999987654322 233456999999999999999999999999999999999999999743
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.28 Aligned_cols=201 Identities=24% Similarity=0.319 Sum_probs=177.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC--ccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN--IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.++|.+.+.||+|+||.||+|..+ +|+.||+|+++... .......+.+|++++..++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357888999999999999999975 68999999997542 123445788999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++|+|.+++.+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 9999999999998753 4689999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 207 (337)
T 1o6l_A 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC
Confidence 222 223455699999999999999999999999999999999999999974
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=314.44 Aligned_cols=202 Identities=30% Similarity=0.498 Sum_probs=176.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|...+.||+|+||.||+|... +++.||+|++.... ......+.+|++++.+++||||+++++++..++..++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 356788899999999999999975 58999999986533 3445679999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 88 YIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 99999999999763 35699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCce-------------eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHV-------------TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... .....||+.|+|||++.+..++.++||||||+++|||++|..|+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~ 224 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence 2211 1145699999999999999999999999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=314.20 Aligned_cols=203 Identities=26% Similarity=0.371 Sum_probs=173.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.++|.+.+.||+|+||.||+|... +++.||+|++...... .....+.+|++++.+++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357888999999999999999964 6899999998654322 2235789999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999999753 4689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
...........||+.|+|||.+.+..++.++||||||+++|||+||+.||+..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 215 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 44333344556999999999999999999999999999999999999999743
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=325.83 Aligned_cols=201 Identities=25% Similarity=0.362 Sum_probs=176.0
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcccc--HHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG--EVQFQTEVETISLA-VHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 375 (540)
.++|.+.+.||+|+||.||+|+.+ +++.||+|+++....... ...+.+|..++.++ +||||+++++++...+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467889999999999999999976 578999999986542222 23578899999876 89999999999999999999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||+++|+|..++.+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999998753 4699999999999999999999999 9999999999999999999999999999853
Q ss_pred CCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 204 ~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 204 LRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp CCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred ccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 322 2234456799999999999999999999999999999999999999974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=324.75 Aligned_cols=200 Identities=26% Similarity=0.340 Sum_probs=176.3
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC--ccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN--IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|.+.+.||+|+||.||++... +++.||+|+++... .......+.+|++++..++||||+++++++...+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888999999999999999975 58899999986532 1233457889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 95 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999875 35699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeecccccccccccccccc---CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 32 2345569999999999864 35899999999999999999999999743
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.32 Aligned_cols=201 Identities=25% Similarity=0.402 Sum_probs=177.9
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
..+|.+.+.||+|+||.||+|.. .+|+.||||++..... .....++.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46788999999999999999997 5799999999976432 233456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999999753 4689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccccccccccccccccCCCC-ccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSS-EKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. ......||+.|+|||++.+..++ .++||||+||++|||++|+.||+..
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 32 23445699999999999887764 8999999999999999999999743
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=325.09 Aligned_cols=203 Identities=30% Similarity=0.391 Sum_probs=173.6
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC--ccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN--IAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 374 (540)
..++|.+.+.||+|+||.||+|..+ +|+.||+|+++... .......+.+|.+++..+ +||||+++++++...+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999975 58999999997542 123345678999999987 6999999999999999999
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 101 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 999999999999999753 4699999999999999999999999 999999999999999999999999999985
Q ss_pred cCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 174 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 174 GICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence 4322 22334557999999999999888999999999999999999999999743
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=323.26 Aligned_cols=206 Identities=30% Similarity=0.437 Sum_probs=178.5
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC--------CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecC
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS--------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE 370 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 370 (540)
.++|.+.+.||+|+||.||+|... ++..||||+++.........++.+|++++.++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888899999999999999852 35679999998765444556799999999999 899999999999999
Q ss_pred CeeEEEEecCCCCChhhhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl 438 (540)
+..++||||+++|+|.+++..... ....+++..+..++.|+++||+|||+. +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999976421 124589999999999999999999999 99999999999999
Q ss_pred CCCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 439 DEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 439 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~ 308 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999866543221 2233457889999999999999999999999999999999 9999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=317.36 Aligned_cols=203 Identities=26% Similarity=0.397 Sum_probs=174.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.++..++||||+++++++...+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 357889999999999999999976 7899999999765544445678999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999998864 35699999999999999999999999 9999999999999999999999999999865432
Q ss_pred CC-ceeeccccccccccccccccCCC-CccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 459 DS-HVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 459 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||+..
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 211 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 21 22234569999999999987765 78999999999999999999999743
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.96 Aligned_cols=203 Identities=17% Similarity=0.184 Sum_probs=175.7
Q ss_pred HhcCCCcCCeeeeccCccEEEEE------eCCCcEEEEEEeccCCccccHHHHHHHHHHHhccc---CCCccceeEEEec
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGC------FSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV---HRNLLRLCGFCST 369 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~ 369 (540)
..++|.+.+.||+|+||.||+|. ..+++.||||+++.. ...++..|++++..++ |+||+++++++..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 35678889999999999999994 346899999998753 3456788888888776 9999999999999
Q ss_pred CCeeEEEEecCCCCChhhhccccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC--------
Q 009208 370 ENERLLVYPYMPNGSVASRLRDHIH-GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-------- 440 (540)
Q Consensus 370 ~~~~~lV~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-------- 440 (540)
.+..++||||+++|+|.+++..... ....+++..+..++.|+++||+|||+. +|+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999975322 245799999999999999999999999 9999999999999998
Q ss_pred ---CCCeEEcccccccccCC-CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 441 ---DFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 441 ---~~~~kl~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
++.+||+|||+++.+.. ..........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 89999999999976542 223344556799999999999999999999999999999999999999963
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=308.30 Aligned_cols=218 Identities=43% Similarity=0.739 Sum_probs=189.5
Q ss_pred cccccCHHHHHHHhcCCCcC------CeeeeccCccEEEEEeCCCcEEEEEEeccCC---ccccHHHHHHHHHHHhcccC
Q 009208 287 HLKRYTFKELRAATSNFSAK------NILGRGGFGIVYKGCFSDGALVAVKRLKDYN---IAGGEVQFQTEVETISLAVH 357 (540)
Q Consensus 287 ~~~~~~~~~l~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h 357 (540)
....+++.++..++.+|... +.||+|+||.||+|.. +++.||||++.... .......+.+|++++.+++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678999999999999887 8999999999999987 68899999987532 12335679999999999999
Q ss_pred CCccceeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCcee
Q 009208 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANIL 437 (540)
Q Consensus 358 ~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIL 437 (540)
|||+++++++...+..++||||+++|+|.+++... .....+++..+..++.|+++||.|||+. +|+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 99999999999999999999999999999998753 2345699999999999999999999999 9999999999999
Q ss_pred eCCCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 438 LDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 438 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
+++++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||+...
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 999999999999999876543222 2334569999999998764 58899999999999999999999998543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=316.31 Aligned_cols=198 Identities=30% Similarity=0.398 Sum_probs=176.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.++|.+.+.||+|+||.||+|... +|+.||+|+++.... ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 356888999999999999999975 689999999975421 22345688999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999975 24689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 205 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 32 2345699999999999999999999999999999999999999974
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=318.74 Aligned_cols=205 Identities=29% Similarity=0.420 Sum_probs=178.1
Q ss_pred HHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcc-cCCCccceeEEEecCCe
Q 009208 297 RAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENE 372 (540)
Q Consensus 297 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 372 (540)
....++|.+.+.||+|+||.||+|..+ +|+.||+|+++.... ......+..|.+++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999985 589999999976421 23345678899999876 89999999999999999
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence 99999999999999999753 4689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (345)
T 1xjd_A 166 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221 (345)
T ss_dssp BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence 8543222 2234567999999999999999999999999999999999999999743
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=317.36 Aligned_cols=200 Identities=23% Similarity=0.324 Sum_probs=178.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-----cHHHHHHHHHHHhcccCCCccceeEEEecCCee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-----GEVQFQTEVETISLAVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 373 (540)
.+.|.+.+.||+|+||.||+|... +|+.||+|.++...... ....+.+|++++.+++||||+++++++...+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467889999999999999999975 58999999997654322 356799999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC----CeEEccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF----EAVVGDF 449 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Df 449 (540)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||++++++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999864 35699999999999999999999999 999999999999998777 7999999
Q ss_pred ccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~ 220 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9998765432 23345699999999999988999999999999999999999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=313.12 Aligned_cols=202 Identities=25% Similarity=0.355 Sum_probs=172.6
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccc-cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|.+.+.||+|+||.||+|...+|+.||+|+++...... ....+.+|++++++++||||+++++++..++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46788899999999999999999889999999997544322 24578899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9985 788777642 34689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 173 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (311)
T 3niz_A 173 VRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence 222 233468999999999876 56899999999999999999999999743
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=312.71 Aligned_cols=202 Identities=21% Similarity=0.341 Sum_probs=176.6
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCC--eeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN--ERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lV~ 377 (540)
++|.+.+.||+|+||.||+|... +++.||||+++..........+.+|++++.+++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888899999999999999986 489999999987655556677899999999999999999999987655 679999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----CCCCCeEEccccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL----DEDFEAVVGDFGLAK 453 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~Dfgla~ 453 (540)
||+++|+|.+++.... ....+++..+..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 9999999999998642 233489999999999999999999999 99999999999999 778889999999998
Q ss_pred ccCCCCCceeeccccccccccccccc--------cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLS--------TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
....... .....||+.|+|||++. +..++.++|||||||++|||+||+.||..
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 7654332 23446999999999986 56789999999999999999999999974
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=333.20 Aligned_cols=206 Identities=28% Similarity=0.393 Sum_probs=181.9
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.++|...+.||+|+||.||+|..+ +|+.||+|+++.... ......+.+|++++.+++||||+++++++...+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888899999999999999985 689999999975432 23345788999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++|+|.+++.........+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999986544456799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 4332 233457999999999999999999999999999999999999999753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=319.02 Aligned_cols=198 Identities=25% Similarity=0.313 Sum_probs=177.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|.+.+.||+|+||.||+|... +|+.||+|+++.... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 56888899999999999999975 689999999875431 233457889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999763 4589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 241 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence 2 23456999999999999999999999999999999999999999743
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=313.98 Aligned_cols=204 Identities=32% Similarity=0.494 Sum_probs=169.2
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
...+|.+.+.||+|+||.||+|.. +|+.||||++...... ....++.+|++++.+++||||+++++++...+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 456788899999999999999987 6889999998765432 22357899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK--IIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||+++|+|.+++... .....+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|||+++..
T Consensus 114 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 114 EYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp ECCTTCBHHHHHHST-THHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred ecCCCCcHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999752 1122489999999999999999999998 8 999999999999999999999999999855
Q ss_pred CCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~ 241 (309)
T 3p86_A 190 ASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred cccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4322 223345699999999999999999999999999999999999999974
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=318.61 Aligned_cols=204 Identities=22% Similarity=0.325 Sum_probs=177.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc----cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI----AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
+.|.+.+.||+|+||.||+|... +|+.||||+++.... ......+.+|++++..++||||+++++++...+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 56888999999999999999875 689999999864321 1235679999999999999999999999999999999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC---eEEcccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE---AVVGDFGLA 452 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfgla 452 (540)
||||+++|+|.+++.+.......+++..+..++.|+++||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999988876444445689999999999999999999999 9999999999999986654 999999999
Q ss_pred cccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence 87654322 23345699999999999998999999999999999999999999974
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=315.04 Aligned_cols=202 Identities=29% Similarity=0.450 Sum_probs=174.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeC----CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
++|.+.+.||+|+||.||+|.+. .+..||||+++..........+.+|++++.+++||||+++++++...+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56778899999999999999984 35569999998765455566899999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++|+|.++++.. ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 129 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 129 TEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999643 34699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc--eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 457 HRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 457 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 257 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc
Confidence 43222 2223346788999999998899999999999999999999 9999963
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=315.68 Aligned_cols=200 Identities=26% Similarity=0.366 Sum_probs=176.3
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc--cHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV 376 (540)
++|.+.+.||+|+||.||+|..+ +++.||+|+++...... ....+.+|..++.++ +||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888899999999999999985 58999999998654322 234578999999887 899999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999998753 4689999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 222 223455799999999999999999999999999999999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=307.12 Aligned_cols=201 Identities=28% Similarity=0.475 Sum_probs=178.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.++|.+.+.||+|+||.||+|...+++.||+|+++... ....++.+|++++.+++||||+++++++..++..++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 35688889999999999999999889999999998654 3346799999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 87 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9999999999653 34689999999999999999999999 99999999999999999999999999998665433
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
........+|+.|+|||.+....++.++||||+|+++|||++ |+.||..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~ 210 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 210 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC
Confidence 222334457788999999998999999999999999999999 9999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=318.68 Aligned_cols=203 Identities=26% Similarity=0.344 Sum_probs=177.8
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCc--cccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNI--AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 374 (540)
..++|.+.+.||+|+||.||+|..+. |+.||+|+++.... ......+..|.+++..+ +||||+++++++...+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 35789999999999999999999864 78999999975431 23345688999999887 7999999999999999999
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 999999999999999753 4689999999999999999999999 999999999999999999999999999985
Q ss_pred cCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 171 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 43222 2234567999999999999999999999999999999999999999743
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=304.73 Aligned_cols=201 Identities=30% Similarity=0.476 Sum_probs=179.6
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.++|.+.+.||+|+||.||+|..+++..||+|+++... ....++.+|++++.+++||||+++++++...+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS--MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT--BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC--CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 46788889999999999999999888899999997644 2346799999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999763 33589999999999999999999999 99999999999999999999999999998766544
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc
Confidence 333344457788999999998899999999999999999999 9999974
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=311.13 Aligned_cols=205 Identities=28% Similarity=0.407 Sum_probs=164.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|.+.+.||+|+||.||+|... +|+.||+|+++..........+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467889999999999999999875 5899999999865544445678999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 379 YMPNGSVASRLRDHI--HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|++ |+|.+++.... .....+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999886532 2224589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 212 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3322 22334689999999998764 6899999999999999999999999754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=321.32 Aligned_cols=203 Identities=29% Similarity=0.466 Sum_probs=166.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC----CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
..+|.+.+.||+|+||.||+|... ++..||||+++.........+|.+|++++.+++||||+++++++...+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999875 5778999999865444455689999999999999999999999999999999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999753 34699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCce--eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 456 DHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 456 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
....... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~ 253 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 5432211 122235778999999999999999999999999999998 9999963
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=315.81 Aligned_cols=202 Identities=26% Similarity=0.350 Sum_probs=168.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEe----CCCcEEEEEEeccCCc---cccHHHHHHHHHHHhcccCCCccceeEEEecCCe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNI---AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 372 (540)
.++|.+.+.||+|+||.||++.. .+|+.||+|+++.... ......+.+|++++.+++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46788999999999999999987 4789999999976532 1233467899999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 99999999999999998753 4688999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 7543222 2234456999999999999989999999999999999999999999743
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=332.40 Aligned_cols=203 Identities=29% Similarity=0.407 Sum_probs=179.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.++|...+.||+|+||.||+|... +|+.||+|+++.... ......+.+|++++..++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888899999999999999985 689999999975421 23345688999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++|+|.+++... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 263 mEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999998753 234599999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 338 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 338 EGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp TTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred cCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 432 233457999999999999989999999999999999999999999854
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=310.64 Aligned_cols=199 Identities=22% Similarity=0.308 Sum_probs=177.0
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|.+.+.||+|+||.||+|... +++.||+|.++... .....+.+|++++..++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 467888999999999999999975 58899999987532 334568899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC--CCCeEEcccccccccC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE--DFEAVVGDFGLAKLLD 456 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgla~~~~ 456 (540)
|+++|+|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 82 ~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999998642 34689999999999999999999999 9999999999999997 7899999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 205 (321)
T 1tki_A 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence 433 23445699999999999988899999999999999999999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=311.85 Aligned_cols=204 Identities=24% Similarity=0.367 Sum_probs=174.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCC-------
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN------- 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------- 371 (540)
.++|.+.+.||+|+||.||+|... +|+.||||+++..........+.+|++++++++||||+++++++...+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888999999999999999986 799999999986655555678999999999999999999999985543
Q ss_pred --------------------------------------------------eeEEEEecCCCCChhhhccccCCCCCCCCH
Q 009208 372 --------------------------------------------------ERLLVYPYMPNGSVASRLRDHIHGRPALDW 401 (540)
Q Consensus 372 --------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~ 401 (540)
..++||||+++|+|.+++.... .....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence 2789999999999999998642 2345678
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC-----------ceeecccccc
Q 009208 402 ARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS-----------HVTTAVRGTV 470 (540)
Q Consensus 402 ~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~ 470 (540)
..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 88999999999999999999 999999999999999999999999999987664321 1123346999
Q ss_pred ccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 471 ~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
.|+|||++.+..++.++||||||+++|||++|..|+.
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 9999999999999999999999999999999988874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=319.61 Aligned_cols=216 Identities=25% Similarity=0.369 Sum_probs=183.3
Q ss_pred ccCHHHHHHHhcCCCcCCeeeeccCccEEEEEe------CCCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccc
Q 009208 290 RYTFKELRAATSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLR 362 (540)
Q Consensus 290 ~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~ 362 (540)
.+...++....++|.+.+.||+|+||.||+|.+ .+++.||||+++..........+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 344556666788999999999999999999974 246899999998765455556799999999999 7899999
Q ss_pred eeEEEecCCe-eEEEEecCCCCChhhhccccCCC----------------------------------------------
Q 009208 363 LCGFCSTENE-RLLVYPYMPNGSVASRLRDHIHG---------------------------------------------- 395 (540)
Q Consensus 363 l~~~~~~~~~-~~lV~e~~~~gsL~~~l~~~~~~---------------------------------------------- 395 (540)
+++++...+. .++||||+++|+|.++++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 89999999999999999764221
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 396 ----------------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 396 ----------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 12289999999999999999999999 99999999999999999999999999998664332
Q ss_pred C-ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 460 S-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 460 ~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
. .......||+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 298 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCc
Confidence 2 23344568999999999999999999999999999999998 9999974
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=322.96 Aligned_cols=203 Identities=28% Similarity=0.420 Sum_probs=176.5
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|.+.+.||+|+||.||+|.+. +++.||||.++.........+|.+|++++.+++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467888899999999999999986 6899999999865433344578999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999753 24589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCcee-eccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 459 DSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 459 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
..... ....+++.|+|||.+....++.++|||||||++|||+| |+.||..
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~ 318 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN 318 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 11111 12235778999999998899999999999999999998 9999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=309.24 Aligned_cols=199 Identities=23% Similarity=0.338 Sum_probs=177.0
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-----ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-----GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
+.|.+.+.||+|+||.||+|... +|+.||+|.++..... .....+.+|++++.+++||||+++++++...+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56888999999999999999975 5899999999764422 23567999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC----CeEEcccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF----EAVVGDFG 450 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Dfg 450 (540)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999864 35689999999999999999999999 999999999999999887 89999999
Q ss_pred cccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
+++....... .....||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus 164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 219 (326)
T 2y0a_A 164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219 (326)
T ss_dssp TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 9987653322 2345699999999999988999999999999999999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=314.39 Aligned_cols=200 Identities=24% Similarity=0.372 Sum_probs=176.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
.++|.+.+.||+|+||.||+|... +|+.||+|+++..... .....+.+|++++.+++||||+++++++...+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999975 5899999999765432 23456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC---CeEEcccccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF---EAVVGDFGLAKL 454 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgla~~ 454 (540)
||+++|+|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+|||++.++ .+||+|||++..
T Consensus 108 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999998864 34689999999999999999999999 999999999999998654 599999999987
Q ss_pred cCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 232 (362)
T 2bdw_A 181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232 (362)
T ss_dssp CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 65432 22345699999999999998999999999999999999999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=319.25 Aligned_cols=202 Identities=28% Similarity=0.354 Sum_probs=169.0
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHH-HhcccCCCccceeEEEecCCeeEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVET-ISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
.++|.+.+.||+|+||.||+|+.+ +++.||+|+++..... .....+.+|..+ ++.++||||+++++++...+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 356888999999999999999986 5889999999765432 223356777776 467899999999999999999999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999999998753 4688999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 242 (373)
T 2r5t_A 190 IEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242 (373)
T ss_dssp BCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 3222 2334567999999999999999999999999999999999999999743
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=304.24 Aligned_cols=200 Identities=27% Similarity=0.407 Sum_probs=168.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-------------------------cHHHHHHHHHHHh
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-------------------------GEVQFQTEVETIS 353 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-------------------------~~~~~~~E~~~l~ 353 (540)
.++|.+.+.||+|+||.||+|... +++.||||+++...... ....+.+|++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367888999999999999999874 68999999987543211 1246889999999
Q ss_pred cccCCCccceeEEEec--CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 009208 354 LAVHRNLLRLCGFCST--ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDV 431 (540)
Q Consensus 354 ~l~h~nIv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl 431 (540)
+++||||+++++++.. .+..++||||+++++|.+++. ...+++..+..++.|+++||+|||+. +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 567899999999999887654 34699999999999999999999999 9999999
Q ss_pred CCCceeeCCCCCeEEcccccccccCCCCCceeeccccccccccccccccCC---CCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 432 KAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 432 k~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
||+||+++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654332 233456999999999987655 47889999999999999999999974
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=305.93 Aligned_cols=201 Identities=23% Similarity=0.361 Sum_probs=171.5
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
++|.+.+.||+|+||.||+|...+|+.||+|+++..... .....+.+|++++.+++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 468888999999999999999988999999999754422 2235788999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++ +|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 985 888888643 35689999999999999999999999 99999999999999999999999999998665332
Q ss_pred CceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2 22334589999999998764 5899999999999999999999999743
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=314.86 Aligned_cols=208 Identities=27% Similarity=0.427 Sum_probs=179.3
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCC
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN 371 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 371 (540)
...++|.+.+.||+|+||.||+|... +++.||||.++..........+.+|++++.+++||||+++++++...+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578899999999999999999974 348899999987654445567999999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhccccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHG--------------------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDV 431 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl 431 (540)
..++||||+++|+|.+++...... ...+++..++.++.|+++||.|||+. +|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 999999999999999999764211 25799999999999999999999999 9999999
Q ss_pred CCCceeeCCCCCeEEcccccccccCCCCC-ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 432 KAANILLDEDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 432 k~~NILl~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
||+||++++++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999986543221 12234458899999999998899999999999999999999 9999974
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=311.02 Aligned_cols=199 Identities=23% Similarity=0.417 Sum_probs=174.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
..+|.+.+.||+|+||.||+|.. .+++.||+|++..... ......+.+|+++++.++||||+++++++..++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35788899999999999999997 4789999999865321 22234789999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+ +|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 78999888653 4689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccccccccccccccccCCC-CccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ......||+.|+|||++.+..+ ++++|||||||++|||++|+.||+.
T Consensus 160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 210 (336)
T 3h4j_B 160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210 (336)
T ss_dssp TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence 432 2234569999999999988776 7899999999999999999999974
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=320.59 Aligned_cols=202 Identities=22% Similarity=0.336 Sum_probs=176.2
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
..++|.+.+.||+|+||.||+|... +|+.||+|++...... .....+.+|++++++++||||+++++++...+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3567899999999999999999864 6899999999765432 2345689999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC---CCCCeEEccccccc
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAK 453 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgla~ 453 (540)
|||+++|+|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+|||++ +++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999875 34699999999999999999999999 999999999999998 46789999999998
Q ss_pred ccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||..
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~ 215 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 7654332 23345699999999999998999999999999999999999999964
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=305.46 Aligned_cols=202 Identities=25% Similarity=0.437 Sum_probs=175.9
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
..++|.+.+.||+|+||.||+|.+.++..||+|+++... ....++.+|++++.+++||||+++++++...+..++|||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC--CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 346788889999999999999999888999999998654 234679999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 100 YMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999753 34589999999999999999999999 9999999999999999999999999999866543
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.........+|+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~ 224 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 2222233447788999999998899999999999999999998 9999974
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=310.62 Aligned_cols=207 Identities=31% Similarity=0.426 Sum_probs=179.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEe------CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 373 (540)
.++|.+.+.||+|+||.||+|.. .+++.||||+++..........+.+|++++.+++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 56788899999999999999986 245889999998655444556799999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhccccCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 009208 374 LLVYPYMPNGSVASRLRDHIH--------------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKA 433 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~ 433 (540)
++||||+++|+|.+++..... ....+++..+..++.|+++||.|||+. +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999976432 123589999999999999999999999 999999999
Q ss_pred CceeeCCCCCeEEcccccccccCCCCCce-eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCcc
Q 009208 434 ANILLDEDFEAVVGDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFG 509 (540)
Q Consensus 434 ~NILl~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~~ 509 (540)
+||++++++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998765433222 223447889999999998889999999999999999999 99999743
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=312.68 Aligned_cols=200 Identities=22% Similarity=0.324 Sum_probs=176.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|.+.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|++++.+++||||+++++++...+..++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 467899999999999999999975 68999999987543 2334578999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC--CCCeEEcccccccccC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE--DFEAVVGDFGLAKLLD 456 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgla~~~~ 456 (540)
|+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999988642 34689999999999999999999999 9999999999999974 5689999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 203 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 252 (387)
T 1kob_A 203 PDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252 (387)
T ss_dssp TTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence 4332 2334699999999999998999999999999999999999999974
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=318.51 Aligned_cols=206 Identities=31% Similarity=0.401 Sum_probs=177.0
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 373 (540)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.........++.+|+.++.+++||||+++++++...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 356888899999999999999953 46789999997665555666899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhccccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC---CeEEc
Q 009208 374 LLVYPYMPNGSVASRLRDHI---HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF---EAVVG 447 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~ 447 (540)
++||||+++|+|.+++.... .....+++..+..++.|+++||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997643 2234699999999999999999999999 999999999999999554 59999
Q ss_pred ccccccccCCC-CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 448 DFGLAKLLDHR-DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 448 Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
|||+++..... .........||+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~ 289 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999754321 1122334558999999999999999999999999999999998 9999974
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=303.96 Aligned_cols=203 Identities=24% Similarity=0.377 Sum_probs=164.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC----CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
.++|.+.+.||+|+||.||+|.... +..||+|+++..........+.+|+.++.+++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4578888999999999999998743 45799999876554455567999999999999999999999984 567899
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||+++|+|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 93 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999999753 34689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCcc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFG 509 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~~ 509 (540)
............+|+.|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence 5443333334457889999999998899999999999999999997 99999743
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=308.82 Aligned_cols=199 Identities=19% Similarity=0.200 Sum_probs=174.8
Q ss_pred cCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
++|.+.+.||+|+||.||+|.. .+|+.||||.+..... ...+.+|++++.++ +||||+++++++...+..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 5788899999999999999996 4789999999875432 23588999999999 99999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC-----eEEccccccc
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE-----AVVGDFGLAK 453 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~Dfgla~ 453 (540)
|+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 99999999753 35799999999999999999999999 9999999999999998887 9999999998
Q ss_pred ccCCCCCc------eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 454 LLDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 454 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 76543221 123456999999999999999999999999999999999999999854
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=315.75 Aligned_cols=206 Identities=31% Similarity=0.419 Sum_probs=179.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC--------CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecC
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS--------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE 370 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 370 (540)
.++|.+.+.||+|+||.||+|... .+..||||+++.........++.+|++++.++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467888899999999999999852 34679999998765555556799999999999 899999999999999
Q ss_pred CeeEEEEecCCCCChhhhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl 438 (540)
+..++||||+++|+|.+++..... ....+++..+..++.|+++||+|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 999999999999999999976431 124699999999999999999999999 99999999999999
Q ss_pred CCCCCeEEcccccccccCCCCC-ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 439 DEDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 439 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
++++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999987654322 22334457899999999999999999999999999999999 9999974
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=312.13 Aligned_cols=201 Identities=31% Similarity=0.443 Sum_probs=171.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCC----eeEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN----ERLL 375 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~l 375 (540)
.++|++.+.||+|+||.||+|.+. ++.||||+++... .....+..|+.++.+++||||+++++++.... ..++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 467889999999999999999884 8999999986542 23345677999999999999999999997644 3699
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCCeEecCCCCCceeeCCCCCeEEcc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ-------CDPKIIHRDVKAANILLDEDFEAVVGD 448 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-------~~~~ivH~Dlk~~NILl~~~~~~kl~D 448 (540)
||||+++|+|.++++. ..+++..+..++.|+++||+|||+. +.++|+||||||+|||++.++.+||+|
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999999975 3589999999999999999999975 244899999999999999999999999
Q ss_pred cccccccCCCCCc-eeecccccccccccccccc-----CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 449 FGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 449 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 9999876543322 2233569999999999876 3567789999999999999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=304.75 Aligned_cols=193 Identities=23% Similarity=0.377 Sum_probs=152.4
Q ss_pred CCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEecCCeeEEEEecCCCC
Q 009208 306 KNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYPYMPNG 383 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~~~g 383 (540)
.+.||+|+||.||+|... +++.||||++... ....+.+|++++..+. ||||+++++++.+.+..++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999999999999985 5899999998653 3457889999999997 999999999999999999999999999
Q ss_pred ChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC---CeEEcccccccccCCCCC
Q 009208 384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF---EAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 384 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~Dfgla~~~~~~~~ 460 (540)
+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++ .+||+|||+++......
T Consensus 92 ~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 163 (325)
T 3kn6_A 92 ELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN- 163 (325)
T ss_dssp BHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-
Confidence 99999975 35699999999999999999999999 999999999999998665 89999999998655432
Q ss_pred ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 22334568999999999999999999999999999999999999998543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=328.98 Aligned_cols=204 Identities=25% Similarity=0.440 Sum_probs=177.4
Q ss_pred HHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 297 RAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 297 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
+...++|.+.+.||+|+||.||+|.++++..||||+++... ....+|.+|++++.+++||||+++++++. .+..++|
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 34567788899999999999999999889999999998643 34668999999999999999999999986 5678999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++|+|.++++... ...+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 261 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp ECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999997531 23578899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
...........+|+.|+|||++....++.++|||||||++|||+| |+.||..
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 322222223346789999999998999999999999999999999 9999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=310.97 Aligned_cols=203 Identities=25% Similarity=0.352 Sum_probs=168.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccc--cHHHHHHHHHHHhcccCCCccceeEEEecCCe----
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENE---- 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---- 372 (540)
.++|.+.+.||+|+||.||+|.. .+++.||||+++...... ....+.+|++++.+++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788999999999999999996 578999999997654322 23468999999999999999999999876543
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 39999999999999999753 4689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc--eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 453 KLLDHRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 453 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 222 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 866543222 223456899999999999999999999999999999999999999743
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=313.52 Aligned_cols=210 Identities=27% Similarity=0.391 Sum_probs=176.9
Q ss_pred HHHhcCCCcCCeeeeccCccEEEEEe------CCCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEec
Q 009208 297 RAATSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCST 369 (540)
Q Consensus 297 ~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 369 (540)
+...++|.+.+.||+|+||.||+|.. .++..||||.++..........+.+|++++.++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 33467889999999999999999986 245689999998654444456799999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCChhhhccccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 009208 370 ENERLLVYPYMPNGSVASRLRDHIHG-------------------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRD 430 (540)
Q Consensus 370 ~~~~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~D 430 (540)
.+..++||||+++|+|.+++...... ...+++..+..++.|+++||.|||+. +|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence 99999999999999999999764211 13489999999999999999999999 999999
Q ss_pred CCCCceeeCCCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 431 VKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 431 lk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
|||+||+++.++.+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999999866543322 2334557889999999999999999999999999999998 9999974
Q ss_pred c
Q 009208 509 G 509 (540)
Q Consensus 509 ~ 509 (540)
.
T Consensus 278 ~ 278 (344)
T 1rjb_A 278 I 278 (344)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.78 Aligned_cols=201 Identities=25% Similarity=0.312 Sum_probs=167.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC--ccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN--IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.++|.+.+.||+|+||.||+|... +|+.||||+++... .......+.+|++++..++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 457888999999999999999975 68999999997542 122334678999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999998753 468999999999999999999998 7 9999999999999999999999999999854
Q ss_pred CCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 300 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 351 (446)
T 4ejn_A 300 IKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 3322 223446799999999999999999999999999999999999999974
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=327.25 Aligned_cols=204 Identities=29% Similarity=0.449 Sum_probs=179.6
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
..++|.+.+.||+|+||.||+|.+.. +..||||.++... ....+|.+|++++.+++||||++++++|...+..++||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 34668888999999999999999864 8899999997653 34568999999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.++++.. ....+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 296 E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 296 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp ECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 999999999999753 235689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCcc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFG 509 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~~ 509 (540)
..........+++.|+|||++....++.++|||||||++|||+| |+.||...
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 33222333446789999999998999999999999999999999 99999743
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=301.22 Aligned_cols=199 Identities=22% Similarity=0.325 Sum_probs=171.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
++|.+.+.||+|+||.||+|... +++.||+|+++...... ....+.+|++++.+++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999985 58999999997654333 34578899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++ ++.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9976 555555432 35699999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCceeeccccccccccccccccCC-CCccCCeehhhHHHHHHHhCCCCCC
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
.. ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 22 233456899999999997765 7999999999999999999998864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=310.13 Aligned_cols=201 Identities=27% Similarity=0.493 Sum_probs=167.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCc----EEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
++|...+.||+|+||.||+|.+. +++ +||+|.++.........++.+|++++.+++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56888899999999999999964 343 468888876555556678999999999999999999999998754 789
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
|+||+++|+|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 94 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999763 35699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 456 DHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 456 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
...... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 222 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC
Confidence 543322 2233457889999999999999999999999999999999 9999974
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=317.49 Aligned_cols=203 Identities=27% Similarity=0.365 Sum_probs=174.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEe----CCCcEEEEEEeccCCc---cccHHHHHHHHHHHhcc-cCCCccceeEEEecCC
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNI---AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTEN 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 371 (540)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.... ......+.+|++++..+ .||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788899999999999999997 3689999999875432 12234577899999999 5999999999999999
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
..++||||+++|+|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 999999999999999999753 4689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccccccccc--CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
++..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 98665433333445679999999999975 34789999999999999999999999743
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=302.27 Aligned_cols=202 Identities=24% Similarity=0.314 Sum_probs=173.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
++|.+.+.||+|+||.||++... ++..||+|++...........+.+|++++.+++||||+++++++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56888999999999999999975 68999999998766555667899999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---CCCCCeEEcccccccccC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~~~ 456 (540)
+++|+|.+++.........+++..+..++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999875433346799999999999999999999999 99999999999999 456789999999998655
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ......||+.|+|||++. ..++.++||||||+++|||++|+.||..
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~ 227 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG 227 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence 432 233456999999999875 5689999999999999999999999974
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=314.14 Aligned_cols=198 Identities=24% Similarity=0.336 Sum_probs=162.6
Q ss_pred cCCCcC-CeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHh-cccCCCccceeEEEec----CCee
Q 009208 301 SNFSAK-NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLLRLCGFCST----ENER 373 (540)
Q Consensus 301 ~~~~~~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~----~~~~ 373 (540)
++|.+. +.||+|+||.||+|... +|+.||||+++.. ..+.+|++++. ..+||||+++++++.. .+..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 455554 68999999999999975 6899999998642 35678888874 4589999999998865 5678
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEcccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDFG 450 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfg 450 (540)
++||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 9999999999999999753 234699999999999999999999999 9999999999999997 7899999999
Q ss_pred cccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcccc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA 511 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~ 511 (540)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 998654322 22345689999999999999999999999999999999999999975443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.48 Aligned_cols=202 Identities=26% Similarity=0.409 Sum_probs=162.6
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC-ccccHHHHHHHHHHHhccc-CCCccceeEEEecCC--ee
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN-IAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTEN--ER 373 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~~ 373 (540)
..++|.+.+.||+|+||.||+|... +|+.||||++.... ......++.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999874 68999999986532 2233456889999999997 999999999997544 68
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++||||++ |+|.++++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999997 588888864 3688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCC--------------------CCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 454 LLDHR--------------------DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 454 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.+... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 65321 1112234569999999999876 67899999999999999999999999754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=310.06 Aligned_cols=197 Identities=27% Similarity=0.389 Sum_probs=160.5
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.+.|.+.+.||+|+||.||+|... +++.||||+++... ....+.+|++++.+++||||+++++++...+..++|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 467888999999999999999986 57899999997543 34568899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEccccccccc
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDFGLAKLL 455 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfgla~~~ 455 (540)
|+++|+|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||+++..
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999998864 34689999999999999999999999 9999999999999975 889999999999865
Q ss_pred CCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 252 (349)
T 2w4o_A 202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 4322 22345699999999999998999999999999999999999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=312.04 Aligned_cols=195 Identities=26% Similarity=0.353 Sum_probs=167.2
Q ss_pred CCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCC
Q 009208 306 KNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS 384 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 384 (540)
.+.||+|+||.||+|... +|+.||+|+++... .....++.+|++++.+++||||+++++++...+..++||||+++|+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 568999999999999874 68999999998654 2345579999999999999999999999999999999999999999
Q ss_pred hhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee--CCCCCeEEcccccccccCCCCCce
Q 009208 385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL--DEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 385 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl--~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|.+++.+. ...+++..+..++.|+++||+|||+. +|+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 173 L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 173 LFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 99988642 34689999999999999999999999 99999999999999 5678999999999987654332
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.....||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 291 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 23345999999999999889999999999999999999999999743
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=301.75 Aligned_cols=197 Identities=27% Similarity=0.280 Sum_probs=166.4
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|+..+.||+|+||+||+|... +|+.||||++..... .....++..|+..+.++ +||||+++++++...+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57899999999999999999986 699999999865432 22333556666666555 8999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+ +++|.+++... ...++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 77999988754 34699999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|+.|+.
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 32 2334459999999999875 78999999999999999999977765
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=310.07 Aligned_cols=209 Identities=26% Similarity=0.309 Sum_probs=172.9
Q ss_pred HHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC----ccccHHHHHHHHHHHhcccCCCccceeEEEecCC
Q 009208 297 RAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN----IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN 371 (540)
Q Consensus 297 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 371 (540)
....++|.+.+.||+|+||.||+|... +++.||+|+++... .......+.+|++++.+++||||+++++++...+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 445678999999999999999999974 68899999986532 1334567999999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhccccCCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHG------------------------------------RPALDWARRKRIALGTARGL 415 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~~l 415 (540)
..++||||+++|+|.+++...... ...+++..+..++.|+++||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998632111 12346778889999999999
Q ss_pred HHHHhcCCCCeEecCCCCCceeeCCCC--CeEEcccccccccCCCC---Cceeecccccccccccccccc--CCCCccCC
Q 009208 416 LYLHEQCDPKIIHRDVKAANILLDEDF--EAVVGDFGLAKLLDHRD---SHVTTAVRGTVGHIAPEYLST--GQSSEKTD 488 (540)
Q Consensus 416 ~~LH~~~~~~ivH~Dlk~~NILl~~~~--~~kl~Dfgla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~k~D 488 (540)
+|||+. +|+||||||+||+++.++ .+||+|||+++.+.... ........||+.|+|||++.. ..++.++|
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 999999999999998776 89999999998654321 112344569999999999865 67899999
Q ss_pred eehhhHHHHHHHhCCCCCCc
Q 009208 489 VFGFGILLLELITGQRALDF 508 (540)
Q Consensus 489 v~S~Gvil~elltg~~p~~~ 508 (540)
|||||+++|||++|+.||..
T Consensus 259 iwslG~il~el~~g~~pf~~ 278 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPG 278 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCC
T ss_pred HHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999974
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=302.24 Aligned_cols=196 Identities=29% Similarity=0.434 Sum_probs=166.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhc--ccCCCccceeEEEec----CCee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL--AVHRNLLRLCGFCST----ENER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~----~~~~ 373 (540)
.++|.+.+.||+|+||.||+|.. +++.||||++... ....+.+|.+++.. ++||||+++++++.. ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46788999999999999999998 7899999998653 34456677777765 799999999998654 3457
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCceeeCCCCCeE
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH--------EQCDPKIIHRDVKAANILLDEDFEAV 445 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~Dlk~~NILl~~~~~~k 445 (540)
++||||+++|+|.++++. ..+++..+..++.|+++||+||| +. +|+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence 899999999999999953 36999999999999999999999 66 999999999999999999999
Q ss_pred EcccccccccCCCCCce---eeccccccccccccccccC------CCCccCCeehhhHHHHHHHhC----------CCCC
Q 009208 446 VGDFGLAKLLDHRDSHV---TTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELITG----------QRAL 506 (540)
Q Consensus 446 l~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~S~Gvil~elltg----------~~p~ 506 (540)
|+|||+++......... .....||+.|+|||++.+. .+++++||||||+++|||+|| +.||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999998665443322 1234699999999999876 456799999999999999999 8888
Q ss_pred Cc
Q 009208 507 DF 508 (540)
Q Consensus 507 ~~ 508 (540)
..
T Consensus 234 ~~ 235 (301)
T 3q4u_A 234 YD 235 (301)
T ss_dssp TT
T ss_pred cc
Confidence 53
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=320.36 Aligned_cols=199 Identities=27% Similarity=0.446 Sum_probs=176.3
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|.+.+.||+|+||.||+|... +|+.||||+++.... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888899999999999999975 799999999975432 123457899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.+ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 96 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999864 35699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccccccccccccccccCCC-CccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||+.
T Consensus 169 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 169 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp TC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 32 2334569999999999988765 7899999999999999999999974
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=298.54 Aligned_cols=201 Identities=28% Similarity=0.463 Sum_probs=177.6
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.++|.+.+.||+|+||.||+|...+++.||+|+++... ....++.+|++++.+++||||+++++++..++..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT--BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 35688889999999999999999889999999998654 2346799999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++++|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 85 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999999753 34689999999999999999999999 99999999999999999999999999998664322
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
........+++.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence 222233457789999999998899999999999999999999 8999974
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=321.95 Aligned_cols=202 Identities=30% Similarity=0.453 Sum_probs=170.9
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
..++|.+.+.||+|+||.||+|.+.++..||||+++... ....+|.+|++++.+++||||+++++++.. +..++|||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 346688889999999999999999888889999998654 235679999999999999999999999876 67899999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.++++... ...+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 259 ~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 259 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999997531 24589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.........+++.|+|||.+....++.++||||||+++|||+| |+.||..
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 384 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence 3222334457889999999999999999999999999999999 9999974
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=295.06 Aligned_cols=203 Identities=26% Similarity=0.397 Sum_probs=178.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|.+.+.||+|+||.||+|... +++.||+|+++..........+.+|++++..++||||+++++++...+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 457888999999999999999975 6899999999765545556789999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++++|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999998864 35689999999999999999999999 9999999999999999999999999999865432
Q ss_pred CC-ceeeccccccccccccccccCCC-CccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 459 DS-HVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 459 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 211 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence 21 12234568999999999987665 78999999999999999999999753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=303.87 Aligned_cols=206 Identities=29% Similarity=0.401 Sum_probs=179.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEe------CCCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 372 (540)
.++|.+.+.||+|+||.||+|.+ .+++.||+|+++..........+.+|++++.++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46788899999999999999985 356899999998665444556799999999999 99999999999999999
Q ss_pred eEEEEecCCCCChhhhccccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009208 373 RLLVYPYMPNGSVASRLRDHIH--------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl 438 (540)
.++||||+++|+|.+++..... ....+++..+..++.|+++||.|||+. +|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 9999999999999999976421 123589999999999999999999999 99999999999999
Q ss_pred CCCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 439 DEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 439 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
++++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999876544332 2234457889999999999999999999999999999999 9999974
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.43 Aligned_cols=204 Identities=21% Similarity=0.284 Sum_probs=175.9
Q ss_pred hcCCCcCCeeeec--cCccEEEEEeC-CCcEEEEEEeccCCccc-cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 300 TSNFSAKNILGRG--GFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 300 ~~~~~~~~~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
..+|.+.+.||+| +||.||+|... +|+.||||+++...... ....+.+|++++++++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4568889999999 99999999986 68999999997654322 23468889999999999999999999999999999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||+++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999997632 34589999999999999999999999 9999999999999999999999999988654
Q ss_pred CCCC------Cceeecccccccccccccccc--CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 456 DHRD------SHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 456 ~~~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 2211 111122358999999999987 5789999999999999999999999974
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=297.16 Aligned_cols=203 Identities=27% Similarity=0.450 Sum_probs=157.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.++|.+.+.||+|+||.||+|.. .+|+.||+|.+..... ......+.+|++++.+++||||+++++++...+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35688899999999999999997 4789999999865321 22345789999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++++|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999998753 35689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 215 (278)
T 3cok_A 164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCh
Confidence 3322 223346899999999999888999999999999999999999999753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.56 Aligned_cols=199 Identities=24% Similarity=0.298 Sum_probs=165.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|.+.+.||+|+||.||++... +++.||||++..... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 467889999999999999999986 689999999976432 23468899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC--eEEcccccccccC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE--AVVGDFGLAKLLD 456 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~Dfgla~~~~ 456 (540)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++...
T Consensus 97 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999998653 4689999999999999999999999 9999999999999987765 9999999997433
Q ss_pred CCCCceeeccccccccccccccccCCCCcc-CCeehhhHHHHHHHhCCCCCCcc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEK-TDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
... ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||...
T Consensus 170 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (361)
T 3uc3_A 170 LHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP 221 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred ccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence 221 2234469999999999988877655 89999999999999999999743
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=302.17 Aligned_cols=200 Identities=23% Similarity=0.332 Sum_probs=177.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-----cHHHHHHHHHHHhcccCCCccceeEEEecCCee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-----GEVQFQTEVETISLAVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 373 (540)
.++|.+.+.||+|+||.||+|... +|+.||+|.++...... ...++.+|++++.+++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356889999999999999999975 68999999997654322 356799999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC----CeEEccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF----EAVVGDF 449 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Df 449 (540)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999975 34689999999999999999999999 999999999999999887 7999999
Q ss_pred ccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 220 (321)
T 2a2a_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220 (321)
T ss_dssp TTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred ccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence 99987654322 2344699999999999988999999999999999999999999974
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=305.23 Aligned_cols=206 Identities=30% Similarity=0.441 Sum_probs=177.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC--------CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecC
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS--------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE 370 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 370 (540)
.++|.+.+.||+|+||.||+|... ++..||+|+++.........++.+|++++.++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467889999999999999999863 46789999998665445556799999999999 899999999999999
Q ss_pred CeeEEEEecCCCCChhhhccccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIHG------------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl 438 (540)
+..++||||+++|+|.+++...... ...+++..+..++.|+++||.|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 9999999999999999999764221 23489999999999999999999999 99999999999999
Q ss_pred CCCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 439 DEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 439 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence 99999999999999876543322 1233457889999999988889999999999999999999 9999974
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=302.63 Aligned_cols=203 Identities=30% Similarity=0.463 Sum_probs=181.2
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCC-CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
..++|.+.+.||+|+||.||+|.... +..||+|.++... ....++.+|++++.+++||||+++++++...+..++||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 45778889999999999999999864 8899999997543 34567999999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 89 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp ECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 999999999999753 345689999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 54444455567889999999998999999999999999999999 9999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=303.73 Aligned_cols=202 Identities=29% Similarity=0.493 Sum_probs=170.0
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-----CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEec--CCe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST--ENE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~ 372 (540)
.++|++.+.||+|+||.||+|.+ .+++.||||+++... ......+.+|++++.+++||||+++++++.. ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 35688889999999999999984 368899999987543 3334578999999999999999999999864 355
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred eEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 89999999999999999763 23589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc--eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 453 KLLDHRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 453 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
+........ ......++..|+|||.+.+..++.++||||||+++|||+||..|+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 876543221 22334477889999999999999999999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=308.94 Aligned_cols=202 Identities=27% Similarity=0.387 Sum_probs=166.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
++|.+.+.||+|+||.||+|... +++.||+|+++..........+.+|++++.+++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999986 68999999997544332222456899999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
++ |+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 5898888753 34689999999999999999999999 99999999999999999999999999998654332
Q ss_pred Cceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 460 SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 205 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST 205 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 2233458999999999876 568999999999999999999999997543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=311.31 Aligned_cols=196 Identities=22% Similarity=0.344 Sum_probs=170.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
.++|.+.+.||+|+||.||++..+ +|+.||+|+++.... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999975 589999999976432 235688888877 7999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-C---CeEEccccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-F---EAVVGDFGLAK 453 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~---~~kl~Dfgla~ 453 (540)
||+++|+|.+++.+ ...+++..+..++.|++.||+|||+. +|+||||||+|||+.++ + .+||+|||+++
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999998865 34689999999999999999999999 99999999999998533 3 59999999998
Q ss_pred ccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 169 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 169 QLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp ECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred cCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 7654332 23345689999999999888899999999999999999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.03 Aligned_cols=196 Identities=33% Similarity=0.478 Sum_probs=171.5
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCC-eeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN-ERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lV~e 378 (540)
.++|.+.+.||+|+||.||+|.+ .|+.||||+++... ....|.+|++++.+++||||+++++++...+ ..++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 46788889999999999999998 47899999998643 3457999999999999999999999987665 7899999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.++++.. ....+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999999864 233478999999999999999999999 9999999999999999999999999999854322
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.....+++.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 389 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 122357889999999999999999999999999999998 9999974
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=307.77 Aligned_cols=201 Identities=29% Similarity=0.492 Sum_probs=170.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCc----EEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
++|.+.+.||+|+||.||+|.+. +++ .||+|.+...........+.+|+.++.+++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56788899999999999999974 344 388888765443333446788999999999999999999986 456889
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999753 34688999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 456 DHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 456 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
...... ......||+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 220 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG 220 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccc
Confidence 544322 2344557889999999999999999999999999999999 9999974
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=300.49 Aligned_cols=203 Identities=23% Similarity=0.300 Sum_probs=167.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc--cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.++|.+.+.||+|+||.||+|... +++.||+|+++...... ....+.+|++++.+++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 477899999999999999999975 68899999997653322 235789999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999753 4689999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
...........||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 44333334456999999999999989999999999999999999999999743
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=334.14 Aligned_cols=203 Identities=26% Similarity=0.335 Sum_probs=177.9
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC--ccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN--IAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 374 (540)
..++|.+.+.||+|+||.||+|... +++.||||+++... .......+..|.+++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999975 58899999997532 123344678899999887 7999999999999999999
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999763 4699999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp CCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 43322 2344567999999999999999999999999999999999999999743
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=309.65 Aligned_cols=210 Identities=28% Similarity=0.388 Sum_probs=179.8
Q ss_pred HHHHhcCCCcCCeeeeccCccEEEEEeCC------CcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEe
Q 009208 296 LRAATSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCS 368 (540)
Q Consensus 296 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 368 (540)
++...++|.+.+.||+|+||.||+|.... +..||+|.++..........+.+|++++.++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 33456789999999999999999999642 3489999998765445566799999999999 8999999999999
Q ss_pred cCCeeEEEEecCCCCChhhhccccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009208 369 TENERLLVYPYMPNGSVASRLRDHIH----------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438 (540)
Q Consensus 369 ~~~~~~lV~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl 438 (540)
..+..++||||+++|+|.+++..... ....+++..+..++.|+++||.|||+. +|+||||||+||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence 99999999999999999999875311 134589999999999999999999999 99999999999999
Q ss_pred CCCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 439 DEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 439 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
++++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 269 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999865433322 2234457889999999998899999999999999999999 9999974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=300.40 Aligned_cols=202 Identities=30% Similarity=0.485 Sum_probs=175.9
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
..++|.+.+.||+|+||.||+|...++..||+|.++... .....+.+|++++.+++||||+++++++. .+..++|||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 346788899999999999999999888899999997643 33567999999999999999999999986 456899999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++++|.+++... ....+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 88 ~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 88 YMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred cCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999998742 112589999999999999999999999 9999999999999999999999999999876644
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 213 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence 3333334457889999999988889999999999999999999 9999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.57 Aligned_cols=209 Identities=21% Similarity=0.259 Sum_probs=180.7
Q ss_pred cccCHHHHHHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhccc-----CCCccc
Q 009208 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-----HRNLLR 362 (540)
Q Consensus 289 ~~~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~ 362 (540)
..+++.+.....++|.+.+.||+|+||.||+|... +++.||||+++.. ......+..|++++..+. ||||++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 44555555556789999999999999999999974 6899999998743 233446788999999886 999999
Q ss_pred eeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC--
Q 009208 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-- 440 (540)
Q Consensus 363 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-- 440 (540)
+++++...+..++||||+ +++|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPY 174 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTT
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccc
Confidence 999999999999999999 99999999763 234589999999999999999999999 9999999999999975
Q ss_pred -----------------------CCCeEEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHH
Q 009208 441 -----------------------DFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLL 497 (540)
Q Consensus 441 -----------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ 497 (540)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 789999999999865432 23456899999999999999999999999999999
Q ss_pred HHHhCCCCCCcc
Q 009208 498 ELITGQRALDFG 509 (540)
Q Consensus 498 elltg~~p~~~~ 509 (540)
||++|+.||...
T Consensus 251 ell~g~~pf~~~ 262 (360)
T 3llt_A 251 ELYTGSLLFRTH 262 (360)
T ss_dssp HHHHSSCSCCCS
T ss_pred HHHHCCCCCCCC
Confidence 999999999743
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=297.84 Aligned_cols=202 Identities=23% Similarity=0.415 Sum_probs=171.9
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC----CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.++..........+.+|++++.+++||||+++++++.. +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678888999999999999998643 346999999876545556789999999999999999999999864 45689
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||+++++|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999753 34689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence 5443333344557889999999998899999999999999999998 9999964
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=300.45 Aligned_cols=202 Identities=24% Similarity=0.308 Sum_probs=170.4
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
++|.+.+.||+|+||.||+|... +|+.||+|++....... ....+.+|++++.+++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999999999999985 58999999987654322 24568899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++++|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999888764 34689999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 207 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 22 2234468999999999876 568999999999999999999999997543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=300.87 Aligned_cols=201 Identities=27% Similarity=0.452 Sum_probs=173.2
Q ss_pred cCCCcCCeeeeccCccEEEEEe-----CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecC--Cee
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NER 373 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 373 (540)
..|.+.+.||+|+||.||+|.+ .+++.||+|+++..........+.+|++++.+++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4577889999999999999984 368999999998665555667899999999999999999999999876 668
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 9999999999999999653 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc--eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 454 LLDHRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 454 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
........ ......||..|+|||++.+..++.++||||||+++|||+||+.|+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 77654332 2234458889999999999999999999999999999999999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=293.71 Aligned_cols=198 Identities=22% Similarity=0.337 Sum_probs=174.9
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|.+.+.||+|+||.||+|... ++..||+|++.... ......+.+|++++.+++||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 456888999999999999999975 47899999987654 2345679999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---CCCCCeEEccccccccc
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~~ 455 (540)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 99999999988753 4689999999999999999999999 99999999999999 78899999999999876
Q ss_pred CCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||..
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (277)
T 3f3z_A 160 KPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA 209 (277)
T ss_dssp CTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCC
Confidence 5433 22344699999999998654 89999999999999999999999974
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.71 Aligned_cols=202 Identities=21% Similarity=0.338 Sum_probs=175.6
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCC--eeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN--ERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lV~ 377 (540)
++|.+.+.||+|+||.||+|... +|+.||||+++..........+.+|++++.+++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56888899999999999999986 489999999987655556677899999999999999999999998655 679999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----CCCCCeEEccccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL----DEDFEAVVGDFGLAK 453 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~Dfgla~ 453 (540)
||+++|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 89 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred ecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 9999999999997642 223489999999999999999999999 99999999999999 777889999999998
Q ss_pred ccCCCCCceeecccccccccccccccc--------CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLST--------GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 765432 2234569999999999865 5678899999999999999999999974
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.87 Aligned_cols=201 Identities=24% Similarity=0.333 Sum_probs=175.6
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-------cHHHHHHHHHHHhcccCCCccceeEEEecC
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-------GEVQFQTEVETISLAVHRNLLRLCGFCSTE 370 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 370 (540)
..++|.+.+.||+|+||.||+|... +++.||||+++...... ....+.+|++++.+++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3467899999999999999999864 68999999997653211 223577899999999999999999999999
Q ss_pred CeeEEEEecCCCC-ChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccc
Q 009208 371 NERLLVYPYMPNG-SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF 449 (540)
Q Consensus 371 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 449 (540)
+..++||||+.+| +|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999877 99998875 34699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeccccccccccccccccCCC-CccCCeehhhHHHHHHHhCCCCCCc
Q 009208 450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|++........ .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 99987654332 234569999999999988776 8899999999999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=298.39 Aligned_cols=203 Identities=28% Similarity=0.377 Sum_probs=170.7
Q ss_pred HhcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCc----cccHHHHHHHHHHHhccc---CCCccceeEEEecC
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNI----AGGEVQFQTEVETISLAV---HRNLLRLCGFCSTE 370 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~ 370 (540)
..++|.+.+.||+|+||.||+|.. .+++.||+|+++.... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999996 4689999999874321 112345677888877665 99999999999765
Q ss_pred C-----eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeE
Q 009208 371 N-----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV 445 (540)
Q Consensus 371 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 445 (540)
. ..++||||+. |+|.+++... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 5 4789999997 6999998753 234499999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 446 VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 446 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 161 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 222 (308)
T 3g33_A 161 LADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 222 (308)
T ss_dssp ECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCS
T ss_pred EeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999998665332 234456899999999999999999999999999999999999999743
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-37 Score=303.70 Aligned_cols=215 Identities=26% Similarity=0.372 Sum_probs=182.8
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccCccEEEEEe------CCCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccce
Q 009208 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRL 363 (540)
Q Consensus 291 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l 363 (540)
+...++....++|.+.+.||+|+||.||+|.+ .+++.||||+++..........+.+|++++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44455556678899999999999999999984 356899999998765444556799999999999 68999999
Q ss_pred eEEEecCC-eeEEEEecCCCCChhhhccccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 009208 364 CGFCSTEN-ERLLVYPYMPNGSVASRLRDHIHG------------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRD 430 (540)
Q Consensus 364 ~~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~D 430 (540)
++++...+ ..++||||+++|+|.+++...... ...+++..+..++.|+++||.|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99987655 489999999999999999764221 22388999999999999999999999 999999
Q ss_pred CCCCceeeCCCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 431 VKAANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 431 lk~~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
|||+||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999866543322 2334558899999999999999999999999999999998 9999974
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=295.81 Aligned_cols=200 Identities=18% Similarity=0.228 Sum_probs=174.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++.... ...+.+|++++..+ +|+|++++++++......++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 35688899999999999999996 5789999999875432 23578899999998 7999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC-----eEEcccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE-----AVVGDFGLA 452 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~Dfgla 452 (540)
||+ +++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 86 e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999 99999999753 34699999999999999999999999 9999999999999987776 999999999
Q ss_pred cccCCCCCc------eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 453 KLLDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 453 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence 876543321 223456999999999999999999999999999999999999999853
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=303.24 Aligned_cols=208 Identities=27% Similarity=0.403 Sum_probs=161.5
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeCCC----cEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCe
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFSDG----ALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE 372 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~g----~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 372 (540)
...++|.+.+.||+|+||.||+|..... ..||||+++.... .....++.+|++++.+++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 3456799999999999999999997543 2799999976432 2335679999999999999999999999987765
Q ss_pred e------EEEEecCCCCChhhhccccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCe
Q 009208 373 R------LLVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA 444 (540)
Q Consensus 373 ~------~lV~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 444 (540)
. ++||||+++|+|.+++..... ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 5 999999999999999865322 223589999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 445 VVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 445 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 242 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG 242 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 99999999866443221 2223447889999999999999999999999999999999 9999974
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=308.28 Aligned_cols=210 Identities=23% Similarity=0.287 Sum_probs=172.3
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccc----------cHHHHHHHHHHHhcccCCCc
Q 009208 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG----------GEVQFQTEVETISLAVHRNL 360 (540)
Q Consensus 291 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~nI 360 (540)
..+.++....++|.+.+.||+|+||.||+|...+|+.||||++....... ....+.+|++++.+++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 34667888899999999999999999999998889999999986533221 12578999999999999999
Q ss_pred cceeEEEec-----CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 009208 361 LRLCGFCST-----ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAAN 435 (540)
Q Consensus 361 v~l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~N 435 (540)
+++++++.. ....++||||++ |+|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHH
Confidence 999999843 335799999998 688888764 245699999999999999999999999 99999999999
Q ss_pred eeeCCCCCeEEcccccccccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 436 ILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 436 ILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
|+++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred EEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999999999997544322 2234568999999999877 67899999999999999999999999853
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=305.55 Aligned_cols=214 Identities=26% Similarity=0.408 Sum_probs=182.2
Q ss_pred CHHHHHHHhcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeE
Q 009208 292 TFKELRAATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365 (540)
Q Consensus 292 ~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 365 (540)
..++++...++|.+.+.||+|+||.||+|... +++.||+|.++.........++.+|++++.+++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 33444556788999999999999999999864 368899999986654555567999999999999999999999
Q ss_pred EEecCCeeEEEEecCCCCChhhhccccC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC
Q 009208 366 FCSTENERLLVYPYMPNGSVASRLRDHI------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD 439 (540)
Q Consensus 366 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~ 439 (540)
++...+..++||||+++|+|.+++.... .....+++..+..++.|+++||.|||+. +|+||||||+||+++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEc
Confidence 9999999999999999999999987521 1124578999999999999999999999 999999999999999
Q ss_pred CCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 440 EDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 440 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 243 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 243 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence 9999999999999865432221 1123346889999999998899999999999999999999 8999974
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=294.11 Aligned_cols=200 Identities=23% Similarity=0.369 Sum_probs=175.9
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
.++|.+.+.||+|+||.||+|... +|+.||+|++...... .....+.+|++++.+++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467889999999999999999975 5899999999765432 23456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC---eEEcccccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE---AVVGDFGLAKL 454 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfgla~~ 454 (540)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999888753 4689999999999999999999999 9999999999999986655 99999999986
Q ss_pred cCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 209 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC
Confidence 654322 2345699999999999999999999999999999999999999964
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=295.47 Aligned_cols=200 Identities=29% Similarity=0.404 Sum_probs=179.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.+.|...+.||+|+||.||+|... +++.||+|.++..........+.+|+.++..++||||+++++++...+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356888899999999999999864 6899999999876655566789999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999863 4689999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence 22 22345689999999999999999999999999999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.62 Aligned_cols=196 Identities=32% Similarity=0.432 Sum_probs=171.1
Q ss_pred cCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
+.|...+.||+|+||.||+|.. .+|+.||||++...... ....++.+|++++.+++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4477889999999999999996 47899999999754322 22346899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||++ |++.+++... ...+++..+..++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 6888877543 35689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeccccccccccccccc---cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ....||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 255 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2 2346999999999984 56789999999999999999999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=295.92 Aligned_cols=199 Identities=31% Similarity=0.476 Sum_probs=172.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+|++++.+++||||+++++++...+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467888999999999999999875 578999999865321 22345789999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999998753 4589999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 209 (279)
T 3fdn_A 161 SSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC
Confidence 322 2344689999999999998999999999999999999999999974
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=292.97 Aligned_cols=197 Identities=32% Similarity=0.564 Sum_probs=169.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccH------HHHHHHHHHHhcccCCCccceeEEEecCCe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGE------VQFQTEVETISLAVHRNLLRLCGFCSTENE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~------~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 372 (540)
.++|.+.+.||+|+||.||+|... +++.||+|++......... ..+.+|++++.+++||||+++++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367888899999999999999974 7899999998754433222 57899999999999999999999986655
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeeCCCCC-----eE
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK--IIHRDVKAANILLDEDFE-----AV 445 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~Dlk~~NILl~~~~~-----~k 445 (540)
++||||+++|+|.+++.+. ...+++..+..++.|++.||+|||+. + |+||||||+||+++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 6999999999999988653 45799999999999999999999998 7 999999999999988776 99
Q ss_pred EcccccccccCCCCCceeeccccccccccccccc--cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 446 VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS--TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 446 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|+|||+++.... ......||+.|+|||++. ...++.++||||||+++|||++|+.||+.
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 230 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 999999974332 234456999999999983 45578999999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=296.65 Aligned_cols=201 Identities=24% Similarity=0.391 Sum_probs=177.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.++|.+.+.||+|+||.||++... +++.||+|.+..... ......+.+|+++++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356888899999999999999986 578999999875432 23345789999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999988653 4689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 217 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3322 22345689999999999988899999999999999999999999974
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=310.49 Aligned_cols=202 Identities=18% Similarity=0.224 Sum_probs=167.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC------CcEEEEEEeccCCccc----------cHHHHHHHHHHHhcccCCCccce
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAG----------GEVQFQTEVETISLAVHRNLLRL 363 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~nIv~l 363 (540)
.++|.+.+.||+|+||.||+|.+.. ++.||||++....... ....+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578899999999999999998864 4789999987543110 01124456666778889999999
Q ss_pred eEEEecC----CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC
Q 009208 364 CGFCSTE----NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD 439 (540)
Q Consensus 364 ~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~ 439 (540)
++++... ...++||||+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 9998764 4579999999 99999999753 35699999999999999999999999 999999999999999
Q ss_pred --CCCCeEEcccccccccCCCCCc------eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 440 --EDFEAVVGDFGLAKLLDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 440 --~~~~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 8899999999999866432211 11234599999999999999999999999999999999999999984
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=293.35 Aligned_cols=199 Identities=22% Similarity=0.345 Sum_probs=174.0
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-----ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-----GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
++|.+.+.||+|+||.||+|... +|+.||+|.++..... .....+.+|++++.+++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999986 6899999998764322 23567999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC----CeEEcccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF----EAVVGDFG 450 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Dfg 450 (540)
+||||+++++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999752 4689999999999999999999999 999999999999999877 89999999
Q ss_pred cccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
++....... ......||+.|+|||++....++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 213 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence 998765432 22344589999999999988999999999999999999999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=302.55 Aligned_cols=201 Identities=24% Similarity=0.391 Sum_probs=177.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
..+|.+.+.||+|+||.||++... +++.||+|++..... ......+.+|+.++..++||||+++++++...+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 356888899999999999999985 478999999875432 23345789999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999988653 4689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 243 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence 3322 23345689999999999988899999999999999999999999974
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.61 Aligned_cols=203 Identities=28% Similarity=0.401 Sum_probs=171.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEec--------
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCST-------- 369 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------- 369 (540)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++...... .....+.+|++++.+++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35788999999999999999998 47899999998654432 234568899999999999999999999876
Q ss_pred CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccc
Q 009208 370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF 449 (540)
Q Consensus 370 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 449 (540)
.+..++||||+++ +|.+.+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 3468999999975 777777543 34689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCC---Cceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 450 GLAKLLDHRD---SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 450 gla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
|+++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9998765322 112234568999999999876 45799999999999999999999999854
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=293.71 Aligned_cols=205 Identities=20% Similarity=0.247 Sum_probs=170.9
Q ss_pred HhcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEE-ecCCeeEEE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC-STENERLLV 376 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lV 376 (540)
..++|.+.+.||+|+||.||+|.. .+++.||||++...... .++.+|++++..++|++++..++++ ...+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 357899999999999999999996 57899999987654322 2578899999999998888777766 567788999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---CCCCCeEEccccccc
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAK 453 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~ 453 (540)
|||+ +++|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||++ ++++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 99999998743 34699999999999999999999999 99999999999999 788999999999998
Q ss_pred ccCCCCCc------eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcccccc
Q 009208 454 LLDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAAN 513 (540)
Q Consensus 454 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~~~ 513 (540)
........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 222 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhh
Confidence 76543321 1234569999999999999999999999999999999999999998644333
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.51 Aligned_cols=200 Identities=22% Similarity=0.309 Sum_probs=167.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccC--CCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVH--RNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lV 376 (540)
.+.|.+.+.||+|+||.||++...+++.||||+++..... .....+.+|++++.+++| +||+++++++...+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3568888999999999999999988999999998754422 233578999999999986 9999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|| +.+|+|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 568899999975 34689999999999999999999999 999999999999997 5789999999998765
Q ss_pred CCCCc-eeecccccccccccccccc-----------CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSH-VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 43322 2334569999999999865 6789999999999999999999999973
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=295.94 Aligned_cols=201 Identities=27% Similarity=0.424 Sum_probs=173.5
Q ss_pred cCCCcCC-eeeeccCccEEEEEeC---CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 301 SNFSAKN-ILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 301 ~~~~~~~-~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
++|.+.+ .||+|+||.||+|.+. ++..||||+++.........++.+|++++.+++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455555 8999999999999864 57889999998765445566799999999999999999999999 45668999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++++|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999998642 45699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcee--eccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 457 HRDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 457 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
....... ....+|+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 216 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 4332221 23346899999999988889999999999999999999 9999974
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=316.00 Aligned_cols=199 Identities=23% Similarity=0.264 Sum_probs=165.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC-ccccHHHHHHHHHHHhcccCCCccceeEEEecC------C
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN-IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE------N 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 371 (540)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ......++.+|+++++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467889999999999999999865 68999999997542 223345788999999999999999999999654 3
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
..++||||++++ +.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 569999999765 5555532 488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp C-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 98665422 2344569999999999999999999999999999999999999997543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=310.62 Aligned_cols=200 Identities=24% Similarity=0.362 Sum_probs=163.8
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-------ccHHHHHHHHHHHhcccCCCccceeEEEecC
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-------GGEVQFQTEVETISLAVHRNLLRLCGFCSTE 370 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 370 (540)
..++|.+.+.||+|+||.||+|... +++.||||++...... .....+.+|++++.+++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 4678999999999999999999875 5899999998754321 11224889999999999999999999975 4
Q ss_pred CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC---CeEEc
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF---EAVVG 447 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~ 447 (540)
+..++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 557999999999999988864 35699999999999999999999999 999999999999997544 59999
Q ss_pred ccccccccCCCCCceeecccccccccccccccc---CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 448 DFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 448 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|||+++..... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 346 (419)
T 3i6u_A 285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999876532 22344569999999999853 5678999999999999999999999974
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=326.88 Aligned_cols=195 Identities=27% Similarity=0.419 Sum_probs=166.9
Q ss_pred eeeeccCccEEEEEeC---CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCCCC
Q 009208 308 ILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS 384 (540)
Q Consensus 308 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gs 384 (540)
.||+|+||.||+|.+. ++..||||+++.........+|.+|++++.+++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999874 4678999999876555567789999999999999999999999976 56899999999999
Q ss_pred hhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCcee-
Q 009208 385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT- 463 (540)
Q Consensus 385 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~- 463 (540)
|.+++... ...+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.+........
T Consensus 422 L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99999653 45699999999999999999999999 999999999999999999999999999987654322211
Q ss_pred -eccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCcc
Q 009208 464 -TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFG 509 (540)
Q Consensus 464 -~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~~ 509 (540)
....+|+.|+|||++....++.++|||||||++|||+| |+.||...
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 543 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 22335689999999999999999999999999999998 99999743
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=301.92 Aligned_cols=202 Identities=30% Similarity=0.487 Sum_probs=168.8
Q ss_pred cCCCcCCeeeeccCccEEEEEeCC-----CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSD-----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
.+|...+.||+|+||.||+|.... +..||||.++.........++.+|++++.+++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456677899999999999998643 246999999865544455679999999999999999999999999999999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||+++|+|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 124 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999753 35689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 456 DHRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 456 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
...... ......+|+.|+|||.+....++.++||||||+++|||++ |+.||..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 543221 1222346789999999998899999999999999999999 9999963
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=299.13 Aligned_cols=198 Identities=32% Similarity=0.470 Sum_probs=173.3
Q ss_pred CCcCCeeeeccCccEEEEEeC-----CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecC--CeeEE
Q 009208 303 FSAKNILGRGGFGIVYKGCFS-----DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERLL 375 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 375 (540)
|.+.+.||+|+||.||++.+. +++.||||+++..........+.+|++++.+++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999998753 58899999998765445566799999999999999999999999874 57899
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999753 489999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCc--eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 456 DHRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 456 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
...... ......+|+.|+|||++.+..++.++||||||+++|||+||+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 654322 12344578899999999998999999999999999999999999974
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=307.57 Aligned_cols=201 Identities=24% Similarity=0.361 Sum_probs=176.5
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|.+.+.||+|+||.||+|... +++.||+|+++..........+.+|++++.+++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 356888899999999999999986 6899999999876544455679999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.+++... ..+++..+..++.+++.||.|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999763 46899999999999999999999842 7999999999999999999999999999755322
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 123346899999999999999999999999999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=297.32 Aligned_cols=206 Identities=26% Similarity=0.367 Sum_probs=175.5
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEe--cCCeeEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCS--TENERLL 375 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~l 375 (540)
.++|.+.+.||+|+||.||+|... +++.||+|.+..... ......+.+|++++.+++||||+++++++. ..+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 457888999999999999999985 689999999976543 233457899999999999999999999874 4678899
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCceeeCCCCCeEEcccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK-----IIHRDVKAANILLDEDFEAVVGDFG 450 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-----ivH~Dlk~~NILl~~~~~~kl~Dfg 450 (540)
||||+++|+|.+++.........+++..+..++.|+++||+|||+. + |+||||||+||++++++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999986544455699999999999999999999998 7 9999999999999999999999999
Q ss_pred cccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 219 (279)
T 2w5a_A 162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219 (279)
T ss_dssp HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc
Confidence 998765432 1223346899999999999889999999999999999999999999743
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=301.17 Aligned_cols=202 Identities=27% Similarity=0.491 Sum_probs=168.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCc----EEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
.++|.+.+.||+|+||.||+|... +++ +||+|.++.........++.+|++++.+++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 357888999999999999999964 343 468888876655666778999999999999999999999998754 78
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+|+||+++|+|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 999999999999999763 34689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 455 LDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 455 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||+.
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 222 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 6533222 2233447889999999999999999999999999999999 9999974
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=292.61 Aligned_cols=197 Identities=23% Similarity=0.366 Sum_probs=170.6
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecC--CeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE--NERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lV 376 (540)
.++|.+.+.||+|+||.||+|.+ +++.||||+++.... .....++.+|++++.+++||||+++++++... +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 35688889999999999999998 489999999986542 23345799999999999999999999999877 778999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK--IIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
|||+++|+|.+++... ....+++..+..++.|+++||+|||+. + |+||||||+||++++++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 9999999999999753 234689999999999999999999998 7 99999999999999999999999988764
Q ss_pred cCCCCCceeeccccccccccccccccCCCCc---cCCeehhhHHHHHHHhCCCCCCc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE---KTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||..
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 213 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 332 2235899999999998765544 89999999999999999999974
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=308.04 Aligned_cols=201 Identities=34% Similarity=0.509 Sum_probs=161.8
Q ss_pred CCCcCCeeeeccCccEEEEEeC--C--CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEec-CCeeEEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS--D--GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST-ENERLLV 376 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~--~--g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV 376 (540)
.|...+.||+|+||.||+|.+. + +..||||.++.........+|.+|++++.+++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3566789999999999999864 2 246899998765544556689999999999999999999999754 5678999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++|+|.++++.. ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999753 34688999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCc---eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 457 HRDSH---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 457 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
..... ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~ 299 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCC
Confidence 32211 1233457889999999999999999999999999999999 6777763
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=292.84 Aligned_cols=200 Identities=30% Similarity=0.459 Sum_probs=162.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCcc---ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA---GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.++|.+.+.||+|+||.||+|.+ .++.||||+++..... .....+.+|+++++.++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 35788889999999999999998 4899999998754322 2345789999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC--------CCCeEEcc
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE--------DFEAVVGD 448 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~--------~~~~kl~D 448 (540)
|||+++++|.+++.. ..+++..+..++.|+++||.|||+....+|+||||||+||++++ ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999998853 46899999999999999999999982222999999999999986 67899999
Q ss_pred cccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 449 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 449 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
||++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 160 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (271)
T 3dtc_A 160 FGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred CCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99998654332 2234589999999999998999999999999999999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=305.77 Aligned_cols=202 Identities=21% Similarity=0.344 Sum_probs=172.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecC-----Cee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 373 (540)
..+|.+.+.||+|+||.||+|... +++.||||++...........+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357889999999999999999875 68899999998655444456789999999999999999999998654 368
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++||||++ |+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 589988864 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce--eecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 454 LLDHRDSHV--TTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 454 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
......... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 665332211 234469999999998755 458999999999999999999999997543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=299.13 Aligned_cols=197 Identities=31% Similarity=0.493 Sum_probs=163.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
++|.+.+.||+|+||.||+|.+ .++.||||++... .....|.+|++++.+++||||+++++++. +..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 4677889999999999999998 5789999998643 34567999999999999999999999886 4478999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC-eEEcccccccccCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE-AVVGDFGLAKLLDHRD 459 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~-~kl~Dfgla~~~~~~~ 459 (540)
++|+|.+++... .....+++..+..++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 999999999753 12235789999999999999999999943339999999999999998886 799999999755432
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||+.
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 205 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence 2233589999999999998999999999999999999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=297.88 Aligned_cols=201 Identities=23% Similarity=0.329 Sum_probs=168.1
Q ss_pred cCCCcC-CeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAK-NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
+.|.+. +.||+|+||.||+|... +++.||||+++... ......+.+|++++.++ +||||+++++++...+..++||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 457664 78999999999999964 68999999997653 34456789999999884 7999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC---eEEcccccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE---AVVGDFGLAKL 454 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Dfgla~~ 454 (540)
||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999763 4689999999999999999999999 9999999999999998776 99999999976
Q ss_pred cCCCCC------ceeecccccccccccccccc-----CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 455 LDHRDS------HVTTAVRGTVGHIAPEYLST-----GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 455 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
...... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 229 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence 542211 11223459999999999875 45789999999999999999999999754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=292.19 Aligned_cols=202 Identities=20% Similarity=0.248 Sum_probs=173.0
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEE-ecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC-STENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lV~ 377 (540)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... ..++.+|++++..++|++++..+.++ ...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 46788999999999999999996 5789999999875432 23688999999999998877777666 5667789999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---CCCCCeEEcccccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKL 454 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~ 454 (540)
||+ +++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++ ++++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 99999999743 34699999999999999999999999 99999999999999 4888999999999987
Q ss_pred cCCCCCc------eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcccc
Q 009208 455 LDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA 511 (540)
Q Consensus 455 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~ 511 (540)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence 6544321 12345699999999999999999999999999999999999999985443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=308.19 Aligned_cols=199 Identities=22% Similarity=0.303 Sum_probs=168.3
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCc-cccHHHHHHHHHHHhccc--CCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNI-AGGEVQFQTEVETISLAV--HRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lV~ 377 (540)
..|.+.+.||+|+||.||+|...+++.||||++..... ......+.+|++++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45888999999999999999988899999999976442 233457899999999996 599999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
| +.+++|.+++... ..+++..+..++.||++||.|||+. +|+||||||+|||++ ++.+||+|||+++.+..
T Consensus 136 E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 5688999999753 4688999999999999999999999 999999999999996 57999999999987654
Q ss_pred CCCc-eeecccccccccccccccc-----------CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSH-VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 3322 2334569999999999865 3688999999999999999999999974
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=300.49 Aligned_cols=196 Identities=23% Similarity=0.367 Sum_probs=169.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC-C-------cEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCC
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD-G-------ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 371 (540)
.++|.+.+.||+|+||.||+|.... + ..||+|++.... ......+.+|++++.+++||||+++++++..++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 3568888999999999999998653 3 579999986543 344567999999999999999999999999999
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC--------
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE-------- 443 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~-------- 443 (540)
..++||||+++|+|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence 999999999999999999763 33489999999999999999999999 9999999999999998887
Q ss_pred eEEcccccccccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 444 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 444 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
+||+|||++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|..|+.
T Consensus 160 ~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~ 219 (289)
T 4fvq_A 160 IKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219 (289)
T ss_dssp EEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCc
Confidence 99999999975432 123458999999999987 678999999999999999999654443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=307.36 Aligned_cols=202 Identities=23% Similarity=0.328 Sum_probs=169.6
Q ss_pred HHHhcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecC-----
Q 009208 297 RAATSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE----- 370 (540)
Q Consensus 297 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----- 370 (540)
....++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 34567899999999999999999987 4789999999875432 234799999999999999999998443
Q ss_pred ---------------------------------CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 009208 371 ---------------------------------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417 (540)
Q Consensus 371 ---------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~ 417 (540)
...++||||++ |+|.+.+.........+++..+..++.|+++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 33789999998 58888887655556789999999999999999999
Q ss_pred HHhcCCCCeEecCCCCCceeeC-CCCCeEEcccccccccCCCCCceeeccccccccccccccccC-CCCccCCeehhhHH
Q 009208 418 LHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGIL 495 (540)
Q Consensus 418 LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvi 495 (540)
||+. +|+||||||+||+++ +++.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+||+
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9999 999999999999998 688999999999987654332 2344589999999998765 48999999999999
Q ss_pred HHHHHhCCCCCCcc
Q 009208 496 LLELITGQRALDFG 509 (540)
Q Consensus 496 l~elltg~~p~~~~ 509 (540)
+|||++|+.||...
T Consensus 232 l~ell~g~~pf~~~ 245 (383)
T 3eb0_A 232 FGELILGKPLFSGE 245 (383)
T ss_dssp HHHHHHSSCSSCCS
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999999854
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.71 Aligned_cols=202 Identities=30% Similarity=0.453 Sum_probs=175.9
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
..++|.+.+.||+|+||.||+|.+.++..||||+++... ....+|.+|++++.+++||||+++++++.. +..++|||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 456788889999999999999999888899999998654 235679999999999999999999999876 67899999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.++++... ...+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 342 ~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 342 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred hhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999999997531 23589999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.........++..|+|||++....++.++|||||||++|||+| |+.||..
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 2111223346789999999999999999999999999999999 9999974
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=293.38 Aligned_cols=200 Identities=24% Similarity=0.365 Sum_probs=173.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV 376 (540)
.++|.+.+.||+|+||.||+|... +++.||+|+++.... .....++.+|+..+..+ +||||+++++++..++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467889999999999999999986 789999999976432 23455788999999998 999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC----------------
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---------------- 440 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---------------- 440 (540)
|||+++|+|.+++.........+++..+..++.|+++||.|||+. +|+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976433335689999999999999999999999 9999999999999984
Q ss_pred ---CCCeEEcccccccccCCCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 441 ---DFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 441 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
...+||+|||.+....... ...||+.|+|||.+.+. .+++++||||||+++|||++|+.|+.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 4479999999998765432 23489999999999766 56789999999999999999998765
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=301.19 Aligned_cols=201 Identities=23% Similarity=0.355 Sum_probs=175.9
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCcccc----------------HHHHHHHHHHHhcccCCCccce
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGG----------------EVQFQTEVETISLAVHRNLLRL 363 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~----------------~~~~~~E~~~l~~l~h~nIv~l 363 (540)
.++|.+.+.||+|+||.||+|.. +|+.||+|++........ ...+.+|++++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46788999999999999999999 999999999875432211 1679999999999999999999
Q ss_pred eEEEecCCeeEEEEecCCCCChhhh------ccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCce
Q 009208 364 CGFCSTENERLLVYPYMPNGSVASR------LRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANI 436 (540)
Q Consensus 364 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NI 436 (540)
++++...+..++||||+++|+|.++ +.. .....+++..+..++.|++.||.|||+ . +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 443 124679999999999999999999999 8 999999999999
Q ss_pred eeCCCCCeEEcccccccccCCCCCceeeccccccccccccccccC-CCCc-cCCeehhhHHHHHHHhCCCCCCcc
Q 009208 437 LLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSE-KTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 437 Ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+++.++.+||+|||.+...... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||...
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999876433 33445699999999999877 5666 999999999999999999999743
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=297.10 Aligned_cols=205 Identities=21% Similarity=0.381 Sum_probs=167.5
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
..+|.+.+.||+|+||.||+|.. .+|+.||+|+++.... .....++.+|++++.+++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35688889999999999999997 4789999999975432 23345789999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++|+|.+++.........+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999976444456789999999999999999999999 99999999999999999999999999998655
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 238 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 238 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 4322 22344689999999999998999999999999999999999999964
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=293.15 Aligned_cols=199 Identities=29% Similarity=0.451 Sum_probs=176.0
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.++|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+|++++.+++||||+++++++...+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 356888999999999999999976 578999999865321 22345789999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++|+|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 9999999999998753 3689999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... .....|++.|+|||++.+..++.++||||||+++|||++|+.||+.
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 214 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC
Confidence 322 2344689999999999998999999999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.91 Aligned_cols=206 Identities=23% Similarity=0.383 Sum_probs=178.1
Q ss_pred HHHHHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-------ccHHHHHHHHHHHhcc-cCCCcccee
Q 009208 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-------GGEVQFQTEVETISLA-VHRNLLRLC 364 (540)
Q Consensus 294 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l-~h~nIv~l~ 364 (540)
.......++|.+.+.||+|+||.||+|... +|+.||||+++..... .....+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334445677999999999999999999985 6999999998754321 1134678999999999 799999999
Q ss_pred EEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCe
Q 009208 365 GFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA 444 (540)
Q Consensus 365 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 444 (540)
+++...+..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999753 4689999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCceeecccccccccccccccc------CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 445 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 445 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 240 kl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 307 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307 (365)
T ss_dssp EECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence 9999999987654322 234569999999999863 3578999999999999999999999974
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=300.69 Aligned_cols=203 Identities=30% Similarity=0.485 Sum_probs=170.8
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcE--EEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGAL--VAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~--vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV 376 (540)
++|.+.+.||+|+||.||+|... ++.. ||+|.++..........+.+|++++.++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999875 4554 5999987655444556799999999999 899999999999999999999
Q ss_pred EecCCCCChhhhccccC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCe
Q 009208 377 YPYMPNGSVASRLRDHI------------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA 444 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 444 (540)
|||+++|+|.+++.... .....+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997532 2235799999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 445 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 445 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 244 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC
Confidence 999999997433211 1223347889999999988889999999999999999998 9999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=311.85 Aligned_cols=200 Identities=14% Similarity=0.152 Sum_probs=164.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCc--cccHHHHHHHH---HHHhcccCCCcccee-------EE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNI--AGGEVQFQTEV---ETISLAVHRNLLRLC-------GF 366 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~~E~---~~l~~l~h~nIv~l~-------~~ 366 (540)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++.... ......+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46688889999999999999997 4699999999975422 23346789999 455566899999998 66
Q ss_pred EecCC-----------------eeEEEEecCCCCChhhhccccC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 009208 367 CSTEN-----------------ERLLVYPYMPNGSVASRLRDHI---HGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426 (540)
Q Consensus 367 ~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 426 (540)
+..++ ..++||||+ +|+|.+++.... .....+++..+..++.|+++||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 65543 278999999 689999997531 1123455788999999999999999999 99
Q ss_pred EecCCCCCceeeCCCCCeEEcccccccccCCCCCceeeccccccccccccccccC-----------CCCccCCeehhhHH
Q 009208 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-----------QSSEKTDVFGFGIL 495 (540)
Q Consensus 427 vH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~Dv~S~Gvi 495 (540)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985332 3344557 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCc
Q 009208 496 LLELITGQRALDF 508 (540)
Q Consensus 496 l~elltg~~p~~~ 508 (540)
+|||++|+.||..
T Consensus 303 l~elltg~~Pf~~ 315 (377)
T 3byv_A 303 IYWIWCADLPITK 315 (377)
T ss_dssp HHHHHHSSCCC--
T ss_pred HHHHHHCCCCCcc
Confidence 9999999999974
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=301.24 Aligned_cols=202 Identities=22% Similarity=0.309 Sum_probs=165.6
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
..++|.+.+.||+|+||.||+|... +++.||||+++...... ....+.+|++++.+++||||+++++++...+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4567899999999999999999864 68999999997544322 234678999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-----CCCCeEEccccc
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-----EDFEAVVGDFGL 451 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-----~~~~~kl~Dfgl 451 (540)
|||++ |+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++ +++.+||+|||+
T Consensus 112 ~e~~~-~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCS-EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCC-CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 99998 5999988753 4689999999999999999999999 999999999999994 555699999999
Q ss_pred ccccCCCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
++........ .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 184 a~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 184 ARAFGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 9876533222 2334589999999999775 4899999999999999999999999743
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=303.44 Aligned_cols=197 Identities=26% Similarity=0.374 Sum_probs=165.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCC------
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN------ 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 371 (540)
.++|...+.||+|+||.||+|... +|+.||||++..... .....++.+|++++..++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 357888899999999999999974 689999999865332 223457899999999999999999999997653
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 8899998874 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 229 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9875432 234468999999999877 67899999999999999999999999854
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=312.62 Aligned_cols=195 Identities=23% Similarity=0.327 Sum_probs=154.0
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEec-----CCe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCST-----ENE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~~~ 372 (540)
.++|.+.+.||+|+||.||+|... +++.||||++..... .....++.+|++++..++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367899999999999999999875 689999999865432 2234578999999999999999999999843 356
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.++||||+ +|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 5788888864 35699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC--------------------------ceeecccccccccccccc-ccCCCCccCCeehhhHHHHHHHhC
Q 009208 453 KLLDHRDS--------------------------HVTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITG 502 (540)
Q Consensus 453 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~Dv~S~Gvil~elltg 502 (540)
+....... .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 87643221 122345689999999986 456799999999999999999993
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=299.31 Aligned_cols=201 Identities=23% Similarity=0.364 Sum_probs=169.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
++|.+.+.||+|+||.||+|... +|+.||+|++....... ....+.+|++++.+++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 56888899999999999999986 48999999987554322 24467899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 105 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999998887653 34689999999999999999999999 9999999999999999999999999999865543
Q ss_pred CCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 22 23344689999999998775 6899999999999999999999999754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=301.49 Aligned_cols=203 Identities=28% Similarity=0.349 Sum_probs=167.9
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcccc----HHHHHHHHHHHhcccCCCccceeEEEecCCee
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG----EVQFQTEVETISLAVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 373 (540)
..++|.+.+.||+|+||.||+|... +|+.||||+++....... ...+.+|++++.+++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999985 589999999875432211 23678999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++||||+++ +|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999986 888887642 34688899999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 7654322 23345689999999998664 4899999999999999999999999743
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=294.03 Aligned_cols=200 Identities=34% Similarity=0.508 Sum_probs=160.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|.+.+.||+|+||.||+|... ..||+|+++..... .....+.+|++++.+++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467889999999999999999874 35999999765432 3345789999999999999999999965 4566899999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++++|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 100 WCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred ecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999998643 45699999999999999999999999 9999999999999999999999999999865432
Q ss_pred C-Cceeeccccccccccccccc---cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 D-SHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~-~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ........||+.|+|||.+. ...++.++||||||+++|||++|+.||..
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 227 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence 2 22233456899999999986 56688899999999999999999999974
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=293.57 Aligned_cols=200 Identities=28% Similarity=0.391 Sum_probs=172.0
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
..++|.+.+.||+|+||.||+|... +|+.||+|.++... ...++.+|++++.+++||||+++++++...+..++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 4567899999999999999999986 58999999987643 3357899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++... ...+++..+..++.+++.||.|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 104 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999998642 35689999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 322 22344689999999999998999999999999999999999999974
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=299.26 Aligned_cols=208 Identities=28% Similarity=0.409 Sum_probs=159.4
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
...++|.+.+.||+|+||.||+|... +++.||||++..........++.+|++++.+++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999864 68999999987654444456789999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 377 YPYMPNGSVASRLRDHI----HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
|||+++++|.+++.... .....+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 99999999999986421 1245689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC----Cceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 453 KLLDHRD----SHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 453 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
....... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 229 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 7654321 112234468999999999876 5689999999999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.14 Aligned_cols=200 Identities=24% Similarity=0.323 Sum_probs=166.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecC-----Ce
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 372 (540)
.++|.+.+.||+|+||.||+|... +++.||||+++.... .....++.+|++++..++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467889999999999999999975 588999999975432 23345789999999999999999999998765 57
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.++||||++ |+|.+++.. ...+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999986 599988864 35699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc---------------------eeecccccccccccccc-ccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 453 KLLDHRDSH---------------------VTTAVRGTVGHIAPEYL-STGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 453 ~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
+........ ......||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876543211 12455699999999986 55669999999999999999998655553
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=292.32 Aligned_cols=200 Identities=32% Similarity=0.438 Sum_probs=169.6
Q ss_pred CCCcCCeeeeccCccEEEEEeCC----CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCee-EEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER-LLV 376 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~lV 376 (540)
.|...+.||+|+||.||+|.+.+ +..||+|.++..........+.+|++++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 34556899999999999998632 3379999998755445556799999999999999999999999876655 999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
+||+.+|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999752 45689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC---CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 457 HRD---SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 457 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
... ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~ 229 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC
Confidence 321 112233457899999999999999999999999999999999665543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=296.50 Aligned_cols=207 Identities=24% Similarity=0.322 Sum_probs=175.0
Q ss_pred HHHHHhcCCCcC-CeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhccc-CCCccceeEEEecC
Q 009208 295 ELRAATSNFSAK-NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAV-HRNLLRLCGFCSTE 370 (540)
Q Consensus 295 ~l~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 370 (540)
..+...+.|.+. +.||+|+||.||+|... +++.||+|+++.... .....++.+|+.++..++ ||||+++++++...
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 334445667766 88999999999999976 589999999876432 334568999999999985 69999999999999
Q ss_pred CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEc
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVG 447 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~ 447 (540)
+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEe
Confidence 9999999999999999998642 235699999999999999999999999 9999999999999997 7899999
Q ss_pred ccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 448 DFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 448 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999998765332 22345699999999999999999999999999999999999999974
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=297.79 Aligned_cols=205 Identities=28% Similarity=0.386 Sum_probs=172.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEe----cCCeeE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS----TENERL 374 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~ 374 (540)
.++|.+.+.||+|+||.||++.. .+|+.||||++.... ......+.+|++++..++||||+++++++. .....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 46788999999999999999997 578999999986543 334557899999999999999999999986 345788
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+||||+++|+|.+++.........+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 99999999999999987555567799999999999999999999999 999999999999999999999999999875
Q ss_pred cCCCCCc--------eeeccccccccccccccccCC---CCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 455 LDHRDSH--------VTTAVRGTVGHIAPEYLSTGQ---SSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 455 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
....... ......||+.|+|||++.... ++.++||||||+++|||++|+.||+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 4321100 011234799999999987543 68999999999999999999999963
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=314.82 Aligned_cols=200 Identities=27% Similarity=0.412 Sum_probs=176.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|++++.+++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356888999999999999999986 789999999875432 34466799999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---CCCCCeEEccccccc
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAK 453 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~ 453 (540)
|||+.+|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999998865 34689999999999999999999999 99999999999999 567899999999998
Q ss_pred ccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
....... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||...
T Consensus 178 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 230 (484)
T 3nyv_A 178 HFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA 230 (484)
T ss_dssp HBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred Ecccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC
Confidence 7654332 234569999999999865 6899999999999999999999999743
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=293.18 Aligned_cols=201 Identities=35% Similarity=0.531 Sum_probs=169.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeCC----CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEe-cCCeeEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS-TENERLL 375 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~l 375 (540)
..|.+.+.||+|+||.||+|...+ +..||+|.++..........+.+|++++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457778999999999999998643 23689999887554455567999999999999999999999865 4567899
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||+++|+|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999752 35689999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCC---ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCC
Q 009208 456 DHRDS---HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALD 507 (540)
Q Consensus 456 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~ 507 (540)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 234 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCc
Confidence 43221 12233457889999999999999999999999999999999 555655
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.20 Aligned_cols=200 Identities=24% Similarity=0.348 Sum_probs=172.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc------------ccHHHHHHHHHHHhcccCCCccceeEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA------------GGEVQFQTEVETISLAVHRNLLRLCGF 366 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~nIv~l~~~ 366 (540)
.++|.+.+.||+|+||.||+|... +++.||+|+++..... .....+.+|++++.+++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 567889999999999999999975 5789999999764322 234578999999999999999999999
Q ss_pred EecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC---C
Q 009208 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF---E 443 (540)
Q Consensus 367 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~---~ 443 (540)
+...+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999988753 4689999999999999999999999 999999999999999775 6
Q ss_pred eEEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 444 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 444 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+||+|||++....... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||...
T Consensus 188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~ 250 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ 250 (504)
T ss_dssp EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999998765432 233456999999999986 46899999999999999999999999743
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=293.37 Aligned_cols=204 Identities=23% Similarity=0.293 Sum_probs=161.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHH-HHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
.++|.+.+.||+|+||.||+|... +|+.||+|+++.........+ +.++...++.++||||+++++++...+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467888999999999999999974 789999999976543333333 445555578889999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||++ |+|.+++.........+++..+..++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9997 5888888765555678999999999999999999999842 899999999999999999999999999986654
Q ss_pred CCCceeecccccccccccccc----ccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYL----STGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... .....||+.|+|||++ ....++.++||||||+++|||++|+.||+.
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 322 2334599999999996 556789999999999999999999999973
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=298.54 Aligned_cols=206 Identities=31% Similarity=0.406 Sum_probs=173.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEe------CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 373 (540)
.++|.+.+.||+|+||.||+|.+ .+++.||||.+..........++.+|+.++.+++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46788999999999999999984 247789999997655455566899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhccccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEc
Q 009208 374 LLVYPYMPNGSVASRLRDHIH---GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVG 447 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~ 447 (540)
++||||+++|+|.+++..... ....+++..+..++.|+++||.|||+. +|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999986432 124589999999999999999999999 9999999999999994 4469999
Q ss_pred ccccccccCCCCC-ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 448 DFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 448 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
|||++........ .......||+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 248 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999975543221 22234458899999999998899999999999999999998 9999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=293.82 Aligned_cols=198 Identities=25% Similarity=0.403 Sum_probs=173.0
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|.+.+.||+|+||.||++... +|+.||+|.++... ......+.+|++++.+++||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 456888999999999999999975 68999999998643 2234468899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---CCCCCeEEccccccccc
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~~ 455 (540)
|+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++ ++++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 99999999988653 4689999999999999999999999 99999999999999 78889999999999754
Q ss_pred CCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 209 (304)
T 2jam_A 160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209 (304)
T ss_dssp CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 432 12334589999999999998999999999999999999999999974
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=298.23 Aligned_cols=201 Identities=30% Similarity=0.444 Sum_probs=174.7
Q ss_pred cCCCcCCeeeeccCccEEEEEe-----CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEe--cCCee
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS--TENER 373 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~ 373 (540)
++|.+.+.||+|+||.||+|.+ .+++.||||+++... ......+.+|++++.+++||||+++++++. .....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 5688889999999999999984 368899999997643 333457999999999999999999999886 45668
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++||||+++++|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 8999999999999999753 23589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce--eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 454 LLDHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 454 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 765443322 2234578889999999988899999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=288.77 Aligned_cols=200 Identities=25% Similarity=0.426 Sum_probs=168.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC--ccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN--IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
.++|.+.+.||+|+||.||+|... +|+.||+|.++... .......+.+|++++..++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888999999999999999986 68999999986532 123345789999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999999999999753 4589999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCceeeccccccccccccccccCCC-CccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+.
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 213 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 432 2234458999999999987765 6899999999999999999999974
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=288.68 Aligned_cols=201 Identities=25% Similarity=0.412 Sum_probs=170.5
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
+|.....||+|+||.||+|... +++.||+|.++... ......+.+|+.++..++||||+++++++...+..++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 4555679999999999999974 68899999987653 334557899999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-CCCeEEcccccccccCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfgla~~~~~~~ 459 (540)
++++|.+++... .....+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999999999763 2234577999999999999999999999 9999999999999987 8999999999998765322
Q ss_pred CceeeccccccccccccccccCC--CCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.......||+.|+|||++.... ++.++||||||+++|||++|+.||..
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 2223456899999999987643 78999999999999999999999963
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=294.72 Aligned_cols=201 Identities=27% Similarity=0.395 Sum_probs=169.8
Q ss_pred hcCCCcCC-eeeeccCccEEEEEeC---CCcEEEEEEeccCCccc-cHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 300 TSNFSAKN-ILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 300 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
..+|.+.+ .||+|+||.||+|.+. .++.||||+++...... ...++.+|++++..++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 9999999999999652 46889999997654322 245799999999999999999999999 566789
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+||||+++++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 999999999999999752 4589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcee--eccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 455 LDHRDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 455 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
......... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 223 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 655433222 22346789999999988889999999999999999999 9999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.61 Aligned_cols=199 Identities=26% Similarity=0.373 Sum_probs=173.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
.++|.+.+.||+|+||.||+|... +++.||||+++.... ......+.+|++++.+++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467899999999999999999975 689999999865322 234567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC---CCCCeEEcccccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKL 454 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgla~~ 454 (540)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999988653 4689999999999999999999999 999999999999995 456799999999987
Q ss_pred cCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 224 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG 224 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 65432 2334569999999999875 589999999999999999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=293.92 Aligned_cols=210 Identities=28% Similarity=0.399 Sum_probs=165.7
Q ss_pred HHHhcCCCcCCeeeeccCccEEEEEeC----CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCC
Q 009208 297 RAATSNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTEN 371 (540)
Q Consensus 297 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 371 (540)
....++|.+.+.||+|+||.||+|... .+..||+|.++..... .....+.+|++++.+++||||+++++++...+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 334577888999999999999999864 3458999998765322 23456899999999999999999999997655
Q ss_pred e-----eEEEEecCCCCChhhhccccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCe
Q 009208 372 E-----RLLVYPYMPNGSVASRLRDHI--HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA 444 (540)
Q Consensus 372 ~-----~~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 444 (540)
. .++||||+++|+|.+++.... .....+++..+..++.|+++||.|||+. +|+||||||+||++++++.+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence 3 499999999999999985322 2345799999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCcc
Q 009208 445 VVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFG 509 (540)
Q Consensus 445 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~~ 509 (540)
||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 253 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 99999999866443221 2233457889999999999999999999999999999999 89999743
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=308.27 Aligned_cols=198 Identities=28% Similarity=0.388 Sum_probs=164.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecC----C--ee
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE----N--ER 373 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----~--~~ 373 (540)
.+|...+.||+|+||.||+|... +|+.||||++..... .+.+|+++++.++||||+++++++... + ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 35778899999999999999985 589999999865431 234799999999999999999988532 2 35
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-CCeEEcccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLA 452 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~Dfgla 452 (540)
++||||+++ ++.+.+.........+++..+..++.|+++||+|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 689999986 66666654334456799999999999999999999999 99999999999999955 56899999999
Q ss_pred cccCCCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 205 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 205 KQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp EECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 87654322 2345689999999998765 7899999999999999999999999854
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=302.39 Aligned_cols=200 Identities=19% Similarity=0.209 Sum_probs=164.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeC----CCcEEEEEEeccCCccc----------cHHHHHHHHHHHhcccCCCccceeEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNIAG----------GEVQFQTEVETISLAVHRNLLRLCGF 366 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~nIv~l~~~ 366 (540)
++|.+.+.||+|+||.||+|... .+..||+|++....... ....+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888899999999999999985 57889999987643211 11246778889999999999999999
Q ss_pred Eec----CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 009208 367 CST----ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442 (540)
Q Consensus 367 ~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~ 442 (540)
+.. ....++||||+ +++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 987 67899999999 99999999753 3799999999999999999999999 999999999999999877
Q ss_pred --CeEEcccccccccCCCCC------ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 443 --EAVVGDFGLAKLLDHRDS------HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 443 --~~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999999999986643211 111344699999999999998999999999999999999999999963
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=292.73 Aligned_cols=192 Identities=20% Similarity=0.300 Sum_probs=169.4
Q ss_pred cCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEec--CCeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCST--ENERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lV 376 (540)
++|++.+.||+|+||.||+|.. .+++.||||+++.. ....+.+|++++.+++ ||||+++++++.. ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 5688899999999999999986 46899999998743 3567899999999997 9999999999987 5678999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEccccccccc
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLL 455 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~ 455 (540)
|||+++++|.+++. .+++..+..++.|+++||+|||+. +|+||||||+|||++.++ .+||+|||+++..
T Consensus 112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999885 378899999999999999999999 999999999999999776 8999999999876
Q ss_pred CCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 54332 233468999999999877 6689999999999999999999999964
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.48 Aligned_cols=199 Identities=25% Similarity=0.395 Sum_probs=169.5
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
.+.|.+.+.||+|+||.||+|... ++..||+|+++.... ......+.+|++++..++||||+++++++...+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 356888999999999999999985 689999999976432 233457899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC---CCeEEcccccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED---FEAVVGDFGLAKL 454 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Dfgla~~ 454 (540)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999988653 4689999999999999999999999 99999999999999764 4599999999987
Q ss_pred cCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||..
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG 239 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 65432 233456999999999986 5689999999999999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.85 Aligned_cols=198 Identities=25% Similarity=0.340 Sum_probs=154.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecC------C
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTE------N 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~ 371 (540)
.++|.+.+.||+|+||.||+|... +|+.||||++..... .....++.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 367889999999999999999864 689999999865432 23345788999999999999999999998654 5
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
..++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 6898888753 4689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 234 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9865432 234568999999999877 678999999999999999999999997543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=292.71 Aligned_cols=199 Identities=27% Similarity=0.416 Sum_probs=164.3
Q ss_pred HHHHHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcc--cCCCccceeEEEecC-
Q 009208 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA--VHRNLLRLCGFCSTE- 370 (540)
Q Consensus 294 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~~~- 370 (540)
.......++|.+.+.||+|+||.||+|... ++.||||++... ....+..|.+++... +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 333445678999999999999999999984 899999998643 234556666666554 899999999999876
Q ss_pred ---CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCceeeCCCC
Q 009208 371 ---NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC-----DPKIIHRDVKAANILLDEDF 442 (540)
Q Consensus 371 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~Dlk~~NILl~~~~ 442 (540)
...++||||+++|+|.++++. ..+++..+..++.|++.||.|||+.+ .++|+||||||+||+++.++
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 678999999999999999965 25899999999999999999999752 44899999999999999999
Q ss_pred CeEEcccccccccCCCCCce---eeccccccccccccccccCCCCcc------CCeehhhHHHHHHHhC
Q 009208 443 EAVVGDFGLAKLLDHRDSHV---TTAVRGTVGHIAPEYLSTGQSSEK------TDVFGFGILLLELITG 502 (540)
Q Consensus 443 ~~kl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------~Dv~S~Gvil~elltg 502 (540)
.+||+|||++.......... .....||+.|+|||++.+...+.+ +|||||||++|||+||
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 99999999997665433221 124469999999999987766655 9999999999999999
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=298.39 Aligned_cols=210 Identities=29% Similarity=0.432 Sum_probs=171.1
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEe
Q 009208 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCS 368 (540)
Q Consensus 291 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 368 (540)
+.+.++....++|.+.+.||+|+||.||+|... +|+.||||++.... .....+.+|++++.++ +||||+++++++.
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 334444456788999999999999999999974 68999999987543 3345789999999998 7999999999987
Q ss_pred c------CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 009208 369 T------ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442 (540)
Q Consensus 369 ~------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~ 442 (540)
. .+..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCC
Confidence 6 467899999999999999997532 34689999999999999999999999 999999999999999999
Q ss_pred CeEEcccccccccCCCCCceeeccccccccccccccc-----cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 443 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 443 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.+||+|||++........ ......||+.|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 167 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp CEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 999999999986543221 223446899999999986 56689999999999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=299.71 Aligned_cols=198 Identities=23% Similarity=0.275 Sum_probs=162.6
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCC------
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN------ 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 371 (540)
.++|.+.+.||+|+||.||+|... +++.||||+++.... ......+.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367889999999999999999875 689999999975432 233456889999999999999999999997654
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
..++||||+++ +|.+++.. .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 68999999975 78777752 488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 98654322 223456899999999999989999999999999999999999999754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=293.17 Aligned_cols=201 Identities=24% Similarity=0.360 Sum_probs=169.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.+.|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++..++||||+++++++...+..++|||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 467889999999999999999986 58999999987543 3445679999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++++|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999988753 34689999999999999999999999 9999999999999999999999999987532211
Q ss_pred CCceeeccccccccccccccc-----cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
........||+.|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 224 (302)
T 2j7t_A 171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224 (302)
T ss_dssp -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc
Confidence 11122345899999999983 56789999999999999999999999974
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=289.58 Aligned_cols=196 Identities=26% Similarity=0.448 Sum_probs=172.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEec---------
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST--------- 369 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------- 369 (540)
..+|.+.+.||+|+||.||+|... +++.||+|+++... ..+.+|++++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 456889999999999999999986 78999999987543 257789999999999999999998754
Q ss_pred -------CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC
Q 009208 370 -------ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442 (540)
Q Consensus 370 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~ 442 (540)
....++||||+++|+|.+++.... ...+++..+..++.|+++||.|||+. +|+||||||+||++++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 345789999999999999997532 34689999999999999999999999 999999999999999999
Q ss_pred CeEEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 443 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 443 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 160 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred CEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 999999999987654322 233458999999999999899999999999999999999999885
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=287.09 Aligned_cols=196 Identities=29% Similarity=0.420 Sum_probs=168.8
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEec----CCeeEE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCST----ENERLL 375 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~l 375 (540)
.|.+.+.||+|+||.||+|... ++..||+|.+..... ......+.+|++++.+++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3667788999999999999875 578999999876443 2334578999999999999999999998864 455899
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeeC-CCCCeEEcccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK--IIHRDVKAANILLD-EDFEAVVGDFGLA 452 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~Dlk~~NILl~-~~~~~kl~Dfgla 452 (540)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+||+++ +++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 99999999999999753 4689999999999999999999998 7 99999999999998 7899999999999
Q ss_pred cccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
....... .....||+.|+|||++. ..++.++||||||+++|||++|+.||..
T Consensus 180 ~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 180 TLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp GGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 7554322 23456999999999876 4589999999999999999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=294.26 Aligned_cols=205 Identities=28% Similarity=0.396 Sum_probs=174.4
Q ss_pred cCHHHHHHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhc--ccCCCccceeEEEe
Q 009208 291 YTFKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL--AVHRNLLRLCGFCS 368 (540)
Q Consensus 291 ~~~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~ 368 (540)
.++.......++|.+.+.||+|+||.||+|.. +|+.||||+++.. ....+.+|.+++.. ++||||+++++++.
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 34444455678899999999999999999998 6899999998643 34567888888887 78999999999998
Q ss_pred cCC----eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCce
Q 009208 369 TEN----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH--------EQCDPKIIHRDVKAANI 436 (540)
Q Consensus 369 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~Dlk~~NI 436 (540)
..+ ..++||||+++|+|.+++.+ ..+++..+..++.|++.||.||| +. +|+||||||+||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NI 178 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNI 178 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHE
Confidence 776 78999999999999999975 35899999999999999999999 66 999999999999
Q ss_pred eeCCCCCeEEcccccccccCCCCCc---eeeccccccccccccccccC------CCCccCCeehhhHHHHHHHhC-----
Q 009208 437 LLDEDFEAVVGDFGLAKLLDHRDSH---VTTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELITG----- 502 (540)
Q Consensus 437 Ll~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~S~Gvil~elltg----- 502 (540)
++++++.+||+|||++......... ......||+.|+|||++.+. .++.++||||||+++|||+||
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 9999999999999999876544332 12344699999999998765 334789999999999999999
Q ss_pred -----CCCCCc
Q 009208 503 -----QRALDF 508 (540)
Q Consensus 503 -----~~p~~~ 508 (540)
+.||..
T Consensus 259 ~~~~~~~p~~~ 269 (342)
T 1b6c_B 259 IHEDYQLPYYD 269 (342)
T ss_dssp BCCCCCCTTTT
T ss_pred cccccccCccc
Confidence 778864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=299.21 Aligned_cols=209 Identities=23% Similarity=0.306 Sum_probs=163.9
Q ss_pred HHHHHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCe
Q 009208 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE 372 (540)
Q Consensus 294 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 372 (540)
.+.....++|.+.+.||+|+||.||+|... +|+.||||++...... ...+.+|++.+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 445667789999999999999999999985 6899999998654322 2356778888899999999999999865433
Q ss_pred -------eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCceeeCC-CC
Q 009208 373 -------RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH--EQCDPKIIHRDVKAANILLDE-DF 442 (540)
Q Consensus 373 -------~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--~~~~~~ivH~Dlk~~NILl~~-~~ 442 (540)
.++||||+++ +|...+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence 7899999986 555555544445667899999999999999999999 77 9999999999999996 89
Q ss_pred CeEEcccccccccCCCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 443 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 443 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 999999999987654332 2344689999999998665 48999999999999999999999998543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=293.48 Aligned_cols=200 Identities=26% Similarity=0.379 Sum_probs=168.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-------ccHHHHHHHHHHHhcccCCCccceeEEEecCC
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-------GGEVQFQTEVETISLAVHRNLLRLCGFCSTEN 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 371 (540)
.++|.+.+.||+|+||.||+|... +++.||||.++..... .....+.+|++++.+++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 467899999999999999999975 5789999998754321 12235889999999999999999999987655
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC---eEEcc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE---AVVGD 448 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~D 448 (540)
.++||||+++|+|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 8999999999999998864 35689999999999999999999999 9999999999999987654 99999
Q ss_pred cccccccCCCCCceeeccccccccccccccc---cCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 449 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 449 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
||+++..... .......||+.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 161 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (322)
T 2ycf_A 161 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH 222 (322)
T ss_dssp CTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred Cccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 9999876432 2223456899999999974 466889999999999999999999999743
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=296.81 Aligned_cols=201 Identities=24% Similarity=0.398 Sum_probs=171.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecC-----Cee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~~ 373 (540)
.++|.+.+.||+|+||.||+|... +|+.||||+++.........++.+|++++.+++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467889999999999999999975 68999999997655444456788999999999999999999988654 678
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++||||++ |+|.+++.. ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 689888864 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc---------eeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 454 LLDHRDSH---------VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 454 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
........ ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 226 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 76532211 1123468999999998765 67899999999999999999999999754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=303.68 Aligned_cols=199 Identities=11% Similarity=0.036 Sum_probs=152.9
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc--ccHHHHHHHHHHHhcc--cCCCcccee-------EEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA--GGEVQFQTEVETISLA--VHRNLLRLC-------GFC 367 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l--~h~nIv~l~-------~~~ 367 (540)
..+|...+.||+|+||.||+|... +|+.||||+++..... .....+.+|++++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345788899999999999999975 7899999999875432 2234577885544444 699988754 444
Q ss_pred ecC-----------------CeeEEEEecCCCCChhhhccccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCC
Q 009208 368 STE-----------------NERLLVYPYMPNGSVASRLRDHIHGRPALDWARR------KRIALGTARGLLYLHEQCDP 424 (540)
Q Consensus 368 ~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~~~ 424 (540)
..+ ...++||||++ |+|.+++... ...+.+..+ ..++.|+++||+|||+.
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 332 33799999999 8999999863 123344555 77889999999999999
Q ss_pred CeEecCCCCCceeeCCCCCeEEcccccccccCCCCCceeecccccccccccccccc--CCCCccCCeehhhHHHHHHHhC
Q 009208 425 KIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITG 502 (540)
Q Consensus 425 ~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvil~elltg 502 (540)
+|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999986542 2224457899999999987 6789999999999999999999
Q ss_pred CCCCCcc
Q 009208 503 QRALDFG 509 (540)
Q Consensus 503 ~~p~~~~ 509 (540)
+.||...
T Consensus 290 ~~Pf~~~ 296 (371)
T 3q60_A 290 FLPFGLV 296 (371)
T ss_dssp SCSTTBC
T ss_pred CCCCCCc
Confidence 9999754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.38 Aligned_cols=199 Identities=24% Similarity=0.341 Sum_probs=165.1
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCe------eE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE------RL 374 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~~ 374 (540)
.+|...+.||+|+||.||+|....+..||+|++...... ..+|+++++.++||||+++++++...+. .+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 468888999999999999999987777999988654321 2469999999999999999999864433 78
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-CCCCeEEccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAK 453 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~ 453 (540)
+||||++++. ...+.........+++..+..++.|+++||+|||+. +|+||||||+|||++ .++.+||+|||+++
T Consensus 115 lv~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPETV-YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSEEH-HHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCccH-HHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 9999998754 333333223345799999999999999999999999 999999999999999 79999999999998
Q ss_pred ccCCCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 7644332 2345689999999998764 58999999999999999999999998543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=297.10 Aligned_cols=200 Identities=34% Similarity=0.527 Sum_probs=162.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHH--HhcccCCCccceeEEEec-----CCe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVET--ISLAVHRNLLRLCGFCST-----ENE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~~~-----~~~ 372 (540)
.++|.+.+.||+|+||.||+|.. +++.||||+++... ...+..|.++ +..++||||+++++.+.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 46788899999999999999987 78999999987532 3345555555 445899999999986532 335
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCceeeCCCCCeEE
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC------DPKIIHRDVKAANILLDEDFEAVV 446 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivH~Dlk~~NILl~~~~~~kl 446 (540)
.++||||+++|+|.+++... ..++..+..++.|+++||+|||+.+ .++|+||||||+|||++.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence 68999999999999999753 4589999999999999999999863 348999999999999999999999
Q ss_pred cccccccccCCCC-------Cceeecccccccccccccccc-------CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 447 GDFGLAKLLDHRD-------SHVTTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 447 ~Dfgla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+|||+++.+.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..+
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999998765322 111224469999999999876 45678999999999999999998877543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=304.10 Aligned_cols=199 Identities=21% Similarity=0.252 Sum_probs=171.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcc------cCCCccceeEEEecCCe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLA------VHRNLLRLCGFCSTENE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~l~~~~~~~~~ 372 (540)
..+|.+.+.||+|+||.||+|... +++.||||+++... ....++.+|++++..+ .|+||+++++++...+.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 356888999999999999999875 58999999997532 2344677888888776 56799999999999999
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC--eEEcccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE--AVVGDFG 450 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~Dfg 450 (540)
.++||||+. ++|.+++... ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999996 6899988753 234589999999999999999999999 9999999999999999887 9999999
Q ss_pred cccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
++...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99765432 233468999999999999999999999999999999999999997543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=294.63 Aligned_cols=202 Identities=28% Similarity=0.482 Sum_probs=173.6
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-----CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCC--e
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-----SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN--E 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~ 372 (540)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++... ......+.+|++++.+++||||+++++++...+ .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 35678889999999999999984 368999999997643 334557999999999999999999999987654 6
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.++||||+++|+|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence 89999999999999999763 34689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCce--eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 453 KLLDHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 453 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.......... .....++..|+|||.+.+..++.++||||||+++|||+||+.|+..
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 8765443321 1233477889999999988899999999999999999999999863
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=320.00 Aligned_cols=194 Identities=28% Similarity=0.412 Sum_probs=164.7
Q ss_pred CeeeeccCccEEEEEeC---CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFS---DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||.||+|.+. .++.||||+++.... .....++.+|++++.+++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999763 467899999986433 2335689999999999999999999999964 458899999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCc-
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH- 461 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~- 461 (540)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999975 34689999999999999999999999 9999999999999999999999999999876543321
Q ss_pred -eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 462 -VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 462 -~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
......+|+.|+|||++....++.++|||||||++|||++ |+.||..
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 575 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 575 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2233346789999999999999999999999999999998 9999974
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=301.48 Aligned_cols=197 Identities=20% Similarity=0.257 Sum_probs=169.3
Q ss_pred cCCCcCCeeeeccCccEEEEEeCC---------CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccc---------
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSD---------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLR--------- 362 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~--------- 362 (540)
++|.+.+.||+|+||.||+|.... ++.||+|.++.. ..+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 578889999999999999999764 789999998754 25889999999999999998
Q ss_pred ------eeEEEec-CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 009208 363 ------LCGFCST-ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAAN 435 (540)
Q Consensus 363 ------l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~N 435 (540)
+++++.. .+..++||||+ +++|.+++... ....+++..+..++.|+++||.|||+. +|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 5677765 67889999999 99999999753 135699999999999999999999999 99999999999
Q ss_pred eeeCCCC--CeEEcccccccccCCCCCc------eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 436 ILLDEDF--EAVVGDFGLAKLLDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 436 ILl~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
|+++.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 9999999999866432211 1133469999999999999899999999999999999999999998
Q ss_pred cc
Q 009208 508 FG 509 (540)
Q Consensus 508 ~~ 509 (540)
..
T Consensus 270 ~~ 271 (352)
T 2jii_A 270 NC 271 (352)
T ss_dssp GG
T ss_pred cC
Confidence 53
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=320.22 Aligned_cols=203 Identities=24% Similarity=0.382 Sum_probs=172.3
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCC----CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
..++|.+.+.||+|+||.||+|.+.. +..||+|+++..........+.+|+.++.+++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 34678888999999999999998742 56799999876554445567999999999999999999999985 46689
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+||||+++|+|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 467 lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCee
Confidence 999999999999999753 34689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.............+|+.|+|||++....++.++||||||+++|||++ |+.||..
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 595 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 65544333344457889999999998899999999999999999997 9999974
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=295.30 Aligned_cols=203 Identities=27% Similarity=0.354 Sum_probs=157.0
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEe--------c
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCS--------T 369 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~--------~ 369 (540)
..+|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++.++. ||||+++++++. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 356888999999999999999975 68999999986543 333457899999999996 999999999984 3
Q ss_pred CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCceeeCCCCCeEEc
Q 009208 370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPK--IIHRDVKAANILLDEDFEAVVG 447 (540)
Q Consensus 370 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~Dlk~~NILl~~~~~~kl~ 447 (540)
....++||||+. |+|.+++.... ....+++..+..++.|++.||.|||+. + |+||||||+||++++++.+||+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence 345789999996 79999887532 245699999999999999999999998 7 9999999999999999999999
Q ss_pred ccccccccCCCCCce-----------eecccccccccccccc---ccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 448 DFGLAKLLDHRDSHV-----------TTAVRGTVGHIAPEYL---STGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 448 Dfgla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|||+++......... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||..
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 999998765432211 1134589999999998 566789999999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=286.58 Aligned_cols=200 Identities=26% Similarity=0.366 Sum_probs=174.5
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--------cccHHHHHHHHHHHhccc-CCCccceeEEEec
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--------AGGEVQFQTEVETISLAV-HRNLLRLCGFCST 369 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 369 (540)
.++|.+.+.||+|+||.||+|... +|+.||||+++.... ......+.+|++++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467889999999999999999985 689999999975431 112346889999999996 9999999999999
Q ss_pred CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccc
Q 009208 370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF 449 (540)
Q Consensus 370 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 449 (540)
.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999753 4689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCceeeccccccccccccccc------cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLS------TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|++........ .....||+.|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 169 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence 99987654322 23456899999999985 45678999999999999999999999964
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=298.49 Aligned_cols=196 Identities=23% Similarity=0.345 Sum_probs=166.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCee----
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENER---- 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~---- 373 (540)
.++|...+.||+|+||.||+|... +|+.||||+++..... .....+.+|++++..++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357888899999999999999875 6899999999764322 2245788999999999999999999999876654
Q ss_pred --EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 374 --LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 374 --~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
++||||++ ++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 688777642 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9865432 234568999999999877 67899999999999999999999999743
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=288.52 Aligned_cols=197 Identities=32% Similarity=0.469 Sum_probs=164.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecC-CeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE-NERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lV~e 378 (540)
.++|.+.+.||+|+||.||+|.. .|+.||||.++... ....+.+|++++.+++||||+++++++... +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 46788899999999999999988 58899999987532 345789999999999999999999997654 47899999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.+++... ....+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999753 122378999999999999999999999 9999999999999999999999999999755432
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCcc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFG 509 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~~ 509 (540)
. ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 171 ~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 218 (278)
T 1byg_A 171 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred c----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 22347889999999998899999999999999999998 99999743
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.87 Aligned_cols=201 Identities=19% Similarity=0.241 Sum_probs=171.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccC-CCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH-RNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lV~ 377 (540)
.++|.+.+.||+|+||.||+|.. .+++.||||+++..... .++.+|++++..++| +++..+..++...+..++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 36788999999999999999997 46899999987754322 257899999999987 55556666667788899999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee---CCCCCeEEcccccccc
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKL 454 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~Dfgla~~ 454 (540)
||+ +++|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 99999999753 34699999999999999999999999 99999999999999 6889999999999987
Q ss_pred cCCCCCc------eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 455 LDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 455 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 6543321 1224569999999999999999999999999999999999999998543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=285.45 Aligned_cols=203 Identities=23% Similarity=0.337 Sum_probs=170.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc---cccHHHHHHHHHHHhcccCCCccceeEEEe--cCCee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI---AGGEVQFQTEVETISLAVHRNLLRLCGFCS--TENER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~ 373 (540)
.++|.+.+.||+|+||.||++... +++.||+|+++.... ......+.+|++++.+++||||+++++++. ..+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 467999999999999999999975 689999999975431 234567999999999999999999999984 45678
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++||||++++ |.+++... ....+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999877 77777643 245689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCC-CceeeccccccccccccccccCC--CCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 454 LLDHRD-SHVTTAVRGTVGHIAPEYLSTGQ--SSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 454 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
...... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 765322 22234456999999999987644 47899999999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=302.37 Aligned_cols=200 Identities=25% Similarity=0.342 Sum_probs=154.2
Q ss_pred CCc-CCeeeeccCccEEEEEeC---CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEe--cCCeeEEE
Q 009208 303 FSA-KNILGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS--TENERLLV 376 (540)
Q Consensus 303 ~~~-~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~~~lV 376 (540)
|.+ .+.||+|+||.||+|..+ +++.||+|++..... ...+.+|++++++++||||+++++++. .....++|
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 444 458999999999999975 578999999975432 246889999999999999999999995 46789999
Q ss_pred EecCCCCChhhhccccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee----CCCCCeEEc
Q 009208 377 YPYMPNGSVASRLRDHI-----HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL----DEDFEAVVG 447 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~ 447 (540)
|||++ |+|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99997 57887775321 1223589999999999999999999999 99999999999999 678899999
Q ss_pred ccccccccCCCCC--ceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 448 DFGLAKLLDHRDS--HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 448 Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 9999987654321 222345689999999998874 5899999999999999999999999743
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=289.04 Aligned_cols=200 Identities=25% Similarity=0.373 Sum_probs=163.1
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEe-----------
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCS----------- 368 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----------- 368 (540)
++|.+.+.||+|+||.||+|... +++.||+|++.... .....++.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 57888899999999999999986 48999999987543 334457899999999999999999999874
Q ss_pred ---cCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-CCCCe
Q 009208 369 ---TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEA 444 (540)
Q Consensus 369 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~ 444 (540)
..+..++||||++ |+|.+++.+ ..+++..+..++.|+++||+|||+. +|+||||||+||+++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 699998863 4689999999999999999999999 999999999999997 56799
Q ss_pred EEcccccccccCCCCC--ceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 445 VVGDFGLAKLLDHRDS--HVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 445 kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
||+|||+++....... .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999987643221 12233457999999998865 678999999999999999999999998543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=291.07 Aligned_cols=203 Identities=25% Similarity=0.390 Sum_probs=171.2
Q ss_pred HhcCCCcCCeeeeccCccEEEEEe--CCCcEEEEEEeccCCccc-cHHHHHHHHHHHhcc---cCCCccceeEEEe----
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAG-GEVQFQTEVETISLA---VHRNLLRLCGFCS---- 368 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~nIv~l~~~~~---- 368 (540)
..++|.+.+.||+|+||.||+|.. .+|+.||+|+++...... ....+.+|++++..+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 368899999987543221 123466777777666 8999999999987
Q ss_pred -cCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEc
Q 009208 369 -TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVG 447 (540)
Q Consensus 369 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 447 (540)
.....++||||++ |+|.+++.... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999998 69999987632 34589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 448 DFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 448 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 222 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 222 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 999998654321 223456899999999999989999999999999999999999999754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=287.47 Aligned_cols=202 Identities=34% Similarity=0.477 Sum_probs=163.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC--CCc--EEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS--DGA--LVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 373 (540)
.++|.+.+.||+|+||.||+|.+. +++ .||||.++.... ......+.+|++++.+++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 356888899999999999999863 333 699999876432 233457899999999999999999999998765 8
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++|+||+++|+|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 8999999999999999753 24689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCce--eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 454 LLDHRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 454 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 765443322 223457889999999988889999999999999999999 9999974
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.48 Aligned_cols=200 Identities=21% Similarity=0.252 Sum_probs=169.5
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhccc--------CCCccceeEEEe--
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV--------HRNLLRLCGFCS-- 368 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~l~~~~~-- 368 (540)
.++|.+.+.||+|+||.||+|... +++.||||+++.. ......+.+|++++..++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 367899999999999999999864 6889999999753 233457889999999886 788999999987
Q ss_pred --cCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC----
Q 009208 369 --TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF---- 442 (540)
Q Consensus 369 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~---- 442 (540)
.....++||||+ ++++.+++... ....+++..+..++.|++.||.|||+++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence 556789999999 66666666542 2346899999999999999999999854 799999999999999775
Q ss_pred ---------------------------------------------CeEEcccccccccCCCCCceeeccccccccccccc
Q 009208 443 ---------------------------------------------EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477 (540)
Q Consensus 443 ---------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~ 477 (540)
.+||+|||++...... .....||+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999866432 233468999999999
Q ss_pred cccCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 478 LSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 478 ~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
+.+..++.++|||||||++|||+||+.||....
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 999999999999999999999999999998544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=290.16 Aligned_cols=199 Identities=22% Similarity=0.318 Sum_probs=172.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEe--CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCC------ccceeEEEecCC
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF--SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN------LLRLCGFCSTEN 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~ 371 (540)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+|++++..++|++ ++++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 35788999999999999999986 368899999987532 33456889999998887654 999999999999
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-----------
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE----------- 440 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~----------- 440 (540)
..++||||+ +++|.+++... ....+++..+..++.|+++||+|||+. +|+||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 89999998753 234689999999999999999999999 9999999999999987
Q ss_pred --------CCCeEEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 441 --------DFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 441 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 668999999999865432 233468999999999999899999999999999999999999998543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=290.65 Aligned_cols=196 Identities=23% Similarity=0.341 Sum_probs=165.9
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCe-----
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENE----- 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 372 (540)
.++|...+.||+|+||.||+|... +|+.||||++...... .....+.+|+.++..++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 356888899999999999999975 6899999999754322 224578899999999999999999999987654
Q ss_pred -eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 373 -RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 373 -~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
.++||||++ |+|.+++.. .+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 588777642 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 227 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9865432 233468999999999877 67899999999999999999999999854
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=289.10 Aligned_cols=204 Identities=26% Similarity=0.334 Sum_probs=153.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHH-HHhcccCCCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVE-TISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
.++|...+.||+|+||.||+|... +|+.||||+++.........++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367888899999999999999985 689999999986544444455666666 677889999999999999999999999
Q ss_pred ecCCCCChhhhccccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 378 PYMPNGSVASRLRDHI-HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
||+++ +|.+++.... .....+++..+..++.|+++||.|||+.. +|+||||||+||+++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 7777765311 12457899999999999999999999842 89999999999999999999999999998664
Q ss_pred CCCCceeecccccccccccccc----ccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYL----STGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||..
T Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 3322 2233589999999998 456689999999999999999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=281.65 Aligned_cols=201 Identities=25% Similarity=0.361 Sum_probs=174.5
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
...++|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+|++++.+++||||+++++++...+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34567999999999999999999986 689999999875432 3345679999999999999999999999999999999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC---CCeEEcccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED---FEAVVGDFGLA 452 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~Dfgla 452 (540)
|+||+++++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999988653 3689999999999999999999999 99999999999999754 47999999999
Q ss_pred cccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
........ .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||..
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG 224 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence 86654322 223458999999999865 489999999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=289.01 Aligned_cols=197 Identities=23% Similarity=0.310 Sum_probs=146.1
Q ss_pred hcCCCcC-CeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEec----CCee
Q 009208 300 TSNFSAK-NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST----ENER 373 (540)
Q Consensus 300 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~ 373 (540)
.++|.+. +.||+|+||.||+|... +|+.||||++.... ....+....+..+.||||+++++++.. ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4678774 46999999999999986 68999999986532 122223334566789999999999865 4458
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEcccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDFG 450 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfg 450 (540)
++||||+++|+|.+++.+. ....+++..+..++.|+++||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 9999999999999999753 234699999999999999999999999 9999999999999986 4559999999
Q ss_pred cccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+++...... .....||+.|+|||++....++.++||||||+++|||++|+.||...
T Consensus 177 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 177 FAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 998654322 23445899999999998888999999999999999999999999743
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=290.97 Aligned_cols=204 Identities=25% Similarity=0.406 Sum_probs=168.2
Q ss_pred HHHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 296 LRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 296 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
+....++|.+.+.||+|+||.||+|...+ .||+|+++.... ......+.+|++++.+++||||+++++++...+..+
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 33446788999999999999999998853 499999875432 222345788999999999999999999999999999
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+||||+++++|.+++.+. ...+++..+..++.|+++||+|||+. +|+||||||+||+++ ++.+||+|||++..
T Consensus 106 iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 999999999999999753 34689999999999999999999999 999999999999998 67999999999875
Q ss_pred cCCCC----Cceeecccccccccccccccc---------CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 455 LDHRD----SHVTTAVRGTVGHIAPEYLST---------GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 455 ~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||..
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 245 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 43211 112233458999999999864 3578899999999999999999999974
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.71 Aligned_cols=192 Identities=23% Similarity=0.339 Sum_probs=166.8
Q ss_pred cCCCcCCeeeeccCccEEEEEeC--CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCe-----e
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS--DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE-----R 373 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-----~ 373 (540)
++|.+.+.||+|+||.||+|... +|+.||||++...........+.+|++++.+++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67889999999999999999975 5899999998765444445678999999999999999999999987655 6
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++||||+++++|.+++.. .+++..+..++.|+++||.|||+. +|+||||||+|||++++ .+||+|||+++
T Consensus 160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 999999999999887643 589999999999999999999999 99999999999999986 99999999998
Q ss_pred ccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
..... ....||++|+|||++.+.. +.++|||||||++|||++|..||..
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 76543 3346999999999987654 8999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=282.74 Aligned_cols=194 Identities=28% Similarity=0.421 Sum_probs=161.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEec---------
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST--------- 369 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------- 369 (540)
.++|.+.+.||+|+||.||+|... +++.||+|+++.. ......+.+|++++.+++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 457888999999999999999974 7899999998643 2334578999999999999999999998754
Q ss_pred ----CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeE
Q 009208 370 ----ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAV 445 (540)
Q Consensus 370 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 445 (540)
.+..++||||+++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 35678999999999999999752 34678899999999999999999999 999999999999999999999
Q ss_pred EcccccccccCCCC-------------CceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHh
Q 009208 446 VGDFGLAKLLDHRD-------------SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELIT 501 (540)
Q Consensus 446 l~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~ellt 501 (540)
|+|||++....... ........||+.|+|||++.+. .++.++||||||+++|||++
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 99999998654321 1122344589999999998764 68999999999999999998
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=285.01 Aligned_cols=201 Identities=21% Similarity=0.298 Sum_probs=167.5
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCc-cccHHHHHHHHHHHhccc--CCCccceeEEEecCCeeEE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNI-AGGEVQFQTEVETISLAV--HRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~l 375 (540)
..++|.+.+.||+|+||.||++...+++.||||++..... ......+.+|++++.+++ |+||+++++++...+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 4567889999999999999999998899999999975432 223457899999999997 5999999999999999999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||| +.+++|.+++... ..+++..+..++.|+++||.|||+. +|+||||||+||++++ +.+||+|||+++..
T Consensus 106 v~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 999 6688999999753 4689999999999999999999999 9999999999999975 79999999999876
Q ss_pred CCCCCc-eeecccccccccccccccc-----------CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 456 DHRDSH-VTTAVRGTVGHIAPEYLST-----------GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 456 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
...... ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||..
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 543221 2234468999999999865 4678899999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=291.75 Aligned_cols=201 Identities=24% Similarity=0.297 Sum_probs=170.2
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CC-----CccceeEEEecCC
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HR-----NLLRLCGFCSTEN 371 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~~ 371 (540)
..++|.+.+.||+|+||.||+|... +++.||||+++... ....++..|++++..++ |+ +|+++.+++...+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 4578999999999999999999875 68899999997532 23446778888888775 55 4999999999999
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC--CCCCeEEccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD--EDFEAVVGDF 449 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~Df 449 (540)
..++||||++ |+|.+++... ....+++..+..++.|++.||.|||.. ..+|+||||||+|||++ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999996 5999998763 224589999999999999999999952 22899999999999995 5778999999
Q ss_pred ccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
|+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999876432 23356899999999999999999999999999999999999999854
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=298.68 Aligned_cols=199 Identities=25% Similarity=0.293 Sum_probs=156.5
Q ss_pred CCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEEecC
Q 009208 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
.|...+.||+|+||+||.+...+|+.||||++... ....+.+|++++.++ +||||+++++++...+..++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 34456889999999998776668999999998653 234678999999876 8999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC-------------CCe
Q 009208 381 PNGSVASRLRDHIHGRPA---LDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED-------------FEA 444 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~-------------~~~ 444 (540)
+ |+|.+++......... .++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999999754221111 13334678999999999999999 99999999999999754 489
Q ss_pred EEcccccccccCCCCCc---eeecccccccccccccccc-------CCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 445 VVGDFGLAKLLDHRDSH---VTTAVRGTVGHIAPEYLST-------GQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 445 kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||..
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 99999999877643322 1234569999999999865 568999999999999999999 9999963
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=288.23 Aligned_cols=202 Identities=26% Similarity=0.393 Sum_probs=164.9
Q ss_pred HHHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-----cHHHHHHHHHHHhcc----cCCCccceeEE
Q 009208 297 RAATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-----GEVQFQTEVETISLA----VHRNLLRLCGF 366 (540)
Q Consensus 297 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l----~h~nIv~l~~~ 366 (540)
....++|.+.+.||+|+||.||+|... +++.||||+++...... ....+.+|++++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344578999999999999999999874 68999999997543221 122466789999888 89999999999
Q ss_pred EecCCeeEEEEec-CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-CCCCe
Q 009208 367 CSTENERLLVYPY-MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEA 444 (540)
Q Consensus 367 ~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~ 444 (540)
+...+..++|+|| +.+++|.+++.+. ..+++..+..++.|+++||.|||+. +|+||||||+||+++ +++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9999999999999 8899999999763 4689999999999999999999999 999999999999999 88999
Q ss_pred EEcccccccccCCCCCceeeccccccccccccccccCCC-CccCCeehhhHHHHHHHhCCCCCCc
Q 009208 445 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 445 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 999999998765432 234458999999999877666 4589999999999999999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=289.97 Aligned_cols=201 Identities=24% Similarity=0.366 Sum_probs=173.2
Q ss_pred HHhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-----cHHHHHHHHHHHhccc--CCCccceeEEEec
Q 009208 298 AATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-----GEVQFQTEVETISLAV--HRNLLRLCGFCST 369 (540)
Q Consensus 298 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~ 369 (540)
...++|.+.+.||+|+||.||+|... +++.||||+++...... ....+.+|++++.+++ |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34577999999999999999999864 68999999997653221 2235678999999986 5999999999999
Q ss_pred CCeeEEEEecCCC-CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-CCCCeEEc
Q 009208 370 ENERLLVYPYMPN-GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVG 447 (540)
Q Consensus 370 ~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~ 447 (540)
.+..++|+||+.+ ++|.+++.+. ..+++..+..++.|+++||+|||+. +|+||||||+||+++ +++.+||+
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEe
Confidence 9999999999986 8999998752 4689999999999999999999999 999999999999999 78899999
Q ss_pred ccccccccCCCCCceeeccccccccccccccccCCC-CccCCeehhhHHHHHHHhCCCCCCc
Q 009208 448 DFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 448 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..
T Consensus 193 Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 193 DFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp CCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred eCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 999998765432 233459999999999887665 7889999999999999999999974
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.76 Aligned_cols=203 Identities=28% Similarity=0.392 Sum_probs=174.6
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEec------CCe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST------ENE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~ 372 (540)
.++|.+.+.||+|+||.||+|... +|+.||||+++..........+.+|++++.+++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 367999999999999999999874 6899999998765545556679999999999999999999998765 667
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCC---eEEccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE---AVVGDF 449 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~Df 449 (540)
.++||||+++|+|.+++... .....+++..+..++.+++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 89999999999999999863 2234688999999999999999999999 9999999999999997665 899999
Q ss_pred ccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|.+........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 169 G~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 169 GYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 99987654332 2345699999999999999999999999999999999999999964
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=286.31 Aligned_cols=198 Identities=19% Similarity=0.294 Sum_probs=170.0
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CC-cEEEEEEeccCCccccHHHHHHHHHHHhcccCCC------ccceeEEEecCC
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DG-ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN------LLRLCGFCSTEN 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~~ 371 (540)
.++|.+.+.||+|+||.||+|... ++ +.||+|+++.. ......+.+|++++.+++|++ ++.+.+++...+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 467889999999999999999974 34 78999998753 233456888999999988766 899999999999
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee-------------
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL------------- 438 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl------------- 438 (540)
..++||||+ ++++.+++... ....+++..+..++.|+++||+|||+. +|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 999999999 66777777653 234689999999999999999999999 99999999999999
Q ss_pred ------CCCCCeEEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 439 ------DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 439 ------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 56789999999999864432 23346999999999999999999999999999999999999999854
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=292.90 Aligned_cols=192 Identities=16% Similarity=0.152 Sum_probs=160.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCc-------cccHHHHHHHHHHHhccc---------CCCccce
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNI-------AGGEVQFQTEVETISLAV---------HRNLLRL 363 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~---------h~nIv~l 363 (540)
.++|.+.+.||+|+||.||+|+. +|+.||||+++.... ......+.+|++++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688889999999999999998 789999999986532 223367889999998886 6666666
Q ss_pred eEEE-----------------ec-------------CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHH
Q 009208 364 CGFC-----------------ST-------------ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTAR 413 (540)
Q Consensus 364 ~~~~-----------------~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~ 413 (540)
.+++ .. .+..++||||+++|++.+.+.+ ..+++..+..++.|++.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 6653 22 6789999999999987776643 45899999999999999
Q ss_pred HHHHHH-hcCCCCeEecCCCCCceeeCCCC--------------------CeEEcccccccccCCCCCceeecccccccc
Q 009208 414 GLLYLH-EQCDPKIIHRDVKAANILLDEDF--------------------EAVVGDFGLAKLLDHRDSHVTTAVRGTVGH 472 (540)
Q Consensus 414 ~l~~LH-~~~~~~ivH~Dlk~~NILl~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y 472 (540)
||+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 88 999999999999999887 8999999999876532 23699999
Q ss_pred ccccccccCCCCccCCeehhhHH-HHHHHhCCCCCC
Q 009208 473 IAPEYLSTGQSSEKTDVFGFGIL-LLELITGQRALD 507 (540)
Q Consensus 473 ~aPE~~~~~~~~~k~Dv~S~Gvi-l~elltg~~p~~ 507 (540)
+|||++.+.. +.++||||+|++ .+++++|..||.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 9999998666 899999998766 888999999995
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=287.80 Aligned_cols=200 Identities=21% Similarity=0.299 Sum_probs=167.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhccc-----------CCCccceeEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-----------HRNLLRLCGFC 367 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~ 367 (540)
..+|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+|++++.+++ |+||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 35788999999999999999997 468999999987532 23456889999998876 89999999998
Q ss_pred ecCC----eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC----
Q 009208 368 STEN----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---- 439 (540)
Q Consensus 368 ~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~---- 439 (540)
...+ ..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence 7544 789999999 899999997632 345899999999999999999999853 899999999999994
Q ss_pred --CCCCeEEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 440 --EDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 440 --~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||+...
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4458999999999866532 223468999999999999999999999999999999999999998543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=280.51 Aligned_cols=200 Identities=24% Similarity=0.343 Sum_probs=151.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHH-HHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
.++|...+.||+|+||.||+|... +|+.||||+++.........+ +.++..++..++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 456888899999999999999985 689999999986543333333 444555678889999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
||+ ++.+....... ...+++..+..++.|+++||.|||+ . +|+||||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 44444444321 3468999999999999999999998 5 89999999999999999999999999997654
Q ss_pred CCCCceeeccccccccccccccc-----cCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ......||+.|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 322 223345899999999984 45688999999999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.66 Aligned_cols=197 Identities=27% Similarity=0.361 Sum_probs=157.5
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
..+|...+.||+|+||+||.....+|+.||||++...... .+.+|++++.++ +||||+++++++...+..++|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3457788999999999976555568999999999754322 356799999998 79999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-----CCCeEEccccccc
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-----DFEAVVGDFGLAK 453 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~Dfgla~ 453 (540)
|++ |+|.+++.... ....+..+..++.|+++||.|||+. +|+||||||+|||++. ...+||+|||+++
T Consensus 99 ~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 99 LCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 996 69999987532 2344445678999999999999999 9999999999999953 3368899999998
Q ss_pred ccCCCCC--ceeeccccccccccccccc---cCCCCccCCeehhhHHHHHHHh-CCCCCC
Q 009208 454 LLDHRDS--HVTTAVRGTVGHIAPEYLS---TGQSSEKTDVFGFGILLLELIT-GQRALD 507 (540)
Q Consensus 454 ~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~k~Dv~S~Gvil~ellt-g~~p~~ 507 (540)
....... .......||+.|+|||++. ...++.++|||||||++|||+| |+.||.
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~ 231 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 7653321 2233456999999999997 4567889999999999999999 999996
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=268.44 Aligned_cols=173 Identities=12% Similarity=0.046 Sum_probs=150.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc--cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|.+.+.||+|+||.||+|... +++.||||+++...... ....+.+|++.+.+++||||+++++++..++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56888899999999999999986 48999999998654322 2357899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++++|.+++++. .....+..++.|+++||+|||+. +|+||||||+||++++++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999998531 34557888999999999999999 99999999999999999999998543
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
|++| ++.++|||||||++|||+||+.||....
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3332 6889999999999999999999998543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-33 Score=287.35 Aligned_cols=200 Identities=16% Similarity=0.122 Sum_probs=155.3
Q ss_pred cCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccc--cHHHHHHHHHHHhcccC-CCcccee---------EEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVH-RNLLRLC---------GFC 367 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h-~nIv~l~---------~~~ 367 (540)
.+|...+.||+|+||.||+|.+ .+|+.||||+++...... ....+.+|+.++..++| +|..... ..+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4566778999999999999996 469999999987443222 24578999999999987 3322111 111
Q ss_pred ------------ec-----CCeeEEEEecCCCCChhhhcccc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 009208 368 ------------ST-----ENERLLVYPYMPNGSVASRLRDH---IHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427 (540)
Q Consensus 368 ------------~~-----~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv 427 (540)
.. ....+++|+++ +++|.+++... ......+++..+..++.|+++||+|||+. +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 11 12356677755 68999888521 22345688999999999999999999999 999
Q ss_pred ecCCCCCceeeCCCCCeEEcccccccccCCCCCceeecccccccccccccc----------ccCCCCccCCeehhhHHHH
Q 009208 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL----------STGQSSEKTDVFGFGILLL 497 (540)
Q Consensus 428 H~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~k~Dv~S~Gvil~ 497 (540)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999864422 344557 999999999 5556889999999999999
Q ss_pred HHHhCCCCCCcc
Q 009208 498 ELITGQRALDFG 509 (540)
Q Consensus 498 elltg~~p~~~~ 509 (540)
||+||+.||...
T Consensus 309 elltg~~Pf~~~ 320 (413)
T 3dzo_A 309 WIWCADLPNTDD 320 (413)
T ss_dssp HHHHSSCCCCTT
T ss_pred HHHHCCCCCCCc
Confidence 999999999854
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=262.42 Aligned_cols=174 Identities=24% Similarity=0.363 Sum_probs=150.7
Q ss_pred cCCCcC-CeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHH-hcccCCCccceeEEEec----CCee
Q 009208 301 SNFSAK-NILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETI-SLAVHRNLLRLCGFCST----ENER 373 (540)
Q Consensus 301 ~~~~~~-~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~----~~~~ 373 (540)
++|.+. +.||+|+||.||+|... +++.||+|+++.. ..+.+|++++ ...+||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456665 78999999999999974 6899999998642 3577888888 56689999999999876 6678
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEcccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDFG 450 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Dfg 450 (540)
++||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 9999999999999999863 234699999999999999999999999 9999999999999998 7899999999
Q ss_pred cccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
++.... +..++.++|||||||++|||++|+.||..
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~ 200 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYS 200 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 986432 13467899999999999999999999963
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=277.42 Aligned_cols=186 Identities=15% Similarity=0.057 Sum_probs=130.2
Q ss_pred eeeccCccEEEEE-eCCCcEEEEEEeccCCc---------cccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEEE
Q 009208 309 LGRGGFGIVYKGC-FSDGALVAVKRLKDYNI---------AGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 309 lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
.+.|+.|.+.++. ..-|+.+|+|.+..... ....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4455555555433 22488999999975421 12234699999999999 6999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||++|++|.++|.+ ..+++.. +|+.||++||+|+|++ +||||||||+|||+++++.+||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999975 2456653 5889999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCC
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRAL 506 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~ 506 (540)
... ......||++|+|||++.+ .+..++|+||+|++++++.++..++
T Consensus 392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 332 2345679999999999865 4677899999999988877665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.8e-28 Score=255.15 Aligned_cols=186 Identities=16% Similarity=0.195 Sum_probs=148.6
Q ss_pred CcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccc-------cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 304 SAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAG-------GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 304 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
...+.||+|+||.||+|.. .++.+++|+........ ..+++.+|++++.+++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999955 67889999865432211 123589999999999999999777777788888999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++++|.+++.+ +..++.|+++||+|||++ +|+||||||+|||+++ .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999874 458999999999999999 9999999999999999 99999999999775
Q ss_pred CCCCce------eecccccccccccccccc--CCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 457 HRDSHV------TTAVRGTVGHIAPEYLST--GQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 457 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
...... .....||+.|+|||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 432211 135569999999999977 567888999999999999998887774
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=233.98 Aligned_cols=171 Identities=28% Similarity=0.519 Sum_probs=157.0
Q ss_pred CCCchHHHHHHHHHHhcCCCCCccCCCCCCCCCCcc--ceeeeecCC---CcEEEecCCCCCCcc--ccCccccCCCccC
Q 009208 29 AGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCS--WRMITCSPD---GYVSALGLPSQSLSG--TLSPWIGNLTKLQ 101 (540)
Q Consensus 29 ~~~~~~~~~l~~~k~~~~~~~~~~~~w~~~~~~~c~--w~gv~c~~~---~~l~~l~l~~~~l~~--~~~~~~~~l~~L~ 101 (540)
.|.+.|+.||++||.++.||. .+++|+. +.+||. |.||+|+.. ++|+.|+|++|+++| .+|+.|+++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 477889999999999999887 7899974 578998 999999864 799999999999999 9999999999999
Q ss_pred EEEccc-CCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccC
Q 009208 102 SVLLQN-NAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN 180 (540)
Q Consensus 102 ~L~l~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 180 (540)
+|+|++ |.+.+.+|..|.++++|++|+|++|++++.+|..|.++++|++|+|++|++++.+|..+..+++|++|++++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999994 9999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCc------ccccccCCCC
Q 009208 181 NLSGSLPKISA------RTFKVTGNPL 201 (540)
Q Consensus 181 ~l~~~~p~~~~------~~~~~~~n~~ 201 (540)
++++.+|.... +.+++++|.+
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l 186 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRL 186 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCee
Confidence 99988886432 4567777765
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.3e-24 Score=207.82 Aligned_cols=166 Identities=12% Similarity=0.048 Sum_probs=129.1
Q ss_pred HHHHHHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCcc-----------------ccHHHHHHHHHHHhcc
Q 009208 293 FKELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-----------------GGEVQFQTEVETISLA 355 (540)
Q Consensus 293 ~~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l 355 (540)
+..+......|.+.+.||+|+||.||+|...+|+.||+|.++..... .....+.+|++++.++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34455555667778999999999999999977999999998643211 1245689999999999
Q ss_pred cCCCccceeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 009208 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAAN 435 (540)
Q Consensus 356 ~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~N 435 (540)
+ | +++.+++. .+..++||||+++|+|.+ +.. .....++.|+++||.|||+. +|+||||||+|
T Consensus 162 ~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred c--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence 8 5 66666553 356799999999999988 531 12346999999999999999 99999999999
Q ss_pred eeeCCCCCeEEcccccccccCCCCCceeecccccccccccccccc----------CCCCccCCeeh
Q 009208 436 ILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST----------GQSSEKTDVFG 491 (540)
Q Consensus 436 ILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~k~Dv~S 491 (540)
||++ ++.+||+|||+++. +..|.|||++.. ..+..++|+|.
T Consensus 224 ILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9999 99999999999963 345688998753 34555666654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.9e-24 Score=238.13 Aligned_cols=153 Identities=31% Similarity=0.486 Sum_probs=92.7
Q ss_pred CCCCCchHHHHHHHHHHhcCCCCCccCCCCCCCCCCccceeeeecCCCcEEEecCCCCCCccc---cCccccCCCccCEE
Q 009208 27 SPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGT---LSPWIGNLTKLQSV 103 (540)
Q Consensus 27 ~~~~~~~~~~~l~~~k~~~~~~~~~~~~w~~~~~~~c~w~gv~c~~~~~l~~l~l~~~~l~~~---~~~~~~~l~~L~~L 103 (540)
++++.+.|+.||++||+++.||. .+++|+ ++.|||.|+||+|+ .++|+.|+|+++.+.|. +|+.+.+|++|+.+
T Consensus 6 ~~~~~~~~~~all~~k~~~~~~~-~l~~W~-~~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 6 PSQSLYREIHQLISFKDVLPDKN-LLPDWS-SNKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp --CCHHHHHHHHHHHHTTCSCTT-SSTTCC-TTSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred cccCCHHHHHHHHHHHhhCCCcc-cccCCC-CCCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 34446789999999999999998 899997 56899999999999 78999999999999987 66544444444444
Q ss_pred EcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCc--cccCCCCcchhhccCccCCCCCCccc-cCCccccEEecccC
Q 009208 104 LLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD--SLGDLGNLNYLRLNNNSLTGSCPESL-SKIESLTLVDLSYN 180 (540)
Q Consensus 104 ~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~l~~N 180 (540)
+++.|.+. .+|+.|+++++|++|||++|+++|.+|. .++++++|++|+|++|++++.+|..+ .++++|++|++++|
T Consensus 83 ~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n 161 (768)
T 3rgz_A 83 FLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161 (768)
T ss_dssp ECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred CCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence 44444433 2333444444444444444444444444 44444444444444444443333332 33333444444443
Q ss_pred ccc
Q 009208 181 NLS 183 (540)
Q Consensus 181 ~l~ 183 (540)
+++
T Consensus 162 ~l~ 164 (768)
T 3rgz_A 162 SIS 164 (768)
T ss_dssp CCE
T ss_pred ccC
Confidence 333
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.89 E-value=8e-24 Score=235.33 Aligned_cols=171 Identities=24% Similarity=0.314 Sum_probs=150.4
Q ss_pred CCCCchHHHHHHHHHHhcCCCCCccCCCCCCC----CCC--ccc------------eeeeecCCCcEEEecCCCCCCccc
Q 009208 28 PAGINYEVVALVAVKNNLHDPYNVLENWDITS----VDP--CSW------------RMITCSPDGYVSALGLPSQSLSGT 89 (540)
Q Consensus 28 ~~~~~~~~~~l~~~k~~~~~~~~~~~~w~~~~----~~~--c~w------------~gv~c~~~~~l~~l~l~~~~l~~~ 89 (540)
.+....|+.||++||+++.+| +|+.++ .+| |.| .||+|+..++|+.|+|++|+|+|.
T Consensus 264 ~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ 338 (876)
T 4ecn_A 264 TAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338 (876)
T ss_dssp CCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEE
T ss_pred cccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCc
Confidence 344567899999999999887 797654 466 999 999999889999999999999999
Q ss_pred cCccccCCCccCEEEc-ccCCCCCC-------------------------------------------------------
Q 009208 90 LSPWIGNLTKLQSVLL-QNNAILGP------------------------------------------------------- 113 (540)
Q Consensus 90 ~~~~~~~l~~L~~L~l-~~N~l~~~------------------------------------------------------- 113 (540)
+|++|++|++|+.|+| ++|.++|.
T Consensus 339 ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~ 418 (876)
T 4ecn_A 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418 (876)
T ss_dssp ECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCC
T ss_pred CchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccc
Confidence 9999999999999999 77765444
Q ss_pred ---------------------CCcccCCCCcccEEEeeCCCCcc-----------------cCCcccc--CCCCcchhhc
Q 009208 114 ---------------------IPASLGKLEKLQTLDLSNNKFTG-----------------EIPDSLG--DLGNLNYLRL 153 (540)
Q Consensus 114 ---------------------~p~~~~~l~~L~~L~ls~N~l~~-----------------~~p~~~~--~l~~L~~L~l 153 (540)
+|..|+++++|++|+|++|+|+| .+|+.++ ++++|++|+|
T Consensus 419 ~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~L 498 (876)
T 4ecn_A 419 KDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498 (876)
T ss_dssp CCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEE
T ss_pred cccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEEC
Confidence 88899999999999999999998 3999988 9999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCc-ccc-cCCCC------------CcccccccCCCCCc
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNN-LSG-SLPKI------------SARTFKVTGNPLIC 203 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~-~~p~~------------~~~~~~~~~n~~~~ 203 (540)
++|++.+.+|..|.++++|+.|+|++|+ ++| .+|.. ..+.+++++|.+..
T Consensus 499 s~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ 562 (876)
T 4ecn_A 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE 562 (876)
T ss_dssp ESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCB
T ss_pred cCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCc
Confidence 9999999999999999999999999998 998 66642 23567888888763
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-23 Score=227.08 Aligned_cols=172 Identities=22% Similarity=0.346 Sum_probs=150.3
Q ss_pred CCchHHHHHHHHHHhcCCC-CC-------ccCCCCCCCCCCccc---eeeeecCCCcEEEecCCCCCCccccCccccCCC
Q 009208 30 GINYEVVALVAVKNNLHDP-YN-------VLENWDITSVDPCSW---RMITCSPDGYVSALGLPSQSLSGTLSPWIGNLT 98 (540)
Q Consensus 30 ~~~~~~~~l~~~k~~~~~~-~~-------~~~~w~~~~~~~c~w---~gv~c~~~~~l~~l~l~~~~l~~~~~~~~~~l~ 98 (540)
....|+.||.++|.++++| +. ..++|+. +.+||.| .||+|+..++|+.|+|++++++|.+|+++++|+
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~ 105 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCT
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCc
Confidence 3446889999999998654 22 3458984 6899999 999999889999999999999999999999999
Q ss_pred ccCEEEcccCC---------------------------------------------------------------------
Q 009208 99 KLQSVLLQNNA--------------------------------------------------------------------- 109 (540)
Q Consensus 99 ~L~~L~l~~N~--------------------------------------------------------------------- 109 (540)
+|++|+|++|.
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~ 185 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCT
T ss_pred cceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhh
Confidence 99999999884
Q ss_pred ---------CCCCCCcccCCCCcccEEEeeCCCCccc-----------------CCcccc--CCCCcchhhccCccCCCC
Q 009208 110 ---------ILGPIPASLGKLEKLQTLDLSNNKFTGE-----------------IPDSLG--DLGNLNYLRLNNNSLTGS 161 (540)
Q Consensus 110 ---------l~~~~p~~~~~l~~L~~L~ls~N~l~~~-----------------~p~~~~--~l~~L~~L~l~~N~l~~~ 161 (540)
++| +|+.|+++++|++|+|++|+|+|. +|+.++ ++++|++|+|++|++.+.
T Consensus 186 l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~ 264 (636)
T 4eco_A 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264 (636)
T ss_dssp TTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSS
T ss_pred hhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCcc
Confidence 445 889999999999999999999986 999999 999999999999999999
Q ss_pred CCccccCCccccEEecccCc-ccc-cCCCC-----------CcccccccCCCCCc
Q 009208 162 CPESLSKIESLTLVDLSYNN-LSG-SLPKI-----------SARTFKVTGNPLIC 203 (540)
Q Consensus 162 ~p~~~~~l~~L~~L~l~~N~-l~~-~~p~~-----------~~~~~~~~~n~~~~ 203 (540)
+|..|.++++|+.|++++|+ ++| .+|.. ..+.+++++|.+..
T Consensus 265 ~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ 319 (636)
T 4eco_A 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT 319 (636)
T ss_dssp CCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSS
T ss_pred ChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCc
Confidence 99999999999999999999 998 77752 23567888888763
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.8e-21 Score=184.09 Aligned_cols=148 Identities=22% Similarity=0.260 Sum_probs=131.3
Q ss_pred CCCCCccceeeeecCC----------CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEE
Q 009208 58 TSVDPCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTL 127 (540)
Q Consensus 58 ~~~~~c~w~gv~c~~~----------~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 127 (540)
.+.+.|+|++|.|+.. ..++.|+|++|.|++..|..|.++++|++|+|++|+|++..+..|.++++|++|
T Consensus 14 ~~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L 93 (229)
T 3e6j_A 14 PSQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVL 93 (229)
T ss_dssp CTTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEE
Confidence 4678899999999842 369999999999999889999999999999999999997666778999999999
Q ss_pred EeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCC
Q 009208 128 DLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLI 202 (540)
Q Consensus 128 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~ 202 (540)
+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+.... +.+.+.+|++.
T Consensus 94 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 94 DLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred ECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 99999999666666899999999999999999 8999999999999999999999976655332 56789999999
Q ss_pred cCCC
Q 009208 203 CGPK 206 (540)
Q Consensus 203 ~~~~ 206 (540)
|.+.
T Consensus 173 c~c~ 176 (229)
T 3e6j_A 173 CECR 176 (229)
T ss_dssp TTBG
T ss_pred CCcc
Confidence 8764
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.1e-22 Score=198.41 Aligned_cols=175 Identities=19% Similarity=0.272 Sum_probs=150.1
Q ss_pred ccCCCCCchHHHHHHHHHHhc-CCCCCccCCCC---CCCCCCccceeeeec---------CCCcEEEecCCCCCCccccC
Q 009208 25 TLSPAGINYEVVALVAVKNNL-HDPYNVLENWD---ITSVDPCSWRMITCS---------PDGYVSALGLPSQSLSGTLS 91 (540)
Q Consensus 25 ~~~~~~~~~~~~~l~~~k~~~-~~~~~~~~~w~---~~~~~~c~w~gv~c~---------~~~~l~~l~l~~~~l~~~~~ 91 (540)
....+....++.||++||.++ .||.+.+.+|. ....++|.|.|++|. ...+|+.|+|++|+++ .+|
T Consensus 19 ~~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp 97 (328)
T 4fcg_A 19 FQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFP 97 (328)
T ss_dssp CC--CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCC
T ss_pred eeccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcC
Confidence 344566778999999999998 68877888994 346789999999995 2368999999999999 889
Q ss_pred ccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccC---
Q 009208 92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSK--- 168 (540)
Q Consensus 92 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~--- 168 (540)
+.++++++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..+.++++|++|+|++|++.+.+|..+..
T Consensus 98 ~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~ 175 (328)
T 4fcg_A 98 DQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA 175 (328)
T ss_dssp SCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-
T ss_pred hhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccc
Confidence 99999999999999999999 89999999999999999999999 89999999999999999999998899987765
Q ss_pred ------CccccEEecccCcccccCCCCCc-----ccccccCCCCCc
Q 009208 169 ------IESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLIC 203 (540)
Q Consensus 169 ------l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~ 203 (540)
+++|+.|++++|+++ .+|.... +.+++++|.+..
T Consensus 176 ~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~ 220 (328)
T 4fcg_A 176 SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA 220 (328)
T ss_dssp CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC
T ss_pred hhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc
Confidence 999999999999998 6665322 567788887753
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1e-20 Score=177.70 Aligned_cols=147 Identities=23% Similarity=0.312 Sum_probs=129.9
Q ss_pred CCCccceeeeecCC----------CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEe
Q 009208 60 VDPCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL 129 (540)
Q Consensus 60 ~~~c~w~gv~c~~~----------~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 129 (540)
...|.|..|.|+.. ..++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 8 ~C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L 87 (220)
T 2v9t_B 8 ACTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVL 87 (220)
T ss_dssp TSEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEEC
T ss_pred CCEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEEC
Confidence 34578999999742 36999999999999877789999999999999999999888999999999999999
Q ss_pred eCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCcC
Q 009208 130 SNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICG 204 (540)
Q Consensus 130 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~ 204 (540)
++|+|++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+.... +.+++.+|+|.|+
T Consensus 88 s~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 88 YGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 99999944445578999999999999999988899999999999999999999987776432 5678999999997
Q ss_pred CC
Q 009208 205 PK 206 (540)
Q Consensus 205 ~~ 206 (540)
|.
T Consensus 168 c~ 169 (220)
T 2v9t_B 168 CH 169 (220)
T ss_dssp GG
T ss_pred Cc
Confidence 64
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.1e-20 Score=174.42 Aligned_cols=147 Identities=20% Similarity=0.279 Sum_probs=130.1
Q ss_pred CCCccceeeeecCC----------CcEEEecCCCCCCccccC-ccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEE
Q 009208 60 VDPCSWRMITCSPD----------GYVSALGLPSQSLSGTLS-PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLD 128 (540)
Q Consensus 60 ~~~c~w~gv~c~~~----------~~l~~l~l~~~~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 128 (540)
..-|.|+.+.|+.. ..++.|+|++|.|++..+ ..|.++++|++|+|++|+|++..|..|.++++|++|+
T Consensus 8 ~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~ 87 (220)
T 2v70_A 8 KCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEIL 87 (220)
T ss_dssp TCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEE
Confidence 34578999999742 257899999999998755 4689999999999999999988888999999999999
Q ss_pred eeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCc
Q 009208 129 LSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLIC 203 (540)
Q Consensus 129 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~ 203 (540)
|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|.... +.+++++|++.|
T Consensus 88 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 88 LTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp CCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred CCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 999999977777799999999999999999988899999999999999999999988776543 567899999999
Q ss_pred CCC
Q 009208 204 GPK 206 (540)
Q Consensus 204 ~~~ 206 (540)
.+.
T Consensus 168 ~c~ 170 (220)
T 2v70_A 168 NCY 170 (220)
T ss_dssp SGG
T ss_pred CCc
Confidence 765
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=1e-19 Score=169.33 Aligned_cols=147 Identities=23% Similarity=0.262 Sum_probs=127.2
Q ss_pred CCCccceeeeecCC----------CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEe
Q 009208 60 VDPCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL 129 (540)
Q Consensus 60 ~~~c~w~gv~c~~~----------~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 129 (540)
...|.|.+|.|+.. .+++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 4 ~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 83 (208)
T 2o6s_A 4 RCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNL 83 (208)
T ss_dssp TCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEEC
Confidence 34589999999753 36999999999999777778899999999999999999777777899999999999
Q ss_pred eCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCcC
Q 009208 130 SNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICG 204 (540)
Q Consensus 130 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~ 204 (540)
++|+|++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|++++.++.... +.+++.+|++.|.
T Consensus 84 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 163 (208)
T 2o6s_A 84 STNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 163 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC
T ss_pred CCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC
Confidence 99999966566689999999999999999977777789999999999999999977665332 5678999999887
Q ss_pred CC
Q 009208 205 PK 206 (540)
Q Consensus 205 ~~ 206 (540)
++
T Consensus 164 ~~ 165 (208)
T 2o6s_A 164 CP 165 (208)
T ss_dssp TT
T ss_pred CC
Confidence 65
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=175.02 Aligned_cols=138 Identities=17% Similarity=0.155 Sum_probs=106.1
Q ss_pred CCcCCeeeeccCccEEEEEe-CCCcE--EEEEEeccCCcc-----------------------ccHHHHHHHHHHHhccc
Q 009208 303 FSAKNILGRGGFGIVYKGCF-SDGAL--VAVKRLKDYNIA-----------------------GGEVQFQTEVETISLAV 356 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~ 356 (540)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... .....+.+|++.+.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 55778999999999999998 68888 999997643211 01135789999999998
Q ss_pred CCCc--cceeEEEecCCeeEEEEecCCC-C----ChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEe
Q 009208 357 HRNL--LRLCGFCSTENERLLVYPYMPN-G----SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH-EQCDPKIIH 428 (540)
Q Consensus 357 h~nI--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH 428 (540)
|+++ ..++.+ +..++||||+.+ | +|.+.... .++..+..++.|++.||.||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8865 333332 357899999942 5 55544322 224456789999999999999 88 9999
Q ss_pred cCCCCCceeeCCCCCeEEcccccccccC
Q 009208 429 RDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 429 ~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||||+|||+++ .++|+|||++....
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCC
Confidence 999999999998 99999999998654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.78 E-value=6.5e-19 Score=161.70 Aligned_cols=147 Identities=23% Similarity=0.309 Sum_probs=121.5
Q ss_pred CCCccceeeeecCC----------CcEEEecCCCCCCccccCc-cccCCCccCEEEcccCCCCCCCCcccCCCCcccEEE
Q 009208 60 VDPCSWRMITCSPD----------GYVSALGLPSQSLSGTLSP-WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLD 128 (540)
Q Consensus 60 ~~~c~w~gv~c~~~----------~~l~~l~l~~~~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 128 (540)
...|.|+.+.|+.. ..++.|+|++|.|++..+. .|+++++|++|+|++|+|++..|..|.++++|++|+
T Consensus 5 ~C~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 84 (192)
T 1w8a_A 5 MCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84 (192)
T ss_dssp TSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCEECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEE
Confidence 34578999999743 2789999999999866654 489999999999999999988899999999999999
Q ss_pred eeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCCcC
Q 009208 129 LSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICG 204 (540)
Q Consensus 129 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~ 204 (540)
|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+-... +...+.++...|.
T Consensus 85 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~ 164 (192)
T 1w8a_A 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCC
Confidence 999999987788899999999999999999988899999999999999999999987653211 1223455555665
Q ss_pred CC
Q 009208 205 PK 206 (540)
Q Consensus 205 ~~ 206 (540)
.+
T Consensus 165 ~P 166 (192)
T 1w8a_A 165 AP 166 (192)
T ss_dssp SS
T ss_pred CC
Confidence 44
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=7.1e-19 Score=195.71 Aligned_cols=135 Identities=35% Similarity=0.583 Sum_probs=124.7
Q ss_pred EEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCc
Q 009208 77 SALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN 156 (540)
Q Consensus 77 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 156 (540)
..++++.|.++|.+|..++++++|+.|+|++|+++|.+|.+|+++++|+.|+|++|+|+|.+|..++++++|+.|||++|
T Consensus 611 ~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N 690 (768)
T 3rgz_A 611 NPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690 (768)
T ss_dssp CCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred cccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCC
Confidence 34677789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCCcCCCCCCCCc
Q 009208 157 SLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGPKATNNCT 212 (540)
Q Consensus 157 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~~~~~~c~ 212 (540)
+++|.+|..+..+++|++|++++|+++|.||.... ...++.||+.+|+.+.. .|.
T Consensus 691 ~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~ 749 (768)
T 3rgz_A 691 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCD 749 (768)
T ss_dssp CCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCC
T ss_pred cccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCC
Confidence 99999999999999999999999999999998643 34578999999998754 564
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.74 E-value=3.9e-18 Score=163.48 Aligned_cols=128 Identities=23% Similarity=0.239 Sum_probs=107.4
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
.++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 115 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG 115 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence 58889999999998888889999999999999999998888888999999999999999996666778889999999999
Q ss_pred CccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCC
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLI 202 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~ 202 (540)
+|+|++..+..|..+++|+.|+|++|+|++.+|.... +.+++++|.+.
T Consensus 116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 168 (251)
T 3m19_A 116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ 168 (251)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCC
Confidence 9999866666678899999999999999876664322 56778888764
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.4e-18 Score=153.91 Aligned_cols=128 Identities=27% Similarity=0.297 Sum_probs=104.9
Q ss_pred CCccceeeeecCC----------CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEee
Q 009208 61 DPCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLS 130 (540)
Q Consensus 61 ~~c~w~gv~c~~~----------~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls 130 (540)
..|+|++|.|+.. ..++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|+
T Consensus 5 C~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 5 CSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp CEEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CEeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence 4578999999742 368889999999887666678888999999999999987666678889999999999
Q ss_pred CCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCC
Q 009208 131 NNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188 (540)
Q Consensus 131 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 188 (540)
+|+|++..+..+..+++|++|+|++|++++..+..+..+++|+.|++++|++++.+|.
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 9999866566678889999999999999855555568888999999999998887764
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.74 E-value=8.4e-20 Score=192.19 Aligned_cols=138 Identities=20% Similarity=0.192 Sum_probs=74.2
Q ss_pred cceeeeecCCCcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccC-CCCcccEEEeeCCCCcccCCccc
Q 009208 64 SWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLG-KLEKLQTLDLSNNKFTGEIPDSL 142 (540)
Q Consensus 64 ~w~gv~c~~~~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~~~~p~~~ 142 (540)
.+.++.|..-..++.|+|++|.|++..|..++++++|+.|+|++|.+++.+|..+. ++++|++|+|++|+|++. |. +
T Consensus 110 ~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~ 187 (487)
T 3oja_A 110 NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-Q 187 (487)
T ss_dssp CCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-C
T ss_pred cCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-c
Confidence 34444444334556666666666655555566666666666666666655555554 456666666666666533 22 2
Q ss_pred cCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCC----cccccccCCCCCcC
Q 009208 143 GDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS----ARTFKVTGNPLICG 204 (540)
Q Consensus 143 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~----~~~~~~~~n~~~~~ 204 (540)
..+++|+.|+|++|+|++ +|..+..+++|+.|+|++|+|++.++.+. ...+++++|++.|+
T Consensus 188 ~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 188 VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHH
T ss_pred ccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCc
Confidence 245666666666666663 33345566666666666666664222221 13345555655543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-17 Score=160.04 Aligned_cols=131 Identities=24% Similarity=0.285 Sum_probs=117.8
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 59 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 138 (251)
T 3m19_A 59 TKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRL 138 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEEC
Confidence 47999999999999888888999999999999999999888888999999999999999999666666899999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCcC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICG 204 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~ 204 (540)
++|+|++..+..|..+++|+.|+|++|+|++.+|.... +.+++.+|++.|.
T Consensus 139 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 139 NTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99999976666899999999999999999977775432 5678999999887
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=1e-17 Score=153.68 Aligned_cols=127 Identities=20% Similarity=0.333 Sum_probs=113.4
Q ss_pred EEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCc-ccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccC
Q 009208 77 SALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPA-SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155 (540)
Q Consensus 77 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 155 (540)
+.+++++|+|+ .+|..+.. +|++|+|++|+|++..|. .|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 67999999997 78877654 999999999999976664 489999999999999999988899999999999999999
Q ss_pred ccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCcCCC
Q 009208 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPK 206 (540)
Q Consensus 156 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~ 206 (540)
|+|++..|..|..+++|+.|+|++|+|++.+|.... +.+++++|++.|.++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 999988888899999999999999999998886543 567899999988764
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.72 E-value=3.4e-18 Score=169.49 Aligned_cols=132 Identities=27% Similarity=0.455 Sum_probs=94.3
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
.++.|+|++|.+++.+|..+..++ |++|+|++|.+++.+|..|.++++|+.|+|++|++++.+|. +..+++|++|+|+
T Consensus 175 ~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls 252 (313)
T 1ogq_A 175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR 252 (313)
T ss_dssp TCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECC
T ss_pred cCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECc
Confidence 344555555555555555555554 55555555555555666666777777777777777755544 6778888888888
Q ss_pred CccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCCcCCCCC
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGPKAT 208 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~~~~ 208 (540)
+|++++.+|..+..+++|+.|++++|+++|.+|.... +.+++.+|++.|+.+..
T Consensus 253 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred CCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC
Confidence 8888888888899999999999999999998888632 56788999988986543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.71 E-value=3.5e-17 Score=158.78 Aligned_cols=133 Identities=22% Similarity=0.236 Sum_probs=91.5
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.+++..+..++++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+..+++|+.|++
T Consensus 85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 164 (272)
T 3rfs_A 85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL 164 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence 35777777777777655666677777777777777777666666777777777777777777555555677777777777
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCcCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPK 206 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~ 206 (540)
++|++++..+..+..+++|+.|++++|++++.+|.... +.+++.+|++.|.++
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 77777765555667777777777777777766654322 446677777766543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.5e-17 Score=158.60 Aligned_cols=128 Identities=27% Similarity=0.330 Sum_probs=88.6
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
.++.|+|++|++++..+..|.++++|++|+|++|+++...+..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 46777777777776555677777777777777777775555556777777777777777775444556777777777777
Q ss_pred CccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCC
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLI 202 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~ 202 (540)
+|++++..|..|..+++|++|++++|++++..+.... +.+++++|.+.
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 170 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK 170 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCc
Confidence 7777766666677777777777777777755444221 44566666553
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-17 Score=169.31 Aligned_cols=127 Identities=27% Similarity=0.325 Sum_probs=102.0
Q ss_pred CCccceeeeecCC----------CcEEEecCCCCCCccccCcccc-CCCccCEEEcccCCCCCCCCcccCCCCcccEEEe
Q 009208 61 DPCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIG-NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL 129 (540)
Q Consensus 61 ~~c~w~gv~c~~~----------~~l~~l~l~~~~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 129 (540)
.-|.+..|.|+.. ..++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..|..|.++++|++|+|
T Consensus 16 C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L 95 (361)
T 2xot_A 16 CLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDL 95 (361)
T ss_dssp CEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEEC
Confidence 3467888888642 3578899999999877777777 8889999999999988777778888888999999
Q ss_pred eCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCC
Q 009208 130 SNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187 (540)
Q Consensus 130 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 187 (540)
++|+|++..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+
T Consensus 96 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~ 153 (361)
T 2xot_A 96 SSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPV 153 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCG
T ss_pred CCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCH
Confidence 8888886666678888888888888888887667788888888888888888875433
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=3e-17 Score=150.56 Aligned_cols=124 Identities=24% Similarity=0.344 Sum_probs=87.4
Q ss_pred ecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccC
Q 009208 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSL 158 (540)
Q Consensus 79 l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 158 (540)
+++++|+|+ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 445566666 5565443 57777788888777 6677777777888888888887766666677777888888888887
Q ss_pred CCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCcCCC
Q 009208 159 TGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPK 206 (540)
Q Consensus 159 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~ 206 (540)
++..|..|..+++|+.|+|++|+|++..+..+. +.+++.+|+|.|+|.
T Consensus 91 ~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 766666777777888888888877755554322 456777888877654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.6e-17 Score=150.98 Aligned_cols=125 Identities=22% Similarity=0.281 Sum_probs=112.3
Q ss_pred CCCccceeeeecCC----------CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEe
Q 009208 60 VDPCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL 129 (540)
Q Consensus 60 ~~~c~w~gv~c~~~----------~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 129 (540)
...|.|..|.|+.. ..++.|+|++|.|+ .+|..|.++++|+.|+|++|+|++..|..|.++++|++|+|
T Consensus 7 ~C~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~L 85 (193)
T 2wfh_A 7 ECTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLIL 85 (193)
T ss_dssp TCEEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEEC
Confidence 34577888888742 37999999999998 78899999999999999999999888889999999999999
Q ss_pred eCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCccccc
Q 009208 130 SNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGS 185 (540)
Q Consensus 130 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 185 (540)
++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++...
T Consensus 86 s~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 86 SYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 99999977777899999999999999999965556799999999999999999854
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=8.3e-18 Score=168.41 Aligned_cols=148 Identities=14% Similarity=0.106 Sum_probs=102.5
Q ss_pred HHHHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCc-------------cccHHHHH--------HHHHHHh
Q 009208 295 ELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNI-------------AGGEVQFQ--------TEVETIS 353 (540)
Q Consensus 295 ~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-------------~~~~~~~~--------~E~~~l~ 353 (540)
.+.....-|.+.+.||+|++|.||+|...+|+.||||+++.... ........ +|...+.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 33333344888999999999999999999999999999764211 01112222 3444444
Q ss_pred cccCCCccceeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 009208 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKA 433 (540)
Q Consensus 354 ~l~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~ 433 (540)
++.+.++.-..-+.. ...++||||+++++|...... .....++.|++.+|.|||+. +||||||||
T Consensus 169 rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp 233 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNE 233 (397)
T ss_dssp HHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred HHHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCH
Confidence 443333221111111 234799999999887665421 12356789999999999998 999999999
Q ss_pred CceeeCCCCC----------eEEcccccccccCC
Q 009208 434 ANILLDEDFE----------AVVGDFGLAKLLDH 457 (540)
Q Consensus 434 ~NILl~~~~~----------~kl~Dfgla~~~~~ 457 (540)
.|||+++++. +.|+||+-+....+
T Consensus 234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 234 FNILIREEKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp TSEEEEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred HHEEEeCCCCcccccccccceEEEEeCCcccCCC
Confidence 9999998763 89999998765443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.70 E-value=4.9e-17 Score=159.21 Aligned_cols=131 Identities=25% Similarity=0.229 Sum_probs=97.5
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
..++.|+|++|.|+ .+|..+.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 77 ~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 155 (290)
T 1p9a_G 77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (290)
T ss_dssp TTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEEC
Confidence 36777788888777 67777788888888888888888666677888888888888888888555556777888888888
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCCcCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGP 205 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~ 205 (540)
++|+|++..+..|..+++|+.|+|++|+|+..++.+.. +.+.+.+|||.|.|
T Consensus 156 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 156 ANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence 88888854445567788888888888888843333221 45677888888875
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=9.2e-17 Score=155.65 Aligned_cols=110 Identities=23% Similarity=0.275 Sum_probs=52.5
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
+++.|+|++|.++...+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|++|+|+
T Consensus 62 ~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls 141 (270)
T 2o6q_A 62 KLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLG 141 (270)
T ss_dssp TCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECC
Confidence 45555555555553333334455555555555555554444444445555555555555553333344444555555555
Q ss_pred CccCCCCCCccccCCccccEEecccCcccc
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSG 184 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 184 (540)
+|++++..+..|..+++|+.|++++|++++
T Consensus 142 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 171 (270)
T 2o6q_A 142 YNELQSLPKGVFDKLTSLKELRLYNNQLKR 171 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCcCCccCHhHccCCcccceeEecCCcCcE
Confidence 554443333334444444444444444443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=4.8e-17 Score=176.81 Aligned_cols=131 Identities=18% Similarity=0.141 Sum_probs=114.7
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
..++.|||++|.|++..+.+|.++++|++|+|++|+|++..|..|.+|++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 37999999999999877789999999999999999999887889999999999999999999655567999999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccc-cCCCCCc-----ccccccCCCCCcC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG-SLPKISA-----RTFKVTGNPLICG 204 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~-----~~~~~~~n~~~~~ 204 (540)
++|++++..+..|+++++|++|++++|++++ .+|.... +.+++.+|.+...
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 188 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 188 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccc
Confidence 9999997667789999999999999999986 3455432 5678888887543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.2e-16 Score=149.78 Aligned_cols=114 Identities=20% Similarity=0.255 Sum_probs=107.6
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 57 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 136 (220)
T 2v70_A 57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSL 136 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEEC
T ss_pred CCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEEC
Confidence 47999999999999888889999999999999999999888888999999999999999999888999999999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 187 (540)
++|+|++..|..|..+++|+.|++++|++++..+
T Consensus 137 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 137 YDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 9999998889999999999999999999997654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.2e-16 Score=166.83 Aligned_cols=133 Identities=21% Similarity=0.212 Sum_probs=122.6
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
..++.|+|++|.+++..|..++++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+.++++|++|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 37999999999999999999999999999999999999888999999999999999999999877889999999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCcCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPK 206 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~ 206 (540)
++|++++..|..|..+++|+.|++++|+|++.++.... +.+++++|++.|.++
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 99999988899999999999999999999976665432 567899999999876
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=7.6e-17 Score=157.48 Aligned_cols=114 Identities=24% Similarity=0.295 Sum_probs=62.7
Q ss_pred cEEEecCCCCC-CccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 75 YVSALGLPSQS-LSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 75 ~l~~l~l~~~~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
+++.|+|++|. ++...|..+.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..+..+++|++|+|
T Consensus 81 ~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 160 (285)
T 1ozn_A 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160 (285)
T ss_dssp TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEEC
Confidence 45566666664 54444555555666666666666665555555555556666666666555333344555555555555
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 188 (540)
++|++++..+..+..+++|+.|++++|++++..|.
T Consensus 161 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 195 (285)
T 1ozn_A 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195 (285)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred CCCcccccCHHHhcCccccCEEECCCCcccccCHh
Confidence 55555533333455555555555555555544443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.5e-16 Score=157.12 Aligned_cols=110 Identities=21% Similarity=0.324 Sum_probs=55.2
Q ss_pred cEEEecCCCCCCccccC-ccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcc-cCCccccCCCCcchhh
Q 009208 75 YVSALGLPSQSLSGTLS-PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG-EIPDSLGDLGNLNYLR 152 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~ 152 (540)
+++.|+|++|.+++..+ ..+.++++|++|+|++|.+++..|..|.++++|++|+|++|++++ .+|..+..+++|++|+
T Consensus 102 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 181 (306)
T 2z66_A 102 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181 (306)
T ss_dssp TCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEE
Confidence 45555555555553332 345555555555555555554444445555555555555555543 3444455555555555
Q ss_pred ccCccCCCCCCccccCCccccEEecccCcccc
Q 009208 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184 (540)
Q Consensus 153 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 184 (540)
|++|++++..|..+..+++|+.|++++|++++
T Consensus 182 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 213 (306)
T 2z66_A 182 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 213 (306)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSCCSB
T ss_pred CCCCCcCCcCHHHhcCCCCCCEEECCCCccCc
Confidence 55555554444445555555555555555543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=4.7e-16 Score=140.53 Aligned_cols=128 Identities=21% Similarity=0.239 Sum_probs=109.3
Q ss_pred EEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccC
Q 009208 76 VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155 (540)
Q Consensus 76 l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 155 (540)
.+.+++++++++ .+|..+ .++|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..+..+++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 467899999998 566554 37999999999999977777889999999999999999966566689999999999999
Q ss_pred ccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCcCCC
Q 009208 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPK 206 (540)
Q Consensus 156 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~ 206 (540)
|++++..+..+..+++|+.|++++|+|++.++.... +.+++.+|++.|.++
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 999977777789999999999999999976665432 567899999988653
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=4.6e-16 Score=139.27 Aligned_cols=125 Identities=25% Similarity=0.279 Sum_probs=108.3
Q ss_pred CcEEEecCCCCCCc-cccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhh
Q 009208 74 GYVSALGLPSQSLS-GTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152 (540)
Q Consensus 74 ~~l~~l~l~~~~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 152 (540)
.+++.|+|++|.++ +.+|..+.++++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 47999999999998 78999999999999999999999965 7899999999999999999977888888899999999
Q ss_pred ccCccCCCCCC--ccccCCccccEEecccCcccccCC---CCC-----cccccccCCCC
Q 009208 153 LNNNSLTGSCP--ESLSKIESLTLVDLSYNNLSGSLP---KIS-----ARTFKVTGNPL 201 (540)
Q Consensus 153 l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p---~~~-----~~~~~~~~n~~ 201 (540)
|++|++++ +| ..+..+++|+.|++++|++++..+ ... .+.+++.+|..
T Consensus 102 Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 102 LSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp CBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred ccCCccCc-chhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence 99999995 44 789999999999999999997655 111 14566666665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.63 E-value=7e-16 Score=138.41 Aligned_cols=110 Identities=27% Similarity=0.322 Sum_probs=96.4
Q ss_pred EEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCc
Q 009208 77 SALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN 156 (540)
Q Consensus 77 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 156 (540)
+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 35667788888 5777663 89999999999999888999999999999999999999666666899999999999999
Q ss_pred cCCCCCCccccCCccccEEecccCcccccCCCC
Q 009208 157 SLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189 (540)
Q Consensus 157 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 189 (540)
+|++..+..|..+++|+.|+|++|+++...+++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~l 121 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSDI 121 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGGG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchhH
Confidence 999766667999999999999999999776644
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.63 E-value=7.4e-16 Score=144.43 Aligned_cols=112 Identities=25% Similarity=0.261 Sum_probs=104.3
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.|++..|..|.++++|++|+|++|+|+...+..|.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 56 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 135 (220)
T 2v9t_B 56 KKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSL 135 (220)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEEC
Confidence 47999999999999888999999999999999999999666667899999999999999999888899999999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCccccc
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGS 185 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 185 (540)
++|+|++..+..|..+++|+.|+|++|++...
T Consensus 136 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 136 YDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 99999977777899999999999999999853
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=3.3e-16 Score=157.85 Aligned_cols=140 Identities=22% Similarity=0.298 Sum_probs=116.7
Q ss_pred CCCccceeeeecC------------CCcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEE
Q 009208 60 VDPCSWRMITCSP------------DGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTL 127 (540)
Q Consensus 60 ~~~c~w~gv~c~~------------~~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 127 (540)
..+|.|.|+ |+. ..+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 466888776 542 1379999999999997767799999999999999999998888899999999999
Q ss_pred EeeCCCCcccCCcc-ccCCCCcchhhccCccCCCCCCc--cccCCccccEEecccCc-ccccCCCCCc-----ccccccC
Q 009208 128 DLSNNKFTGEIPDS-LGDLGNLNYLRLNNNSLTGSCPE--SLSKIESLTLVDLSYNN-LSGSLPKISA-----RTFKVTG 198 (540)
Q Consensus 128 ~ls~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~-l~~~~p~~~~-----~~~~~~~ 198 (540)
+|++|+++ .+|.. +.++++|++|+|++|+++ .+|. .+..+++|+.|++++|+ +++..|.... +.+++++
T Consensus 106 ~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~ 183 (353)
T 2z80_A 106 DLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183 (353)
T ss_dssp ECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEE
T ss_pred ECCCCcCC-cCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCC
Confidence 99999999 55554 899999999999999999 5555 78999999999999995 6655454332 5567888
Q ss_pred CCCC
Q 009208 199 NPLI 202 (540)
Q Consensus 199 n~~~ 202 (540)
|.+.
T Consensus 184 n~l~ 187 (353)
T 2z80_A 184 SDLQ 187 (353)
T ss_dssp TTCC
T ss_pred CCcC
Confidence 8763
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1e-15 Score=148.69 Aligned_cols=127 Identities=18% Similarity=0.175 Sum_probs=106.7
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
.++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 58999999999997777789999999999999999997777789999999999999999997777889999999999999
Q ss_pred CccCCCCCCccccCCccccEEecccCcccc-cCCCCCc-----ccccccCCCC
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSG-SLPKISA-----RTFKVTGNPL 201 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~-----~~~~~~~n~~ 201 (540)
+|++++..+..+..+++|+.|++++|++++ .+|.... +.+++++|.+
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l 161 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCC
Confidence 999987666678899999999999999986 3465332 4567777765
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=149.16 Aligned_cols=129 Identities=21% Similarity=0.230 Sum_probs=113.0
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCC-CcccCCccccCCCCcchhh
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNK-FTGEIPDSLGDLGNLNYLR 152 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~-l~~~~p~~~~~l~~L~~L~ 152 (540)
..++.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+ ++...|..+..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 479999999999998777889999999999999999998889999999999999999997 8855588899999999999
Q ss_pred ccCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCC
Q 009208 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLI 202 (540)
Q Consensus 153 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~ 202 (540)
|++|++++..|..+..+++|++|++++|++++..+.... +.+++++|.+.
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 166 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccc
Confidence 999999987788899999999999999999976665332 56778888764
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=6.1e-16 Score=161.38 Aligned_cols=143 Identities=22% Similarity=0.233 Sum_probs=122.2
Q ss_pred CCcccee--eeecCC---------CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCC-CcccCCCCcccEEE
Q 009208 61 DPCSWRM--ITCSPD---------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPI-PASLGKLEKLQTLD 128 (540)
Q Consensus 61 ~~c~w~g--v~c~~~---------~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~ 128 (540)
..|.|.+ |.|+.. .+++.|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 4465555 788642 46999999999999888999999999999999999998655 56799999999999
Q ss_pred eeCCCCcccCCccccCCCCcchhhccCccCCCCCCcc--ccCCccccEEecccCcccccCCCC-Cc-----ccccccCCC
Q 009208 129 LSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPES--LSKIESLTLVDLSYNNLSGSLPKI-SA-----RTFKVTGNP 200 (540)
Q Consensus 129 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~p~~-~~-----~~~~~~~n~ 200 (540)
|++|++++..|..|.++++|++|+|++|++++.+|.. +..+++|+.|++++|++++..|.. .. +.+++++|.
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999888999999999999999999999766555 999999999999999999887763 11 567888888
Q ss_pred CCc
Q 009208 201 LIC 203 (540)
Q Consensus 201 ~~~ 203 (540)
+..
T Consensus 166 l~~ 168 (455)
T 3v47_A 166 VKS 168 (455)
T ss_dssp BSC
T ss_pred ccc
Confidence 744
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.1e-15 Score=165.59 Aligned_cols=130 Identities=18% Similarity=0.148 Sum_probs=108.5
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 47889999999999877788999999999999999999877888999999999999999998777888999999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccc-cCCCCCc-----ccccccCCCCCc
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG-SLPKISA-----RTFKVTGNPLIC 203 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~-----~~~~~~~n~~~~ 203 (540)
++|++++..|..++++++|++|++++|++++ .+|.... +.+++++|.+..
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~ 167 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCE
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCccee
Confidence 9999986666788888899999999998875 5565432 556777776643
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=5.6e-16 Score=168.34 Aligned_cols=133 Identities=19% Similarity=0.261 Sum_probs=120.7
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCC-CCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhh
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAIL-GPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 152 (540)
..++.++++.|.+++..+..+..+++|+.|+|++|++. +.+|..|..+++|++|+|++|+|++..|..|.++++|++|+
T Consensus 445 ~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~ 524 (635)
T 4g8a_A 445 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 524 (635)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEE
Confidence 36788999999999989999999999999999999754 46788999999999999999999988899999999999999
Q ss_pred ccCccCCCCCCccccCCccccEEecccCcccccCCCCCc------ccccccCCCCCcCCC
Q 009208 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA------RTFKVTGNPLICGPK 206 (540)
Q Consensus 153 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~------~~~~~~~n~~~~~~~ 206 (540)
|++|+|++..|..|..+++|+.|+|++|+|++.+|.... +.+++++|||.|+|.
T Consensus 525 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 525 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 999999988888999999999999999999998887532 457899999999875
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=2e-15 Score=140.08 Aligned_cols=126 Identities=23% Similarity=0.222 Sum_probs=109.7
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..+..+++|++|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 131 (208)
T 2o6s_A 52 TSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRL 131 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEEC
Confidence 47999999999999766677899999999999999999777777899999999999999999666666899999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCcccccccCCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPL 201 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~n~~ 201 (540)
++|++++..+..+..+++|+.|++++|++.+..|.+ +.+.+.+|.+
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l--~~L~~~~n~~ 177 (208)
T 2o6s_A 132 YQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGI--RYLSEWINKH 177 (208)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTTT--HHHHHHHHHC
T ss_pred CCCccceeCHHHhccCCCccEEEecCCCeecCCCCH--HHHHHHHHhC
Confidence 999999766667899999999999999999988865 3444455544
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.8e-15 Score=136.19 Aligned_cols=110 Identities=26% Similarity=0.286 Sum_probs=96.8
Q ss_pred EEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCc
Q 009208 77 SALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN 156 (540)
Q Consensus 77 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 156 (540)
+.+++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 57899999997 7887775 89999999999999988999999999999999999999554455789999999999999
Q ss_pred cCCCCCCccccCCccccEEecccCcccccCCCC
Q 009208 157 SLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189 (540)
Q Consensus 157 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 189 (540)
+|++..+..|..+++|+.|+|++|++....+++
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~~ 124 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECRDI 124 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBGGG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccccH
Confidence 999655556999999999999999999765543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=6.1e-16 Score=135.50 Aligned_cols=112 Identities=27% Similarity=0.309 Sum_probs=102.2
Q ss_pred CcEEEecCCCCCCc-cccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhh
Q 009208 74 GYVSALGLPSQSLS-GTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152 (540)
Q Consensus 74 ~~l~~l~l~~~~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 152 (540)
.+++.|++++|.++ +.+|..+..+++|++|+|++|.+++. ..+.++++|++|+|++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 47899999999998 88999999999999999999999966 7899999999999999999977898888899999999
Q ss_pred ccCccCCCC-CCccccCCccccEEecccCcccccCC
Q 009208 153 LNNNSLTGS-CPESLSKIESLTLVDLSYNNLSGSLP 187 (540)
Q Consensus 153 l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p 187 (540)
+++|++++. .|..+..+++|+.|++++|++++..+
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 999999953 34789999999999999999996654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.9e-15 Score=142.58 Aligned_cols=114 Identities=25% Similarity=0.234 Sum_probs=104.8
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|
T Consensus 64 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 142 (229)
T 3e6j_A 64 INLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL 142 (229)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEEC
T ss_pred cCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEEC
Confidence 47999999999998666677899999999999999999877778899999999999999999 89999999999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 188 (540)
++|+|++..+..|..+++|+.|++++|++++..++
T Consensus 143 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 177 (229)
T 3e6j_A 143 DQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECRD 177 (229)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBGG
T ss_pred CCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcch
Confidence 99999966667899999999999999999987764
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.8e-16 Score=172.92 Aligned_cols=110 Identities=28% Similarity=0.420 Sum_probs=67.9
Q ss_pred EEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccC
Q 009208 76 VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155 (540)
Q Consensus 76 l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 155 (540)
++.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|++|++|++|+|++
T Consensus 226 L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~ 302 (727)
T 4b8c_D 226 WHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFD 302 (727)
T ss_dssp CCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCS
T ss_pred CcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCC
Confidence 445666666665 45555556666666666666666 55666666666666666666666 5566666666666666666
Q ss_pred ccCCCCCCccccCCccccEEecccCcccccCCCC
Q 009208 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189 (540)
Q Consensus 156 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 189 (540)
|.|+ .+|..|.+|++|+.|+|++|+|++.+|..
T Consensus 303 N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~ 335 (727)
T 4b8c_D 303 NMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKI 335 (727)
T ss_dssp SCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHH
T ss_pred CCCC-ccChhhhcCCCccEEeCCCCccCCCChHH
Confidence 6665 55655666666666666666666655544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.1e-15 Score=159.36 Aligned_cols=130 Identities=18% Similarity=0.136 Sum_probs=111.1
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
..++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 47999999999999988999999999999999999999888899999999999999999999666666999999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCC-C-----cccccccCCCCCc
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI-S-----ARTFKVTGNPLIC 203 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~-----~~~~~~~~n~~~~ 203 (540)
++|+++...+..|.++++|+.|++++|+..+.+|.. . .+.+++++|.+..
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 210 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD 210 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc
Confidence 999999666668889999999999986555555542 1 1556778887643
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=6.2e-16 Score=165.34 Aligned_cols=140 Identities=19% Similarity=0.259 Sum_probs=119.3
Q ss_pred CccceeeeecCC------------CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEe
Q 009208 62 PCSWRMITCSPD------------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL 129 (540)
Q Consensus 62 ~c~w~gv~c~~~------------~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 129 (540)
.|.|.|+ |+.. .+++.|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4888887 7521 37999999999999888899999999999999999999888899999999999999
Q ss_pred eCCCCcccCCccccCCCCcchhhccCccCCC-CCCccccCCccccEEecccCcccccCCCC-Cc-----ccccccCCCCC
Q 009208 130 SNNKFTGEIPDSLGDLGNLNYLRLNNNSLTG-SCPESLSKIESLTLVDLSYNNLSGSLPKI-SA-----RTFKVTGNPLI 202 (540)
Q Consensus 130 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~-----~~~~~~~n~~~ 202 (540)
++|++++..|..|+++++|++|+|++|++++ ..|..+.++++|+.|++++|++.+.+|.. .. +.+++.+|.+.
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 9999997666679999999999999999986 35778999999999999999966666632 21 45677777764
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.7e-15 Score=146.91 Aligned_cols=126 Identities=25% Similarity=0.229 Sum_probs=111.5
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
..++.|+|++|.+++..+..++++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+..+++|++|+|
T Consensus 109 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 188 (272)
T 3rfs_A 109 TNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRL 188 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEEC
Confidence 47999999999999877788999999999999999999887778899999999999999999777777899999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCcccccccCCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPL 201 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~n~~ 201 (540)
++|++++..|..+..+++|+.|++++|++.+.+|.+ +.+.+.+|.+
T Consensus 189 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l--~~l~~~~n~~ 234 (272)
T 3rfs_A 189 YQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGI--RYLSEWINKH 234 (272)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT--HHHHHHHHHT
T ss_pred CCCcCCccCHHHHhCCcCCCEEEccCCCccccCcHH--HHHHHHHHhC
Confidence 999999888888999999999999999999998865 3344444433
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.2e-15 Score=152.06 Aligned_cols=127 Identities=22% Similarity=0.340 Sum_probs=111.5
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCC---------CCcccEEEeeCCCCcccCCccccC
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGK---------LEKLQTLDLSNNKFTGEIPDSLGD 144 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~---------l~~L~~L~ls~N~l~~~~p~~~~~ 144 (540)
.+++.|+|++|.++ .+|..++++++|++|+|++|++.+.+|..+.. +++|++|+|++|+|+ .+|..+++
T Consensus 127 ~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~ 204 (328)
T 4fcg_A 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN 204 (328)
T ss_dssp TTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGG
T ss_pred CCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcC
Confidence 47999999999999 88999999999999999999998899987765 999999999999999 89999999
Q ss_pred CCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCc
Q 009208 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLIC 203 (540)
Q Consensus 145 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~ 203 (540)
+++|++|+|++|+++ .+|..+..+++|+.|++++|++.+.+|.... +.+++.+|.+..
T Consensus 205 l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 267 (328)
T 4fcg_A 205 LQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267 (328)
T ss_dssp CTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCC
T ss_pred CCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchh
Confidence 999999999999999 5777899999999999999999998887543 556788876543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.4e-15 Score=147.77 Aligned_cols=114 Identities=21% Similarity=0.254 Sum_probs=77.9
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|++++|++++..+..+..+++|++|++
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 35777777777777655566777777777777777777666666777777777777777777544445677777777777
Q ss_pred cCccCCC-CCCccccCCccccEEecccCcccccCC
Q 009208 154 NNNSLTG-SCPESLSKIESLTLVDLSYNNLSGSLP 187 (540)
Q Consensus 154 ~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p 187 (540)
++|++++ .+|..+..+++|+.|++++|++++..+
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~ 166 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred cCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence 7777764 246667777777777777777665433
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=6.7e-16 Score=167.20 Aligned_cols=132 Identities=19% Similarity=0.212 Sum_probs=99.1
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCC-CCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhh
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 152 (540)
..++.|++++|.+++..|..++++++|++|+|++|.+++ .+|..|.++++|++|+|++|++++..|..+.++++|++|+
T Consensus 424 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 503 (606)
T 3vq2_A 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLN 503 (606)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred ccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEE
Confidence 357777777777777777777777778888888887776 3677777888888888888888877777788888888888
Q ss_pred ccCccCCCCCCccccCCccccEEecccCcccccCCCCC------cccccccCCCCCcCCC
Q 009208 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS------ARTFKVTGNPLICGPK 206 (540)
Q Consensus 153 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~------~~~~~~~~n~~~~~~~ 206 (540)
|++|++++..|..+..+++|+.|++++|+|+. +|... .+.+++.+|++.|+|+
T Consensus 504 Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 504 MSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp CCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccCCc
Confidence 88888887777778888888888888888873 44321 2456788888888765
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=8.8e-16 Score=172.58 Aligned_cols=131 Identities=24% Similarity=0.281 Sum_probs=99.2
Q ss_pred cEEEecCCCCCCccccCc-cccCCCccCEEEcccCCCC-----CCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCc
Q 009208 75 YVSALGLPSQSLSGTLSP-WIGNLTKLQSVLLQNNAIL-----GPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~-~~~~l~~L~~L~l~~N~l~-----~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 148 (540)
+++.|+|++|.+++..+. .+..+++|+.|+|++|.++ +..|..|.++++|+.|+|++|+|++..|..|..+++|
T Consensus 427 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 506 (844)
T 3j0a_A 427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL 506 (844)
T ss_dssp TCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSC
T ss_pred ccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhh
Confidence 566677777777654332 3555677777777777776 3445567888888888888888887777778888888
Q ss_pred chhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc--ccccccCCCCCcCCCC
Q 009208 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA--RTFKVTGNPLICGPKA 207 (540)
Q Consensus 149 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~~~~~~n~~~~~~~~ 207 (540)
+.|+|++|+|++..|..+. ++|+.|++++|+|++.+|+... ..+++++||+.|+|..
T Consensus 507 ~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 507 RGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp SEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred heeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence 8888888888865555554 7888899999999888887644 5678999999998763
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.4e-15 Score=158.09 Aligned_cols=138 Identities=20% Similarity=0.187 Sum_probs=113.7
Q ss_pred ceeeeecCC----------CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCC
Q 009208 65 WRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKF 134 (540)
Q Consensus 65 w~gv~c~~~----------~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 134 (540)
|..|.|... ..++.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 556777632 4689999999999988889999999999999999999988888999999999999999999
Q ss_pred cccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCC-C-----cccccccCCCCC
Q 009208 135 TGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI-S-----ARTFKVTGNPLI 202 (540)
Q Consensus 135 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~-----~~~~~~~~n~~~ 202 (540)
++..+..|..+++|++|+|++|+++...+..|.++++|+.|++++|+..+.+|.. . .+.+++++|.+.
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 198 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc
Confidence 9555557999999999999999999666668888999999999986555555542 1 145677777664
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=6.9e-16 Score=152.25 Aligned_cols=142 Identities=22% Similarity=0.239 Sum_probs=118.0
Q ss_pred CCCccceeeeecCC----------CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCC--CCCcccCCCCcccEE
Q 009208 60 VDPCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILG--PIPASLGKLEKLQTL 127 (540)
Q Consensus 60 ~~~c~w~gv~c~~~----------~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L 127 (540)
...|.|.+|.|+.. ..++.|+|++|+++...+..|.++++|++|+|++|.++. ..|..+..+++|++|
T Consensus 4 ~C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L 83 (306)
T 2z66_A 4 RCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYL 83 (306)
T ss_dssp TCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEE
T ss_pred CCeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEE
Confidence 34589999999853 379999999999995444568999999999999999983 236777889999999
Q ss_pred EeeCCCCcccCCccccCCCCcchhhccCccCCCCCC-ccccCCccccEEecccCcccccCCCCCc-----ccccccCCCC
Q 009208 128 DLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCP-ESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPL 201 (540)
Q Consensus 128 ~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~ 201 (540)
+|++|+++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|++++.+|.... +.+++++|.+
T Consensus 84 ~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 162 (306)
T 2z66_A 84 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162 (306)
T ss_dssp ECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEE
T ss_pred ECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcc
Confidence 99999999 788889999999999999999985544 5788999999999999999987776432 5567888876
Q ss_pred C
Q 009208 202 I 202 (540)
Q Consensus 202 ~ 202 (540)
.
T Consensus 163 ~ 163 (306)
T 2z66_A 163 Q 163 (306)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.6e-15 Score=156.10 Aligned_cols=130 Identities=24% Similarity=0.285 Sum_probs=97.1
Q ss_pred cEEEecCCCCCCccccCc-------------------------cccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEe
Q 009208 75 YVSALGLPSQSLSGTLSP-------------------------WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL 129 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~-------------------------~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 129 (540)
+++.|+|++|.|++..+. .|.++++|++|+|++|+++ .+| .+..+++|++|+|
T Consensus 137 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~L 214 (440)
T 3zyj_A 137 KLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDL 214 (440)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEEC
T ss_pred cCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEEC
Confidence 677778877777654433 3555666666666666666 444 3667777888888
Q ss_pred eCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCcC
Q 009208 130 SNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICG 204 (540)
Q Consensus 130 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~ 204 (540)
++|+|++..|..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+.... +.+++.+|||.|+
T Consensus 215 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred CCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence 88888877777888888888888888888877778888888899999999988876665432 5678899999988
Q ss_pred CC
Q 009208 205 PK 206 (540)
Q Consensus 205 ~~ 206 (540)
|.
T Consensus 295 C~ 296 (440)
T 3zyj_A 295 CD 296 (440)
T ss_dssp ST
T ss_pred CC
Confidence 75
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=2.3e-15 Score=158.14 Aligned_cols=140 Identities=16% Similarity=0.181 Sum_probs=119.4
Q ss_pred cceeeeecCC----------CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCC
Q 009208 64 SWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNK 133 (540)
Q Consensus 64 ~w~gv~c~~~----------~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 133 (540)
.|..|.|... ..++.|+|++|.|++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 3677888632 378999999999998888999999999999999999998889999999999999999999
Q ss_pred CcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCc
Q 009208 134 FTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLIC 203 (540)
Q Consensus 134 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~ 203 (540)
+++..+..|.++++|++|+|++|++++..|..|..+++|+.|++++|++++..|.... +.+++.+|.+..
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 166 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS 166 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSS
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcc
Confidence 9954445689999999999999999988888999999999999999999877665432 556777876643
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.58 E-value=3.8e-15 Score=145.72 Aligned_cols=126 Identities=24% Similarity=0.203 Sum_probs=90.4
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
..++.|+|++|.|++..+..|.++++|++|+|++|.|++. |. ...+++|++|+|++|+|+ .+|..+..+++|++|+|
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l 107 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-EC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cC-CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence 3678888888888877777888888888888888887743 32 266777777777777777 67777777777777777
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLI 202 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~ 202 (540)
++|+|++..|..|..+++|+.|+|++|+|++.+|..+. +.+++++|.+.
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 161 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC
Confidence 77777755556677777777777777777765554322 44566677654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=2.6e-15 Score=162.53 Aligned_cols=139 Identities=17% Similarity=0.140 Sum_probs=121.7
Q ss_pred ceeeeecCC----------CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCC
Q 009208 65 WRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKF 134 (540)
Q Consensus 65 w~gv~c~~~----------~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l 134 (540)
+..+.|... ..++.|+|++|.|++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 455778631 4799999999999988899999999999999999999988899999999999999999999
Q ss_pred cccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccc-cCCCCCc----ccccccCCCCCc
Q 009208 135 TGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG-SLPKISA----RTFKVTGNPLIC 203 (540)
Q Consensus 135 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~----~~~~~~~n~~~~ 203 (540)
++..|..|+++++|++|+|++|++++..|..+.++++|++|++++|++++ .+|.... +.+++++|.+..
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 167 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCE
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccc
Confidence 98889999999999999999999997667889999999999999999997 4455432 567788887643
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.5e-15 Score=164.15 Aligned_cols=152 Identities=13% Similarity=0.117 Sum_probs=94.1
Q ss_pred CccCCCCCCCCCCcc----ceeeeecC------C-----------CcEEEecCCCCCCccccCccccCCCccCEEEcccC
Q 009208 50 NVLENWDITSVDPCS----WRMITCSP------D-----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNN 108 (540)
Q Consensus 50 ~~~~~w~~~~~~~c~----w~gv~c~~------~-----------~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N 108 (540)
..+++|. ++.+||. |.++.|+. . ..++.|++++|.++...+..+.++++|++|+|++|
T Consensus 7 ~~l~~~~-~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n 85 (597)
T 3oja_B 7 YNVKPRQ-PEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL 85 (597)
T ss_dssp ----CCC-SEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTS
T ss_pred ccccCCC-CCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCC
Confidence 3467886 3456663 66655541 0 24566666777666444445666777777777777
Q ss_pred CCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCC
Q 009208 109 AILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188 (540)
Q Consensus 109 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 188 (540)
.+++..|..|.++++|++|+|++|.|++..|..|+++++|++|+|++|.+++..+..|.++++|++|+|++|++++.+|.
T Consensus 86 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 165 (597)
T 3oja_B 86 QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD 165 (597)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTT
T ss_pred CCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChh
Confidence 77766666777777777777777777765556667777777777777777744444456777777777777777766654
Q ss_pred CCc-----ccccccCCCCC
Q 009208 189 ISA-----RTFKVTGNPLI 202 (540)
Q Consensus 189 ~~~-----~~~~~~~n~~~ 202 (540)
... +.+++++|.+.
T Consensus 166 ~~~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 166 TFQATTSLQNLQLSSNRLT 184 (597)
T ss_dssp TTTTCTTCCEEECTTSCCS
T ss_pred hhhcCCcCcEEECcCCCCC
Confidence 322 44566666553
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.57 E-value=9.5e-15 Score=145.84 Aligned_cols=139 Identities=24% Similarity=0.320 Sum_probs=119.2
Q ss_pred CccceeeeecCC----------CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeC
Q 009208 62 PCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN 131 (540)
Q Consensus 62 ~c~w~gv~c~~~----------~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~ 131 (540)
.|.|+.+.|+.. ..++.|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 32 ~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred cccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 378999999742 3799999999999987788999999999999999999988899999999999999999
Q ss_pred CCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccc--cCCCCC----cccccccCCCCCc
Q 009208 132 NKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG--SLPKIS----ARTFKVTGNPLIC 203 (540)
Q Consensus 132 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~----~~~~~~~~n~~~~ 203 (540)
|+++ .+|..+. ++|++|++++|++++..+..|..+++|+.|++++|+++. ..|... .+.+++++|.+..
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG 186 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSS
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCc
Confidence 9999 8888766 899999999999996666679999999999999999963 444432 2556777776643
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.56 E-value=4.9e-15 Score=154.51 Aligned_cols=131 Identities=24% Similarity=0.275 Sum_probs=102.2
Q ss_pred CcEEEecCCCCCCccccCcc-------------------------ccCCCccCEEEcccCCCCCCCCcccCCCCcccEEE
Q 009208 74 GYVSALGLPSQSLSGTLSPW-------------------------IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLD 128 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~-------------------------~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 128 (540)
.+++.|+|++|.|++..+.. |.++++|++|+|++|++++ +| .+..+++|++|+
T Consensus 147 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~ 224 (452)
T 3zyi_A 147 SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELE 224 (452)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEE
T ss_pred CCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEE
Confidence 36888888888887544333 5556667777777777773 34 477778888888
Q ss_pred eeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCc
Q 009208 129 LSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLIC 203 (540)
Q Consensus 129 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~ 203 (540)
|++|+|++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++.++.... +.+++.+|||.|
T Consensus 225 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 225 MSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp CTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred CcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 888888877788888999999999999999877788889999999999999999876665432 567899999999
Q ss_pred CCC
Q 009208 204 GPK 206 (540)
Q Consensus 204 ~~~ 206 (540)
+|.
T Consensus 305 dC~ 307 (452)
T 3zyi_A 305 DCD 307 (452)
T ss_dssp STT
T ss_pred CCC
Confidence 875
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.56 E-value=5.5e-15 Score=140.29 Aligned_cols=127 Identities=21% Similarity=0.270 Sum_probs=109.3
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCC-CCCCCCcccCCCCcccEEEeeC-CCCcccCCccccCCCCcchh
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNA-ILGPIPASLGKLEKLQTLDLSN-NKFTGEIPDSLGDLGNLNYL 151 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~l~~L~~L 151 (540)
..++.|+|++|++++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 479999999999997777799999999999999997 8866667899999999999999 99996666789999999999
Q ss_pred hccCccCCCCCCccccCCcccc---EEecccC-cccccCCCCCc-----c-cccccCCCCC
Q 009208 152 RLNNNSLTGSCPESLSKIESLT---LVDLSYN-NLSGSLPKISA-----R-TFKVTGNPLI 202 (540)
Q Consensus 152 ~l~~N~l~~~~p~~~~~l~~L~---~L~l~~N-~l~~~~p~~~~-----~-~~~~~~n~~~ 202 (540)
++++|++++ +|. +..+++|+ .|++++| ++++..+.... + .+++++|.+.
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence 999999994 776 88888888 9999999 99866655332 4 6777788764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=2.7e-15 Score=162.38 Aligned_cols=131 Identities=28% Similarity=0.348 Sum_probs=74.0
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCC---CCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchh
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILG---PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~---~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 151 (540)
+++.|+|++|.+++..|..++++++|++|+|++|.+++ ..+..+..+++|++|+|++|++++..|..|..+++|++|
T Consensus 426 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 505 (606)
T 3t6q_A 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV 505 (606)
T ss_dssp TCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEE
Confidence 45555555555555455555555555555555555554 122345555555555555555555555556666666666
Q ss_pred hccCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCcCCC
Q 009208 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPK 206 (540)
Q Consensus 152 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~ 206 (540)
+|++|++++..|..+..+++| .|++++|++++.+|.... +.+++.+|++.|.|.
T Consensus 506 ~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 506 DLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp ECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred ECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 666666665555666666666 666666666655554321 456677777766543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.55 E-value=3.4e-15 Score=152.53 Aligned_cols=129 Identities=15% Similarity=0.146 Sum_probs=98.7
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
..++.|++++|.++...+..+.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 35777888888887544445788888888888888888777778888888888888888888766777888888888888
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLI 202 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~ 202 (540)
++|+++...+..|.++++|++|++++|++++..|.... +.+++++|.+.
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 178 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCS
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCC
Confidence 88888843334467888888888888888876665332 45677777664
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=4.5e-15 Score=159.35 Aligned_cols=132 Identities=20% Similarity=0.302 Sum_probs=83.6
Q ss_pred cEEEecCCCCCCccccC-ccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCc-ccCCccccCCCCcchhh
Q 009208 75 YVSALGLPSQSLSGTLS-PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT-GEIPDSLGDLGNLNYLR 152 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~l~~L~~L~ 152 (540)
+++.|++++|.+++..| ..+.++++|++|+|++|.+++..|..|.++++|++|+|++|+++ +.+|..+..+++|++|+
T Consensus 397 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~ 476 (570)
T 2z63_A 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476 (570)
T ss_dssp TCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEE
Confidence 34455555555554433 34566666666666666666666666666667777777777665 45666666777777777
Q ss_pred ccCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCcCCC
Q 009208 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPK 206 (540)
Q Consensus 153 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~ 206 (540)
|++|++++..|..|..+++|+.|++++|++++.+|.... +.+++.+|++.|.++
T Consensus 477 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 477 LSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 777777666666677777777777777777766554322 445667777766554
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.9e-15 Score=164.30 Aligned_cols=128 Identities=22% Similarity=0.389 Sum_probs=117.8
Q ss_pred CcEEEecCCCCCCccc-----------------cCcccc--CCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCC-
Q 009208 74 GYVSALGLPSQSLSGT-----------------LSPWIG--NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNK- 133 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~-----------------~~~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~- 133 (540)
.+++.|+|++|.++|. +|..++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~ 285 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCC
Confidence 4799999999999986 999999 99999999999999999999999999999999999999
Q ss_pred Ccc-cCCccccCC------CCcchhhccCccCCCCCCc--cccCCccccEEecccCcccccCCCCCc----ccccccCCC
Q 009208 134 FTG-EIPDSLGDL------GNLNYLRLNNNSLTGSCPE--SLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNP 200 (540)
Q Consensus 134 l~~-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~ 200 (540)
++| .+|..++++ ++|++|+|++|+++ .+|. .+.++++|+.|++++|+++|.+|.+.. +.+++++|.
T Consensus 286 l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N~ 364 (636)
T 4eco_A 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQ 364 (636)
T ss_dssp SCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSSE
T ss_pred CccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCCc
Confidence 998 899999887 99999999999999 8998 899999999999999999999994422 567888887
Q ss_pred CC
Q 009208 201 LI 202 (540)
Q Consensus 201 ~~ 202 (540)
+.
T Consensus 365 l~ 366 (636)
T 4eco_A 365 IT 366 (636)
T ss_dssp EE
T ss_pred cc
Confidence 65
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.3e-14 Score=159.40 Aligned_cols=129 Identities=22% Similarity=0.228 Sum_probs=105.7
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.+++..+..|+++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 47889999999999777778999999999999999999888888888999999999999998433346888999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLI 202 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~ 202 (540)
++|++++..|..|.++++|++|++++|++++.+|.... +.+++.+|.+.
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 158 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQ 158 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccc
Confidence 99998866667888889999999999988887765432 45667777653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=9.1e-15 Score=156.11 Aligned_cols=110 Identities=26% Similarity=0.321 Sum_probs=102.1
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
.++.|+|++|.|++ +|. |+++++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .++++++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 58889999999996 676 999999999999999999 889999999999999999999995 78 89999999999999
Q ss_pred CccCCCCC-CccccCCccccEEecccCcccccCCCC
Q 009208 155 NNSLTGSC-PESLSKIESLTLVDLSYNNLSGSLPKI 189 (540)
Q Consensus 155 ~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~ 189 (540)
+|+|++.. |..+..+++|+.|+|++|+|++.+|..
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 99999776 999999999999999999999877654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=1e-14 Score=163.92 Aligned_cols=139 Identities=21% Similarity=0.209 Sum_probs=109.3
Q ss_pred ccceeeeecCCCcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCC-CcccCCCCcccEEEeeCCCCcccCCcc
Q 009208 63 CSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPI-PASLGKLEKLQTLDLSNNKFTGEIPDS 141 (540)
Q Consensus 63 c~w~gv~c~~~~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p~~ 141 (540)
|.|..|.+ -..+++.|+|++|.|++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|+|++..|..
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 45666766 3468899999999999888888888999999999888666555 778888888888888888888777888
Q ss_pred ccCCCCcchhhccCccCCCCCCcc--ccCCccccEEecccCcccccCCC-CC-----cccccccCCCCC
Q 009208 142 LGDLGNLNYLRLNNNSLTGSCPES--LSKIESLTLVDLSYNNLSGSLPK-IS-----ARTFKVTGNPLI 202 (540)
Q Consensus 142 ~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~p~-~~-----~~~~~~~~n~~~ 202 (540)
|.++++|++|+|++|.+++.+|.. |.++++|++|+|++|++++..|. .. .+.+++++|.+.
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~ 161 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCC
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCC
Confidence 888888888888888888766655 88888888888888888876542 11 145667777653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=2.2e-14 Score=143.11 Aligned_cols=139 Identities=23% Similarity=0.352 Sum_probs=117.7
Q ss_pred CCccceeeeecCC----------CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEee
Q 009208 61 DPCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLS 130 (540)
Q Consensus 61 ~~c~w~gv~c~~~----------~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls 130 (540)
..|.|+.+.|+.. ..++.|+|++|.+++..+..|+++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 29 c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 29 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4478999999742 368999999999998777799999999999999999998889999999999999999
Q ss_pred CCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccc--cCCCCCc-----ccccccCCCCC
Q 009208 131 NNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG--SLPKISA-----RTFKVTGNPLI 202 (540)
Q Consensus 131 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~-----~~~~~~~n~~~ 202 (540)
+|+++ .+|..+. ++|++|++++|++++..+..+.++++|+.|++++|+++. ..|.... +.+++++|.+.
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 99999 7888765 799999999999997777789999999999999999963 4443221 45667777653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.52 E-value=9e-15 Score=134.51 Aligned_cols=103 Identities=17% Similarity=0.284 Sum_probs=51.3
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
+++.|++++|.++ .+| .+..+++|++|++++|.++ . +..+..+++|++|+|++|++++..|..+..+++|++|+|+
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 3445555555554 333 3455555555555555443 1 2244555555555555555554444455555555555555
Q ss_pred CccCCCCCCccccCCccccEEecccCc
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNN 181 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~ 181 (540)
+|++++..|..+..+++|+.|++++|+
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCC
Confidence 555554444445555555555555554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.52 E-value=2.9e-14 Score=127.76 Aligned_cols=105 Identities=24% Similarity=0.260 Sum_probs=92.0
Q ss_pred ccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecc
Q 009208 99 KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLS 178 (540)
Q Consensus 99 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 178 (540)
+.+.|++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 3578999999999 6787664 899999999999998778899999999999999999997777778999999999999
Q ss_pred cCcccccCCCCCc-----ccccccCCCCCcCCC
Q 009208 179 YNNLSGSLPKISA-----RTFKVTGNPLICGPK 206 (540)
Q Consensus 179 ~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~ 206 (540)
+|+|++..|.... +.+++++|++.|.+.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9999987775432 567899999999864
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.51 E-value=2.6e-14 Score=143.60 Aligned_cols=132 Identities=20% Similarity=0.199 Sum_probs=105.3
Q ss_pred CccceeeeecCCCcEEEecCCCC-CCccccCccccCCCccCEEEccc-CCCCCCCCcccCCCCcccEEEeeCCCCcccCC
Q 009208 62 PCSWRMITCSPDGYVSALGLPSQ-SLSGTLSPWIGNLTKLQSVLLQN-NAILGPIPASLGKLEKLQTLDLSNNKFTGEIP 139 (540)
Q Consensus 62 ~c~w~gv~c~~~~~l~~l~l~~~-~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 139 (540)
.|.|..|.|+ ++ +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|++|+|++|+|++..|
T Consensus 7 ~C~~~~v~~~-----------~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 73 (347)
T 2ifg_A 7 PHGSSGLRCT-----------RDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73 (347)
T ss_dssp CSSSSCEECC-----------SSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT
T ss_pred cccCCEEEcC-----------CCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCH
Confidence 3888888775 34 677 4788 99999999999996 99998877899999999999999999998888
Q ss_pred ccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCC------cccccccCCCCCcCCCC
Q 009208 140 DSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS------ARTFKVTGNPLICGPKA 207 (540)
Q Consensus 140 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~------~~~~~~~~n~~~~~~~~ 207 (540)
..|.+|++|+.|+|++|+|++..+..|..++ |+.|+|++|+|.....-.. .....+..+.+.|..+.
T Consensus 74 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp TGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred HHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 8999999999999999999965555566665 9999999999985432100 02233455667776543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.1e-14 Score=134.03 Aligned_cols=123 Identities=15% Similarity=0.242 Sum_probs=105.9
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|++++|.++ .++.+.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+..+++|++|+|
T Consensus 66 ~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L 143 (197)
T 4ezg_A 66 HNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143 (197)
T ss_dssp TTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEEC
T ss_pred CCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEc
Confidence 47999999999775 3458999999999999999999878899999999999999999999888999999999999999
Q ss_pred cCcc-CCCCCCccccCCccccEEecccCcccccCCCCC----cccccccCCCC
Q 009208 154 NNNS-LTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS----ARTFKVTGNPL 201 (540)
Q Consensus 154 ~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~----~~~~~~~~n~~ 201 (540)
++|+ ++ .+| .+..+++|+.|++++|++++ ++.+. .+.+++.+|++
T Consensus 144 ~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 144 SYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp CSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CTTGGGCSSCCEEEECBC--
T ss_pred cCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hHHhccCCCCCEEEeeCccc
Confidence 9998 66 676 69999999999999999996 33322 15677888875
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.51 E-value=1.1e-14 Score=144.54 Aligned_cols=105 Identities=20% Similarity=0.158 Sum_probs=48.9
Q ss_pred EEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccC-CCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 76 VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLG-KLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 76 l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
++.|+|++|.+++..+..++++++|++|+|++|.+++..|..+. .+++|++|+|++|+|++ +|. ...+++|++|+|+
T Consensus 122 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~l~~L~~L~Ls 199 (317)
T 3o53_A 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLS 199 (317)
T ss_dssp CEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEEECC
T ss_pred CCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccc-ccccccCCEEECC
Confidence 44444444444444444444445555555555555444333332 34455555555555542 222 1234455555555
Q ss_pred CccCCCCCCccccCCccccEEecccCccc
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS 183 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 183 (540)
+|+++ .+|..+..+++|+.|++++|+|+
T Consensus 200 ~N~l~-~l~~~~~~l~~L~~L~L~~N~l~ 227 (317)
T 3o53_A 200 SNKLA-FMGPEFQSAAGVTWISLRNNKLV 227 (317)
T ss_dssp SSCCC-EECGGGGGGTTCSEEECTTSCCC
T ss_pred CCcCC-cchhhhcccCcccEEECcCCccc
Confidence 55555 23333445555555555555555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=3e-14 Score=156.33 Aligned_cols=132 Identities=24% Similarity=0.288 Sum_probs=96.9
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCC--------CcccCCCCcccEEEeeCCCCcccCCc-cccCC
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPI--------PASLGKLEKLQTLDLSNNKFTGEIPD-SLGDL 145 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~--------p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l 145 (540)
.++.|+|++|+|++..+..|.++++|++|+|++|++++.. +..|.++++|++|+|++|+|+ .+|. .|.++
T Consensus 481 ~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l 559 (680)
T 1ziw_A 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKDL 559 (680)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTTC
T ss_pred CCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHcccc
Confidence 5777777777777666666777777777777777776431 123677777888888888887 5554 57888
Q ss_pred CCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCC------cccccccCCCCCcCCCC
Q 009208 146 GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS------ARTFKVTGNPLICGPKA 207 (540)
Q Consensus 146 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~------~~~~~~~~n~~~~~~~~ 207 (540)
++|+.|+|++|++++..+..|..+++|+.|++++|+|++.+|... .+.+++.+|||.|+|..
T Consensus 560 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred cCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 888888888888886555667788888888888888887666422 25678999999998763
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.50 E-value=2e-14 Score=145.21 Aligned_cols=132 Identities=24% Similarity=0.245 Sum_probs=114.4
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 64 ~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 143 (361)
T 2xot_A 64 TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYL 143 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEEC
Confidence 47999999999999888889999999999999999999877778999999999999999999877889999999999999
Q ss_pred cCccCCCCCCcc-c---cCCccccEEecccCcccccCCCCC-------cccccccCCCCCcCCC
Q 009208 154 NNNSLTGSCPES-L---SKIESLTLVDLSYNNLSGSLPKIS-------ARTFKVTGNPLICGPK 206 (540)
Q Consensus 154 ~~N~l~~~~p~~-~---~~l~~L~~L~l~~N~l~~~~p~~~-------~~~~~~~~n~~~~~~~ 206 (540)
++|+|++ +|.. | ..+++|+.|+|++|+|++..+... .+.+.+.+|+|.|+|.
T Consensus 144 ~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 144 SQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp CSSCCCS-CCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred CCCcCCe-eCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 9999994 5554 4 579999999999999995443211 2568899999999864
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.8e-14 Score=153.01 Aligned_cols=108 Identities=24% Similarity=0.299 Sum_probs=66.7
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCC--CCCcccCCCCcccEEEeeCCCCcccCCcc-ccCCCCcch
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILG--PIPASLGKLEKLQTLDLSNNKFTGEIPDS-LGDLGNLNY 150 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~ 150 (540)
..++.|+|++|.+++.+|..++++++|++|+|++|++++ .+|..+.++++|++|+|++|++++.+|.. +..+++|++
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~ 403 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403 (520)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCE
T ss_pred CcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCE
Confidence 467777777777777777777777777777777777775 44556777777777777777777545553 555555555
Q ss_pred hhccCccCCCCCCccccCCccccEEecccCccc
Q 009208 151 LRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183 (540)
Q Consensus 151 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 183 (540)
|+|++|++++.+|..+. ++|+.|++++|+|+
T Consensus 404 L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 404 LNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK 434 (520)
T ss_dssp EECCSSCCCGGGGGSCC--TTCCEEECCSSCCC
T ss_pred EECcCCCCCcchhhhhc--ccCCEEECCCCccc
Confidence 55555555444333332 34444444444444
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.50 E-value=4e-14 Score=152.91 Aligned_cols=128 Identities=20% Similarity=0.146 Sum_probs=110.7
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.|++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|+|++..+..|+++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 47999999999999888889999999999999999999988888999999999999999999444445799999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc--ccccccCCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA--RTFKVTGNPL 201 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~~~~~~n~~ 201 (540)
++|.+++..|..|..+++|+.|++++|++++..+.... ..+++.+|.+
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l 204 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLL 204 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCC
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCcc
Confidence 99999988888999999999999999999965332221 4456666654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.50 E-value=1.5e-14 Score=129.43 Aligned_cols=111 Identities=27% Similarity=0.297 Sum_probs=99.1
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCC--ccccCCCCcchh
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP--DSLGDLGNLNYL 151 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p--~~~~~l~~L~~L 151 (540)
.+++.|+|++|.|++. ..+..+++|++|+|++|++++.+|..+.++++|++|+|++|+|+ .+| ..+..+++|+.|
T Consensus 49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~l~~l~~L~~L 125 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLECLKSL 125 (168)
T ss_dssp GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCC-SSGGGGGGSSCSCCCEE
T ss_pred CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccC-cchhHHHHhcCCCCCEE
Confidence 4799999999999965 88999999999999999999878988888999999999999999 454 789999999999
Q ss_pred hccCccCCCCCC---ccccCCccccEEecccCcccccCCC
Q 009208 152 RLNNNSLTGSCP---ESLSKIESLTLVDLSYNNLSGSLPK 188 (540)
Q Consensus 152 ~l~~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~~~~p~ 188 (540)
++++|++++..+ ..+..+++|+.|++++|.+. .+|+
T Consensus 126 ~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 126 DLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp ECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred EeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 999999995444 38999999999999999998 4443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.50 E-value=2.6e-14 Score=153.27 Aligned_cols=132 Identities=20% Similarity=0.290 Sum_probs=76.8
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCC--CCcccCCCCcccEEEeeCCCCcccCCcc-ccCC-----
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGP--IPASLGKLEKLQTLDLSNNKFTGEIPDS-LGDL----- 145 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~l----- 145 (540)
.+++.|+|++|.+++.+|..++++++|++|+|++|++++. +|..|.++++|++|+|++|++++.+|.. +..+
T Consensus 353 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~ 432 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432 (562)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCE
T ss_pred CCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCE
Confidence 3566666666666666666666666666666666666642 2344566666666666666666434433 3333
Q ss_pred -----------------CCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCc
Q 009208 146 -----------------GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLIC 203 (540)
Q Consensus 146 -----------------~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~ 203 (540)
++|+.|+|++|+++ .+|..+..+++|+.|++++|+|++.++.... +.+++++|++.|
T Consensus 433 L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c 511 (562)
T 3a79_B 433 LNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 511 (562)
T ss_dssp EECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCC
T ss_pred EECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCC
Confidence 45566666666665 5565555666777777777777633222111 345667777766
Q ss_pred CCC
Q 009208 204 GPK 206 (540)
Q Consensus 204 ~~~ 206 (540)
.|+
T Consensus 512 ~c~ 514 (562)
T 3a79_B 512 TCP 514 (562)
T ss_dssp CHH
T ss_pred Ccc
Confidence 543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.5e-14 Score=151.78 Aligned_cols=131 Identities=20% Similarity=0.208 Sum_probs=95.2
Q ss_pred EEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccC
Q 009208 76 VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155 (540)
Q Consensus 76 l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 155 (540)
++.|+|++|.+.+.+|+.+....+|+.|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++
T Consensus 202 L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 281 (477)
T 2id5_A 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVG 281 (477)
T ss_dssp CCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCS
T ss_pred cceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCC
Confidence 33344444333333443333344566666666777744335678888899999999998877777788899999999999
Q ss_pred ccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCcCCC
Q 009208 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPK 206 (540)
Q Consensus 156 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~ 206 (540)
|++++..|..|..+++|+.|+|++|+|++..+..+. +.+++.+|++.|+|.
T Consensus 282 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 282 GQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCR 337 (477)
T ss_dssp SCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred CccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccc
Confidence 999888888899999999999999999876554432 567899999998765
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=3.6e-14 Score=152.30 Aligned_cols=129 Identities=18% Similarity=0.154 Sum_probs=96.7
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 36788888888888777778888888888888888888776777888888888888888888666677888888888888
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccc-cCCCCCc-----ccccccCCCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSG-SLPKISA-----RTFKVTGNPLI 202 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~-----~~~~~~~n~~~ 202 (540)
++|++++..+..++++++|++|++++|.+++ .+|.... +.+++++|.+.
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~ 162 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccc
Confidence 8888875444467788888888888888776 3454322 45667777654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.48 E-value=7.7e-14 Score=125.49 Aligned_cols=103 Identities=29% Similarity=0.307 Sum_probs=89.8
Q ss_pred CEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccC
Q 009208 101 QSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN 180 (540)
Q Consensus 101 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 180 (540)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 68999999998 7888775 89999999999999888889999999999999999999665566799999999999999
Q ss_pred cccccCCCCCc-----ccccccCCCCCcCCC
Q 009208 181 NLSGSLPKISA-----RTFKVTGNPLICGPK 206 (540)
Q Consensus 181 ~l~~~~p~~~~-----~~~~~~~n~~~~~~~ 206 (540)
+|++.++.... +.+++.+|++.|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 99977665332 567899999988764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.3e-14 Score=161.32 Aligned_cols=127 Identities=21% Similarity=0.301 Sum_probs=114.3
Q ss_pred CcEEEecCCCCCCcc-----------------ccCcccc--CCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCC-
Q 009208 74 GYVSALGLPSQSLSG-----------------TLSPWIG--NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNK- 133 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~-----------------~~~~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~- 133 (540)
.+++.|+|++|.|+| .+|+.++ ++++|++|+|++|++.+.+|..|.++++|++|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ 527 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence 579999999999998 4999988 99999999999999999999999999999999999998
Q ss_pred Ccc-cCCccccCCC-------CcchhhccCccCCCCCCc--cccCCccccEEecccCcccccCCCCCc----ccccccCC
Q 009208 134 FTG-EIPDSLGDLG-------NLNYLRLNNNSLTGSCPE--SLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGN 199 (540)
Q Consensus 134 l~~-~~p~~~~~l~-------~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n 199 (540)
|+| .+|..+++++ +|+.|+|++|+++ .+|. .+.++++|+.|+|++|+++ .+|.+.. +.+++++|
T Consensus 528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~N 605 (876)
T 4ecn_A 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYN 605 (876)
T ss_dssp SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCSS
T ss_pred cccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcCC
Confidence 998 8998777665 9999999999999 8998 8999999999999999999 8885432 56788888
Q ss_pred CCC
Q 009208 200 PLI 202 (540)
Q Consensus 200 ~~~ 202 (540)
.+.
T Consensus 606 ~l~ 608 (876)
T 4ecn_A 606 QIE 608 (876)
T ss_dssp CCS
T ss_pred ccc
Confidence 875
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.48 E-value=7.8e-14 Score=142.42 Aligned_cols=127 Identities=21% Similarity=0.194 Sum_probs=110.0
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCcc-ccCCCCcchhh
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDS-LGDLGNLNYLR 152 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~L~ 152 (540)
.+++.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+++ .+|.. |.++++|++|+
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEE
Confidence 47999999999999877789999999999999999999888888999999999999999999 66665 68999999999
Q ss_pred ccCccCCCCCCccccCCccccEEecccCcccccCCCCCc--ccccccCCCC
Q 009208 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA--RTFKVTGNPL 201 (540)
Q Consensus 153 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~~~~~~n~~ 201 (540)
+++|++++..|..+..+++|+.|++++|++++....... +.+++++|.+
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLL 198 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCC
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccc
Confidence 999999977788899999999999999999864222111 4456666654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=9.2e-14 Score=138.53 Aligned_cols=125 Identities=26% Similarity=0.281 Sum_probs=77.1
Q ss_pred CcEEEecCCCCCCcc--ccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchh
Q 009208 74 GYVSALGLPSQSLSG--TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 151 (540)
..++.|+|++|.++. ..+..+.++++|++|++++|.++ .+|..+. ++|++|+|++|++++..|..+..+++|+.|
T Consensus 145 ~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 221 (330)
T 1xku_A 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKL 221 (330)
T ss_dssp TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred ccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEE
Confidence 367777777777753 55666777777777777777766 3454443 566666666666665555666666666666
Q ss_pred hccCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCC
Q 009208 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLI 202 (540)
Q Consensus 152 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~ 202 (540)
+|++|++++..+..+..+++|+.|++++|+++ .+|.... +.+++++|++.
T Consensus 222 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~ 276 (330)
T 1xku_A 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276 (330)
T ss_dssp ECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred ECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCC
Confidence 66666666555555666666666666666666 3333211 34556666553
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.47 E-value=3.5e-14 Score=142.96 Aligned_cols=127 Identities=18% Similarity=0.199 Sum_probs=109.4
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCc--cccCCCCcchh
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD--SLGDLGNLNYL 151 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~--~~~~l~~L~~L 151 (540)
.+++.|+|++|.+++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|+++ .+|. .+.++++|++|
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L 154 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQIL 154 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEE
Confidence 47999999999999888889999999999999999999655555999999999999999999 6766 78999999999
Q ss_pred hccCc-cCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCC
Q 009208 152 RLNNN-SLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPL 201 (540)
Q Consensus 152 ~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~ 201 (540)
++++| .+++..|..|..+++|+.|++++|++++..|.... +.+++.+|.+
T Consensus 155 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l 210 (353)
T 2z80_A 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH 210 (353)
T ss_dssp EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCS
T ss_pred ECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcc
Confidence 99999 47766678899999999999999999988776543 3456666654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.47 E-value=7e-15 Score=145.50 Aligned_cols=108 Identities=23% Similarity=0.312 Sum_probs=64.9
Q ss_pred EEEecCCCCCC-ccccCcccc-------CCCccCEEEcccCCCCCCCCccc--CCCCcccEEEeeCCCCcccCCccccCC
Q 009208 76 VSALGLPSQSL-SGTLSPWIG-------NLTKLQSVLLQNNAILGPIPASL--GKLEKLQTLDLSNNKFTGEIPDSLGDL 145 (540)
Q Consensus 76 l~~l~l~~~~l-~~~~~~~~~-------~l~~L~~L~l~~N~l~~~~p~~~--~~l~~L~~L~ls~N~l~~~~p~~~~~l 145 (540)
++.|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|..+ ..+++|++|+|++|++++. |..+..+
T Consensus 65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l 143 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAEL 143 (312)
T ss_dssp HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHH
T ss_pred HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHH
Confidence 55566666666 334454444 56666666666666666666554 5666666666666666644 5555555
Q ss_pred -----CCcchhhccCccCCCCCCccccCCccccEEecccCcccc
Q 009208 146 -----GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184 (540)
Q Consensus 146 -----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 184 (540)
++|++|+|++|++++..|..|..+++|+.|++++|++.+
T Consensus 144 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 187 (312)
T 1wwl_A 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187 (312)
T ss_dssp HTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCH
T ss_pred HHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCc
Confidence 666666666666665555666666666666666666554
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.46 E-value=4.4e-14 Score=151.52 Aligned_cols=125 Identities=21% Similarity=0.189 Sum_probs=108.7
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.|++..|..|.++++|++|+|++|++++..|+.|.++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 57999999999999888889999999999999999999888999999999999999999999 78887 8999999999
Q ss_pred cCccCCC-CCCccccCCccccEEecccCcccccC----CCCCcccccccCCCC
Q 009208 154 NNNSLTG-SCPESLSKIESLTLVDLSYNNLSGSL----PKISARTFKVTGNPL 201 (540)
Q Consensus 154 ~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~----p~~~~~~~~~~~n~~ 201 (540)
++|++++ .+|..|.++++|++|++++|++++.. +.+..+.+++++|.+
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSC
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccc
Confidence 9999986 35689999999999999999998521 111115567777766
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.46 E-value=4e-14 Score=150.53 Aligned_cols=134 Identities=25% Similarity=0.431 Sum_probs=95.5
Q ss_pred cCCCCCCCCCCc-----cceee-eecCCCcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCccc
Q 009208 52 LENWDITSVDPC-----SWRMI-TCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQ 125 (540)
Q Consensus 52 ~~~w~~~~~~~c-----~w~gv-~c~~~~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 125 (540)
+.+|.. +.+|| .|.|+ .|.. ++++.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|+
T Consensus 33 l~~W~~-~~~~~~~~~~~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~ 103 (571)
T 3cvr_A 33 WDKWEK-QALPGENRNEAVSLLKECLI-NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLE 103 (571)
T ss_dssp HHHHHT-TCCTTCCHHHHHHHHHHHHH-TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCC
T ss_pred HHHHhc-cCCccccccchhhhcccccc-CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCC
Confidence 556753 56778 79999 7863 478999999999986 777663 78888888888888 667 4467888
Q ss_pred EEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc--ccccccCCCCCc
Q 009208 126 TLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA--RTFKVTGNPLIC 203 (540)
Q Consensus 126 ~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~~~~~~n~~~~ 203 (540)
+|+|++|+|++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|.... +.+++++|.+..
T Consensus 104 ~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~~l~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 104 YLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPELPTSLEVLSVRNNQLTF 174 (571)
T ss_dssp EEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSC
T ss_pred EEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCCcCCCcCEEECCCCCCCC
Confidence 88888888884 777 554 77788888887774 665 56777777777777775 444221 445666666533
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.46 E-value=8.5e-14 Score=138.92 Aligned_cols=106 Identities=26% Similarity=0.309 Sum_probs=56.1
Q ss_pred CcEEEecCCCCCCc--cccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchh
Q 009208 74 GYVSALGLPSQSLS--GTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151 (540)
Q Consensus 74 ~~l~~l~l~~~~l~--~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 151 (540)
.+++.|++++|.++ +..+..+..+ +|++|++++|++++ +|..+. ++|++|+|++|++++..|..+..+++|+.|
T Consensus 147 ~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L 222 (332)
T 2ft3_A 147 RNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRL 222 (332)
T ss_dssp SSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCC
T ss_pred ccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEE
Confidence 36777777777775 3555666655 55555555555552 343332 445555555555554444445555555555
Q ss_pred hccCccCCCCCCccccCCccccEEecccCccc
Q 009208 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183 (540)
Q Consensus 152 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 183 (540)
+|++|++++..|..+..+++|+.|++++|+++
T Consensus 223 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 254 (332)
T 2ft3_A 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254 (332)
T ss_dssp BCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC
T ss_pred ECCCCcCCcCChhHhhCCCCCCEEECCCCcCe
Confidence 55555555444444455555555555555554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.2e-14 Score=140.72 Aligned_cols=128 Identities=22% Similarity=0.234 Sum_probs=93.9
Q ss_pred CcEEEecCCCCCCccccCccccCC-----CccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCccc--CCccc--cC
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNL-----TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGE--IPDSL--GD 144 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~--~p~~~--~~ 144 (540)
.+++.|+|++|.+++. |..++++ ++|++|+|++|++++..|..|.++++|++|+|++|++.+. +|..+ ..
T Consensus 121 ~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 199 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199 (312)
T ss_dssp CCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTS
T ss_pred CCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhcc
Confidence 4688888888888876 7777776 8888888888888877778888888888888888887755 34444 77
Q ss_pred CCCcchhhccCccCCC--CCC-ccccCCccccEEecccCcccccCCC--CC----cccccccCCCCC
Q 009208 145 LGNLNYLRLNNNSLTG--SCP-ESLSKIESLTLVDLSYNNLSGSLPK--IS----ARTFKVTGNPLI 202 (540)
Q Consensus 145 l~~L~~L~l~~N~l~~--~~p-~~~~~l~~L~~L~l~~N~l~~~~p~--~~----~~~~~~~~n~~~ 202 (540)
+++|++|+|++|++++ .++ ..+..+++|+.|++++|++++.+|. .. .+.+++++|.+.
T Consensus 200 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 266 (312)
T 1wwl_A 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266 (312)
T ss_dssp CTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred CCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence 8888888888888873 122 2345677888888888888876642 11 155677777765
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=4.2e-14 Score=139.73 Aligned_cols=110 Identities=20% Similarity=0.102 Sum_probs=49.4
Q ss_pred cEEEecCCCCCCccccC----ccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCccc--CC--ccccCCC
Q 009208 75 YVSALGLPSQSLSGTLS----PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGE--IP--DSLGDLG 146 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~----~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~--~p--~~~~~l~ 146 (540)
+++.|+|++|.+++..+ ..+..+++|++|+|++|++++..|..|.++++|++|+|++|++.+. ++ ..+..++
T Consensus 118 ~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~ 197 (310)
T 4glp_A 118 ALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFP 197 (310)
T ss_dssp CCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSC
T ss_pred CCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCC
Confidence 34555555555554322 2233445555555555555544444555555555555555554321 11 1123444
Q ss_pred CcchhhccCccCCCCCCc----cccCCccccEEecccCccccc
Q 009208 147 NLNYLRLNNNSLTGSCPE----SLSKIESLTLVDLSYNNLSGS 185 (540)
Q Consensus 147 ~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~ 185 (540)
+|++|+|++|+++ .+|. .+..+++|++|+|++|+|++.
T Consensus 198 ~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 239 (310)
T 4glp_A 198 AIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRAT 239 (310)
T ss_dssp CCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCC
T ss_pred CCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCcc
Confidence 4445555554444 2222 123444444444444444444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.45 E-value=6.9e-14 Score=132.66 Aligned_cols=126 Identities=20% Similarity=0.206 Sum_probs=107.3
Q ss_pred CcEEEecCCCCC-CccccCccccCCCccCEEEccc-CCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcc--
Q 009208 74 GYVSALGLPSQS-LSGTLSPWIGNLTKLQSVLLQN-NAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLN-- 149 (540)
Q Consensus 74 ~~l~~l~l~~~~-l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~-- 149 (540)
.+++.|+|++|. +++..+..|.++++|++|+|++ |++++..+..|.++++|++|+|++|+++ .+|. +..+++|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCC-SCCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCc-cccc-cccccccccc
Confidence 479999999997 8866667899999999999998 9999777788999999999999999999 4887 88888888
Q ss_pred -hhhccCc-cCCCCCCccccCCcccc-EEecccCcccccCCCC-Cc----ccccccCCC-CC
Q 009208 150 -YLRLNNN-SLTGSCPESLSKIESLT-LVDLSYNNLSGSLPKI-SA----RTFKVTGNP-LI 202 (540)
Q Consensus 150 -~L~l~~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~-~~----~~~~~~~n~-~~ 202 (540)
+|++++| ++++..+..|..+++|+ .|++++|+++ .+|.. +. +.+++.+|+ +.
T Consensus 133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~ 193 (239)
T 2xwt_C 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLT 193 (239)
T ss_dssp EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCC
T ss_pred cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcc
Confidence 9999999 99966666799999999 9999999999 55543 21 456788885 53
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.44 E-value=9.1e-14 Score=125.29 Aligned_cols=109 Identities=22% Similarity=0.231 Sum_probs=91.3
Q ss_pred CcEEEecCCCCCCccccCccccCCC-ccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhh
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLT-KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 152 (540)
..++.|+|++|+++. +|. +..+. +|++|+|++|.|++. ..|.++++|++|+|++|+|++..|..+..+++|++|+
T Consensus 19 ~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 19 VRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 378999999999994 554 55555 999999999999965 6799999999999999999944334458999999999
Q ss_pred ccCccCCCCCCc--cccCCccccEEecccCcccccCCC
Q 009208 153 LNNNSLTGSCPE--SLSKIESLTLVDLSYNNLSGSLPK 188 (540)
Q Consensus 153 l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~ 188 (540)
|++|+++ .+|. .+..+++|+.|++++|+++. +|.
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~ 130 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKH 130 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STT
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHh
Confidence 9999997 6776 78899999999999999984 444
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=1e-13 Score=147.11 Aligned_cols=126 Identities=17% Similarity=0.249 Sum_probs=80.5
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcc--cCCccccCCCCcchhh
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG--EIPDSLGDLGNLNYLR 152 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~L~ 152 (540)
+++.|++++|++.... .+..+++|++|+|++|++++.+|..+.++++|++|+|++|++++ .+|..+..+++|++|+
T Consensus 303 ~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~ 380 (520)
T 2z7x_B 303 NIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380 (520)
T ss_dssp CCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEE
T ss_pred ceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEE
Confidence 4666777777665321 12566677777777777776666677777777777777777764 4455666777777777
Q ss_pred ccCccCCCCCCcc-ccCCccccEEecccCcccccCCCCC---cccccccCCCCC
Q 009208 153 LNNNSLTGSCPES-LSKIESLTLVDLSYNNLSGSLPKIS---ARTFKVTGNPLI 202 (540)
Q Consensus 153 l~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~p~~~---~~~~~~~~n~~~ 202 (540)
|++|++++.+|.. +..+++|+.|++++|++++.+|... .+.+++++|.+.
T Consensus 381 Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK 434 (520)
T ss_dssp CCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCCTTCCEEECCSSCCC
T ss_pred CCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhcccCCEEECCCCccc
Confidence 7777777545543 6666777777777777766555432 245566666654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=9.1e-14 Score=148.49 Aligned_cols=117 Identities=19% Similarity=0.209 Sum_probs=104.9
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcc-cCCccccCCCCcchhh
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG-EIPDSLGDLGNLNYLR 152 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~ 152 (540)
.++++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++ .+|..++++++|++|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 479999999999998888999999999999999999998877779999999999999999996 4678899999999999
Q ss_pred ccCccCCCCCC-ccccCCccccEEecccCcccccCCCCC
Q 009208 153 LNNNSLTGSCP-ESLSKIESLTLVDLSYNNLSGSLPKIS 190 (540)
Q Consensus 153 l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~ 190 (540)
+++|++.+.+| ..|.++++|+.|++++|++++.+|...
T Consensus 130 L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l 168 (549)
T 2z81_A 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSL 168 (549)
T ss_dssp EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTT
T ss_pred CCCCccccccCHhhhhcccccCeeeccCCcccccChhhh
Confidence 99999555665 689999999999999999998777653
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.42 E-value=3.9e-14 Score=123.90 Aligned_cols=104 Identities=25% Similarity=0.249 Sum_probs=93.3
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCccc-CCccccCCCCcchhh
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGE-IPDSLGDLGNLNYLR 152 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-~p~~~~~l~~L~~L~ 152 (540)
.+++.|+|++|.+++. ..++++++|++|+|++|.+++.+|..+.++++|++|+|++|++++. .|..+..+++|++|+
T Consensus 42 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~ 119 (149)
T 2je0_A 42 EELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119 (149)
T ss_dssp TTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEE
T ss_pred CCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEe
Confidence 5799999999999976 8899999999999999999987898888899999999999999952 348899999999999
Q ss_pred ccCccCCCCCC---ccccCCccccEEeccc
Q 009208 153 LNNNSLTGSCP---ESLSKIESLTLVDLSY 179 (540)
Q Consensus 153 l~~N~l~~~~p---~~~~~l~~L~~L~l~~ 179 (540)
+++|++++..+ ..+..+++|+.|++++
T Consensus 120 l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 120 LFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 99999996554 4789999999999874
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.2e-13 Score=131.19 Aligned_cols=121 Identities=24% Similarity=0.327 Sum_probs=87.8
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.|++..+ +.++++|++|+|++|++++ +|. +.. ++|++|+|++|+|++ +| .+..+++|+.|+|
T Consensus 63 ~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~L 135 (263)
T 1xeu_A 63 TNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSI 135 (263)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEEC
Confidence 368888888888885433 7888888888888888884 443 333 788888888888884 44 5788888888888
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCCcC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICG 204 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~ 204 (540)
++|++++ +| .+..+++|+.|++++|++++. +.+.. +.+++++|++.+.
T Consensus 136 s~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 136 RNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp TTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCcCCC-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 8888884 44 677888888888888888865 33321 4567778877554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.42 E-value=1.6e-13 Score=150.89 Aligned_cols=169 Identities=24% Similarity=0.203 Sum_probs=107.0
Q ss_pred CCchHHHHHHHHHHhcC-CCCCccCCCCCCCCCCccceeeeecCCCcE------------------EEecCCCCCCcc--
Q 009208 30 GINYEVVALVAVKNNLH-DPYNVLENWDITSVDPCSWRMITCSPDGYV------------------SALGLPSQSLSG-- 88 (540)
Q Consensus 30 ~~~~~~~~l~~~k~~~~-~~~~~~~~w~~~~~~~c~w~gv~c~~~~~l------------------~~l~l~~~~l~~-- 88 (540)
....++.+|+++..+.. .....-.+|..+....+.|.+++++. +++ ..++|+.|.|.+
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~ 207 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST-PLTPKIELFANGKDEANQALLQHKKLSQYSIDEDD 207 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC-CccceEEeeCCCCCcchhhHhhcCccCcccccCcc
Confidence 34456678888887762 22333445755555667788877654 223 334444444443
Q ss_pred -------ccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCC
Q 009208 89 -------TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGS 161 (540)
Q Consensus 89 -------~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 161 (540)
..+..+..+++|+.|+|++|.+. .+|..+.++++|++|+|++|+|+ .+|..|++|++|+.|+|++|+|+ .
T Consensus 208 ~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~ 284 (727)
T 4b8c_D 208 DIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-S 284 (727)
T ss_dssp --------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-S
T ss_pred ccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-c
Confidence 33677889999999999999999 78888889999999999999999 99999999999999999999999 8
Q ss_pred CCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCc
Q 009208 162 CPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLIC 203 (540)
Q Consensus 162 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~ 203 (540)
+|..|.+|++|++|+|++|.|+ .+|.... +.+++++|++..
T Consensus 285 lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~ 330 (727)
T 4b8c_D 285 LPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEK 330 (727)
T ss_dssp CCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCS
T ss_pred cChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCC
Confidence 8999999999999999999998 6665332 567899998854
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.42 E-value=4.8e-14 Score=127.14 Aligned_cols=105 Identities=24% Similarity=0.306 Sum_probs=95.3
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCc--cccCCCCcchhh
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD--SLGDLGNLNYLR 152 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~--~~~~l~~L~~L~ 152 (540)
+++.|+|++|.|++. +.++++++|++|+|++|+|++..|..|..+++|++|+|++|+|+ .+|. .+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence 799999999999975 78999999999999999999655555699999999999999997 7887 899999999999
Q ss_pred ccCccCCCCCCcc----ccCCccccEEecccCccc
Q 009208 153 LNNNSLTGSCPES----LSKIESLTLVDLSYNNLS 183 (540)
Q Consensus 153 l~~N~l~~~~p~~----~~~l~~L~~L~l~~N~l~ 183 (540)
+++|.++ .+|.. +..+++|+.|++++|.+.
T Consensus 120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 9999999 67775 899999999999999876
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=8.5e-14 Score=137.55 Aligned_cols=128 Identities=21% Similarity=0.235 Sum_probs=107.0
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCC--C--CcccCCCCcccEEEeeCCCCcccCCc----cccCC
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGP--I--PASLGKLEKLQTLDLSNNKFTGEIPD----SLGDL 145 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~--p~~~~~l~~L~~L~ls~N~l~~~~p~----~~~~l 145 (540)
.+++.|+|++|.+++..+..++++++|++|+|++|++.+. + +..+.++++|++|+|++|+++ .+|. .+..+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence 4799999999999988889999999999999999998752 2 233478999999999999998 5554 25788
Q ss_pred CCcchhhccCccCCCCCCccccCC---ccccEEecccCcccccCCCCCc---ccccccCCCCCc
Q 009208 146 GNLNYLRLNNNSLTGSCPESLSKI---ESLTLVDLSYNNLSGSLPKISA---RTFKVTGNPLIC 203 (540)
Q Consensus 146 ~~L~~L~l~~N~l~~~~p~~~~~l---~~L~~L~l~~N~l~~~~p~~~~---~~~~~~~n~~~~ 203 (540)
++|++|+|++|++++..|..+..+ ++|++|+|++|+|+ .+|.... +.+++++|.+..
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~~ 286 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLNR 286 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCCS
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCCC
Confidence 999999999999998878888777 69999999999999 5555322 667899998753
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.41 E-value=9.2e-14 Score=146.06 Aligned_cols=126 Identities=24% Similarity=0.278 Sum_probs=66.5
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCc----------------ccCCCCcccEEEeeCCCCcccC
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPA----------------SLGKLEKLQTLDLSNNKFTGEI 138 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~----------------~~~~l~~L~~L~ls~N~l~~~~ 138 (540)
.++.|+|++|.+++..| ++++++|++|+|++|.|++..+. ....+++|+.|+|++|+|++..
T Consensus 59 ~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~~~ 136 (487)
T 3oja_A 59 KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLR 136 (487)
T ss_dssp TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCSGG
T ss_pred CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCCCC
Confidence 56666666666665444 55555555555555554421110 0012344555555555555555
Q ss_pred CccccCCCCcchhhccCccCCCCCCcccc-CCccccEEecccCcccccCCCCC---cccccccCCCCC
Q 009208 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLS-KIESLTLVDLSYNNLSGSLPKIS---ARTFKVTGNPLI 202 (540)
Q Consensus 139 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~---~~~~~~~~n~~~ 202 (540)
|..++.+++|+.|+|++|++++..|..+. .+++|+.|+|++|.|++..+... .+.+++++|.+.
T Consensus 137 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~Ls~N~l~ 204 (487)
T 3oja_A 137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA 204 (487)
T ss_dssp GBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCC
T ss_pred chhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEECCCCCCC
Confidence 55566666666666666666655555554 55666666666666654433221 134455555553
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.39 E-value=5.3e-13 Score=130.50 Aligned_cols=120 Identities=28% Similarity=0.421 Sum_probs=90.4
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.+++..+ +.++++|++|+|++|.+++ +| .+.++++|++|+|++|++++ + +.+..+++|+.|++
T Consensus 68 ~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (291)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEc
Confidence 468888888888885443 8888888888888888884 34 48888888888888888884 4 45778888888888
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLI 202 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~ 202 (540)
++|++++. ..+..+++|+.|++++|++++..| +.. +.+++++|.+.
T Consensus 142 ~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 142 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC
T ss_pred cCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCC
Confidence 88888843 567888888888888888886554 221 45667777653
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.39 E-value=4e-13 Score=134.83 Aligned_cols=104 Identities=23% Similarity=0.313 Sum_probs=92.3
Q ss_pred CEEEcccC-CCCCCCCcccCCCCcccEEEeeC-CCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecc
Q 009208 101 QSVLLQNN-AILGPIPASLGKLEKLQTLDLSN-NKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLS 178 (540)
Q Consensus 101 ~~L~l~~N-~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 178 (540)
..++++++ +|+ .+|. |..+++|++|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35689988 899 6888 99999999999996 99997766889999999999999999998888899999999999999
Q ss_pred cCcccccCCCCCc----ccccccCCCCCcCCC
Q 009208 179 YNNLSGSLPKISA----RTFKVTGNPLICGPK 206 (540)
Q Consensus 179 ~N~l~~~~p~~~~----~~~~~~~n~~~~~~~ 206 (540)
+|+|++.+|..+. +.+++.+|++.|.|.
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred CCccceeCHHHcccCCceEEEeeCCCccCCCc
Confidence 9999977666543 567899999999865
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.38 E-value=4.9e-13 Score=130.79 Aligned_cols=122 Identities=28% Similarity=0.370 Sum_probs=103.7
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.+++ + +.+.++++|++|+|++|++++. +.+..+++|++|+|++|++++ + ..+..+++|+.|+|
T Consensus 90 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L 163 (291)
T 1h6t_A 90 KNLGWLFLDENKVKD-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSL 163 (291)
T ss_dssp TTCCEEECCSSCCCC-G-GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCCCEEECCCCcCCC-C-hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCc-c-hhhccCCCCCEEEc
Confidence 579999999999986 3 3499999999999999999964 579999999999999999995 4 67999999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCCcC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICG 204 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~ 204 (540)
++|++++..| +..+++|+.|++++|++++ +|.+.. +.+++.+|++.+.
T Consensus 164 ~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 164 EDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEEEEEECC
T ss_pred cCCccccchh--hcCCCccCEEECCCCcCCC-ChhhccCCCCCEEECcCCcccCC
Confidence 9999995544 9999999999999999995 444322 5678888887553
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.38 E-value=7.5e-13 Score=127.43 Aligned_cols=121 Identities=21% Similarity=0.312 Sum_probs=101.6
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|++++|+++ .++ .+..+++|++|+|++|+|++. |. +.++++|++|+|++|+++ .+|.... ++|+.|+|
T Consensus 41 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N~l~-~l~~~~~--~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRNRLK-NLNGIPS--ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSSCCS-CCTTCCC--SSCCEEEC
T ss_pred CcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEEECCCCccC-CcCcccc--CcccEEEc
Confidence 47999999999998 455 799999999999999999965 44 999999999999999999 5665433 99999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCCcC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICG 204 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~ 204 (540)
++|++++ ++ .+..+++|+.|++++|++++. |.+.. +.+++++|.+...
T Consensus 114 ~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 114 DNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSCCCBC
T ss_pred cCCccCC-Ch-hhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCcCcch
Confidence 9999995 54 699999999999999999964 43321 5678899987543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.37 E-value=4.3e-13 Score=132.34 Aligned_cols=122 Identities=25% Similarity=0.363 Sum_probs=96.9
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.+++ + +.+.++++|++|+|++|++++ +| .+..+++|++|+|++|++++ +|. +..+++|+.|+|
T Consensus 85 ~~L~~L~L~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 158 (308)
T 1h6u_A 85 TKITELELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITD-VT-PLAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSI 158 (308)
T ss_dssp CSCCEEECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEEC
T ss_pred CCCCEEEccCCcCCC-c-hhhcCCCCCCEEECCCCCCCC-ch-hhcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEc
Confidence 479999999999985 3 368899999999999999985 44 38889999999999999984 444 888899999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCC----cccccccCCCCCcC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS----ARTFKVTGNPLICG 204 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~----~~~~~~~~n~~~~~ 204 (540)
++|++++ ++. +..+++|+.|++++|++++..| +. .+.+++++|.+...
T Consensus 159 ~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~ 210 (308)
T 1h6u_A 159 GNAQVSD-LTP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDV 210 (308)
T ss_dssp CSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBC
T ss_pred cCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCcc
Confidence 9999984 444 8888999999999999886543 21 15567888877544
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.36 E-value=2.3e-15 Score=138.57 Aligned_cols=125 Identities=23% Similarity=0.316 Sum_probs=78.0
Q ss_pred cEEEecCCCCCCccccCc------cccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCc
Q 009208 75 YVSALGLPSQSLSGTLSP------WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNL 148 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~------~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 148 (540)
+++.++++.+.++|.+|. .+.++++|++|+|++|.+++ +| .+.++++|++|+|++|+|+ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 455556666666665555 66667777777777777764 55 6666777777777777776 566666666677
Q ss_pred chhhccCccCCCCCCccccCCccccEEecccCcccccCC-----CC-CcccccccCCCCCcC
Q 009208 149 NYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP-----KI-SARTFKVTGNPLICG 204 (540)
Q Consensus 149 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-----~~-~~~~~~~~~n~~~~~ 204 (540)
+.|+|++|++++ +| .+..+++|+.|++++|++++..+ .. ..+.+++.+|++.+.
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence 777777777763 44 46666777777777777664211 11 114456666665443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.2e-12 Score=129.12 Aligned_cols=120 Identities=25% Similarity=0.443 Sum_probs=88.5
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.+++. ++ +.++++|++|+|++|++++ +| .+.++++|++|+|++|++++ +|. +..+++|++|++
T Consensus 63 ~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 136 (308)
T 1h6u_A 63 NNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYL 136 (308)
T ss_dssp TTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEEC
Confidence 4688888888888754 33 8888888888888888885 33 68888888888888888884 544 788888888888
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLI 202 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~ 202 (540)
++|++++ ++. +..+++|+.|++++|++++..+ +.. +.+++++|.+.
T Consensus 137 ~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 137 DLNQITN-ISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp CSSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC
T ss_pred CCCccCc-Ccc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccC
Confidence 8888884 333 7788888888888888885433 211 45667777653
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.34 E-value=1e-12 Score=131.69 Aligned_cols=121 Identities=21% Similarity=0.319 Sum_probs=67.4
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
.++.|++++|.+++..+ +..+++|++|+|++|.+++. |. +..+++|++|+|++|++++ + +.+..+++|++|+++
T Consensus 200 ~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~ 273 (347)
T 4fmz_A 200 SLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVG 273 (347)
T ss_dssp TCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECC
T ss_pred ccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEcc
Confidence 45666666666654333 55666666666666666633 22 5566666666666666653 3 345566666666666
Q ss_pred CccCCCCCCccccCCccccEEecccCcccccCCCCC-----cccccccCCCCCc
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS-----ARTFKVTGNPLIC 203 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-----~~~~~~~~n~~~~ 203 (540)
+|++++ + ..+..+++|+.|++++|++++..|... .+.+++++|++..
T Consensus 274 ~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 325 (347)
T 4fmz_A 274 SNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325 (347)
T ss_dssp SSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred CCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence 666653 2 235556666666666666655443321 1345556665543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.34 E-value=1.3e-12 Score=131.32 Aligned_cols=140 Identities=18% Similarity=0.181 Sum_probs=99.8
Q ss_pred CccceeeeecCC----------CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCC-cccCCCCcccE-EEe
Q 009208 62 PCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIP-ASLGKLEKLQT-LDL 129 (540)
Q Consensus 62 ~c~w~gv~c~~~----------~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~-L~l 129 (540)
-|+|+.|.|+.. ..++.|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.++++|++ +++
T Consensus 8 ~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 8 HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred EeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 378999999742 357888888888885445678888888888888888876555 46778887765 566
Q ss_pred eCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEeccc-CcccccCCCCCc------ccccccCCCC
Q 009208 130 SNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSY-NNLSGSLPKISA------RTFKVTGNPL 201 (540)
Q Consensus 130 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~------~~~~~~~n~~ 201 (540)
+.|+|++..|..|..+++|++|++++|++++..+..+....++..|++.+ |++....+..+. ..+.+++|.+
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i 166 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccc
Confidence 77888866677788888888888888888865555666677777787765 455533222211 2345666665
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.33 E-value=2.1e-12 Score=138.68 Aligned_cols=120 Identities=29% Similarity=0.419 Sum_probs=81.1
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+|+.|+|++|.|++..| +.++++|+.|+|++|.|++ +| .+..+++|+.|+|++|+|++ + +.+..+++|+.|+|
T Consensus 65 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 138 (605)
T ss_dssp TTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEEC
Confidence 367778888887775443 7777777777777777774 33 57777777777777777773 3 34677777777777
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLI 202 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~ 202 (540)
++|+|++. ..+..+++|+.|+|++|+|++.+| +.. +.+++++|.+.
T Consensus 139 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~ 188 (605)
T 1m9s_A 139 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHIS 188 (605)
T ss_dssp CSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC
T ss_pred CCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCC
Confidence 77777743 456777777777777777776554 211 44566666553
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.32 E-value=1.9e-12 Score=138.97 Aligned_cols=122 Identities=28% Similarity=0.374 Sum_probs=103.9
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.|++ + +.+.++++|+.|+|++|.|++ + +.+..+++|+.|+|++|+|++ + ..+..+++|+.|+|
T Consensus 87 ~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~L 160 (605)
T 1m9s_A 87 KNLGWLFLDENKIKD-L-SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSL 160 (605)
T ss_dssp TTCCEEECCSSCCCC-C-TTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCC-C-GGGGSCTTCSEEEC
T ss_pred CCCCEEECcCCCCCC-C-hhhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCC-c-hhhcccCCCCEEEC
Confidence 479999999999985 3 479999999999999999995 3 469999999999999999995 4 67999999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCCcC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICG 204 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~ 204 (540)
++|+|++..| +..+++|+.|+|++|+|++. |.+.. +.+++.+|++...
T Consensus 161 s~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 161 EDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEECC
T ss_pred cCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcCC
Confidence 9999996655 99999999999999999964 44322 5678888887544
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.30 E-value=2.2e-12 Score=127.75 Aligned_cols=112 Identities=25% Similarity=0.281 Sum_probs=99.0
Q ss_pred CcEEEecCCCCCCccccCccc-cCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhh
Q 009208 74 GYVSALGLPSQSLSGTLSPWI-GNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 152 (540)
.+++.|+|++|.+++..+..+ .++++|++|+|++|.+++. | ....+++|++|+|++|+|+ .+|..+..+++|+.|+
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~ 220 (317)
T 3o53_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220 (317)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEE
T ss_pred CCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCC-cchhhhcccCcccEEE
Confidence 479999999999998877777 4799999999999999955 4 3446999999999999999 6777799999999999
Q ss_pred ccCccCCCCCCccccCCccccEEecccCccc-ccCCCC
Q 009208 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLS-GSLPKI 189 (540)
Q Consensus 153 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~ 189 (540)
|++|+++ .+|..+..+++|+.|++++|+++ +.+|..
T Consensus 221 L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 257 (317)
T 3o53_A 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257 (317)
T ss_dssp CTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHH
T ss_pred CcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHH
Confidence 9999999 68889999999999999999999 555544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.29 E-value=1e-12 Score=141.33 Aligned_cols=136 Identities=23% Similarity=0.316 Sum_probs=91.7
Q ss_pred CccCCCCCCCCCCccceeeeecC-------CCcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCC
Q 009208 50 NVLENWDITSVDPCSWRMITCSP-------DGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLE 122 (540)
Q Consensus 50 ~~~~~w~~~~~~~c~w~gv~c~~-------~~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 122 (540)
...++|. .+.+||.|+|..|.. ...++.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|. .++
T Consensus 10 ~~w~~W~-~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~ 81 (622)
T 3g06_A 10 AVWSAWR-RAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPP 81 (622)
T ss_dssp CHHHHHH-HTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCT
T ss_pred HHHHHHH-hcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCC
Confidence 3455675 346788886643221 134788888888888 6777665 78888888888888 5665 567
Q ss_pred cccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc--ccccccCCC
Q 009208 123 KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA--RTFKVTGNP 200 (540)
Q Consensus 123 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~~~~~~~n~ 200 (540)
+|++|+|++|+|+ .+|. .+++|++|+|++|+++ .+|. .+++|+.|++++|+|++ +|.... +.+++++|.
T Consensus 82 ~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~---~l~~L~~L~L~~N~l~~-lp~~l~~L~~L~Ls~N~ 152 (622)
T 3g06_A 82 ELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA---LPSGLCKLWIFGNQLTS-LPVLPPGLQELSVSDNQ 152 (622)
T ss_dssp TCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSC
T ss_pred CCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC---CCCCcCEEECCCCCCCc-CCCCCCCCCEEECcCCc
Confidence 8888888888888 6776 5677888888888887 4554 45667777777777764 333211 445666665
Q ss_pred CC
Q 009208 201 LI 202 (540)
Q Consensus 201 ~~ 202 (540)
+.
T Consensus 153 l~ 154 (622)
T 3g06_A 153 LA 154 (622)
T ss_dssp CS
T ss_pred CC
Confidence 53
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.2e-11 Score=118.97 Aligned_cols=147 Identities=13% Similarity=0.061 Sum_probs=113.4
Q ss_pred HHHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEecCCeeE
Q 009208 296 LRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERL 374 (540)
Q Consensus 296 l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 374 (540)
+.....+|......+.|+.+.||+... +++.+++|....... .....+.+|.++++.+. +..+.++++++...+..+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 344556788888888889999999976 478999999864221 12235888999998884 677888999998888999
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ--------------------------------- 421 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~--------------------------------- 421 (540)
+||||++|.+|.+.+.. ......++.++++++..||+.
T Consensus 87 lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred EEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 99999999998775321 112346888999999999981
Q ss_pred -----------------------CCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 422 -----------------------CDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 422 -----------------------~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
..+.++|+|+++.||+++++..+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01469999999999999876556799999875
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.28 E-value=3.9e-12 Score=133.03 Aligned_cols=102 Identities=28% Similarity=0.421 Sum_probs=55.9
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
+++.|++++|.+++..+ +.++++|+.|+|++|.+++..| +..+++|+.|+|++|++++. +. +..+++|+.|+|+
T Consensus 244 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~L~ 317 (466)
T 1o6v_A 244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI-SP-ISNLKNLTYLTLY 317 (466)
T ss_dssp TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCC-GG-GGGCTTCSEEECC
T ss_pred CCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCc-hh-hcCCCCCCEEECc
Confidence 56666666666664333 5566666666666666664322 55556666666666665532 22 4555555555555
Q ss_pred CccCCCCCCccccCCccccEEecccCcccc
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSG 184 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 184 (540)
+|++++..| +..+++|+.|++++|++++
T Consensus 318 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 318 FNNISDISP--VSSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp SSCCSCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred CCcCCCchh--hccCccCCEeECCCCccCC
Confidence 555554333 4455555555555555553
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.27 E-value=2.3e-14 Score=131.89 Aligned_cols=109 Identities=22% Similarity=0.280 Sum_probs=98.4
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
..++.|+|++|.+++ +| .+.++++|++|+|++|.++ .+|..+..+++|++|+|++|+|++ +| .+..+++|+.|+|
T Consensus 48 ~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence 479999999999996 67 8999999999999999999 788888889999999999999994 66 6899999999999
Q ss_pred cCccCCCCCC--ccccCCccccEEecccCcccccCCC
Q 009208 154 NNNSLTGSCP--ESLSKIESLTLVDLSYNNLSGSLPK 188 (540)
Q Consensus 154 ~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~ 188 (540)
++|++++ +| ..+..+++|+.|++++|++++.+|.
T Consensus 123 ~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 123 SNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEECCC-HHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CCCcCCc-hhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 9999994 44 4789999999999999999988765
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=4.5e-12 Score=135.25 Aligned_cols=102 Identities=23% Similarity=0.304 Sum_probs=90.1
Q ss_pred ccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecc
Q 009208 99 KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLS 178 (540)
Q Consensus 99 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 178 (540)
.|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..++++++|+.|+|++|+|++ +| .+..+++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 46789999999995 776 999999999999999999 999999999999999999999995 78 89999999999999
Q ss_pred cCcccccC-CCCCc-----ccccccCCCCCcCC
Q 009208 179 YNNLSGSL-PKISA-----RTFKVTGNPLICGP 205 (540)
Q Consensus 179 ~N~l~~~~-p~~~~-----~~~~~~~n~~~~~~ 205 (540)
+|+|++.+ |.... +.+++++|++...+
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 549 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 549 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence 99999886 65432 56789999875443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.25 E-value=5.6e-12 Score=134.03 Aligned_cols=112 Identities=24% Similarity=0.329 Sum_probs=80.7
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
.++.|+|++|.|++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|+
T Consensus 121 ~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls 188 (571)
T 3cvr_A 121 SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVS 188 (571)
T ss_dssp TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECC
T ss_pred CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECc
Confidence 56666666666665 554 56778888888888885 665 56788999999999884 777 65 888888888
Q ss_pred CccCCCCCCccccCCccc-------cEEecccCcccccCCC-CCc----ccccccCCCCCc
Q 009208 155 NNSLTGSCPESLSKIESL-------TLVDLSYNNLSGSLPK-ISA----RTFKVTGNPLIC 203 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L-------~~L~l~~N~l~~~~p~-~~~----~~~~~~~n~~~~ 203 (540)
+|+|+ .+|. +.. +| +.|+|++|+|+. +|. +.. +.+++++|++.+
T Consensus 189 ~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~ 244 (571)
T 3cvr_A 189 TNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSS 244 (571)
T ss_dssp SSCCS-SCCC-CC----------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCH
T ss_pred CCCCC-chhh-HHH--hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCC
Confidence 88888 7777 554 67 888888888884 554 221 456788888754
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.22 E-value=2.8e-11 Score=126.04 Aligned_cols=99 Identities=26% Similarity=0.330 Sum_probs=61.1
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
+++.|+|++|.+++. | .++++++|++|+|++|++++. | ++.+++|++|+|++|+|++ +| ++++++|++|+++
T Consensus 43 ~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~ 114 (457)
T 3bz5_A 43 TLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCD 114 (457)
T ss_dssp TCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECC
T ss_pred CCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECC
Confidence 566666666666643 3 566666666666666666643 3 6666666666666666663 33 5666666666666
Q ss_pred CccCCCCCCccccCCccccEEecccCcccc
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSG 184 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 184 (540)
+|++++ +| +..+++|+.|++++|++++
T Consensus 115 ~N~l~~-l~--~~~l~~L~~L~l~~N~l~~ 141 (457)
T 3bz5_A 115 TNKLTK-LD--VSQNPLLTYLNCARNTLTE 141 (457)
T ss_dssp SSCCSC-CC--CTTCTTCCEEECTTSCCSC
T ss_pred CCcCCe-ec--CCCCCcCCEEECCCCccce
Confidence 666664 33 5666666666666666665
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.22 E-value=1.4e-11 Score=128.68 Aligned_cols=123 Identities=30% Similarity=0.392 Sum_probs=96.0
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|++++|.+++. +.+..+++|+.|+|++|.+++..| +..+++|++|+|++|++++ +|. +..+++|+.|+|
T Consensus 221 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L 294 (466)
T 1o6v_A 221 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAGLTALTNLEL 294 (466)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEEC
T ss_pred CCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc-ccc-ccCCCccCeEEc
Confidence 4688899999988853 467888999999999999986544 8888999999999999984 444 888899999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCC---CcccccccCCCCCcC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI---SARTFKVTGNPLICG 204 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~---~~~~~~~~~n~~~~~ 204 (540)
++|++++..| +..+++|+.|++++|++++..|-. ..+.+++.+|++...
T Consensus 295 ~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred CCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc
Confidence 9999985433 788899999999999998766521 115567788876543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.22 E-value=9.6e-12 Score=124.64 Aligned_cols=121 Identities=24% Similarity=0.353 Sum_probs=104.7
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.+++..+ +..+++|++|+|++|.+++. +.+..+++|++|++++|++++ + +.+..+++|+.|++
T Consensus 221 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L 294 (347)
T 4fmz_A 221 TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFL 294 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEEC
Confidence 479999999999996443 99999999999999999964 479999999999999999994 4 46899999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCC----cccccccCCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS----ARTFKVTGNPL 201 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~----~~~~~~~~n~~ 201 (540)
++|++++..|..+..+++|+.|++++|++++.+| +. .+.+++.+|++
T Consensus 295 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQVI 345 (347)
T ss_dssp CSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC--
T ss_pred cCCcCCCcChhHhhccccCCEEEccCCccccccC-hhhhhccceeehhhhcc
Confidence 9999998888899999999999999999998776 22 15678888876
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.18 E-value=4.1e-11 Score=124.75 Aligned_cols=104 Identities=21% Similarity=0.197 Sum_probs=88.4
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
..++.|++++|...+.+ .++.+++|+.|+|++|++++ +| +..+++|+.|++++|++++ + .++.+++|+.|++
T Consensus 148 ~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~-~--~l~~l~~L~~L~L 219 (457)
T 3bz5_A 148 TQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITK-L--DLNQNIQLTFLDC 219 (457)
T ss_dssp TTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSC-C--CCTTCTTCSEEEC
T ss_pred CcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCe-e--ccccCCCCCEEEC
Confidence 47889999999766666 58889999999999999996 55 8889999999999999995 3 3888999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK 188 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 188 (540)
++|++++ +| +..+++|+.|++++|++++..+.
T Consensus 220 s~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~ 251 (457)
T 3bz5_A 220 SSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS 251 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT
T ss_pred cCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHH
Confidence 9999996 66 88899999999999999976544
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.18 E-value=3.5e-11 Score=115.25 Aligned_cols=137 Identities=14% Similarity=0.052 Sum_probs=99.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCC--ccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN--LLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lV~e 378 (540)
.++......+.|..+.||+....+|..+++|...... ...+.+|.++++.+.+.+ +.+++++....+..++|||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3444433334556699999988778889999976531 135778999998886545 4568888887788899999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC------------------------------------ 422 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------ 422 (540)
|++|.++. ... .+ ...++.++++.+..||+..
T Consensus 96 ~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 96 EVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp CCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred ecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 99998874 211 11 2356778888888888642
Q ss_pred -------------------CCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 423 -------------------DPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 423 -------------------~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
...++|+|++|.||+++++..+.|+|||.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999877666799999875
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.17 E-value=6.8e-11 Score=122.96 Aligned_cols=96 Identities=26% Similarity=0.397 Sum_probs=62.2
Q ss_pred CccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEec
Q 009208 98 TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDL 177 (540)
Q Consensus 98 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 177 (540)
++|++|+|++|++++ +| +|+++++|++|++++|+++ .+|..+ ++|++|++++|++++ +| .+..+++|+.|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~-~lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCS-CCCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCc-ccCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 466777777777774 56 4777777777777777777 355543 467777777777774 55 4777777777777
Q ss_pred ccCcccccCCCCC--cccccccCCCCC
Q 009208 178 SYNNLSGSLPKIS--ARTFKVTGNPLI 202 (540)
Q Consensus 178 ~~N~l~~~~p~~~--~~~~~~~~n~~~ 202 (540)
++|++++ +|... .+.+++++|.+.
T Consensus 203 ~~N~l~~-l~~~~~~L~~L~l~~n~l~ 228 (454)
T 1jl5_A 203 DNNSLKK-LPDLPLSLESIVAGNNILE 228 (454)
T ss_dssp CSSCCSS-CCCCCTTCCEEECCSSCCS
T ss_pred CCCcCCc-CCCCcCcccEEECcCCcCC
Confidence 7777775 34332 245566666553
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.17 E-value=8.6e-11 Score=122.16 Aligned_cols=116 Identities=26% Similarity=0.329 Sum_probs=90.7
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|.+++ +| +++++++|++|++++|++++ +|..+ .+|++|+|++|++++ +| .++++++|++|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 478999999999996 77 69999999999999999995 67544 589999999999995 77 5888999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLI 202 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~ 202 (540)
++|++++ +|... ++|+.|++++|+++ .+|++.. +.+++++|.+.
T Consensus 203 ~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~~~~l~~L~~L~l~~N~l~ 250 (454)
T 1jl5_A 203 DNNSLKK-LPDLP---LSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLK 250 (454)
T ss_dssp CSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCS
T ss_pred CCCcCCc-CCCCc---CcccEEECcCCcCC-cccccCCCCCCCEEECCCCcCC
Confidence 9998884 55433 47778888888877 5665322 44566777653
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.15 E-value=1.2e-12 Score=133.38 Aligned_cols=110 Identities=21% Similarity=0.273 Sum_probs=55.1
Q ss_pred cEEEecCCCCCCcc----ccCccccCC---------CccCEEEcccCCCC-CCCC---cccCCCCcccEEEeeCCCCc--
Q 009208 75 YVSALGLPSQSLSG----TLSPWIGNL---------TKLQSVLLQNNAIL-GPIP---ASLGKLEKLQTLDLSNNKFT-- 135 (540)
Q Consensus 75 ~l~~l~l~~~~l~~----~~~~~~~~l---------~~L~~L~l~~N~l~-~~~p---~~~~~l~~L~~L~ls~N~l~-- 135 (540)
+++.|+|++|.+++ .++..+..+ ++|++|+|++|+++ +.+| ..+..+++|++|+|++|+|+
T Consensus 123 ~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~ 202 (386)
T 2ca6_A 123 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 202 (386)
T ss_dssp TCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH
T ss_pred CCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHh
Confidence 45555555555542 233444444 55555555555554 2233 23444555555555555554
Q ss_pred c---cCCccccCCCCcchhhccCccCC----CCCCccccCCccccEEecccCcccc
Q 009208 136 G---EIPDSLGDLGNLNYLRLNNNSLT----GSCPESLSKIESLTLVDLSYNNLSG 184 (540)
Q Consensus 136 ~---~~p~~~~~l~~L~~L~l~~N~l~----~~~p~~~~~l~~L~~L~l~~N~l~~ 184 (540)
| .+|..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+|++|++++
T Consensus 203 g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~ 258 (386)
T 2ca6_A 203 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 258 (386)
T ss_dssp HHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred HHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCch
Confidence 1 22334555555555555555553 3444555555555555555555543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.14 E-value=5.6e-12 Score=127.28 Aligned_cols=128 Identities=21% Similarity=0.238 Sum_probs=93.3
Q ss_pred cEEEecCCCCCCccccC----ccccCCC-ccCEEEcccCCCCCCCCcccCCC-----CcccEEEeeCCCCcccCCcccc-
Q 009208 75 YVSALGLPSQSLSGTLS----PWIGNLT-KLQSVLLQNNAILGPIPASLGKL-----EKLQTLDLSNNKFTGEIPDSLG- 143 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~----~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~ls~N~l~~~~p~~~~- 143 (540)
.++.|+|++|.|++..+ ..+.+++ +|++|+|++|.+++..+..+..+ ++|++|+|++|++++..+..+.
T Consensus 23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~ 102 (362)
T 3goz_A 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK 102 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence 48888888888886655 6777888 88889998888887777777665 8888899998888866665443
Q ss_pred ---CC-CCcchhhccCccCCCCCCccc----cC-CccccEEecccCcccccCCC----------CCcccccccCCCCC
Q 009208 144 ---DL-GNLNYLRLNNNSLTGSCPESL----SK-IESLTLVDLSYNNLSGSLPK----------ISARTFKVTGNPLI 202 (540)
Q Consensus 144 ---~l-~~L~~L~l~~N~l~~~~p~~~----~~-l~~L~~L~l~~N~l~~~~p~----------~~~~~~~~~~n~~~ 202 (540)
.+ ++|++|+|++|++++..+..+ .. .++|+.|+|++|++++..+. ...+.+++++|.+.
T Consensus 103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~ 180 (362)
T 3goz_A 103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180 (362)
T ss_dssp HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCc
Confidence 34 788888999888886555443 33 25888889998888842211 12356677777663
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=3e-10 Score=114.40 Aligned_cols=142 Identities=14% Similarity=0.200 Sum_probs=105.6
Q ss_pred CCeeeeccCccEEEEEeCCCcEEEEEEec--cCCccccHHHHHHHHHHHhccc--CCCccceeEEEecC---CeeEEEEe
Q 009208 306 KNILGRGGFGIVYKGCFSDGALVAVKRLK--DYNIAGGEVQFQTEVETISLAV--HRNLLRLCGFCSTE---NERLLVYP 378 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~---~~~~lV~e 378 (540)
.+.++.|.++.||+.... +..+++|+.. ..........+.+|.++++.+. +..+.+++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 467899999999999875 4678888875 3322223346788999998886 45578888888766 45899999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC------------------------------------ 422 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------ 422 (540)
|++|..+.+.. ...++...+..++.++++.|..||...
T Consensus 122 ~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 122 FVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred ecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99998764421 124678888899999999999999731
Q ss_pred -------------------CCCeEecCCCCCceeeCCCCC--eEEcccccccc
Q 009208 423 -------------------DPKIIHRDVKAANILLDEDFE--AVVGDFGLAKL 454 (540)
Q Consensus 423 -------------------~~~ivH~Dlk~~NILl~~~~~--~kl~Dfgla~~ 454 (540)
.+.++|||+++.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998863
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.10 E-value=3.7e-12 Score=129.78 Aligned_cols=130 Identities=22% Similarity=0.291 Sum_probs=108.3
Q ss_pred CcEEEecCCCCCCc-cccC---ccccCCCccCEEEcccCCCC--C---CCCcccCCCCcccEEEeeCCCCc----ccCCc
Q 009208 74 GYVSALGLPSQSLS-GTLS---PWIGNLTKLQSVLLQNNAIL--G---PIPASLGKLEKLQTLDLSNNKFT----GEIPD 140 (540)
Q Consensus 74 ~~l~~l~l~~~~l~-~~~~---~~~~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~~L~ls~N~l~----~~~p~ 140 (540)
.+++.|+|++|.++ +.++ ..+.++++|+.|+|++|+++ | ..|..+.++++|++|+|++|+|+ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 58999999999998 4455 57788999999999999998 3 34557889999999999999996 67899
Q ss_pred cccCCCCcchhhccCccCCCC----CCccc--cCCccccEEecccCcccc----cCCCCC------cccccccCCCCCc
Q 009208 141 SLGDLGNLNYLRLNNNSLTGS----CPESL--SKIESLTLVDLSYNNLSG----SLPKIS------ARTFKVTGNPLIC 203 (540)
Q Consensus 141 ~~~~l~~L~~L~l~~N~l~~~----~p~~~--~~l~~L~~L~l~~N~l~~----~~p~~~------~~~~~~~~n~~~~ 203 (540)
.+..+++|+.|+|++|++++. +|..+ ..+++|+.|+|++|++++ .+|... .+.+++.+|++..
T Consensus 239 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 999999999999999999865 56666 449999999999999997 355422 2567889998754
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.10 E-value=2.5e-12 Score=128.22 Aligned_cols=128 Identities=21% Similarity=0.290 Sum_probs=100.3
Q ss_pred CcEEEecCCCCCCccc-cCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCC-CCcc-cCCccccCCCCcch
Q 009208 74 GYVSALGLPSQSLSGT-LSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNN-KFTG-EIPDSLGDLGNLNY 150 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N-~l~~-~~p~~~~~l~~L~~ 150 (540)
.+++.|+|++|.+++. ++..+.++++|++|+|++|.+++..|..+.++++|++|+|++| .+++ .+|..+.++++|++
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~ 172 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence 4788899999988866 7888888999999999999888778888888999999999998 6775 36777888889999
Q ss_pred hhccCc-cCCCC-CCccccCCc-cccEEecccC--ccc-ccCCCCC-----cccccccCCCC
Q 009208 151 LRLNNN-SLTGS-CPESLSKIE-SLTLVDLSYN--NLS-GSLPKIS-----ARTFKVTGNPL 201 (540)
Q Consensus 151 L~l~~N-~l~~~-~p~~~~~l~-~L~~L~l~~N--~l~-~~~p~~~-----~~~~~~~~n~~ 201 (540)
|++++| .+++. ++..+..++ +|+.|++++| .++ +.+|... .+.+++++|..
T Consensus 173 L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~ 234 (336)
T 2ast_B 173 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM 234 (336)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT
T ss_pred EcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCc
Confidence 999998 88753 566778888 8899999888 455 3333321 25667777773
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.10 E-value=2.7e-12 Score=127.97 Aligned_cols=117 Identities=20% Similarity=0.222 Sum_probs=64.2
Q ss_pred CccceeeeecCCCcEEEecCCCCCCccccCccccCC--CccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCccc-C
Q 009208 62 PCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNL--TKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGE-I 138 (540)
Q Consensus 62 ~c~w~gv~c~~~~~l~~l~l~~~~l~~~~~~~~~~l--~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-~ 138 (540)
|..|.++.|++ ..++.|+++++.+. +..+..+ ++++.|++++|.+++..|. +.++++|++|+|++|++++. +
T Consensus 36 c~~W~~~~~~~-~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~ 110 (336)
T 2ast_B 36 CKRWYRLASDE-SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTL 110 (336)
T ss_dssp CHHHHHHHTCS-TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHH
T ss_pred HHHHHHHhcCc-hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHH
Confidence 34566665542 23555666655554 3334444 5556666666665544443 44555666666666655543 5
Q ss_pred CccccCCCCcchhhccCccCCCCCCccccCCccccEEecccC-ccc
Q 009208 139 PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN-NLS 183 (540)
Q Consensus 139 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~ 183 (540)
|..+..+++|++|+|++|++++..|..++.+++|++|++++| .++
T Consensus 111 ~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~ 156 (336)
T 2ast_B 111 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 156 (336)
T ss_dssp HHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCC
T ss_pred HHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCC
Confidence 555555566666666666555555555555566666666665 444
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.10 E-value=1e-10 Score=125.78 Aligned_cols=72 Identities=32% Similarity=0.400 Sum_probs=43.0
Q ss_pred CcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccc
Q 009208 122 EKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKV 196 (540)
Q Consensus 122 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~ 196 (540)
++|++|+|++|+|+ .+| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|.... +.+++
T Consensus 221 ~~L~~L~Ls~N~L~-~lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L 291 (622)
T 3g06_A 221 SGLKELIVSGNRLT-SLP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 291 (622)
T ss_dssp TTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred CCCCEEEccCCccC-cCC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence 55666666666666 355 34466666677777666 4554 4566667777777766 4443221 34566
Q ss_pred cCCCCC
Q 009208 197 TGNPLI 202 (540)
Q Consensus 197 ~~n~~~ 202 (540)
++|++.
T Consensus 292 ~~N~l~ 297 (622)
T 3g06_A 292 EGNPLS 297 (622)
T ss_dssp CSCCCC
T ss_pred cCCCCC
Confidence 666654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.09 E-value=5.6e-12 Score=127.28 Aligned_cols=113 Identities=23% Similarity=0.236 Sum_probs=69.5
Q ss_pred cEEEecCCCCCCccccCccccCC-----CccCEEEcccCCCCCCCCcccCC----C-CcccEEEeeCCCCcccCCcccc-
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNL-----TKLQSVLLQNNAILGPIPASLGK----L-EKLQTLDLSNNKFTGEIPDSLG- 143 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~~----l-~~L~~L~ls~N~l~~~~p~~~~- 143 (540)
+++.|+|++|.|++..+..+..+ ++|++|+|++|.+++..+..+.. + ++|++|+|++|+|++..+..+.
T Consensus 52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 131 (362)
T 3goz_A 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ 131 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence 57777777777776555555554 77777777777777555543333 3 6777777777777644443332
Q ss_pred ---C-CCCcchhhccCccCCCCC----CccccCCc-cccEEecccCcccccCC
Q 009208 144 ---D-LGNLNYLRLNNNSLTGSC----PESLSKIE-SLTLVDLSYNNLSGSLP 187 (540)
Q Consensus 144 ---~-l~~L~~L~l~~N~l~~~~----p~~~~~l~-~L~~L~l~~N~l~~~~p 187 (540)
. .++|++|+|++|++++.. +..+..++ +|+.|+|++|++++..+
T Consensus 132 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~ 184 (362)
T 3goz_A 132 AFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNC 184 (362)
T ss_dssp HHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCH
T ss_pred HHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhH
Confidence 2 247777777777776432 22334444 67777777777765443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.09 E-value=9.8e-11 Score=117.53 Aligned_cols=115 Identities=12% Similarity=0.123 Sum_probs=95.2
Q ss_pred eeecCCCcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCc-cccCCC
Q 009208 68 ITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD-SLGDLG 146 (540)
Q Consensus 68 v~c~~~~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~ 146 (540)
.+|+. ++++.++++|+ .+|..+ .++|++|+|++|+|+...+..|.++++|++|+|++|++.+.+|. .|.+++
T Consensus 7 C~C~~----~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~ 79 (350)
T 4ay9_X 7 CHCSN----RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79 (350)
T ss_dssp SEEET----TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCT
T ss_pred cEeeC----CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcch
Confidence 45653 34678899999 788766 36899999999999955556899999999999999999767775 578898
Q ss_pred Ccch-hhccCccCCCCCCccccCCccccEEecccCcccccCCCC
Q 009208 147 NLNY-LRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189 (540)
Q Consensus 147 ~L~~-L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 189 (540)
+|++ +.+++|+++...|..|..+++|++|++++|++++..+..
T Consensus 80 ~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~ 123 (350)
T 4ay9_X 80 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH 123 (350)
T ss_dssp TCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCT
T ss_pred hhhhhhcccCCcccccCchhhhhccccccccccccccccCCchh
Confidence 8775 677789999777889999999999999999999655543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.94 E-value=3.9e-10 Score=110.79 Aligned_cols=186 Identities=19% Similarity=0.164 Sum_probs=120.0
Q ss_pred CCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCC--ccceeEEEecCC---eeEEEEec
Q 009208 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRN--LLRLCGFCSTEN---ERLLVYPY 379 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--Iv~l~~~~~~~~---~~~lV~e~ 379 (540)
.+.++.|....||+.. ..+++|..... .....+.+|.++++.+. +.. +.+++......+ ..++||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568999999999862 56888886432 23456889999998773 333 334444433332 35789999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ-------------------------------------- 421 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-------------------------------------- 421 (540)
++|.++.+... ..++...+..++.++++.+..||+.
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988765332 1356677778888888888888851
Q ss_pred -----------------CCCCeEecCCCCCceeeCC--CCCeEEcccccccccCCCCCceeec--------------ccc
Q 009208 422 -----------------CDPKIIHRDVKAANILLDE--DFEAVVGDFGLAKLLDHRDSHVTTA--------------VRG 468 (540)
Q Consensus 422 -----------------~~~~ivH~Dlk~~NILl~~--~~~~kl~Dfgla~~~~~~~~~~~~~--------------~~g 468 (540)
..+.++|+|+++.||++++ +..+.|+||+.+..-+... ..... ...
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHH
Confidence 1246899999999999998 4567899999886433210 00000 000
Q ss_pred cccccc-ccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 469 TVGHIA-PEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 469 t~~y~a-PE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
..+... |+.... .....+.|+++.++|++.+|+.+|-
T Consensus 251 ~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 251 HYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 001111 222111 1122588999999999999998874
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.88 E-value=1.6e-11 Score=128.02 Aligned_cols=129 Identities=19% Similarity=0.178 Sum_probs=85.0
Q ss_pred CcEEEecCCCCCCcccc-----CccccCCCccCEEEcccCCCCCC----CCcccCCCCcccEEEeeCCCCcccCCccccC
Q 009208 74 GYVSALGLPSQSLSGTL-----SPWIGNLTKLQSVLLQNNAILGP----IPASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~-----~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 144 (540)
.+++.|+|++|.+++.- +..+..+++|++|+|++|.++.. +|..+.++++|++|+|++|++++..+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 46888888888877532 22334577888888888888743 5666777788888888888876543333332
Q ss_pred -----CCCcchhhccCccCCCC----CCccccCCccccEEecccCcccccCCC----------CCcccccccCCCCC
Q 009208 145 -----LGNLNYLRLNNNSLTGS----CPESLSKIESLTLVDLSYNNLSGSLPK----------ISARTFKVTGNPLI 202 (540)
Q Consensus 145 -----l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~----------~~~~~~~~~~n~~~ 202 (540)
.++|++|+|++|.+++. +|..+..+++|+.|++++|++++..+. ...+.+++++|.+.
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 25788888888887754 455566677888888888877653211 12245667777653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.87 E-value=2.9e-11 Score=115.28 Aligned_cols=163 Identities=20% Similarity=0.236 Sum_probs=102.2
Q ss_pred HhhccCCCCCchHHHHHHHHHHhc-CCCCCccCCCCC-------------CCCCCccceeeeecCCC-cEEEecCCC---
Q 009208 22 CYATLSPAGINYEVVALVAVKNNL-HDPYNVLENWDI-------------TSVDPCSWRMITCSPDG-YVSALGLPS--- 83 (540)
Q Consensus 22 ~~~~~~~~~~~~~~~~l~~~k~~~-~~~~~~~~~w~~-------------~~~~~c~w~gv~c~~~~-~l~~l~l~~--- 83 (540)
|.....+.+..+|..-|+.+-... ..|.. .-.|.. +....|.|.|+.|+.++ +|..+...+
T Consensus 24 w~kv~I~~g~ky~k~~ll~~i~~~~~~~f~-p~~~~~~~~~~~ffV~~~~~A~~l~~~~g~i~~~~~~ki~~~v~~~~~~ 102 (267)
T 3rw6_A 24 WFKITIPYGRKYDKAWLLSMIQSKCSVPFT-PIEFHYENTRAQFFVEDASTASALKAVNYKILDRENRRISIIINSSAPP 102 (267)
T ss_dssp CEEEEETTGGGSCHHHHHHHHHHTCSSCCC-CEEEEEETTEEEEEESCHHHHHHHHHTTSSCBCTTSCBCCCEEEECCCC
T ss_pred eEEEEecCccccCHHHHHHHHHHhCCCCcE-eEEEEEeCCEEEEEeCChHHHHHHHhcCcEEECCCCCEEEEEEecCCCc
Confidence 445556778888888777665543 33321 111210 11235789999998753 554444433
Q ss_pred CCCccccCc------------------------cccCCCccCE--EEcccCCCCCCCCc----ccCCCCcccEEEeeCCC
Q 009208 84 QSLSGTLSP------------------------WIGNLTKLQS--VLLQNNAILGPIPA----SLGKLEKLQTLDLSNNK 133 (540)
Q Consensus 84 ~~l~~~~~~------------------------~~~~l~~L~~--L~l~~N~l~~~~p~----~~~~l~~L~~L~ls~N~ 133 (540)
..+.+.+++ .+...+.|.. ++++.|+.. .++. ...++++|+.|+||+|+
T Consensus 103 ~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~ 181 (267)
T 3rw6_A 103 HTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNR 181 (267)
T ss_dssp HHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSC
T ss_pred ccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCC
Confidence 122222221 1223333444 566666433 2222 22457899999999999
Q ss_pred Ccc--cCCccccCCCCcchhhccCccCCCCCCccccCCc--cccEEecccCcccccCCC
Q 009208 134 FTG--EIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIE--SLTLVDLSYNNLSGSLPK 188 (540)
Q Consensus 134 l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~ 188 (540)
|++ .+|..+..+++|+.|+|++|+|++. ..+..++ +|+.|+|++|++++.+|+
T Consensus 182 l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 182 LYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRD 238 (267)
T ss_dssp CCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSS
T ss_pred CCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCc
Confidence 997 5667788899999999999999854 3345555 899999999999987774
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.78 E-value=1.3e-10 Score=121.17 Aligned_cols=129 Identities=20% Similarity=0.166 Sum_probs=101.0
Q ss_pred CcEEEecCCCCCCccc----cCccccCCCccCEEEcccCCCCCCCCcccCC-----CCcccEEEeeCCCCccc----CCc
Q 009208 74 GYVSALGLPSQSLSGT----LSPWIGNLTKLQSVLLQNNAILGPIPASLGK-----LEKLQTLDLSNNKFTGE----IPD 140 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~ls~N~l~~~----~p~ 140 (540)
.+++.|+|++|.+++. ++..+.++++|++|+|++|.+++..+..+.. .++|++|+|++|++++. +|.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 5799999999999864 6778888999999999999987544433433 36999999999999865 567
Q ss_pred cccCCCCcchhhccCccCCCCCCccccC-----CccccEEecccCcccc----cCCCC-----CcccccccCCCCC
Q 009208 141 SLGDLGNLNYLRLNNNSLTGSCPESLSK-----IESLTLVDLSYNNLSG----SLPKI-----SARTFKVTGNPLI 202 (540)
Q Consensus 141 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~----~~p~~-----~~~~~~~~~n~~~ 202 (540)
.+..+++|++|+|++|++++..+..+.. .++|+.|++++|++++ .+|.. ..+.+++++|++.
T Consensus 336 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred HHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 7888899999999999998654444432 6799999999999985 44432 1266788888774
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.73 E-value=1.7e-10 Score=116.50 Aligned_cols=128 Identities=20% Similarity=0.193 Sum_probs=89.9
Q ss_pred CcEEEecCCCCCCccccCccc-cCCCccCEEEcccCCCCCCCCccc-----CCCCcccEEEeeCCCCcc----cCCcccc
Q 009208 74 GYVSALGLPSQSLSGTLSPWI-GNLTKLQSVLLQNNAILGPIPASL-----GKLEKLQTLDLSNNKFTG----EIPDSLG 143 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~p~~~-----~~l~~L~~L~ls~N~l~~----~~p~~~~ 143 (540)
..++.|+|++|.|+..-...+ ..+++|+.|+|++|.|+......+ ...++|++|+|++|+|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 478899999998875433333 345678899999998874433333 346789999999998873 3555567
Q ss_pred CCCCcchhhccCccCCCC----CCccccCCccccEEecccCccccc----CCC-----CCcccccccCCCC
Q 009208 144 DLGNLNYLRLNNNSLTGS----CPESLSKIESLTLVDLSYNNLSGS----LPK-----ISARTFKVTGNPL 201 (540)
Q Consensus 144 ~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~-----~~~~~~~~~~n~~ 201 (540)
.+++|++|+|++|+|++. ++..+...++|+.|+|++|+|+.. ++. -..+.+++++|++
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i 251 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSC
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCC
Confidence 788899999999998742 345667778899999999988742 111 1125677888876
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.72 E-value=1.2e-09 Score=104.00 Aligned_cols=80 Identities=28% Similarity=0.392 Sum_probs=66.7
Q ss_pred cCCCccCEEEcccCCCCC--CCCcccCCCCcccEEEeeCCCCcccCCccccCCC--CcchhhccCccCCCCCCc------
Q 009208 95 GNLTKLQSVLLQNNAILG--PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLG--NLNYLRLNNNSLTGSCPE------ 164 (540)
Q Consensus 95 ~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~------ 164 (540)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+++.+|+
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 568999999999999997 4567778999999999999999954 4455555 999999999999987763
Q ss_pred -cccCCccccEEe
Q 009208 165 -SLSKIESLTLVD 176 (540)
Q Consensus 165 -~~~~l~~L~~L~ 176 (540)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 367788888876
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.71 E-value=6.7e-10 Score=112.14 Aligned_cols=111 Identities=20% Similarity=0.235 Sum_probs=89.3
Q ss_pred cEEEecCCCCCCccccCccc-----cCCCccCEEEcccCCCCC----CCCcccCCCCcccEEEeeCCCCcc----cCCcc
Q 009208 75 YVSALGLPSQSLSGTLSPWI-----GNLTKLQSVLLQNNAILG----PIPASLGKLEKLQTLDLSNNKFTG----EIPDS 141 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~-----~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~----~~p~~ 141 (540)
+++.|+|++|.|+..-...+ ...++|++|+|++|.|+. .++..+..+++|++|+|++|+|+. .++..
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~ 206 (372)
T 3un9_A 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQ 206 (372)
T ss_dssp TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHH
T ss_pred hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHH
Confidence 69999999999986444444 356899999999999974 244556788999999999999984 24566
Q ss_pred ccCCCCcchhhccCccCCCC----CCccccCCccccEEecccCccccc
Q 009208 142 LGDLGNLNYLRLNNNSLTGS----CPESLSKIESLTLVDLSYNNLSGS 185 (540)
Q Consensus 142 ~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~ 185 (540)
+...++|++|+|++|.|++. ++..+...++|+.|+|++|+|+..
T Consensus 207 L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 207 LDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp GGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred HhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 78889999999999999852 344556678999999999999853
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.55 E-value=7.1e-08 Score=95.63 Aligned_cols=100 Identities=15% Similarity=0.104 Sum_probs=66.4
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCccc-EEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQ-TLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~-~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.++.|+|++|+++..-+..|.++++|+.|+|.+| ++..-+..|.++++|+ .|+|++ +++..-+..|.++++|+.|++
T Consensus 227 ~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l 304 (329)
T 3sb4_A 227 NLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLA 304 (329)
T ss_dssp TCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEE
T ss_pred CCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEe
Confidence 5677777777776444456777777777777776 5545555677777777 777776 565344456777777777777
Q ss_pred cCccCCCCCCccccCCccccEEe
Q 009208 154 NNNSLTGSCPESLSKIESLTLVD 176 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~ 176 (540)
++|+++..-+..|.++++|+.++
T Consensus 305 ~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 305 TGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp CSSCCCEECTTTTCTTCCCCEEE
T ss_pred CCCccCccchhhhcCCcchhhhc
Confidence 77777644455677777777665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.52 E-value=4.3e-09 Score=95.24 Aligned_cols=110 Identities=15% Similarity=0.194 Sum_probs=86.2
Q ss_pred CcEEEecCCCC-CCcc----ccCccccCCCccCEEEcccCCCCCC----CCcccCCCCcccEEEeeCCCCccc----CCc
Q 009208 74 GYVSALGLPSQ-SLSG----TLSPWIGNLTKLQSVLLQNNAILGP----IPASLGKLEKLQTLDLSNNKFTGE----IPD 140 (540)
Q Consensus 74 ~~l~~l~l~~~-~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~----~p~ 140 (540)
..++.|+|++| .|.. .+...+...++|++|+|++|.|... +...+...++|++|+|++|+|+.. +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 47999999999 8874 2556677789999999999998742 334455668899999999999843 556
Q ss_pred cccCCCCcchhhc--cCccCCCC----CCccccCCccccEEecccCccc
Q 009208 141 SLGDLGNLNYLRL--NNNSLTGS----CPESLSKIESLTLVDLSYNNLS 183 (540)
Q Consensus 141 ~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 183 (540)
.+...++|++|+| ++|.|+.. +...+...++|+.|+|++|.+.
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 6778889999999 88999743 3345566688999999999886
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.42 E-value=3.8e-07 Score=90.38 Aligned_cols=124 Identities=15% Similarity=0.155 Sum_probs=83.3
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccC-----------------------------------
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLG----------------------------------- 119 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~----------------------------------- 119 (540)
.++.|+|++ +++..-+.+|.++++|+.|+|++|.++...+..|.
T Consensus 102 ~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~ 180 (329)
T 3sb4_A 102 TLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLET 180 (329)
T ss_dssp TCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEE
T ss_pred CCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccce
Confidence 688888888 78765567788888888888888875321111110
Q ss_pred -------------------------------------------CCCcccEEEeeCCCCcccCCccccCCCCcchhhccCc
Q 009208 120 -------------------------------------------KLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN 156 (540)
Q Consensus 120 -------------------------------------------~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 156 (540)
.+++|+.|+|++|+++..-+..|.++++|+.|+|.+|
T Consensus 181 ~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n 260 (329)
T 3sb4_A 181 TIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN 260 (329)
T ss_dssp EEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT
T ss_pred eEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc
Confidence 1568888888888888433445888888888888887
Q ss_pred cCCCCCCccccCCcccc-EEecccCcccccCCCCCc-----ccccccCCCC
Q 009208 157 SLTGSCPESLSKIESLT-LVDLSYNNLSGSLPKISA-----RTFKVTGNPL 201 (540)
Q Consensus 157 ~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~ 201 (540)
++..-+.+|.++++|+ .+++.+ +++..-+..+. +.+.+.+|.+
T Consensus 261 -i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i 309 (329)
T 3sb4_A 261 -LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKI 309 (329)
T ss_dssp -CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCC
T ss_pred -cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCcc
Confidence 6645566788888888 888887 56533223222 3345555554
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=3.1e-06 Score=82.79 Aligned_cols=136 Identities=18% Similarity=0.181 Sum_probs=92.0
Q ss_pred CCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCC---CccceeEEEe-cCCeeEEEEecCC
Q 009208 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR---NLLRLCGFCS-TENERLLVYPYMP 381 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~-~~~~~~lV~e~~~ 381 (540)
.+.++.|....||+. |..+++|+... ......+.+|.+++..+.+. .+.+++.++. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 356788888899987 56788888532 22345788999999988653 2456666664 4556789999999
Q ss_pred CCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 009208 382 NGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ---------------------------------------- 421 (540)
Q Consensus 382 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------------------------------------- 421 (540)
|.++.+.... .++......++.++++.|..||+.
T Consensus 97 G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9887653211 123334444444555555444432
Q ss_pred -----------------CCCCeEecCCCCCceeeCC---CCCe-EEcccccccc
Q 009208 422 -----------------CDPKIIHRDVKAANILLDE---DFEA-VVGDFGLAKL 454 (540)
Q Consensus 422 -----------------~~~~ivH~Dlk~~NILl~~---~~~~-kl~Dfgla~~ 454 (540)
..+.++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2346799999999999997 4554 7999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=4e-06 Score=80.30 Aligned_cols=135 Identities=19% Similarity=0.137 Sum_probs=95.0
Q ss_pred eeeeccCc-cEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEecCCeeEEEEecCCCCC
Q 009208 308 ILGRGGFG-IVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENERLLVYPYMPNGS 384 (540)
Q Consensus 308 ~lG~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lV~e~~~~gs 384 (540)
.+..|..| .||+.... ++..+.+|+.... ....+.+|...++.+. +--+.++++++...+..++|||++++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 45556666 58988765 4567889986532 2346788999887764 3335678888888899999999999987
Q ss_pred hhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 009208 385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC------------------------------------------ 422 (540)
Q Consensus 385 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------------ 422 (540)
+.+..... ......+..++++.|..||...
T Consensus 107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 76654321 1123345566666666666421
Q ss_pred -------------CCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 423 -------------DPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 423 -------------~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
.+.++|+|+++.||++++++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12489999999999999877777999998863
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=2.5e-06 Score=85.40 Aligned_cols=81 Identities=9% Similarity=-0.048 Sum_probs=54.4
Q ss_pred Cee-eeccCccEEEEEeC-------CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccC---CCccceeEEEecC---
Q 009208 307 NIL-GRGGFGIVYKGCFS-------DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVH---RNLLRLCGFCSTE--- 370 (540)
Q Consensus 307 ~~l-G~G~~g~Vy~~~~~-------~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~--- 370 (540)
+.| +.|....+|+.... ++..+++|....... ......+.+|.++++.+.. -.+.+++.++...
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 556 78888999998764 267888998654320 0011346778888877642 3466777777654
Q ss_pred CeeEEEEecCCCCChhh
Q 009208 371 NERLLVYPYMPNGSVAS 387 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~ 387 (540)
+..++||||++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35789999999877654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.18 E-value=1.9e-07 Score=100.31 Aligned_cols=103 Identities=11% Similarity=0.131 Sum_probs=61.6
Q ss_pred EEEecCCCCC-Ccc-ccCccccCCCccCEEEcccCCCCCC----CCcccCCCCcccEEEeeCCCCc----ccCCccccCC
Q 009208 76 VSALGLPSQS-LSG-TLSPWIGNLTKLQSVLLQNNAILGP----IPASLGKLEKLQTLDLSNNKFT----GEIPDSLGDL 145 (540)
Q Consensus 76 l~~l~l~~~~-l~~-~~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~----~~~p~~~~~l 145 (540)
++.|+|++|. ++. .++....++++|++|+|++|.+++. ++..+.++++|++|+|++|+++ +.++..+.++
T Consensus 140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~ 219 (592)
T 3ogk_B 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNC 219 (592)
T ss_dssp CCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHC
T ss_pred CcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhC
Confidence 7777777665 111 1222233567777777777776654 2333455667777777777775 2344445566
Q ss_pred CCcchhhccCccCCCCCCccccCCccccEEeccc
Q 009208 146 GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSY 179 (540)
Q Consensus 146 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 179 (540)
++|+.|+|++|.+.+ +|..+..+++|+.|+++.
T Consensus 220 ~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 220 RSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp TTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred CCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 777777777777663 555566666666666654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.11 E-value=6.7e-07 Score=95.92 Aligned_cols=106 Identities=14% Similarity=0.070 Sum_probs=75.5
Q ss_pred CcEEEecCCCCCCccc----cCccccCCCccCEEEcccCCCCC----CCCcccCCCCcccEEEeeCCCCcccCCccccCC
Q 009208 74 GYVSALGLPSQSLSGT----LSPWIGNLTKLQSVLLQNNAILG----PIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDL 145 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~----~~~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 145 (540)
.+++.|+|++|.+++. ++..+.++++|++|+|++|.+++ .++..+.++++|+.|+|++|.+. .+|..+.++
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~-~l~~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL-ELVGFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGG-GGHHHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHH-HHHHHHhhh
Confidence 4789999999988765 44456678899999999999873 33445567889999999999888 477778888
Q ss_pred CCcchhhccCccCC---CCCCccccCCccccEEecccC
Q 009208 146 GNLNYLRLNNNSLT---GSCPESLSKIESLTLVDLSYN 180 (540)
Q Consensus 146 ~~L~~L~l~~N~l~---~~~p~~~~~l~~L~~L~l~~N 180 (540)
++|++|+++++... +..+..+..+++|+.|+++++
T Consensus 243 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 280 (592)
T 3ogk_B 243 ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYM 280 (592)
T ss_dssp TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTC
T ss_pred hHHHhhcccccccccchHHHHHHhhccccccccCcccc
Confidence 88888888753322 223344555566666666554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.11 E-value=1.6e-05 Score=78.68 Aligned_cols=141 Identities=17% Similarity=0.214 Sum_probs=79.6
Q ss_pred CeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhccc-----CCCcccee-E--EEecCCeeEEEEe
Q 009208 307 NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-----HRNLLRLC-G--FCSTENERLLVYP 378 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~l~-~--~~~~~~~~~lV~e 378 (540)
+.++.|..+.||+....+| .+++|+.... ..+...|.+++..+. .|.++... | +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 3456677899999987555 5889988652 123334455444432 23333311 1 1234667899999
Q ss_pred cCCCCChh--------------hhccccCCCC----------CCCCHHHHH-----------------------------
Q 009208 379 YMPNGSVA--------------SRLRDHIHGR----------PALDWARRK----------------------------- 405 (540)
Q Consensus 379 ~~~~gsL~--------------~~l~~~~~~~----------~~l~~~~~~----------------------------- 405 (540)
|++|.++. ..+|...... ..-.|....
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99987653 0122111100 012332211
Q ss_pred --HHHHHHHHHHHHHHh----------cCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 406 --RIALGTARGLLYLHE----------QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 406 --~i~~~ia~~l~~LH~----------~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
.+...+.+++.+|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666653 124589999999999999888899999999875
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.08 E-value=1.9e-07 Score=84.28 Aligned_cols=96 Identities=22% Similarity=0.237 Sum_probs=77.3
Q ss_pred ccCccccCCCccCEEEcccC-CCCCC----CCcccCCCCcccEEEeeCCCCcc----cCCccccCCCCcchhhccCccCC
Q 009208 89 TLSPWIGNLTKLQSVLLQNN-AILGP----IPASLGKLEKLQTLDLSNNKFTG----EIPDSLGDLGNLNYLRLNNNSLT 159 (540)
Q Consensus 89 ~~~~~~~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~ 159 (540)
.+...+...++|++|+|++| .|... +...+...++|++|+|++|+|.. .+...+...++|++|+|++|.|+
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 45566778899999999999 88742 34456778999999999999973 24455667789999999999998
Q ss_pred CC----CCccccCCccccEEec--ccCcccc
Q 009208 160 GS----CPESLSKIESLTLVDL--SYNNLSG 184 (540)
Q Consensus 160 ~~----~p~~~~~l~~L~~L~l--~~N~l~~ 184 (540)
.. +...+...++|+.|+| ++|.|+.
T Consensus 107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~ 137 (185)
T 1io0_A 107 GSGILALVEALQSNTSLIELRIDNQSQPLGN 137 (185)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCCCCCH
Confidence 53 4567788889999999 8899984
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.01 E-value=4.5e-07 Score=90.73 Aligned_cols=107 Identities=15% Similarity=0.208 Sum_probs=70.1
Q ss_pred CcEEEecCCCCC-CccccCccccCCCccCEEEcccCCCCCCCCcccC--CCCcccEEEeeC--CCCccc-----CCccc-
Q 009208 74 GYVSALGLPSQS-LSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLG--KLEKLQTLDLSN--NKFTGE-----IPDSL- 142 (540)
Q Consensus 74 ~~l~~l~l~~~~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~ls~--N~l~~~-----~p~~~- 142 (540)
.+++.|+|++|. + .+++ +. +++|+.|+|..|.++......+. .+++|+.|+|+. |...+. +...+
T Consensus 172 P~L~~L~L~g~~~l--~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~ 247 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL--SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247 (362)
T ss_dssp TTCCEEEEECCBTC--BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred CCCcEEEEeCCCCc--eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence 479999998873 3 2333 43 78899999988877633222333 688899998863 222111 11222
Q ss_pred -cCCCCcchhhccCccCCCCCCcccc---CCccccEEecccCcccc
Q 009208 143 -GDLGNLNYLRLNNNSLTGSCPESLS---KIESLTLVDLSYNNLSG 184 (540)
Q Consensus 143 -~~l~~L~~L~l~~N~l~~~~p~~~~---~l~~L~~L~l~~N~l~~ 184 (540)
..+++|+.|+|++|.+.+..+..+. .+++|+.|+|+.|.|++
T Consensus 248 ~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence 2478899999998888743333332 47889999999998875
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.01 E-value=1.8e-07 Score=100.52 Aligned_cols=127 Identities=12% Similarity=0.092 Sum_probs=84.5
Q ss_pred CcEEEecCCCCCCccccCcccc-CCCccCEEEcc--c----CCCCCCC-----CcccCCCCcccEEEeeCCCCcccCCcc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIG-NLTKLQSVLLQ--N----NAILGPI-----PASLGKLEKLQTLDLSNNKFTGEIPDS 141 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~-~l~~L~~L~l~--~----N~l~~~~-----p~~~~~l~~L~~L~ls~N~l~~~~p~~ 141 (540)
.+++.|++..|++++.....+. ++++|+.|+|+ + |.++... +..+.++++|+.|+|++ ++++..+..
T Consensus 372 ~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~ 450 (594)
T 2p1m_B 372 PKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEY 450 (594)
T ss_dssp TTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHH
T ss_pred hhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHH
Confidence 3678888888888876666665 58888898888 3 5565221 11256678888888876 666555555
Q ss_pred ccC-CCCcchhhccCccCCCCCCccc-cCCccccEEecccCcccccCCC-C-----CcccccccCCCC
Q 009208 142 LGD-LGNLNYLRLNNNSLTGSCPESL-SKIESLTLVDLSYNNLSGSLPK-I-----SARTFKVTGNPL 201 (540)
Q Consensus 142 ~~~-l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~-~-----~~~~~~~~~n~~ 201 (540)
+.. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|++++..+. + ..+.+++++|+.
T Consensus 451 l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 451 IGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 555 7888888888888865444444 5678888888888888643221 1 114566777654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.98 E-value=1.7e-07 Score=100.67 Aligned_cols=126 Identities=17% Similarity=0.223 Sum_probs=87.9
Q ss_pred CcEEEecC---------CCCCCccccCcccc-CCCccCEEEcccCCCCCCCCcccC-CCCcccEEEee--C----CCCcc
Q 009208 74 GYVSALGL---------PSQSLSGTLSPWIG-NLTKLQSVLLQNNAILGPIPASLG-KLEKLQTLDLS--N----NKFTG 136 (540)
Q Consensus 74 ~~l~~l~l---------~~~~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~ls--~----N~l~~ 136 (540)
.+++.|+| +.+.+++.....+. ++++|+.|+++.|.+++..+..+. .+++|+.|+|+ + |+++
T Consensus 338 ~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~- 416 (594)
T 2p1m_B 338 KDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT- 416 (594)
T ss_dssp TTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT-
T ss_pred CCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc-
Confidence 46888888 44566644333333 488999999999999865555554 58899999999 4 6666
Q ss_pred cCC------ccccCCCCcchhhccCccCCCCCCccccC-CccccEEecccCcccccCCC-C-----CcccccccCCCC
Q 009208 137 EIP------DSLGDLGNLNYLRLNNNSLTGSCPESLSK-IESLTLVDLSYNNLSGSLPK-I-----SARTFKVTGNPL 201 (540)
Q Consensus 137 ~~p------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p~-~-----~~~~~~~~~n~~ 201 (540)
..| ..+..+++|+.|+|++ .+++..+..+.. +++|+.|++++|.+++..+. + ..+.+++++|++
T Consensus 417 ~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 417 LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred CCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 222 2366789999999977 666554455555 88999999999998753221 1 126678888886
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=3e-05 Score=78.68 Aligned_cols=76 Identities=12% Similarity=0.064 Sum_probs=48.8
Q ss_pred CCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc------cccHHHHHHHHHHHhcccC--CCcc-ceeEEEecCCeeEE
Q 009208 306 KNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI------AGGEVQFQTEVETISLAVH--RNLL-RLCGFCSTENERLL 375 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h--~nIv-~l~~~~~~~~~~~l 375 (540)
.+.+|.|..+.||++... +++.++||....... .....++..|.+++..+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357899999999999764 468899998653221 1122356778888877642 3333 44443 3455789
Q ss_pred EEecCCCC
Q 009208 376 VYPYMPNG 383 (540)
Q Consensus 376 V~e~~~~g 383 (540)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.84 E-value=0.00013 Score=71.13 Aligned_cols=139 Identities=17% Similarity=0.150 Sum_probs=92.6
Q ss_pred CCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhccc---CCCccceeEEEecCCeeEEEEecCCC
Q 009208 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV---HRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
.+.|+.|....+|+... ++..+++|+.... ....+..|.+.++.+. ...+.+++.++...+..++||||+++
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 45789999999999887 5678889986542 2456888988888774 35677888888888889999999999
Q ss_pred CChhh-----------hccccCC-C-----------------CCCCCHHHHH---HHHH----------------HHHHH
Q 009208 383 GSVAS-----------RLRDHIH-G-----------------RPALDWARRK---RIAL----------------GTARG 414 (540)
Q Consensus 383 gsL~~-----------~l~~~~~-~-----------------~~~l~~~~~~---~i~~----------------~ia~~ 414 (540)
..+.. .||.... . .-.-+|.... ++.. .+.+.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 86532 1232211 0 0012465432 1111 11111
Q ss_pred -HHHHHh-cCCCCeEecCCCCCceeeCCCCCeEEcccc
Q 009208 415 -LLYLHE-QCDPKIIHRDVKAANILLDEDFEAVVGDFG 450 (540)
Q Consensus 415 -l~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 450 (540)
...|.. ...+.++|+|+.+.|++++.++ +.|+|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123321 2357899999999999999887 8999984
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.76 E-value=3.2e-05 Score=78.52 Aligned_cols=104 Identities=13% Similarity=0.129 Sum_probs=75.8
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCc-----ccCCccccCCCCcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT-----GEIPDSLGDLGNLN 149 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-----~~~p~~~~~l~~L~ 149 (540)
.++.|+|+++ ++..-..+|.+ .+|+.+.| .|.++..-+..|.++++|+.+++.+|.+. ..-+..|.++++|+
T Consensus 227 ~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~ 303 (401)
T 4fdw_A 227 QLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLA 303 (401)
T ss_dssp TCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCC
T ss_pred CCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCC
Confidence 5777888764 55444566766 78888888 45566555678888889999998888765 23445688888888
Q ss_pred hhhccCccCCCCCCccccCCccccEEecccCccc
Q 009208 150 YLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183 (540)
Q Consensus 150 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 183 (540)
.++|.+ .++..-..+|.++++|+.+.+..| ++
T Consensus 304 ~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~ 335 (401)
T 4fdw_A 304 RFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VT 335 (401)
T ss_dssp EECCCT-TCCEECTTTTTTCCSCCEEEECTT-CC
T ss_pred eEEeCC-ceEEEhhhhhcCCCCccEEEECcc-cc
Confidence 888884 466445567888888888888655 44
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.75 E-value=4.1e-06 Score=73.96 Aligned_cols=82 Identities=15% Similarity=0.150 Sum_probs=38.2
Q ss_pred ccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCC-CcccCCccccCC----CCcchhhccCcc-CCCCCCccccCCccc
Q 009208 99 KLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNK-FTGEIPDSLGDL----GNLNYLRLNNNS-LTGSCPESLSKIESL 172 (540)
Q Consensus 99 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~p~~~~~l~~L 172 (540)
+|+.|||+++.|+..--..+.++++|++|+|++|. |+..--..+..+ ++|++|+|+++. ++..--..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 35555555555443322334455555555555553 442211223332 245555555543 443222234455666
Q ss_pred cEEecccC
Q 009208 173 TLVDLSYN 180 (540)
Q Consensus 173 ~~L~l~~N 180 (540)
+.|+++++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 66666655
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00023 Score=72.77 Aligned_cols=79 Identities=13% Similarity=0.073 Sum_probs=46.7
Q ss_pred CCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCceeecc-ccccccccccccccC---CCCccCCeehhhHHHHH
Q 009208 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAV-RGTVGHIAPEYLSTG---QSSEKTDVFGFGILLLE 498 (540)
Q Consensus 423 ~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~k~Dv~S~Gvil~e 498 (540)
.+.++|||+++.||+++.++ ++++||+.+..-... ....... .-...|++|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 45899999999999999776 999999988642211 0000000 012346666654311 11223445567777777
Q ss_pred HHhCC
Q 009208 499 LITGQ 503 (540)
Q Consensus 499 lltg~ 503 (540)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 76654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00011 Score=70.82 Aligned_cols=78 Identities=18% Similarity=0.224 Sum_probs=54.8
Q ss_pred CCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCC---CccceeEEEecCCeeEEEEec
Q 009208 303 FSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR---NLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 303 ~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~~~~~lV~e~ 379 (540)
....+.+|.|..+.||+.++.+|+.|.+|+..... ......|..|.+.|+.+.-. -+.+++++ +..++||||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 44457789999999999999999999999865432 22233578899888877422 23344443 234789999
Q ss_pred CCCCCh
Q 009208 380 MPNGSV 385 (540)
Q Consensus 380 ~~~gsL 385 (540)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987754
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.55 E-value=1.3e-05 Score=70.83 Aligned_cols=86 Identities=15% Similarity=0.148 Sum_probs=66.4
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCC-CCCCCCcccCCC----CcccEEEeeCCC-CcccCCccccCCCC
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNA-ILGPIPASLGKL----EKLQTLDLSNNK-FTGEIPDSLGDLGN 147 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~L~~L~ls~N~-l~~~~p~~~~~l~~ 147 (540)
-+++.|||+++.|+..--..+.++++|+.|+|+++. |+..--..+..+ ++|++|+|++|. |+..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 379999999999886545667899999999999985 664322345554 479999999985 87433345778999
Q ss_pred cchhhccCcc-CC
Q 009208 148 LNYLRLNNNS-LT 159 (540)
Q Consensus 148 L~~L~l~~N~-l~ 159 (540)
|++|+|+++. ++
T Consensus 141 L~~L~L~~c~~It 153 (176)
T 3e4g_A 141 LKYLFLSDLPGVK 153 (176)
T ss_dssp CCEEEEESCTTCC
T ss_pred CCEEECCCCCCCC
Confidence 9999999975 44
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.53 E-value=1.3e-05 Score=80.03 Aligned_cols=125 Identities=14% Similarity=0.177 Sum_probs=81.4
Q ss_pred CcEEEecCCCCCCc---------cccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCcccc-
Q 009208 74 GYVSALGLPSQSLS---------GTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLG- 143 (540)
Q Consensus 74 ~~l~~l~l~~~~l~---------~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~- 143 (540)
.+++.|.+.++... +.++..+..+++|+.|+|++|.-. .+|. + .+++|+.|+|..|.++......+.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~ 215 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILG 215 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHH
Confidence 47888888655331 234455677899999999988312 2343 4 389999999999988744334444
Q ss_pred -CCCCcchhhccC--ccCCCC-----CCccc--cCCccccEEecccCcccccCC-------CC-CcccccccCCCC
Q 009208 144 -DLGNLNYLRLNN--NSLTGS-----CPESL--SKIESLTLVDLSYNNLSGSLP-------KI-SARTFKVTGNPL 201 (540)
Q Consensus 144 -~l~~L~~L~l~~--N~l~~~-----~p~~~--~~l~~L~~L~l~~N~l~~~~p-------~~-~~~~~~~~~n~~ 201 (540)
.+++|+.|+|+. |...+. +...+ ..+++|++|+|++|.+++..+ .. ..+.++++.|.+
T Consensus 216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L 291 (362)
T 2ra8_A 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL 291 (362)
T ss_dssp SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCC
T ss_pred ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCC
Confidence 789999999863 332221 11122 257899999999999874321 11 125677777765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00035 Score=67.84 Aligned_cols=71 Identities=8% Similarity=0.022 Sum_probs=43.8
Q ss_pred CCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCcc-ceeEEEecCCeeEEEEecC-CCC
Q 009208 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL-RLCGFCSTENERLLVYPYM-PNG 383 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~lV~e~~-~~g 383 (540)
.+.++.|....+|+. ..+++|+........ ....+|..+++.+....+. +++++ ..+..++|+||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~--~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY--INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C--CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce--eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 577889999999998 568888876432110 1234677777666433333 44443 344457899999 554
Q ss_pred Ch
Q 009208 384 SV 385 (540)
Q Consensus 384 sL 385 (540)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00017 Score=73.21 Aligned_cols=106 Identities=13% Similarity=0.076 Sum_probs=86.6
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCC-----CCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAIL-----GPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLN 149 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~-----~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~ 149 (540)
.++.+.| .++++..-+..|.++++|+.+++.+|.+. ...+..|.++++|+.++|. |+++..-...|.++++|+
T Consensus 249 ~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~ 326 (401)
T 4fdw_A 249 GITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVT 326 (401)
T ss_dssp CCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCC
T ss_pred CccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCcc
Confidence 5788888 45577566789999999999999998875 3456789999999999999 558844456799999999
Q ss_pred hhhccCccCCCCCCccccCCccccEEecccCcccc
Q 009208 150 YLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184 (540)
Q Consensus 150 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 184 (540)
.++|.+| ++..-+.+|.++ +|+.|++++|.+..
T Consensus 327 ~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~ 359 (401)
T 4fdw_A 327 QLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQ 359 (401)
T ss_dssp EEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCB
T ss_pred EEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcc
Confidence 9999665 664556789999 99999999997763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0022 Score=62.89 Aligned_cols=159 Identities=16% Similarity=0.105 Sum_probs=89.0
Q ss_pred cCHHHHHHHhcCCCc-----CCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCC--ccce
Q 009208 291 YTFKELRAATSNFSA-----KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN--LLRL 363 (540)
Q Consensus 291 ~~~~~l~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l 363 (540)
.+.+++....+.|.. ...++ |....||+....+|+.+++|...... .....+..|..++..+.... +.++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~~~g~~vp~~ 87 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAP 87 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHHHcCCeecce
Confidence 344444444444432 23466 88889999887778789999986432 12345667777777664222 3344
Q ss_pred eEE-----EecCCeeEEEEecCCCCChhh----h----------ccccCC-----CCCCCCHHHH----HHH--------
Q 009208 364 CGF-----CSTENERLLVYPYMPNGSVAS----R----------LRDHIH-----GRPALDWARR----KRI-------- 407 (540)
Q Consensus 364 ~~~-----~~~~~~~~lV~e~~~~gsL~~----~----------l~~~~~-----~~~~l~~~~~----~~i-------- 407 (540)
+.. ....+..+++++|++|.++.. . +|.... .....++... ..+
T Consensus 88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 167 (328)
T 1zyl_A 88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP 167 (328)
T ss_dssp CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence 432 122456678999998865421 0 111110 1112333221 001
Q ss_pred -------HHHHHHHHHHHHhc----CCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 408 -------ALGTARGLLYLHEQ----CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 408 -------~~~ia~~l~~LH~~----~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
...+.+.++.+... ....++|||+++.||+++ + .+.|+||+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333221 234689999999999999 4 899999987753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.002 Score=62.99 Aligned_cols=159 Identities=11% Similarity=0.041 Sum_probs=87.4
Q ss_pred cCHHHHHHHhcCCCcC-----CeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCC--ccce
Q 009208 291 YTFKELRAATSNFSAK-----NILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRN--LLRL 363 (540)
Q Consensus 291 ~~~~~l~~~~~~~~~~-----~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l 363 (540)
++.+++......|... +.++.|....+|+....+| .+++|...... ...++..|.+++..+.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 4455555555556542 3456688889999987655 67889876521 1123556676666553222 2233
Q ss_pred eEE------EecCCeeEEEEecCCCCChhhh--------------ccccCCC---C-----CCCCHHHHHH---------
Q 009208 364 CGF------CSTENERLLVYPYMPNGSVASR--------------LRDHIHG---R-----PALDWARRKR--------- 406 (540)
Q Consensus 364 ~~~------~~~~~~~~lV~e~~~~gsL~~~--------------l~~~~~~---~-----~~l~~~~~~~--------- 406 (540)
+.. ....+..+++++|++|..+... +|..... . ....|.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 1224567899999998654320 2211110 0 0012332111
Q ss_pred ---HHHHHHHHHHHHHhc----CCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 407 ---IALGTARGLLYLHEQ----CDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 407 ---i~~~ia~~l~~LH~~----~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
+...+.+.+++++.. ....++|+|+++.||+++++..+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455566532 23479999999999999987556899998775
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.22 E-value=2e-05 Score=70.87 Aligned_cols=109 Identities=18% Similarity=0.195 Sum_probs=58.1
Q ss_pred CcEEEecCCCC-CCcc----ccCccccCCCccCEEEcccCCCCCC----CCcccCCCCcccEEEeeCCCCccc----CCc
Q 009208 74 GYVSALGLPSQ-SLSG----TLSPWIGNLTKLQSVLLQNNAILGP----IPASLGKLEKLQTLDLSNNKFTGE----IPD 140 (540)
Q Consensus 74 ~~l~~l~l~~~-~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~----~p~ 140 (540)
..++.|+|++| .|.. .+-..+..-++|+.|+|++|+|... +-+.+..-+.|+.|+|++|+|+.. +-+
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 35667777764 5542 2334455556677777777776631 222333456677777777776521 223
Q ss_pred cccCCCCcchhhccCcc---CCC----CCCccccCCccccEEecccCcc
Q 009208 141 SLGDLGNLNYLRLNNNS---LTG----SCPESLSKIESLTLVDLSYNNL 182 (540)
Q Consensus 141 ~~~~l~~L~~L~l~~N~---l~~----~~p~~~~~l~~L~~L~l~~N~l 182 (540)
.+..-+.|++|+|++|. +.. .+...+..-++|+.|+++.|.+
T Consensus 121 aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 34444566666666542 221 1223344445666666665543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00042 Score=58.09 Aligned_cols=56 Identities=20% Similarity=0.274 Sum_probs=30.6
Q ss_pred EecCCCCCCc-cccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCc
Q 009208 78 ALGLPSQSLS-GTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFT 135 (540)
Q Consensus 78 ~l~l~~~~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 135 (540)
.++.++++|+ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555566664 23443321 24666666666666444445555666666666666543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00044 Score=57.98 Aligned_cols=55 Identities=22% Similarity=0.245 Sum_probs=25.9
Q ss_pred EEEcccCCCC-CCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccC
Q 009208 102 SVLLQNNAIL-GPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSL 158 (540)
Q Consensus 102 ~L~l~~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 158 (540)
.++.+++.++ ..+|..+. ++|++|+|++|+|+..-+..|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 5566666654 23443322 2455556666655522222344444444444444443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0019 Score=66.07 Aligned_cols=72 Identities=18% Similarity=0.230 Sum_probs=48.8
Q ss_pred CeeeeccCccEEEEEeCC--------CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCc-cceeEEEecCCeeEEEE
Q 009208 307 NILGRGGFGIVYKGCFSD--------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL-LRLCGFCSTENERLLVY 377 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~ 377 (540)
+.|+.|....||+....+ +..+++|+.... .....+.+|..++..+...++ .++++.+. + .+|+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 567788889999998753 578999987432 111355678888887754444 45666543 2 3899
Q ss_pred ecCCCCCh
Q 009208 378 PYMPNGSV 385 (540)
Q Consensus 378 e~~~~gsL 385 (540)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0014 Score=64.50 Aligned_cols=142 Identities=15% Similarity=0.038 Sum_probs=71.7
Q ss_pred CeeeeccCcc-EEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccC--CCccceeEEEecCCeeEEEEecCCCC
Q 009208 307 NILGRGGFGI-VYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH--RNLLRLCGFCSTENERLLVYPYMPNG 383 (540)
Q Consensus 307 ~~lG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lV~e~~~~g 383 (540)
+.++.|+... +|+....+|..+++|....... ..+..|++++..+.. -.+.+++.+....+ +++||++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 3455555444 6677654477777776543211 123445565555532 23445666543333 7899999776
Q ss_pred Chhhhccc---------------------cCC-CCCCCCHHHHH--------------------HHHHHHHHHHHHHHh-
Q 009208 384 SVASRLRD---------------------HIH-GRPALDWARRK--------------------RIALGTARGLLYLHE- 420 (540)
Q Consensus 384 sL~~~l~~---------------------~~~-~~~~l~~~~~~--------------------~i~~~ia~~l~~LH~- 420 (540)
.+.+++.. ... ..+.++..... .....+.+.+..+..
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 66443321 000 01112221110 000111222233311
Q ss_pred --cCCCCeEecCCCCCceeeCCC----CCeEEcccccccc
Q 009208 421 --QCDPKIIHRDVKAANILLDED----FEAVVGDFGLAKL 454 (540)
Q Consensus 421 --~~~~~ivH~Dlk~~NILl~~~----~~~kl~Dfgla~~ 454 (540)
...+.++|||+++.||+++.+ ..+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 124589999999999999874 6789999998864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0041 Score=62.23 Aligned_cols=141 Identities=14% Similarity=0.175 Sum_probs=82.8
Q ss_pred CeeeeccCccEEEEEeC--------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCc-cceeEEEecCCeeEEEE
Q 009208 307 NILGRGGFGIVYKGCFS--------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL-LRLCGFCSTENERLLVY 377 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~ 377 (540)
+.+..|-...+|+.... +++.+.+|+.... ........+|.++++.+....+ .++++++.+ .+|+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 45667888899998874 2478999986331 2234456789998887753333 455665543 2999
Q ss_pred ecCCCCChhhh-----------------cccc-CCCCCCC--CHHHHHHHHHHHHH-------------------HHHHH
Q 009208 378 PYMPNGSVASR-----------------LRDH-IHGRPAL--DWARRKRIALGTAR-------------------GLLYL 418 (540)
Q Consensus 378 e~~~~gsL~~~-----------------l~~~-~~~~~~l--~~~~~~~i~~~ia~-------------------~l~~L 418 (540)
||++|.++..- ||.. ....... -|.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998665421 1111 1111122 24555555444322 23333
Q ss_pred H----h-cCCCCeEecCCCCCceeeCCC----CCeEEccccccc
Q 009208 419 H----E-QCDPKIIHRDVKAANILLDED----FEAVVGDFGLAK 453 (540)
Q Consensus 419 H----~-~~~~~ivH~Dlk~~NILl~~~----~~~kl~Dfgla~ 453 (540)
. . .....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 2 123478999999999999876 789999999876
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.003 Score=63.08 Aligned_cols=73 Identities=7% Similarity=-0.027 Sum_probs=42.9
Q ss_pred CeeeeccCccEEEEEeCC---------CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCc-cceeEEEecCCeeEEE
Q 009208 307 NILGRGGFGIVYKGCFSD---------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL-LRLCGFCSTENERLLV 376 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV 376 (540)
+.++.|....+|+....+ +..+++|+....... ......|.+++..+...++ .++++.. . .++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 457778888999988754 268888987543211 1123567777776643333 3555543 2 3689
Q ss_pred EecCCCCCh
Q 009208 377 YPYMPNGSV 385 (540)
Q Consensus 377 ~e~~~~gsL 385 (540)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0083 Score=61.62 Aligned_cols=73 Identities=14% Similarity=0.110 Sum_probs=46.4
Q ss_pred CeeeeccCccEEEEEeCC-CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCc-cceeEEEecCCeeEEEEecCCCCC
Q 009208 307 NILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL-LRLCGFCSTENERLLVYPYMPNGS 384 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~e~~~~gs 384 (540)
+.|+.|-...+|+....+ +..+++|+..... .. ...-.+|..++..+...++ .++++.+. + .+|+||++|.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 567888889999998865 4788899874322 11 1112578888887765555 45666652 2 35999999755
Q ss_pred h
Q 009208 385 V 385 (540)
Q Consensus 385 L 385 (540)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.68 E-value=0.00021 Score=64.28 Aligned_cols=91 Identities=14% Similarity=0.149 Sum_probs=68.1
Q ss_pred cCccccCCCccCEEEcccC-CCCCC----CCcccCCCCcccEEEeeCCCCcc----cCCccccCCCCcchhhccCccCCC
Q 009208 90 LSPWIGNLTKLQSVLLQNN-AILGP----IPASLGKLEKLQTLDLSNNKFTG----EIPDSLGDLGNLNYLRLNNNSLTG 160 (540)
Q Consensus 90 ~~~~~~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~ 160 (540)
+...+.+-+.|++|+|++| +|... +-+.+..-+.|+.|+|++|+|.. .+.+.+..-+.|+.|+|++|+|..
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 3344556688999999986 77631 33456677899999999999973 344556677899999999999984
Q ss_pred C----CCccccCCccccEEecccC
Q 009208 161 S----CPESLSKIESLTLVDLSYN 180 (540)
Q Consensus 161 ~----~p~~~~~l~~L~~L~l~~N 180 (540)
. +-..+..-+.|+.|+|++|
T Consensus 113 ~Ga~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 113 ELLARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHHHHHhhCCceeEEECCCC
Confidence 2 3345666778999999875
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0029 Score=63.86 Aligned_cols=87 Identities=15% Similarity=0.177 Sum_probs=46.1
Q ss_pred ccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCcc
Q 009208 92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIES 171 (540)
Q Consensus 92 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 171 (540)
..|.++++|+.+.+. +.++..-...|.++.+|+.++|.+| ++..-...|.++++|+.+.+..+ ++..-..+|.++++
T Consensus 282 ~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~ 358 (394)
T 4gt6_A 282 GAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTA 358 (394)
T ss_dssp TTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTT
T ss_pred cccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCC
Confidence 445555566666554 3333233445666666666666543 44222344666666666666443 44233345666666
Q ss_pred ccEEecccCc
Q 009208 172 LTLVDLSYNN 181 (540)
Q Consensus 172 L~~L~l~~N~ 181 (540)
|+.+++.+|.
T Consensus 359 L~~i~~~~~~ 368 (394)
T 4gt6_A 359 LNNIEYSGSR 368 (394)
T ss_dssp CCEEEESSCH
T ss_pred CCEEEECCce
Confidence 6666666553
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.017 Score=56.88 Aligned_cols=32 Identities=22% Similarity=0.339 Sum_probs=28.0
Q ss_pred CCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 423 ~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34799999999999999888899999987763
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0029 Score=63.38 Aligned_cols=101 Identities=14% Similarity=0.108 Sum_probs=53.6
Q ss_pred EEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccC
Q 009208 76 VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155 (540)
Q Consensus 76 l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 155 (540)
++.+.+..+ +...-...+.+++.|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-...|.++++|+.+.+.+
T Consensus 219 l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~ 295 (379)
T 4h09_A 219 LKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDN 295 (379)
T ss_dssp CSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECC
T ss_pred cceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccc
Confidence 444444332 33233445566666666666554 34333445566666666666543 4422233455666666666666
Q ss_pred ccCCCCCCccccCCccccEEeccc
Q 009208 156 NSLTGSCPESLSKIESLTLVDLSY 179 (540)
Q Consensus 156 N~l~~~~p~~~~~l~~L~~L~l~~ 179 (540)
|.++..-..+|.++.+|+.+.|..
T Consensus 296 ~~i~~I~~~aF~~c~~L~~i~lp~ 319 (379)
T 4h09_A 296 SAIETLEPRVFMDCVKLSSVTLPT 319 (379)
T ss_dssp TTCCEECTTTTTTCTTCCEEECCT
T ss_pred cccceehhhhhcCCCCCCEEEcCc
Confidence 665533344566666666666653
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0028 Score=63.96 Aligned_cols=87 Identities=14% Similarity=0.054 Sum_probs=69.5
Q ss_pred CccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCc
Q 009208 91 SPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIE 170 (540)
Q Consensus 91 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 170 (540)
...|..+++|+.+.+.++ ++..-..+|.++++|+.++|.++ ++..-...|.++++|+.+++..| ++..-..+|.+++
T Consensus 290 ~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~ 366 (394)
T 4fs7_A 290 EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCI 366 (394)
T ss_dssp TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCT
T ss_pred cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCC
Confidence 356788999999999766 66455678999999999999755 77344567999999999999877 6644567899999
Q ss_pred cccEEecccC
Q 009208 171 SLTLVDLSYN 180 (540)
Q Consensus 171 ~L~~L~l~~N 180 (540)
+|+.+++..|
T Consensus 367 ~L~~i~lp~~ 376 (394)
T 4fs7_A 367 NLKKVELPKR 376 (394)
T ss_dssp TCCEEEEEGG
T ss_pred CCCEEEECCC
Confidence 9999999765
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=96.21 E-value=0.0036 Score=63.11 Aligned_cols=103 Identities=10% Similarity=0.155 Sum_probs=69.3
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
.++.+.++ +.++..-...|.++++|+.++|..| ++..-..+|.++++|+.+.|..+ ++..-...|.++++|+.+++.
T Consensus 289 ~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~ 365 (394)
T 4gt6_A 289 ALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYS 365 (394)
T ss_dssp TCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEES
T ss_pred ccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEEC
Confidence 35555554 3455444568999999999999865 66455678999999999999765 773334569999999999999
Q ss_pred CccCCCCCCccccCCccccEEecccCccc
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS 183 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 183 (540)
+|.... ..+....+|+.+.+..|.+.
T Consensus 366 ~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 366 GSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp SCHHHH---HTCBCCCCC-----------
T ss_pred Cceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 987542 45777888999988877654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=95.89 E-value=0.0076 Score=60.72 Aligned_cols=102 Identities=12% Similarity=0.104 Sum_probs=76.9
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
.++.+.+..+..+ .-...|.++..|+.+.+..+.+. ...|..+.+|+.+.+.++ ++..-...|.++++|+.++|.
T Consensus 254 ~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp 328 (394)
T 4fs7_A 254 DLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLP 328 (394)
T ss_dssp SCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCC
T ss_pred cceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeC
Confidence 4555556555333 55677888999999988877544 357889999999999876 663445568999999999997
Q ss_pred CccCCCCCCccccCCccccEEecccCccc
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLS 183 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 183 (540)
++ ++..-..+|.++++|+.+.+..| ++
T Consensus 329 ~~-v~~I~~~aF~~c~~L~~i~lp~~-l~ 355 (394)
T 4fs7_A 329 YL-VEEIGKRSFRGCTSLSNINFPLS-LR 355 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCCTT-CC
T ss_pred Cc-ccEEhHHhccCCCCCCEEEECcc-cc
Confidence 55 66344678999999999999876 55
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=95.09 E-value=0.035 Score=55.31 Aligned_cols=88 Identities=13% Similarity=0.053 Sum_probs=37.9
Q ss_pred cccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccc
Q 009208 93 WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESL 172 (540)
Q Consensus 93 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 172 (540)
.+...++|+.+.+..+ +.......|.++..|+.+.+..+ ++..-...|.++.+|+.+.+..+ +...-...|.++++|
T Consensus 212 ~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L 288 (379)
T 4h09_A 212 GFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL 288 (379)
T ss_dssp TTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred ccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccc
Confidence 3444445555554433 22123334445555555555443 33122233444555555554332 221222344455555
Q ss_pred cEEecccCccc
Q 009208 173 TLVDLSYNNLS 183 (540)
Q Consensus 173 ~~L~l~~N~l~ 183 (540)
+.+.+.+|.++
T Consensus 289 ~~i~l~~~~i~ 299 (379)
T 4h09_A 289 TKVVMDNSAIE 299 (379)
T ss_dssp CEEEECCTTCC
T ss_pred ccccccccccc
Confidence 55555544444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.82 E-value=0.073 Score=53.90 Aligned_cols=140 Identities=9% Similarity=0.067 Sum_probs=82.4
Q ss_pred CeeeeccCccEEEEEeCC--------CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCc-cceeEEEecCCeeEEEE
Q 009208 307 NILGRGGFGIVYKGCFSD--------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL-LRLCGFCSTENERLLVY 377 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~ 377 (540)
+.+..|-...+|+....+ +..+++|+..... .......+|.++++.+...++ .++++.+ . .++|+
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 456678888999998753 5789999864422 111123567777776643333 3455433 2 37899
Q ss_pred ecCCCCChhhh-----------------cccc-C-----C---CCCCCCHHHHHHHHHHH-------------------H
Q 009208 378 PYMPNGSVASR-----------------LRDH-I-----H---GRPALDWARRKRIALGT-------------------A 412 (540)
Q Consensus 378 e~~~~gsL~~~-----------------l~~~-~-----~---~~~~l~~~~~~~i~~~i-------------------a 412 (540)
||++|.+|..- ||.. . . ...+..|.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998764321 1110 0 1 11222344444443322 2
Q ss_pred HHHHHHHh---------------------cCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 413 RGLLYLHE---------------------QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 413 ~~l~~LH~---------------------~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
..+.+|.+ .....++|+|+.+.||+ +.++.+.++||..+.
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 22333321 11346899999999999 778899999999886
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.01 E-value=0.044 Score=35.50 Aligned_cols=32 Identities=19% Similarity=0.409 Sum_probs=20.0
Q ss_pred chhhhhhhhhhHHHHHHHHHhhhhheeccccc
Q 009208 239 VAVALGASFGAAFFVIIVVGLLVWLRYRHNQQ 270 (540)
Q Consensus 239 ~~iii~~~~g~~~~~ii~~~~~~~~~~r~~~~ 270 (540)
..++.+++.|.++++++++.+++++|+|+.++
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~ 42 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHIVR 42 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTCCS
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHhhc
Confidence 45666666666666666666666666665543
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.83 E-value=0.061 Score=34.72 Aligned_cols=33 Identities=21% Similarity=0.309 Sum_probs=20.3
Q ss_pred cchhhhhhhhhhHHHHHHHHHhhhhheeccccc
Q 009208 238 RVAVALGASFGAAFFVIIVVGLLVWLRYRHNQQ 270 (540)
Q Consensus 238 ~~~iii~~~~g~~~~~ii~~~~~~~~~~r~~~~ 270 (540)
...++.+++.|.++++++++.+++++|+|+.++
T Consensus 9 ~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 9 TPLIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred cceEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 345666666666666666666666666665543
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=92.14 E-value=0.13 Score=33.14 Aligned_cols=30 Identities=17% Similarity=0.314 Sum_probs=17.9
Q ss_pred hhhhhhhhhhHHHHHHHHHhhhhheecccc
Q 009208 240 AVALGASFGAAFFVIIVVGLLVWLRYRHNQ 269 (540)
Q Consensus 240 ~iii~~~~g~~~~~ii~~~~~~~~~~r~~~ 269 (540)
..+++.++|.++++++.+.+++|+|+|+.+
T Consensus 12 ~~Ia~~vVGvll~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 12 TSIISAVVGILLVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred cchHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence 344555566555566666666676666654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.99 E-value=0.087 Score=53.04 Aligned_cols=29 Identities=31% Similarity=0.461 Sum_probs=24.8
Q ss_pred CeEecCCCCCceee------CCCCCeEEccccccc
Q 009208 425 KIIHRDVKAANILL------DEDFEAVVGDFGLAK 453 (540)
Q Consensus 425 ~ivH~Dlk~~NILl------~~~~~~kl~Dfgla~ 453 (540)
.++|+|+.+.||++ +++..+.++||.+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 35799999999999 456789999999886
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=89.37 E-value=0.59 Score=42.21 Aligned_cols=105 Identities=16% Similarity=0.095 Sum_probs=67.5
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
-||.+.|... ..++++.+++.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence 3788888754 46899999999999999998776221111 1233456889999999998764 1110
Q ss_pred eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 463 TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 463 ~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
.....+.|||... ...+.+.=|||+|+++|.-+--..|-+
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~ 137 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN 137 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc
Confidence 0123456888753 345678889999999998877555543
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.12 E-value=0.1 Score=53.51 Aligned_cols=61 Identities=5% Similarity=-0.046 Sum_probs=17.6
Q ss_pred cCCeeeeccCccEEEEEeCC-CcEEEE------EEeccCCccc-cHHHHHHHHHHHhcccCCCccceeEEEe
Q 009208 305 AKNILGRGGFGIVYKGCFSD-GALVAV------KRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCS 368 (540)
Q Consensus 305 ~~~~lG~G~~g~Vy~~~~~~-g~~vav------K~~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 368 (540)
+.+.+| ||.||+|.+.. ..+||| |..+...... ....|.+|..++...+|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 345566 99999999864 367888 7766533322 2346888999999999999999988764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.35 E-value=2.1 Score=38.52 Aligned_cols=116 Identities=10% Similarity=0.098 Sum_probs=77.0
Q ss_pred cCCCccceeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCc
Q 009208 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAAN 435 (540)
Q Consensus 356 ~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~N 435 (540)
.||+.++. .+....+...+.|+.-+.+-=...++ ..+...+++++..|+....+++.. +|=-++|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-------~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-------SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-------GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-------hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 57888866 56666666666666544322111232 467889999999999988666654 788899999
Q ss_pred eeeCCCCCeEEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 436 ILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 436 ILl~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
++++.++.+++.=.|+-..+ +|.- .++..=.-.+=+++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~l------------------~P~~-----~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV------------------DPLP-----VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTB------------------SCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCC------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999866654322 2211 1111112236678888889988886
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.49 E-value=2.6 Score=37.96 Aligned_cols=84 Identities=14% Similarity=0.103 Sum_probs=60.3
Q ss_pred cCCCccceeEEEecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEecCCCCC
Q 009208 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL-YLHEQCDPKIIHRDVKAA 434 (540)
Q Consensus 356 ~h~nIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~-~LH~~~~~~ivH~Dlk~~ 434 (540)
.||++ -...-.+.+...+.|+.-+++.=...++ ..+...+++++..++.... +++.. +|--++|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCc
Confidence 47777 4555577777777777654442222332 3677889999999888766 55544 77889999
Q ss_pred ceeeCCCCCeEEccccccc
Q 009208 435 NILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 435 NILl~~~~~~kl~Dfgla~ 453 (540)
|+++|.++.+++.=.|+-.
T Consensus 114 NL~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp GEEECTTCCEEESCCEETT
T ss_pred eEEEeCCCcEEEEEcCCcc
Confidence 9999999999998666543
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=82.30 E-value=1.3 Score=27.66 Aligned_cols=14 Identities=14% Similarity=0.157 Sum_probs=6.8
Q ss_pred hhhhhhhhhhHHHH
Q 009208 240 AVALGASFGAAFFV 253 (540)
Q Consensus 240 ~iii~~~~g~~~~~ 253 (540)
..+.++++|+++.+
T Consensus 11 GaIAGiVvG~v~gv 24 (38)
T 2k1k_A 11 GEIVAVIFGLLLGA 24 (38)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred CceeeeehHHHHHH
Confidence 34455555554433
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.10 E-value=1 Score=28.64 Aligned_cols=26 Identities=19% Similarity=0.271 Sum_probs=12.2
Q ss_pred chhhhhhhhhhHHHHHHHHHhhhhhe
Q 009208 239 VAVALGASFGAAFFVIIVVGLLVWLR 264 (540)
Q Consensus 239 ~~iii~~~~g~~~~~ii~~~~~~~~~ 264 (540)
..++.+++.|.++++.+++.+++++|
T Consensus 13 ~~I~~~vv~Gv~ll~~iv~~~~~~~r 38 (41)
T 2k9y_A 13 LAVIGGVAVGVVLLLVLAGVGFFIHR 38 (41)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHSSSS
T ss_pred EEEEeehhHHHHHHHHHHHHheeEee
Confidence 44555555565554423333334433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 540 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-57 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-52 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-50 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-40 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-39 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-38 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-57
Identities = 49/213 (23%), Positives = 95/213 (44%), Gaps = 10/213 (4%)
Query: 296 LRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
+ +F + LG G G+V+K G ++A K + Q E++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 355 AVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARG 414
++ G ++ E + +M GS L + + ++++ +G
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGS----LDQVLKKAGRIPEQILGKVSIAVIKG 116
Query: 415 LLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIA 474
L YL E+ KI+HRDVK +NIL++ E + DFG++ L + + GT +++
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMS 171
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507
PE L S ++D++ G+ L+E+ G+ +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 5e-57
Identities = 70/210 (33%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
+ +G G FG VYKG + VAVK L ++Q F+ EV + H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIALGTARGLLYL 418
+L G+ T + +V + S L H+H + + IA TA+G+ YL
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSS----LYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH-RDSHVTTAVRGTVGHIAPEY 477
H + IIHRD+K+ NI L ED +GDFGLA + SH + G++ +APE
Sbjct: 121 HAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 478 LSTGQS---SEKTDVFGFGILLLELITGQR 504
+ S ++DV+ FGI+L EL+TGQ
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 6e-56
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 8/214 (3%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
LG G FG V+ G ++ VAVK LK ++ F E + H+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRL 70
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
+RL T+ ++ YM NGS+ L L + +A A G+ ++ E
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
+ IHRD++AANIL+ + + DFGLA+L++ + + + APE ++
Sbjct: 128 RN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 481 GQSSEKTDVFGFGILLLELITGQRALDFGRAANQ 514
G + K+DV+ FGILL E++T R G +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-54
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 7/209 (3%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRN 359
++ +G G +G K SDG ++ K L ++ E Q +EV + H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 360 LLRLCGFCSTENERLL--VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
++R L V Y G +AS + R LD R+ L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 418 LHEQ--CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
H + ++HRD+K AN+ LD +GDFGLA++L+H D+ A GT +++P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTPYYMSP 183
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQR 504
E ++ +EK+D++ G LL EL
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMP 212
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (461), Expect = 1e-53
Identities = 56/231 (24%), Positives = 100/231 (43%), Gaps = 23/231 (9%)
Query: 291 YTFKELRAATSNFSAK---------NILGRGGFGIVYKGCF----SDGALVAVKRLKDYN 337
+TF++ A F+ + ++G G FG V G VA+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 338 IAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP 397
F +E + H N++ L G + +++ +M NGS+ S LR +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 398 ALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457
+ + G A G+ YL + +HRD+ A NIL++ + V DFGL++ L+
Sbjct: 127 ---VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 458 RDSHVTT----AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 504
S T + + APE + + + +DV+ +GI++ E+++
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 5e-53
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 10/215 (4%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
S + +G G FG+V+ G + + VA+K +++ + E F E E + H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKL 62
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPAL-DWARRKRIALGTARGLLYLH 419
++L G C + LV+ +M +G L D++ + L + L G+ YL
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
E C +IHRD+ A N L+ E+ V DFG+ + + +T + V +PE S
Sbjct: 119 EAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 480 TGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ 514
+ S K+DV+ FG+L+ E+ + + R+ ++
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (451), Expect = 3e-52
Identities = 59/249 (23%), Positives = 103/249 (41%), Gaps = 30/249 (12%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKG------CFSDGALVAVKRLKDYNIAGGEVQFQ 346
L +N +G G FG V++ + +VAVK LK+ A + FQ
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 347 TEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH-------------- 392
E ++ + N+++L G C+ L++ YM G + LR
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 393 ------IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVV 446
G P L A + IA A G+ YL E+ K +HRD+ N L+ E+ +
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 181
Query: 447 GDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRA 505
DFGL++ + D + + PE + + + ++DV+ +G++L E+ +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 506 LDFGRAANQ 514
+G A +
Sbjct: 242 PYYGMAHEE 250
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-52
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 15/218 (6%)
Query: 294 KELRAATSNFSAKNI-LGRGGFGIVYKGCF---SDGALVAVKRLKDYNIAGGEVQFQTEV 349
K+L N +I LG G FG V +G + VA+K LK + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 350 ETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHG-RPALDWARRKRIA 408
+ + + ++RL G C +LV G L + G R + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP----LHKFLVGKREEIPVSNVAELL 115
Query: 409 LGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVT--TAV 466
+ G+ YL E+ +HRD+ A N+LL A + DFGL+K L DS+ T +A
Sbjct: 116 HQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172
Query: 467 RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 504
+ + APE ++ + S ++DV+ +G+ + E ++ +
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-52
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 8/214 (3%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
+ + LG+G FG V+ G ++ VA+K LK + F E + + H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKL 74
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
++L +E +V YM GS+ L + +A A G+ Y+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
+HRD++AANIL+ E+ V DFGLA+L++ + + + APE
Sbjct: 132 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188
Query: 481 GQSSEKTDVFGFGILLLELITGQRALDFGRAANQ 514
G+ + K+DV+ FGILL EL T R G +
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 7e-52
Identities = 49/204 (24%), Positives = 92/204 (45%), Gaps = 8/204 (3%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
+ + LG G FG+V G + VA+K +K+ ++ E +F E + + H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKL 61
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
++L G C+ + ++ YM NG + L R + + + YL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCL---LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
+ +HRD+ A N L+++ V DFGL++ + + + + V PE L
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 481 GQSSEKTDVFGFGILLLELITGQR 504
+ S K+D++ FG+L+ E+ + +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGK 199
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-51
Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 10/216 (4%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
++ LG G +G V VAVK + + E+ + H N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
++ G N + L Y G + D I + +R G++YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD-HRDSHVTTAVRGTVGHIAPEYLS 479
I HRD+K N+LLDE + DFGLA + + + + GT+ ++APE L
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 480 TGQ-SSEKTDVFGFGILLLELITGQRALDFGRAANQ 514
+ +E DV+ GI+L ++ G+ D + Q
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 6e-51
Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 16/211 (7%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVH 357
+F ++GRG FG VY G D AVK L G QF TE + H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 358 RNLLRLCGFCS-TENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLL 416
N+L L G C +E L+V PYM +G + + + L A+G+
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN---FIRNETHNPTVKDLIGFGLQVAKGM- 143
Query: 417 YLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD---SHVTTAVRGTVGHI 473
K +HRD+ A N +LDE F V DFGLA+ + ++ H T + V +
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQR 504
A E L T + + K+DV+ FG+LL EL+T
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 8e-51
Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 13/207 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVH 357
+F LG+G FG VY ++A+K L + AG E Q + EVE S H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
N+LRL G+ L+ Y P G+ + + D R A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSY 121
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
H + ++IHRD+K N+LL E + DFG + H S T + GT+ ++ PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEM 175
Query: 478 LSTGQSSEKTDVFGFGILLLELITGQR 504
+ EK D++ G+L E + G+
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP 202
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 9e-51
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 306 KNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQ-FQTEVETISLAVHRNLLRL 363
+GRG F VYKG ++ VA L+D + E Q F+ E E + H N++R
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 364 CGFCST----ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
+ + +LV M +G+ L+ ++ + + +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGT----LKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 420 EQCDPKIIHRDVKAANILL-DEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
+ P IIHRD+K NI + +GD GLA L + AV GT +APE
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMY 185
Query: 479 STGQSSEKTDVFGFGILLLELITGQR 504
+ E DV+ FG+ +LE+ T +
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEY 210
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-50
Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 13/221 (5%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDG-----ALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
S + + ++G G FG VYKG VA+K LK V F E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
H N++RL G S +++ YM NG++ LR+ + + G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGM 123
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHI 473
YL +HRD+ A NIL++ + V DFGL+++L D ++ T+ + +
Sbjct: 124 KYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ 514
APE +S + + +DV+ FGI++ E++T + + ++
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-50
Identities = 65/205 (31%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
+G+G FG V G + G VAVK +K+ F E ++ H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNL 62
Query: 361 LRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
++L G E L +V YM GS+ LR GR L + +L + YL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
+HRD+ A N+L+ ED A V DFGL K + V APE L
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALR 173
Query: 480 TGQSSEKTDVFGFGILLLELITGQR 504
+ S K+DV+ FGILL E+ + R
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGR 198
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 3e-50
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 21/220 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSDGAL---VAVKRLKDYNIAGGEVQFQTEVETIS-LAV 356
++ ++++G G FG V K L A+KR+K+Y F E+E + L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARR 404
H N++ L G C L Y P+G++ LR L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
A ARG+ YL + + IHRD+ A NIL+ E++ A + DFGL++ T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 184
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 504
R V +A E L+ + +DV+ +G+LL E+++
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 4e-50
Identities = 58/241 (24%), Positives = 95/241 (39%), Gaps = 30/241 (12%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETIS- 353
N +LG G FG V VAVK LK+ + +E++ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH------------------- 394
L H N++ L G C+ L++ Y G + + LR
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 395 GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454
L + A A+G+ +L + +HRD+ A N+L+ + DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 455 LDHRDSHVT-TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAAN 513
+ ++V R V +APE L G + K+DV+ +GILL E+ + G +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 514 Q 514
Sbjct: 274 A 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (435), Expect = 8e-50
Identities = 66/231 (28%), Positives = 93/231 (40%), Gaps = 25/231 (10%)
Query: 280 DPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNI 338
DP+V+ FK+ FS +G G FG VY + +VA+K++
Sbjct: 1 DPDVA-----ELFFKD--DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK 53
Query: 339 AGGEV--QFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGR 396
E EV + H N ++ G E+ LV Y + +
Sbjct: 54 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA----SDLLEVHK 109
Query: 397 PALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456
L + G +GL YLH +IHRDVKA NILL E +GDFG A ++
Sbjct: 110 KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166
Query: 457 HRDSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQR 504
+S V GT +APE + GQ K DV+ GI +EL +
Sbjct: 167 PANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (432), Expect = 1e-49
Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 8/227 (3%)
Query: 289 KRYTFKELRAATSNFSAKNILGRGGFGIVYKGCFSD-GALVAVKRLKDYNIAGGEVQFQT 347
+ + ++ + K+ LG G +G VY+G + VAVK LK+ + E F
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK 62
Query: 348 EVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRI 407
E + H NL++L G C+ E ++ +M G++ L R + +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYM 120
Query: 408 ALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVR 467
A + + YL + IHRD+ A N L+ E+ V DFGL++L+ +
Sbjct: 121 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 468 GTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ 514
+ APE L+ + S K+DV+ FG+LL E+ T + G +Q
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 224
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-49
Identities = 60/237 (25%), Positives = 96/237 (40%), Gaps = 25/237 (10%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETIS- 353
+ S LG G FG V + VAVK LK +E++ +S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 354 LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH--------------GRPAL 399
L H N++ L G C+ L++ Y G + + LR AL
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 400 DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
D + A+G+ +L + IHRD+ A NILL + DFGLA+ + +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 460 SH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQR 515
++ V R V +APE + + ++DV+ +GI L EL + + G + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 3e-49
Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 28/238 (11%)
Query: 306 KNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG 365
+ +G+G FG V++G + G VAVK + E+ + H N+L
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIA 64
Query: 366 FCSTEN----ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
+ +N + LV Y +GS L D+++ + ++AL TA GL +LH +
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGS----LFDYLNRYT-VTVEGMIKLALSTASGLAHLHME 119
Query: 422 C-----DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV---TTAVRGTVGHI 473
P I HRD+K+ NIL+ ++ + D GLA D + GT ++
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 474 APEYLST------GQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVCSH 525
APE L +S ++ D++ G++ E+ G + + D V S
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI--GGIHEDYQLPYYDLVPSD 235
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 7e-49
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 14/204 (6%)
Query: 307 NILGRGGFGIVYKGCFSD---GALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNLLR 362
LG G FG V KG + VAVK LK + N + + E + + ++R
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
+ G C E+ +LV G L ++ + + + G+ YL E
Sbjct: 73 MIGICEAES-WMLVMEMAELGP----LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 126
Query: 423 DPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT--AVRGTVGHIAPEYLST 480
+HRD+ A N+LL A + DFGL+K L +++ + V APE ++
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 481 GQSSEKTDVFGFGILLLELITGQR 504
+ S K+DV+ FG+L+ E + +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQ 208
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-47
Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 14/202 (6%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
LG G FG VYK L A K + + E + E++ ++ H N+++L
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPNIVKLLDAF 78
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
EN ++ + G+V + + + L ++ + + T L YLH+ KII
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KII 132
Query: 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS---- 483
HRD+KA NIL D + + DFG++ + + GT +APE + S
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRP 191
Query: 484 -SEKTDVFGFGILLLELITGQR 504
K DV+ GI L+E+ +
Sbjct: 192 YDYKADVWSLGITLIEMAEIEP 213
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 4e-46
Identities = 51/219 (23%), Positives = 95/219 (43%), Gaps = 13/219 (5%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAV 356
+G G FG V++G + VA+K K+ +F E T+
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 357 HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRP-ALDWARRKRIALGTARGL 415
H ++++L G TEN ++ G LR + R +LD A A + L
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGE----LRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
YL + + +HRD+ A N+L+ + +GDFGL++ ++ + + + + +AP
Sbjct: 122 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 476 EYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ 514
E ++ + + +DV+ FG+ + E++ G N
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 5e-46
Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 13/210 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKGCFSD-----GALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
+ F +LG G FG VYKG + VA+K L++ + E ++
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
+ ++ RL G C T +L+ MP G + L + + + A+G+
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQ-LMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIA 474
YL ++ +++HRD+ A N+L+ + DFGLAKLL + + + + +A
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 475 PEYLSTGQSSEKTDVFGFGILLLELITGQR 504
E + + ++DV+ +G+ + EL+T
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGS 211
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 5e-46
Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 17/220 (7%)
Query: 292 TFKELRAATS------NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQ 344
++LR+ S ++ +G+G G VY + G VA++++ E
Sbjct: 5 ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-L 63
Query: 345 FQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARR 404
E+ + + N++ +E +V Y+ GS L D + D +
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCM-DEGQI 118
Query: 405 KRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTT 464
+ + L +LH ++IHRD+K+ NILL D + DFG + S +T
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
Query: 465 AVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 504
V GT +APE ++ K D++ GI+ +E+I G+
Sbjct: 176 MV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 161 bits (408), Expect = 2e-45
Identities = 61/239 (25%), Positives = 98/239 (41%), Gaps = 28/239 (11%)
Query: 273 FDVNDQYDP---EVSLGH-LKRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFSDGAL 327
FD+ QY P E+ H L Y E LG G FG+V++ + G
Sbjct: 6 FDIWKQYYPQPVEIKHDHVLDHYDIHEE------------LGTGAFGVVHRVTERATGNN 53
Query: 328 VAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVAS 387
A K + + + E + E++T+S+ H L+ L +NE +++Y +M G +
Sbjct: 54 FAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 112
Query: 388 RLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL--DEDFEAV 445
++ D + +GL ++HE +H D+K NI+ E
Sbjct: 113 KVADE---HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELK 166
Query: 446 VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 504
+ DFGL LD + S T GT APE TD++ G+L L++G
Sbjct: 167 LIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 223
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 3e-45
Identities = 52/207 (25%), Positives = 85/207 (41%), Gaps = 11/207 (5%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHR 358
+F ILG G F V + A+K L+ +I E + +S H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
++L + + Y NG L +I + D + L YL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEY 477
H + IIHRD+K NILL+ED + DFG AK+L + GT +++PE
Sbjct: 125 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 478 LSTGQSSEKTDVFGFGILLLELITGQR 504
L+ + + +D++ G ++ +L+ G
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLP 208
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-45
Identities = 61/256 (23%), Positives = 103/256 (40%), Gaps = 28/256 (10%)
Query: 272 FFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKGCF------SDG 325
+F D Y P+ ++ T LG+G FG+VY+G
Sbjct: 3 YFSAADVYVPDEWEVAREKITMSR------------ELGQGSFGMVYEGVAKGVVKDEPE 50
Query: 326 ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSV 385
VA+K + + ++F E + +++RL G S L++ M G +
Sbjct: 51 TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 110
Query: 386 ASRLRDHIHG------RPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD 439
S LR ++ ++A A G+ YL+ K +HRD+ A N ++
Sbjct: 111 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 167
Query: 440 EDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLE 498
EDF +GDFG+ + + D V ++PE L G + +DV+ FG++L E
Sbjct: 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 227
Query: 499 LITGQRALDFGRAANQ 514
+ T G + Q
Sbjct: 228 IATLAEQPYQGLSNEQ 243
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 3e-44
Identities = 69/221 (31%), Positives = 96/221 (43%), Gaps = 15/221 (6%)
Query: 302 NFSAKNILGRGGFGIVYKGCF----SDGALVAVKRLKDYNIAGGEV--QFQTEVETISLA 355
+ LG G FG+V +G + VAVK LK ++ E F EV +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 356 VHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
HRNL+RL G T ++ V P GS+ RLR H + R A+ A G+
Sbjct: 69 DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGM 124
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSH--VTTAVRGTVGHI 473
YL + IHRD+ A N+LL +GDFGL + L D H + +
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ 514
APE L T S +D + FG+ L E+ T + G +Q
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 222
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 153 bits (387), Expect = 2e-43
Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 25/218 (11%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLK--------DYNIAGGEVQFQTEVETI 352
N+ K ILGRG +V + AVK + + EV+ +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 353 S-LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
++ H N+++L T LV+ M G L D++ + L ++I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE----LFDYLTEKVTLSEKETRKIMRAL 119
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVG 471
+ LH+ I+HRD+K NILLD+D + DFG + LD V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPS 174
Query: 472 HIAPEYLSTGQS------SEKTDVFGFGILLLELITGQ 503
++APE + + ++ D++ G+++ L+ G
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 155 bits (392), Expect = 4e-43
Identities = 60/232 (25%), Positives = 96/232 (41%), Gaps = 17/232 (7%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRL--KDYNIAGGEVQFQTEVETISLAV-- 356
+FS I+GRGGFG VY G + A+K L K + GE E +SL
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 357 -HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGL 415
++ + T ++ + M G L H+ A + A GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGD----LHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 416 LYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAP 475
++H + +++RD+K ANILLDE + D GLA + H + GT G++AP
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 174
Query: 476 EYLSTGQS-SEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDWVCSHI 526
E L G + D F G +L +L+ G + ++ + + +
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 154 bits (389), Expect = 8e-43
Identities = 51/242 (21%), Positives = 91/242 (37%), Gaps = 28/242 (11%)
Query: 270 QIFFDVNDQYDP---EVSLGHL-KRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFSD 324
+ + D+ +Y P EV G + Y E LG G FG+V++ +
Sbjct: 6 KFYEDIWKKYVPQPVEVKQGSVYDYYDILEE------------LGSGAFGVVHRCVEKAT 53
Query: 325 GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGS 384
G + K + + E+ ++ H L+ L + E +L+ ++ G
Sbjct: 54 GRVFVAKFINTPYPLDKY-TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 112
Query: 385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD--EDF 442
+ R+ + A GL ++HE I+H D+K NI+ + +
Sbjct: 113 LFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKAS 166
Query: 443 EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG 502
+ DFGLA L+ + T APE + TD++ G+L L++G
Sbjct: 167 SVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224
Query: 503 QR 504
Sbjct: 225 LS 226
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 1e-42
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 13/216 (6%)
Query: 293 FKELRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVET 351
+K+ + +++LG G F V LVA+K + + G E + E+
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 352 ISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGT 411
+ H N++ L + L+ + G L D I + R+
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE----LFDRIVEKGFYTERDASRLIFQV 116
Query: 412 ARGLLYLHEQCDPKIIHRDVKAANILL---DEDFEAVVGDFGLAKLLDHRDSHVTTAVRG 468
+ YLH+ I+HRD+K N+L DED + ++ DFGL+K+ D V + G
Sbjct: 117 LDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACG 171
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 504
T G++APE L+ S+ D + G++ L+ G
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-42
Identities = 62/236 (26%), Positives = 95/236 (40%), Gaps = 25/236 (10%)
Query: 301 SNFSAKNILGRGGFGIVYKG--------CFSDGALVAVKRLKDYNIAGGEVQFQTEVETI 352
LG G FG V + VAVK LK +E+E +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 353 S-LAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDH------------IHGRPAL 399
+ H+N++ L G C+ + ++ Y G++ L+ + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 400 DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
A ARG+ YL K IHRD+ A N+L+ ED + DFGLA+ + H D
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 460 SHVTTAV-RGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ 514
+ T R V +APE L + ++DV+ FG+LL E+ T + G +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-42
Identities = 64/207 (30%), Positives = 93/207 (44%), Gaps = 12/207 (5%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRL-KDYNIAGGEVQ-FQTEVETISLAV-H 357
+F +LG+G FG V+ A+K L KD + +V+ E +SLA H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
L + T+ V Y+ G L HI D +R A GL +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGD----LMYHIQSCHKFDLSRATFYAAEIILGLQF 118
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
LH + I++RD+K NILLD+D + DFG+ K D+ T GT +IAPE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174
Query: 478 LSTGQSSEKTDVFGFGILLLELITGQR 504
L + + D + FG+LL E++ GQ
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-42
Identities = 56/235 (23%), Positives = 98/235 (41%), Gaps = 24/235 (10%)
Query: 301 SNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISL 354
LGRG FG V + + VAVK LK+ +E++ +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 355 AVHR-NLLRLCGFCSTENERL-LVYPYMPNGSVASRLRDHIH------------GRPALD 400
H N++ L G C+ L ++ + G++++ LR + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 401 WARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460
+ A+G+ +L + K IHRD+ A NILL E + DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 461 HV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ 514
+V R + +APE + + ++DV+ FG+LL E+ + + G ++
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-40
Identities = 41/208 (19%), Positives = 89/208 (42%), Gaps = 8/208 (3%)
Query: 300 TSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHR 358
++ + +G G +G+V + VA+K++ + + E++ + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
N++ + + Y+ + + L + + L RGL Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYI 125
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL--DHRDSHVTTAVRGTVGHIAPE 476
H ++HRD+K +N+LL+ + + DFGLA++ DH + T T + APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 477 YLSTGQ-SSEKTDVFGFGILLLELITGQ 503
+ + ++ D++ G +L E+++ +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-40
Identities = 45/199 (22%), Positives = 80/199 (40%), Gaps = 13/199 (6%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
LGRG FGIV++ S K +K +V + E+ +++A HRN+L L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK--VKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
+ E ++++ ++ + R+ L+ L +LH I
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIG 124
Query: 428 HRDVKAANILLDEDFEAVV--GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSE 485
H D++ NI+ + + +FG A+ L D+ + APE S
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVST 182
Query: 486 KTDVFGFGILLLELITGQR 504
TD++ G L+ L++G
Sbjct: 183 ATDMWSLGTLVYVLLSGIN 201
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-39
Identities = 46/205 (22%), Positives = 82/205 (40%), Gaps = 8/205 (3%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRN 359
NF +G G +G+VYK G +VA+K+++ D G E+ + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
+++L TEN+ LV+ ++ + + K +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDL---KKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 420 EQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLS 479
++HRD+K N+L++ + + DFGLA+ T V L
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 480 TGQSSEKTDVFGFGILLLELITGQR 504
S D++ G + E++T +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (363), Expect = 2e-39
Identities = 55/207 (26%), Positives = 87/207 (42%), Gaps = 14/207 (6%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVH 357
+F LG G FG V+ +G A+K LK + + E +S+ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
++R+ G + ++ Y+ L + K A L Y
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 477
LH + II+RD+K NILLD++ + DFG AK + + GT +IAPE
Sbjct: 120 LHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEV 172
Query: 478 LSTGQSSEKTDVFGFGILLLELITGQR 504
+ST ++ D + FGIL+ E++ G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 142 bits (358), Expect = 3e-39
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 16/206 (7%)
Query: 308 ILGRGGFGIVYKG-CFSDGALVAVKRLK--DYNIAGGEVQFQTEVETISLAVHRNLLRLC 364
ILG GG V+ VAVK L+ ++F+ E + + H ++ +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 365 GFCSTENERL----LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
E +V Y+ + LRD +H + R + + L + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVT----LRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 129
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV--TTAVRGTVGHIAPEYL 478
IIHRDVK ANI++ V DFG+A+ + + V T AV GT +++PE
Sbjct: 130 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 479 STGQSSEKTDVFGFGILLLELITGQR 504
++DV+ G +L E++TG+
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEP 212
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 4e-39
Identities = 53/230 (23%), Positives = 94/230 (40%), Gaps = 13/230 (5%)
Query: 299 ATSNFSAKNILGRGGFGIVYKG--CFSDGALVAVKRLK-DYNIAGGEVQFQTEVETISLA 355
A + +G G +G V+K + G VA+KR++ G + EV +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 356 V---HRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIH--GRPALDWARRKRIALG 410
H N++RL C+ + V L ++ P + K +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 470
RGL +LH +++HRD+K NIL+ + + DFGLA++ + + + V T+
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTL 179
Query: 471 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLD 520
+ APE L + D++ G + E+ + +Q G +LD
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-38
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 14/203 (6%)
Query: 307 NILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIA----GGEVQFQTEVETISLAVHRNLL 361
+ LG G F VYK + +VA+K++K + + G E++ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 362 RLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
L ++ LV+ +M L + K L T +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 422 CDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTG 481
I+HRD+K N+LLDE+ + DFGLAK + T V T + APE L
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 482 QS-SEKTDVFGFGILLLELITGQ 503
+ D++ G +L EL+
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (349), Expect = 6e-38
Identities = 41/203 (20%), Positives = 85/203 (41%), Gaps = 8/203 (3%)
Query: 302 NFSAKNILGRGGFGIVYKGCFSDGALVAVKRLK-DYNIAGGEVQFQTEVETISLAVHRNL 360
+ +G G +G+VYK + G A+K+++ + G E+ + H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
++L T+ +LV+ ++ + L+ K L G+ Y H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDL----KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLST 480
+ +++HRD+K N+L++ + E + DFGLA+ T + + +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 481 GQSSEKTDVFGFGILLLELITGQ 503
+ S D++ G + E++ G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-37
Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 18/216 (8%)
Query: 297 RAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLA 355
R +++ ++G G FG+VY+ G LVA+K++ + E++ +
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 70
Query: 356 VHRNLLRLCGFCSTENER------LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIAL 409
H N++RL F + E+ LV Y+P R + + L K
Sbjct: 71 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMY 129
Query: 410 GTARGLLYLHEQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAKLLDHRDSHVTTAVRG 468
R L Y+H I HRD+K N+LLD D + DFG AK L + +V+ +
Sbjct: 130 QLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICS 185
Query: 469 TVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR 504
+ DV+ G +L EL+ GQ
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 3e-36
Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 19/207 (9%)
Query: 308 ILGRGGFGIVYKG-CFSDGALVAVKRLK-----DYNIAGGEVQFQTEVETISL--AVHRN 359
+LG GGFG VY G SD VA+K ++ D+ + EV + +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 360 LLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLH 419
++RL + + +L+ L D I R AL + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 420 EQCDPKIIHRDVKAANILLDED-FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
++HRD+K NIL+D + E + DFG LL V T GT + PE++
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWI 181
Query: 479 STGQ-SSEKTDVFGFGILLLELITGQR 504
+ V+ GILL +++ G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI 208
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-36
Identities = 50/206 (24%), Positives = 80/206 (38%), Gaps = 22/206 (10%)
Query: 308 ILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCG 365
+LG G G V + A+K L+D + + EVE A +++R+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 72
Query: 366 FC----STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ 421
+ L+V + G + SR++D G A I + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 422 CDPKIIHRDVKAANILLDEDFE---AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
I HRDVK N+L + DFG AK +S T T ++APE L
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL 185
Query: 479 STGQSSEKTDVFGFGILLLELITGQR 504
+ + D++ G+++ L+ G
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYP 211
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 6e-36
Identities = 53/206 (25%), Positives = 82/206 (39%), Gaps = 11/206 (5%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRL-KDYNIAGGEV-QFQTEVETISLAVHR 358
+F +LG+G FG V + G A+K L K+ IA EV TE + H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
L L T + V Y G L H+ R + A + L
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFYG---AEIVSAL 118
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
+++RD+K N++LD+D + DFGL K + GT ++APE L
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVL 177
Query: 479 STGQSSEKTDVFGFGILLLELITGQR 504
D +G G+++ E++ G+
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (335), Expect = 8e-36
Identities = 43/223 (19%), Positives = 74/223 (33%), Gaps = 19/223 (8%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
+G G FG +Y G + G VA+K + Q E + + + +C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLEC---VKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 368 STENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427
E + ++ + S+ +A + Y+H + I
Sbjct: 72 GAEGDYNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFI 125
Query: 428 HRDVKAANIL---LDEDFEAVVGDFGLAKLLDHRDSHV------TTAVRGTVGHIAPEYL 478
HRDVK N L + + DFGLAK +H + GT + +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 479 STGQSSEKTDVFGFGILLLELITGQRALDFGRAANQRGVMLDW 521
+ S + D+ G +L+ G +AA +R
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 129 bits (325), Expect = 2e-34
Identities = 37/225 (16%), Positives = 74/225 (32%), Gaps = 21/225 (9%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL 360
++ +G G FG++++G + VA+K + A Q + E T L
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTG 62
Query: 361 LRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE 420
+ + E ++ + S+ L A + +HE
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 421 QCDPKIIHRDVKAANILLDEDFEAVVG-----DFGLAKLLD------HRDSHVTTAVRGT 469
+ +++RD+K N L+ DFG+ K H + GT
Sbjct: 120 K---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 470 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRAANQ 514
+++ + S + D+ G + + + G +AA
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-34
Identities = 46/197 (23%), Positives = 82/197 (41%), Gaps = 8/197 (4%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
+G G +G V GA VA+K+L + + + E+ + H N++ L
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
+ + + + L R + + +GL Y+H I
Sbjct: 86 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---I 142
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
IHRD+K N+ ++ED E + DFGLA+ DS +T V L+ + ++
Sbjct: 143 IHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRWYRAPEVILNWMRYTQT 199
Query: 487 TDVFGFGILLLELITGQ 503
D++ G ++ E+ITG+
Sbjct: 200 VDIWSVGCIMAEMITGK 216
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-34
Identities = 47/205 (22%), Positives = 79/205 (38%), Gaps = 19/205 (9%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEV-----QFQTEVETISLAVHRNLLR 362
LG G F +V K S G A K +K + EV + H N++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 363 LCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC 422
L + + +L+ + G L D + + +L G+ YLH
Sbjct: 78 LHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 133
Query: 423 DPKIIHRDVKAANILLDED----FEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
I H D+K NI+L + + DFGLA +D + + GT +APE +
Sbjct: 134 ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGTPEFVAPEIV 188
Query: 479 STGQSSEKTDVFGFGILLLELITGQ 503
+ + D++ G++ L++G
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 8e-34
Identities = 45/225 (20%), Positives = 82/225 (36%), Gaps = 21/225 (9%)
Query: 288 LKRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLK-DYNIAGGEVQF 345
+++Y E +G G +G V+K +VA+KR++ D + G
Sbjct: 1 MQKYEKLEK------------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA 48
Query: 346 QTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRK 405
E+ + H+N++RL ++ + LV+ + + LD K
Sbjct: 49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVK 104
Query: 406 RIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTA 465
+ L L ++HRD+K N+L++ + E + +FGLA+ +
Sbjct: 105 SFL---FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161
Query: 466 VRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510
V S D++ G + EL R L G
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-33
Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 21/218 (9%)
Query: 301 SNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLAVHR 358
S + +G+G FG V+K G VA+K++ + G + E++ + L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 359 NLLRLCGFCST--------ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALG 410
N++ L C T + LV+ + + + + KR+
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL----AGLLSNVLVKFTLSEIKRVMQM 125
Query: 411 TARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS---HVTTAVR 467
GL + KI+HRD+KAAN+L+ D + DFGLA+ + + T
Sbjct: 126 LLNGL---YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 468 GTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQR 504
T+ + PE L + D++G G ++ E+ T
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (319), Expect = 5e-33
Identities = 46/206 (22%), Positives = 75/206 (36%), Gaps = 14/206 (6%)
Query: 302 NFSAKNILGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEV--QFQTEVETISLAVHR 358
F LG G FG V G A+K L + + E +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 359 NLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYL 418
L++L + +V Y+ G + H+ + A YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGG----EMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 419 HEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYL 478
H +I+RD+K N+L+D+ V DFG AK + R + GT +APE +
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEII 210
Query: 479 STGQSSEKTDVFGFGILLLELITGQR 504
+ ++ D + G+L+ E+ G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 5e-31
Identities = 60/243 (24%), Positives = 96/243 (39%), Gaps = 24/243 (9%)
Query: 272 FFDVNDQYDPEVSLGHLKRYTFKELRAATSNFSAKNILGRGGFGIVYKG----CFSDGAL 327
V + GH ++ + NF +LG G +G V+ G L
Sbjct: 2 LLTVKHELRTANLTGHAEKVGIE-------NFELLKVLGTGAYGKVFLVRKISGHDTGKL 54
Query: 328 VAVKRLKDYNIAGGE---VQFQTEVETIS-LAVHRNLLRLCGFCSTENERLLVYPYMPNG 383
A+K LK I +TE + + + L+ L TE + L+ Y+ G
Sbjct: 55 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 114
Query: 384 SVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFE 443
L H+ R + +L L II+RD+K NILLD +
Sbjct: 115 E----LFTHLSQRERFTEHEVQIYV---GEIVLALEHLHKLGIIYRDIKLENILLDSNGH 167
Query: 444 AVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS--SEKTDVFGFGILLLELIT 501
V+ DFGL+K ++ GT+ ++AP+ + G S + D + G+L+ EL+T
Sbjct: 168 VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 227
Query: 502 GQR 504
G
Sbjct: 228 GAS 230
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 114 bits (285), Expect = 1e-28
Identities = 48/250 (19%), Positives = 89/250 (35%), Gaps = 32/250 (12%)
Query: 270 QIFFDVNDQYDPEVSLGHLKRYTFKELRAATSN---FSAKNILGRGGFGIVYKG-CFSDG 325
+++ DVN E + ++ N + LGRG + V++ ++
Sbjct: 8 RVYTDVNTHRPRE-------YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNN 60
Query: 326 ALVAVKRLKDYNIAGGEVQFQTEVETIS-LAVHRNLLRLCGFCSTENERL--LVYPYMPN 382
V VK LK + + E++ + L N++ L R LV+ ++ N
Sbjct: 61 EKVVVKILKPVKKK----KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 116
Query: 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF 442
+ L + + L Y H I+HRDVK N+++D +
Sbjct: 117 TD----FKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEH 166
Query: 443 EAV-VGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELI 500
+ + D+GLA+ + + PE L Q D++ G +L +I
Sbjct: 167 RKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224
Query: 501 TGQRALDFGR 510
+ G
Sbjct: 225 FRKEPFFHGH 234
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-28
Identities = 48/224 (21%), Positives = 83/224 (37%), Gaps = 32/224 (14%)
Query: 288 LKRYTFKELRAATSNFSAKNILGRGGFGIVYKG-CFSDGALVAVKRL-KDYNIAGGEVQF 345
LKRY + +G G GIV VA+K+L + + +
Sbjct: 16 LKRYQNLKP------------IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA 63
Query: 346 QTEVETISLAVHRNLLRLCGFCSTE------NERLLVYPYMPNGSVASRLRDHIHGRPAL 399
E+ + H+N++ L + + + LV M +
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELD-- 117
Query: 400 DWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459
R + G+ +LH IIHRD+K +NI++ D + DFGLA+
Sbjct: 118 -HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGT 171
Query: 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ 503
S + T T + APE + E D++ G ++ E++ +
Sbjct: 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 7e-27
Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 8/197 (4%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRL-KDYNIAGGEVQFQTEVETISLAVHRNLLRLCGF 366
+G G +G V G VAVK+L + + + E+ + H N++ L
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKI 426
+ + ++I L + + RGL Y+H I
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---I 142
Query: 427 IHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEK 486
IHRD+K +N+ ++ED E + DFGLA+ D +T V L+ ++
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQT 199
Query: 487 TDVFGFGILLLELITGQ 503
D++ G ++ EL+TG+
Sbjct: 200 VDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (258), Expect = 7e-25
Identities = 42/210 (20%), Positives = 75/210 (35%), Gaps = 19/210 (9%)
Query: 309 LGRGGFGIVYKG-CFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367
LG G F V+ + VA+K ++ + + E++ + + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 368 STENERLLVYPY--MPNGSV----------ASRLRDHIHGRPALDWARRKRIALGTARGL 415
+ +LL + PNG + + K+I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 416 LYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLDHRDSHVTTA-VRGTVGHI 473
Y+H +C IIH D+K N+L++ D + +A L + T +
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 474 APEYLSTGQSSEKTDVFGFGILLLELITGQ 503
+PE L D++ L+ ELITG
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 88.3 bits (218), Expect = 6e-21
Identities = 22/163 (13%), Positives = 47/163 (28%), Gaps = 20/163 (12%)
Query: 307 NILGRGGFGIVYKGCFSDGALVAVKRLK---------DYNIAGGEVQFQTEVETISLAVH 357
++G G V+ VK K G++ F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 358 RNLLRLCGFCSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLY 417
R L +L G + Y + N + + R ++ + +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD--EVLDMILEEVAK 118
Query: 418 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460
+ + I+H D+ N+L+ + + DF + +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGW 157
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 74.0 bits (180), Expect = 4e-15
Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 34 EVVALVAVKNNLHDPYNVLENWDITSVDPC--SWRMITCSPDGY---VSALGLPSQSLSG 88
+ AL+ +K +L +P L +W + D C +W + C D V+ L L +L
Sbjct: 7 DKQALLQIKKDLGNP-TTLSSWL-PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 89 --TLSPWIGNLTKLQSVLLQNNA-ILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDL 145
+ + NL L + + ++GPIP ++ KL +L L +++ +G IPD L +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 146 GNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
L L + N+L+G+ P S+S + +L + N +SG++P
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.2 bits (170), Expect = 8e-14
Identities = 25/118 (21%), Positives = 43/118 (36%), Gaps = 1/118 (0%)
Query: 46 HDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLL 105
N+ + S + + +++ +G L + L
Sbjct: 192 PTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDL 251
Query: 106 QNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCP 163
+NN I G +P L +L+ L +L++S N GEIP G+L + NN P
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 63.6 bits (153), Expect = 1e-11
Identities = 16/60 (26%), Positives = 27/60 (45%), Gaps = 1/60 (1%)
Query: 128 DLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
DL NN+ G +P L L L+ L ++ N+L G P+ ++ + + N P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.0 bits (141), Expect = 4e-10
Identities = 20/63 (31%), Positives = 34/63 (53%), Gaps = 4/63 (6%)
Query: 147 NLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI----SARTFKVTGNPLI 202
NLN L L NN + G+ P+ L++++ L +++S+NNL G +P+ N +
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
Query: 203 CGP 205
CG
Sbjct: 305 CGS 307
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.0 bits (175), Expect = 4e-14
Identities = 36/167 (21%), Positives = 65/167 (38%), Gaps = 7/167 (4%)
Query: 15 VLALIDICYATLSPAGINYEVVALVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDG 74
L+L + + L N + + + +T + + ++ SP
Sbjct: 223 ELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLA 282
Query: 75 YVSALGLPSQSL-SGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNK 133
++AL + I NL L + L N I P + L KLQ L +NNK
Sbjct: 283 GLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNK 340
Query: 134 FTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN 180
+ SL +L N+N+L +N ++ P L+ + +T + L+
Sbjct: 341 VSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.0 bits (157), Expect = 6e-12
Identities = 31/173 (17%), Positives = 59/173 (34%), Gaps = 29/173 (16%)
Query: 38 LVAVKNNLHDPYNVLENWDITSVDPCSWRMITCSPDGYVS---ALGLPSQSLSGTLSPWI 94
L+A N + D + ++ + ++ ++ L L + +S +
Sbjct: 202 LIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISN--LAPL 259
Query: 95 GNLTKLQSVLLQNNAILGPIP--------------------ASLGKLEKLQTLDLSNNKF 134
LTKL + L N I P + + L+ L L L N
Sbjct: 260 SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 319
Query: 135 TGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
+ P + L L L NN ++ SL+ + ++ + +N +S P
Sbjct: 320 SDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 5e-08
Identities = 33/136 (24%), Positives = 49/136 (36%), Gaps = 6/136 (4%)
Query: 93 WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152
+ LT L+S++ NN I P + L L L+ N+ +L L NL L
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLD 247
Query: 153 LNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNCT 212
L NN ++ P LS + LT + L N +S P +
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305
Query: 213 AVFPEPLSLPPNGLKD 228
L+L N + D
Sbjct: 306 LKNLTYLTLYFNNISD 321
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 12/67 (17%), Positives = 26/67 (38%), Gaps = 4/67 (5%)
Query: 121 LEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN 180
L + L T + + DL + L+ + + + + + +LT ++ S N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNN 76
Query: 181 NLSGSLP 187
L+ P
Sbjct: 77 QLTDITP 83
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 3e-06
Identities = 17/78 (21%), Positives = 32/78 (41%), Gaps = 5/78 (6%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L + +L + + S L+++ TL D + L NL + +N
Sbjct: 20 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75
Query: 156 NSLTGSCP-ESLSKIESL 172
N LT P ++L+K+ +
Sbjct: 76 NQLTDITPLKNLTKLVDI 93
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 18/76 (23%), Positives = 34/76 (44%), Gaps = 6/76 (7%)
Query: 81 LPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD 140
L +++ T+S +L ++ ++ I + L L ++ SNN+ T P
Sbjct: 29 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP- 83
Query: 141 SLGDLGNLNYLRLNNN 156
L +L L + +NNN
Sbjct: 84 -LKNLTKLVDILMNNN 98
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.9 bits (138), Expect = 1e-09
Identities = 25/129 (19%), Positives = 43/129 (33%), Gaps = 9/129 (6%)
Query: 46 HDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLL 105
D Y S+ S + + S + L+ + +
Sbjct: 232 RDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNV 291
Query: 106 QNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPES 165
NN ++ +PA +LE+L S N E+P+ NL L + N L P+
Sbjct: 292 SNNKLIE-LPALPPRLERL---IASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDI 342
Query: 166 LSKIESLTL 174
+E L +
Sbjct: 343 PESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.8 bits (135), Expect = 2e-09
Identities = 23/85 (27%), Positives = 32/85 (37%), Gaps = 9/85 (10%)
Query: 105 LQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPE 164
NA I + L+ L++SNNK E+P L L + N L PE
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 321
Query: 165 SLSKIESLTLVDLSYNNLSGSLPKI 189
++ L + YN L P I
Sbjct: 322 LPQNLKQL---HVEYNPLR-EFPDI 342
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 4e-04
Identities = 17/68 (25%), Positives = 27/68 (39%), Gaps = 8/68 (11%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
+L+ L N L +P L ++L S N T E+P+ L +L N
Sbjct: 39 QAHELE---LNNLG-LSSLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNL 90
Query: 156 NSLTGSCP 163
+L+ P
Sbjct: 91 KALSDLPP 98
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.002
Identities = 16/43 (37%), Positives = 23/43 (53%), Gaps = 5/43 (11%)
Query: 147 NLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
+ L LNN L+ S PE +ESL S N+L+ LP++
Sbjct: 39 QAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPEL 76
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.7 bits (137), Expect = 1e-09
Identities = 14/83 (16%), Positives = 31/83 (37%), Gaps = 5/83 (6%)
Query: 124 LQTLDLSNNKFTGE-IPDSLGDLGNLNYLRLNNNSLTGSC----PESLSKIESLTLVDLS 178
+Q+LD+ + + + L L +RL++ LT + +L +L ++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 179 YNNLSGSLPKISARTFKVTGNPL 201
N L + + +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.8 bits (132), Expect = 8e-09
Identities = 17/87 (19%), Positives = 30/87 (34%), Gaps = 9/87 (10%)
Query: 93 WIGNLTKLQSVLLQNNAI----LGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGD---- 144
+ L+ + L + + + A+L L+ LDLSNN L +
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423
Query: 145 -LGNLNYLRLNNNSLTGSCPESLSKIE 170
L L L + + + L +E
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.0 bits (130), Expect = 1e-08
Identities = 16/90 (17%), Positives = 30/90 (33%), Gaps = 5/90 (5%)
Query: 100 LQSVLLQNNAIL-GPIPASLGKLEKLQTLDLSNNKFTGE----IPDSLGDLGNLNYLRLN 154
+QS+ +Q + L L++ Q + L + T I +L L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
+N L + + + +L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 4e-07
Identities = 14/76 (18%), Positives = 26/76 (34%), Gaps = 9/76 (11%)
Query: 123 KLQTLDLSNNKFTGE----IPDSLGDLGNLNYLRLNNNSLTGSCPESLSKI-----ESLT 173
L+ L L++ + + +L +L L L+NN L + L + L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 174 LVDLSYNNLSGSLPKI 189
+ L S +
Sbjct: 430 QLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 5e-07
Identities = 16/90 (17%), Positives = 31/90 (34%), Gaps = 5/90 (5%)
Query: 79 LGLPSQSLSGT-LSPWIGNLTKLQSVLLQNNAI----LGPIPASLGKLEKLQTLDLSNNK 133
L + + LS + + L + Q V L + + I ++L L L+L +N+
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 134 FTGEIPDSLGDLGNLNYLRLNNNSLTGSCP 163
+ ++ SL C
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 5e-06
Identities = 20/123 (16%), Positives = 37/123 (30%), Gaps = 15/123 (12%)
Query: 46 HDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGT----LSPWIGNLTKLQ 101
+ N + P + L L +S + L+ + L+
Sbjct: 341 FLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 400
Query: 102 SVLLQNNAILGPIPASLGK-----LEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN 156
+ L NN + L + L+ L L + ++ E+ D L L +
Sbjct: 401 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQA------LEKDKP 454
Query: 157 SLT 159
SL
Sbjct: 455 SLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.003
Identities = 14/59 (23%), Positives = 22/59 (37%), Gaps = 4/59 (6%)
Query: 147 NLNYLRLNNNSLTGSC----PESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPL 201
L L L + ++ S +L SL +DLS N L + + + G L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (134), Expect = 2e-09
Identities = 25/130 (19%), Positives = 42/130 (32%), Gaps = 28/130 (21%)
Query: 79 LGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLE---------------- 122
L L +S L L +LL N + P + L
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP 217
Query: 123 --------KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTL 174
LQ L L++N + + + L R +++ + S P+ L+ L
Sbjct: 218 TEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRLA---GRDL 273
Query: 175 VDLSYNNLSG 184
L+ N+L G
Sbjct: 274 KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.3 bits (113), Expect = 9e-07
Identities = 30/156 (19%), Positives = 51/156 (32%), Gaps = 4/156 (2%)
Query: 52 LENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAIL 111
L + + L L +L +L L + L N I
Sbjct: 107 LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166
Query: 112 GPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIES 171
+ L L L L N+ P + DLG L L L N+L+ E+L+ + +
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226
Query: 172 LTLVDLSYNNLSGSLPKIS----ARTFKVTGNPLIC 203
L + L+ N + F+ + + + C
Sbjct: 227 LQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.7 bits (109), Expect = 3e-06
Identities = 33/170 (19%), Positives = 56/170 (32%), Gaps = 8/170 (4%)
Query: 28 PAGINYEVVALVAVKNNLH-------DPYNVLENWDITSVDPCSWRMITCSPDGYVSALG 80
P GI + N + L + S + + L
Sbjct: 27 PVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLD 86
Query: 81 LPSQSLSGTLSP-WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIP 139
L + ++ P L +L ++ L + P L LQ L L +N
Sbjct: 87 LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD 146
Query: 140 DSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI 189
D+ DLGNL +L L+ N ++ + + SL + L N ++ P
Sbjct: 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.2 bits (134), Expect = 3e-09
Identities = 27/120 (22%), Positives = 40/120 (33%), Gaps = 14/120 (11%)
Query: 63 CSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLE 122
C R++ CS L + L LQNN I L+
Sbjct: 10 CHLRVVQCS-----------DLGLEKVPKDLPPDTALLD---LQNNKITEIKDGDFKNLK 55
Query: 123 KLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNL 182
L TL L NNK + P + L L L L+ N L + ++ L + + +
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKV 115
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.7 bits (130), Expect = 8e-09
Identities = 22/71 (30%), Positives = 31/71 (43%), Gaps = 2/71 (2%)
Query: 114 IPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLT 173
+P L LDL NNK T +L NL+ L L NN ++ P + + + L
Sbjct: 25 VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 174 LVDLSYNNLSG 184
+ LS N L
Sbjct: 83 RLYLSKNQLKE 93
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 48.9 bits (115), Expect = 6e-07
Identities = 33/161 (20%), Positives = 52/161 (32%), Gaps = 7/161 (4%)
Query: 65 WRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL 124
+ V LG SG + + KL + + + + IP L L
Sbjct: 117 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN-ITTIPQGL--PPSL 173
Query: 125 QTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
L L NK T SL L NL L L+ NS++ SL+ L + L+ N L
Sbjct: 174 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK 233
Query: 185 SLPKISA----RTFKVTGNPLICGPKATNNCTAVFPEPLSL 221
++ + + N + + S
Sbjct: 234 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 274
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 46.6 bits (109), Expect = 3e-06
Identities = 34/181 (18%), Positives = 54/181 (29%), Gaps = 33/181 (18%)
Query: 46 HDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWI--GNLTKLQSV 103
+N L + + + + L ++ T I G L +
Sbjct: 117 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTEL 176
Query: 104 LLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI-----------------------PD 140
L N I ASL L L L LS N + P
Sbjct: 177 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG 236
Query: 141 SLGDLGNLNYLRLNNNSLTG------SCPESLSKIESLTLVDLSYNNLSGSLPKISARTF 194
L D + + L+NN+++ P +K S + V L N + +I TF
Sbjct: 237 GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV--QYWEIQPSTF 294
Query: 195 K 195
+
Sbjct: 295 R 295
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.6 bits (91), Expect = 5e-04
Identities = 15/80 (18%), Positives = 27/80 (33%), Gaps = 8/80 (10%)
Query: 106 QNNAILGPIPASLGKLEKLQTLDLSNNKFTG------EIPDSLGDLGNLNYLRLNNNSLT 159
NN L +P L + +Q + L NN + P + + + L +N +
Sbjct: 226 LNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
Query: 160 GSC--PESLSKIESLTLVDL 177
P + + V L
Sbjct: 286 YWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.3 bits (90), Expect = 7e-04
Identities = 14/65 (21%), Positives = 26/65 (40%), Gaps = 3/65 (4%)
Query: 124 LQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
L+ + S+ ++P L + L L NN +T +++L + L N +S
Sbjct: 12 LRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 184 GSLPK 188
P
Sbjct: 69 KISPG 73
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.6 bits (122), Expect = 4e-08
Identities = 19/64 (29%), Positives = 29/64 (45%), Gaps = 4/64 (6%)
Query: 92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
+ NL+KL ++ +N I P L L L + L NN+ + P L + NL +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 152 RLNN 155
L N
Sbjct: 223 TLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 1e-05
Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 4/61 (6%)
Query: 118 LGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDL 177
L L KL TL +NK + P L L NL + L NN ++ P L+ +L +V L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 178 S 178
+
Sbjct: 225 T 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 3e-04
Identities = 13/70 (18%), Positives = 24/70 (34%), Gaps = 4/70 (5%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L + + + + + L+ + TL T + + L NL L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 156 NSLTGSCPES 165
N +T P
Sbjct: 73 NQITDLAPLK 82
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 2e-07
Identities = 23/103 (22%), Positives = 36/103 (34%), Gaps = 26/103 (25%)
Query: 105 LQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLN--------------- 149
L + + + L +L + LDLS+N+ P +L L L
Sbjct: 5 LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGV 61
Query: 150 -------YLRLNNNSLTG-SCPESLSKIESLTLVDLSYNNLSG 184
L L NN L + + L L L++L N+L
Sbjct: 62 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 3e-05
Identities = 22/107 (20%), Positives = 30/107 (28%), Gaps = 24/107 (22%)
Query: 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKL----------------------QT 126
T+ + L + + L +N + P +L L L Q
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANLPRLQE 69
Query: 127 LDLSNNKFTG-EIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESL 172
L L NN+ L L L L NSL E L
Sbjct: 70 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.7 bits (92), Expect = 1e-04
Identities = 20/121 (16%), Positives = 37/121 (30%), Gaps = 33/121 (27%)
Query: 125 QTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCP--------------------- 163
+ L L++ T + L L + +L L++N L P
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 164 ESLSKIESLTLVDLSYNNLS--------GSLPKISARTFKVTGNPLICGPKATNNCTAVF 215
+ ++ + L + L N L S P++ + GN L +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL--VLLNLQGNSLCQEEGIQERLAEML 116
Query: 216 P 216
P
Sbjct: 117 P 117
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.8 bits (82), Expect = 0.003
Identities = 12/55 (21%), Positives = 20/55 (36%), Gaps = 4/55 (7%)
Query: 101 QSVLLQNNAILG-PIPASLGKLEKLQTLDLSNNKFTGE---IPDSLGDLGNLNYL 151
Q +LL NN + L +L L+L N E L +++ +
Sbjct: 68 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 3e-07
Identities = 16/57 (28%), Positives = 20/57 (35%), Gaps = 1/57 (1%)
Query: 106 QNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSC 162
NN + L LE L TL L N IP L + L+ N +C
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 6e-07
Identities = 13/64 (20%), Positives = 18/64 (28%), Gaps = 3/64 (4%)
Query: 94 IGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153
+ + V L +P L K L LS N +L L L L
Sbjct: 6 VSKVASHLEVNCDKRN-LTALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 154 NNNS 157
+
Sbjct: 63 DRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 1e-05
Identities = 12/65 (18%), Positives = 22/65 (33%), Gaps = 3/65 (4%)
Query: 117 SLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVD 176
+ K+ ++ T +P L + L L+ N L +L LT ++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 177 LSYNN 181
L
Sbjct: 62 LDRAE 66
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 3e-07
Identities = 20/95 (21%), Positives = 36/95 (37%), Gaps = 4/95 (4%)
Query: 86 LSG-TLSP-WIGNLTKLQSVLLQ-NNAILGPIPASLGKLEKLQTLDLSNNKFTGE-IPDS 141
L+G L P G L + + + + A ++Q +DLSN+ +
Sbjct: 7 LTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGI 66
Query: 142 LGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVD 176
L L L L L+ +L+K +L ++
Sbjct: 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 9e-05
Identities = 16/74 (21%), Positives = 30/74 (40%), Gaps = 3/74 (4%)
Query: 125 QTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSG 184
QTLDL+ ++ L G + R + + E S + +DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEV 60
Query: 185 -SLPKISARTFKVT 197
+L I ++ K+
Sbjct: 61 STLHGILSQCSKLQ 74
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.002
Identities = 18/114 (15%), Positives = 35/114 (30%), Gaps = 4/114 (3%)
Query: 62 PCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQN-NAILGPIPASLGK 120
+ V S L L LQ + L I+ LG+
Sbjct: 164 KSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE 223
Query: 121 LEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTL 174
+ L+TL + G + L + L++N + T ++ ++ +
Sbjct: 224 IPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTIGNKKNQEI 274
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.8 bits (109), Expect = 4e-06
Identities = 14/91 (15%), Positives = 32/91 (35%), Gaps = 8/91 (8%)
Query: 100 LQSVLLQNNAI----LGPIPASLGKLEKLQTLDLSNNKFTGE----IPDSLGDLGNLNYL 151
++ L+ +AI + A L + + ++ + LS N E + +++ +L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 152 RLNNNSLTGSCPESLSKIESLTLVDLSYNNL 182
++ E + L L L
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.1 bits (102), Expect = 3e-05
Identities = 14/61 (22%), Positives = 26/61 (42%), Gaps = 6/61 (9%)
Query: 117 SLGKLEKLQTLDLSNNKFTGEIPDSLGD-----LGNLNYLRLNNNSLTGSCPESLSKIES 171
S + LQTL L N+ + +L + +L +L LN N + + + +I
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE-DDVVDEIRE 326
Query: 172 L 172
+
Sbjct: 327 V 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 2e-04
Identities = 23/114 (20%), Positives = 40/114 (35%), Gaps = 12/114 (10%)
Query: 54 NWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGN------LTKLQSVLLQN 107
+ + S I + LGL LS + + + LQ++ LQ
Sbjct: 223 QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQY 282
Query: 108 NAILGPIPASL-----GKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN 156
N I +L K+ L L+L+ N+F E D + ++ + R
Sbjct: 283 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.6 bits (85), Expect = 0.003
Identities = 13/66 (19%), Positives = 24/66 (36%), Gaps = 11/66 (16%)
Query: 129 LSNNKFTGEIPDSLGD------LGNLNYLRLNNNSLTGSCPESL-----SKIESLTLVDL 177
L++ + ++ D L LRL N + +L K+ L ++L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 178 SYNNLS 183
+ N S
Sbjct: 310 NGNRFS 315
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 6e-06
Identities = 13/84 (15%), Positives = 32/84 (38%), Gaps = 8/84 (9%)
Query: 105 LQNNAILGPIPAS----LGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTG 160
L + I P P + +L T + + +L +++ + NN+ +
Sbjct: 3 LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS 60
Query: 161 SCPESLSKIESLTLVDLSYNNLSG 184
+ + ++T + L+ N L+
Sbjct: 61 VQG--IQYLPNVTKLFLNGNKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 6e-06
Identities = 12/70 (17%), Positives = 26/70 (37%), Gaps = 4/70 (5%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
+ L+ ++ + + +L + + +N+ + L N+ L LN
Sbjct: 22 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 156 NSLTGSCPES 165
N LT P +
Sbjct: 78 NKLTDIKPLA 87
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 4e-04
Identities = 23/63 (36%), Positives = 33/63 (52%), Gaps = 4/63 (6%)
Query: 93 WIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLR 152
+ LTKL ++ L++N I +P L L KLQ L LS N + +L L NL+ L
Sbjct: 151 VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLE 206
Query: 153 LNN 155
L +
Sbjct: 207 LFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.5 bits (83), Expect = 0.004
Identities = 13/40 (32%), Positives = 20/40 (50%), Gaps = 2/40 (5%)
Query: 92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSN 131
+ LTKLQ++ L N I +L L+ L L+L +
Sbjct: 172 VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (103), Expect = 1e-05
Identities = 16/112 (14%), Positives = 24/112 (21%)
Query: 46 HDPYNVLENWDITSVDPCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLL 105
H VL + R L L + + + L
Sbjct: 125 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLS 184
Query: 106 QNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNS 157
NN + LD+S + L +L L N
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 7e-04
Identities = 10/66 (15%), Positives = 17/66 (25%), Gaps = 3/66 (4%)
Query: 124 LQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183
+ NN D L ++ + L ++ L NL
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236
Query: 184 GSLPKI 189
LP +
Sbjct: 237 -KLPTL 241
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 4e-05
Identities = 24/116 (20%), Positives = 40/116 (34%), Gaps = 3/116 (2%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
N + + + L+ I I L++ +D S+N+ D L L L +NN
Sbjct: 16 NAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNN 72
Query: 156 NSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISARTFKVTGNPLICGPKATNNC 211
N + + LT + L+ N+L + K I TN
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 3e-04
Identities = 22/89 (24%), Positives = 41/89 (46%), Gaps = 2/89 (2%)
Query: 86 LSGTLSPWIGNLTKLQSVLLQNNAILG--PIPASLGKLEKLQTLDLSNNKFTGEIPDSLG 143
++ TL N+ +L S+ L NN + + + + K L+ L+LS N+ E
Sbjct: 53 MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKI 112
Query: 144 DLGNLNYLRLNNNSLTGSCPESLSKIESL 172
L L L+ NSL+ + + + I ++
Sbjct: 113 KGLKLEELWLDGNSLSDTFRDQSTYISAI 141
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 5e-04
Identities = 19/98 (19%), Positives = 38/98 (38%), Gaps = 3/98 (3%)
Query: 92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTG--EIPDSLGDLGNLN 149
P + + +++ + + + +L +L+LSNN+ ++ + NL
Sbjct: 36 PDLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 94
Query: 150 YLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187
L L+ N L K L + L N+LS +
Sbjct: 95 ILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.001
Identities = 14/67 (20%), Positives = 24/67 (35%), Gaps = 4/67 (5%)
Query: 96 NLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNN 155
L + +L + + S L+++ TL D + L NL + +N
Sbjct: 16 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71
Query: 156 NSLTGSC 162
N LT
Sbjct: 72 NQLTDIT 78
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.001
Identities = 15/46 (32%), Positives = 21/46 (45%), Gaps = 4/46 (8%)
Query: 106 QNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYL 151
+N + P L L L+ LD+S+NK + L L NL L
Sbjct: 158 SSNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 36.6 bits (83), Expect = 0.003
Identities = 16/61 (26%), Positives = 25/61 (40%), Gaps = 8/61 (13%)
Query: 97 LTKLQSVLLQNNAILGPIP------ASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNY 150
+ + + + G IP A+L L+ + L LS N +I SL + NL
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRI 74
Query: 151 L 151
L
Sbjct: 75 L 75
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 540 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.61 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.61 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.58 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.57 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.49 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.48 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.47 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.45 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.42 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.4 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.37 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.36 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.35 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.21 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.19 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.13 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.12 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.11 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.09 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.08 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.99 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.88 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.86 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.84 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.8 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.42 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.42 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.39 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.39 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.38 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.12 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.08 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.0 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.98 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.86 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.71 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.65 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.57 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.31 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.11 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.05 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.48 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.23 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.78 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=371.37 Aligned_cols=202 Identities=26% Similarity=0.399 Sum_probs=175.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
++|++.+.||+|+||+||+|..+ +|+.||||+++.....+...++.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56888999999999999999975 68999999997655444456799999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++|+|.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999864 35799999999999999999999999 99999999999999999999999999998765332
Q ss_pred C-ceeeccccccccccccccccCCC-CccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 460 S-HVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 460 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
. .......||+.|+|||++.+..+ +.++||||+||++|||+||+.||+..
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~ 209 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 209 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCC
Confidence 2 22345679999999999988776 67899999999999999999999743
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=365.97 Aligned_cols=198 Identities=23% Similarity=0.376 Sum_probs=178.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
++|.+.+.||+|+||+||+|... +|+.||||+++... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc-ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 46889999999999999999974 69999999987654 23456799999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++|+|.+++.+ ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++.+....
T Consensus 99 ~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999998764 3589999999999999999999999 99999999999999999999999999998775433
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ......||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 171 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 218 (293)
T d1yhwa1 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (293)
T ss_dssp C-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred c-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC
Confidence 2 23445699999999999999999999999999999999999999974
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=361.66 Aligned_cols=199 Identities=28% Similarity=0.472 Sum_probs=166.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
++|++.+.||+|+||.||+|.+.+++.||||+++... ..+.+|.+|++++++++||||++++|+|..++..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 4678889999999999999999889999999997643 34568999999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++|+|.+++... ...++|..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999998753 45689999999999999999999999 999999999999999999999999999987765444
Q ss_pred ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhC-CCCCC
Q 009208 461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG-QRALD 507 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg-~~p~~ 507 (540)
.......||+.|+|||++.+..++.++|||||||++|||+|+ +.||.
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~ 204 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC
Confidence 444456699999999999999999999999999999999995 55554
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=365.15 Aligned_cols=207 Identities=26% Similarity=0.373 Sum_probs=168.3
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-cHHHHHHHHHHHhcccCCCccceeEEEec--CCeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-GEVQFQTEVETISLAVHRNLLRLCGFCST--ENERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lV 376 (540)
++|++.+.||+|+||+||+|..+ +|+.||||.++.....+ ....+.+|++++++++||||+++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67899999999999999999875 68999999997654332 34568999999999999999999999865 4567999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC--DPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
|||+++|+|.+++.+.......+++..++.++.|++.||+|||++. ..+|+||||||+|||+++++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999765444567999999999999999999999872 12499999999999999999999999999987
Q ss_pred cCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence 764332 23456799999999999999999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=358.33 Aligned_cols=198 Identities=31% Similarity=0.482 Sum_probs=177.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|++.+.||+|+||+||+|..+ +|+.||+|++..... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999985 689999999865332 234567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.+. ..+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999999999999753 4699999999999999999999999 999999999999999999999999999986553
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 206 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 206 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence 32 3445699999999999999999999999999999999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=363.82 Aligned_cols=200 Identities=33% Similarity=0.501 Sum_probs=168.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|.+.+.||+|+||+||+|+++ ..||||+++.... ....++|.+|++++.+++|||||++++++.. +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467889999999999999999874 3599999975543 3345679999999999999999999998754 56899999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.++++.. ...+++..+..++.|+++||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999753 34699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC-ceeecccccccccccccccc---CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DS-HVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~-~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. .......||+.|+|||++.. ..++.++|||||||++|||+||+.||..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~ 211 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC
Confidence 22 23345679999999999864 3478999999999999999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-46 Score=366.26 Aligned_cols=202 Identities=29% Similarity=0.442 Sum_probs=180.9
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
..++|.+.+.||+|+||+||+|.++ +|+.||||+++... ...++|.+|++++++++|||||++++++.+.+..++||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 3567888899999999999999986 58899999987643 34567999999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.+. ....+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 93 E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 93 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp ECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred ecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 999999999999753 345799999999999999999999999 999999999999999999999999999998766
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
..........||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 55554555668999999999999999999999999999999999877765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-46 Score=365.87 Aligned_cols=202 Identities=27% Similarity=0.453 Sum_probs=165.8
Q ss_pred cCCCcCCeeeeccCccEEEEEeCC-C---cEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSD-G---ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
++|.+.+.||+|+||+||+|.++. + ..||||.+.........++|.+|++++++++|||||+++|++..++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 345567899999999999999752 2 369999987765555566899999999999999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++|+|.+++... ...++|..+..++.||++||.|||++ +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 106 ~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999988753 45699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCce----eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 457 HRDSHV----TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 457 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
...... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence 433221 122457899999999999999999999999999999998 8999974
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=363.07 Aligned_cols=200 Identities=30% Similarity=0.480 Sum_probs=175.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.++|.+.+.||+|+||.||+|.+++++.||||+++... ....+|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 45688889999999999999999888999999997643 345679999999999999999999998754 567999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++|+|.+++... ....++|..+..++.||++||.|||++ +|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 89 ~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc
Confidence 9999999987643 223589999999999999999999999 99999999999999999999999999999876554
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
........||+.|+|||++.+..++.++|||||||++|||+||..|+.
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 444455678999999999999999999999999999999999765554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=371.23 Aligned_cols=201 Identities=24% Similarity=0.354 Sum_probs=179.0
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|++.+.||+|+||+||+|... +|+.||+|+++.........++.+|++++++++|||||++++++.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467999999999999999999975 6899999999866545556689999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+++|+|.+++.+. ..+++..+..++.|+++||.|||+++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 y~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 99999999999753 46999999999999999999999731 8999999999999999999999999999865432
Q ss_pred CCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 159 ~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 159 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp T---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred c---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 2 23457999999999999999999999999999999999999999754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=362.48 Aligned_cols=202 Identities=26% Similarity=0.390 Sum_probs=176.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|++.+.||+|+||+||+|... +|+.||||+++.... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56889999999999999999975 689999999875321 233457899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 999999999988753 4699999999999999999999999 999999999999999999999999999987754
Q ss_pred CC-CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. ........||+.|+|||++.+..++.++||||+||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 32 22334557999999999999999999999999999999999999999743
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=351.78 Aligned_cols=200 Identities=26% Similarity=0.442 Sum_probs=181.0
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
++|+..+.||+|+||+||+|++++++.||||+++... ..+.+|.+|++++++++||||++++|+|.+++..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 5788999999999999999999889999999998654 34568999999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++|+|.+++... ...+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++.+.....
T Consensus 82 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 999999987643 34689999999999999999999999 999999999999999999999999999987765544
Q ss_pred ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.......||+.|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~ 204 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 204 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC
Confidence 44445669999999999999999999999999999999998 8999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=364.17 Aligned_cols=201 Identities=26% Similarity=0.347 Sum_probs=175.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
+.|++.+.||+|+||+||+|... +|+.||||+++... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 46788899999999999999975 68999999997653 33345789999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++|+|.+++.+. ...+++..+..++.|+++||.|||++ +|+||||||+|||++.++++||+|||+|+......
T Consensus 91 ~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 91 CAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp CTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 9999999988653 34699999999999999999999999 99999999999999999999999999997543221
Q ss_pred Cceeeccccccccccccccc-----cCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 460 SHVTTAVRGTVGHIAPEYLS-----TGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.......||+.|+|||++. ...++.++|||||||++|||+||+.||...
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 1223456999999999984 456789999999999999999999999743
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-45 Score=359.03 Aligned_cols=200 Identities=25% Similarity=0.408 Sum_probs=161.9
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.+.|.+.+.||+|+||+||+|..+ +|+.||||++...........+.+|++++++++||||+++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 456889999999999999999975 6899999999876555555678899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC---CCCCeEEccccccccc
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLL 455 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgla~~~ 455 (540)
|+++|+|.+++.+ ...+++..+..++.|++.||+|||++ +|+||||||+||++. +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999965 35799999999999999999999999 999999999999995 5789999999999866
Q ss_pred CCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 211 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 211 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence 5332 23445699999999999999999999999999999999999999974
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=355.01 Aligned_cols=201 Identities=27% Similarity=0.432 Sum_probs=174.2
Q ss_pred cCCCcCCe-eeeccCccEEEEEeC---CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEE
Q 009208 301 SNFSAKNI-LGRGGFGIVYKGCFS---DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 301 ~~~~~~~~-lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
++|.+.+. ||+|+||+||+|.++ ++..||||+++.........+|.+|++++.+++|||||+++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 44555564 999999999999864 3567999999876555556789999999999999999999999865 468899
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++|+|.+++... +..+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 87 mE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999988542 45799999999999999999999999 99999999999999999999999999999776
Q ss_pred CCCCce--eeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 457 HRDSHV--TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 457 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
...... .....||+.|+|||++....++.++|||||||++|||+| |+.||..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~ 215 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 215 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCC
Confidence 543322 223458999999999999999999999999999999998 9999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=359.99 Aligned_cols=201 Identities=25% Similarity=0.326 Sum_probs=179.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|.+.+.||+|+||.||+|+.+ +|+.||+|++++... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 56889999999999999999974 699999999975421 234567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|.+++.+. ..+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999998763 4689999999999999999999999 999999999999999999999999999986553
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 158 ~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~ 208 (337)
T d1o6la_ 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc
Confidence 32 2334567999999999999999999999999999999999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=347.63 Aligned_cols=196 Identities=29% Similarity=0.443 Sum_probs=167.5
Q ss_pred CcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEec----CCeeEEEE
Q 009208 304 SAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCST----ENERLLVY 377 (540)
Q Consensus 304 ~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lV~ 377 (540)
...+.||+|+||+||+|... +++.||+|+++.... ......|.+|++++++++|||||++++++.. +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44567999999999999975 588999999876543 2334579999999999999999999999864 34578999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC-CCCCeEEcccccccccC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD-EDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~Dfgla~~~~ 456 (540)
||+++|+|.+++.+. ..+++..+..++.||++||+|||++ .++|+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999763 4689999999999999999999998 12299999999999996 57899999999998654
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.. ......||+.|+|||++.+ .++.++|||||||++|||++|+.||..
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~ 214 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 214 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence 32 2345579999999999865 599999999999999999999999973
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=351.85 Aligned_cols=201 Identities=29% Similarity=0.468 Sum_probs=168.6
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCC-----cEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDG-----ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
+.|+..++||+|+||.||+|.++.. ..||||+++.........+|.+|++++.+++|||||+++|++...+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577789999999999999997542 47999999766555556689999999999999999999999999999999
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||+.+|++.+++... ...++|..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+
T Consensus 87 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999887653 45799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 456 DHRDSH--VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 456 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
...... ......||+.|+|||++.+..++.++|||||||++|||+||..|+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 543222 2234458999999999999999999999999999999999766664
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-44 Score=355.54 Aligned_cols=197 Identities=30% Similarity=0.403 Sum_probs=176.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|++.+.||+|+||+||+|+.+ +|+.||||+++.... ......+.+|+.++++++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56888999999999999999974 699999999975321 234567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|+|..++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999988875 34678899999999999999999999 999999999999999999999999999987653
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. .....||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 203 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 203 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC
Confidence 2 2345799999999999999999999999999999999999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=357.72 Aligned_cols=206 Identities=28% Similarity=0.412 Sum_probs=174.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC------CcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD------GALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 372 (540)
.++|.+.+.||+|+||+||+|++.. ...||||.+...........+.+|+.++.++ +|||||++++++...+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4678899999999999999998743 2369999987655455556799999999998 89999999999999999
Q ss_pred eEEEEecCCCCChhhhccccCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 009208 373 RLLVYPYMPNGSVASRLRDHIH-------------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKA 433 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~ 433 (540)
.++||||+++|+|.++|+.... ....++|..++.++.|+++||+|||++ +|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 9999999999999999975321 124589999999999999999999999 999999999
Q ss_pred CceeeCCCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 434 ANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 434 ~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+|||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999876544333 2344568999999999999999999999999999999998 8999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.6e-44 Score=356.94 Aligned_cols=200 Identities=25% Similarity=0.389 Sum_probs=178.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++|||||++++++.+++..++|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 357999999999999999999974 68999999997654 3345578999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC--CCCCeEEcccccccccC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD--EDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~Dfgla~~~~ 456 (540)
|+++|+|.+++.+. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++.+.
T Consensus 104 ~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 104 FMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred cCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 99999999998642 34699999999999999999999999 999999999999996 45789999999998776
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... .....||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 178 ~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 227 (350)
T d1koaa2 178 PKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227 (350)
T ss_dssp TTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC
Confidence 4432 3445699999999999999999999999999999999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-44 Score=352.26 Aligned_cols=196 Identities=30% Similarity=0.393 Sum_probs=172.5
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc--cHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
+.|+..+.||+|+||.||+|... +|+.||||+++...... ....+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 34888899999999999999864 68999999997654332 2346899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+++|++..++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999776654 35699999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeecccccccccccccccc---CCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLST---GQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 168 ~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~ 216 (309)
T d1u5ra_ 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (309)
T ss_dssp B-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC
Confidence 2 23469999999999864 4589999999999999999999999963
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=347.80 Aligned_cols=201 Identities=22% Similarity=0.328 Sum_probs=178.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-----ccHHHHHHHHHHHhcccCCCccceeEEEecCCee
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-----GGEVQFQTEVETISLAVHRNLLRLCGFCSTENER 373 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 373 (540)
.+.|.+.+.||+|+||+||+|..+ +|+.||||+++..... .....+.+|++++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357889999999999999999974 6899999999754322 2356799999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC----CeEEccc
Q 009208 374 LLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF----EAVVGDF 449 (540)
Q Consensus 374 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~Df 449 (540)
++||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 9999999999999999763 4699999999999999999999999 999999999999999776 4999999
Q ss_pred ccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
|++....... ......||+.|+|||++.+..++.++||||+||++|||+||+.||...
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 219 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence 9998765433 233456999999999999999999999999999999999999999743
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=350.28 Aligned_cols=201 Identities=31% Similarity=0.449 Sum_probs=169.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
.++|++.+.||+|+||.||+|.+++++.||||+++... .....|.+|+.++.+++|||||+++|++. .+..++||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence 35788999999999999999999888899999997654 34567999999999999999999999985 4568999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++|+|..++... ....++|..++.++.||++||+|||+. +|+||||||+|||+++++++||+|||+++......
T Consensus 93 ~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 93 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred cCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 9999999988753 234699999999999999999999999 99999999999999999999999999998776544
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
........||+.|+|||++....++.++|||||||++|||+||..|+..
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 4444556699999999999999999999999999999999997766653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-44 Score=346.60 Aligned_cols=194 Identities=28% Similarity=0.409 Sum_probs=165.9
Q ss_pred CeeeeccCccEEEEEeCC---CcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecCCC
Q 009208 307 NILGRGGFGIVYKGCFSD---GALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYMPN 382 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~~~ 382 (540)
+.||+|+||+||+|.+++ ++.||||+++..... ....+|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998743 468999999754332 234579999999999999999999999865 457899999999
Q ss_pred CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCCce
Q 009208 383 GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHV 462 (540)
Q Consensus 383 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~~~ 462 (540)
|+|.+++++ ...++|..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999875 34699999999999999999999999 99999999999999999999999999998776544332
Q ss_pred e--eccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 463 T--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 463 ~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
. ....||+.|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~ 213 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 213 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC
Confidence 2 33568999999999999999999999999999999998 8999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-43 Score=354.49 Aligned_cols=200 Identities=22% Similarity=0.335 Sum_probs=178.4
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|++.+.||+|+||.||+|... +|+.||||+++... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 357899999999999999999974 69999999987644 2335578899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC--CCCCeEEcccccccccC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD--EDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~Dfgla~~~~ 456 (540)
|+++|+|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++ +++.+||+|||+|+.+.
T Consensus 107 ~~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 107 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecC
Confidence 99999998877542 44699999999999999999999999 999999999999998 67899999999999876
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... ......||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 230 (352)
T d1koba_ 181 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230 (352)
T ss_dssp TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 533 23445699999999999999999999999999999999999999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-43 Score=354.10 Aligned_cols=197 Identities=25% Similarity=0.314 Sum_probs=177.3
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVY 377 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~ 377 (540)
++|++.+.||+|+||.||+|..+ +|+.||||+++.... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46889999999999999999975 699999999864321 233457899999999999999999999999999999999
Q ss_pred ecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCC
Q 009208 378 PYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDH 457 (540)
Q Consensus 378 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~ 457 (540)
||+.+|+|.+++.+. ..+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+++.+..
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999998753 4689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 458 RDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 458 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 240 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC
Confidence 3 2345699999999999999999999999999999999999999974
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=343.59 Aligned_cols=203 Identities=24% Similarity=0.377 Sum_probs=166.0
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC----CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD----GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
.++|.+.+.||+|+||.||+|.+.. +..||||.++..........|.+|++++++++||||+++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4678889999999999999998743 45799999876655555678999999999999999999999985 567899
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
||||+++|+|.+++... ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 99999999999987653 45789999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCcc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDFG 509 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~~ 509 (540)
............||+.|+|||++.+..++.++|||||||++|||+| |+.||...
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~ 213 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC
Confidence 6554444555668999999999999999999999999999999998 89999753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=346.61 Aligned_cols=200 Identities=29% Similarity=0.415 Sum_probs=175.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCC--ccccHHHHHHHHHHHh-cccCCCccceeEEEecCCeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYN--IAGGEVQFQTEVETIS-LAVHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~lV 376 (540)
++|.+.+.||+|+||+||+|+.. +|+.||||+++... .......+..|..++. .++||||+++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999985 68999999997532 1233445677777765 68999999999999999999999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccC
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLD 456 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~ 456 (540)
|||+++|+|.++++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 9999999999999763 4688999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
.... ......||+.|+|||++.+..++.++||||+||++|||+||+.||..
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~ 205 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC
Confidence 4332 23445699999999999999999999999999999999999999974
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-43 Score=348.82 Aligned_cols=212 Identities=27% Similarity=0.420 Sum_probs=180.7
Q ss_pred HHHHHHhcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEE
Q 009208 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFC 367 (540)
Q Consensus 294 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 367 (540)
.+++...++|++.+.||+|+||+||+|+++ +++.||||+++.........+|.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 344455678999999999999999999864 35789999998766555567899999999999999999999999
Q ss_pred ecCCeeEEEEecCCCCChhhhccccC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 009208 368 STENERLLVYPYMPNGSVASRLRDHI--------------------HGRPALDWARRKRIALGTARGLLYLHEQCDPKII 427 (540)
Q Consensus 368 ~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv 427 (540)
...+..++||||+++|+|.++++... .....+++..+..++.|++.||+|||+. +||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence 99999999999999999999986421 1233589999999999999999999999 999
Q ss_pred ecCCCCCceeeCCCCCeEEcccccccccCCCC-CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCC-CC
Q 009208 428 HRDVKAANILLDEDFEAVVGDFGLAKLLDHRD-SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ-RA 505 (540)
Q Consensus 428 H~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~-~p 505 (540)
||||||+|||++.++.+||+|||+++.+.... ........||+.|+|||.+.+..++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998664432 22234456899999999999999999999999999999999996 56
Q ss_pred CCc
Q 009208 506 LDF 508 (540)
Q Consensus 506 ~~~ 508 (540)
|..
T Consensus 243 ~~~ 245 (301)
T d1lufa_ 243 YYG 245 (301)
T ss_dssp TTT
T ss_pred CCC
Confidence 663
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-43 Score=354.85 Aligned_cols=199 Identities=29% Similarity=0.396 Sum_probs=171.8
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc--cccHHHHHH---HHHHHhcccCCCccceeEEEecCCeeE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI--AGGEVQFQT---EVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~~---E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
++|.+.+.||+|+||.||+|+.. +|+.||||++..... ......+.+ |+++++.++|||||++++++..++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999975 699999999864321 222333444 466777888999999999999999999
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999763 4688999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 455 LDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 455 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
..... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 65432 234569999999999875 46899999999999999999999999743
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-43 Score=345.67 Aligned_cols=201 Identities=27% Similarity=0.492 Sum_probs=169.7
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCc----EEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGA----LVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLL 375 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 375 (540)
++|++.+.||+|+||+||+|.+. +|+ +||+|+++........++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888999999999999999874 343 69999988766566677899999999999999999999999865 5678
Q ss_pred EEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccccccc
Q 009208 376 VYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL 455 (540)
Q Consensus 376 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~ 455 (540)
++||+.+|+|.+++... ...+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 89999999999988753 45799999999999999999999999 9999999999999999999999999999977
Q ss_pred CCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 456 DHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 456 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
...... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||+.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~ 216 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence 544332 2334468999999999999999999999999999999999 7889874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-42 Score=335.03 Aligned_cols=202 Identities=24% Similarity=0.335 Sum_probs=168.9
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccc--cHHHHHHHHHHHhcccCCCccceeEEEecCC----e
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAG--GEVQFQTEVETISLAVHRNLLRLCGFCSTEN----E 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~ 372 (540)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++.....+ ....|.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35688999999999999999997 469999999997654332 2346999999999999999999999987644 3
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.++||||+++|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 78999999999999988653 4699999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCC--ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 453 KLLDHRDS--HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 453 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
........ .......||+.|+|||++.+..+++++||||+||++|||+||+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 216 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC
Confidence 76543322 233455699999999999999999999999999999999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=341.36 Aligned_cols=200 Identities=22% Similarity=0.304 Sum_probs=177.1
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
.++|.+.+.||+|+||+||+|... +|+.||||.++... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 467889999999999999999975 68899999997643 234568899999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCC--CCeEEcccccccccC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDED--FEAVVGDFGLAKLLD 456 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~Dfgla~~~~ 456 (540)
|+++|+|.+++.+. ...+++..+..++.||++||+|||+. +|+||||||+|||++.+ ..+||+|||+++...
T Consensus 82 ~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 99999999998653 34699999999999999999999999 99999999999999854 489999999998765
Q ss_pred CCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 457 HRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 457 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
... ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 156 ~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~ 206 (321)
T d1tkia_ 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence 432 234456899999999999999999999999999999999999999743
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.5e-42 Score=333.01 Aligned_cols=200 Identities=26% Similarity=0.371 Sum_probs=175.6
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc--------cHHHHHHHHHHHhccc-CCCccceeEEEecC
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG--------GEVQFQTEVETISLAV-HRNLLRLCGFCSTE 370 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 370 (540)
++|++.+.||+|+||+||+|+.. +|+.||||+++...... ....+.+|++++.+++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57889999999999999999974 68999999987643221 1235889999999997 99999999999999
Q ss_pred CeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccc
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFG 450 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfg 450 (540)
+..++||||+++|+|.++++.. ..+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999753 4699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccccccccccc------CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLST------GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
+++....... .....||+.|+|||.+.+ ..++.++||||+||++|||+||+.||...
T Consensus 156 ~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~ 218 (277)
T d1phka_ 156 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 218 (277)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred heeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC
Confidence 9987764332 234569999999999853 34688999999999999999999999844
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-43 Score=335.36 Aligned_cols=195 Identities=32% Similarity=0.478 Sum_probs=163.4
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEec-CCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST-ENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~e~ 379 (540)
++|++.+.||+|+||.||+|.+ .|..||||+++.. ...++|.+|++++++++||||++++|+|.+ ++..++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 4577789999999999999998 5789999999753 334679999999999999999999999865 4668999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+++|+|.++|... ....++|..+++++.||+.||.|||+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 83 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC-
Confidence 9999999999753 123589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CceeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
.....+|+.|+|||++.+..+++++|||||||++|||+| |+.||..
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~ 203 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC
Confidence 223458899999999999999999999999999999998 6888764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=340.15 Aligned_cols=212 Identities=25% Similarity=0.339 Sum_probs=168.3
Q ss_pred HHHHHHhcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEE
Q 009208 294 KELRAATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGF 366 (540)
Q Consensus 294 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 366 (540)
++++...++|++.+.||+|+||.||+|.+. +++.||||+++.........++.+|.+.+.++ +|+||++++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344444578999999999999999999863 34689999998765555566788888888777 68999999999
Q ss_pred EecC-CeeEEEEecCCCCChhhhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 009208 367 CSTE-NERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKA 433 (540)
Q Consensus 367 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~ 433 (540)
+..+ +..++||||+++|+|.++++.... ....+++..+..++.||++||.|||++ +|+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCc
Confidence 8654 468999999999999999975321 134589999999999999999999999 999999999
Q ss_pred CceeeCCCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCC-CCCCc
Q 009208 434 ANILLDEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ-RALDF 508 (540)
Q Consensus 434 ~NILl~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~-~p~~~ 508 (540)
+|||+++++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||..
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999866543322 233456999999999999999999999999999999999975 57763
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-42 Score=340.53 Aligned_cols=196 Identities=25% Similarity=0.339 Sum_probs=169.2
Q ss_pred hcCCCcC-CeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhc-ccCCCccceeEEEec----CCe
Q 009208 300 TSNFSAK-NILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISL-AVHRNLLRLCGFCST----ENE 372 (540)
Q Consensus 300 ~~~~~~~-~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~----~~~ 372 (540)
.++|.+. +.||+|+||.||+|.. .+|+.||||+++.. ..+.+|++++.+ .+||||+++++++.+ +..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 3578765 4699999999999997 46899999998643 357889998765 489999999999864 456
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC---CCCeEEccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE---DFEAVVGDF 449 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~Df 449 (540)
.++||||+++|+|.+++.+. +...+++..+..++.|++.||+|||+. +|+||||||+|||+++ ++.+||+||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccc
Confidence 89999999999999999753 335699999999999999999999999 9999999999999985 557999999
Q ss_pred ccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 450 GLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 450 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|+++....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 159 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~ 215 (335)
T d2ozaa1 159 GFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215 (335)
T ss_dssp TTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred ceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence 99987654332 3445699999999999999999999999999999999999999974
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-42 Score=338.67 Aligned_cols=202 Identities=29% Similarity=0.469 Sum_probs=170.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeCC-Cc--EEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSD-GA--LVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lV 376 (540)
++|++.+.||+|+||.||+|.+++ |. .||||+++........++|.+|++++.++ +||||++++|++..++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578888999999999999999854 43 58889887655455566899999999998 799999999999999999999
Q ss_pred EecCCCCChhhhcccc------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCe
Q 009208 377 YPYMPNGSVASRLRDH------------IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEA 444 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~------------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 444 (540)
|||+++|+|.++|+.. ......++|..+..++.||++||.|+|+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999753 12345799999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCC-CCC
Q 009208 445 VVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQR-ALD 507 (540)
Q Consensus 445 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~-p~~ 507 (540)
||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||.
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~ 228 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence 9999999985543222 223458999999999999999999999999999999999765 565
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=332.87 Aligned_cols=200 Identities=35% Similarity=0.493 Sum_probs=162.8
Q ss_pred cCCCcCCeeeeccCccEEEEEeC--CC--cEEEEEEeccCCcc--ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS--DG--ALVAVKRLKDYNIA--GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERL 374 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~--~g--~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 374 (540)
++|++.+.||+|+||.||+|.+. ++ ..||||+++..... ...++|.+|++++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888899999999999999863 22 47999998765432 234579999999999999999999999975 4678
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
+||||+++|++.+++... ...+++..+..++.|+++||.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 999999999999988653 34699999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCcee--eccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCC
Q 009208 455 LDHRDSHVT--TAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALD 507 (540)
Q Consensus 455 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~ 507 (540)
......... ....||..|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~ 216 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence 755433322 23457889999999999999999999999999999998 899996
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=334.29 Aligned_cols=197 Identities=35% Similarity=0.511 Sum_probs=170.3
Q ss_pred CCeeeeccCccEEEEEeCCC----cEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEec-CCeeEEEEecC
Q 009208 306 KNILGRGGFGIVYKGCFSDG----ALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCST-ENERLLVYPYM 380 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lV~e~~ 380 (540)
.++||+|+||+||+|.+.++ ..||||+++.........+|.+|++++++++||||++++|++.. ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997542 36999999765545556789999999999999999999999875 56889999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
++|+|.++++.. ....++..+..++.|+++||.|+|+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999988753 45678899999999999999999999 999999999999999999999999999987654322
Q ss_pred c---eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 461 H---VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 461 ~---~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ......||+.|+|||.+....++.++||||||+++|||+||+.||..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 2 22234689999999999999999999999999999999998888864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-42 Score=335.38 Aligned_cols=196 Identities=28% Similarity=0.318 Sum_probs=165.2
Q ss_pred CCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcccc----HHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEecC
Q 009208 306 KNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGG----EVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPYM 380 (540)
Q Consensus 306 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~~ 380 (540)
.++||+|+||+||+|..+ +|+.||||+++....... ...+.+|++++++++|||||++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999975 689999999875433222 236889999999999999999999999999999999999
Q ss_pred CCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCCC
Q 009208 381 PNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDS 460 (540)
Q Consensus 381 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~~ 460 (540)
+++++..... ....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9887665543 245688899999999999999999999 999999999999999999999999999986654332
Q ss_pred ceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 461 HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 461 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
......||+.|+|||++... .++.++||||+||++|||+||+.||...
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 23345699999999998654 5799999999999999999999999743
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-42 Score=338.50 Aligned_cols=206 Identities=27% Similarity=0.420 Sum_probs=178.5
Q ss_pred HhcCCCcCCeeeeccCccEEEEEeC------CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCCe
Q 009208 299 ATSNFSAKNILGRGGFGIVYKGCFS------DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTENE 372 (540)
Q Consensus 299 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 372 (540)
..++|.+.+.||+|+||.||+|.+. ++..||||+++..........|.+|++++.+++||||+++++++..++.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3567888999999999999999873 3578999999876555555679999999999999999999999999999
Q ss_pred eEEEEecCCCCChhhhcccc------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEE
Q 009208 373 RLLVYPYMPNGSVASRLRDH------IHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVV 446 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl 446 (540)
.++||||+++|+|.+++... ......+++..+..++.|+++||.|||++ +|+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEE
Confidence 99999999999999998642 12234579999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCCCCCce-eeccccccccccccccccCCCCccCCeehhhHHHHHHHhCC-CCCC
Q 009208 447 GDFGLAKLLDHRDSHV-TTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQ-RALD 507 (540)
Q Consensus 447 ~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~-~p~~ 507 (540)
+|||+++.+....... .....||+.|+|||.+.+..++.++||||||+++|||+||+ .||.
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~ 237 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC
Confidence 9999998765433322 23345899999999999999999999999999999999985 6665
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-42 Score=334.95 Aligned_cols=197 Identities=28% Similarity=0.420 Sum_probs=163.1
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHH--HHHHHHhcccCCCccceeEEEecCC----eeE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQ--TEVETISLAVHRNLLRLCGFCSTEN----ERL 374 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~--~E~~~l~~l~h~nIv~l~~~~~~~~----~~~ 374 (540)
++|.+.+.||+|+||.||+|++ +|+.||||+++... ..++. .|+..+.+++||||++++++|..++ ..+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 4567788999999999999997 68999999986532 23344 4555556789999999999997654 578
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCceeeCCCCCeEEccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQ-----CDPKIIHRDVKAANILLDEDFEAVVGDF 449 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----~~~~ivH~Dlk~~NILl~~~~~~kl~Df 449 (540)
+||||+++|+|.++|++ ..++|..+..++.|++.||.|+|+. +.++|+||||||+|||+++++.+||+||
T Consensus 78 lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 99999999999999975 3589999999999999999999973 2359999999999999999999999999
Q ss_pred ccccccCCCCCc---eeeccccccccccccccccC------CCCccCCeehhhHHHHHHHhCCCCCC
Q 009208 450 GLAKLLDHRDSH---VTTAVRGTVGHIAPEYLSTG------QSSEKTDVFGFGILLLELITGQRALD 507 (540)
Q Consensus 450 gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~Dv~S~Gvil~elltg~~p~~ 507 (540)
|+++........ ......||+.|+|||++... .++.++|||||||++|||+||..||.
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 999876543322 22345699999999998754 26789999999999999999998875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=333.10 Aligned_cols=202 Identities=24% Similarity=0.371 Sum_probs=170.2
Q ss_pred cCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
++|.+.+.||+|+||+||+|.. .+|+.||||+++..... ....++.+|++++++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999997 46999999999754322 234578999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
|+.++ +.+++.. .....+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~~-~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCc-hhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99765 4444432 2245699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccccccccccccccccCC-CCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
. .......||+.|+|||.+.... ++.++||||+||++|||++|+.||...
T Consensus 156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred c-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 3 2233446999999999877665 588999999999999999999999743
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=335.06 Aligned_cols=205 Identities=28% Similarity=0.394 Sum_probs=178.2
Q ss_pred hcCCCcCCeeeeccCccEEEEEe------CCCcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecCCe
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF------SDGALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTENE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 372 (540)
.++|++.+.||+|+||.||+|++ .+++.||||+++.........+|.+|+.++.++ +|||||+++++|.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 46788889999999999999986 246789999998766566666899999999998 69999999999999999
Q ss_pred eEEEEecCCCCChhhhccccC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009208 373 RLLVYPYMPNGSVASRLRDHI--------------HGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~--------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl 438 (540)
.++||||+++|+|.++++... .....+++..+..++.||++||+|||++ +|+||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 999999999999999997532 1234689999999999999999999999 99999999999999
Q ss_pred CCCCCeEEcccccccccCCCCC-ceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhC-CCCCC
Q 009208 439 DEDFEAVVGDFGLAKLLDHRDS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITG-QRALD 507 (540)
Q Consensus 439 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg-~~p~~ 507 (540)
+.++.+|++|||.++....... .......||+.|+|||++.+..++.++|||||||++|||+|+ ++||.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 9999999999999987765433 333456789999999999999999999999999999999995 55554
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=332.88 Aligned_cols=206 Identities=31% Similarity=0.415 Sum_probs=173.5
Q ss_pred hcCCCcCCeeeeccCccEEEEEeCC--------CcEEEEEEeccCCccccHHHHHHHHHHHhcc-cCCCccceeEEEecC
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFSD--------GALVAVKRLKDYNIAGGEVQFQTEVETISLA-VHRNLLRLCGFCSTE 370 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 370 (540)
.++|.+.+.||+|+||.||+|+... +..||||+++.........++.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4678888999999999999998532 3579999998766555567899999999888 899999999999999
Q ss_pred CeeEEEEecCCCCChhhhccccCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceee
Q 009208 371 NERLLVYPYMPNGSVASRLRDHIH------------GRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILL 438 (540)
Q Consensus 371 ~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl 438 (540)
+..++||||+++|+|.+++..... ....+++..++.++.|+++||+|||+. +||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 999999999999999999975421 234689999999999999999999999 99999999999999
Q ss_pred CCCCCeEEcccccccccCCCCCc-eeeccccccccccccccccCCCCccCCeehhhHHHHHHHh-CCCCCCc
Q 009208 439 DEDFEAVVGDFGLAKLLDHRDSH-VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELIT-GQRALDF 508 (540)
Q Consensus 439 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~ellt-g~~p~~~ 508 (540)
+.++.+||+|||+++........ ......||+.|+|||.+.+..+++++|||||||++|||+| |+.||..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence 99999999999999876543322 2344568999999999999999999999999999999998 6888863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.9e-41 Score=327.82 Aligned_cols=200 Identities=23% Similarity=0.341 Sum_probs=171.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEec
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYPY 379 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e~ 379 (540)
++|.+.+.||+|+||+||+|..++|+.||||+++.... .....++.+|+.++++++||||+++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57888999999999999999999999999999976543 23346799999999999999999999999999999999999
Q ss_pred CCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCCC
Q 009208 380 MPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRD 459 (540)
Q Consensus 380 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~~ 459 (540)
+.++.+..+... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 988776666543 46799999999999999999999999 99999999999999999999999999998765433
Q ss_pred CceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 460 SHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 460 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
. ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 2 23344589999999998764 568999999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=327.86 Aligned_cols=198 Identities=25% Similarity=0.374 Sum_probs=169.5
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccc-----cHHHHHHHHHHHhccc--CCCccceeEEEecCCe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAG-----GEVQFQTEVETISLAV--HRNLLRLCGFCSTENE 372 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~ 372 (540)
++|++.+.||+|+||+||+|... +|+.||||+++...... ...++.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 56889999999999999999974 68999999987543221 1224678999999886 8999999999999999
Q ss_pred eEEEEecCCC-CChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-CCCeEEcccc
Q 009208 373 RLLVYPYMPN-GSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-DFEAVVGDFG 450 (540)
Q Consensus 373 ~~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~Dfg 450 (540)
.++||||+.+ +++.+++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 577777764 34699999999999999999999999 9999999999999985 5799999999
Q ss_pred cccccCCCCCceeeccccccccccccccccCCC-CccCCeehhhHHHHHHHhCCCCCCc
Q 009208 451 LAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQS-SEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 451 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
+++...... .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||..
T Consensus 157 ~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 157 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred cceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 998654322 334569999999999987765 6779999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-40 Score=326.70 Aligned_cols=202 Identities=24% Similarity=0.370 Sum_probs=167.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-C-CcEEEEEEeccCCccc-cHHHHHHHHHHHhcc---cCCCccceeEEEec----
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-D-GALVAVKRLKDYNIAG-GEVQFQTEVETISLA---VHRNLLRLCGFCST---- 369 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~---- 369 (540)
.++|++.+.||+|+||+||+|... + ++.||||+++...... ....+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999973 4 6789999987543222 223466777777655 79999999999853
Q ss_pred -CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcc
Q 009208 370 -ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGD 448 (540)
Q Consensus 370 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 448 (540)
....+++|||++++++...... ....+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 3467899999998876544332 345689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 449 FGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 449 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
||+++..... .......||+.|+|||++.+..++.++||||+||++|||+||+.||...
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence 9999864432 2234556999999999999999999999999999999999999999754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=328.41 Aligned_cols=203 Identities=28% Similarity=0.373 Sum_probs=174.5
Q ss_pred cCCCcCCeeeeccCccEEEEEeC----CCcEEEEEEeccCCc---cccHHHHHHHHHHHhcccC-CCccceeEEEecCCe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS----DGALVAVKRLKDYNI---AGGEVQFQTEVETISLAVH-RNLLRLCGFCSTENE 372 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~ 372 (540)
++|++.+.||+|+||+||+|... +|+.||||.++.... ......+.+|++++.+++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999852 478999999875432 1223468899999999987 899999999999999
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.++||||+.+|+|.+++... ..+.......++.|++.|++|+|+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999998763 3567888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeccccccccccccccccC--CCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTG--QSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
+.+............|++.|+|||.+... .++.++||||+||++|||+||+.||....
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~ 236 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 236 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 87654444444556799999999998754 46889999999999999999999997543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-39 Score=325.43 Aligned_cols=202 Identities=20% Similarity=0.332 Sum_probs=168.3
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecCC----eeE
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTEN----ERL 374 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~ 374 (540)
.++|.+.+.||+|+||+||+|.. .+|+.||||+++.........++.+|++++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35688899999999999999986 4799999999986554455567899999999999999999999986543 234
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKL 454 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~ 454 (540)
++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55566779999999964 2589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCc--eeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 455 LDHRDSH--VTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 455 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
....... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~ 216 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 216 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence 5432221 2234569999999999854 46789999999999999999999999743
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.6e-39 Score=312.81 Aligned_cols=200 Identities=18% Similarity=0.236 Sum_probs=171.5
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccC-CCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH-RNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lV~e 378 (540)
++|.+.+.||+|+||.||+|+.. +|+.||||+++.... ...+.+|++.+..+.| +|++.+++++......++|||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 57889999999999999999975 689999999865432 2246788888888875 899999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCC-----CCCeEEccccccc
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDE-----DFEAVVGDFGLAK 453 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~Dfgla~ 453 (540)
|+ +++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 68999988653 34689999999999999999999999 9999999999999974 5689999999998
Q ss_pred ccCCCCCc------eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCccc
Q 009208 454 LLDHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGR 510 (540)
Q Consensus 454 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~ 510 (540)
........ ......||+.|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 76543211 2234569999999999999999999999999999999999999997543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-39 Score=318.03 Aligned_cols=202 Identities=27% Similarity=0.375 Sum_probs=167.0
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCc-cccHHHHHHHHHHHhcccCCCccceeEEEec--------
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNI-AGGEVQFQTEVETISLAVHRNLLRLCGFCST-------- 369 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------- 369 (540)
.++|++.+.||+|+||+||+|... +|+.||||+++.... .....++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 367889999999999999999974 799999999865433 2334578999999999999999999998855
Q ss_pred CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccc
Q 009208 370 ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDF 449 (540)
Q Consensus 370 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Df 449 (540)
++..++||||++++.+..+... ...++...++.++.|+++||.|||+. +|+||||||+|||+++++.+|++||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 3467899999998876655432 45688999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCC---ceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 450 GLAKLLDHRDS---HVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 450 gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
|+++....... .......||+.|+|||++.+. .+++++||||+||++|||++|+.||+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 99986653221 122334699999999998765 689999999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-39 Score=321.54 Aligned_cols=197 Identities=28% Similarity=0.370 Sum_probs=164.3
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeEEEecC------CeeE
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCGFCSTE------NERL 374 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 374 (540)
+|...++||+|+||+||+|+.. +|+.||||+++.... ...+|++++++++||||+++++++... ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 5777889999999999999985 689999999976432 234799999999999999999998543 3468
Q ss_pred EEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEccccccc
Q 009208 375 LVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAK 453 (540)
Q Consensus 375 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~ 453 (540)
+||||++++. .+.+.........+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++
T Consensus 96 lv~Ey~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 96 LVLDYVPETV-YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEECCSEEH-HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEeccCCcc-HHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchh
Confidence 9999998764 334433333456799999999999999999999999 999999999999999765 89999999998
Q ss_pred ccCCCCCceeecccccccccccccccc-CCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 454 LLDHRDSHVTTAVRGTVGHIAPEYLST-GQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 454 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 172 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 172 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp ECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred hccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 7654332 234569999999998765 56899999999999999999999999754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-38 Score=309.80 Aligned_cols=200 Identities=23% Similarity=0.298 Sum_probs=174.6
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lV~e 378 (540)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... ....++.+|+++++.++||||+++++++...+..++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 46888999999999999999974 6899999999765433 335678999999999999999999999999999999999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccccccCCC
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHR 458 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~~~~~~ 458 (540)
++.++++..++.. ...+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999998877754 35688999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeccccccccccccccccCC-CCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 459 DSHVTTAVRGTVGHIAPEYLSTGQ-SSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 459 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
... .....+++.|+|||.+.... ++.++||||+||++|||++|+.||..
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 322 23345788999999987665 68999999999999999999999753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=317.79 Aligned_cols=197 Identities=26% Similarity=0.371 Sum_probs=163.7
Q ss_pred hcCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecCC------
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTEN------ 371 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 371 (540)
.++|.+.+.||+|+||+||+|... +|+.||||+++..... .....+.+|++++++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 357888999999999999999974 6999999999754322 23456889999999999999999999997654
Q ss_pred eeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEccccc
Q 009208 372 ERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGL 451 (540)
Q Consensus 372 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgl 451 (540)
..++||||+ +.+|....+. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 569999999 5677766643 4699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 452 AKLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 452 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
++...... ....||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 168 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 168 ARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp CEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCC
Confidence 98765432 345699999999998764 5689999999999999999999999754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-38 Score=307.55 Aligned_cols=201 Identities=20% Similarity=0.216 Sum_probs=165.9
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCccceeE-EEecCCeeEEEEe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLLRLCG-FCSTENERLLVYP 378 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~-~~~~~~~~~lV~e 378 (540)
++|++.+.||+|+||.||+|... +|+.||||+++.... ..++..|++++++++|+|++..+. +....+..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 46889999999999999999874 689999999875432 235788999999998877665554 4567788899999
Q ss_pred cCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeC---CCCCeEEccccccccc
Q 009208 379 YMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLD---EDFEAVVGDFGLAKLL 455 (540)
Q Consensus 379 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~Dfgla~~~ 455 (540)
|+ ++++...+... ...+++..+..++.|+++||+|||++ +|+||||||+|||++ .+..+|++|||+|+.+
T Consensus 84 ~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99 55666655432 35699999999999999999999999 999999999999986 4557999999999977
Q ss_pred CCCCCc------eeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcccc
Q 009208 456 DHRDSH------VTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFGRA 511 (540)
Q Consensus 456 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~~~ 511 (540)
...... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~ 218 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccch
Confidence 543321 22345699999999999999999999999999999999999999975433
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.3e-38 Score=311.33 Aligned_cols=193 Identities=21% Similarity=0.296 Sum_probs=167.2
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEec--CCeeEEE
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCST--ENERLLV 376 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~lV 376 (540)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. ...++.+|++++.++. ||||+++++++.. ....++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 57999999999999999999974 6899999998753 2457899999999995 9999999999874 4568999
Q ss_pred EecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCC-CeEEccccccccc
Q 009208 377 YPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDF-EAVVGDFGLAKLL 455 (540)
Q Consensus 377 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~Dfgla~~~ 455 (540)
|||+++++|..+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 111 ~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 111 FEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence 9999999987654 2589999999999999999999999 999999999999998655 6899999999876
Q ss_pred CCCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 456 DHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 456 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
..... .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||...
T Consensus 181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~ 233 (328)
T d3bqca1 181 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233 (328)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence 54332 3345689999999998765 4799999999999999999999999754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-37 Score=309.86 Aligned_cols=198 Identities=24% Similarity=0.320 Sum_probs=165.8
Q ss_pred hcCCCcCCeeeeccCccEEEEEe-CCCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEecC-----Ce
Q 009208 300 TSNFSAKNILGRGGFGIVYKGCF-SDGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCSTE-----NE 372 (540)
Q Consensus 300 ~~~~~~~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 372 (540)
.++|++.+.||+|+||+||+|.. .+|+.||||+++..... ....++.+|++++++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46789999999999999999996 47999999999764422 2344688999999999999999999998643 34
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.+++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||.+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 5677788889999998853 3599999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceeeccccccccccccccccC-CCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTG-QSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
..... ......||+.|+|||...+. .++.++||||+||++|||++|+.||...
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 75432 23345689999999987665 4689999999999999999999999743
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-37 Score=308.52 Aligned_cols=196 Identities=23% Similarity=0.265 Sum_probs=159.1
Q ss_pred cCCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCcc-ccHHHHHHHHHHHhcccCCCccceeEEEec------CCe
Q 009208 301 SNFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIA-GGEVQFQTEVETISLAVHRNLLRLCGFCST------ENE 372 (540)
Q Consensus 301 ~~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~ 372 (540)
++|.+.+.||+|+||+||+|... +|+.||||+++..... ....++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56888999999999999999975 6999999999765432 233468899999999999999999999864 367
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEEcccccc
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLA 452 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla 452 (540)
.++||||+.++.+. .+. ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 89999999766544 332 2488999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCc
Q 009208 453 KLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDF 508 (540)
Q Consensus 453 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~ 508 (540)
+..... .......||+.|+|||++.+..+++++||||+||+++||++|+.||..
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence 865432 223445689999999999999999999999999999999999999963
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1.3e-32 Score=277.09 Aligned_cols=198 Identities=22% Similarity=0.230 Sum_probs=157.9
Q ss_pred CCCcCCeeeeccCccEEEEEeC-CCcEEEEEEeccCCccccHHHHHHHHHHHhccc-----------CCCccceeEEEec
Q 009208 302 NFSAKNILGRGGFGIVYKGCFS-DGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-----------HRNLLRLCGFCST 369 (540)
Q Consensus 302 ~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~ 369 (540)
+|.+.+.||+|+||+||+|+.. +|+.||||+++... .....+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4888999999999999999974 79999999997643 22346788888887765 5789999988754
Q ss_pred --CCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeeCCCC----
Q 009208 370 --ENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDF---- 442 (540)
Q Consensus 370 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~~~---- 442 (540)
....+++++++..+........ ......+++..+..++.|++.||+|||+ . +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence 4556677776655543332222 2335678899999999999999999998 5 899999999999998655
Q ss_pred --CeEEcccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhHHHHHHHhCCCCCCcc
Q 009208 443 --EAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQRALDFG 509 (540)
Q Consensus 443 --~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gvil~elltg~~p~~~~ 509 (540)
.++++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||...
T Consensus 168 ~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 3999999999855432 23456999999999999999999999999999999999999999854
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.94 E-value=1.3e-27 Score=235.32 Aligned_cols=159 Identities=29% Similarity=0.538 Sum_probs=148.3
Q ss_pred CCchHHHHHHHHHHhcCCCCCccCCCCCCCCCCc--cceeeeecCC---CcEEEecCCCCCCcc--ccCccccCCCccCE
Q 009208 30 GINYEVVALVAVKNNLHDPYNVLENWDITSVDPC--SWRMITCSPD---GYVSALGLPSQSLSG--TLSPWIGNLTKLQS 102 (540)
Q Consensus 30 ~~~~~~~~l~~~k~~~~~~~~~~~~w~~~~~~~c--~w~gv~c~~~---~~l~~l~l~~~~l~~--~~~~~~~~l~~L~~ 102 (540)
|.+.|++||++||+++.||. .+++|. .++||| .|.||+|+.. .||+.|+|++|+++| .+|+++++|++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~-~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWL-PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCC-TTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCC-CCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 77899999999999999885 699997 568999 4999999864 379999999999998 58899999999999
Q ss_pred EEccc-CCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCc
Q 009208 103 VLLQN-NAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNN 181 (540)
Q Consensus 103 L~l~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 181 (540)
|+|++ |+++|.+|.+|++|++|++|+|++|+|.+..|..+..+.+|+.+++++|++.+.+|..+.++++|+.+++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 99996 89999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC
Q 009208 182 LSGSLPKIS 190 (540)
Q Consensus 182 l~~~~p~~~ 190 (540)
++|.+|+..
T Consensus 161 l~~~ip~~~ 169 (313)
T d1ogqa_ 161 ISGAIPDSY 169 (313)
T ss_dssp CEEECCGGG
T ss_pred ccccccccc
Confidence 999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=8.9e-24 Score=191.89 Aligned_cols=168 Identities=11% Similarity=0.076 Sum_probs=119.4
Q ss_pred CcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCcc-----------------ccHHHHHHHHHHHhcccCCCccceeEE
Q 009208 304 SAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIA-----------------GGEVQFQTEVETISLAVHRNLLRLCGF 366 (540)
Q Consensus 304 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~l~~~ 366 (540)
.+.+.||+|+||.||+|...+|+.||||+++..... .......+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356889999999999999989999999987642110 011235678888999999999988765
Q ss_pred EecCCeeEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCceeeCCCCCeEE
Q 009208 367 CSTENERLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQCDPKIIHRDVKAANILLDEDFEAVV 446 (540)
Q Consensus 367 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl 446 (540)
. ..+++|||++++.+.+ ++......++.|++++++|||+. +|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 2479999998865433 22233567899999999999999 99999999999999965 5899
Q ss_pred cccccccccCCCCCceeeccccccccccccccccCCCCccCCeehhhH
Q 009208 447 GDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGI 494 (540)
Q Consensus 447 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~Dv~S~Gv 494 (540)
+|||.|....++...... ......+ .|.+ ...|+.++|+||..-
T Consensus 144 iDFG~a~~~~~~~~~~~l--~rd~~~~-~~~f-~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 144 IDFPQSVEVGEEGWREIL--ERDVRNI-ITYF-SRTYRTEKDINSAID 187 (191)
T ss_dssp CCCTTCEETTSTTHHHHH--HHHHHHH-HHHH-HHHHCCCCCHHHHHH
T ss_pred EECCCcccCCCCCcHHHH--HHHHHHH-HHHH-cCCCCCcccHHHHHH
Confidence 999999865533211000 0000000 1111 356788999999753
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=1.3e-18 Score=157.45 Aligned_cols=146 Identities=23% Similarity=0.302 Sum_probs=118.7
Q ss_pred CCccceeeeecCC----------CcEEEecCCCCCCcccc-CccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEe
Q 009208 61 DPCSWRMITCSPD----------GYVSALGLPSQSLSGTL-SPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL 129 (540)
Q Consensus 61 ~~c~w~gv~c~~~----------~~l~~l~l~~~~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 129 (540)
.-|+|..|.|+.. ..++.|+|++|.|++.+ +..|.++++|+.|+|++|.+.+..+..|..+++|++|+|
T Consensus 6 C~C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L 85 (192)
T d1w8aa_ 6 CHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL 85 (192)
T ss_dssp SEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CEEcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeee
Confidence 4477888999742 36899999999998755 567899999999999999999888899999999999999
Q ss_pred eCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCCcCC
Q 009208 130 SNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGP 205 (540)
Q Consensus 130 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~ 205 (540)
++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++....+.... +...+.+|.+.|..
T Consensus 86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCS
T ss_pred ccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCC
Confidence 99999976677899999999999999999977788899999999999999999864432111 23345566666654
Q ss_pred C
Q 009208 206 K 206 (540)
Q Consensus 206 ~ 206 (540)
+
T Consensus 166 p 166 (192)
T d1w8aa_ 166 P 166 (192)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=1.3e-17 Score=150.82 Aligned_cols=134 Identities=20% Similarity=0.350 Sum_probs=115.8
Q ss_pred eeeeecCCCcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCC-CcccCCCCcccEEEeeCCCCcccCCccccC
Q 009208 66 RMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPI-PASLGKLEKLQTLDLSNNKFTGEIPDSLGD 144 (540)
Q Consensus 66 ~gv~c~~~~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 144 (540)
.+-+|+. +.++.++++|+ .+|..+. +++++|+|++|+|++.+ +..|.++++|++|+|++|++++..+..+..
T Consensus 4 ~~C~C~~----~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~ 76 (192)
T d1w8aa_ 4 AMCHCEG----TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEG 76 (192)
T ss_dssp TTSEEET----TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTT
T ss_pred CCCEEcC----CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccc
Confidence 3556753 46899999999 7887764 78999999999998644 667899999999999999999888889999
Q ss_pred CCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCcCCC
Q 009208 145 LGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLICGPK 206 (540)
Q Consensus 145 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~~~~ 206 (540)
+++|++|+|++|+|+...|..|.++++|+.|+|++|+|++..|+.+. +.+.+.+|++.|.+.
T Consensus 77 ~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 77 ASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred ccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 99999999999999977788899999999999999999987776543 567899999988754
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=9.7e-16 Score=145.75 Aligned_cols=130 Identities=27% Similarity=0.294 Sum_probs=89.0
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
.++.|+|++|.++ ..+..+.++++|+.|++++|.+.+..+..+..+.+|++|++++|.++...+..+..+++|+.|+++
T Consensus 78 ~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~ 156 (266)
T d1p9ag_ 78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156 (266)
T ss_dssp TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred ccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccc
Confidence 3445555555554 234445555555555555555554444455555566666666666664445556778899999999
Q ss_pred CccCCCCCCccccCCccccEEecccCcccccCCC-CCc----ccccccCCCCCcCCC
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPK-ISA----RTFKVTGNPLICGPK 206 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~----~~~~~~~n~~~~~~~ 206 (540)
+|++++..+..|..+++|++|+|++|+|+ .+|. +.. +.+.+.||||.|+|.
T Consensus 157 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp TSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred cccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 99999777788999999999999999999 5664 322 567899999999864
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.61 E-value=4.6e-16 Score=129.43 Aligned_cols=103 Identities=27% Similarity=0.380 Sum_probs=91.0
Q ss_pred EEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCc
Q 009208 77 SALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNN 156 (540)
Q Consensus 77 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 156 (540)
+.|+|++|+|+ .++ .++++++|++|+|++|+|+ .+|+.|+.+++|+.|++++|+|+ .+| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 36899999998 555 5899999999999999999 67888999999999999999999 565 4899999999999999
Q ss_pred cCCCCC-CccccCCccccEEecccCcccc
Q 009208 157 SLTGSC-PESLSKIESLTLVDLSYNNLSG 184 (540)
Q Consensus 157 ~l~~~~-p~~~~~l~~L~~L~l~~N~l~~ 184 (540)
+++... ...+..+++|+.|++++|+++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 998432 2568899999999999999984
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=6.9e-16 Score=148.27 Aligned_cols=133 Identities=23% Similarity=0.300 Sum_probs=118.4
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|++++|.+....+..+...++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|++
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l 184 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhh
Confidence 47999999999998777788889999999999999999777788999999999999999999777788999999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCC-----cccccccCCCCCcCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS-----ARTFKVTGNPLICGPK 206 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-----~~~~~~~~n~~~~~~~ 206 (540)
++|++++..|..|..+++|++|++++|++++.+|... .+.+++++|++.|+|.
T Consensus 185 ~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred hhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 9999998889999999999999999999997766543 2667899999999764
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.57 E-value=6.5e-16 Score=150.64 Aligned_cols=131 Identities=25% Similarity=0.455 Sum_probs=105.5
Q ss_pred cEEEecCCCCCCccccCccccCCCcc-CEEEcccCCCC-----------------------CCCCcccCCCCcccEEEee
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKL-QSVLLQNNAIL-----------------------GPIPASLGKLEKLQTLDLS 130 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L-~~L~l~~N~l~-----------------------~~~p~~~~~l~~L~~L~ls 130 (540)
.++.+++++|.++|.+|..+.++.++ +.+++++|+++ +.+|..+..+++|+.|+++
T Consensus 150 ~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~ 229 (313)
T d1ogqa_ 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229 (313)
T ss_dssp TCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECC
T ss_pred ccceeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 56667777777777777766666554 55555555554 4555666778889999999
Q ss_pred CCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCCcCCC
Q 009208 131 NNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLICGPK 206 (540)
Q Consensus 131 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~~ 206 (540)
+|++++.+| .++.+++|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|.... +.+++.||+.+|+.+
T Consensus 230 ~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 230 KNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp SSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred ccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC
Confidence 999996654 688999999999999999999999999999999999999999999998632 567899999999865
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.49 E-value=1.3e-14 Score=126.62 Aligned_cols=107 Identities=22% Similarity=0.247 Sum_probs=90.9
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.++++|+|++|+|+ .++..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+|+...+..+..+++|+.|++
T Consensus 18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 36899999999998 56777788999999999999999 454 5899999999999999999444444678999999999
Q ss_pred cCccCCCCCC--ccccCCccccEEecccCcccc
Q 009208 154 NNNSLTGSCP--ESLSKIESLTLVDLSYNNLSG 184 (540)
Q Consensus 154 ~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~ 184 (540)
++|+++ .++ ..+..+++|++|++++|+++.
T Consensus 95 ~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 95 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred cccccc-ccccccccccccccchhhcCCCcccc
Confidence 999998 444 368889999999999999973
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=4.9e-14 Score=133.72 Aligned_cols=127 Identities=24% Similarity=0.205 Sum_probs=103.5
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
..++.|+|++|.|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|+++ .+|..+..+++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccc
Confidence 36999999999999776788999999999999999998 455 4678999999999999999 67888889999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc-----ccccccCCCCCc
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA-----RTFKVTGNPLIC 203 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----~~~~~~~n~~~~ 203 (540)
++|.+.+..+..+..+.+|+.|++++|.+++..+.... +.+++++|.+..
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~ 162 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccc
Confidence 99998876677777888888888888888765554432 345677776643
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.47 E-value=3.1e-14 Score=118.20 Aligned_cols=98 Identities=23% Similarity=0.343 Sum_probs=83.3
Q ss_pred CEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEEecccC
Q 009208 101 QSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYN 180 (540)
Q Consensus 101 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 180 (540)
++|+|++|+|+ .+| .+.++++|++|++++|+|+ .+|+.+..+++|+.|++++|+|+ .+| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 58999999999 566 4899999999999999999 89999999999999999999999 566 5999999999999999
Q ss_pred cccccCC--CCC----cccccccCCCCCc
Q 009208 181 NLSGSLP--KIS----ARTFKVTGNPLIC 203 (540)
Q Consensus 181 ~l~~~~p--~~~----~~~~~~~~n~~~~ 203 (540)
+|+...+ .+. .+.++++||++..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 9984322 111 1567899998744
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=1.1e-13 Score=119.83 Aligned_cols=109 Identities=20% Similarity=0.162 Sum_probs=88.9
Q ss_pred CccceeeeecCCCcEEEecCCCCCCccccCccccCCCccCEEEcccC-CCCCCCCcccCCCCcccEEEeeCCCCcccCCc
Q 009208 62 PCSWRMITCSPDGYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNN-AILGPIPASLGKLEKLQTLDLSNNKFTGEIPD 140 (540)
Q Consensus 62 ~c~w~gv~c~~~~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 140 (540)
|+.+++|+|. ++++. ..|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+...|.
T Consensus 7 c~~~~~l~c~-----------~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~ 74 (156)
T d2ifga3 7 PHGSSGLRCT-----------RDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (156)
T ss_dssp CSSSSCEECC-----------SSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred cCCCCeEEec-----------CCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccc
Confidence 3346666664 44454 56777888999999999766 58866667899999999999999999966678
Q ss_pred cccCCCCcchhhccCccCCCCCCccccCCccccEEecccCccc
Q 009208 141 SLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLS 183 (540)
Q Consensus 141 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 183 (540)
.|..+++|++|+|++|+|+ .+|.......+|+.|+|++|+|.
T Consensus 75 ~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp GGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 8999999999999999999 66665555557999999999886
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=6.7e-14 Score=134.09 Aligned_cols=131 Identities=22% Similarity=0.275 Sum_probs=113.9
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
..++.+++++|.|++..+..|..+++|+.|+|++|++++..|..|.++++|++|++++|++++..|..|..+++|++|++
T Consensus 129 ~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l 208 (284)
T d1ozna_ 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208 (284)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccc
Confidence 46899999999999777788999999999999999999888899999999999999999999888999999999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCC----cccccccCCCCCcC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS----ARTFKVTGNPLICG 204 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~----~~~~~~~~n~~~~~ 204 (540)
++|++.+..|..|..+++|++|++++|++....+... .+.+....+.+.|.
T Consensus 209 ~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~ 263 (284)
T d1ozna_ 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS 263 (284)
T ss_dssp CSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEE
T ss_pred cccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeC
Confidence 9999998888899999999999999999997654211 13344455555554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=2.8e-13 Score=117.18 Aligned_cols=109 Identities=22% Similarity=0.267 Sum_probs=91.7
Q ss_pred CCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCC-CCcccCCccccCCCCcchhhccCccCCCCCCccccCCccccEE
Q 009208 97 LTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNN-KFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLV 175 (540)
Q Consensus 97 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 175 (540)
....+.++++++.+. ..|..+..+++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+...|.+|..+++|+.|
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 345567899999998 67888999999999999876 4885445679999999999999999997778889999999999
Q ss_pred ecccCcccccCCCCCc----ccccccCCCCCcCCC
Q 009208 176 DLSYNNLSGSLPKISA----RTFKVTGNPLICGPK 206 (540)
Q Consensus 176 ~l~~N~l~~~~p~~~~----~~~~~~~n~~~~~~~ 206 (540)
+|++|+|+...+..+. ..+++.+|+|.|+|.
T Consensus 86 ~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~ 120 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120 (156)
T ss_dssp ECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred eccCCCCcccChhhhccccccccccCCCcccCCch
Confidence 9999999955554432 567899999999764
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=1.4e-13 Score=119.89 Aligned_cols=106 Identities=21% Similarity=0.230 Sum_probs=87.4
Q ss_pred ccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccCCcc
Q 009208 92 PWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSKIES 171 (540)
Q Consensus 92 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 171 (540)
+.+.+..+|++|+|++|+|+ .+|..+..+++|+.||||+|+|+ .++ .+..+++|++|++++|+++...+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 45678889999999999999 56877788999999999999999 664 5899999999999999999544455678999
Q ss_pred ccEEecccCcccccCCCC---C----cccccccCCCC
Q 009208 172 LTLVDLSYNNLSGSLPKI---S----ARTFKVTGNPL 201 (540)
Q Consensus 172 L~~L~l~~N~l~~~~p~~---~----~~~~~~~~n~~ 201 (540)
|+.|++++|+|+. ++++ . .+.+++.+|++
T Consensus 89 L~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 89 LTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp CCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGG
T ss_pred cccceeccccccc-cccccccccccccchhhcCCCcc
Confidence 9999999999984 2321 1 15567888876
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.36 E-value=1.3e-12 Score=126.21 Aligned_cols=76 Identities=28% Similarity=0.380 Sum_probs=66.5
Q ss_pred CCCccceeeeecCC----------CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEe
Q 009208 60 VDPCSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDL 129 (540)
Q Consensus 60 ~~~c~w~gv~c~~~----------~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 129 (540)
..-|.|++|.|+.. ..++.|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|++
T Consensus 7 ~c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 7 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86 (305)
T ss_dssp TCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence 44578999999742 46899999999999655568999999999999999999888889999999999999
Q ss_pred eCCCCc
Q 009208 130 SNNKFT 135 (540)
Q Consensus 130 s~N~l~ 135 (540)
++|+|+
T Consensus 87 ~~n~l~ 92 (305)
T d1xkua_ 87 SKNQLK 92 (305)
T ss_dssp CSSCCS
T ss_pred cCCccC
Confidence 999886
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.35 E-value=8.2e-13 Score=127.67 Aligned_cols=127 Identities=26% Similarity=0.263 Sum_probs=107.9
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
..++.+++++|+++ .+|..+ +++|+.|++++|.+++..+..|.+++.++.|++++|++++..|..+.++++|++|+|
T Consensus 150 ~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 150 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp TTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred cccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeec
Confidence 36889999999998 566543 689999999999999999999999999999999999999877888999999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCC-----------cccccccCCCCCcC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS-----------ARTFKVTGNPLICG 204 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-----------~~~~~~~~n~~~~~ 204 (540)
++|+|+ .+|.+|.++++|++|+|++|+|+......+ .+.+++.||++.+.
T Consensus 227 ~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 227 NNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp CSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred cccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 999999 789999999999999999999994322111 14567889988654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.21 E-value=1.5e-11 Score=110.75 Aligned_cols=102 Identities=34% Similarity=0.527 Sum_probs=58.1
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
+++.|+|++|.+++..| ++++++|++|++++|.+. .+| .+.++++|+.|++++|.+.. + ..+..+++|+.|+++
T Consensus 63 nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l~ 136 (199)
T d2omxa2 63 NLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLELS 136 (199)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECC
T ss_pred CcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccccccccccc-c-cccchhhhhHHhhhh
Confidence 56666666666654222 556666666666666655 233 35566666666666666552 2 235556666666666
Q ss_pred CccCCCCCCccccCCccccEEecccCcccc
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSG 184 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 184 (540)
+|++. .++ .+..+++|+.|++++|++++
T Consensus 137 ~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~ 164 (199)
T d2omxa2 137 SNTIS-DIS-ALSGLTSLQQLNFSSNQVTD 164 (199)
T ss_dssp SSCCC-CCG-GGTTCTTCSEEECCSSCCCC
T ss_pred hhhhc-ccc-cccccccccccccccccccC
Confidence 66665 333 35566666666666666654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.19 E-value=1.6e-11 Score=110.61 Aligned_cols=119 Identities=25% Similarity=0.396 Sum_probs=97.9
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|++++|+++. + +.+..+++|++|+|++|++++. + .+.++++|++|++++|.+. .+| .+.++++|+.|++
T Consensus 40 ~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~-~-~l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCc-c-cccCCcccccccccccccc-ccc-ccccccccccccc
Confidence 378899999999984 4 3588999999999999999964 3 3999999999999999998 565 4889999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPL 201 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~ 201 (540)
++|.+.. + ..+..+++|+.|++++|++.. +|.+.. +.+.+.+|.+
T Consensus 114 ~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n~l 162 (199)
T d2omxa2 114 FNNQITD-I-DPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQV 162 (199)
T ss_dssp CSSCCCC-C-GGGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCC
T ss_pred ccccccc-c-cccchhhhhHHhhhhhhhhcc-cccccccccccccccccccc
Confidence 9999984 3 358899999999999999974 443322 4566777765
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.13 E-value=1.4e-13 Score=124.07 Aligned_cols=104 Identities=23% Similarity=0.298 Sum_probs=51.1
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
+++.|+|++|+|+ .++ .+.++++|+.|+|++|.|+ .+|..+..+++|++|++++|+|+ .++ .+..+++|+.|+|+
T Consensus 49 ~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~ 123 (198)
T d1m9la_ 49 ACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMS 123 (198)
T ss_dssp TCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEES
T ss_pred ccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccccccccccc
Confidence 4555555555554 232 3455555555555555554 33433333445555555555555 232 24455555555555
Q ss_pred CccCCCCCC--ccccCCccccEEecccCcccc
Q 009208 155 NNSLTGSCP--ESLSKIESLTLVDLSYNNLSG 184 (540)
Q Consensus 155 ~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~ 184 (540)
+|+++ .++ ..+..+++|+.|++++|+++.
T Consensus 124 ~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 124 NNKIT-NWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp EEECC-CHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred cchhc-cccccccccCCCccceeecCCCcccc
Confidence 55554 222 234555555555555555543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.12 E-value=5.5e-11 Score=107.97 Aligned_cols=118 Identities=28% Similarity=0.405 Sum_probs=74.4
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
++++|+|++|.|++ ++ .++++++|++|++++|+|++ +| .+.++++|+.|++++|.+. .+ ..+..+++|+.++++
T Consensus 69 ~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~ 142 (210)
T d1h6ta2 69 NVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLG 142 (210)
T ss_dssp TCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECC
T ss_pred CCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-ccccccccccccccccccc-cc-ccccccccccccccc
Confidence 57777777777764 33 25667777777777777763 44 4666777777777777765 33 346666777777777
Q ss_pred CccCCCCCCccccCCccccEEecccCcccccCCCCC----cccccccCCCC
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS----ARTFKVTGNPL 201 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~----~~~~~~~~n~~ 201 (540)
+|.+++ +..+..+++|+.+++++|++++. +.+. .+.+++++|.+
T Consensus 143 ~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~~l~~l~~L~~L~Ls~N~i 190 (210)
T d1h6ta2 143 NNKITD--ITVLSRLTKLDTLSLEDNQISDI-VPLAGLTKLQNLYLSKNHI 190 (210)
T ss_dssp SSCCCC--CGGGGGCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSSCC
T ss_pred cccccc--ccccccccccccccccccccccc-ccccCCCCCCEEECCCCCC
Confidence 777663 23466677777777777777643 2221 14456666655
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.11 E-value=6.2e-11 Score=107.62 Aligned_cols=119 Identities=21% Similarity=0.293 Sum_probs=98.0
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
.++.|++++|.++. ++ .+..+++|++|+|++|+|++. + .++++++|++|++++|+|+ .+| .+..+++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc-c-ccccCcccccccccccccc-ccc-cccccccccccccc
Confidence 68899999999985 33 488999999999999999964 4 4789999999999999999 566 58999999999999
Q ss_pred CccCCCCCCccccCCccccEEecccCcccccCCCC---CcccccccCCCC
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKI---SARTFKVTGNPL 201 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~---~~~~~~~~~n~~ 201 (540)
+|.+. .++ .+..+++|+.+++++|.+++..+.. ..+.+.+.+|.+
T Consensus 121 ~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l 168 (210)
T d1h6ta2 121 HNGIS-DIN-GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQI 168 (210)
T ss_dssp TSCCC-CCG-GGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCC
T ss_pred ccccc-ccc-cccccccccccccccccccccccccccccccccccccccc
Confidence 99998 444 6889999999999999998532211 115567777766
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.09 E-value=3.7e-13 Score=121.31 Aligned_cols=110 Identities=23% Similarity=0.323 Sum_probs=90.6
Q ss_pred ccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhccCccCCCCCCccccC
Q 009208 89 TLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLNNNSLTGSCPESLSK 168 (540)
Q Consensus 89 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 168 (540)
.++.++.+|++|++|+|++|+|+ .++ .+.++++|++|+|++|+|+ .+|..+..+++|+.|++++|+++ .++ .+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccc
Confidence 45677899999999999999999 555 5999999999999999999 78877777789999999999999 453 5888
Q ss_pred CccccEEecccCcccccC-----CCC-CcccccccCCCCCc
Q 009208 169 IESLTLVDLSYNNLSGSL-----PKI-SARTFKVTGNPLIC 203 (540)
Q Consensus 169 l~~L~~L~l~~N~l~~~~-----p~~-~~~~~~~~~n~~~~ 203 (540)
+++|+.|++++|+|+... ... ..+.+.++||++.+
T Consensus 114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred cccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 999999999999998421 111 12667889998644
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.08 E-value=6.6e-11 Score=117.50 Aligned_cols=121 Identities=24% Similarity=0.333 Sum_probs=72.2
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccC----------------
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI---------------- 138 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~---------------- 138 (540)
+++.|++++|.++. + +.+..+++|+.|++++|.+++.. .+..+++|+.|++++|++++..
T Consensus 220 ~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n 295 (384)
T d2omza2 220 NLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN 295 (384)
T ss_dssp TCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSS
T ss_pred CCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCCcccccccccccccccc
Confidence 56666666666653 2 34556666666666666666432 2555566666666655554221
Q ss_pred ----CccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCCCCC
Q 009208 139 ----PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGNPLI 202 (540)
Q Consensus 139 ----p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n~~~ 202 (540)
+..+..+++++.|++++|++++. + .+..+++|+.|++++|+|++ +|.+.. +.+++++|++.
T Consensus 296 ~l~~~~~~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 296 QLEDISPISNLKNLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQIS 364 (384)
T ss_dssp CCSCCGGGGGCTTCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCC
T ss_pred ccccccccchhcccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCC
Confidence 12355667777777788877743 3 36777778888888887774 333321 55667777654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.00 E-value=3.5e-10 Score=104.75 Aligned_cols=97 Identities=22% Similarity=0.364 Sum_probs=51.0
Q ss_pred ccceeeeecCC----------CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCC-CcccCCCCcccEEEeeC
Q 009208 63 CSWRMITCSPD----------GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPI-PASLGKLEKLQTLDLSN 131 (540)
Q Consensus 63 c~w~gv~c~~~----------~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~ls~ 131 (540)
|..+.|.|+.. ..+++|+|++|.|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|++..
T Consensus 8 C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 8 CSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp ECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 56777777631 13555555555555333334555555555555555554332 23455555555555442
Q ss_pred -CCCcccCCccccCCCCcchhhccCccCC
Q 009208 132 -NKFTGEIPDSLGDLGNLNYLRLNNNSLT 159 (540)
Q Consensus 132 -N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 159 (540)
|++....+..|.++++|+.|++++|++.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred cccccccccccccccccccccccchhhhc
Confidence 4454444444555555555555555554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.99 E-value=1.7e-10 Score=114.48 Aligned_cols=117 Identities=21% Similarity=0.322 Sum_probs=95.8
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+++++.+++.. .+.+++.++.++++.|.+++. ..+..+++++.|++++|++++ ++ .+..+++|++|++
T Consensus 263 ~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L 336 (384)
T d2omza2 263 TKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFF 336 (384)
T ss_dssp TTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEEC
T ss_pred ccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCC-Cc-ccccCCCCCEEEC
Confidence 47899999999998543 378899999999999999853 458889999999999999995 44 3889999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcccccCCCCCc----ccccccCC
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKISA----RTFKVTGN 199 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----~~~~~~~n 199 (540)
++|+|+ .++ .+.++++|++|++++|+|++.+| +.. +.+++++|
T Consensus 337 ~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 337 ANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 999998 455 68999999999999999997654 221 44556655
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.88 E-value=1.1e-09 Score=100.45 Aligned_cols=104 Identities=25% Similarity=0.396 Sum_probs=83.1
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
..++.++++++...+. ..+...+.++.+.++++.+... ..+.+.++|++|++++|++++ .+ .+.++++|+.|+|
T Consensus 107 ~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~L 180 (227)
T d1h6ua2 107 QSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKA 180 (227)
T ss_dssp TTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEEC
T ss_pred cccccccccccccccc--chhccccchhhhhchhhhhchh--hhhcccccccccccccccccc-ch-hhcccccceeccc
Confidence 3688889988887753 3466788899999999988754 347788899999999999873 33 3888999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCccccc
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNLSGS 185 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 185 (540)
++|++++ +| .+.++++|++|++++|++++.
T Consensus 181 s~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 181 DDNKISD-IS-PLASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp CSSCCCC-CG-GGGGCTTCCEEECTTSCCCBC
T ss_pred CCCccCC-Ch-hhcCCCCCCEEECcCCcCCCC
Confidence 9999984 54 388899999999999998853
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.86 E-value=3.6e-09 Score=96.83 Aligned_cols=122 Identities=22% Similarity=0.388 Sum_probs=81.6
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccC---------------
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEI--------------- 138 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~--------------- 138 (540)
.+++.|++++|.+++..| +.++++|+.|++++|.++ .++ .+.++++|+.|++++|++.+..
T Consensus 63 ~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~ 138 (227)
T d1h6ua2 63 NNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138 (227)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCS
T ss_pred CCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhchh
Confidence 467888888888775433 777788888888888777 343 5777778888887777665321
Q ss_pred -----CccccCCCCcchhhccCccCCCCCCccccCCccccEEecccCcccccCCCCC----cccccccCCCCC
Q 009208 139 -----PDSLGDLGNLNYLRLNNNSLTGSCPESLSKIESLTLVDLSYNNLSGSLPKIS----ARTFKVTGNPLI 202 (540)
Q Consensus 139 -----p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~----~~~~~~~~n~~~ 202 (540)
...+.++++|++|++++|.+++ .+ .+.++++|+.|+|++|++++ +|.+. .+.+++++|++.
T Consensus 139 ~~~~~~~~~~~~~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 139 NQITNISPLAGLTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp SCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCC
T ss_pred hhhchhhhhcccccccccccccccccc-ch-hhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCC
Confidence 1234566677778888887763 22 37778888888888888874 33332 145667777653
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.84 E-value=1.5e-09 Score=100.41 Aligned_cols=106 Identities=12% Similarity=0.180 Sum_probs=89.2
Q ss_pred EEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCc-cccCCCCcchhhccC
Q 009208 77 SALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPD-SLGDLGNLNYLRLNN 155 (540)
Q Consensus 77 ~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~l~~ 155 (540)
+.++.++++++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+|. .|.+++++++|++..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 35777888888 7887663 5899999999999965556799999999999999999865554 588999999998864
Q ss_pred -ccCCCCCCccccCCccccEEecccCccccc
Q 009208 156 -NSLTGSCPESLSKIESLTLVDLSYNNLSGS 185 (540)
Q Consensus 156 -N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 185 (540)
|++....+..|.++++|+.|++++|+++..
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~ 118 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHL 118 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSC
T ss_pred cccccccccccccccccccccccchhhhccc
Confidence 778867788899999999999999999854
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.80 E-value=5.2e-09 Score=101.91 Aligned_cols=99 Identities=27% Similarity=0.383 Sum_probs=82.3
Q ss_pred cEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhcc
Q 009208 75 YVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRLN 154 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 154 (540)
+++.|||++++|+ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .+++. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 5778999999998 67754 578999999999999 778754 57899999999998 66642 2469999999
Q ss_pred CccCCCCCCccccCCccccEEecccCcccccCC
Q 009208 155 NNSLTGSCPESLSKIESLTLVDLSYNNLSGSLP 187 (540)
Q Consensus 155 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 187 (540)
+|+++ .+|. +..+++|+.|++++|.++...+
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~ 137 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPD 137 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCC
T ss_pred ccccc-cccc-hhhhccceeecccccccccccc
Confidence 99999 6775 6889999999999999985544
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.42 E-value=3.7e-09 Score=91.29 Aligned_cols=65 Identities=28% Similarity=0.276 Sum_probs=32.1
Q ss_pred cCCCccCEEEcccCCCCCCC--CcccCCCCcccEEEeeCCCCcccCCc-cccCCCCcchhhccCccCCC
Q 009208 95 GNLTKLQSVLLQNNAILGPI--PASLGKLEKLQTLDLSNNKFTGEIPD-SLGDLGNLNYLRLNNNSLTG 160 (540)
Q Consensus 95 ~~l~~L~~L~l~~N~l~~~~--p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~ 160 (540)
.++++|++|+|++|+|+..- +..+..+++|+.|+|++|+|+ .+++ .+....+|+.|++++|.++.
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCc
Confidence 34555555555555555321 223444555555555555555 3332 22233345555555555553
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.42 E-value=6.7e-07 Score=86.41 Aligned_cols=95 Identities=28% Similarity=0.411 Sum_probs=71.6
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCcccCCccccCCCCcchhhc
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGEIPDSLGDLGNLNYLRL 153 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 153 (540)
.+++.|+|++|+|+ .+|..+ .+|+.|++++|+++ .+++ + .+.|++|+|++|.++ .+|. ++.+++|+.|++
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l 127 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDV 127 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-h--ccccccccccccccc-cccc-hhhhccceeecc
Confidence 47999999999999 778654 57899999999998 5553 2 146999999999999 7885 688999999999
Q ss_pred cCccCCCCCCccccCCccccEEecccCcc
Q 009208 154 NNNSLTGSCPESLSKIESLTLVDLSYNNL 182 (540)
Q Consensus 154 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 182 (540)
++|.+.. .|... ..+..+.+..+..
T Consensus 128 ~~~~~~~-~~~~~---~~l~~l~~~~~~~ 152 (353)
T d1jl5a_ 128 DNNSLKK-LPDLP---PSLEFIAAGNNQL 152 (353)
T ss_dssp CSSCCSC-CCCCC---TTCCEEECCSSCC
T ss_pred ccccccc-ccccc---ccccchhhccccc
Confidence 9999883 33322 3334444444433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.39 E-value=5.8e-07 Score=83.46 Aligned_cols=149 Identities=13% Similarity=0.074 Sum_probs=97.1
Q ss_pred HHHHHHhcCCCcCCeeeeccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhccc-CCCccceeEEEecCCe
Q 009208 294 KELRAATSNFSAKNILGRGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAV-HRNLLRLCGFCSTENE 372 (540)
Q Consensus 294 ~~l~~~~~~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 372 (540)
.++....+.|...+..+-++.+.||+... +++.+.+|+...... .....+.+|...+..+. +--+.+++.+...++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 34555556676555444344568999875 566677888654321 11224677888776653 3335677788888888
Q ss_pred eEEEEecCCCCChhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 009208 373 RLLVYPYMPNGSVASRLRDHIHGRPALDWARRKRIALGTARGLLYLHEQC------------------------------ 422 (540)
Q Consensus 373 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------ 422 (540)
.++||+++++.++.+..... - ....++.++++.++.||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred eEEEEEeccccccccccccc------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 99999999998775543210 1 12334555666666666421
Q ss_pred --------------------------CCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 423 --------------------------DPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 423 --------------------------~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
.+.++|+|+.|.||++++++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987666799999875
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.39 E-value=5.2e-09 Score=105.68 Aligned_cols=110 Identities=24% Similarity=0.298 Sum_probs=86.6
Q ss_pred cEEEecCCCCCCccc-cCccccCCCccCEEEcccCCCCC----CCCcccCCCCcccEEEeeCCCCccc----CCcccc-C
Q 009208 75 YVSALGLPSQSLSGT-LSPWIGNLTKLQSVLLQNNAILG----PIPASLGKLEKLQTLDLSNNKFTGE----IPDSLG-D 144 (540)
Q Consensus 75 ~l~~l~l~~~~l~~~-~~~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~----~p~~~~-~ 144 (540)
+|+.||++.|++++. +...+..+++|+.|+|++|.|+. .++..+..+++|++|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 689999999999863 24456678999999999999873 2345577899999999999999621 222332 2
Q ss_pred CCCcchhhccCccCCCC----CCccccCCccccEEecccCcccc
Q 009208 145 LGNLNYLRLNNNSLTGS----CPESLSKIESLTLVDLSYNNLSG 184 (540)
Q Consensus 145 l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 184 (540)
..+|++|+|++|++++. ++..+..+++|++|++++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 35899999999999743 45678889999999999999874
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.38 E-value=3.6e-08 Score=84.87 Aligned_cols=106 Identities=23% Similarity=0.158 Sum_probs=75.4
Q ss_pred EEEecCCCCCCccccCccccCCCccCEEEcccCCCCCCCCcccCCCCcccEEEeeCCCCccc--CCccccCCCCcchhhc
Q 009208 76 VSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNNAILGPIPASLGKLEKLQTLDLSNNKFTGE--IPDSLGDLGNLNYLRL 153 (540)
Q Consensus 76 l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~--~p~~~~~l~~L~~L~l 153 (540)
...|++++.... +.+..+..+..+++.+|... .++..+.++++|++|+||+|+|+.. ++..+..+++|+.|+|
T Consensus 24 ~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~L 98 (162)
T d1koha1 24 QQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 98 (162)
T ss_dssp SCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCC
T ss_pred hCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccccc
Confidence 345666655432 23445555666666666554 4555566799999999999999942 2345778999999999
Q ss_pred cCccCCCCCCc-cccCCccccEEecccCcccccCC
Q 009208 154 NNNSLTGSCPE-SLSKIESLTLVDLSYNNLSGSLP 187 (540)
Q Consensus 154 ~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p 187 (540)
++|+|+ .+++ .+....+|+.|++++|+++....
T Consensus 99 s~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 99 SGNELK-SERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp TTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred ccCccc-cchhhhhhhccccceeecCCCCcCcCcc
Confidence 999999 4443 33445679999999999986544
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.12 E-value=8.8e-08 Score=93.17 Aligned_cols=127 Identities=22% Similarity=0.275 Sum_probs=89.0
Q ss_pred CcEEEecCCCCCCcc----ccCccccCCCccCEEEcccCCCCCC-----CCcccCCCCcccEEEeeCCCCccc----CCc
Q 009208 74 GYVSALGLPSQSLSG----TLSPWIGNLTKLQSVLLQNNAILGP-----IPASLGKLEKLQTLDLSNNKFTGE----IPD 140 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~-----~p~~~~~l~~L~~L~ls~N~l~~~----~p~ 140 (540)
..++.+++++|.++. .+...+...++|+.|+|++|+++.. +...+..+++|+.|+|++|.|+.. +..
T Consensus 158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~ 237 (344)
T d2ca6a1 158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237 (344)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence 468888888888763 2344566778899999999988731 334567788899999999988632 445
Q ss_pred cccCCCCcchhhccCccCCCC----CCcccc--CCccccEEecccCccccc------------CCCCCcccccccCCCCC
Q 009208 141 SLGDLGNLNYLRLNNNSLTGS----CPESLS--KIESLTLVDLSYNNLSGS------------LPKISARTFKVTGNPLI 202 (540)
Q Consensus 141 ~~~~l~~L~~L~l~~N~l~~~----~p~~~~--~l~~L~~L~l~~N~l~~~------------~p~~~~~~~~~~~n~~~ 202 (540)
.+..+++|++|+|++|.|++. +-..+. ..++|+.|++++|+|+.. .|. .+.++++||.+.
T Consensus 238 ~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~--L~~L~l~~N~~~ 315 (344)
T d2ca6a1 238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD--LLFLELNGNRFS 315 (344)
T ss_dssp HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTT--CCEEECTTSBSC
T ss_pred cccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCC--CCEEECCCCcCC
Confidence 677888999999999988743 212222 235788999999988631 122 256778888774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.08 E-value=7.7e-06 Score=75.18 Aligned_cols=130 Identities=16% Similarity=0.099 Sum_probs=84.9
Q ss_pred eeeeccC-ccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccC--CCccceeEEEecCCeeEEEEecCCCCC
Q 009208 308 ILGRGGF-GIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVH--RNLLRLCGFCSTENERLLVYPYMPNGS 384 (540)
Q Consensus 308 ~lG~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lV~e~~~~gs 384 (540)
.+..|.. +.||+...+++..+.+|....... ..+..|.+.++.+.. -.+.+++.+...++..++||+|++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 3444554 578999988888889998654432 235677777766543 235567788888888999999998876
Q ss_pred hhhhccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 009208 385 VASRLRDHIHGRPALDWARRKRIALGTARGLLYLHE-------------------------------------------- 420 (540)
Q Consensus 385 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-------------------------------------------- 420 (540)
+.+.- .. ....+.++++.|.-||+
T Consensus 93 ~~~~~---------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 93 LLSSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp TTTSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred ccccc---------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 54321 00 01112233333333332
Q ss_pred -------c----CCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 421 -------Q----CDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 421 -------~----~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
. ..+.++|+|+.|.||+++++..+-|+||+.+.
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 11248999999999999987667899999875
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.00 E-value=5.3e-07 Score=85.02 Aligned_cols=111 Identities=20% Similarity=0.245 Sum_probs=75.6
Q ss_pred CcEEEecCCCCCCccccCccccCCCccCEEEcccC-CCCCC-CCcccCCCCcccEEEeeCC-CCcc--------------
Q 009208 74 GYVSALGLPSQSLSGTLSPWIGNLTKLQSVLLQNN-AILGP-IPASLGKLEKLQTLDLSNN-KFTG-------------- 136 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~~L~ls~N-~l~~-------------- 136 (540)
.+++.|+|+++.+++..+..++++++|++|+|+++ .++.. +..-+.++++|++|+|+++ +++.
T Consensus 71 ~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L 150 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 150 (284)
T ss_dssp CCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred CCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccccccc
Confidence 36778888888777777777777888888888774 55421 1112345677777777764 2320
Q ss_pred ---------------cCCccccCCCCcchhhccCc-cCCCCCCccccCCccccEEecccC-cccc
Q 009208 137 ---------------EIPDSLGDLGNLNYLRLNNN-SLTGSCPESLSKIESLTLVDLSYN-NLSG 184 (540)
Q Consensus 137 ---------------~~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N-~l~~ 184 (540)
.+...+.++++|++|++++| .+++.....+.++++|++|+++++ .+++
T Consensus 151 ~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~ 215 (284)
T d2astb2 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP 215 (284)
T ss_dssp CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCG
T ss_pred chhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCCh
Confidence 01112245789999999986 577777778899999999999994 6764
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.98 E-value=2.3e-07 Score=90.07 Aligned_cols=128 Identities=20% Similarity=0.227 Sum_probs=91.3
Q ss_pred CcEEEecCCCCCCc--c--cc---------CccccCCCccCEEEcccCCCCCC----CCcccCCCCcccEEEeeCCCCcc
Q 009208 74 GYVSALGLPSQSLS--G--TL---------SPWIGNLTKLQSVLLQNNAILGP----IPASLGKLEKLQTLDLSNNKFTG 136 (540)
Q Consensus 74 ~~l~~l~l~~~~l~--~--~~---------~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~ 136 (540)
..++.|++++|.+. + .+ .......+.|+.|++++|.++.. +...+...+.|++|+|++|+|+.
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 200 (344)
T d2ca6a1 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccc
Confidence 47899999999862 1 11 11224567899999999988732 22335567899999999999873
Q ss_pred c-----CCccccCCCCcchhhccCccCCCC----CCccccCCccccEEecccCccccc-----------CCCCCcccccc
Q 009208 137 E-----IPDSLGDLGNLNYLRLNNNSLTGS----CPESLSKIESLTLVDLSYNNLSGS-----------LPKISARTFKV 196 (540)
Q Consensus 137 ~-----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~-----------~p~~~~~~~~~ 196 (540)
. +...+..+++|+.|+|++|.++.. +...+..+++|+.|+|++|+|++. .+....+.+++
T Consensus 201 ~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~l 280 (344)
T d2ca6a1 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 280 (344)
T ss_dssp HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEEC
T ss_pred cccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEEC
Confidence 2 344577789999999999998632 445677889999999999998742 12223356788
Q ss_pred cCCCC
Q 009208 197 TGNPL 201 (540)
Q Consensus 197 ~~n~~ 201 (540)
++|.+
T Consensus 281 s~N~i 285 (344)
T d2ca6a1 281 QYNEI 285 (344)
T ss_dssp CSSCC
T ss_pred CCCcC
Confidence 88865
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.86 E-value=3.2e-07 Score=92.06 Aligned_cols=111 Identities=23% Similarity=0.244 Sum_probs=80.2
Q ss_pred CcEEEecCCCCCCccccCcc----c-cCCCccCEEEcccCCCCCCCCc----ccCCCCcccEEEeeCCCCccc----CCc
Q 009208 74 GYVSALGLPSQSLSGTLSPW----I-GNLTKLQSVLLQNNAILGPIPA----SLGKLEKLQTLDLSNNKFTGE----IPD 140 (540)
Q Consensus 74 ~~l~~l~l~~~~l~~~~~~~----~-~~l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~ls~N~l~~~----~p~ 140 (540)
..+..+++++|.++..-... + ...+.|+.+++++|.++..... .+...++|++|+|++|+|+.. ++.
T Consensus 283 ~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~ 362 (460)
T d1z7xw1 283 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 362 (460)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhh
Confidence 46888999999987432222 1 2346899999999988754222 334566899999999998742 444
Q ss_pred ccc-CCCCcchhhccCccCCC----CCCccccCCccccEEecccCcccc
Q 009208 141 SLG-DLGNLNYLRLNNNSLTG----SCPESLSKIESLTLVDLSYNNLSG 184 (540)
Q Consensus 141 ~~~-~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~ 184 (540)
.+. ..+.|++|+|++|+|+. .++..+..+++|++|++++|+|+.
T Consensus 363 ~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred hhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 443 46779999999999974 244556778899999999999874
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.71 E-value=2.3e-06 Score=73.56 Aligned_cols=109 Identities=17% Similarity=0.156 Sum_probs=69.9
Q ss_pred CcEEEecCCCC-CCccc----cCccccCCCccCEEEcccCCCCC----CCCcccCCCCcccEEEeeCCCCccc----CCc
Q 009208 74 GYVSALGLPSQ-SLSGT----LSPWIGNLTKLQSVLLQNNAILG----PIPASLGKLEKLQTLDLSNNKFTGE----IPD 140 (540)
Q Consensus 74 ~~l~~l~l~~~-~l~~~----~~~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~ls~N~l~~~----~p~ 140 (540)
..+++|+|+++ .++.. +-..+...++|+.|+|++|.+.. .+.+.+...+.|++|+|++|.|+.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 46888888864 45432 33456677788888888888763 2223445567788888888888732 223
Q ss_pred cccCCCCcchhhccCccCCCC-------CCccccCCccccEEecccCcc
Q 009208 141 SLGDLGNLNYLRLNNNSLTGS-------CPESLSKIESLTLVDLSYNNL 182 (540)
Q Consensus 141 ~~~~l~~L~~L~l~~N~l~~~-------~p~~~~~l~~L~~L~l~~N~l 182 (540)
.+...++|++|+|++|.+... +...+...++|+.|+++.+..
T Consensus 95 aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 455667788888888766521 233444567777777766543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.65 E-value=5.9e-05 Score=73.90 Aligned_cols=76 Identities=12% Similarity=0.073 Sum_probs=46.6
Q ss_pred CeeeeccCccEEEEEeCC-CcEEEEEEeccCC------ccccHHHHHHHHHHHhccc-C--CCccceeEEEecCCeeEEE
Q 009208 307 NILGRGGFGIVYKGCFSD-GALVAVKRLKDYN------IAGGEVQFQTEVETISLAV-H--RNLLRLCGFCSTENERLLV 376 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~------~~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~~~~~lV 376 (540)
+.||.|....||+....+ ++.|+||.-.... .+....+...|.+.+..+. + ..+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998754 6789999754311 1111223456777776552 2 234444443 45567899
Q ss_pred EecCCCCC
Q 009208 377 YPYMPNGS 384 (540)
Q Consensus 377 ~e~~~~gs 384 (540)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998753
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.57 E-value=8.6e-06 Score=76.37 Aligned_cols=107 Identities=14% Similarity=0.160 Sum_probs=81.1
Q ss_pred CcEEEecCCCC-CCcc-ccCccccC-CCccCEEEcccC--CCCCC-CCcccCCCCcccEEEeeCC-CCcccCCccccCCC
Q 009208 74 GYVSALGLPSQ-SLSG-TLSPWIGN-LTKLQSVLLQNN--AILGP-IPASLGKLEKLQTLDLSNN-KFTGEIPDSLGDLG 146 (540)
Q Consensus 74 ~~l~~l~l~~~-~l~~-~~~~~~~~-l~~L~~L~l~~N--~l~~~-~p~~~~~l~~L~~L~ls~N-~l~~~~p~~~~~l~ 146 (540)
.+++.|+++++ .++. .+...+.. .++|+.|++++. .++.. +...+.++++|++|+|++| .+++..+..+.+++
T Consensus 121 ~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred HhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 47999999985 4543 22333433 478999999864 34421 2233456899999999986 58877888899999
Q ss_pred CcchhhccC-ccCCCCCCccccCCccccEEecccC
Q 009208 147 NLNYLRLNN-NSLTGSCPESLSKIESLTLVDLSYN 180 (540)
Q Consensus 147 ~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N 180 (540)
+|++|+|++ +.+++.....++++++|+.|+++++
T Consensus 201 ~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 999999999 5787666677889999999999987
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.31 E-value=1.4e-05 Score=68.39 Aligned_cols=89 Identities=16% Similarity=0.156 Sum_probs=66.9
Q ss_pred cCCCccCEEEcccC-CCCCC----CCcccCCCCcccEEEeeCCCCcc----cCCccccCCCCcchhhccCccCCCC----
Q 009208 95 GNLTKLQSVLLQNN-AILGP----IPASLGKLEKLQTLDLSNNKFTG----EIPDSLGDLGNLNYLRLNNNSLTGS---- 161 (540)
Q Consensus 95 ~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~---- 161 (540)
.+.++|++|+|+++ .++.. +-..+...+.|++|+|++|.+.. .+.+.+...+.|++|+|++|.++..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 45689999999974 56531 22356778899999999999973 2334456678999999999999742
Q ss_pred CCccccCCccccEEecccCccc
Q 009208 162 CPESLSKIESLTLVDLSYNNLS 183 (540)
Q Consensus 162 ~p~~~~~l~~L~~L~l~~N~l~ 183 (540)
+-..+...++|+.|++++|.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHhCCcCCEEECCCCcCC
Confidence 2335677789999999999765
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.11 E-value=0.00059 Score=64.70 Aligned_cols=136 Identities=15% Similarity=0.126 Sum_probs=78.4
Q ss_pred CccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCc--cceeE-----EEecCCeeEEEEecCCCCChh
Q 009208 314 FGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL--LRLCG-----FCSTENERLLVYPYMPNGSVA 386 (540)
Q Consensus 314 ~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI--v~l~~-----~~~~~~~~~lV~e~~~~gsL~ 386 (540)
--.||+...++|+.+++|..+... ....++..|.+.+..+....+ +..+. .....+..+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 458999999999999999987543 234567788888776643222 11111 223456778999999875322
Q ss_pred hh--------------cccc-----CCCCCCCCHHH-------------------HHHHHHHHHHHHHHHHh----cCCC
Q 009208 387 SR--------------LRDH-----IHGRPALDWAR-------------------RKRIALGTARGLLYLHE----QCDP 424 (540)
Q Consensus 387 ~~--------------l~~~-----~~~~~~l~~~~-------------------~~~i~~~ia~~l~~LH~----~~~~ 424 (540)
.. ++.. .......++.. +..+...+.+.++.+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 10 1110 01111222211 11122222333333322 2245
Q ss_pred CeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 425 KIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 425 ~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
++||+|+.+.|||++++ ..++||+-+.
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eeecCCCCcccEEEeCC--ceEEechhcc
Confidence 78999999999999754 5689999875
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.05 E-value=2e-05 Score=67.36 Aligned_cols=109 Identities=13% Similarity=0.159 Sum_probs=75.3
Q ss_pred CcEEEecCCC-CCCcc----ccCccccCCCccCEEEcccCCCCCC----CCcccCCCCcccEEEeeCCCCccc----CCc
Q 009208 74 GYVSALGLPS-QSLSG----TLSPWIGNLTKLQSVLLQNNAILGP----IPASLGKLEKLQTLDLSNNKFTGE----IPD 140 (540)
Q Consensus 74 ~~l~~l~l~~-~~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~----~p~ 140 (540)
..++.|+|++ +.++. .+-..+...++|++|+|++|.++.. +-+.+...++|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 4688888887 45653 2445566788999999999988742 223455678899999999988632 334
Q ss_pred cccCCCCcch--hhccCccCCC----CCCccccCCccccEEecccCcc
Q 009208 141 SLGDLGNLNY--LRLNNNSLTG----SCPESLSKIESLTLVDLSYNNL 182 (540)
Q Consensus 141 ~~~~l~~L~~--L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l 182 (540)
.+...++|+. |++++|.+.. .+...+...++|+.|+++.|+.
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 5667788876 4556677753 2444566778899998877654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.48 E-value=0.0086 Score=57.95 Aligned_cols=73 Identities=18% Similarity=0.241 Sum_probs=48.1
Q ss_pred CeeeeccCccEEEEEeCC--------CcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCc-cceeEEEecCCeeEEEE
Q 009208 307 NILGRGGFGIVYKGCFSD--------GALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNL-LRLCGFCSTENERLLVY 377 (540)
Q Consensus 307 ~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lV~ 377 (540)
+.|+.|-.-.+|+....+ .+.|.+++.-. ........+|.++++.+.-.++ .++++++.. .+|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~---~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN---PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS---CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC---cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 567778888999998754 34577776542 1223455678888887753344 466676632 6899
Q ss_pred ecCCCCChh
Q 009208 378 PYMPNGSVA 386 (540)
Q Consensus 378 e~~~~gsL~ 386 (540)
||+++.++.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999875443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.23 E-value=0.014 Score=54.28 Aligned_cols=159 Identities=10% Similarity=-0.003 Sum_probs=82.3
Q ss_pred cCHHHHHHHhcCCCcCCeee-----eccCccEEEEEeCCCcEEEEEEeccCCccccHHHHHHHHHHHhcccCCCcc--ce
Q 009208 291 YTFKELRAATSNFSAKNILG-----RGGFGIVYKGCFSDGALVAVKRLKDYNIAGGEVQFQTEVETISLAVHRNLL--RL 363 (540)
Q Consensus 291 ~~~~~l~~~~~~~~~~~~lG-----~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv--~l 363 (540)
.+.+|+.....+|.+.+... .|---+.|+.+..+|+ +++|++.... .. .+...|++++..+.+.++. ..
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-~~--~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV-EK--NDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----C--CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC-CH--HHHHHHHHHHHhhhhcccccccc
Confidence 45677777888887765543 4545678999886654 8899876432 11 2344456666555322221 11
Q ss_pred eE------EEecCCeeEEEEecCCCCChhhhc--------------ccc---CCCC---CC-CCH---------------
Q 009208 364 CG------FCSTENERLLVYPYMPNGSVASRL--------------RDH---IHGR---PA-LDW--------------- 401 (540)
Q Consensus 364 ~~------~~~~~~~~~lV~e~~~~gsL~~~l--------------~~~---~~~~---~~-l~~--------------- 401 (540)
+. +....+....++.+..+......- +.. .... .. ..+
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 11 122345566777777664322110 000 0000 00 000
Q ss_pred -HHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCceeeCCCCCeEEccccccc
Q 009208 402 -ARRKRIALGTARGLLYLHE-QCDPKIIHRDVKAANILLDEDFEAVVGDFGLAK 453 (540)
Q Consensus 402 -~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~Dfgla~ 453 (540)
......+......+.-.+. ....++||+|+.+.||+++.+...-|+||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0011122222222222221 234489999999999999988777899999875
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.78 E-value=0.00024 Score=60.28 Aligned_cols=94 Identities=21% Similarity=0.232 Sum_probs=65.8
Q ss_pred cCccccCCCccCEEEccc-CCCCCC----CCcccCCCCcccEEEeeCCCCccc----CCccccCCCCcchhhccCccCCC
Q 009208 90 LSPWIGNLTKLQSVLLQN-NAILGP----IPASLGKLEKLQTLDLSNNKFTGE----IPDSLGDLGNLNYLRLNNNSLTG 160 (540)
Q Consensus 90 ~~~~~~~l~~L~~L~l~~-N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 160 (540)
+.....+.++|++|+|++ |.++.. +-..+...++|++|+|++|+++.. +-..+...++|+.|++++|.++.
T Consensus 9 l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~ 88 (166)
T d1io0a_ 9 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 88 (166)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence 333445678999999997 556521 223456788999999999998743 22345667899999999999864
Q ss_pred C----CCccccCCccccEEec--ccCccc
Q 009208 161 S----CPESLSKIESLTLVDL--SYNNLS 183 (540)
Q Consensus 161 ~----~p~~~~~l~~L~~L~l--~~N~l~ 183 (540)
. +-..+...++|+.++| ++|++.
T Consensus 89 ~g~~~l~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 89 SGILALVEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred hhHHHHHHHHHhCccccEEeeccCCCcCc
Confidence 2 3345677788887555 566665
|